1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_1	[p1l1517t81r1844b105],
2	2006	CD	DATE	2006	num	1	SENT_1	[p1l1857t81r2116b110],
3	;	:	O	;	_	0	SENT_1	[p1l1857t81r2116b110],
4	130:55	CD	NUMBER	130:55	number	5	SENT_1	[p1l1857t81r2116b110],
5	—	CD	NUMBER	—	num	6	SENT_1	[p1l1857t81r2116b110],
6	64	CD	NUMBER	64	dep	1	SENT_1	[p1l1857t81r2116b110],

1	Marked	JJ	O	marked	amod	3	SENT_2	[p1l47t186r282b237],
2	Interindividual	JJ	O	interindividual	amod	3	SENT_2	[p1l317t186r764b238],
3	Variability	NN	O	variability	_	0	SENT_2	[p1l794t186r1111b250],
4	in	IN	O	in	_	0	SENT_2	[p1l1141t186r1190b237],
5	the	DT	O	the	det	6	SENT_2	[p1l1221t186r1322b238],
6	Response	NN	O	response	prep_in	3	SENT_2	[p1l1355t186r1662b249],
7	to	TO	O	to	_	0	SENT_2	[p1l1691t189r1751b238],
8	Selective	JJ	O	selective	amod	9	SENT_2	[p1l1779t185r2066b238],
9	Inhibitors	NNS	O	inhibitor	prep_to	6	SENT_2	[p1l47t265r341b317],
10	of	IN	O	of	_	0	SENT_2	[p1l370t264r430b317],
11	Cyclooxygenase-2	NN	O	cyclooxygenase-2	prep_of	3	SENT_2	[p1l458t264r1023b329],

1	SUSANNE	NNP	PERSON	SUSANNE	nn	2	SENT_3	[p1l43t404r238b437],
2	FR	NN	O	fr	_	0	SENT_3	[p1l266t404r415b442],
3	|	CD	NUMBER	|	num	4	SENT_3	[p1l266t404r415b442],
4	ES	NN	O	e	dep	2	SENT_3	[p1l266t404r415b442],
5	,	,	O	,	_	0	SENT_3	[p1l266t404r415b442],
6	*	CD	NUMBER	*	appos	4	SENT_3	[p1l266t404r415b442],
7	TILO	NNP	O	TILO	nn	11	SENT_3	[p1l443t404r528b437],
8	GROSSER	NNP	O	GROSSER	nn	11	SENT_3	[p1l556t404r790b442],
9	,	,	O	,	_	0	SENT_3	[p1l556t404r790b442],
10	*	NNP	O	*	appos	11	SENT_3	[p1l556t404r790b442],
11	THOMAS	NNP	O	THOMAS	dep	6	SENT_3	[p1l818t404r991b437],
12	8	CD	NUMBER	8	num	11	SENT_3	[p1l1017t404r1054b437],
13	.	.	O	.	_	0	SENT_3	[p1l1017t404r1054b437],

1	PRICE	NN	O	price	dep	24	SENT_4	[p1l1083t404r1237b442],
2	,	,	O	,	_	0	SENT_4	[p1l1083t404r1237b442],
3	*	CD	NUMBER	*	num	6	SENT_4	[p1l1083t404r1237b442],
4	JOHN	NNP	PERSON	JOHN	nn	6	SENT_4	[p1l1265t404r1371b437],
5	A.	NN	PERSON	a.	nn	6	SENT_4	[p1l1397t405r1432b436],
6	LAWSON	NNP	PERSON	LAWSON	appos	1	SENT_4	[p1l1463t404r1671b442],
7	,	,	O	,	_	0	SENT_4	[p1l1463t404r1671b442],
8	*	CD	NUMBER	*	num	10	SENT_4	[p1l1463t404r1671b442],
9	SHIV	NNP	O	SHIV	nn	10	SENT_4	[p1l1700t404r1794b437],
10	KAPOOR	NNP	LOCATION	KAPOOR	appos	1	SENT_4	[p1l1821t404r2023b442],
11	,	,	O	,	_	0	SENT_4	[p1l1821t404r2023b442],
12	*	CD	NUMBER	*	num	14	SENT_4	[p1l1821t404r2023b442],
13	SUSAN	NNP	PERSON	SUSAN	nn	14	SENT_4	[p1l43t462r180b495],
14	DEMARCO	NNP	PERSON	DEMARCO	appos	1	SENT_4	[p1l210t462r449b500],
15	,	,	O	,	_	0	SENT_4	[p1l210t462r449b500],
16	*	CD	NUMBER	*	num	19	SENT_4	[p1l210t462r449b500],
17	MATHEW	NNP	PERSON	MATHEW	nn	19	SENT_4	[p1l480t462r656b494],
18	T.	NNP	PERSON	T.	nn	19	SENT_4	[p1l679t462r712b494],
19	PLETCHER	NNP	PERSON	PLETCHER	appos	1	SENT_4	[p1l741t454r981b500],
20	,	,	O	,	_	0	SENT_4	[p1l741t454r981b500],
21	T	NN	O	t	nn	23	SENT_4	[p1l741t454r981b500],
22	TIM	NNP	O	TIM	nn	23	SENT_4	[p1l1007t462r1076b494],
23	W	NNP	O	W	appos	1	SENT_4	[p1l1102t454r1354b500],
24	|	VBD	O	|	_	0	SENT_4	[p1l1102t454r1354b500],
25	LTSH	NN	O	ltsh	dep	35	SENT_4	[p1l1102t454r1354b500],
26	|	CD	NUMBER	|	num	27	SENT_4	[p1l1102t454r1354b500],
27	RE	NN	O	re	dep	25	SENT_4	[p1l1102t454r1354b500],
28	,	,	O	,	_	0	SENT_4	[p1l1102t454r1354b500],
29	T	NN	O	t	dep	25	SENT_4	[p1l1102t454r1354b500],
30	and	CC	O	and	_	0	SENT_4	[p1l1382t462r1451b495],
31	GARRET	NNP	O	GARRET	nn	32	SENT_4	[p1l1479t462r1638b495],
32	A.	NNP	O	A.	dep	25	SENT_4	[p1l1661t462r1696b494],
33	F	NN	O	f	dep	35	SENT_4	[p1l1727t462r1991b495],
34	|	CD	NUMBER	|	num	33	SENT_4	[p1l1727t462r1991b495],
35	TZGERALD	NN	O	tzgerald	dep	24	SENT_4	[p1l1727t462r1991b495],
36	*	CD	NUMBER	*	number	37	SENT_4	[p1l1727t462r1991b495],
37	*	CD	NUMBER	*	dep	35	SENT_4	[p1l45t521r113b545],
38	The	DT	O	the	det	39	SENT_4	[p1l45t521r113b545],
39	Institute	NNP	ORGANIZATION	Institute	dep	37	SENT_4	[p1l128t521r244b545],
40	for	IN	ORGANIZATION	for	_	0	SENT_4	[p1l256t521r295b545],
41	Translational	JJ	ORGANIZATION	translational	amod	42	SENT_4	[p1l306t521r491b545],
42	Medicine	NN	ORGANIZATION	medicine	prep_for	24	SENT_4	[p1l507t521r634b545],
43	and	CC	O	and	_	0	SENT_4	[p1l648t521r699b545],
44	Therapeutics	NNS	O	therapeutics	conj_and	42	SENT_4	[p1l712t521r906b550],
45	,	,	O	,	_	0	SENT_4	[p1l712t521r906b550],
46	University	NNP	ORGANIZATION	University	prep_for	24	SENT_4	[p1l923t521r1061b550],
47	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l1073t521r1101b545],
48	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	52	SENT_4	[p1l1113t521r1307b550],
49	,	,	O	,	_	0	SENT_4	[p1l1113t521r1307b550],
50	Philadelphia	NNP	LOCATION	Philadelphia	appos	52	SENT_4	[p1l1323t521r1505b550],
51	,	,	O	,	_	0	SENT_4	[p1l1323t521r1505b550],
52	Pennsylvania	NNP	LOCATION	Pennsylvania	prep_of	46	SENT_4	[p1l1520t521r1715b550],
53	,	,	O	,	_	0	SENT_4	[p1l1520t521r1715b550],
54	and	CC	O	and	_	0	SENT_4	[p1l1730t521r1780b545],
55	*	CD	NUMBER	*	prep_for	24	SENT_4	[p1l1795t516r1860b545],
56	The	DT	O	the	det	58	SENT_4	[p1l1795t516r1860b545],
57	Genomics	NNP	ORGANIZATION	Genomics	nn	58	SENT_4	[p1l1874t521r2015b545],
58	Institute	NNP	ORGANIZATION	Institute	dep	55	SENT_4	[p1l18t576r266b626],
59	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l295t576r355b626],
60	the	DT	ORGANIZATION	the	det	62	SENT_4	[p1l376t576r473b626],
61	Novartis	NNP	ORGANIZATION	Novartis	nn	62	SENT_4	[p1l505t576r752b626],
62	Foundation	NNP	ORGANIZATION	Foundation	prep_of	58	SENT_4	[p1l784t576r1138b635],
63	,	,	O	,	_	0	SENT_4	[p1l784t576r1138b635],
64	San	NNP	LOCATION	San	nn	65	SENT_4	[p1l1171t576r1284b626],
65	Diego	NNP	LOCATION	Diego	appos	62	SENT_4	[p1l1318t576r1505b639],
66	,	,	O	,	_	0	SENT_4	[p1l1318t576r1505b639],
67	California	NNP	LOCATION	California	nsubj	24	SENT_4	[p1l1537t576r1825b626],

1	Background	NN	O	background	_	0	SENT_5	[p1l15t800r789b882],
2	&	CC	O	&	_	0	SENT_5	[p1l15t800r789b882],
3	Aims	NNS	O	aim	conj_and	1	SENT_5	[p1l15t800r789b882],
4	:	:	O	:	_	0	SENT_5	[p1l15t800r789b882],
5	Variability	NN	O	variability	nsubj	11	SENT_5	[p1l847t802r1224b877],
6	in	IN	O	in	_	0	SENT_5	[p1l1285t802r1344b862],
7	response	NN	O	response	prep_in	5	SENT_5	[p1l1411t816r1750b876],
8	to	TO	O	to	_	0	SENT_5	[p1l1809t805r1881b862],
9	drugs	NNS	O	drug	prep_to	7	SENT_5	[p1l1942t802r2150b877],
10	may	MD	O	may	aux	11	SENT_5	[p1l17t924r177b985],
11	influence	VB	O	influence	dep	1	SENT_5	[p1l209t909r550b970],
12	both	DT	O	both	preconj	13	SENT_5	[p1l584t909r745b970],
13	efficacy	NN	O	efficacy	dobj	11	SENT_5	[p1l780t908r1071b985],
14	and	CC	O	and	_	0	SENT_5	[p1l1100t909r1236b970],
15	safety	NN	O	safety	conj_and	13	SENT_5	[p1l1268t908r1517b985],
16	.	.	O	.	_	0	SENT_5	[p1l1268t908r1517b985],

1	Cyclooxygenase	NNP	MISC	Cyclooxygenase	nsubj	7	SENT_6	[p1l1551t909r2149b985],
2	(	CD	NUMBER	(	num	6	SENT_6	[p1l15t1015r296b1091],
3	COX	NNP	O	COX	nn	6	SENT_6	[p1l15t1015r296b1091],
4	)	CD	NUMBER	)	num	6	SENT_6	[p1l15t1015r296b1091],
5	-2	CD	NUMBER	-2	num	6	SENT_6	[p1l15t1015r296b1091],
6	inhibitors	NNS	O	inhibitor	dep	1	SENT_6	[p1l341t1016r689b1077],
7	pose	VBP	O	pose	_	0	SENT_6	[p1l731t1031r905b1091],
8	a	DT	O	a	det	10	SENT_6	[p1l946t1031r987b1077],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_6	[p1l1029t1016r1579b1077],
10	risk	NN	O	risk	dobj	7	SENT_6	[p1l1620t1016r1753b1077],
11	by	IN	O	by	_	0	SENT_6	[p1l1794t1016r1876b1092],
12	potentially	RB	O	potentially	advmod	13	SENT_6	[p1l1917t1019r2152b1091, p1l13t1123r193b1198],
13	increasing	VBG	O	increase	prepc_by	7	SENT_6	[p1l230t1123r617b1198],
14	the	DT	O	the	det	15	SENT_6	[p1l649t1123r769b1183],
15	likelihood	NN	O	likelihood	dobj	13	SENT_6	[p1l808t1123r1169b1183],
16	of	IN	O	of	_	0	SENT_6	[p1l1209t1122r1280b1183],
17	thrombosis	NN	O	thrombosis	prep_of	15	SENT_6	[p1l1313t1123r1758b1195],
18	,	,	O	,	_	0	SENT_6	[p1l1313t1123r1758b1195],
19	hypertension	NN	O	hypertension	conj_and	17	SENT_6	[p1l1800t1123r2152b1198, p1l12t1230r186b1303],
20	,	,	O	,	_	0	SENT_6	[p1l1800t1123r2152b1198, p1l12t1230r186b1303],
21	and	CC	O	and	_	0	SENT_6	[p1l228t1230r365b1291],
22	atherogenesis	NN	O	atherogenesis	prep_of	15	SENT_6	[p1l407t1230r961b1306],
23	.	.	O	.	_	0	SENT_6	[p1l407t1230r961b1306],

1	Differences	NNS	O	difference	nsubjpass	12	SENT_7	[p1l1006t1229r1435b1291],
2	between	IN	O	between	_	0	SENT_7	[p1l1477t1230r1793b1291],
3	individuals	NNS	O	individual	prep_between	1	SENT_7	[p1l1839t1230r2152b1291, p1l15t1337r121b1398],
4	in	IN	O	in	_	0	SENT_7	[p1l191t1337r249b1397],
5	the	DT	O	the	det	6	SENT_7	[p1l318t1337r438b1398],
6	response	NN	O	response	prep_in	3	SENT_7	[p1l510t1351r849b1412],
7	to	TO	O	to	_	0	SENT_7	[p1l915t1340r987b1398],
8	COX-2	NN	MISC	cox-2	nn	9	SENT_7	[p1l1056t1336r1282b1398],
9	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_7	[p1l1355t1337r1703b1398],
10	would	MD	O	would	aux	12	SENT_7	[p1l1768t1337r1989b1398],
11	be	VB	O	be	auxpass	12	SENT_7	[p1l2063t1337r2149b1398],
12	expected	VBN	O	expect	_	0	SENT_7	[p1l15t1444r352b1519],
13	to	TO	O	to	aux	14	SENT_7	[p1l383t1447r455b1505],
14	influence	VB	O	influence	xcomp	12	SENT_7	[p1l487t1443r829b1504],
15	their	PRP$	O	they	poss	16	SENT_7	[p1l856t1444r1030b1504],
16	susceptibility	NN	O	susceptibility	dobj	14	SENT_7	[p1l1055t1444r1552b1519],
17	to	TO	O	to	_	0	SENT_7	[p1l1577t1447r1649b1504],
18	cardiovascular	JJ	O	cardiovascular	amod	19	SENT_7	[p1l1679t1444r2152b1504, p1l17t1551r111b1612],
19	complications	NNS	O	complication	prep_to	14	SENT_7	[p1l136t1551r684b1626],
20	.	.	O	.	_	0	SENT_7	[p1l136t1551r684b1626],

1	We	PRP	O	we	nsubj	2	SENT_8	[p1l713t1551r834b1612],
2	examined	VBD	O	examine	_	0	SENT_8	[p1l863t1551r1231b1612],
3	the	DT	O	the	det	4	SENT_8	[p1l1260t1551r1380b1612],
4	variability	NN	O	variability	dobj	2	SENT_8	[p1l1405t1551r1773b1627],
5	in	IN	O	in	_	0	SENT_8	[p1l1801t1551r1860b1611],
6	degree	NN	O	degree	prep_in	2	SENT_8	[p1l1891t1551r2149b1627],
7	and	CC	O	and	_	0	SENT_8	[p1l15t1658r151b1719],
8	selectivity	NN	O	selectivity	prep_in	2	SENT_8	[p1l207t1658r584b1734],
9	of	IN	O	of	_	0	SENT_8	[p1l638t1657r709b1719],
10	COX-2	NN	O	cox-2	nn	11	SENT_8	[p1l764t1657r990b1719],
11	inhibition	NN	O	inhibition	prep_of	6	SENT_8	[p1l1051t1658r1395b1719],
12	in	IN	O	in	_	0	SENT_8	[p1l1457t1658r1516b1718],
13	humans	NNS	O	human	prep_in	11	SENT_8	[p1l1577t1658r1881b1719],
14	in	IN	O	in	_	0	SENT_8	[p1l1939t1658r1997b1718],
15	response	NN	O	response	prep_in	13	SENT_8	[p1l2060t1672r2152b1719, p1l12t1779r280b1839],
16	to	TO	O	to	_	0	SENT_8	[p1l352t1768r424b1825],
17	celecoxib	NN	O	celecoxib	prep_to	2	SENT_8	[p1l498t1765r847b1825],
18	and	CC	O	and	_	0	SENT_8	[p1l920t1765r1056b1825],
19	rofecoxib	NN	O	rofecoxib	conj_and	17	SENT_8	[p1l1135t1764r1496b1825],
20	.	.	O	.	_	0	SENT_8	[p1l1135t1764r1496b1825],

1	Methods	NNS	O	method	_	0	SENT_9	[p1l1572t1765r1918b1826],
2	:	:	O	:	_	0	SENT_9	[p1l1572t1765r1918b1826],
3	Fifty	CD	NUMBER	fifty	num	5	SENT_9	[p1l1995t1764r2151b1840],
4	healthy	JJ	O	healthy	amod	5	SENT_9	[p1l17t1872r293b1948],
5	volunteers	NNS	O	volunteer	nsubj	6	SENT_9	[p1l321t1872r716b1933],
6	received	VBD	O	receive	dep	1	SENT_9	[p1l750t1872r1060b1933],
7	placebo	NN	O	placebo	nsubj	22	SENT_9	[p1l1098t1872r1411b1947],
8	,	,	O	,	_	0	SENT_9	[p1l1098t1872r1411b1947],
9	rofecoxib	NN	O	rofecoxib	appos	7	SENT_9	[p1l1449t1871r1791b1933],
10	(	CD	NUMBER	(	number	11	SENT_9	[p1l1824t1871r1950b1947],
11	25	CD	NUMBER	25	num	13	SENT_9	[p1l1824t1871r1950b1947],
12	mg	NN	O	mg	nn	13	SENT_9	[p1l1985t1872r2147b1948],
13	)	NN	O	)	dep	9	SENT_9	[p1l1985t1872r2147b1948],
14	,	,	O	,	_	0	SENT_9	[p1l1985t1872r2147b1948],
15	and	CC	O	and	_	0	SENT_9	[p1l15t1979r151b2040],
16	celecoxib	NN	O	celecoxib	nn	17	SENT_9	[p1l200t1979r549b2040],
17	(	NN	O	(	appos	7	SENT_9	[p1l596t1978r774b2054],
18	200	CD	NUMBER	200	num	20	SENT_9	[p1l596t1978r774b2054],
19	mg	NN	O	mg	nn	20	SENT_9	[p1l823t1979r986b2055],
20	)	NN	O	)	dep	17	SENT_9	[p1l823t1979r986b2055],
21	,	,	O	,	_	0	SENT_9	[p1l823t1979r986b2055],
22	randomized	VBN	O	randomize	ccomp	6	SENT_9	[p1l1037t1979r1479b2040],
23	by	IN	O	by	_	0	SENT_9	[p1l1531t1979r1613b2055],
24	order	NN	O	order	prep_by	22	SENT_9	[p1l1657t1979r1872b2040],
25	.	.	O	.	_	0	SENT_9	[p1l1657t1979r1872b2040],

1	COX-1	NN	O	cox-1	nn	4	SENT_10	[p1l1922t1978r2151b2040],
2	and	CC	O	and	_	0	SENT_10	[p1l15t2086r151b2146],
3	COX-2	NN	MISC	cox-2	conj_and	1	SENT_10	[p1l188t2085r415b2146],
4	inhibition	NN	O	inhibition	nsubjpass	6	SENT_10	[p1l453t2086r797b2146],
5	was	VBD	O	be	auxpass	6	SENT_10	[p1l833t2100r981b2146],
6	determined	VBN	O	determine	_	0	SENT_10	[p1l1014t2086r1448b2147],
7	using	VBG	O	use	xcomp	6	SENT_10	[p1l1488t2086r1687b2161],
8	ex	FW	O	ex	nn	9	SENT_10	[p1l1719t2100r1802b2146],
9	vivo	FW	O	vivo	dobj	7	SENT_10	[p1l1831t2086r1976b2146],
10	and	CC	O	and	_	0	SENT_10	[p1l2011t2086r2147b2146],
11	in	FW	O	in	nn	12	SENT_10	[p1l17t2193r76b2253],
12	vivo	FW	O	vivo	advmod	13	SENT_10	[p1l112t2193r257b2254],
13	indices	NNS	O	index	conj_and	6	SENT_10	[p1l296t2193r557b2254],
14	of	IN	O	of	_	0	SENT_10	[p1l592t2192r663b2254],
15	enzymatic	JJ	O	enzymatic	amod	16	SENT_10	[p1l697t2193r1082b2269],
16	activity	NN	O	activity	prep_of	13	SENT_10	[p1l1117t2193r1400b2269],
17	.	.	O	.	_	0	SENT_10	[p1l1117t2193r1400b2269],

1	A	DT	O	a	det	2	SENT_11	[p1l1436t2193r1489b2253],
2	subset	NN	O	subset	nsubj	6	SENT_11	[p1l1521t2193r1770b2254],
3	of	IN	O	of	_	0	SENT_11	[p1l1805t2192r1877b2254],
4	5	CD	NUMBER	5	num	5	SENT_11	[p1l1911t2193r1958b2254],
5	individuals	NNS	O	individual	prep_of	2	SENT_11	[p1l1996t2193r2152b2254, p1l12t2300r278b2361],
6	underwent	VBD	O	undergo	_	0	SENT_11	[p1l318t2300r717b2361],
7	5	CD	NUMBER	5	nsubj	8	SENT_11	[p1l755t2300r802b2361],
8	replicate	VBP	O	replicate	ccomp	6	SENT_11	[p1l842t2300r1167b2375],
9	studies	NNS	O	study	nsubj	11	SENT_11	[p1l1203t2300r1475b2361],
10	to	TO	O	to	aux	11	SENT_11	[p1l1511t2303r1583b2361],
11	estimate	VB	O	estimate	xcomp	8	SENT_11	[p1l1621t2300r1955b2361],
12	variability	NN	O	variability	dobj	11	SENT_11	[p1l1991t2300r2152b2361, p1l15t2407r241b2482],
13	in	IN	O	in	_	0	SENT_11	[p1l283t2407r342b2467],
14	drug	NN	O	drug	nn	15	SENT_11	[p1l386t2407r555b2482],
15	response	NN	O	response	prep_in	12	SENT_11	[p1l597t2421r936b2482],
16	both	CC	O	both	preconj	11	SENT_11	[p1l980t2407r1141b2467],
17	within	IN	O	within	_	0	SENT_11	[p1l1184t2407r1408b2467],
18	and	CC	O	and	_	0	SENT_11	[p1l1452t2407r1588b2467],
19	between	IN	O	between	_	0	SENT_11	[p1l1635t2407r1952b2467],
20	subjects	NNS	O	subject	prep_between	11	SENT_11	[p1l1994t2407r2152b2467, p1l7t2514r208b2592],
21	.	.	O	.	_	0	SENT_11	[p1l1994t2407r2152b2467, p1l7t2514r208b2592],

1	Results	NNS	O	result	_	0	SENT_12	[p1l258t2514r557b2575],
2	:	:	O	:	_	0	SENT_12	[p1l258t2514r557b2575],
3	Despite	IN	O	despite	_	0	SENT_12	[p1l607t2514r890b2589],
4	the	DT	O	the	det	7	SENT_12	[p1l935t2514r1055b2575],
5	higher	JJR	O	higher	amod	7	SENT_12	[p1l1105t2514r1340b2590],
6	COX-2	NN	MISC	cox-2	nn	7	SENT_12	[p1l1385t2513r1612b2575],
7	selectivity	NN	O	selectivity	prep_despite	29	SENT_12	[p1l1658t2514r2034b2590],
8	of	IN	O	of	_	0	SENT_12	[p1l2079t2513r2151b2575],
9	rofecoxib	NN	O	rofecoxib	prep_of	7	SENT_12	[p1l18t2620r359b2682],
10	in	FW	O	in	nn	11	SENT_12	[p1l394t2621r452b2681],
11	vitro	FW	O	vitro	dep	9	SENT_12	[p1l486t2621r668b2694],
12	,	,	O	,	_	0	SENT_12	[p1l486t2621r668b2694],
13	the	DT	O	the	det	15	SENT_12	[p1l702t2621r822b2682],
14	average	JJ	O	average	amod	15	SENT_12	[p1l854t2628r1154b2697],
15	selectivity	NN	O	selectivity	nsubj	29	SENT_12	[p1l1185t2621r1561b2697],
16	attained	VBN	O	attain	partmod	15	SENT_12	[p1l1591t2621r1901b2682],
17	by	IN	O	by	_	0	SENT_12	[p1l1939t2621r2021b2697],
18	25	CD	NUMBER	25	num	20	SENT_12	[p1l2051t2620r2150b2682],
19	mg	NN	O	mg	nn	20	SENT_12	[p1l18t2734r136b2803],
20	rofecoxib	NN	O	rofecoxib	agent	16	SENT_12	[p1l181t2727r523b2788],
21	and	CC	O	and	_	0	SENT_12	[p1l568t2728r704b2788],
22	200	CD	NUMBER	200	num	24	SENT_12	[p1l753t2727r903b2788],
23	mg	NN	O	mg	nn	24	SENT_12	[p1l951t2734r1070b2803],
24	celecoxib	NN	O	celecoxib	conj_and	20	SENT_12	[p1l1112t2728r1462b2788],
25	in	FW	O	in	prep	24	SENT_12	[p1l1510t2728r1569b2788],
26	vivo	FW	O	vivo	pobj	25	SENT_12	[p1l1615t2728r1760b2788],
27	were	VBD	O	be	cop	29	SENT_12	[p1l1803t2742r1985b2788],
28	not	RB	O	not	neg	29	SENT_12	[p1l2033t2731r2150b2788],
29	different	JJ	O	different	dep	1	SENT_12	[p1l15t2834r355b2896],
30	.	.	O	.	_	0	SENT_12	[p1l15t2834r355b2896],

1	However	RB	O	however	advmod	4	SENT_13	[p1l392t2835r732b2908],
2	,	,	O	,	_	0	SENT_13	[p1l392t2835r732b2908],
3	there	EX	O	there	expl	4	SENT_13	[p1l764t2835r960b2896],
4	was	VBD	O	be	_	0	SENT_13	[p1l990t2850r1138b2896],
5	considerable	JJ	O	considerable	amod	6	SENT_13	[p1l1169t2835r1651b2896],
6	variability	NN	O	variability	nsubj	4	SENT_13	[p1l1681t2835r2049b2911],
7	at	IN	O	at	_	0	SENT_13	[p1l2078t2838r2150b2896],
8	an	DT	O	a	det	10	SENT_13	[p1l15t2957r102b3003],
9	individual	JJ	O	individual	amod	10	SENT_13	[p1l140t2942r496b3003],
10	level	NN	O	level	prep_at	6	SENT_13	[p1l532t2942r698b3003],
11	in	IN	O	in	_	0	SENT_13	[p1l735t2942r794b3002],
12	the	DT	O	the	det	13	SENT_13	[p1l826t2942r946b3003],
13	degree	NN	O	degree	prep_in	10	SENT_13	[p1l978t2942r1236b3018],
14	of	IN	O	of	_	0	SENT_13	[p1l1268t2941r1340b3003],
15	COX-2	NN	MISC	cox-2	nn	16	SENT_13	[p1l1370t2941r1596b3003],
16	inhibition	NN	O	inhibition	prep_of	13	SENT_13	[p1l1632t2942r1976b3003],
17	and	CC	O	and	_	0	SENT_13	[p1l2011t2942r2147b3003],
18	selectivity	NN	O	selectivity	prep_of	13	SENT_13	[p1l12t3049r389b3124],
19	attained	VBN	O	attain	partmod	10	SENT_13	[p1l435t3049r745b3109],
20	by	IN	O	by	prep	19	SENT_13	[p1l799t3049r880b3124],
21	both	CC	O	both	prep	19	SENT_13	[p1l930t3049r1091b3109],
22	drugs	NNS	O	drug	dep	21	SENT_13	[p1l1142t3049r1369b3124],
23	.	.	O	.	_	0	SENT_13	[p1l1142t3049r1369b3124],

1	Approximately	RB	O	approximately	quantmod	2	SENT_14	[p1l1417t3049r1966b3124],
2	one	CD	NUMBER	one	num	3	SENT_14	[p1l2013t3063r2149b3109],
3	third	JJ	ORDINAL	third	nsubj	8	SENT_14	[p1l13t3156r183b3217],
4	of	IN	O	of	_	0	SENT_14	[p1l233t3155r305b3217],
5	the	DT	O	the	det	6	SENT_14	[p1l349t3156r469b3217],
6	variability	NN	O	variability	prep_of	3	SENT_14	[p1l515t3156r883b3232],
7	was	VBD	O	be	cop	8	SENT_14	[p1l926t3171r1074b3217],
8	attributable	JJ	O	attributable	_	0	SENT_14	[p1l1122t3156r1563b3217],
9	to	TO	O	to	_	0	SENT_14	[p1l1609t3160r1681b3217],
10	differences	NNS	O	difference	prep_to	8	SENT_14	[p1l1729t3155r2150b3217],
11	between	IN	O	between	_	0	SENT_14	[p1l18t3263r334b3324],
12	individuals	NNS	O	individual	prep_between	10	SENT_14	[p1l378t3263r796b3336],
13	,	,	O	,	_	0	SENT_14	[p1l378t3263r796b3336],
14	suggesting	VBG	O	suggest	xcomp	8	SENT_14	[p1l835t3263r1248b3339],
15	the	DT	O	the	det	16	SENT_14	[p1l1282t3263r1401b3324],
16	contribution	NN	O	contribution	dobj	14	SENT_14	[p1l1440t3263r1890b3324],
17	of	IN	O	of	_	0	SENT_14	[p1l1932t3262r2003b3324],
18	genetic	JJ	O	genetic	amod	19	SENT_14	[p1l2038t3270r2152b3339, p1l18t3370r198b3430],
19	sources	NNS	O	source	prep_of	16	SENT_14	[p1l236t3384r528b3430],
20	of	IN	O	of	_	0	SENT_14	[p1l570t3369r641b3430],
21	variance	NN	O	variance	prep_of	19	SENT_14	[p1l680t3370r1019b3442],
22	,	,	O	,	_	0	SENT_14	[p1l680t3370r1019b3442],
23	such	JJ	O	such	_	0	SENT_14	[p1l1063t3370r1234b3430],
24	as	IN	O	as	_	0	SENT_14	[p1l1280t3384r1364b3430],
25	candidate	NN	O	candidate	nn	26	SENT_14	[p1l1406t3370r1780b3430],
26	polymorphisms	NNS	O	polymorphism	prep_such_as	16	SENT_14	[p1l1825t3370r2152b3445, p1l17t3477r286b3552],
27	detected	VBN	O	detect	partmod	26	SENT_14	[p1l336t3477r663b3538],
28	in	IN	O	in	_	0	SENT_14	[p1l719t3477r778b3537],
29	COX-1	NN	O	cox-1	prep_in	27	SENT_14	[p1l832t3476r1062b3538],
30	and	CC	O	and	_	0	SENT_14	[p1l1110t3477r1246b3538],
31	CYP2C9	NN	O	cyp2c9	prep_in	27	SENT_14	[p1l1299t3476r1622b3538],
32	.	.	O	.	_	0	SENT_14	[p1l1299t3476r1622b3538],

1	Conclusions	NNS	O	conclusion	_	0	SENT_15	[p1l1677t3476r2149b3539],
2	:	:	O	:	_	0	SENT_15	[p1l1677t3476r2149b3539],
3	The	DT	O	the	det	5	SENT_15	[p1l11t3584r147b3645],
4	actual	JJ	O	actual	amod	5	SENT_15	[p1l188t3584r416b3645],
5	degree	NN	O	degree	dep	1	SENT_15	[p1l459t3584r718b3660],
6	of	IN	O	of	_	0	SENT_15	[p1l758t3583r830b3645],
7	selectivity	NN	O	selectivity	prep_of	5	SENT_15	[p1l866t3584r1243b3660],
8	for	IN	O	for	mark	16	SENT_15	[p1l1279t3583r1382b3645],
9	inhibition	NN	O	inhibition	nsubj	16	SENT_15	[p1l1423t3584r1768b3645],
10	of	IN	O	of	_	0	SENT_15	[p1l1811t3583r1883b3645],
11	COX-2	NN	MISC	cox-2	prep_of	9	SENT_15	[p1l1922t3583r2148b3645],
12	achieved	VBN	O	achieve	partmod	11	SENT_15	[p1l15t3691r347b3751],
13	by	IN	O	by	_	0	SENT_15	[p1l386t3691r467b3766],
14	the	DT	O	the	det	15	SENT_15	[p1l497t3691r617b3751],
15	coxibs	NNS	O	coxib	agent	12	SENT_15	[p1l650t3691r883b3751],
16	relates	VBZ	O	relate	dep	1	SENT_15	[p1l918t3691r1173b3751],
17	both	DT	O	both	dobj	16	SENT_15	[p1l1208t3691r1369b3751],
18	to	TO	O	to	_	0	SENT_15	[p1l1404t3694r1476b3751],
19	chemical	NN	O	chemical	nn	20	SENT_15	[p1l1509t3691r1848b3751],
20	properties	NNS	O	property	prep_to	16	SENT_15	[p1l1887t3705r2152b3766, p2l13t23r148b84],

1	of	IN	O	of	_	0	SENT_16	[p2l182t22r254b84],
2	the	DT	O	the	det	3	SENT_16	[p2l286t23r406b84],
3	drug	NN	O	drug	prep_of	11	SENT_16	[p2l441t23r611b99],
4	and	CC	O	and	_	0	SENT_16	[p2l643t23r779b84],
5	to	TO	O	to	_	0	SENT_16	[p2l816t27r888b84],
6	factors	NNS	O	factor	prep_to	11	SENT_16	[p2l921t22r1182b84],
7	within	IN	O	within	_	0	SENT_16	[p2l1215t23r1439b84],
8	an	DT	O	a	det	9	SENT_16	[p2l1478t38r1566b84],
9	individual	NN	O	individual	prep_within	6	SENT_16	[p2l1606t23r1962b84],
10	that	WDT	O	that	nsubj	11	SENT_16	[p2l1999t23r2150b84],
11	modulate	VBP	O	modulate	conj_and	11	SENT_16	[p2l18t130r375b191],
12	drug	NN	O	drug	nn	13	SENT_16	[p2l426t130r595b206],
13	response	NN	O	response	dobj	11	SENT_16	[p2l645t144r1004b205],
14	.	.	O	.	_	0	SENT_16	[p2l645t144r1004b205],

1	These	DT	O	these	det	2	SENT_17	[p2l1053t130r1276b191],
2	sources	NNS	O	source	nsubjpass	7	SENT_17	[p2l1325t144r1616b191],
3	of	IN	O	of	_	0	SENT_17	[p2l1666t129r1737b191],
4	variability	NN	O	variability	prep_of	2	SENT_17	[p2l1784t130r2151b206],
5	might	MD	O	might	aux	7	SENT_17	[p2l18t237r233b312],
6	be	VB	O	be	auxpass	7	SENT_17	[p2l268t237r355b297],
7	exploited	VBN	O	exploit	_	0	SENT_17	[p2l388t237r728b312],
8	to	TO	O	to	aux	9	SENT_17	[p2l763t240r834b297],
9	identify	VB	O	identify	xcomp	7	SENT_17	[p2l871t236r1147b312],
10	patients	NNS	O	patient	nsubj	14	SENT_17	[p2l1181t237r1485b312],
11	uniquely	RB	O	uniquely	advmod	12	SENT_17	[p2l1520t237r1836b312],
12	susceptible	JJ	O	susceptible	dep	14	SENT_17	[p2l1865t251r2152b312, p2l13t344r176b405],
13	to	TO	O	to	aux	14	SENT_17	[p2l217t348r289b405],
14	benefit	VB	O	benefit	xcomp	9	SENT_17	[p2l334t343r593b405],
15	or	CC	O	or	_	0	SENT_17	[p2l635t359r708b405],
16	at	IN	O	at	conj_or	14	SENT_17	[p2l748t347r820b405],
17	developing	VBG	O	develop	amod	18	SENT_17	[p2l862t344r1274b420],
18	risk	NN	O	risk	pobj	16	SENT_17	[p2l1316t344r1449b405],
19	of	IN	O	of	_	0	SENT_17	[p2l1489t343r1561b405],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_17	[p2l1601t344r2151b405],
21	complications	NNS	O	complication	prep_of	18	SENT_17	[p2l15t451r562b526],
22	.	.	O	.	_	0	SENT_17	[p2l15t451r562b526],

1	he	PRP	O	he	dep	2	SENT_18	[p2l189t690r271b755],
2	coxibs	NNS	O	coxib	_	0	SENT_18	[p2l335t687r587b768],
3	,	,	O	,	_	0	SENT_18	[p2l335t687r587b768],
4	selective	JJ	O	selective	amod	5	SENT_18	[p2l654t690r965b755],
5	inhibitors	NNS	O	inhibitor	appos	2	SENT_18	[p2l1029t687r1393b755],
6	of	IN	O	of	_	0	SENT_18	[p2l1458t687r1536b755],
7	cyclooxygenase	NN	O	cyclooxygenase	prep_of	5	SENT_18	[p2l1588t689r2150b775],
8	(	CD	NUMBER	(	num	7	SENT_18	[p2l189t807r545b884],
9	COX	NNP	O	COX	dep	5	SENT_18	[p2l189t807r545b884],
10	)	CD	NUMBER	)	num	9	SENT_18	[p2l189t807r545b884],
11	.	.	O	.	_	0	SENT_18	[p2l189t807r545b884],

1	—	NN	O	—	_	0	SENT_19	[p2l189t807r545b884],
2	.	.	O	.	_	0	SENT_19	[p2l189t807r545b884],

1	2	CD	NUMBER	2	dep	4	SENT_20	[p2l189t807r545b884],
2	,	,	O	,	_	0	SENT_20	[p2l189t807r545b884],
3	were	VBD	O	be	auxpass	4	SENT_20	[p2l581t828r753b871],
4	designed	VBN	O	design	_	0	SENT_20	[p2l788t805r1116b890],
5	to	TO	O	to	aux	6	SENT_20	[p2l1153t825r1224b871],
6	inhibit	VB	O	inhibit	xcomp	4	SENT_20	[p2l1260t803r1516b871],
7	the	DT	O	the	det	10	SENT_20	[p2l1553t806r1667b871],
8	major	JJ	O	major	amod	10	SENT_20	[p2l1703t808r1918b890],
9	enzymatic	JJ	O	enzymatic	amod	10	SENT_20	[p2l1953t828r2148b890, p2l14t924r221b987],
10	source	NN	O	source	nsubj	14	SENT_20	[p2l254t945r483b988],
11	of	IN	O	of	_	0	SENT_20	[p2l514t920r592b987],
12	the	DT	O	the	det	13	SENT_20	[p2l612t922r727b988],
13	prostaglandins	NNS	O	prostaglandin	prep_of	10	SENT_20	[p2l756t922r1303b1007],
14	(	VBP	O	(	dep	6	SENT_20	[p2l1335t923r1566b1001],
15	PGS	NN	ORGANIZATION	pg	nn	16	SENT_20	[p2l1335t923r1566b1001],
16	)	NN	O	)	dobj	14	SENT_20	[p2l1335t923r1566b1001],
17	,	,	O	,	_	0	SENT_20	[p2l1335t923r1566b1001],
18	which	WDT	O	which	nsubj	19	SENT_20	[p2l1597t922r1824b987],
19	mediate	VBP	O	mediate	rcmod	16	SENT_20	[p2l1854t922r2149b987],
20	pain	NN	O	pain	dobj	19	SENT_20	[p2l12t1041r195b1124],
21	,	,	O	,	_	0	SENT_20	[p2l12t1041r195b1124],
22	inﬂammation	NN	O	inﬂammation	appos	20	SENT_20	[p2l240t1037r764b1118],
23	,	,	O	,	_	0	SENT_20	[p2l240t1037r764b1118],
24	and	CC	O	and	_	0	SENT_20	[p2l807t1039r962b1118],
25	,	,	O	,	_	0	SENT_20	[p2l807t1039r962b1118],
26	perhaps	RB	O	perhaps	dep	16	SENT_20	[p2l1004t1039r1313b1124],
27	,	,	O	,	_	0	SENT_20	[p2l1004t1039r1313b1124],
28	tumorigenesis	NN	O	tumorigenesis	conj_and	16	SENT_20	[p2l1357t1041r1903b1124],
29	,	,	O	,	_	0	SENT_20	[p2l1357t1041r1903b1124],
30	While	IN	O	while	mark	31	SENT_20	[p2l1945t1039r2150b1105],
31	sparing	VBG	O	spare	advcl	55	SENT_20	[p2l15t1150r286b1233],
32	COX	NNP	O	COX	nsubj	35	SENT_20	[p2l339t1148r928b1214],
33	—	CD	NUMBER	—	number	34	SENT_20	[p2l339t1148r928b1214],
34	1	CD	NUMBER	1	num	35	SENT_20	[p2l339t1148r928b1214],
35	—	NN	O	—	xcomp	31	SENT_20	[p2l339t1148r928b1214],
36	derived	VBN	O	derive	partmod	35	SENT_20	[p2l339t1148r928b1214],
37	PGS	NNP	ORGANIZATION	PGS	dobj	36	SENT_20	[p2l981t1149r1156b1227],
38	,	,	O	,	_	0	SENT_20	[p2l981t1149r1156b1227],
39	which	WDT	O	which	nsubj	40	SENT_20	[p2l1208t1148r1434b1214],
40	contribute	VBP	O	contribute	rcmod	37	SENT_20	[p2l1486t1146r1873b1214],
41	dominantly	RB	O	dominantly	advmod	40	SENT_20	[p2l1925t1148r2148b1213, p2l15t1257r250b1342],
42	to	TO	O	to	_	0	SENT_20	[p2l282t1276r354b1323],
43	gastric	JJ	O	gastric	amod	44	SENT_20	[p2l384t1259r631b1342],
44	cytoprotection	NN	O	cytoprotection	prep_to	40	SENT_20	[p2l664t1259r1257b1342],
45	.1	CD	NUMBER	.1	dep	31	SENT_20	[p2l664t1259r1257b1342],
46	Two	CD	NUMBER	two	num	47	SENT_20	[p2l1293t1257r1459b1323],
47	coxibs	NNS	O	coxib	dep	45	SENT_20	[p2l1491t1255r1743b1336],
48	,	,	O	,	_	0	SENT_20	[p2l1491t1255r1743b1336],
49	rofecoxibz	NN	O	rofecoxibz	nsubjpass	55	SENT_20	[p2l1778t1255r2147b1323],
50	and	CC	O	and	_	0	SENT_20	[p2l14t1365r146b1430],
51	lumiracoxib	NN	O	lumiracoxib	nsubjpass	55	SENT_20	[p2l174t1363r677b1443],
52	,3	CD	NUMBER	,3	num	51	SENT_20	[p2l174t1363r677b1443],
53	have	VBP	O	have	aux	55	SENT_20	[p2l706t1365r871b1430],
54	been	VBN	O	be	auxpass	55	SENT_20	[p2l900t1363r1070b1430],
55	shown	VBN	O	show	dep	14	SENT_20	[p2l1097t1365r1333b1430],
56	in	IN	O	in	_	0	SENT_20	[p2l1360t1367r1432b1428],
57	controlled	JJ	O	controlled	amod	58	SENT_20	[p2l1460t1365r1836b1430],
58	trials	NNS	O	trial	prep_in	55	SENT_20	[p2l1865t1365r2049b1430],
59	to	TO	O	to	aux	60	SENT_20	[p2l2078t1384r2150b1430],
60	reduce	VB	O	reduce	xcomp	55	SENT_20	[p2l15t1473r254b1538],
61	the	DT	O	the	det	62	SENT_20	[p2l293t1473r408b1538],
62	incidence	NN	O	incidence	dobj	60	SENT_20	[p2l447t1473r796b1538],
63	of	IN	O	of	_	0	SENT_20	[p2l833t1470r911b1538],
64	serious	JJ	O	serious	amod	70	SENT_20	[p2l938t1475r1188b1538],
65	gastrointestinal	JJ	O	gastrointestinal	amod	70	SENT_20	[p2l1225t1473r1805b1558],
66	(	NN	O	(	nn	70	SENT_20	[p2l1843t1474r1997b1550],
67	GI	NN	O	gi	nn	70	SENT_20	[p2l1843t1474r1997b1550],
68	)	CD	NUMBER	)	num	70	SENT_20	[p2l1843t1474r1997b1550],
69	adverse	JJ	O	adverse	amod	70	SENT_20	[p2l2034t1473r2148b1538, p2l6t1606r190b1648],
70	effects	NNS	O	effect	prep_of	62	SENT_20	[p2l228t1580r458b1648],
71	when	WRB	O	when	advmod	80	SENT_20	[p2l495t1583r695b1648],
72	compared	VBN	O	compare	_	0	SENT_20	[p2l733t1583r1094b1668],
73	with	IN	O	with	prepc_compared_with	80	SENT_20	[p2l1131t1583r1303b1648],
74	traditional	JJ	O	traditional	amod	77	SENT_20	[p2l1341t1583r1735b1648],
75	nonsteroidal	JJ	O	nonsteroidal	amod	77	SENT_20	[p2l1775t1585r2150b1648, p2l9t1693r119b1758],
76	anti	JJ	O	anti	amod	77	SENT_20	[p2l168t1690r854b1778],
77	—	NN	O	—	pobj	80	SENT_20	[p2l168t1690r854b1778],
78	inﬂammatory	JJ	O	inﬂammatory	amod	79	SENT_20	[p2l168t1690r854b1778],
79	drugs	NNS	O	drug	nsubj	80	SENT_20	[p2l902t1693r1110b1778],
80	(	VBP	O	(	advcl	60	SENT_20	[p2l1161t1693r1586b1770],
81	tNSAIDs	NNS	O	tnsaid	dobj	80	SENT_20	[p2l1161t1693r1586b1770],
82	)	CD	NUMBER	)	nsubjpass	4	SENT_20	[p2l1161t1693r1586b1770],
83	.	.	O	.	_	0	SENT_20	[p2l1161t1693r1586b1770],

1	Celecoxib	NNP	O	Celecoxib	nsubj	2	SENT_21	[p2l1641t1690r2002b1759],
2	reduced	VBD	O	reduce	ccomp	37	SENT_21	[p2l2053t1715r2150b1758, p2l9t1811r228b1876],
3	the	DT	O	the	det	4	SENT_21	[p2l275t1811r390b1876],
4	number	NN	O	number	dobj	2	SENT_21	[p2l437t1808r728b1877],
5	of	IN	O	of	_	0	SENT_21	[p2l772t1808r850b1876],
6	colorectal	JJ	O	colorectal	amod	7	SENT_21	[p2l885t1811r1240b1876],
7	polyps	NNS	O	polyp	prep_of	4	SENT_21	[p2l1284t1811r1527b1896],
8	compared	VBN	O	compare	_	0	SENT_21	[p2l1574t1811r1935b1896],
9	with	IN	O	with	prepc_compared_with	2	SENT_21	[p2l1980t1811r2152b1876],
10	placebo	NN	O	placebo	pobj	2	SENT_21	[p2l6t1919r288b2006],
11	in	IN	O	in	_	0	SENT_21	[p2l324t1923r396b1985],
12	patients	NNS	O	patient	prep_in	10	SENT_21	[p2l427t1923r724b2006],
13	with	IN	O	with	_	0	SENT_21	[p2l758t1921r930b1987],
14	familial	JJ	O	familial	amod	16	SENT_21	[p2l964t1919r1249b1986],
15	adenomatous	JJ	O	adenomatous	amod	16	SENT_21	[p2l1284t1921r1771b1987],
16	polyposis	NN	O	polyposis	prep_with	12	SENT_21	[p2l1804t1921r2151b2006],
17	in	IN	O	in	_	0	SENT_21	[p2l10t2033r81b2095],
18	a	DT	O	a	det	21	SENT_21	[p2l129t2056r166b2096],
19	controlled	JJ	O	controlled	amod	21	SENT_21	[p2l212t2031r590b2097],
20	clinical	JJ	O	clinical	amod	21	SENT_21	[p2l639t2031r908b2097],
21	trial	NN	O	trial	prep_in	16	SENT_21	[p2l957t2028r1169b2096],
22	.4	CD	NUMBER	.4	dep	21	SENT_21	[p2l957t2028r1169b2096],
23	However	RB	O	however	advmod	2	SENT_21	[p2l1218t2034r1574b2110],
24	,	,	O	,	_	0	SENT_21	[p2l1218t2034r1574b2110],
25	3	CD	NUMBER	3	num	28	SENT_21	[p2l1629t2035r1665b2102],
26	structurally	RB	O	structurally	advmod	27	SENT_21	[p2l1720t2031r2152b2116],
27	distinct	JJ	O	distinct	amod	28	SENT_21	[p2l8t2140r294b2206],
28	coxibs	NNS	O	coxib	nsubj	37	SENT_21	[p2l330t2138r583b2219],
29	,	,	O	,	_	0	SENT_21	[p2l330t2138r583b2219],
30	rofecoxib	NN	O	rofecoxib	appos	28	SENT_21	[p2l622t2138r984b2219],
31	,	,	O	,	_	0	SENT_21	[p2l622t2138r984b2219],
32	valdecoxib	NN	O	valdecoxib	appos	28	SENT_21	[p2l1020t2138r1439b2219],
33	,	,	O	,	_	0	SENT_21	[p2l1020t2138r1439b2219],
34	and	CC	O	and	_	0	SENT_21	[p2l1477t2140r1610b2206],
35	celecoxib	NN	O	celecoxib	appos	28	SENT_21	[p2l1646t2138r2008b2219],
36	,	,	O	,	_	0	SENT_21	[p2l1646t2138r2008b2219],
37	increased	VBD	O	increase	_	0	SENT_21	[p2l2048t2142r2150b2204, p2l9t2251r272b2317],
38	the	DT	O	the	det	39	SENT_21	[p2l303t2251r418b2316],
39	incidence	NN	O	incidence	dobj	37	SENT_21	[p2l451t2251r801b2317],
40	of	IN	O	of	_	0	SENT_21	[p2l831t2249r910b2317],
41	myocardial	JJ	O	myocardial	amod	42	SENT_21	[p2l929t2251r1339b2336],
42	infarction	NN	O	infarction	prep_of	39	SENT_21	[p2l1372t2249r1733b2317],
43	and	CC	O	and	_	0	SENT_21	[p2l1763t2251r1896b2316],
44	stroke	NN	O	stroke	prep_of	39	SENT_21	[p2l1927t2249r2152b2317],
45	in	IN	O	in	_	0	SENT_21	[p2l10t2363r81b2425],
46	randomized	VBN	O	randomize	prepc_in	37	SENT_21	[p2l120t2361r558b2426],
47	controlled	JJ	O	controlled	amod	48	SENT_21	[p2l596t2361r974b2426],
48	trials	NNS	O	trial	nsubj	51	SENT_21	[p2l1013t2361r1382b2440],
49	,25	CD	NUMBER	,25	number	50	SENT_21	[p2l1013t2361r1382b2440],
50	‘	CD	NUMBER	‘	num	51	SENT_21	[p2l1013t2361r1382b2440],
51	8	CD	NUMBER	8	xcomp	46	SENT_21	[p2l1013t2361r1382b2440],
52	suggesting	VBG	O	suggest	partmod	51	SENT_21	[p2l1422t2363r1826b2446],
53	that	IN	O	that	complm	60	SENT_21	[p2l1866t2361r2013b2426],
54	selectivity	NN	O	selectivity	nsubj	60	SENT_21	[p2l2053t2385r2150b2426, p2l9t2471r317b2556],
55	for	IN	O	for	_	0	SENT_21	[p2l358t2469r459b2537],
56	inhibition	NN	O	inhibition	prep_for	54	SENT_21	[p2l502t2469r879b2537],
57	of	IN	O	of	_	0	SENT_21	[p2l921t2469r999b2537],
58	COX-2	NN	O	cox-2	prep_of	56	SENT_21	[p2l1031t2472r1306b2537],
59	may	MD	O	may	aux	60	SENT_21	[p2l1352t2495r1508b2556],
60	confer	VB	O	confer	ccomp	52	SENT_21	[p2l1550t2469r1776b2537],
61	a	DT	O	a	det	63	SENT_21	[p2l1817t2496r1854b2536],
62	cardiovascular	JJ	O	cardiovascular	amod	63	SENT_21	[p2l1894t2471r2150b2537, p2l7t2581r307b2647],
63	hazard	NN	O	hazard	dobj	60	SENT_21	[p2l341t2581r603b2647],
64	.	.	O	.	_	0	SENT_21	[p2l341t2581r603b2647],

1	Rofecoxib	NNP	O	Rofecoxib	nsubjpass	7	SENT_22	[p2l646t2579r1016b2647],
2	and	CC	O	and	_	0	SENT_22	[p2l1053t2581r1186b2647],
3	valdecoxib	NN	O	valdecoxib	conj_and	1	SENT_22	[p2l1220t2579r1617b2647],
4	have	VBP	O	have	aux	7	SENT_22	[p2l1654t2581r1819b2647],
5	recently	RB	DATE	recently	advmod	7	SENT_22	[p2l1856t2581r2153b2666],
6	been	VBN	O	be	auxpass	7	SENT_22	[p2l9t2689r180b2757],
7	withdrawn	VBN	O	withdraw	_	0	SENT_22	[p2l217t2691r624b2757],
8	from	IN	O	from	_	0	SENT_22	[p2l663t2689r839b2757],
9	the	DT	O	the	det	10	SENT_22	[p2l879t2691r994b2757],
10	market	NN	O	market	prep_from	7	SENT_22	[p2l1032t2689r1316b2757],
11	.	.	O	.	_	0	SENT_22	[p2l1032t2689r1316b2757],

1	Both	DT	O	both	dep	109	SENT_23	[p2l1360t2691r1541b2757],
2	compounds	NNS	O	compound	dep	109	SENT_23	[p2l1580t2691r2006b2776],
3	are	VBP	O	be	dep	109	SENT_23	[p2l2046t2714r2151b2757],
4	more	RBR	O	more	dep	109	SENT_23	[p2l8t2823r195b2866],
5	selective	JJ	O	selective	dep	109	SENT_23	[p2l236t2800r547b2866],
6	for	IN	O	for	dep	109	SENT_23	[p2l587t2798r688b2866],
7	COX-2	NN	MISC	cox-2	dep	109	SENT_23	[p2l726t2802r1001b2866],
8	than	IN	O	than	dep	109	SENT_23	[p2l1046t2800r1211b2865],
9	celecoxib	NN	O	celecoxib	dep	109	SENT_23	[p2l1250t2798r1589b2866],
10	in	FW	O	in	dep	109	SENT_23	[p2l1630t2803r1702b2865],
11	vitro	FW	O	vitro	dep	109	SENT_23	[p2l1738t2802r1975b2866],
12	.9	CD	NUMBER	.9	dep	109	SENT_23	[p2l1738t2802r1975b2866],
13	Despite	IN	O	despite	dep	109	SENT_23	[p2l2013t2802r2150b2866, p2l9t2912r184b2994],
14	such	JJ	O	such	dep	109	SENT_23	[p2l223t2909r387b2975],
15	differences	NNS	O	difference	dep	109	SENT_23	[p2l424t2907r842b2988],
16	,	,	O	,	_	0	SENT_23	[p2l424t2907r842b2988],
17	all	DT	O	all	dep	109	SENT_23	[p2l881t2909r969b2974],
18	of	IN	O	of	dep	109	SENT_23	[p2l1007t2907r1086b2975],
19	the	DT	O	the	dep	109	SENT_23	[p2l1112t2909r1227b2975],
20	coxibs	NNS	O	coxib	dep	109	SENT_23	[p2l1265t2907r1494b2975],
21	depress	VBP	O	depress	dep	109	SENT_23	[p2l1532t2909r1801b2994],
22	substantially	RB	O	substantially	dep	109	SENT_23	[p2l1840t2907r2150b2975, p2l9t3020r202b3105],
23	prostacyclin	NN	O	prostacyclin	dep	109	SENT_23	[p2l273t3020r725b3105],
24	(	CD	NUMBER	(	dep	109	SENT_23	[p2l800t3021r1064b3100],
25	PGI2	NN	O	pgi2	dep	109	SENT_23	[p2l800t3021r1064b3100],
26	)	NN	O	)	dep	109	SENT_23	[p2l800t3021r1064b3100],
27	,	,	O	,	_	0	SENT_23	[p2l800t3021r1064b3100],
28	leaving	VBG	O	leave	dep	109	SENT_23	[p2l1142t3020r1409b3106],
29	platelet	NN	O	platelet	dep	109	SENT_23	[p2l1482t3020r1764b3106],
30	COX1derived	JJ	O	cox1derived	dep	109	SENT_23	[p2l1839t3022r2150b3086, p2l8t3129r283b3195],
31	thromboxane	NN	O	thromboxane	dep	109	SENT_23	[p2l324t3127r816b3195],
32	(	CD	NUMBER	(	dep	109	SENT_23	[p2l856t3130r1010b3207],
33	TX	NNP	O	TX	dep	109	SENT_23	[p2l856t3130r1010b3207],
34	)	CD	NUMBER	)	dep	109	SENT_23	[p2l856t3130r1010b3207],
35	A2	NN	O	a2	dep	109	SENT_23	[p2l1048t3130r1142b3209],
36	unaffected	JJ	O	unaffected	dep	109	SENT_23	[p2l1183t3127r1590b3208],
37	,	,	O	,	_	0	SENT_23	[p2l1183t3127r1590b3208],
38	in	IN	O	in	dep	109	SENT_23	[p2l1633t3132r1704b3194],
39	contrast	NN	O	contrast	dep	109	SENT_23	[p2l1744t3148r2039b3195],
40	to	TO	O	to	dep	109	SENT_23	[p2l2080t3149r2152b3195],
41	aspirin	NN	O	aspirin	dep	109	SENT_23	[p2l8t3243r262b3326],
42	or	CC	O	or	dep	109	SENT_23	[p2l315t3263r389b3306],
43	tNSAIDs	NNS	O	tnsaid	dep	109	SENT_23	[p2l442t3241r814b3319],
44	,	,	O	,	_	0	SENT_23	[p2l442t3241r814b3319],
45	which	WDT	O	which	dep	109	SENT_23	[p2l869t3241r1096b3306],
46	inhibit	VBP	O	inhibit	dep	109	SENT_23	[p2l1150t3238r1407b3306],
47	both	DT	O	both	dep	109	SENT_23	[p2l1462t3238r1632b3306],
48	COX-1	NN	O	cox-1	dep	109	SENT_23	[p2l1686t3242r1957b3306],
49	and	CC	O	and	dep	109	SENT_23	[p2l2019t3240r2151b3306],
50	COX	NNP	O	COX	dep	109	SENT_23	[p2l9t3352r459b3416],
51	—	CD	NUMBER	—	dep	109	SENT_23	[p2l9t3352r459b3416],
52	2.1	CD	NUMBER	2.1	dep	109	SENT_23	[p2l9t3352r459b3416],
53	°	NN	O	°	dep	109	SENT_23	[p2l9t3352r459b3416],
54	>	JJR	O	>	dep	109	SENT_23	[p2l9t3352r459b3416],
55	11	CD	NUMBER	11	dep	109	SENT_23	[p2l9t3352r459b3416],
56	PGI2	NN	O	pgi2	dep	109	SENT_23	[p2l513t3352r698b3430],
57	acts	VBZ	O	act	dep	109	SENT_23	[p2l748t3369r884b3416],
58	as	IN	O	as	dep	109	SENT_23	[p2l934t3374r999b3416],
59	a	DT	O	a	dep	109	SENT_23	[p2l1048t3375r1085b3415],
60	constraint	NN	O	constraint	dep	109	SENT_23	[p2l1131t3353r1503b3416],
61	on	IN	O	on	dep	109	SENT_23	[p2l1552t3373r1641b3416],
62	all	DT	O	all	dep	109	SENT_23	[p2l1688t3350r1776b3415],
63	agonists	NNS	O	agonist	dep	109	SENT_23	[p2l1825t3353r2150b3436],
64	,	,	O	,	_	0	SENT_23	[p2l1825t3353r2150b3436],
65	which	WDT	O	which	dep	109	SENT_23	[p2l7t3461r234b3526],
66	elevate	VBP	O	elevate	dep	109	SENT_23	[p2l297t3460r549b3526],
67	blood	NN	O	blood	dep	109	SENT_23	[p2l612t3458r820b3526],
68	pressure	NN	O	pressure	dep	109	SENT_23	[p2l881t3483r1207b3546],
69	,	,	O	,	_	0	SENT_23	[p2l881t3483r1207b3546],
70	activate	VBP	O	activate	dep	109	SENT_23	[p2l1271t3463r1557b3526],
71	platelets	NNS	O	platelet	dep	109	SENT_23	[p2l1617t3460r1955b3546],
72	,	,	O	,	_	0	SENT_23	[p2l1617t3460r1955b3546],
73	and	CC	O	and	dep	109	SENT_23	[p2l2019t3460r2152b3526],
74	stimulate	VBP	O	stimulate	dep	109	SENT_23	[p2l9t3570r359b3636],
75	atherogenesis	NN	O	atherogenesis	dep	109	SENT_23	[p2l406t3568r1098b3656],
76	.12	CD	NUMBER	.12	dep	109	SENT_23	[p2l406t3568r1098b3656],
77	—	CD	NUMBER	—	dep	109	SENT_23	[p2l406t3568r1098b3656],
78	14	CD	NUMBER	14	dep	109	SENT_23	[p2l406t3568r1098b3656],
79	Thus	RB	O	thus	dep	109	SENT_23	[p2l1144t3571r1354b3649],
80	,	,	O	,	_	0	SENT_23	[p2l1144t3571r1354b3649],
81	drug	NN	O	drug	dep	109	SENT_23	[p2l1403t3570r1579b3656],
82	selectivity	NN	O	selectivity	dep	109	SENT_23	[p2l1628t3570r2006b3655],
83	for	IN	O	for	dep	109	SENT_23	[p2l2052t3568r2153b3636],
84	inhibition	NN	O	inhibition	dep	109	SENT_23	[p2l10t3678r387b3747],
85	of	IN	O	of	dep	109	SENT_23	[p2l438t3678r517b3746],
86	COX-2	NN	O	cox-2	dep	109	SENT_23	[p2l557t3682r832b3746],
87	is	VBZ	O	be	dep	109	SENT_23	[p2l889t3683r942b3746],
88	thought	VBN	O	think	dep	109	SENT_23	[p2l996t3681r1296b3766],
89	to	TO	O	to	dep	109	SENT_23	[p2l1349t3700r1420b3746],
90	contribute	VB	O	contribute	dep	109	SENT_23	[p2l1472t3678r1860b3747],
91	to	TO	O	to	dep	109	SENT_23	[p2l1913t3700r1984b3746],
92	the	DT	O	the	dep	109	SENT_23	[p2l2036t3681r2151b3746],
93	likelihood	NN	O	likelihood	dep	109	SENT_23	[p3l9t18r386b86],
94	of	IN	O	of	dep	109	SENT_23	[p3l439t18r517b86],
95	hypertension	NN	O	hypertension	dep	109	SENT_23	[p3l558t21r1063b106],
96	,	,	O	,	_	0	SENT_23	[p3l558t21r1063b106],
97	myocardial	JJ	O	myocardial	dep	109	SENT_23	[p3l1117t20r1528b106],
98	infarction	NN	O	infarction	dep	109	SENT_23	[p3l1582t18r1965b100],
99	,	,	O	,	_	0	SENT_23	[p3l1582t18r1965b100],
100	and	CC	O	and	dep	109	SENT_23	[p3l2019t20r2151b86],
101	stroke	NN	O	stroke	dep	109	SENT_23	[p3l9t128r234b196],
102	resulting	VBG	O	result	dep	109	SENT_23	[p3l272t131r604b216],
103	from	IN	O	from	dep	109	SENT_23	[p3l642t128r819b196],
104	treatment	NN	O	treatment	dep	109	SENT_23	[p3l856t149r1222b196],
105	with	IN	O	with	dep	109	SENT_23	[p3l1259t131r1431b196],
106	coxibs	NNS	O	coxib	dep	109	SENT_23	[p3l1468t128r1874b196],
107	.15	CD	NUMBER	.15	dep	109	SENT_23	[p3l1468t128r1874b196],
108	»	CD	NUMBER	»	dep	109	SENT_23	[p3l1468t128r1874b196],
109	16	CD	NUMBER	16	_	0	SENT_23	[p3l1468t128r1874b196],

1	The	DT	O	the	det	2	SENT_24	[p3l106t241r250b306],
2	detection	NN	O	detection	nsubj	9	SENT_24	[p3l290t240r636b306],
3	of	IN	O	of	_	0	SENT_24	[p3l677t238r754b306],
4	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_24	[p3l784t240r1311b306],
5	complications	NNS	O	complication	prep_of	2	SENT_24	[p3l1350t240r1869b326],
6	attributable	JJ	O	attributable	amod	5	SENT_24	[p3l1910t238r2150b307, p3l8t356r239b424],
7	to	TO	O	to	_	0	SENT_24	[p3l283t377r355b424],
8	coxibs	NNS	O	coxib	prep_to	6	SENT_24	[p3l398t356r628b424],
9	relates	VBZ	O	relate	_	0	SENT_24	[p3l672t359r907b424],
10	in	IN	O	in	_	0	SENT_24	[p3l952t361r1024b423],
11	patients	NNS	O	patient	prep_in	9	SENT_24	[p3l1064t361r1362b444],
12	to	TO	O	to	_	0	SENT_24	[p3l1407t378r1478b424],
13	their	PRP$	O	they	poss	15	SENT_24	[p3l1522t359r1699b424],
14	underlying	VBG	O	underlie	amod	15	SENT_24	[p3l1740t358r2151b444],
15	risk	NN	O	risk	prep_to	11	SENT_24	[p3l9t465r148b533],
16	of	IN	O	of	_	0	SENT_24	[p3l189t465r268b533],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_24	[p3l299t468r827b533],
18	disease	NN	O	disease	prep_of	15	SENT_24	[p3l868t468r1210b533],
19	.	.	O	.	_	0	SENT_24	[p3l868t468r1210b533],

1	”	NN	O	”	ccomp	6	SENT_25	[p3l868t468r1210b533],
2	Thus	RB	O	thus	advmod	1	SENT_25	[p3l1254t468r1465b547],
3	,	,	O	,	_	0	SENT_25	[p3l1254t468r1465b547],
4	it	PRP	O	it	nsubj	6	SENT_25	[p3l1511t470r1565b533],
5	seems	VBZ	O	seem	cop	6	SENT_25	[p3l1610t492r1822b533],
6	rational	JJ	O	rational	_	0	SENT_25	[p3l1867t468r2151b533],
7	that	IN	O	that	complm	16	SENT_25	[p3l9t579r157b644],
8	patients	NNS	O	patient	nsubjpass	16	SENT_25	[p3l188t581r486b664],
9	with	IN	O	with	_	0	SENT_25	[p3l519t579r691b644],
10	identiﬁable	JJ	O	identiﬁable	amod	13	SENT_25	[p3l725t576r1146b645],
11	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_25	[p3l1180t579r1708b644],
12	risk	NN	O	risk	nn	13	SENT_25	[p3l1740t576r1878b644],
13	factors	NNS	O	factor	prep_with	8	SENT_25	[p3l1910t576r2151b644],
14	will	MD	O	will	aux	16	SENT_25	[p3l7t688r151b753],
15	be	VB	O	be	auxpass	16	SENT_25	[p3l193t685r275b754],
16	excluded	VBN	O	exclude	ccomp	6	SENT_25	[p3l316t688r644b753],
17	from	IN	O	from	_	0	SENT_25	[p3l684t685r861b753],
18	treatment	NN	O	treatment	prep_from	16	SENT_25	[p3l902t707r1268b753],
19	with	IN	O	with	_	0	SENT_25	[p3l1307t688r1479b753],
20	selective	JJ	O	selective	amod	22	SENT_25	[p3l1520t688r1832b753],
21	COX-2	NN	O	cox-2	nn	22	SENT_25	[p3l1872t689r2147b753],
22	inhibitors	NNS	O	inhibitor	prep_with	16	SENT_25	[p3l10t795r396b864],
23	.	.	O	.	_	0	SENT_25	[p3l10t795r396b864],

1	However	RB	O	however	advmod	11	SENT_26	[p3l455t800r811b877],
2	,	,	O	,	_	0	SENT_26	[p3l455t800r811b877],
3	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_26	[p3l867t798r1394b863],
4	adverse	JJ	O	adverse	amod	5	SENT_26	[p3l1445t798r1714b863],
5	events	NNS	O	event	nsubj	11	SENT_26	[p3l1768t817r1997b863],
6	attributable	JJ	O	attributable	amod	5	SENT_26	[p3l2052t817r2150b863, p3l9t906r381b975],
7	to	TO	O	to	_	0	SENT_26	[p3l429t928r500b974],
8	the	DT	O	the	det	9	SENT_26	[p3l547t909r662b974],
9	coxibs	NNS	O	coxib	prep_to	6	SENT_26	[p3l710t906r939b975],
10	also	RB	O	also	advmod	11	SENT_26	[p3l986t909r1124b974],
11	occurred	VBD	O	occur	_	0	SENT_26	[p3l1171t909r1489b974],
12	in	IN	O	in	_	0	SENT_26	[p3l1537t911r1609b973],
13	patients	NNS	O	patient	prep_in	11	SENT_26	[p3l1652t911r1950b994],
14	Who	WP	O	who	nsubj	15	SENT_26	[p3l1996t909r2152b974],
15	were	VBD	O	be	rcmod	13	SENT_26	[p3l7t1042r179b1084],
16	apparently	RB	O	apparently	advmod	15	SENT_26	[p3l215t1019r611b1104],
17	at	IN	O	at	_	0	SENT_26	[p3l645t1038r711b1084],
18	low	JJ	O	low	amod	20	SENT_26	[p3l748t1019r881b1084],
19	initial	JJ	O	initial	amod	20	SENT_26	[p3l917t1019r1141b1084],
20	risk	NN	O	risk	prep_at	15	SENT_26	[p3l1177t1016r1316b1084],
21	of	IN	O	of	_	0	SENT_26	[p3l1350t1016r1428b1084],
22	cardiovascular	JJ	O	cardiovascular	amod	23	SENT_26	[p3l1453t1019r1980b1084],
23	disease	NN	O	disease	prep_of	20	SENT_26	[p3l2014t1019r2150b1084, p3l9t1126r257b1208],
24	,67	CD	NUMBER	,67	dobj	11	SENT_26	[p3l2014t1019r2150b1084, p3l9t1126r257b1208],
25	suggesting	VBG	O	suggest	partmod	24	SENT_26	[p3l320t1131r724b1214],
26	that	IN	O	that	complm	31	SENT_26	[p3l785t1129r932b1194],
27	both	CC	O	both	preconj	28	SENT_26	[p3l992t1126r1162b1195],
28	rofecoxib	NN	O	rofecoxib	nsubj	31	SENT_26	[p3l1222t1126r1561b1195],
29	and	CC	O	and	_	0	SENT_26	[p3l1620t1129r1752b1194],
30	celecoxib	NN	O	celecoxib	conj_and	28	SENT_26	[p3l1812t1126r2151b1195],
31	caused	VBD	O	cause	ccomp	25	SENT_26	[p3l9t1239r250b1304],
32	a	DT	O	a	det	34	SENT_26	[p3l287t1264r324b1304],
33	risk	NN	O	risk	nn	34	SENT_26	[p3l359t1236r498b1304],
34	transformation	NN	O	transformation	dobj	31	SENT_26	[p3l534t1236r1087b1304],
35	during	IN	O	during	_	0	SENT_26	[p3l1123t1239r1375b1324],
36	extended	JJ	O	extended	amod	37	SENT_26	[p3l1413t1239r1747b1304],
37	treatment	NN	O	treatment	prep_during	31	SENT_26	[p3l1785t1258r2151b1304],
38	of	IN	O	of	_	0	SENT_26	[p3l9t1346r87b1414],
39	these	DT	O	these	det	40	SENT_26	[p3l132t1349r318b1414],
40	individuals	NNS	O	individual	prep_of	37	SENT_26	[p3l376t1348r811b1414],
41	.	.	O	.	_	0	SENT_26	[p3l376t1348r811b1414],

1	The	DT	O	the	det	3	SENT_27	[p3l870t1349r1015b1414],
2	emerging	VBG	O	emerge	amod	3	SENT_27	[p3l1071t1351r1426b1434],
3	hazard	NN	O	hazard	nsubj	5	SENT_27	[p3l1484t1348r1725b1414],
4	would	MD	O	would	aux	5	SENT_27	[p3l1780t1348r2012b1414],
5	be	VB	O	be	_	0	SENT_27	[p3l2069t1346r2151b1414],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_28	[p3l76t1610r496b1660],
2	used	VBN	O	use	partmod	1	SENT_28	[p3l537t1611r681b1660],
3	in	IN	O	in	_	0	SENT_28	[p3l720t1610r771b1659],
4	this	DT	O	this	det	5	SENT_28	[p3l813t1610r922b1660],
5	paper	NN	O	paper	prep_in	2	SENT_28	[p3l960t1622r1152b1671],
6	:	:	O	:	_	0	SENT_28	[p3l960t1622r1152b1671],
7	COX	NNP	O	COX	dep	1	SENT_28	[p3l1194t1610r1334b1669],
8	,	,	O	,	_	0	SENT_28	[p3l1194t1610r1334b1669],
9	cyclooxygenase	NN	O	cyclooxygenase	appos	7	SENT_28	[p3l1378t1611r1866b1672],
10	;	:	O	;	_	0	SENT_28	[p3l1378t1611r1866b1672],
11	NSA	NNP	ORGANIZATION	NSA	nn	13	SENT_28	[p3l1912t1610r2150b1669],
12	|	CD	NUMBER	|	num	13	SENT_28	[p3l1912t1610r2150b1669],
13	Ds	NNS	O	d	dep	7	SENT_28	[p3l1912t1610r2150b1669],
14	,	,	O	,	_	0	SENT_28	[p3l1912t1610r2150b1669],
15	nonsteroidal	JJ	O	nonsteroidal	amod	17	SENT_28	[p3l11t1699r384b1748],
16	anti-inflammatory	JJ	O	anti-inflammatory	amod	17	SENT_28	[p3l410t1699r955b1760],
17	drugs	NNS	O	drug	appos	13	SENT_28	[p3l977t1699r1159b1760],
18	;	:	O	;	_	0	SENT_28	[p3l977t1699r1159b1760],
19	PGs	NNS	O	pg	dep	7	SENT_28	[p3l1187t1699r1317b1758],
20	,	,	O	,	_	0	SENT_28	[p3l1187t1699r1317b1758],
21	prostaglandins	NNS	O	prostaglandin	appos	19	SENT_28	[p3l1345t1699r1807b1760],
22	;	:	O	;	_	0	SENT_28	[p3l1345t1699r1807b1760],
23	PGI2	NN	O	pgi2	dep	7	SENT_28	[p3l1835t1699r1981b1759],
24	,	,	O	,	_	0	SENT_28	[p3l1835t1699r1981b1759],
25	prostacyclin	NN	O	prostacyclin	appos	23	SENT_28	[p3l2008t1711r2154b1759, p3l8t1788r254b1848],
26	;	:	O	;	_	0	SENT_28	[p3l2008t1711r2154b1759, p3l8t1788r254b1848],
27	PGI-M	NN	O	pgi-m	dep	7	SENT_28	[p3l294t1787r486b1846],
28	,	,	O	,	_	0	SENT_28	[p3l294t1787r486b1846],
29	2,3-dinor-6	JJ	O	2,3-dinor-6	amod	32	SENT_28	[p3l524t1787r854b1846],
30	keto	NN	O	keto	nn	32	SENT_28	[p3l892t1788r1022b1836],
31	prostaglandin	NN	O	prostaglandin	nn	32	SENT_28	[p3l1060t1787r1472b1848],
32	Fm	NN	O	fm	appos	27	SENT_28	[p3l1513t1788r1620b1847],
33	;	:	O	;	_	0	SENT_28	[p3l1513t1788r1620b1847],
34	TXB2	NN	O	txb2	dep	7	SENT_28	[p3l1655t1787r1807b1847],
35	,	,	O	,	_	0	SENT_28	[p3l1655t1787r1807b1847],
36	thromboxane	NN	O	thromboxane	appos	34	SENT_28	[p3l1844t1788r2154b1836, p3l9t1887r135b1933],
37	;	:	O	;	_	0	SENT_28	[p3l1844t1788r2154b1836, p3l9t1887r135b1933],
38	Tx-M	NN	O	tx-m	dep	7	SENT_28	[p3l163t1875r318b1933],
39	,	,	O	,	_	0	SENT_28	[p3l163t1875r318b1933],
40	11-dehydrothromboxane	JJ	O	11-dehydrothromboxane	amod	41	SENT_28	[p3l350t1874r1100b1936],
41	B2	NN	O	b2	appos	38	SENT_28	[p3l1131t1875r1211b1934],
42	.	.	O	.	_	0	SENT_28	[p3l1131t1875r1211b1934],

1	©	RB	O	©	dep	2	SENT_29	[p3l196t1969r239b2012],
2	2006	CD	DATE	2006	dep	3	SENT_29	[p3l267t1963r430b2012],
3	by	IN	O	by	dep	9	SENT_29	[p3l460t1963r526b2024],
4	the	DT	O	the	det	7	SENT_29	[p3l550t1963r647b2012],
5	American	JJ	ORGANIZATION	american	amod	7	SENT_29	[p3l673t1963r963b2012],
6	Gastroenterological	NNP	ORGANIZATION	Gastroenterological	nn	7	SENT_29	[p3l994t1963r1587b2024],
7	Association	NNP	ORGANIZATION	Association	pobj	3	SENT_29	[p3l1615t1963r1963b2012],
8	doi	FW	O	doi	dep	7	SENT_29	[p3l547t2137r1612b2200],
9	:10.1053	CD	NUMBER	:10.1053	_	0	SENT_29	[p3l547t2137r1612b2200],
10	/	:	O	/	punct	9	SENT_29	[p3l547t2137r1612b2200],
11	j.	NN	O	j.	dep	9	SENT_29	[p3l547t2137r1612b2200],
12	gastro	NN	O	gastro	nn	13	SENT_29	[p3l547t2137r1612b2200],
13	.2005.10.002	NN	O	.2005.10.002	dep	11	SENT_29	[p3l547t2137r1612b2200],

1	56	CD	NUMBER	56	num	2	SENT_30	[p3l43t2275r80b2299],
2	FRIES	NNS	O	fries	_	0	SENT_30	[p3l117t2275r198b2299],
3	El	NNP	O	El	dep	2	SENT_30	[p3l212t2276r244b2298],
4	"	``	O	"	punct	3	SENT_30	[p3l212t2276r244b2298],
5	AL	NNP	O	AL	nn	7	SENT_30	[p3l255t2276r291b2298],
6	GASTROENTEROLOGY	NNP	O	GASTROENTEROLOGY	nn	7	SENT_30	[p3l1576t2275r1888b2299],
7	Vol	NNP	O	Vol	dep	3	SENT_30	[p3l1899t2276r1949b2299],
8	.	.	O	.	_	0	SENT_30	[p3l1899t2276r1949b2299],

1	130	CD	NUMBER	130	_	0	SENT_31	[p3l1964t2275r2027b2303],
2	,	,	O	,	_	0	SENT_31	[p3l1964t2275r2027b2303],
3	No.	NN	O	no.	appos	1	SENT_31	[p3l2042t2276r2086b2299],
4	1	CD	NUMBER	1	num	3	SENT_31	[p3l2101t2275r2118b2298],

1	Table	NNP	O	Table	_	0	SENT_32	[p3l43t2378r132b2405],
2	1	CD	NUMBER	1	dep	1	SENT_32	[p3l147t2378r177b2404],
3	.	.	O	.	_	0	SENT_32	[p3l147t2378r177b2404],

1	Characteristics	NNS	O	characteristic	_	0	SENT_33	[p3l199t2378r442b2405],
2	of	IN	O	of	_	0	SENT_33	[p3l457t2378r489b2405],
3	the	DT	O	the	det	4	SENT_33	[p3l500t2378r551b2405],
4	Subjects	NNS	O	subject	prep_of	1	SENT_33	[p3l566t2378r705b2411],

1	Female	JJ	O	female	dep	118	SENT_34	[p3l860t2447r962b2471],
2	(	NN	O	(	dep	118	SENT_34	[p3l976t2447r1000b2476],
3	n	NN	O	n	dep	118	SENT_34	[p3l976t2447r1000b2476],
4	=	JJ	O	=	dep	118	SENT_34	[p3l1017t2455r1037b2463],
5	22	CD	NUMBER	22	dep	118	SENT_34	[p3l1054t2447r1101b2476],
6	)	CD	NUMBER	)	dep	118	SENT_34	[p3l1054t2447r1101b2476],
7	Male	JJ	O	male	dep	118	SENT_34	[p3l1382t2447r1450b2471],
8	(	NN	O	(	dep	118	SENT_34	[p3l1464t2447r1488b2476],
9	n	NN	O	n	dep	118	SENT_34	[p3l1464t2447r1488b2476],
10	=	JJ	O	=	dep	118	SENT_34	[p3l1505t2455r1525b2463],
11	28	CD	NUMBER	28	dep	118	SENT_34	[p3l1542t2447r1589b2476],
12	)	CD	NUMBER	)	dep	118	SENT_34	[p3l1542t2447r1589b2476],
13	All	DT	O	all	dep	118	SENT_34	[p3l1903t2447r1935b2470],
14	(	NN	O	(	dep	118	SENT_34	[p3l1950t2447r1975b2476],
15	n	NN	O	n	dep	118	SENT_34	[p3l1950t2447r1975b2476],
16	=	JJ	O	=	dep	118	SENT_34	[p3l1991t2455r2012b2463],
17	50	CD	NUMBER	50	dep	118	SENT_34	[p3l2028t2447r2075b2476],
18	)	CD	NUMBER	)	dep	118	SENT_34	[p3l2028t2447r2075b2476],
19	Age	NNP	O	Age	dep	118	SENT_34	[p3l43t2513r94b2543],
20	(	CD	NUMBER	(	dep	118	SENT_34	[p3l108t2513r139b2543],
21	y	NN	O	y	dep	118	SENT_34	[p3l108t2513r139b2543],
22	)	CD	PERCENT	)	dep	118	SENT_34	[p3l108t2513r139b2543],
23	(	CD	PERCENT	(	dep	118	SENT_34	[p3l153t2513r232b2543],
24	25	CD	PERCENT	25	dep	118	SENT_34	[p3l153t2513r232b2543],
25	%	NN	PERCENT	%	dep	118	SENT_34	[p3l153t2513r232b2543],
26	,	,	O	,	_	0	SENT_34	[p3l153t2513r232b2543],
27	median	NN	O	median	dep	118	SENT_34	[p3l248t2513r361b2541],
28	,	,	O	,	_	0	SENT_34	[p3l248t2513r361b2541],
29	75	CD	PERCENT	75	dep	118	SENT_34	[p3l377t2513r447b2543],
30	%	NN	PERCENT	%	dep	118	SENT_34	[p3l377t2513r447b2543],
31	)	CD	NUMBER	)	dep	118	SENT_34	[p3l377t2513r447b2543],
32	23.3	CD	NUMBER	23.3	dep	118	SENT_34	[p3l855t2513r931b2541],
33	,	,	O	,	_	0	SENT_34	[p3l855t2513r931b2541],
34	26.0	CD	NUMBER	26.0	dep	118	SENT_34	[p3l947t2513r1022b2541],
35	,	,	O	,	_	0	SENT_34	[p3l947t2513r1022b2541],
36	31.8	CD	NUMBER	31.8	dep	118	SENT_34	[p3l1037t2513r1105b2537],
37	23.0	CD	NUMBER	23.0	dep	118	SENT_34	[p3l1360t2513r1436b2541],
38	,	,	O	,	_	0	SENT_34	[p3l1360t2513r1436b2541],
39	29.5	CD	NUMBER	29.5	dep	118	SENT_34	[p3l1452t2513r1527b2541],
40	,	,	O	,	_	0	SENT_34	[p3l1452t2513r1527b2541],
41	35.3	CD	NUMBER	35.3	dep	118	SENT_34	[p3l1542t2513r1610b2537],
42	23.0	CD	NUMBER	23.0	dep	118	SENT_34	[p3l1865t2513r1941b2541],
43	,	,	O	,	_	0	SENT_34	[p3l1865t2513r1941b2541],
44	27.5	CD	NUMBER	27.5	dep	118	SENT_34	[p3l1956t2513r2032b2541],
45	,	,	O	,	_	0	SENT_34	[p3l1956t2513r2032b2541],
46	34.5	CD	NUMBER	34.5	dep	118	SENT_34	[p3l2047t2513r2114b2537],
47	Ethnicity	NN	MISC	ethnicity	dep	118	SENT_34	[p3l45t2554r172b2584],
48	,	,	O	,	_	0	SENT_34	[p3l45t2554r172b2584],
49	No.	NN	O	no.	dep	118	SENT_34	[p3l188t2554r233b2578],
50	(	CD	PERCENT	(	dep	118	SENT_34	[p3l248t2554r288b2584],
51	%	NN	PERCENT	%	dep	118	SENT_34	[p3l248t2554r288b2584],
52	)	CD	NUMBER	)	dep	118	SENT_34	[p3l248t2554r288b2584],
53	White	NNP	O	White	dep	118	SENT_34	[p3l76t2596r156b2620],
54	12	CD	NUMBER	12	dep	118	SENT_34	[p3l913t2596r949b2619],
55	(	CD	NUMBER	(	dep	118	SENT_34	[p3l961t2596r1048b2625],
56	54.6	CD	NUMBER	54.6	dep	118	SENT_34	[p3l961t2596r1048b2625],
57	)	NN	O	)	dep	118	SENT_34	[p3l961t2596r1048b2625],
58	17	CD	NUMBER	17	dep	118	SENT_34	[p3l1418t2596r1454b2619],
59	(	CD	NUMBER	(	dep	118	SENT_34	[p3l1465t2596r1553b2625],
60	60.7	CD	NUMBER	60.7	dep	118	SENT_34	[p3l1465t2596r1553b2625],
61	)	NN	O	)	dep	118	SENT_34	[p3l1465t2596r1553b2625],
62	29	CD	NUMBER	29	dep	118	SENT_34	[p3l1922t2596r1959b2620],
63	(	CD	NUMBER	(	dep	118	SENT_34	[p3l1970t2596r2057b2625],
64	58.0	CD	NUMBER	58.0	dep	118	SENT_34	[p3l1970t2596r2057b2625],
65	)	CD	NUMBER	)	dep	118	SENT_34	[p3l1970t2596r2057b2625],
66	Black	JJ	O	black	dep	118	SENT_34	[p3l78t2637r155b2661],
67	7	CD	NUMBER	7	dep	118	SENT_34	[p3l933t2637r949b2660],
68	(	CD	NUMBER	(	dep	118	SENT_34	[p3l960t2637r1048b2666],
69	31.8	CD	NUMBER	31.8	dep	118	SENT_34	[p3l960t2637r1048b2666],
70	)	NN	O	)	dep	118	SENT_34	[p3l960t2637r1048b2666],
71	5	CD	NUMBER	5	dep	118	SENT_34	[p3l1437t2637r1454b2661],
72	(	CD	NUMBER	(	dep	118	SENT_34	[p3l1465t2637r1553b2666],
73	17.9	CD	NUMBER	17.9	dep	118	SENT_34	[p3l1465t2637r1553b2666],
74	)	NN	O	)	dep	118	SENT_34	[p3l1465t2637r1553b2666],
75	12	CD	NUMBER	12	dep	118	SENT_34	[p3l1923t2637r1959b2660],
76	(	CD	NUMBER	(	dep	118	SENT_34	[p3l1970t2637r2057b2666],
77	24.0	CD	NUMBER	24.0	dep	118	SENT_34	[p3l1970t2637r2057b2666],
78	)	JJ	O	)	dep	118	SENT_34	[p3l1970t2637r2057b2666],
79	Asian	JJ	O	asian	dep	118	SENT_34	[p3l76t2678r154b2702],
80	3	CD	NUMBER	3	dep	118	SENT_34	[p3l932t2678r950b2702],
81	(	NN	O	(	dep	118	SENT_34	[p3l960t2678r1048b2707],
82	13.6	CD	NUMBER	13.6	dep	118	SENT_34	[p3l960t2678r1048b2707],
83	)	CD	NUMBER	)	dep	118	SENT_34	[p3l960t2678r1048b2707],
84	6	CD	NUMBER	6	dep	118	SENT_34	[p3l1437t2678r1454b2702],
85	(	NN	O	(	dep	118	SENT_34	[p3l1465t2678r1553b2707],
86	21.4	CD	NUMBER	21.4	dep	118	SENT_34	[p3l1465t2678r1553b2707],
87	)	CD	NUMBER	)	dep	118	SENT_34	[p3l1465t2678r1553b2707],
88	9	CD	NUMBER	9	dep	118	SENT_34	[p3l1942t2678r1959b2702],
89	(	NN	O	(	dep	118	SENT_34	[p3l1970t2678r2057b2707],
90	18.0	CD	NUMBER	18.0	dep	118	SENT_34	[p3l1970t2678r2057b2707],
91	)	CD	NUMBER	)	dep	118	SENT_34	[p3l1970t2678r2057b2707],
92	Body	NN	O	body	dep	118	SENT_34	[p3l45t2719r113b2748],
93	mass	NN	O	mass	dep	118	SENT_34	[p3l126t2725r203b2743],
94	index	NN	O	index	dep	118	SENT_34	[p3l217t2719r292b2743],
95	(	CD	PERCENT	(	dep	118	SENT_34	[p3l304t2719r384b2748],
96	25	CD	PERCENT	25	dep	118	SENT_34	[p3l304t2719r384b2748],
97	%	NN	PERCENT	%	dep	118	SENT_34	[p3l304t2719r384b2748],
98	,	,	O	,	_	0	SENT_34	[p3l304t2719r384b2748],
99	median	NN	O	median	dep	118	SENT_34	[p3l399t2719r512b2747],
100	,	,	O	,	_	0	SENT_34	[p3l399t2719r512b2747],
101	75	CD	PERCENT	75	dep	118	SENT_34	[p3l528t2719r598b2748],
102	%	NN	PERCENT	%	dep	118	SENT_34	[p3l528t2719r598b2748],
103	)	CD	NUMBER	)	dep	118	SENT_34	[p3l528t2719r598b2748],
104	21.0	CD	NUMBER	21.0	dep	118	SENT_34	[p3l855t2719r931b2747],
105	,	,	O	,	_	0	SENT_34	[p3l855t2719r931b2747],
106	23.5	CD	NUMBER	23.5	dep	118	SENT_34	[p3l947t2719r1022b2747],
107	,	,	O	,	_	0	SENT_34	[p3l947t2719r1022b2747],
108	28.2	CD	NUMBER	28.2	dep	118	SENT_34	[p3l1038t2719r1104b2743],
109	23.3	CD	NUMBER	23.3	dep	118	SENT_34	[p3l1360t2719r1436b2747],
110	,	,	O	,	_	0	SENT_34	[p3l1360t2719r1436b2747],
111	25.3	CD	NUMBER	25.3	dep	118	SENT_34	[p3l1452t2719r1527b2747],
112	,	,	O	,	_	0	SENT_34	[p3l1452t2719r1527b2747],
113	27.8	CD	NUMBER	27.8	dep	118	SENT_34	[p3l1543t2719r1610b2743],
114	21.8	CD	NUMBER	21.8	dep	118	SENT_34	[p3l1865t2719r1941b2747],
115	,	,	O	,	_	0	SENT_34	[p3l1865t2719r1941b2747],
116	24.8	CD	NUMBER	24.8	dep	118	SENT_34	[p3l1956t2719r2032b2747],
117	,	,	O	,	_	0	SENT_34	[p3l1956t2719r2032b2747],
118	28.0	CD	NUMBER	28.0	_	0	SENT_34	[p3l2047t2719r2115b2743],

1	expected	VBN	O	expect	dep	104	SENT_35	[p3l9t2944r330b3029],
2	to	TO	O	to	dep	104	SENT_35	[p3l389t2963r460b3010],
3	relate	VB	O	relate	dep	104	SENT_35	[p3l518t2944r720b3010],
4	to	TO	O	to	dep	104	SENT_35	[p3l778t2963r849b3010],
5	multiple	JJ	O	multiple	dep	104	SENT_35	[p3l906t2944r1228b3029],
6	factors	NNS	O	factor	dep	104	SENT_35	[p3l1285t2942r1548b3023],
7	,	,	O	,	_	0	SENT_35	[p3l1285t2942r1548b3023],
8	including	VBG	O	include	dep	104	SENT_35	[p3l1609t2944r1967b3029],
9	the	DT	O	the	dep	104	SENT_35	[p3l2027t2944r2141b3010],
10	degree	NN	O	degree	dep	104	SENT_35	[p3l8t3056r249b3142],
11	of	IN	O	of	dep	104	SENT_35	[p3l297t3054r376b3122],
12	selectivity	NN	O	selectivity	dep	104	SENT_35	[p3l413t3056r790b3142],
13	for	IN	O	for	dep	104	SENT_35	[p3l837t3054r938b3122],
14	inhibition	NN	O	inhibition	dep	104	SENT_35	[p3l986t3054r1362b3122],
15	of	IN	O	of	dep	104	SENT_35	[p3l1410t3054r1488b3122],
16	COX-2	NN	MISC	cox-2	dep	104	SENT_35	[p3l1525t3058r1799b3122],
17	actually	RB	O	actually	dep	104	SENT_35	[p3l1852t3056r2142b3141],
18	attained	VBD	O	attain	dep	104	SENT_35	[p3l8t3167r308b3231],
19	within	IN	O	within	dep	104	SENT_35	[p3l363t3167r611b3231],
20	an	DT	O	a	dep	104	SENT_35	[p3l665t3189r749b3231],
21	individual	JJ	O	individual	dep	104	SENT_35	[p3l805t3167r1208b3245],
22	,	,	O	,	_	0	SENT_35	[p3l805t3167r1208b3245],
23	plasma	NN	O	plasma	dep	104	SENT_35	[p3l1263t3167r1524b3251],
24	concentrations	NNS	O	concentration	dep	104	SENT_35	[p3l1577t3169r2139b3245],
25	,	,	O	,	_	0	SENT_35	[p3l1577t3169r2139b3245],
26	and	CC	O	and	dep	104	SENT_35	[p3l8t3278r140b3344],
27	half	NN	O	half	dep	104	SENT_35	[p3l171t3276r461b3344],
28	—	JJ	O	—	dep	104	SENT_35	[p3l171t3276r461b3344],
29	life	NN	O	life	dep	104	SENT_35	[p3l171t3276r461b3344],
30	and	CC	O	and	dep	104	SENT_35	[p3l492t3278r624b3344],
31	duration	NN	O	duration	dep	104	SENT_35	[p3l655t3278r973b3344],
32	of	IN	O	of	dep	104	SENT_35	[p3l1003t3276r1081b3344],
33	drug	NN	O	drug	dep	104	SENT_35	[p3l1101t3278r1275b3363],
34	action	NN	O	action	dep	104	SENT_35	[p3l1307t3276r1706b3344],
35	.15	CD	NUMBER	.15	dep	104	SENT_35	[p3l1307t3276r1706b3344],
36	’16	CD	NUMBER	’16	dep	104	SENT_35	[p3l1307t3276r1706b3344],
37	Such	JJ	O	such	dep	104	SENT_35	[p3l1738t3278r1913b3344],
38	pharmacokinetic	JJ	O	pharmacokinetic	dep	104	SENT_35	[p3l1942t3278r2139b3363, p3l8t3386r460b3454],
39	and	CC	O	and	dep	104	SENT_35	[p3l506t3388r637b3454],
40	pharmacodynamic	JJ	O	pharmacodynamic	dep	104	SENT_35	[p3l680t3388r1363b3474],
41	characteristics	NNS	O	characteristic	dep	104	SENT_35	[p3l1409t3389r1931b3454],
42	have	VBP	O	have	dep	104	SENT_35	[p3l1977t3389r2141b3454],
43	been	VBN	O	be	dep	104	SENT_35	[p3l9t3497r179b3566],
44	increasingly	RB	O	increasingly	dep	104	SENT_35	[p3l222t3500r669b3585],
45	associated	VBN	O	associate	dep	104	SENT_35	[p3l710t3500r1075b3565],
46	with	IN	O	with	dep	104	SENT_35	[p3l1117t3500r1288b3565],
47	both	DT	O	both	dep	104	SENT_35	[p3l1331t3497r1500b3566],
48	drug	NN	O	drug	dep	104	SENT_35	[p3l1542t3500r1716b3585],
49	safety	NN	O	safety	dep	104	SENT_35	[p3l1760t3497r1968b3585],
50	and	CC	O	and	dep	104	SENT_35	[p3l2009t3500r2141b3565],
51	efﬁcacy	NN	O	efﬁcacy	dep	104	SENT_35	[p3l9t3607r277b3694],
52	and	CC	O	and	dep	104	SENT_35	[p3l310t3609r441b3675],
53	may	MD	O	may	dep	104	SENT_35	[p3l475t3633r630b3694],
54	be	VB	O	be	dep	104	SENT_35	[p3l663t3607r745b3675],
55	successfully	RB	O	successfully	dep	104	SENT_35	[p3l780t3607r1211b3694],
56	exploited	VBN	O	exploit	dep	104	SENT_35	[p3l1244t3609r1587b3694],
57	to	TO	O	to	dep	104	SENT_35	[p3l1622t3628r1693b3675],
58	individualize	VB	O	individualize	dep	104	SENT_35	[p3l1728t3609r2139b3675, p3l10t3724r107b3787],
59	therapy-18	NN	O	therapy-18	dep	104	SENT_35	[p3l153t3722r496b3807],
60	when	WRB	O	when	dep	104	SENT_35	[p3l541t3722r740b3787],
61	heritable	JJ	O	heritable	dep	104	SENT_35	[p3l784t3719r1111b3787],
62	mechanisms	NNS	O	mechanism	dep	104	SENT_35	[p3l1156t3722r1608b3787],
63	or	CC	O	or	dep	104	SENT_35	[p3l1654t3744r1727b3787],
64	predictive	JJ	O	predictive	dep	104	SENT_35	[p3l1768t3721r2141b3807],
65	host	NN	O	host	dep	104	SENT_35	[p4l9t21r161b86],
66	factors	NNS	O	factor	dep	104	SENT_35	[p4l200t18r440b86],
67	such	JJ	O	such	dep	104	SENT_35	[p4l481t21r644b86],
68	as	IN	O	as	dep	104	SENT_35	[p4l683t45r748b86],
69	gender	NN	O	gender	dep	104	SENT_35	[p4l787t21r1062b106],
70	,	,	O	,	_	0	SENT_35	[p4l787t21r1062b106],
71	race	NN	O	race	dep	104	SENT_35	[p4l1104t44r1268b100],
72	,	,	O	,	_	0	SENT_35	[p4l1104t44r1268b100],
73	age	NN	O	age	dep	104	SENT_35	[p4l1308t45r1451b106],
74	,	,	O	,	_	0	SENT_35	[p4l1308t45r1451b106],
75	or	CC	O	or	dep	104	SENT_35	[p4l1493t44r1566b86],
76	weight	NN	O	weight	dep	104	SENT_35	[p4l1602t21r1859b106],
77	can	MD	O	can	dep	104	SENT_35	[p4l1899t44r2020b86],
78	be	VB	O	be	dep	104	SENT_35	[p4l2059t18r2141b87],
79	lCl	NNP	O	lCl	dep	104	SENT_35	[p4l9t129r455b196],
80	€	NNP	O	€	dep	104	SENT_35	[p4l9t129r455b196],
81	l.	VBD	O	l.	dep	104	SENT_35	[p4l9t129r455b196],
82	’	CD	NUMBER	’	dep	104	SENT_35	[p4l9t129r455b196],
83	ltlﬁ	NN	O	ltlﬁ	dep	104	SENT_35	[p4l9t129r455b196],
84	€	CD	NUMBER	€	dep	104	SENT_35	[p4l9t129r455b196],
85	Cl	NN	O	cl	dep	104	SENT_35	[p4l9t129r455b196],
86	.19	CD	NUMBER	.19	dep	104	SENT_35	[p4l9t129r455b196],
87	However	RB	O	however	dep	104	SENT_35	[p4l485t134r840b209],
88	,	,	O	,	_	0	SENT_35	[p4l485t134r840b209],
89	environmental	JJ	O	environmental	dep	104	SENT_35	[p4l872t131r1411b196],
90	sources	NNS	O	source	dep	104	SENT_35	[p4l1442t153r1702b196],
91	of	IN	O	of	dep	104	SENT_35	[p4l1734t129r1811b196],
92	variability	NN	O	variability	dep	104	SENT_35	[p4l1828t129r2139b196, p4l10t243r108b325],
93	such	JJ	O	such	dep	104	SENT_35	[p4l153t241r317b305],
94	as	IN	O	as	dep	104	SENT_35	[p4l360t264r426b305],
95	nutritional	JJ	O	nutritional	dep	104	SENT_35	[p4l472t240r874b305],
96	status	NN	O	status	dep	104	SENT_35	[p4l920t259r1131b305],
97	and	CC	O	and	dep	104	SENT_35	[p4l1177t240r1308b305],
98	physical	JJ	O	physical	dep	104	SENT_35	[p4l1351t240r1652b325],
99	activity	NN	O	activity	dep	104	SENT_35	[p4l1697t243r1977b324],
100	can	MD	O	can	dep	104	SENT_35	[p4l2021t263r2142b305],
101	mask	NN	O	mask	dep	104	SENT_35	[p4l8t349r201b417],
102	clinically	RB	O	clinically	dep	104	SENT_35	[p4l230t352r569b437],
103	relevant	JJ	O	relevant	dep	104	SENT_35	[p4l600t352r893b417],
104	associations	NNS	O	association	_	0	SENT_35	[p4l923t354r1374b417],
105	.	.	O	.	_	0	SENT_35	[p4l923t354r1374b417],

1	The	DT	O	the	det	3	SENT_36	[p4l1407t352r1551b417],
2	relative	JJ	O	relative	amod	3	SENT_36	[p4l1582t352r1854b417],
3	importance	NN	O	importance	nsubj	18	SENT_36	[p4l1886t354r2139b437, p4l9t482r200b529],
4	of	IN	O	of	_	0	SENT_36	[p4l246t461r323b529],
5	stable	JJ	O	stable	amod	7	SENT_36	[p4l358t461r570b529],
6	interindividual	JJ	O	interindividual	amod	7	SENT_36	[p4l617t463r1177b529],
7	sources	NNS	O	source	prep_of	3	SENT_36	[p4l1224t486r1484b529],
8	of	IN	O	of	_	0	SENT_36	[p4l1530t461r1608b529],
9	variability	NN	O	variability	prep_of	7	SENT_36	[p4l1640t461r2025b548],
10	in	IN	O	in	_	0	SENT_36	[p4l2070t466r2142b527],
11	drug	NN	O	drug	nn	12	SENT_36	[p4l8t579r183b664],
12	response	NN	O	response	prep_in	9	SENT_36	[p4l255t580r832b664],
13	—	CD	NUMBER	—	num	12	SENT_36	[p4l255t580r832b664],
14	such	JJ	O	such	_	0	SENT_36	[p4l255t580r832b664],
15	as	IN	O	as	_	0	SENT_36	[p4l902t603r968b644],
16	genetic	JJ	O	genetic	amod	17	SENT_36	[p4l1038t582r1306b664],
17	variants	NNS	O	variant	prep_such_as	9	SENT_36	[p4l1375t579r2141b664],
18	—	VBP	O	—	_	0	SENT_36	[p4l1375t579r2141b664],
19	compared	VBN	O	compare	_	0	SENT_36	[p4l1375t579r2141b664],
20	with	IN	O	with	prepc_compared_with	18	SENT_36	[p4l7t691r178b756],
21	less	JJR	O	less	pobj	18	SENT_36	[p4l215t691r340b756],
22	predictable	JJ	O	predictable	amod	25	SENT_36	[p4l375t688r814b776],
23	,	,	O	,	_	0	SENT_36	[p4l375t688r814b776],
24	environmental	JJ	O	environmental	amod	25	SENT_36	[p4l853t691r1392b756],
25	sources	NNS	O	source	nsubj	34	SENT_36	[p4l1430t714r1690b756],
26	of	IN	O	of	_	0	SENT_36	[p4l1728t688r1805b756],
27	variability	NN	O	variability	prep_of	25	SENT_36	[p4l1828t688r2139b757, p4l10t810r109b892],
28	in	IN	O	in	_	0	SENT_36	[p4l146t810r217b871],
29	the	DT	O	the	det	30	SENT_36	[p4l254t807r368b873],
30	response	NN	O	response	prep_in	27	SENT_36	[p4l406t830r716b892],
31	to	TO	O	to	_	0	SENT_36	[p4l754t826r825b873],
32	coxibs	NNS	O	coxib	prep_to	30	SENT_36	[p4l862t805r1090b873],
33	is	VBZ	O	be	cop	34	SENT_36	[p4l1130t810r1183b873],
34	unknown	JJ	O	unknown	rcmod	21	SENT_36	[p4l1221t805r1590b873],
35	.	.	O	.	_	0	SENT_36	[p4l1221t805r1590b873],

1	We	PRP	O	we	nsubj	2	SENT_37	[p4l106t922r238b985],
2	examined	VBD	O	examine	conj_and	2	SENT_37	[p4l290t919r645b985],
3	the	DT	O	the	det	4	SENT_37	[p4l697t920r812b985],
4	variability	NN	O	variability	dobj	2	SENT_37	[p4l862t917r1268b1005],
5	,	,	O	,	_	0	SENT_37	[p4l862t917r1268b1005],
6	both	CC	O	both	preconj	2	SENT_37	[p4l1323t917r1492b985],
7	within	IN	O	within	_	0	SENT_37	[p4l1543t920r1791b985],
8	and	CC	O	and	_	0	SENT_37	[p4l1842t919r1974b985],
9	between	IN	O	between	_	0	SENT_37	[p4l2026t917r2139b985, p4l9t1050r228b1096],
10	subjects	NNS	O	subject	prep_within	2	SENT_37	[p4l258t1028r574b1116],
11	,	,	O	,	_	0	SENT_37	[p4l258t1028r574b1116],
12	in	IN	O	in	_	0	SENT_37	[p4l606t1033r678b1095],
13	response	NN	O	response	prep_in	2	SENT_37	[p4l707t1053r1018b1116],
14	to	TO	O	to	_	0	SENT_37	[p4l1048t1050r1119b1096],
15	celecoxib	NN	O	celecoxib	prep_to	13	SENT_37	[p4l1149t1028r1486b1097],
16	and	CC	O	and	_	0	SENT_37	[p4l1516t1031r1647b1096],
17	rofecoxib	NN	O	rofecoxib	prep_to	13	SENT_37	[p4l1678t1028r2038b1110],
18	,	,	O	,	_	0	SENT_37	[p4l1678t1028r2038b1110],
19	in	IN	O	in	_	0	SENT_37	[p4l2070t1033r2142b1095],
20	a	DT	O	a	det	23	SENT_37	[p4l8t1165r45b1205],
21	placebo-controlled	JJ	O	placebo-controlled	amod	23	SENT_37	[p4l68t1138r761b1225],
22	crossover	NN	O	crossover	nn	23	SENT_37	[p4l789t1163r1123b1206],
23	study	NN	O	study	prep_in	2	SENT_37	[p4l1150t1140r1371b1225],
24	.	.	O	.	_	0	SENT_37	[p4l1150t1140r1371b1225],

1	Our	PRP$	O	we	poss	2	SENT_38	[p4l1403t1142r1553b1206],
2	studies	NNS	O	study	nsubj	3	SENT_38	[p4l1579t1140r1834b1206],
3	suggest	VBP	O	suggest	_	0	SENT_38	[p4l1863t1159r2140b1225],
4	that	IN	O	that	complm	8	SENT_38	[p4l9t1253r156b1317],
5	even	RB	O	even	advmod	7	SENT_38	[p4l184t1275r349b1318],
6	healthy	JJ	O	healthy	amod	7	SENT_38	[p4l376t1252r650b1338],
7	individuals	NNS	O	individual	nsubj	8	SENT_38	[p4l678t1252r1090b1318],
8	respond	VBP	O	respond	ccomp	3	SENT_38	[p4l1119t1252r1408b1338],
9	quite	RB	O	quite	advmod	10	SENT_38	[p4l1435t1255r1627b1338],
10	differently	RB	O	differently	advmod	8	SENT_38	[p4l1654t1250r2043b1338],
11	to	TO	O	to	_	0	SENT_38	[p4l2070t1271r2141b1318],
12	coxibs	NNS	O	coxib	prep_to	8	SENT_38	[p4l9t1361r257b1430],
13	.	.	O	.	_	0	SENT_38	[p4l9t1361r257b1430],

1	This	DT	O	this	det	2	SENT_39	[p4l306t1364r471b1429],
2	variance	NN	O	variance	nsubj	4	SENT_39	[p4l514t1366r817b1429],
3	might	MD	O	might	aux	4	SENT_39	[p4l862t1364r1091b1449],
4	confound	VB	O	confound	_	0	SENT_39	[p4l1137t1361r1480b1429],
5	the	DT	O	the	det	6	SENT_39	[p4l1526t1364r1641b1429],
6	detection	NN	O	detection	nsubj	10	SENT_39	[p4l1686t1364r2030b1429],
7	of	IN	O	of	_	0	SENT_39	[p4l2075t1361r2152b1429],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_39	[p4l9t1473r534b1539],
9	events	NNS	O	event	prep_of	6	SENT_39	[p4l570t1492r799b1539],
10	attributable	JJ	O	attributable	xcomp	4	SENT_39	[p4l838t1471r1279b1539],
11	to	TO	O	to	_	0	SENT_39	[p4l1319t1492r1389b1539],
12	drug	NN	O	drug	nn	13	SENT_39	[p4l1428t1473r1602b1558],
13	exposure	NN	O	exposure	prep_to	10	SENT_39	[p4l1641t1496r1982b1558],
14	.	.	O	.	_	0	SENT_39	[p4l1641t1496r1982b1558],

1	On	IN	O	on	_	0	SENT_40	[p4l2026t1475r2142b1539],
2	the	DT	O	the	det	4	SENT_40	[p4l9t1586r124b1651],
3	other	JJ	O	other	amod	4	SENT_40	[p4l171t1586r364b1651],
4	hand	NN	O	hand	prep_on	13	SENT_40	[p4l410t1585r613b1664],
5	,	,	O	,	_	0	SENT_40	[p4l410t1585r613b1664],
6	interindividual	JJ	O	interindividual	amod	7	SENT_40	[p4l664t1585r1223b1651],
7	variability	NN	O	variability	nsubjpass	13	SENT_40	[p4l1269t1583r1654b1671],
8	in	IN	O	in	_	0	SENT_40	[p4l1701t1588r1773b1650],
9	drug	NN	O	drug	nn	10	SENT_40	[p4l1819t1585r1994b1671],
10	response	NN	O	response	prep_in	7	SENT_40	[p4l2043t1608r2139b1651, p4l9t1724r249b1787],
11	might	MD	O	might	aux	13	SENT_40	[p4l284t1702r513b1787],
12	be	VB	O	be	auxpass	13	SENT_40	[p4l549t1699r631b1768],
13	exploited	VBN	O	exploit	_	0	SENT_40	[p4l666t1702r1009b1787],
14	to	TO	O	to	aux	15	SENT_40	[p4l1045t1721r1116b1767],
15	identify	VB	O	identify	xcomp	13	SENT_40	[p4l1152t1699r1441b1787],
16	patients	NNS	O	patient	dobj	15	SENT_40	[p4l1473t1704r1769b1787],
17	in	IN	O	in	_	0	SENT_40	[p4l1806t1704r1877b1766],
18	whom	WP	O	whom	dobj	21	SENT_40	[p4l1910t1702r2141b1767],
19	the	DT	O	the	det	20	SENT_40	[p4l9t1813r124b1879],
20	drug	NN	O	drug	nsubj	21	SENT_40	[p4l157t1813r332b1898],
21	exhibits	VBZ	O	exhibit	prepc_in	15	SENT_40	[p4l367t1811r660b1879],
22	unique	JJ	O	unique	amod	23	SENT_40	[p4l695t1816r952b1898],
23	efficacy	NN	O	efficacy	dobj	21	SENT_40	[p4l986t1811r1255b1898],
24	or	CC	O	or	_	0	SENT_40	[p4l1288t1836r1361b1879],
25	in	IN	O	in	_	0	SENT_40	[p4l1394t1816r1465b1877],
26	whom	WP	O	whom	dobj	33	SENT_40	[p4l1497t1813r1729b1879],
27	the	DT	O	the	det	28	SENT_40	[p4l1763t1813r1878b1879],
28	evolution	NN	O	evolution	nsubjpass	33	SENT_40	[p4l1912t1813r2139b1879, p4l9t1926r157b1989],
29	of	IN	O	of	_	0	SENT_40	[p4l195t1921r273b1989],
30	cardiovascular	JJ	O	cardiovascular	amod	31	SENT_40	[p4l300t1923r825b1989],
31	risk	NN	O	risk	prep_of	28	SENT_40	[p4l863t1921r1001b1989],
32	is	VBZ	O	be	auxpass	33	SENT_40	[p4l1039t1926r1092b1989],
33	accelerated	VBN	O	accelerate	conj_or	21	SENT_40	[p4l1132t1923r1555b1989],
34	.	.	O	.	_	0	SENT_40	[p4l1132t1923r1555b1989],

1	This	DT	DATE	this	nsubj	3	SENT_41	[p4l1597t1924r1761b1989],
2	may	MD	DATE	may	aux	3	SENT_41	[p4l1801t1948r1956b2008],
3	permit	VB	O	permit	_	0	SENT_41	[p4l1991t1946r2139b2009, p4l8t2037r140b2099],
4	deﬁnition	NN	O	deﬁnition	dobj	3	SENT_41	[p4l197t2032r558b2100],
5	of	IN	O	of	_	0	SENT_41	[p4l615t2032r692b2100],
6	the	DT	O	the	det	7	SENT_41	[p4l739t2035r853b2100],
7	parameters	NNS	O	parameter	prep_of	4	SENT_41	[p4l908t2054r1313b2120],
8	within	IN	O	within	_	0	SENT_41	[p4l1370t2035r1617b2100],
9	which	WDT	O	which	dep	12	SENT_41	[p4l1672t2035r1898b2100],
10	these	DT	O	these	det	11	SENT_41	[p4l1956t2035r2141b2100],
11	drugs	NNS	O	drug	nsubj	12	SENT_41	[p4l8t2146r297b2231],
12	“	VBP	O	“	prepc_within	3	SENT_41	[p4l8t2146r297b2231],
13	might	MD	O	might	aux	15	SENT_41	[p4l344t2146r573b2231],
14	be	VB	O	be	auxpass	15	SENT_41	[p4l619t2144r701b2212],
15	administered	VBN	O	administer	ccomp	12	SENT_41	[p4l746t2146r1231b2212],
16	chronically	RB	O	chronically	dep	15	SENT_41	[p4l1276t2146r1686b2231],
17	to	TO	O	to	_	0	SENT_41	[p4l1731t2165r1802b2212],
18	patients	NNS	O	patient	prep_to	16	SENT_41	[p4l1844t2148r2140b2231],
19	initially	RB	O	initially	advmod	15	SENT_41	[p4l10t2256r304b2342],
20	at	IN	O	at	_	0	SENT_41	[p4l340t2275r406b2321],
21	low	JJ	O	low	amod	22	SENT_41	[p4l444t2256r576b2322],
22	risk	NN	O	risk	prep_at	15	SENT_41	[p4l613t2254r751b2322],
23	of	IN	O	of	_	0	SENT_41	[p4l787t2254r864b2322],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_41	[p4l890t2256r1414b2322],
25	disease	NN	O	disease	prep_of	22	SENT_41	[p4l1450t2256r1721b2322],
26	.	.	O	.	_	0	SENT_41	[p4l1450t2256r1721b2322],

1	Materials	NNPS	O	Materials	_	0	SENT_42	[p4l279t2476r758b2552],
2	and	CC	O	and	_	0	SENT_42	[p4l796t2477r976b2552],
3	Methods	NNS	O	method	conj_and	1	SENT_42	[p4l1021t2477r1460b2552],

1	Study	NNP	O	Study	nn	2	SENT_43	[p4l274t2644r509b2727],
2	Design	NNP	O	Design	tmod	11	SENT_43	[p4l549t2645r824b2727],
3	This	DT	O	this	nsubj	4	SENT_43	[p4l274t2750r424b2809],
4	randomized	VBN	O	randomize	rcmod	2	SENT_43	[p4l494t2750r910b2822],
5	,	,	O	,	_	0	SENT_43	[p4l494t2750r910b2822],
6	double-blind	JJ	O	double-blind	amod	9	SENT_43	[p4l980t2748r1442b2822],
7	,	,	O	,	_	0	SENT_43	[p4l980t2748r1442b2822],
8	placebo-controlled	JJ	O	placebo-controlled	amod	9	SENT_43	[p4l1510t2748r2141b2827],
9	protocol	NN	O	protocol	nsubjpass	11	SENT_43	[p4l7t2848r286b2925],
10	was	VBD	O	be	auxpass	11	SENT_43	[p4l324t2870r444b2907],
11	approved	VBN	O	approve	_	0	SENT_43	[p4l483t2848r790b2925],
12	by	IN	O	by	_	0	SENT_43	[p4l830t2846r910b2925],
13	the	DT	O	the	det	16	SENT_43	[p4l949t2848r1053b2907],
14	Institutional	JJ	ORGANIZATION	institutional	amod	16	SENT_43	[p4l1091t2848r1518b2907],
15	Review	NNP	ORGANIZATION	Review	nn	16	SENT_43	[p4l1558t2850r1805b2907],
16	Board	NNP	ORGANIZATION	Board	agent	11	SENT_43	[p4l1843t2848r2042b2907],
17	of	IN	ORGANIZATION	of	_	0	SENT_43	[p4l2081t2846r2152b2907],
18	the	DT	ORGANIZATION	the	det	19	SENT_43	[p4l9t2946r113b3005],
19	University	NNP	ORGANIZATION	University	prep_of	16	SENT_43	[p4l162t2948r520b3023],
20	of	IN	ORGANIZATION	of	_	0	SENT_43	[p4l569t2944r639b3005],
21	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	23	SENT_43	[p4l679t2946r1121b3023],
22	Health	NNP	ORGANIZATION	Health	nn	23	SENT_43	[p4l1169t2946r1402b3005],
23	System	NNP	ORGANIZATION	System	prep_of	19	SENT_43	[p4l1451t2947r1689b3023],
24	and	CC	O	and	_	0	SENT_43	[p4l1738t2946r1858b3005],
25	by	IN	O	by	_	0	SENT_43	[p4l1908t2944r1988b3023],
26	the	DT	O	the	det	28	SENT_43	[p4l2037t2946r2141b3005],
27	Advisory	NNP	ORGANIZATION	Advisory	nn	28	SENT_43	[p4l7t3044r312b3121],
28	Council	NNP	ORGANIZATION	Council	conj_and	16	SENT_43	[p4l362t3044r624b3103],
29	of	IN	ORGANIZATION	of	_	0	SENT_43	[p4l676t3042r746b3103],
30	the	DT	ORGANIZATION	the	det	36	SENT_43	[p4l787t3044r891b3103],
31	General	NNP	ORGANIZATION	General	nn	36	SENT_43	[p4l942t3044r1205b3103],
32	Clinical	JJ	ORGANIZATION	clinical	amod	36	SENT_43	[p4l1256t3044r1518b3103],
33	Research	NNP	ORGANIZATION	Research	nn	36	SENT_43	[p4l1571t3044r1867b3103],
34	Center	NNP	ORGANIZATION	Center	nn	36	SENT_43	[p4l1918t3045r2143b3103],
35	(	NNP	O	(	nn	36	SENT_43	[p4l9t3143r391b3219],
36	University	NNP	ORGANIZATION	University	prep_of	28	SENT_43	[p4l9t3143r391b3219],
37	of	IN	ORGANIZATION	of	_	0	SENT_43	[p4l427t3140r497b3201],
38	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	40	SENT_43	[p4l524t3142r984b3219],
39	,	,	O	,	_	0	SENT_43	[p4l524t3142r984b3219],
40	Philadelphia	NNP	LOCATION	Philadelphia	prep_of	28	SENT_43	[p4l1024t3142r1492b3219],
41	)	CD	NUMBER	)	dep	11	SENT_43	[p4l1024t3142r1492b3219],
42	.	.	O	.	_	0	SENT_43	[p4l1024t3142r1492b3219],

1	Screening	NN	O	screening	nsubjpass	12	SENT_44	[p4l1532t3143r1880b3219],
2	,	,	O	,	_	0	SENT_44	[p4l1532t3143r1880b3219],
3	enrollment	NN	O	enrollment	nsubjpass	12	SENT_44	[p4l1918t3142r2140b3201, p4l8t3257r203b3312],
4	,	,	O	,	_	0	SENT_44	[p4l1918t3142r2140b3201, p4l8t3257r203b3312],
5	and	CC	O	and	_	0	SENT_44	[p4l249t3240r369b3299],
6	follow-up	NN	O	follow-up	nsubjpass	12	SENT_44	[p4l414t3238r742b3317],
7	of	IN	O	of	_	0	SENT_44	[p4l787t3238r858b3299],
8	healthy	JJ	O	healthy	amod	10	SENT_44	[p4l893t3240r1142b3317],
9	study	NN	O	study	nn	10	SENT_44	[p4l1187t3240r1370b3317],
10	volunteers	NNS	O	volunteer	prep_of	1	SENT_44	[p4l1413t3240r1761b3299],
11	were	VBD	O	be	auxpass	12	SENT_44	[p4l1806t3260r1962b3299],
12	performed	VBN	O	perform	_	0	SENT_44	[p4l2005t3260r2140b3317, p4l8t3336r247b3397],
13	at	IN	O	at	_	0	SENT_44	[p4l279t3355r340b3397],
14	the	DT	O	the	det	18	SENT_44	[p4l374t3338r478b3397],
15	General	NNP	ORGANIZATION	General	nn	18	SENT_44	[p4l511t3338r774b3397],
16	Clinical	JJ	ORGANIZATION	clinical	amod	18	SENT_44	[p4l807t3338r1070b3397],
17	Research	NNP	ORGANIZATION	Research	nn	18	SENT_44	[p4l1105t3338r1401b3397],
18	Center	NNP	ORGANIZATION	Center	prep_at	12	SENT_44	[p4l1434t3339r1660b3397],
19	from	IN	O	from	_	0	SENT_44	[p4l1690t3336r1851b3397],
20	January	NNP	DATE	January	prep_from	12	SENT_44	[p4l1875t3341r2142b3415],
21	2002	CD	DATE	2002	num	20	SENT_44	[p4l10t3439r179b3495],
22	to	TO	O	to	_	0	SENT_44	[p4l207t3453r271b3495],
23	January	NNP	DATE	January	prep_to	12	SENT_44	[p4l287t3439r553b3513],
24	2004	CD	DATE	2004	num	23	SENT_44	[p4l578t3432r768b3495],
25	.	.	O	.	_	0	SENT_44	[p4l578t3432r768b3495],

1	Written	VBN	O	write	csubjpass	5	SENT_45	[p4l795t3438r1074b3495],
2	informed	JJ	O	informed	amod	3	SENT_45	[p4l1099t3434r1405b3495],
3	consent	NN	O	consent	dobj	1	SENT_45	[p4l1429t3453r1681b3495],
4	was	VBD	O	be	auxpass	5	SENT_45	[p4l1704t3458r1824b3495],
5	obtained	VBN	O	obtain	_	0	SENT_45	[p4l1849t3434r2141b3496],
6	from	IN	O	from	_	0	SENT_45	[p4l8t3532r168b3593],
7	all	DT	O	all	det	8	SENT_45	[p4l197t3534r277b3593],
8	volunteers	NNS	O	volunteer	prep_from	5	SENT_45	[p4l306t3534r673b3593],
9	.	.	O	.	_	0	SENT_45	[p4l306t3534r673b3593],

1	All	DT	O	all	nsubj	2	SENT_46	[p4l706t3534r812b3592],
2	had	VBD	O	have	_	0	SENT_46	[p4l842t3534r961b3593],
3	an	DT	O	a	det	6	SENT_46	[p4l992t3555r1067b3593],
4	unremarkable	JJ	O	unremarkable	amod	5	SENT_46	[p4l1097t3532r1563b3594],
5	medical	JJ	O	medical	amod	6	SENT_46	[p4l1593t3534r1855b3593],
6	history	NN	O	history	dobj	2	SENT_46	[p4l1886t3534r2139b3611],
7	,	,	O	,	_	0	SENT_46	[p4l1886t3534r2139b3611],
8	physical	JJ	O	physical	amod	9	SENT_46	[p4l7t3632r281b3709],
9	examination	NN	O	examination	dobj	2	SENT_46	[p4l316t3634r752b3704],
10	,	,	O	,	_	0	SENT_46	[p4l316t3634r752b3704],
11	and	CC	O	and	_	0	SENT_46	[p4l788t3632r908b3691],
12	routine	JJ	O	routine	amod	16	SENT_46	[p4l943t3634r1185b3691],
13	hematologic	JJ	O	hematologic	amod	16	SENT_46	[p4l1219t3632r1635b3709],
14	and	CC	O	and	_	0	SENT_46	[p4l1670t3632r1790b3691],
15	biochemical	JJ	O	biochemical	conj_and	13	SENT_46	[p4l1825t3630r2140b3692, p4l9t3730r123b3789],
16	screen	NN	O	screen	conj_and	6	SENT_46	[p4l148t3750r351b3789],
17	and	CC	O	and	_	0	SENT_46	[p4l375t3730r494b3789],
18	were	VBD	O	be	conj_and	2	SENT_46	[p4l517t3750r673b3789],
19	within	IN	O	within	_	0	SENT_46	[p4l696t3730r921b3789],
20	30	CD	PERCENT	30	num	21	SENT_46	[p4l948t3731r1099b3794],
21	%	NN	PERCENT	%	prep_within	18	SENT_46	[p4l948t3731r1099b3794],
22	of	IN	O	of	_	0	SENT_46	[p4l1128t3728r1199b3789],
23	ideal	JJ	O	ideal	amod	25	SENT_46	[p4l1213t3730r1371b3789],
24	body	NN	O	body	nn	25	SENT_46	[p4l1396t3728r1560b3807],
25	weight	NN	O	weight	prep_of	21	SENT_46	[p4l1583t3730r1835b3807],
26	.	.	O	.	_	0	SENT_46	[p4l1583t3730r1835b3807],

1	Subjects	NNS	O	subject	nsubj	5	SENT_47	[p4l1864t3728r2140b3807],
2	were	VBD	O	be	cop	3	SENT_47	[p5l8t39r163b77],
3	nonsmokers	NNS	O	nonsmoker	_	0	SENT_47	[p5l205t16r604b77],
4	and	CC	O	and	_	0	SENT_47	[p5l646t18r766b77],
5	abstained	VBD	O	abstain	conj_and	3	SENT_47	[p5l806t16r1123b78],
6	from	IN	O	from	_	0	SENT_47	[p5l1163t16r1323b77],
7	the	DT	O	the	det	8	SENT_47	[p5l1364t19r1468b77],
8	use	NN	O	use	prep_from	5	SENT_47	[p5l1508t40r1613b77],
9	of	IN	O	of	_	0	SENT_47	[p5l1653t16r1724b77],
10	aspirin	NN	O	aspirin	prep_of	8	SENT_47	[p5l1753t20r1983b95],
11	and	CC	O	and	_	0	SENT_47	[p5l2022t18r2142b77],
12	tNSAIDs	NNS	O	tnsaid	conj_and	10	SENT_47	[p5l10t116r347b187],
13	,	,	O	,	_	0	SENT_47	[p5l10t116r347b187],
14	as	IN	O	as	mark	15	SENT_47	[p5l374t137r433b175],
15	assessed	VBN	O	assess	dep	10	SENT_47	[p5l460t116r722b175],
16	by	IN	O	by	_	0	SENT_47	[p5l748t114r829b193],
17	history	NN	O	history	nn	20	SENT_47	[p5l853t116r1087b193],
18	and	CC	O	and	_	0	SENT_47	[p5l1111t116r1230b175],
19	platelet	NN	O	platelet	nn	20	SENT_47	[p5l1254t116r1509b193],
20	aggregometry	NN	O	aggregometry	prep_by	15	SENT_47	[p5l1534t133r2025b193],
21	,	,	O	,	_	0	SENT_47	[p5l1534t133r2025b193],
22	for	IN	O	for	_	0	SENT_47	[p5l2052t114r2144b175],
23	at	IN	DURATION	at	quantmod	25	SENT_47	[p5l9t231r69b272],
24	least	JJS	DURATION	least	mwe	23	SENT_47	[p5l118t214r266b273],
25	2	CD	DURATION	2	num	26	SENT_47	[p5l316t217r350b272],
26	weeks	NNS	NUMBER	week	prep_for	5	SENT_47	[p5l401t212r600b273],
27	before	IN	O	before	_	0	SENT_47	[p5l649t212r852b273],
28	enrollment	NN	O	enrollment	prep_before	5	SENT_47	[p5l899t214r1355b273],
29	.	.	O	.	_	0	SENT_47	[p5l899t214r1355b273],

1	”	NN	O	”	nn	3	SENT_48	[p5l899t214r1355b273],
2	Routine	JJ	O	routine	amod	3	SENT_48	[p5l1404t216r1676b273],
3	hematology	NN	O	hematology	nsubjpass	10	SENT_48	[p5l1723t214r2140b291],
4	,	,	O	,	_	0	SENT_48	[p5l1723t214r2140b291],
5	biochemistry	NN	O	biochemistry	conj_and	3	SENT_48	[p5l10t310r471b389],
6	,	,	O	,	_	0	SENT_48	[p5l10t310r471b389],
7	and	CC	O	and	_	0	SENT_48	[p5l500t312r619b371],
8	urinalysis	NN	O	urinalysis	conj_and	3	SENT_48	[p5l647t312r968b389],
9	were	VBD	O	be	auxpass	10	SENT_48	[p5l995t333r1151b371],
10	assessed	VBN	O	assess	_	0	SENT_48	[p5l1178t312r1441b371],
11	at	IN	O	at	_	0	SENT_48	[p5l1468t330r1528b371],
12	time	NN	O	time	prep_at	10	SENT_48	[p5l1557t314r1710b371],
13	of	IN	O	of	_	0	SENT_48	[p5l1737t310r1808b371],
14	screening	NN	O	screening	prep_of	12	SENT_48	[p5l1826t314r2141b389],
15	and	CC	O	and	_	0	SENT_48	[p5l9t410r129b469],
16	at	IN	O	at	_	0	SENT_48	[p5l162t427r222b469],
17	24	CD	DURATION	24	num	18	SENT_48	[p5l257t406r339b468],
18	hours	NNS	NUMBER	hour	conj_and	12	SENT_48	[p5l373t410r555b469],
19	after	IN	O	after	_	0	SENT_48	[p5l589t408r740b469],
20	administration	NN	O	administration	prep_after	10	SENT_48	[p5l771t410r1272b469],
21	of	IN	O	of	_	0	SENT_48	[p5l1305t408r1375b469],
22	the	DT	O	the	det	23	SENT_48	[p5l1398t410r1502b469],
23	drugs	NNS	O	drug	prep_of	20	SENT_48	[p5l1535t410r1723b487],
24	on	IN	O	on	_	0	SENT_48	[p5l1757t431r1837b469],
25	completion	NN	O	completion	prep_on	10	SENT_48	[p5l1870t410r2141b487, p5l10t510r144b567],
26	of	IN	O	of	_	0	SENT_48	[p5l178t506r248b567],
27	the	DT	O	the	det	28	SENT_48	[p5l272t508r376b567],
28	study	NN	O	study	prep_of	25	SENT_48	[p5l411t508r612b585],
29	.	.	O	.	_	0	SENT_48	[p5l411t508r612b585],

1	Treatments	NNS	O	treatment	_	0	SENT_49	[p5l274t709r754b776],
2	and	CC	O	and	_	0	SENT_49	[p5l791t709r941b776],
3	Assessment	NNP	O	Assessment	conj_and	1	SENT_49	[p5l980t709r1487b776],

1	Fifty	CD	NUMBER	fifty	num	3	SENT_50	[p5l276t868r436b947],
2	healthy	JJ	O	healthy	amod	3	SENT_50	[p5l477t870r726b947],
3	volunteers	NNS	O	volunteer	nsubj	4	SENT_50	[p5l765t870r1114b929],
4	(	VBP	O	(	_	0	SENT_50	[p5l1156t868r1370b939],
5	Table	NNP	O	Table	dobj	4	SENT_50	[p5l1156t868r1370b939],
6	1	CD	NUMBER	1	num	5	SENT_50	[p5l1419t871r1497b941],
7	)	CD	NUMBER	)	nsubj	16	SENT_50	[p5l1419t871r1497b941],
8	,	,	O	,	_	0	SENT_50	[p5l1419t871r1497b941],
9	aged	JJ	O	aged	amod	14	SENT_50	[p5l1541t870r1695b947],
10	between	IN	O	between	_	0	SENT_50	[p5l1738t868r2016b929],
11	21	CD	NUMBER	21	prep_between	9	SENT_50	[p5l2059t873r2135b928],
12	and	CC	O	and	_	0	SENT_50	[p5l9t968r129b1028],
13	43	CD	DURATION	43	conj_and	11	SENT_50	[p5l178t965r259b1033],
14	years	NNS	NUMBER	year	appos	7	SENT_50	[p5l312t989r497b1045],
15	,	,	O	,	_	0	SENT_50	[p5l312t989r497b1045],
16	received	VBD	O	receive	rcmod	5	SENT_50	[p5l549t968r842b1040],
17	,	,	O	,	_	0	SENT_50	[p5l549t968r842b1040],
18	in	IN	O	in	_	0	SENT_50	[p5l894t971r959b1026],
19	random	JJ	O	random	amod	20	SENT_50	[p5l1008t968r1266b1028],
20	order	NN	O	order	prep_in	4	SENT_50	[p5l1315t968r1509b1040],
21	,	,	O	,	_	0	SENT_50	[p5l1315t968r1509b1040],
22	a	DT	O	a	det	24	SENT_50	[p5l1560t991r1593b1027],
23	single	JJ	O	single	amod	24	SENT_50	[p5l1641t968r1839b1046],
24	dose	NN	O	dose	appos	20	SENT_50	[p5l1888t968r2033b1028],
25	of	IN	O	of	_	0	SENT_50	[p5l2082t966r2153b1028],
26	placebo	NN	O	placebo	prep_of	24	SENT_50	[p5l8t1064r283b1143],
27	,	,	O	,	_	0	SENT_50	[p5l8t1064r283b1143],
28	celecoxib	NN	O	celecoxib	nn	29	SENT_50	[p5l332t1064r639b1126],
29	(	NN	O	(	appos	20	SENT_50	[p5l686t1067r839b1136],
30	200	CD	NUMBER	200	num	32	SENT_50	[p5l686t1067r839b1136],
31	mg	NN	O	mg	nn	32	SENT_50	[p5l887t1068r1042b1143],
32	)	NN	O	)	dep	29	SENT_50	[p5l887t1068r1042b1143],
33	,	,	O	,	_	0	SENT_50	[p5l887t1068r1042b1143],
34	and	CC	O	and	_	0	SENT_50	[p5l1090t1066r1210b1125],
35	rofecoxib	NN	O	rofecoxib	dep	24	SENT_50	[p5l1257t1064r1564b1126],
36	(	CD	NUMBER	(	num	35	SENT_50	[p5l1611t1067r1714b1136],
37	25	CD	NUMBER	25	num	39	SENT_50	[p5l1611t1067r1714b1136],
38	mg	NN	O	mg	nn	39	SENT_50	[p5l1767t1067r1902b1143],
39	)	NN	O	)	conj_and	24	SENT_50	[p5l1767t1067r1902b1143],
40	under	IN	O	under	_	0	SENT_50	[p5l1948t1066r2144b1125],
41	double-blind	JJ	O	double-blind	amod	42	SENT_50	[p5l9t1162r450b1223],
42	conditions	NNS	O	condition	prep_under	39	SENT_50	[p5l491t1164r863b1235],
43	,	,	O	,	_	0	SENT_50	[p5l491t1164r863b1235],
44	separated	VBN	O	separate	partmod	24	SENT_50	[p5l906t1164r1218b1241],
45	by	IN	O	by	_	0	SENT_50	[p5l1259t1162r1339b1241],
46	washout	NN	O	washout	nn	47	SENT_50	[p5l1378t1164r1657b1223],
47	periods	NNS	O	period	agent	44	SENT_50	[p5l1695t1164r1940b1241],
48	of	IN	O	of	_	0	SENT_50	[p5l1981t1162r2052b1223],
49	at	IN	DURATION	at	quantmod	51	SENT_50	[p5l2082t1181r2142b1222],
50	least	JJS	DURATION	least	mwe	49	SENT_50	[p5l10t1262r158b1322],
51	2	CD	DURATION	2	num	52	SENT_50	[p5l188t1266r223b1320],
52	Weeks	NNS	DURATION	week	prep_of	47	SENT_50	[p5l253t1260r470b1322],
53	.	.	O	.	_	0	SENT_50	[p5l253t1260r470b1322],

1	The	DT	O	the	det	3	SENT_51	[p5l501t1263r631b1322],
2	randomization	NN	O	randomization	nn	3	SENT_51	[p5l659t1262r1150b1322],
3	sequence	NN	O	sequence	nsubjpass	5	SENT_51	[p5l1177t1283r1474b1340],
4	was	VBD	O	be	auxpass	5	SENT_51	[p5l1500t1284r1620b1322],
5	determined	VBN	O	determine	_	0	SENT_51	[p5l1648t1262r2035b1322],
6	by	IN	O	by	_	0	SENT_51	[p5l2063t1260r2143b1339],
7	the	DT	O	the	det	8	SENT_51	[p5l10t1361r114b1419],
8	General	NNP	ORGANIZATION	General	agent	5	SENT_51	[p5l143t1360r406b1419],
9	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_51	[p5l435t1360r697b1419],
10	Research	NNP	ORGANIZATION	Research	nn	12	SENT_51	[p5l728t1361r1025b1419],
11	Center	NNP	ORGANIZATION	Center	nn	12	SENT_51	[p5l1054t1362r1278b1419],
12	pharmacist	NN	O	pharmacist	dep	5	SENT_51	[p5l1304t1361r1677b1437],
13	by	IN	O	by	_	0	SENT_51	[p5l1707t1358r1787b1437],
14	allocation	NN	O	allocation	agent	5	SENT_51	[p5l1815t1360r2143b1419],
15	of	IN	O	of	_	0	SENT_51	[p5l10t1456r80b1517],
16	the	DT	O	the	det	17	SENT_51	[p5l114t1458r218b1517],
17	drugs	NNS	O	drug	prep_of	14	SENT_51	[p5l261t1458r449b1535],
18	to	TO	O	to	aux	19	SENT_51	[p5l494t1475r558b1517],
19	numbered	VBD	O	number	xcomp	5	SENT_51	[p5l603t1456r944b1517],
20	containers	NNS	O	container	dobj	19	SENT_51	[p5l988t1460r1347b1517],
21	.	.	O	.	_	0	SENT_51	[p5l988t1460r1347b1517],

1	Inhibition	NN	O	inhibition	nsubjpass	6	SENT_52	[p5l1395t1456r1743b1517],
2	of	IN	O	of	_	0	SENT_52	[p5l1785t1456r1856b1517],
3	platelet	NN	O	platelet	nn	4	SENT_52	[p5l1887t1458r2142b1535],
4	COX-1	NN	O	cox-1	prep_of	1	SENT_52	[p5l10t1557r255b1615],
5	was	VBD	O	be	auxpass	6	SENT_52	[p5l285t1577r405b1615],
6	assessed	VBN	O	assess	dep	16	SENT_52	[p5l430t1556r693b1615],
7	by	IN	O	by	_	0	SENT_52	[p5l717t1554r798b1633],
8	measurement	NN	O	measurement	agent	6	SENT_52	[p5l821t1573r1271b1615],
9	of	IN	O	of	_	0	SENT_52	[p5l1296t1554r1366b1615],
10	serum	NN	O	serum	nn	11	SENT_52	[p5l1381t1576r1584b1615],
11	TxB2	NN	O	txb2	prep_of	8	SENT_52	[p5l1606t1556r1860b1629],
12	.21	CD	NUMBER	.21	num	14	SENT_52	[p5l1606t1556r1860b1629],
13	COX-2	NN	O	cox-2	nn	14	SENT_52	[p5l1889t1557r2138b1615],
14	inhibition	NN	O	inhibition	nsubjpass	16	SENT_52	[p5l10t1662r352b1724],
15	was	VBD	O	be	auxpass	16	SENT_52	[p5l376t1686r495b1723],
16	assessed	VBN	O	assess	_	0	SENT_52	[p5l522t1664r784b1723],
17	ex	FW	O	ex	nn	18	SENT_52	[p5l810t1686r881b1723],
18	vivo	FW	O	vivo	dobj	16	SENT_52	[p5l903t1666r1044b1723],
19	by	IN	O	by	_	0	SENT_52	[p5l1070t1662r1150b1741],
20	measurement	NN	O	measurement	agent	16	SENT_52	[p5l1174t1682r1625b1723],
21	of	IN	O	of	_	0	SENT_52	[p5l1651t1662r1721b1723],
22	lipopolysaccharide-stimulated	JJ	O	lipopolysaccharide-stimulated	amod	23	SENT_52	[p5l1736t1664r2141b1741, p5l10t1762r648b1821],
23	PGE2	NN	O	pge2	prep_of	20	SENT_52	[p5l679t1763r864b1835],
24	in	IN	O	in	_	0	SENT_52	[p5l897t1764r961b1820],
25	plasma	NN	O	plasma	prep_in	23	SENT_52	[p5l988t1762r1306b1839],
26	.	.	O	.	_	0	SENT_52	[p5l988t1762r1306b1839],

1	”	NN	O	”	nsubj	15	SENT_53	[p5l988t1762r1306b1839],
2	The	DT	O	the	det	3	SENT_53	[p5l1337t1762r1467b1821],
3	coefﬁcients	NNS	O	coefﬁcients	dep	1	SENT_53	[p5l1497t1760r1868b1821],
4	of	IN	O	of	_	0	SENT_53	[p5l1899t1760r1969b1821],
5	variation	NN	O	variation	prep_of	1	SENT_53	[p5l1986t1764r2141b1821, p5l9t1862r179b1919],
6	for	IN	O	for	_	0	SENT_53	[p5l230t1858r322b1919],
7	repeatability	NN	O	repeatability	prep_for	5	SENT_53	[p5l372t1858r799b1937],
8	and	CC	O	and	_	0	SENT_53	[p5l850t1860r969b1919],
9	reproducibility	NN	O	reproducibility	prep_for	5	SENT_53	[p5l1022t1858r1532b1937],
10	were	VBD	O	be	cop	15	SENT_53	[p5l1582t1880r1738b1919],
11	4.3	CD	PERCENT	4.3	number	15	SENT_53	[p5l1789t1856r1965b1924],
12	%	NN	PERCENT	%	dep	15	SENT_53	[p5l1789t1856r1965b1924],
13	and	CC	O	and	_	0	SENT_53	[p5l2022t1860r2142b1919],
14	4.1	CD	PERCENT	4.1	conj_and	15	SENT_53	[p5l9t1955r211b2030],
15	%	NN	PERCENT	%	_	0	SENT_53	[p5l9t1955r211b2030],
16	,	,	O	,	_	0	SENT_53	[p5l9t1955r211b2030],
17	respectively	RB	O	respectively	advmod	15	SENT_53	[p5l239t1958r655b2036],
18	,	,	O	,	_	0	SENT_53	[p5l239t1958r655b2036],
19	for	IN	O	for	_	0	SENT_53	[p5l682t1956r774b2018],
20	COX-1	NN	O	cox-1	nn	21	SENT_53	[p5l797t1960r1043b2018],
21	inhibition	NN	O	inhibition	prep_for	15	SENT_53	[p5l1076t1956r1418b2018],
22	and	CC	O	and	_	0	SENT_53	[p5l1442t1958r1562b2018],
23	1.9	CD	PERCENT	1.9	num	24	SENT_53	[p5l1594t1960r1763b2024],
24	%	NN	PERCENT	%	prep_for	15	SENT_53	[p5l1594t1960r1763b2024],
25	and	CC	O	and	_	0	SENT_53	[p5l1793t1958r1913b2018],
26	4.3	CD	PERCENT	4.3	num	27	SENT_53	[p5l1937t1955r2140b2030],
27	%	NN	PERCENT	%	conj_and	21	SENT_53	[p5l1937t1955r2140b2030],
28	,	,	O	,	_	0	SENT_53	[p5l1937t1955r2140b2030],
29	respectively	RB	O	respectively	advmod	15	SENT_53	[p5l10t2056r426b2133],
30	,	,	O	,	_	0	SENT_53	[p5l10t2056r426b2133],
31	for	IN	O	for	_	0	SENT_53	[p5l466t2054r558b2115],
32	COX-2	NN	O	cox-2	nn	33	SENT_53	[p5l596t2057r845b2115],
33	inhibition	NN	O	inhibition	prep_for	15	SENT_53	[p5l888t2054r1247b2116],
34	.	.	O	.	_	0	SENT_53	[p5l888t2054r1247b2116],

1	Measurements	NNS	O	measurement	nsubjpass	3	SENT_54	[p5l1290t2059r1775b2115],
2	were	VBD	O	be	auxpass	3	SENT_54	[p5l1813t2076r1969b2115],
3	performed	VBN	O	perform	_	0	SENT_54	[p5l2006t2076r2141b2133, p5l9t2152r248b2213],
4	immediately	RB	O	immediately	advmod	3	SENT_54	[p5l280t2154r706b2231],
5	before	IN	O	before	_	0	SENT_54	[p5l737t2152r940b2213],
6	the	DT	O	the	det	7	SENT_54	[p5l972t2154r1076b2213],
7	administration	NN	O	administration	prep_before	3	SENT_54	[p5l1107t2154r1608b2213],
8	of	IN	O	of	_	0	SENT_54	[p5l1639t2152r1710b2213],
9	drug	NN	O	drug	nn	12	SENT_54	[p5l1730t2154r1889b2231],
10	(	NN	O	(	nn	12	SENT_54	[p5l1921t2155r1985b2223],
11	o	NN	O	o	nn	12	SENT_54	[p5l1921t2155r1985b2223],
12	hrs	NNS	DURATION	hr	prep_of	7	SENT_54	[p5l2017t2154r2142b2224],
13	)	CD	NUMBER	)	num	16	SENT_54	[p5l2017t2154r2142b2224],
14	and	CC	O	and	_	0	SENT_54	[p5l9t2252r129b2312],
15	4	CD	DURATION	4	num	16	SENT_54	[p5l161t2249r201b2310],
16	hours	NNS	NUMBER	hour	npadvmod	17	SENT_54	[p5l234t2253r417b2312],
17	thereafter	RB	O	thereafter	advmod	3	SENT_54	[p5l451t2250r791b2312],
18	.	.	O	.	_	0	SENT_54	[p5l451t2250r791b2312],

1	Urinary	JJ	O	urinary	amod	3	SENT_55	[p5l827t2255r1091b2329],
2	2,3-dinor	JJ	O	2,3-dinor	amod	3	SENT_55	[p5l1125t2249r1665b2324],
3	—	NN	O	—	tmod	33	SENT_55	[p5l1125t2249r1665b2324],
4	6keto	CD	NUMBER	6keto	num	3	SENT_55	[p5l1125t2249r1665b2324],
5	PGF	NN	O	pgf	dep	3	SENT_55	[p5l1699t2254r1851b2312],
6	10	CD	NUMBER	10	num	5	SENT_55	[p5l1860t2290r1916b2326],
7	,	,	O	,	_	0	SENT_55	[p5l1860t2290r1916b2326],
8	(	CD	NUMBER	(	num	10	SENT_55	[p5l1949t2254r2140b2322, p5l8t2352r125b2422],
9	PGIM	NN	O	pgim	nn	10	SENT_55	[p5l1949t2254r2140b2322, p5l8t2352r125b2422],
10	)	NN	O	)	nsubjpass	33	SENT_55	[p5l1949t2254r2140b2322, p5l8t2352r125b2422],
11	,	,	O	,	_	0	SENT_55	[p5l1949t2254r2140b2322, p5l8t2352r125b2422],
12	an	DT	O	a	det	13	SENT_55	[p5l170t2371r246b2409],
13	index	NN	O	index	appos	10	SENT_55	[p5l289t2350r474b2409],
14	of	IN	O	of	_	0	SENT_55	[p5l516t2348r587b2409],
15	PGI2	NN	O	pgi2	nn	16	SENT_55	[p5l621t2352r786b2424],
16	biosynthesis	NN	O	biosynthesis	prep_of	13	SENT_55	[p5l832t2348r1325b2427],
17	,25	CD	NUMBER	,25	dep	25	SENT_55	[p5l832t2348r1325b2427],
18	and	CC	O	and	_	0	SENT_55	[p5l1371t2350r1490b2409],
19	11-dehydro	JJ	O	11-dehydro	amod	20	SENT_55	[p5l1541t2350r1926b2427],
20	TXB2	NN	O	txb2	dep	25	SENT_55	[p5l1968t2351r2140b2424],
21	(	CD	NUMBER	(	num	22	SENT_55	[p5l10t2446r337b2520],
22	TX-M	NN	O	tx-m	dep	25	SENT_55	[p5l10t2446r337b2520],
23	)	CD	NUMBER	)	number	24	SENT_55	[p5l10t2446r337b2520],
24	,24	CD	NUMBER	,24	num	25	SENT_55	[p5l10t2446r337b2520],
25	reﬂective	NN	O	reﬂective	dep	13	SENT_55	[p5l363t2447r665b2508],
26	of	IN	O	of	_	0	SENT_55	[p5l690t2447r761b2508],
27	TXA2	NN	O	txa2	nn	28	SENT_55	[p5l775t2449r952b2522],
28	formation	NN	O	formation	prep_of	25	SENT_55	[p5l979t2447r1312b2508],
29	in	FW	O	in	prep	13	SENT_55	[p5l1338t2451r1402b2507],
30	vivo	FW	O	vivo	pobj	29	SENT_55	[p5l1425t2451r1587b2521],
31	,	,	O	,	_	0	SENT_55	[p5l1425t2451r1587b2521],
32	were	VBD	O	be	auxpass	33	SENT_55	[p5l1613t2470r1769b2508],
33	assessed	VBN	O	assess	_	0	SENT_55	[p5l1793t2449r2056b2508],
34	at	IN	O	at	_	0	SENT_55	[p5l2081t2466r2142b2508],
35	o	NN	O	o	prep_at	33	SENT_55	[p5l11t2550r49b2606],
36	and	CC	O	and	_	0	SENT_55	[p5l89t2547r209b2606],
37	4	CD	DURATION	4	num	38	SENT_55	[p5l248t2543r289b2605],
38	hours	NNS	NUMBER	hour	prep_at	33	SENT_55	[p5l328t2547r511b2606],
39	in	IN	O	in	_	0	SENT_55	[p5l553t2549r618b2605],
40	spot	NN	O	spot	nn	42	SENT_55	[p5l657t2564r796b2624],
41	urine	NN	O	urine	nn	42	SENT_55	[p5l836t2549r1010b2606],
42	samples	NNS	O	sample	prep_in	33	SENT_55	[p5l1050t2547r1311b2624],
43	that	WDT	O	that	nsubjpass	45	SENT_55	[p5l1353t2547r1486b2605],
44	were	VBD	O	be	auxpass	45	SENT_55	[p5l1525t2567r1680b2606],
45	collected	VBN	O	collect	rcmod	42	SENT_55	[p5l1720t2547r2017b2606],
46	30	CD	DURATION	30	num	47	SENT_55	[p5l2061t2550r2140b2611],
47	minutes	NNS	NUMBER	minute	npadvmod	45	SENT_55	[p5l9t2647r282b2704],
48	after	IN	O	after	_	0	SENT_55	[p5l323t2643r474b2704],
49	voiding	VBG	O	void	prepc_after	45	SENT_55	[p5l512t2645r789b2722],
50	.	.	O	.	_	0	SENT_55	[p5l512t2645r789b2722],

1	The	DT	O	the	det	2	SENT_56	[p5l833t2645r964b2704],
2	coefﬁcients	NNS	O	coefﬁcients	nsubj	9	SENT_56	[p5l1005t2643r1376b2704],
3	of	IN	O	of	_	0	SENT_56	[p5l1418t2643r1489b2704],
4	variation	NN	O	variation	prep_of	2	SENT_56	[p5l1517t2647r1817b2704],
5	for	IN	O	for	_	0	SENT_56	[p5l1857t2643r1949b2704],
6	both	DT	O	both	det	7	SENT_56	[p5l1989t2643r2142b2705],
7	assays	NNS	O	assay	prep_for	4	SENT_56	[p5l9t2765r202b2820],
8	were	VBD	O	be	cop	9	SENT_56	[p5l240t2763r395b2802],
9	<	JJR	O	<	_	0	SENT_56	[p5l438t2744r684b2805],
10	10	CD	PERCENT	10	number	11	SENT_56	[p5l438t2744r684b2805],
11	%	NN	PERCENT	%	amod	9	SENT_56	[p5l438t2744r684b2805],
12	.	.	O	.	_	0	SENT_56	[p5l438t2744r684b2805],

1	A	DT	O	a	det	2	SENT_57	[p5l725t2743r782b2801],
2	subset	NN	O	subset	nsubj	6	SENT_57	[p5l819t2741r1027b2803],
3	of	IN	O	of	_	0	SENT_57	[p5l1065t2741r1135b2802],
4	the	DT	O	the	det	5	SENT_57	[p5l1163t2743r1267b2802],
5	volunteers	NNS	O	volunteer	prep_of	2	SENT_57	[p5l1303t2743r1651b2802],
6	(	VBP	O	(	_	0	SENT_57	[p5l1689t2744r1755b2812],
7	n	NN	O	n	nsubj	35	SENT_57	[p5l1689t2744r1755b2812],
8	‘	CD	NUMBER	‘	num	7	SENT_57	[p5l1801t2761r1854b2766],
9	5	CD	NUMBER	5	num	10	SENT_57	[p5l1904t2745r1965b2813],
10	)	NN	O	)	nsubj	11	SENT_57	[p5l1904t2745r1965b2813],
11	progressed	VBD	O	progress	rcmod	7	SENT_57	[p5l2001t2763r2140b2820, p5l8t2852r252b2929],
12	through	IN	O	through	_	0	SENT_57	[p5l288t2852r560b2929],
13	the	DT	O	the	det	15	SENT_57	[p5l595t2852r699b2911],
14	entire	JJ	O	entire	amod	15	SENT_57	[p5l734t2854r928b2911],
15	protocol	NN	O	protocol	prep_through	11	SENT_57	[p5l960t2852r1240b2929],
16	on	IN	O	on	_	0	SENT_57	[p5l1275t2872r1355b2911],
17	5	CD	NUMBER	5	num	18	SENT_57	[p5l1394t2855r1424b2914],
18	occasions	NNS	O	occasion	prep_on	11	SENT_57	[p5l1465t2854r1792b2923],
19	,	,	O	,	_	0	SENT_57	[p5l1465t2854r1792b2923],
20	each	DT	O	each	dobj	11	SENT_57	[p5l1829t2852r1974b2911],
21	separated	VBN	O	separate	partmod	20	SENT_57	[p5l2008t2872r2141b2929, p5l9t2950r213b3010],
22	by	IN	O	by	_	0	SENT_57	[p5l242t2948r322b3027],
23	2	CD	DURATION	2	num	24	SENT_57	[p5l352t2954r387b3008],
24	weeks	NNS	NUMBER	week	agent	21	SENT_57	[p5l418t2948r638b3022],
25	,	,	O	,	_	0	SENT_57	[p5l418t2948r638b3022],
26	to	TO	O	to	aux	27	SENT_57	[p5l669t2968r734b3010],
27	assess	VB	O	assess	xcomp	21	SENT_57	[p5l762t2972r945b3010],
28	intraindividual	JJ	O	intraindividual	amod	29	SENT_57	[p5l976t2950r1485b3010],
29	variability	NN	O	variability	dobj	27	SENT_57	[p5l1512t2948r1862b3027],
30	in	IN	O	in	_	0	SENT_57	[p5l1890t2953r1955b3008],
31	drug	NN	O	drug	nn	32	SENT_57	[p5l1983t2950r2141b3028],
32	response	NN	O	response	prep_in	27	SENT_57	[p5l10t3079r292b3136],
33	in	IN	O	in	_	0	SENT_57	[p5l326t3061r392b3117],
34	5	CD	NUMBER	5	prep_in	32	SENT_57	[p5l429t3063r459b3121],
35	replicates	VBZ	O	replicate	ccomp	6	SENT_57	[p5l499t3059r834b3136],
36	.	.	O	.	_	0	SENT_57	[p5l499t3059r834b3136],

1	Plasma	NN	O	plasma	nn	2	SENT_58	[p5l281t3261r588b3327],
2	Drug	NN	O	drug	_	0	SENT_58	[p5l632t3261r826b3344],
3	Concentrations	NNP	O	Concentrations	nn	5	SENT_58	[p5l861t3260r1489b3327],
4	Plasma	NN	O	plasma	nn	5	SENT_58	[p5l278t3366r517b3425],
5	samples	NNS	O	sample	nsubjpass	7	SENT_58	[p5l546t3366r807b3443],
6	were	VBD	O	be	auxpass	7	SENT_58	[p5l838t3386r993b3425],
7	analyzed	VBN	O	analyze	rcmod	2	SENT_58	[p5l1024t3366r1311b3443],
8	by	IN	O	by	_	0	SENT_58	[p5l1342t3364r1423b3443],
9	liquid	JJ	O	liquid	amod	10	SENT_58	[p5l1453t3366r1656b3443],
10	chromatography	NN	O	chromatography	agent	7	SENT_58	[p5l1687t3366r2141b3443, p6l7t17r134b94],

1	tandem	JJ	O	tandem	amod	3	SENT_59	[p6l170t17r423b76],
2	mass	NN	O	mass	nn	3	SENT_59	[p6l458t38r616b76],
3	spectrometry	NN	O	spectrometry	nsubj	13	SENT_59	[p6l653t34r1094b94],
4	(	CD	NUMBER	(	dep	3	SENT_59	[p6l1129t18r1422b93],
5	Quattro	NNP	PERSON	Quattro	nn	13	SENT_59	[p6l1129t18r1422b93],
6	Ultima	NNP	PERSON	Ultima	nn	13	SENT_59	[p6l1457t17r1721b88],
7	,	,	O	,	_	0	SENT_59	[p6l1457t17r1721b88],
8	Micromass	NNP	ORGANIZATION	Micromass	appos	13	SENT_59	[p6l1757t19r2140b88],
9	,	,	O	,	_	0	SENT_59	[p6l1757t19r2140b88],
10	Beverly	NNP	PERSON	Beverly	appos	13	SENT_59	[p6l10t115r283b192],
11	,	,	O	,	_	0	SENT_59	[p6l10t115r283b192],
12	MA	NNP	LOCATION	MA	appos	13	SENT_59	[p6l334t116r489b185],
13	)	NNP	O	)	_	0	SENT_59	[p6l334t116r489b185],
14	using	VBG	O	use	partmod	13	SENT_59	[p6l538t118r722b193],
15	L75510O	NN	O	l75510o	nn	18	SENT_59	[p6l771t118r1078b178],
16	(	CD	NUMBER	(	num	18	SENT_59	[p6l1129t113r1369b185],
17	Merck	NNP	ORGANIZATION	Merck	nn	18	SENT_59	[p6l1129t113r1369b185],
18	Frosst	NNP	ORGANIZATION	Frosst	dobj	14	SENT_59	[p6l1417t118r1636b187],
19	,	,	O	,	_	0	SENT_59	[p6l1417t118r1636b187],
20	Point	NNP	O	Point	nn	21	SENT_59	[p6l1689t118r1871b175],
21	Claire	NNP	PERSON	Claire	conj_and	18	SENT_59	[p6l1921t115r2140b187],
22	,	,	O	,	_	0	SENT_59	[p6l1921t115r2140b187],
23	Canada	NNP	LOCATION	Canada	conj_and	18	SENT_59	[p6l10t213r277b283],
24	)	CD	NUMBER	)	num	23	SENT_59	[p6l10t213r277b283],
25	and	CC	O	and	_	0	SENT_59	[p6l315t213r434b272],
26	SC58125	CD	NUMBER	sc58125	number	27	SENT_59	[p6l472t214r778b276],
27	(	CD	NUMBER	(	conj_and	18	SENT_59	[p6l822t215r1140b290],
28	Cayman	NNP	PERSON	Cayman	dep	27	SENT_59	[p6l822t215r1140b290],
29	,	,	O	,	_	0	SENT_59	[p6l822t215r1140b290],
30	Ann	NNP	PERSON	Ann	nn	31	SENT_59	[p6l1178t214r1324b271],
31	Arbor	NNP	PERSON	Arbor	dobj	13	SENT_59	[p6l1360t211r1580b285],
32	,	,	O	,	_	0	SENT_59	[p6l1360t211r1580b285],
33	MI	NNP	O	MI	appos	31	SENT_59	[p6l1619t215r1744b283],
34	)	CD	NUMBER	)	num	33	SENT_59	[p6l1619t215r1744b283],
35	as	IN	O	as	_	0	SENT_59	[p6l1781t235r1841b272],
36	internal	JJ	O	internal	amod	37	SENT_59	[p6l1880t213r2141b272],
37	standards	NNS	O	standard	prep_as	33	SENT_59	[p6l10t311r326b370],
38	for	IN	O	for	_	0	SENT_59	[p6l372t309r464b370],
39	celecoxib	NN	O	celecoxib	prep_for	37	SENT_59	[p6l509t309r816b370],
40	and	CC	O	and	_	0	SENT_59	[p6l862t311r982b370],
41	rofecoxib	NN	O	rofecoxib	conj_and	39	SENT_59	[p6l1029t309r1356b382],
42	,	,	O	,	_	0	SENT_59	[p6l1029t309r1356b382],
43	respectively	RB	O	respectively	advmod	31	SENT_59	[p6l1405t311r1819b388],
44	.	.	O	.	_	0	SENT_59	[p6l1405t311r1819b388],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_60	[p6l1870t311r2141b388],
2	were	VBD	O	be	auxpass	3	SENT_60	[p6l8t430r163b469],
3	chromatographed	VBN	O	chromatograph	_	0	SENT_60	[p6l205t409r799b487],
4	on	IN	O	on	_	0	SENT_60	[p6l840t430r921b469],
5	a	DT	O	a	det	7	SENT_60	[p6l961t432r994b468],
6	Luna	NNP	O	Luna	nn	7	SENT_60	[p6l1031t412r1199b469],
7	3p	NN	O	3p	prep_on	3	SENT_60	[p6l1242t413r1337b486],
8	.	.	O	.	_	0	SENT_60	[p6l1242t413r1337b486],

1	C18	NN	O	c18	nn	2	SENT_61	[p6l1379t411r1486b484],
2	(	NN	O	(	_	0	SENT_61	[p6l1528t411r1681b479],
3	150	CD	NUMBER	150	num	4	SENT_61	[p6l1528t411r1681b479],
4	X	NN	O	x	amod	2	SENT_61	[p6l1732t412r1785b464],
5	2.0	CD	NUMBER	2.0	num	7	SENT_61	[p6l1837t413r1941b469],
6	mm	NN	O	mm	nn	7	SENT_61	[p6l1982t411r2142b479],
7	)	NN	O	)	dep	4	SENT_61	[p6l1982t411r2142b479],
8	column	NN	O	column	nn	10	SENT_61	[p6l10t507r263b566],
9	(	CD	NUMBER	(	num	10	SENT_61	[p6l305t507r781b578],
10	Phenomenex	NNP	PERSON	Phenomenex	dep	7	SENT_61	[p6l305t507r781b578],
11	,	,	O	,	_	0	SENT_61	[p6l305t507r781b578],
12	Torrance	NNP	PERSON	Torrance	appos	7	SENT_61	[p6l823t508r1143b578],
13	,	,	O	,	_	0	SENT_61	[p6l823t508r1143b578],
14	CA	NNP	O	CA	nn	15	SENT_61	[p6l1187t507r1321b577],
15	)	NNP	O	)	appos	12	SENT_61	[p6l1187t507r1321b577],
16	and	CC	O	and	_	0	SENT_61	[p6l1363t507r1482b566],
17	quantitated	VBN	O	quantitate	conj_and	15	SENT_61	[p6l1525t507r1916b584],
18	using	VBG	O	use	xcomp	17	SENT_61	[p6l1958t509r2141b584],
19	negative-atmospheric-pressure	JJ	O	negative-atmospheric-pressure	amod	20	SENT_61	[p6l10t616r1044b693],
20	ionization	NN	O	ionization	dobj	18	SENT_61	[p6l1072t618r1410b675],
21	and	CC	O	and	_	0	SENT_61	[p6l1436t615r1556b675],
22	selected	VBN	O	select	conj_and	15	SENT_61	[p6l1585t615r1847b675],
23	reaction	NN	O	reaction	nn	24	SENT_61	[p6l1875t618r2143b675],
24	monitoring	NN	O	monitoring	dobj	22	SENT_61	[p6l9t716r395b791],
25	of	IN	O	of	_	0	SENT_61	[p6l441t712r512b773],
26	m/z	NN	O	m/z	prep_of	24	SENT_61	[p6l546t716r657b774],
27	380.2	CD	NUMBER	380.2	num	26	SENT_61	[p6l705t711r1180b779],
28	+3	CD	NUMBER	+3	num	29	SENT_61	[p6l705t711r1180b779],
29	l6	NN	O	l6	dobj	17	SENT_61	[p6l705t711r1180b779],
30	.1	CD	NUMBER	.1	number	31	SENT_61	[p6l705t711r1180b779],
31	(	CD	NUMBER	(	num	33	SENT_61	[p6l1232t712r1609b786],
32	celecoxib	NN	O	celecoxib	nn	33	SENT_61	[p6l1232t712r1609b786],
33	)	NN	O	)	dep	29	SENT_61	[p6l1232t712r1609b786],
34	,	,	O	,	_	0	SENT_61	[p6l1232t712r1609b786],
35	384.2	CD	PERCENT	384.2	num	36	SENT_61	[p6l1660t711r2135b779],
36	%	NN	PERCENT	%	conj_and	29	SENT_61	[p6l1660t711r2135b779],
37	305.1	CD	NUMBER	305.1	number	38	SENT_61	[p6l1660t711r2135b779],
38	(	CD	NUMBER	(	num	40	SENT_61	[p6l10t814r392b884],
39	SC58125	NN	O	sc58125	nn	40	SENT_61	[p6l10t814r392b884],
40	)	NN	O	)	dep	36	SENT_61	[p6l10t814r392b884],
41	,	,	O	,	_	0	SENT_61	[p6l10t814r392b884],
42	314.2	CD	NUMBER	314.2	number	43	SENT_61	[p6l467t809r942b878],
43	+2	CD	NUMBER	+2	num	44	SENT_61	[p6l467t809r942b878],
44	l5	NN	O	l5	conj_and	29	SENT_61	[p6l467t809r942b878],
45	.1	CD	NUMBER	.1	number	46	SENT_61	[p6l467t809r942b878],
46	(	CD	NUMBER	(	num	48	SENT_61	[p6l1018t811r1396b884],
47	rofecoxib	NN	O	rofecoxib	nn	48	SENT_61	[p6l1018t811r1396b884],
48	)	NN	O	)	dep	44	SENT_61	[p6l1018t811r1396b884],
49	,	,	O	,	_	0	SENT_61	[p6l1018t811r1396b884],
50	and	CC	O	and	_	0	SENT_61	[p6l1467t813r1587b872],
51	328.2	CD	NUMBER	328.2	number	52	SENT_61	[p6l1660t816r2135b878],
52	+3	CD	NUMBER	+3	num	53	SENT_61	[p6l1660t816r2135b878],
53	l3	NN	O	l3	conj_and	29	SENT_61	[p6l1660t816r2135b878],
54	.1	CD	NUMBER	.1	number	55	SENT_61	[p6l1660t816r2135b878],
55	(	CD	NUMBER	(	num	57	SENT_61	[p6l10t913r384b981],
56	L755100	NN	O	l755100	nn	57	SENT_61	[p6l10t913r384b981],
57	)	NN	O	)	dep	53	SENT_61	[p6l10t913r384b981],
58	.	.	O	.	_	0	SENT_61	[p6l10t913r384b981],

1	The	DT	O	the	det	2	SENT_62	[p6l423t912r554b971],
2	coefficients	NNS	O	coefficient	nsubj	10	SENT_62	[p6l590t909r961b971],
3	of	IN	O	of	_	0	SENT_62	[p6l998t909r1069b971],
4	variation	NN	O	variation	prep_of	2	SENT_62	[p6l1092t914r1392b971],
5	for	IN	O	for	_	0	SENT_62	[p6l1427t909r1519b971],
6	these	DT	O	these	det	7	SENT_62	[p6l1554t912r1723b971],
7	assays	NNS	O	assay	prep_for	4	SENT_62	[p6l1758t933r1951b988],
8	were	VBD	O	be	cop	10	SENT_62	[p6l1987t932r2142b971],
9	5.4	CD	PERCENT	5.4	num	10	SENT_62	[p6l14t1005r186b1071],
10	%	NN	PERCENT	%	_	0	SENT_62	[p6l14t1005r186b1071],
11	for	IN	O	for	_	0	SENT_62	[p6l224t1007r316b1068],
12	celecoxib	NN	O	celecoxib	prep_for	10	SENT_62	[p6l349t1007r655b1069],
13	and	CC	O	and	_	0	SENT_62	[p6l689t1009r809b1068],
14	8.6	CD	PERCENT	8.6	num	15	SENT_62	[p6l844t1006r1019b1071],
15	%	NN	PERCENT	%	conj_and	10	SENT_62	[p6l844t1006r1019b1071],
16	for	IN	O	for	_	0	SENT_62	[p6l1057t1007r1149b1068],
17	rofecoxib	NN	O	rofecoxib	nn	18	SENT_62	[p6l1182t1007r1488b1069],
18	measurements	NNS	O	measurement	prep_for	15	SENT_62	[p6l1522t1026r2021b1068],
19	.	.	O	.	_	0	SENT_62	[p6l1522t1026r2021b1068],

1	January	NNP	DATE	January	_	0	SENT_63	[p6l42t1146r152b1175],
2	2006	CD	DATE	2006	num	1	SENT_63	[p6l165t1146r240b1169],
3	VARIABILITY	NNP	O	VARIABILITY	dep	1	SENT_63	[p6l1423t1146r1601b1169],
4	IN	IN	O	in	_	0	SENT_63	[p6l1614t1146r1640b1169],
5	THE	DT	O	the	det	6	SENT_63	[p6l1653t1146r1708b1169],
6	RESPONSE	NN	O	response	prep_in	3	SENT_63	[p6l1722t1146r1877b1169],
7	TO	TO	O	to	infmod	6	SENT_63	[p6l1889t1146r1926b1169],
8	COXIBS	NNP	O	COXIBS	dep	1	SENT_63	[p6l1939t1146r2045b1169],
9	57	CD	NUMBER	57	num	8	SENT_63	[p6l2080t1146r2117b1169],

1	Table	NNP	O	Table	_	0	SENT_64	[p6l43t1250r132b1277],
2	2	CD	NUMBER	2	dep	1	SENT_64	[p6l147t1250r177b1277],
3	.	.	O	.	_	0	SENT_64	[p6l147t1250r177b1277],

1	Single	JJ	O	single	amod	3	SENT_65	[p6l200t1250r297b1284],
2	Nucleotide	NN	O	nucleotide	nn	3	SENT_65	[p6l314t1250r484b1277],
3	Polymorphisms	NNS	O	polymorphism	_	0	SENT_65	[p6l500t1250r744b1284],

1	Allele	NN	MISC	allele	nn	2	SENT_66	[p6l1836t1319r1913b1343],
2	frequency	NN	O	frequency	_	0	SENT_66	[p6l1926t1319r2067b1349],

1	Accessiona/reference	NN	O	accessiona/reference	nn	2	SENT_67	[p6l657t1411r970b1440],
2	Base/amino	NN	O	base/amino	_	0	SENT_67	[p6l1435t1411r1612b1440],
3	Major	JJ	O	major	amod	4	SENT_67	[p6l1787t1411r1866b1440],
4	Minor	NNP	O	Minor	dep	2	SENT_67	[p6l2038t1411r2118b1435],

1	COX-1	NN	O	cox-1	_	0	SENT_68	[p6l7t1541r216b1599],
2	Promoter	NN	O	promoter	nn	4	SENT_68	[p6l727t1542r1045b1599],
3	(	CD	NUMBER	(	num	4	SENT_68	[p6l1525t1542r1875b1612],
4	Halushka	NNP	PERSON	Halushka	dep	1	SENT_68	[p6l1525t1542r1875b1612],
5	et	FW	O	et	dep	4	SENT_68	[p6l1908t1545r1975b1599],
6	al45	FW	O	al45	nn	7	SENT_68	[p6l2006t1534r2153b1612],
7	)	FW	O	)	amod	5	SENT_68	[p6l2006t1534r2153b1612],

1	Signal	NN	O	signal	nn	2	SENT_69	[p6l726t1641r934b1714],
2	rs1236913	NN	O	rs1236913	_	0	SENT_69	[p6l1526t1641r1929b1699],
3	rs3842787	CD	NUMBER	rs3842787	num	5	SENT_69	[p6l1527t1742r1926b1799],
4	EGF	NN	O	egf	nn	5	SENT_69	[p6l729t1841r863b1898],
5	rs3842789	NN	O	rs3842789	dep	2	SENT_69	[p6l1527t1841r1928b1898],
6	Catalytic	JJ	MISC	catalytic	amod	7	SENT_69	[p6l725t1941r1022b2013],
7	rs3842792	NN	O	rs3842792	dep	2	SENT_69	[p6l1526t1941r1927b1999],

1	(	NNP	O	(	nn	2	SENT_70	[p6l1525t2042r1740b2113],
2	Ulrich	NNP	PERSON	Ulrich	dep	13	SENT_70	[p6l1525t2042r1740b2113],
3	et	FW	O	et	nn	7	SENT_70	[p6l1776t2046r1843b2100],
4	al43	FW	O	al43	nn	7	SENT_70	[p6l1874t2034r2022b2113],
5	)	FW	O	)	nn	7	SENT_70	[p6l1874t2034r2022b2113],
6	rs5789	FW	O	rs5789	nn	7	SENT_70	[p6l1527t2141r1782b2198],
7	(	FW	O	(	dep	2	SENT_70	[p6l1525t2242r1740b2312],
8	Ulrich	NNP	PERSON	Ulrich	dep	13	SENT_70	[p6l1525t2242r1740b2312],
9	et	FW	O	et	nn	13	SENT_70	[p6l1776t2246r1843b2300],
10	al43	FW	O	al43	nn	13	SENT_70	[p6l1874t2234r2021b2312],
11	)	FW	O	)	nn	13	SENT_70	[p6l1874t2234r2021b2312],
12	rs5791	NN	O	rs5791	nn	13	SENT_70	[p6l1527t2342r1782b2399],
13	rs5792	NN	O	rs5792	_	0	SENT_70	[p6l1527t2441r1781b2498],
14	rs5793	NN	O	rs5793	nn	15	SENT_70	[p6l1526t2541r1782b2600],
15	rs5794	NN	O	rs5794	dep	13	SENT_70	[p6l1527t2643r1783b2700],

1	COX-2	NN	O	cox-2	_	0	SENT_71	[p6l7t2742r215b2800],
2	Promoter	NN	O	promoter	nn	4	SENT_71	[p6l727t2743r1045b2800],
3	(	CD	NUMBER	(	num	4	SENT_71	[p6l1525t2743r1802b2813],
4	Papatili	NNP	O	Papatili	dep	1	SENT_71	[p6l1525t2743r1802b2813],
5	et	FW	O	et	dep	4	SENT_71	[p6l1838t2746r1905b2800],
6	al44	FW	O	al44	nn	7	SENT_71	[p6l1937t2735r2084b2813],
7	)	FW	O	)	amod	5	SENT_71	[p6l1937t2735r2084b2813],

1	Signal	NN	O	signal	nn	2	SENT_72	[p6l726t2842r934b2915],
2	rs20426	NN	O	rs20426	_	0	SENT_72	[p6l1527t2842r1831b2900],
3	Menﬂwane	NN	O	menﬂwane	nn	4	SENT_72	[p6l729t2943r1098b3000],
4	rs4987011	NN	O	rs4987011	dep	2	SENT_72	[p6l1527t2943r1928b3000],
5	Catalytic	JJ	MISC	catalytic	amod	9	SENT_72	[p6l725t3042r1022b3114],
6	rs3218622	NN	O	rs3218622	nn	9	SENT_72	[p6l1527t3042r1927b3100],
7	rs4648279	NN	O	rs4648279	nn	9	SENT_72	[p6l1527t3142r1928b3201],
8	rs5272	NN	O	rs5272	nn	9	SENT_72	[p6l1527t3244r1781b3301],
9	rs5273	NN	O	rs5273	dep	2	SENT_72	[p6l1527t3343r1782b3400],

1	Ciennmus	NNP	O	Ciennmus	_	0	SENT_73	[p6l725t3443r1100b3502],
2	rs3218625	CD	NUMBER	rs3218625	num	6	SENT_73	[p6l1526t3443r1928b3502],
3	CYP2C9	NNP	O	CYP2C9	nn	6	SENT_73	[p6l7t3545r290b3603],
4	Catalytic	NNP	MISC	Catalytic	nn	6	SENT_73	[p6l725t3545r1022b3616],
5	rs1799853b	NN	O	rs1799853b	nn	6	SENT_73	[p6l1527t3538r1963b3603],
6	rs2256871	NN	O	rs2256871	dep	1	SENT_73	[p6l1527t3644r1960b3701],
7	°	CD	NUMBER	°	num	8	SENT_73	[p6l1527t3644r1960b3701],
8	rs1057909	NN	O	rs1057909	dep	1	SENT_73	[p6l1526t3744r1928b3803],

1	aAccession	NN	O	aaccession	nn	2	SENT_74	[p7l9t2789r336b2839],
2	numbers	NNS	O	number	nsubj	3	SENT_74	[p7l368t2789r628b2839],
3	refer	VBP	O	refer	_	0	SENT_74	[p7l659t2789r796b2839],
4	to	TO	O	to	_	0	SENT_74	[p7l818t2792r875b2839],
5	the	DT	O	the	det	8	SENT_74	[p7l901t2789r997b2839],
6	NCBI	NNP	O	NCBI	nn	8	SENT_74	[p7l1028t2789r1168b2839],
7	(	CD	NUMBER	(	num	8	SENT_74	[p7l1200t2789r1274b2850],
8	rs	NNS	O	r	prep_to	3	SENT_74	[p7l1200t2789r1274b2850],
9	. . .	VBP	O	. . .	dep	8	SENT_74	[p7l1390t2830r1399b2838],[p7l1307t2830r1315b2838],
10	bCYP2C9	NN	O	bcyp2c9	nn	11	SENT_74	[p7l8t2869r372b2926],
11	*	NN	O	*	dobj	9	SENT_74	[p7l8t2869r372b2926],
12	2	CD	NUMBER	2	num	11	SENT_74	[p7l8t2869r372b2926],
13	.	.	O	.	_	0	SENT_74	[p7l8t2869r372b2926],

1	°	NN	O	°	nn	2	SENT_75	[p7l9t2963r369b3012],
2	CYP2C9	NN	O	cyp2c9	_	0	SENT_75	[p7l9t2963r369b3012],
3	*	CD	NUMBER	*	number	4	SENT_75	[p7l9t2963r369b3012],
4	9	CD	NUMBER	9	num	2	SENT_75	[p7l9t2963r369b3012],
5	.	.	O	.	_	0	SENT_75	[p7l9t2963r369b3012],

1	C’CYP	NN	O	c’cyp	nn	2	SENT_76	[p7l9t3042r372b3098],
2	2C9	NN	O	2c9	_	0	SENT_76	[p7l9t3042r372b3098],
3	*	CD	NUMBER	*	number	4	SENT_76	[p7l9t3042r372b3098],
4	3	CD	NUMBER	3	num	2	SENT_76	[p7l9t3042r372b3098],
5	.	.	O	.	_	0	SENT_76	[p7l9t3042r372b3098],

1	eCYP2C9	NN	O	ecyp2c9	_	0	SENT_77	[p7l9t3134r372b3184],
2	*	CD	NUMBER	*	number	3	SENT_77	[p7l9t3134r372b3184],
3	4	CD	NUMBER	4	num	1	SENT_77	[p7l9t3134r372b3184],
4	.	.	O	.	_	0	SENT_77	[p7l9t3134r372b3184],

1	fCYP2C9	NN	O	fcyp2c9	_	0	SENT_78	[p7l10t3214r361b3271],
2	*	CD	NUMBER	*	number	3	SENT_78	[p7l10t3214r361b3271],
3	5	CD	NUMBER	5	num	1	SENT_78	[p7l10t3214r361b3271],
4	.	.	O	.	_	0	SENT_78	[p7l10t3214r361b3271],

1	G/A	NN	O	g/a	nn	2	SENT_79	[p7l694t331r821b397],
2	Trp/Arg	NN	O	trp/arg	_	0	SENT_79	[p7l691t425r936b492],
3	Pro/Leu	NNP	O	Pro/Leu	nn	21	SENT_79	[p7l695t518r950b584],
4	Arg/His	NNP	O	Arg/His	nn	21	SENT_79	[p7l691t610r937b677],
5	Lys/Thr	NNP	O	Lys/Thr	nn	21	SENT_79	[p7l696t704r941b770],
6	Gly/Ser	NNP	O	Gly/Ser	nn	21	SENT_79	[p7l694t797r941b863],
7	Leu/Met	NNP	O	Leu/Met	nn	21	SENT_79	[p7l696t889r975b955],
8	Lys/Arg	NNP	O	Lys/Arg	nn	21	SENT_79	[p7l696t983r942b1050],
9	Lys/Arg	NNP	O	Lys/Arg	nn	21	SENT_79	[p7l696t1076r942b1143],
10	He/Val	NNP	O	He/Val	nn	21	SENT_79	[p7l696t1168r903b1234],
11	Lys/Glu	NNP	O	Lys/Glu	nn	21	SENT_79	[p7l696t1261r941b1328],
12	Val/lle	NNP	O	Val/lle	nn	21	SENT_79	[p7l691t1355r906b1421],
13	G/C	NNP	O	G/C	nn	21	SENT_79	[p7l694t1447r823b1513],
14	Met/lle	NNP	O	Met/lle	nn	21	SENT_79	[p7l696t1541r931b1606],
15	Thr/Arg	NNP	O	Thr/Arg	nn	21	SENT_79	[p7l691t1634r936b1701],
16	Arg/His	NNP	O	Arg/His	nn	21	SENT_79	[p7l691t1726r937b1793],
17	Pro/Ala	NNP	O	Pro/Ala	nn	21	SENT_79	[p7l695t1820r934b1885],
18	Glu/Gly	NNP	O	Glu/Gly	nn	21	SENT_79	[p7l694t1913r938b1979],
19	Val/Ala	NNP	O	Val/Ala	nn	21	SENT_79	[p7l691t2005r928b2071],
20	Gly/Arg	NNP	O	Gly/Arg	nn	21	SENT_79	[p7l694t2098r933b2166],
21	Arg/Cys	NNPS	O	Arg/Cys	dep	2	SENT_79	[p7l691t2192r948b2259],
22	His/Arg	NNP	O	His/Arg	nn	26	SENT_79	[p7l696t2284r941b2351],
23	Tyr/Cys	NNPS	O	Tyr/Cys	nn	26	SENT_79	[p7l691t2377r937b2444],
24	He/Leu	NNP	O	He/Leu	nn	26	SENT_79	[p7l696t2471r921b2537],
25	He/Thr	NNP	O	He/Thr	nn	26	SENT_79	[p7l696t2563r910b2629],
26	Asp/Glu	NNP	O	Asp/Glu	dep	21	SENT_79	[p7l691t2656r955b2722],
27	rs1057910	CD	NUMBER	rs1057910	num	26	SENT_79	[p7l1527t26r1966b91],
28	"	``	O	"	punct	26	SENT_79	[p7l1527t26r1966b91],
29	VAR_013515e	NN	O	var_013515e	nn	30	SENT_79	[p7l1522t133r2028b200],
30	VAR_013516f	NN	O	var_013516f	dep	26	SENT_79	[p7l1522t226r2023b301],
31	)	CD	NUMBER	)	dep	2	SENT_79	[p7l1431t2789r1446b2850],

1	or	CC	O	or	cc	3	SENT_80	[p7l1475t2801r1533b2839],
2	the	DT	O	the	det	3	SENT_80	[p7l1555t2789r1650b2839],
3	EXPASY	NN	O	expasy	_	0	SENT_80	[p7l1682t2789r1914b2839],
4	(	CD	NUMBER	(	num	6	SENT_80	[p7l1941t2789r2115b2850],
5	VAR	NN	O	var	nn	6	SENT_80	[p7l1941t2789r2115b2850],
6	_	NN	O	_	dep	3	SENT_80	[p7l1941t2789r2115b2850],
7	.	.	O	.	_	0	SENT_80	[p7l2145t2830r2153b2838],

1	Single	JJ	O	single	amod	2	SENT_81	[p7l268t3428r519b3511],
2	Nucleotide	NN	O	nucleotide	_	0	SENT_81	[p7l560t3429r991b3495],
3	Polymorphism	NN	O	polymorphism	nn	4	SENT_81	[p7l1032t3429r1615b3511],
4	Genotyping	NN	O	genotyping	dep	2	SENT_81	[p7l271t3543r733b3625],

1	Twenty-six	CD	NUMBER	twenty-six	num	4	SENT_82	[p8l268t19r645b94],
2	single	JJ	O	single	amod	4	SENT_82	[p8l673t19r867b94],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_82	[p8l897t19r1241b76],
4	polymorphism	NN	O	polymorphism	_	0	SENT_82	[p8l1267t19r1756b94],
5	(	CD	NUMBER	(	num	6	SENT_82	[p8l1784t20r1912b87],
6	SN	NN	O	sn	dep	4	SENT_82	[p8l1784t20r1912b87],
7	P	NN	O	p	nn	9	SENT_82	[p8l1916t20r1984b87],
8	)	NN	O	)	nn	9	SENT_82	[p8l1916t20r1984b87],
9	assays	NNS	O	assay	nsubj	10	SENT_82	[p8l2012t40r2099b76, p8l8t137r133b192],
10	(	VBP	O	(	dep	4	SENT_82	[p8l165t114r375b184],
11	Table	NNP	O	Table	dobj	10	SENT_82	[p8l165t114r375b184],
12	2	CD	NUMBER	2	number	13	SENT_82	[p8l408t117r470b184],
13	)	CD	NUMBER	)	nsubjpass	15	SENT_82	[p8l408t117r470b184],
14	were	VBD	O	be	auxpass	15	SENT_82	[p8l500t136r652b174],
15	performed	VBN	O	perform	rcmod	11	SENT_82	[p8l681t114r1044b192],
16	,	,	O	,	_	0	SENT_82	[p8l681t114r1044b192],
17	using	VBG	O	use	partmod	4	SENT_82	[p8l1077t118r1257b192],
18	the	DT	O	the	det	20	SENT_82	[p8l1289t116r1391b174],
19	Sequenom	NNP	O	Sequenom	nn	20	SENT_82	[p8l1422t117r1763b192],
20	MassARRAY	NN	O	massarray	dobj	17	SENT_82	[p8l1793t116r2099b174, p8l8t214r182b270],
21	system	NN	O	system	nn	23	SENT_82	[p8l215t231r439b289],
22	(	CD	NUMBER	(	num	23	SENT_82	[p8l475t215r859b289],
23	Sequenom	NNP	ORGANIZATION	Sequenom	tmod	17	SENT_82	[p8l475t215r859b289],
24	,	,	O	,	_	0	SENT_82	[p8l475t215r859b289],
25	San	NNP	LOCATION	San	nn	29	SENT_82	[p8l897t215r1011b271],
26	Diego	NNP	LOCATION	Diego	nn	29	SENT_82	[p8l1046t216r1266b289],
27	,	,	O	,	_	0	SENT_82	[p8l1046t216r1266b289],
28	CA	NNP	LOCATION	CA	appos	29	SENT_82	[p8l1304t214r1515b282],
29	)	NNP	O	)	appos	23	SENT_82	[p8l1304t214r1515b282],
30	.25	CD	NUMBER	.25	num	29	SENT_82	[p8l1304t214r1515b282],
31	These	DT	O	these	det	32	SENT_82	[p8l1553t214r1745b271],
32	assays	NNS	O	assay	nsubj	34	SENT_82	[p8l1781t235r1970b289],
33	robustly	RB	O	robustly	advmod	34	SENT_82	[p8l2008t234r2099b271, p8l8t309r213b387],
34	detected	VBD	O	detect	rcmod	29	SENT_82	[p8l248t311r525b369],
35	1083	CD	DATE	1083	npadvmod	36	SENT_82	[p8l569t314r728b375],
36	out	IN	O	out	advmod	34	SENT_82	[p8l768t328r875b369],
37	of	IN	O	of	_	0	SENT_82	[p8l911t309r981b369],
38	1482	CD	DATE	1482	num	39	SENT_82	[p8l1013t307r1173b369],
39	genotypes	NNS	O	genotype	prep_of	4	SENT_82	[p8l1212t328r1562b387],
40	.	.	O	.	_	0	SENT_82	[p8l1212t328r1562b387],

1	The	DT	O	the	det	4	SENT_83	[p8l1600t311r1729b369],
2	additional	JJ	O	additional	amod	4	SENT_83	[p8l1764t311r2100b369],
3	399	CD	NUMBER	399	num	4	SENT_83	[p8l11t412r133b474],
4	genotypes	NNS	O	genotype	nsubjpass	6	SENT_83	[p8l158t426r489b485],
5	were	VBD	O	be	auxpass	6	SENT_83	[p8l514t429r667b467],
6	determined	VBN	O	determine	_	0	SENT_83	[p8l692t409r1071b467],
7	by	IN	O	by	_	0	SENT_83	[p8l1097t407r1176b485],
8	resequencing	VBG	O	resequence	agent	6	SENT_83	[p8l1201t411r1632b485],
9	(	CD	NUMBER	(	num	11	SENT_83	[p8l1659t409r1819b478],
10	ABI	NN	O	abus	nn	11	SENT_83	[p8l1659t409r1819b478],
11	3730xl	NN	O	3730xl	dobj	8	SENT_83	[p8l1848t409r2099b479],
12	;	:	O	;	_	0	SENT_83	[p8l1848t409r2099b479],
13	Applied	NNP	ORGANIZATION	Applied	nn	14	SENT_83	[p8l6t507r275b582],
14	Biosystems	NNP	ORGANIZATION	Biosystems	dep	11	SENT_83	[p8l308t509r698b582],
15	,	,	O	,	_	0	SENT_83	[p8l308t509r698b582],
16	Foster	NNP	LOCATION	Foster	nn	17	SENT_83	[p8l733t509r934b564],
17	City	NNP	LOCATION	City	appos	14	SENT_83	[p8l966t508r1127b582],
18	,	,	O	,	_	0	SENT_83	[p8l966t508r1127b582],
19	CA	NNP	LOCATION	CA	nn	20	SENT_83	[p8l1162t507r1311b575],
20	)	NNP	O	)	appos	14	SENT_83	[p8l1162t507r1311b575],
21	.	.	O	.	_	0	SENT_83	[p8l1162t507r1311b575],

1	Statistical	JJ	O	statistical	amod	2	SENT_84	[p8l268t667r672b733],
2	Analysis	NN	O	analysis	nsubj	11	SENT_84	[p8l710t668r1046b749],
3	The	DT	O	the	det	6	SENT_84	[p8l268t776r396b834],
4	primary	JJ	O	primary	amod	6	SENT_84	[p8l433t778r699b852],
5	response	NN	O	response	nn	6	SENT_84	[p8l737t796r1014b852],
6	variables	NNS	O	variable	dep	2	SENT_84	[p8l1051t774r1339b835],
7	were	VBD	O	be	cop	11	SENT_84	[p8l1378t796r1530b834],
8	ex	FW	O	ex	nn	11	SENT_84	[p8l1569t797r1639b834],
9	Vivo	FW	O	vivo	nn	11	SENT_84	[p8l1675t778r1813b834],
10	COX-2	NN	O	cox-2	nn	11	SENT_84	[p8l1852t777r2097b834],
11	inhibition	NN	O	inhibition	_	0	SENT_84	[p8l8t875r363b948],
12	,	,	O	,	_	0	SENT_84	[p8l8t875r363b948],
13	expressed	VBN	O	express	partmod	11	SENT_84	[p8l419t877r730b953],
14	as	IN	O	as	_	0	SENT_84	[p8l783t898r842b935],
15	the	DT	O	the	det	16	SENT_84	[p8l897t877r999b935],
16	ratio	NN	O	ratio	prep_as	13	SENT_84	[p8l1053t879r1204b935],
17	of	IN	O	of	_	0	SENT_84	[p8l1257t875r1327b935],
18	postdrug	NN	O	postdrug	prep_of	16	SENT_84	[p8l1368t877r1666b953],
19	to	TO	O	to	_	0	SENT_84	[p8l1721t894r1784b935],
20	predrug	NN	O	predrug	nn	22	SENT_84	[p8l1835t877r2100b953],
21	plasma	NN	O	plasma	nn	22	SENT_84	[p8l6t978r239b1054],
22	PGE2	NN	O	pge2	prep_to	13	SENT_84	[p8l262t979r466b1050],
23	;	:	O	;	_	0	SENT_84	[p8l262t979r466b1050],
24	ex	FW	O	ex	nn	27	SENT_84	[p8l492t999r562b1036],
25	Vivo	FW	O	vivo	nn	27	SENT_84	[p8l584t980r722b1036],
26	COX-1	NN	O	cox-1	nn	27	SENT_84	[p8l747t979r988b1036],
27	inhibition	NN	O	inhibition	nsubj	44	SENT_84	[p8l1021t976r1376b1049],
28	,	,	O	,	_	0	SENT_84	[p8l1021t976r1376b1049],
29	expressed	VBN	O	express	partmod	27	SENT_84	[p8l1402t978r1713b1054],
30	as	IN	O	as	_	0	SENT_84	[p8l1738t999r1796b1036],
31	the	DT	O	the	det	32	SENT_84	[p8l1823t978r1925b1036],
32	ratio	NN	O	ratio	prep_as	29	SENT_84	[p8l1950t980r2101b1036],
33	of	IN	O	of	_	0	SENT_84	[p8l8t1077r77b1137],
34	postdrug	NN	O	postdrug	prep_of	32	SENT_84	[p8l103t1079r401b1155],
35	to	TO	O	to	_	0	SENT_84	[p8l442t1096r505b1137],
36	predrug	JJ	O	predrug	amod	38	SENT_84	[p8l542t1079r806b1155],
37	serum	NN	O	serum	nn	38	SENT_84	[p8l847t1099r1046b1137],
38	TxB2	NN	O	txb2	prep_to	29	SENT_84	[p8l1084t1080r1275b1151],
39	;	:	O	;	_	0	SENT_84	[p8l1084t1080r1275b1151],
40	urinary	JJ	O	urinary	amod	42	SENT_84	[p8l1315t1081r1555b1155],
41	PGI-M	NN	O	pgi-m	nn	42	SENT_84	[p8l1594t1080r1832b1137],
42	inhibition	NN	O	inhibition	dep	38	SENT_84	[p8l1872t1077r2099b1138, p8l8t1186r159b1254],
43	,	,	O	,	_	0	SENT_84	[p8l1872t1077r2099b1138, p8l8t1186r159b1254],
44	expressed	VBN	O	express	parataxis	11	SENT_84	[p8l192t1184r503b1260],
45	as	IN	O	as	_	0	SENT_84	[p8l534t1205r592b1242],
46	the	DT	O	the	det	47	SENT_84	[p8l624t1184r726b1242],
47	ratio	NN	O	ratio	prep_as	44	SENT_84	[p8l758t1186r909b1242],
48	of	IN	O	of	_	0	SENT_84	[p8l939t1182r1009b1242],
49	concentration	NN	O	concentration	nn	50	SENT_84	[p8l1030t1186r1482b1242],
50	postdrug	NN	O	postdrug	prep_of	47	SENT_84	[p8l1510t1184r1808b1260],
51	to	TO	O	to	_	0	SENT_84	[p8l1841t1201r1904b1242],
52	postplacebo	NN	O	postplacebo	nn	53	SENT_84	[p8l1933t1201r2099b1260, p8l6t1283r256b1361],
53	administration	NN	O	administration	prep_to	44	SENT_84	[p8l285t1285r796b1356],
54	;	:	O	;	_	0	SENT_84	[p8l285t1285r796b1356],
55	urinary	JJ	O	urinary	amod	56	SENT_84	[p8l827t1287r1066b1361],
56	Tx	NN	O	tx	dep	53	SENT_84	[p8l1093t1286r1285b1342],
57	.	.	O	.	_	0	SENT_84	[p8l1093t1286r1285b1342],

1	—	NN	O	—	_	0	SENT_85	[p8l1093t1286r1285b1342],
2	.	.	O	.	_	0	SENT_85	[p8l1093t1286r1285b1342],

1	M	NN	O	m	nn	2	SENT_86	[p8l1093t1286r1285b1342],
2	inhibition	NN	O	inhibition	_	0	SENT_86	[p8l1315t1283r1670b1356],
3	,	,	O	,	_	0	SENT_86	[p8l1315t1283r1670b1356],
4	expressed	VBN	O	express	partmod	2	SENT_86	[p8l1701t1285r2012b1361],
5	as	IN	O	as	_	0	SENT_86	[p8l2041t1306r2100b1343],
6	the	DT	O	the	det	7	SENT_86	[p8l8t1390r110b1448],
7	ratio	NN	O	ratio	prep_as	4	SENT_86	[p8l138t1392r289b1448],
8	of	IN	O	of	_	0	SENT_86	[p8l317t1388r386b1448],
9	concentration	NN	O	concentration	nn	10	SENT_86	[p8l404t1392r856b1448],
10	postdrug	NN	O	postdrug	prep_of	7	SENT_86	[p8l881t1390r1179b1466],
11	to	TO	O	to	_	0	SENT_86	[p8l1208t1407r1272b1448],
12	postplacebo	NN	O	postplacebo	nn	13	SENT_86	[p8l1297t1388r1689b1466],
13	administration	NN	O	administration	prep_to	4	SENT_86	[p8l1716t1390r2099b1448, p8l8t1520r159b1588],
14	;	:	O	;	_	0	SENT_86	[p8l1716t1390r2099b1448, p8l8t1520r159b1588],

1	and	CC	O	and	dep	4	SENT_87	[p8l186t1518r303b1576],
2	plasma	NN	O	plasma	nn	4	SENT_87	[p8l327t1518r560b1594],
3	drug	NN	O	drug	nn	4	SENT_87	[p8l582t1518r738b1594],
4	concentrations	NNS	O	concentration	_	0	SENT_87	[p8l764t1520r1244b1576],
5	4	CD	DURATION	4	num	6	SENT_87	[p8l1269t1514r1309b1575],
6	hours	NNS	NUMBER	hour	npadvmod	7	SENT_87	[p8l1334t1518r1514b1576],
7	postdrug	JJ	O	postdrug	amod	8	SENT_87	[p8l1538t1518r1836b1594],
8	administration	NN	O	administration	dep	4	SENT_87	[p8l1861t1518r2099b1576, p8l8t1621r303b1677],
9	.	.	O	.	_	0	SENT_87	[p8l1861t1518r2099b1576, p8l8t1621r303b1677],

1	Derived	VBN	O	derive	dep	4	SENT_88	[p8l336t1619r599b1677],
2	variables	NNS	O	variable	nsubj	4	SENT_88	[p8l626t1617r914b1678],
3	were	VBD	O	be	cop	4	SENT_88	[p8l943t1639r1096b1677],
4	ratios	NNS	O	ratio	_	0	SENT_88	[p8l1126t1621r1305b1677],
5	of	IN	O	of	_	0	SENT_88	[p8l1335t1617r1404b1677],
6	primary	JJ	O	primary	amod	7	SENT_88	[p8l1421t1621r1687b1695],
7	measures	NNS	O	measure	prep_of	4	SENT_88	[p8l1715t1639r2011b1677],
8	as	IN	O	as	_	0	SENT_88	[p8l2041t1640r2100b1677],
9	estimates	NNS	O	estimate	prep_as	4	SENT_88	[p8l7t1722r313b1778],
10	of	IN	O	of	_	0	SENT_88	[p8l350t1718r419b1778],
11	COX-2	NN	O	cox-2	nn	12	SENT_88	[p8l445t1721r690b1778],
12	selectivity	NN	O	selectivity	prep_of	9	SENT_88	[p8l730t1720r1083b1796],
13	.	.	O	.	_	0	SENT_88	[p8l730t1720r1083b1796],

1	All	DT	O	all	det	2	SENT_89	[p8l1121t1720r1225b1777],
2	variables	NNS	O	variable	nsubj	4	SENT_89	[p8l1260t1718r1548b1779],
3	were	VBD	O	be	cop	4	SENT_89	[p8l1584t1740r1736b1778],
4	log	NN	O	log	_	0	SENT_89	[p8l1772t1720r1874b1796],
5	transformed	VBN	O	transform	partmod	4	SENT_89	[p8l1911t1737r2099b1778, p8l7t1823r241b1883],
6	to	TO	O	to	_	0	SENT_89	[p8l282t1842r345b1883],
7	approximate	JJ	O	approximate	amod	8	SENT_89	[p8l384t1827r798b1901],
8	normality	NN	O	normality	prep_to	5	SENT_89	[p8l838t1825r1181b1901],
9	.	.	O	.	_	0	SENT_89	[p8l838t1825r1181b1901],

1	Four	CD	NUMBER	four	num	2	SENT_90	[p8l1224t1827r1377b1883],
2	data	NNS	O	datum	nsubj	4	SENT_90	[p8l1415t1825r1554b1883],
3	points	NNS	O	point	dep	2	SENT_90	[p8l1590t1827r1795b1901],
4	(	VBP	O	(	_	0	SENT_90	[p8l1836t1826r1895b1894],
5	3	CD	NUMBER	3	num	6	SENT_90	[p8l1836t1826r1895b1894],
6	mea	NN	O	mea	dobj	4	SENT_90	[p8l1939t1846r2099b1883, p8l6t1967r14b1975],
7	.	.	O	.	_	0	SENT_90	[p8l1939t1846r2099b1883, p8l6t1967r14b1975],

1	.	.	O	.	_	0	SENT_91	[p8l47t1967r56b1975],
2	)	SYM	O	)	_	0	SENT_91	[p8l88t1927r102b1987],

1	SNP	NN	O	snp	_	0	SENT_92	[p8l131t1927r253b1976],
2	database	NN	O	database	dep	1	SENT_92	[p8l280t1927r573b1976],
3	.	.	O	.	_	0	SENT_92	[p8l280t1927r573b1976],

1	surements	NNS	O	surement	_	0	SENT_93	[p8l80t2161r410b2202],
2	of	IN	O	of	_	0	SENT_93	[p8l446t2142r514b2202],
3	Tx	NN	O	tx	prep_of	1	SENT_93	[p8l538t2145r727b2200],
4	.	.	O	.	_	0	SENT_93	[p8l538t2145r727b2200],

1	—	NN	O	—	_	0	SENT_94	[p8l538t2145r727b2200],
2	.	.	O	.	_	0	SENT_94	[p8l538t2145r727b2200],

1	M	NN	O	m	nsubjpass	10	SENT_95	[p8l538t2145r727b2200],
2	and	CC	O	and	_	0	SENT_95	[p8l761t2144r877b2202],
3	1	CD	NUMBER	1	num	5	SENT_95	[p8l919t2148r944b2200],
4	plasma	NN	O	plasma	nn	5	SENT_95	[p8l984t2145r1214b2219],
5	concentration	NN	O	concentration	conj_and	1	SENT_95	[p8l1248t2147r1693b2202],
6	of	IN	O	of	_	0	SENT_95	[p8l1728t2143r1797b2202],
7	celecoxib	NN	O	celecoxib	nn	8	SENT_95	[p8l1821t2142r2143b2211],
8	)	NN	O	)	prep_of	5	SENT_95	[p8l1821t2142r2143b2211],
9	were	VBD	O	be	auxpass	10	SENT_95	[p8l78t2258r229b2296],
10	excluded	VBN	O	exclude	_	0	SENT_95	[p8l261t2238r549b2296],
11	because	IN	O	because	_	0	SENT_95	[p8l582t2237r827b2296],
12	of	IN	O	of	_	0	SENT_95	[p8l859t2237r928b2296],
13	technical	JJ	O	technical	amod	14	SENT_95	[p8l951t2239r1242b2296],
14	errors	NNS	O	error	prep_because_of	10	SENT_95	[p8l1276t2258r1457b2296],
15	in	IN	O	in	_	0	SENT_95	[p8l1492t2241r1554b2294],
16	the	DT	O	the	det	17	SENT_95	[p8l1587t2239r1687b2296],
17	assays	NNS	O	assay	prep_in	14	SENT_95	[p8l1720t2259r1925b2313],
18	.	.	O	.	_	0	SENT_95	[p8l1720t2259r1925b2313],

1	Each	DT	O	each	det	2	SENT_96	[p8l166t2333r320b2390],
2	subject	NN	O	subject	nsubj	6	SENT_96	[p8l350t2331r580b2407],
3	in	IN	O	in	_	0	SENT_96	[p8l610t2335r673b2388],
4	the	DT	O	the	det	5	SENT_96	[p8l702t2333r803b2390],
5	study	NN	O	study	prep_in	2	SENT_96	[p8l833t2332r1011b2407],
6	had	VBD	O	have	_	0	SENT_96	[p8l1040t2332r1155b2390],
7	either	CC	O	either	preconj	8	SENT_96	[p8l1185t2333r1374b2390],
8	1	CD	NUMBER	1	dobj	6	SENT_96	[p8l1409t2336r1434b2388],
9	or	CC	O	or	_	0	SENT_96	[p8l1470t2352r1535b2390],
10	5	CD	NUMBER	5	dobj	6	SENT_96	[p8l1567t2336r1596b2393],
11	replicate	VBP	O	replicate	rcmod	8	SENT_96	[p8l1632t2333r1910b2407],
12	sets	NNS	O	set	dobj	11	SENT_96	[p8l1940t2349r2054b2390],
13	of	IN	O	of	_	0	SENT_96	[p8l2085t2331r2153b2390],
14	measurements	NNS	O	measurement	prep_of	12	SENT_96	[p8l79t2444r562b2484],
15	.	.	O	.	_	0	SENT_96	[p8l79t2444r562b2484],

1	Hence	RB	O	hence	advmod	5	SENT_97	[p8l603t2430r829b2496],
2	,	,	O	,	_	0	SENT_97	[p8l603t2430r829b2496],
3	the	DT	O	the	det	4	SENT_97	[p8l868t2428r969b2484],
4	study	NN	O	study	nsubj	5	SENT_97	[p8l1006t2427r1184b2502],
5	followed	VBD	O	follow	_	0	SENT_97	[p8l1220t2425r1498b2484],
6	an	DT	O	a	det	9	SENT_97	[p8l1535t2447r1609b2484],
7	unbalanced	JJ	O	unbalanced	amod	9	SENT_97	[p8l1645t2425r2014b2485],
8	hierarchical	JJ	O	hierarchical	amod	9	SENT_97	[p8l2051t2428r2141b2483, p8l80t2521r391b2578],
9	design	NN	O	design	dobj	5	SENT_97	[p8l446t2521r659b2596],
10	with	IN	O	with	_	0	SENT_97	[p8l712t2522r863b2578],
11	the	DT	O	the	det	14	SENT_97	[p8l918t2522r1019b2578],
12	repeated	JJ	O	repeated	amod	14	SENT_97	[p8l1075t2521r1347b2596],
13	factor	NN	O	factor	nn	14	SENT_97	[p8l1403t2519r1587b2578],
14	DRUG	NN	O	drug	prep_with	5	SENT_97	[p8l1640t2523r1882b2578],
15	nested	JJ	O	nested	amod	14	SENT_97	[p8l1937t2521r2143b2578],
16	within	IN	O	within	_	0	SENT_97	[p8l79t2617r296b2673],
17	measurement	NN	O	measurement	prep_within	15	SENT_97	[p8l329t2633r765b2673],
18	REPLICATE	VB	O	replicate	dep	5	SENT_97	[p8l800t2617r1229b2673],
19	nested	JJ	O	nested	acomp	18	SENT_97	[p8l1265t2616r1470b2673],
20	within	IN	O	within	_	0	SENT_97	[p8l1503t2617r1721b2673],
21	study	NN	O	study	nn	22	SENT_97	[p8l1754t2616r1932b2691],
22	SUBJECT	NNP	O	SUBJECT	prep_within	19	SENT_97	[p8l1965t2618r2141b2673, p8l72t2712r280b2785],
23	.	.	O	.	_	0	SENT_97	[p8l1965t2618r2141b2673, p8l72t2712r280b2785],

1	However	RB	O	however	advmod	7	SENT_98	[p8l322t2714r634b2780],
2	,	,	O	,	_	0	SENT_98	[p8l322t2714r634b2780],
3	the	DT	O	the	det	4	SENT_98	[p8l675t2712r776b2768],
4	effects	NNS	O	effect	nsubj	7	SENT_98	[p8l814t2709r1015b2768],
5	of	IN	O	of	_	0	SENT_98	[p8l1054t2709r1122b2768],
6	REPLICATE	NNP	O	REPLICATE	prep_of	4	SENT_98	[p8l1151t2712r1580b2768],
7	grouped	VBD	O	group	_	0	SENT_98	[p8l1618t2711r1888b2785],
8	within	IN	O	within	_	0	SENT_98	[p8l1925t2712r2143b2768],
9	SUBJECT	NNP	O	SUBJECT	nsubj	11	SENT_98	[p8l80t2807r416b2880],
10	were	VBD	O	be	cop	11	SENT_98	[p8l443t2826r593b2863],
11	minimal	JJ	O	minimal	prepc_within	7	SENT_98	[p8l622t2806r920b2875],
12	,	,	O	,	_	0	SENT_98	[p8l622t2806r920b2875],
13	and	CC	O	and	_	0	SENT_98	[p8l950t2806r1066b2863],
14	a	DT	O	a	det	16	SENT_98	[p8l1095t2828r1127b2863],
15	regression	NN	O	regression	nn	16	SENT_98	[p8l1154t2808r1480b2880],
16	model	NN	O	model	nsubjpass	18	SENT_98	[p8l1508t2806r1710b2863],
17	was	VBD	O	be	auxpass	18	SENT_98	[p8l1738t2827r1854b2863],
18	adopted	VBN	O	adopt	prepc_within	7	SENT_98	[p8l1883t2806r2142b2880],
19	in	IN	O	in	_	0	SENT_98	[p8l81t2903r143b2957],
20	which	WDT	O	which	dobj	25	SENT_98	[p8l186t2901r385b2958],
21	the	DT	O	the	det	23	SENT_98	[p8l429t2902r530b2958],
22	multivariate	JJ	O	multivariate	amod	23	SENT_98	[p8l575t2901r977b2958],
23	outcomes	NNS	O	outcome	nsubjpass	25	SENT_98	[p8l1022t2918r1328b2958],
24	were	VBD	O	be	auxpass	25	SENT_98	[p8l1373t2921r1523b2958],
25	grouped	VBN	O	group	prepc_in	18	SENT_98	[p8l1566t2901r1836b2975],
26	only	RB	O	only	advmod	25	SENT_98	[p8l1881t2901r2021b2975],
27	by	IN	O	by	_	0	SENT_98	[p8l2066t2899r2143b2975],
28	SUBJECT	NNP	O	SUBJECT	agent	25	SENT_98	[p8l80t2996r433b3070],
29	.	.	O	.	_	0	SENT_98	[p8l80t2996r433b3070],

1	These	DT	O	these	det	4	SENT_99	[p8l473t2996r661b3053],
2	semiparametric	JJ	O	semiparametric	amod	4	SENT_99	[p8l699t2998r1201b3070],
3	regression	NN	O	regression	nn	4	SENT_99	[p8l1239t2998r1565b3070],
4	models	NNS	O	model	nsubjpass	6	SENT_99	[p8l1602t2996r1832b3053],
5	were	VBD	O	be	auxpass	6	SENT_99	[p8l1868t3015r2019b3053],
6	estimated	VBN	O	estimate	_	0	SENT_99	[p8l2056t3017r2142b3053, p8l80t3102r334b3159],
7	by	IN	O	by	_	0	SENT_99	[p8l376t3100r453b3176],
8	generalized	VBN	O	generalize	agent	6	SENT_99	[p8l492t3102r862b3176],
9	estimating	NN	O	estimating	nn	10	SENT_99	[p8l904t3104r1252b3176],
10	equations	NNS	O	equation	dobj	8	SENT_99	[p8l1294t3104r1605b3176],
11	using	VBG	O	use	partmod	10	SENT_99	[p8l1647t3104r1824b3176],
12	a	DT	O	a	det	18	SENT_99	[p8l1866t3123r1897b3158],
13	robust	JJ	O	robust	amod	18	SENT_99	[p8l1937t3100r2142b3159],
14	“	NN	O	“	nn	18	SENT_99	[p8l83t3197r446b3254],
15	sandwich	NN	O	sandwich	nn	18	SENT_99	[p8l83t3197r446b3254],
16	”	NN	O	”	nn	18	SENT_99	[p8l83t3197r446b3254],
17	variance	NN	O	variance	nn	18	SENT_99	[p8l480t3199r746b3254],
18	estimator	NN	O	estimator	dobj	11	SENT_99	[p8l778t3199r1087b3254],
19	and	CC	O	and	_	0	SENT_99	[p8l1118t3197r1233b3254],
20	identity	NN	O	identity	nn	21	SENT_99	[p8l1267t3197r1526b3271],
21	link	NN	O	link	conj_and	18	SENT_99	[p8l1559t3195r1689b3253],
22	functions	NNS	O	function	nsubj	29	SENT_99	[p8l1720t3195r2022b3254],
23	for	IN	O	for	_	0	SENT_99	[p8l2055t3195r2144b3254],
24	the	DT	O	the	det	28	SENT_99	[p8l80t3292r181b3349],
25	mean	NN	O	mean	nn	28	SENT_99	[p8l230t3312r404b3349],
26	and	CC	O	and	_	0	SENT_99	[p8l451t3292r567b3349],
27	scale	NN	O	scale	nn	28	SENT_99	[p8l617t3292r766b3349],
28	models	NNS	O	model	prep_for	22	SENT_99	[p8l814t3292r1044b3349],
29	(	VBP	O	(	rcmod	18	SENT_99	[p8l1094t3290r1378b3366],
30	geepack	NN	O	geepack	nn	32	SENT_99	[p8l1094t3290r1378b3366],
31	vO	NN	O	vo	nn	32	SENT_99	[p8l1424t3295r1681b3349],
32	.2	NN	NUMBER	.2	dobj	29	SENT_99	[p8l1424t3295r1681b3349],
33	—	CD	NUMBER	—	num	34	SENT_99	[p8l1424t3295r1681b3349],
34	1O	NN	O	1o	tmod	11	SENT_99	[p8l1424t3295r1681b3349],
35	in	IN	O	in	_	0	SENT_99	[p8l1732t3294r1795b3348],
36	R	NN	O	r	prep_in	34	SENT_99	[p8l1844t3294r1897b3348],
37	2.0-1	CD	NUMBER	2.0-1	num	36	SENT_99	[p8l1948t3295r2141b3360],
38	;	:	O	;	_	0	SENT_99	[p8l1948t3295r2141b3360],
39	http://www.cran.R—project.org26	NN	O	http://www.cran.r—project.org26	nn	40	SENT_99	[p8l80t3383r1191b3460],
40	)	NN	O	)	dep	34	SENT_99	[p8l80t3383r1191b3460],
41	.	.	O	.	_	0	SENT_99	[p8l80t3383r1191b3460],

1	The	DT	O	the	det	3	SENT_100	[p8l1276t3386r1403b3443],
2	multiple	JJ	O	multiple	amod	3	SENT_100	[p8l1485t3386r1768b3460],
3	measures	NNS	O	measure	nsubjpass	8	SENT_100	[p8l1850t3405r2142b3443],
4	grouped	VBN	O	group	partmod	3	SENT_100	[p8l78t3481r348b3555],
5	by	IN	O	by	_	0	SENT_100	[p8l380t3479r458b3555],
6	SUBJECT	NNP	O	SUBJECT	agent	4	SENT_100	[p8l487t3481r823b3555],
7	were	VBD	O	be	auxpass	8	SENT_100	[p8l853t3500r1003b3538],
8	assumed	VBN	O	assume	_	0	SENT_100	[p8l1034t3481r1308b3538],
9	to	TO	O	to	aux	10	SENT_100	[p8l1339t3497r1402b3538],
10	have	VB	O	have	xcomp	8	SENT_100	[p8l1432t3481r1577b3538],
11	an	DT	O	a	det	14	SENT_100	[p8l1607t3501r1681b3537],
12	exchangeable	JJ	O	exchangeable	amod	14	SENT_100	[p8l1711t3479r2143b3555],
13	correlation	NN	O	correlation	nn	14	SENT_100	[p8l80t3576r430b3633],
14	structure	NN	O	structure	dobj	10	SENT_100	[p8l454t3592r763b3633],
15	:	:	O	:	_	0	SENT_100	[p8l454t3592r763b3633],
16	This	DT	O	this	nsubj	18	SENT_100	[p8l791t3576r935b3633],
17	is	VBZ	O	be	cop	18	SENT_100	[p8l961t3578r1008b3633],
18	equivalent	JJ	O	equivalent	parataxis	8	SENT_100	[p8l1033t3576r1373b3650],
19	to	TO	O	to	_	0	SENT_100	[p8l1398t3592r1461b3633],
20	a	DT	O	a	det	22	SENT_100	[p8l1484t3597r1516b3632],
21	hierarchical	JJ	O	hierarchical	amod	22	SENT_100	[p8l1538t3576r1917b3633],
22	model	NN	O	model	prep_to	18	SENT_100	[p8l1941t3576r2142b3633],
23	with	IN	O	with	_	0	SENT_100	[p8l78t3671r229b3728],
24	random	JJ	O	random	amod	25	SENT_100	[p8l266t3670r515b3728],
25	intercepts	NNS	O	intercept	prep_with	22	SENT_100	[p8l552t3673r871b3745],
26	grouped	VBN	O	group	partmod	25	SENT_100	[p8l907t3670r1177b3745],
27	within	IN	O	within	_	0	SENT_100	[p8l1213t3671r1430b3728],
28	SUBJECT	NNP	O	SUBJECT	prep_within	26	SENT_100	[p8l1466t3671r1819b3745],
29	.	.	O	.	_	0	SENT_100	[p8l1466t3671r1819b3745],

1	Variance	NN	O	variance	nn	3	SENT_101	[p8l1858t3673r2143b3728],
2	components	NNS	O	component	nn	3	SENT_101	[p9l80t39r472b97],
3	estimates	NNS	O	estimate	nsubjpass	5	SENT_101	[p9l509t25r810b79],
4	were	VBD	O	be	auxpass	5	SENT_101	[p9l846t42r996b79],
5	calculated	VBN	O	calculate	_	0	SENT_101	[p9l1032t22r1358b79],
6	using	VBG	O	use	xcomp	5	SENT_101	[p9l1394t25r1571b97],
7	Bayesian	JJ	MISC	bayesian	amod	10	SENT_101	[p9l1608t24r1892b96],
8	hierarchical	JJ	O	hierarchical	amod	10	SENT_101	[p9l1927t23r2142b79, p9l80t116r267b173],
9	linear	JJ	O	linear	amod	10	SENT_101	[p9l303t116r487b173],
10	models	NNS	O	model	dobj	6	SENT_101	[p9l521t116r751b173],
11	of	IN	O	of	_	0	SENT_101	[p9l787t114r855b173],
12	this	DT	O	this	det	13	SENT_101	[p9l882t117r1000b173],
13	type	NN	O	type	prep_of	10	SENT_101	[p9l1038t133r1196b191],
14	,	,	O	,	_	0	SENT_101	[p9l1038t133r1196b191],
15	with	IN	O	with	_	0	SENT_101	[p9l1232t117r1383b173],
16	Markov	NNP	PERSON	Markov	nn	20	SENT_101	[p9l1417t114r1670b173],
17	Chain	NNP	PERSON	Chain	nn	20	SENT_101	[p9l1703t117r1896b173],
18	Monte	NNP	PERSON	Monte	nn	20	SENT_101	[p9l1931t119r2143b173],
19	Carlo	NNP	PERSON	Carlo	nn	20	SENT_101	[p9l80t210r253b267],
20	estimation	NN	O	estimation	prep_with	5	SENT_101	[p9l297t212r644b267],
21	in	IN	O	in	_	0	SENT_101	[p9l689t212r751b266],
22	winBUGS	NN	O	winbug	prep_in	20	SENT_101	[p9l795t211r1131b267],
23	1.4.1.27	CD	DATE	1.4.1.27	num	24	SENT_101	[p9l1184t207r1424b267],
24	Comparisons	NNS	O	comparison	nsubj	34	SENT_101	[p9l1471t211r1892b284],
25	of	IN	O	of	_	0	SENT_101	[p9l1938t208r2006b267],
26	the	DT	O	the	det	29	SENT_101	[p9l2041t211r2142b267],
27	primary	JJ	O	primary	amod	29	SENT_101	[p9l78t318r340b390],
28	response	NN	O	response	nn	29	SENT_101	[p9l371t335r644b390],
29	Variables	NNS	O	variable	prep_of	24	SENT_101	[p9l673t314r957b373],
30	between	IN	O	between	_	0	SENT_101	[p9l990t314r1259b373],
31	the	DT	O	the	det	33	SENT_101	[p9l1290t316r1391b373],
32	treatment	NN	O	treatment	nn	33	SENT_101	[p9l1423t332r1743b373],
33	groups	NNS	O	group	prep_between	29	SENT_101	[p9l1774t335r1995b390],
34	had	VBD	O	have	rcmod	22	SENT_101	[p9l2027t316r2142b373],

1	58	CD	NUMBER	58	num	2	SENT_102	[p9l10t550r89b599],
2	FRIES	NNS	O	fries	_	0	SENT_102	[p9l167t550r340b599],
3	ET	NNP	O	ET	nn	4	SENT_102	[p9l370t550r438b598],
4	AL	NNP	O	AL	dep	2	SENT_102	[p9l462t550r539b598],

1	a	DT	O	a	det	2	SENT_103	[p9l9t783r42b819],
2	power	NN	O	power	_	0	SENT_103	[p9l75t781r283b838],
3	in	IN	O	in	_	0	SENT_103	[p9l319t763r384b819],
4	excess	NN	O	excess	prep_in	2	SENT_103	[p9l420t782r618b820],
5	of	IN	O	of	_	0	SENT_103	[p9l656t759r727b820],
6	90	CD	PERCENT	90	num	7	SENT_103	[p9l755t762r907b827],
7	%	NN	PERCENT	%	prep_of	4	SENT_103	[p9l755t762r907b827],
8	to	TO	O	to	aux	9	SENT_103	[p9l950t778r1015b820],
9	detect	VB	O	detect	infmod	4	SENT_103	[p9l1051t761r1255b820],
10	a	DT	O	a	det	13	SENT_103	[p9l1292t783r1325b819],
11	moderate	JJ	O	moderate	amod	13	SENT_103	[p9l1360t761r1672b820],
12	effect	NN	O	effect	nn	13	SENT_103	[p9l1709t759r1888b820],
13	size	NN	O	size	dobj	9	SENT_103	[p9l1926t763r2045b820],
14	of	IN	O	of	_	0	SENT_103	[p9l2082t759r2153b820],
15	0.50	CD	NUMBER	0.50	prep_of	2	SENT_103	[p9l11t863r160b922],
16	for	IN	O	for	_	0	SENT_103	[p9l186t858r278b919],
17	2-sided	JJ	O	2-sided	amod	18	SENT_103	[p9l305t860r551b919],
18	Student	NN	O	student	prep_for	2	SENT_103	[p9l576t860r839b919],
19	2	CD	NUMBER	2	number	20	SENT_103	[p9l864t874r888b919],
20	‘	CD	NUMBER	‘	num	21	SENT_103	[p9l864t874r888b919],
21	test	NN	O	test	npadvmod	2	SENT_103	[p9l912t877r1030b919],
22	of	IN	O	of	_	0	SENT_103	[p9l1056t858r1127b919],
23	paired	JJ	O	paired	amod	24	SENT_103	[p9l1140t860r1351b937],
24	observations	NNS	O	observation	prep_of	2	SENT_103	[p9l1376t858r1791b920],
25	with	IN	O	with	_	0	SENT_103	[p9l1817t860r1973b919],
26	type	NN	O	type	nn	29	SENT_103	[p9l1998t877r2142b937],
27	I	CD	NUMBER	i	num	29	SENT_103	[p9l9t962r35b1017],
28	error	NN	O	error	nn	29	SENT_103	[p9l81t980r242b1018],
29	rate	NN	O	rate	prep_with	24	SENT_103	[p9l287t977r411b1018],
30	of	IN	O	of	_	0	SENT_103	[p9l457t957r528b1018],
31	0.05	CD	NUMBER	0.05	prep_of	2	SENT_103	[p9l564t963r709b1021],
32	in	IN	O	in	_	0	SENT_103	[p9l762t961r827b1017],
33	a	DT	O	a	det	34	SENT_103	[p9l872t981r905b1018],
34	study	NN	O	study	prep_in	2	SENT_103	[p9l950t959r1134b1036],
35	of	IN	O	of	_	0	SENT_103	[p9l1179t957r1250b1018],
36	50	CD	NUMBER	50	num	37	SENT_103	[p9l1290t963r1369b1021],
37	subjects	NNS	O	subject	prep_of	2	SENT_103	[p9l1417t957r1702b1036],
38	.	.	O	.	_	0	SENT_103	[p9l1417t957r1702b1036],

1	Results	NNS	O	result	nsubjpass	3	SENT_104	[p9l1754t959r2000b1018],
2	are	VBP	O	be	auxpass	3	SENT_104	[p9l2047t980r2142b1018],
3	graphed	VBN	O	graph	_	0	SENT_104	[p9l8t1066r282b1144],
4	on	IN	O	on	_	0	SENT_104	[p9l325t1087r406b1126],
5	logarithmic	JJ	O	logarithmic	amod	6	SENT_104	[p9l449t1066r844b1144],
6	scales	NNS	O	scale	prep_on	3	SENT_104	[p9l889t1066r1071b1126],
7	where	WRB	O	where	advmod	11	SENT_104	[p9l1114t1067r1314b1126],
8	error	NN	O	error	nn	9	SENT_104	[p9l1357t1087r1517b1126],
9	estimations	NNS	O	estimation	nsubjpass	11	SENT_104	[p9l1559t1069r1944b1126],
10	were	VBD	O	be	auxpass	11	SENT_104	[p9l1987t1087r2142b1126],
11	performed	VBN	O	perform	advcl	3	SENT_104	[p9l7t1163r356b1242],
12	on	IN	O	on	_	0	SENT_104	[p9l390t1185r471b1224],
13	log	NN	O	log	prep_on	11	SENT_104	[p9l504t1165r608b1242],
14	transformed	VBN	O	transform	partmod	13	SENT_104	[p9l643t1163r1048b1224],
15	data	NNS	O	datum	dobj	14	SENT_104	[p9l1082t1165r1239b1224],
16	.	.	O	.	_	0	SENT_104	[p9l1082t1165r1239b1224],

1	Exploratory	JJ	O	exploratory	amod	2	SENT_105	[p9l98t1272r496b1349],
2	tests	NNS	O	test	nsubjpass	11	SENT_105	[p9l520t1289r667b1331],
3	of	IN	O	of	_	0	SENT_105	[p9l694t1270r764b1331],
4	genetic	JJ	O	genetic	amod	5	SENT_105	[p9l777t1274r1021b1349],
5	association	NN	O	association	prep_of	2	SENT_105	[p9l1046t1274r1409b1331],
6	on	IN	O	on	_	0	SENT_105	[p9l1433t1293r1513b1331],
7	multiple	JJ	O	multiple	amod	9	SENT_105	[p9l1537t1272r1830b1349],
8	outcome	NN	O	outcome	nn	9	SENT_105	[p9l1855t1289r2142b1331],
9	measures	NNS	O	measure	prep_on	5	SENT_105	[p9l9t1419r311b1458],
10	were	VBD	O	be	auxpass	11	SENT_105	[p9l348t1419r503b1458],
11	conducted	VBN	O	conduct	_	0	SENT_105	[p9l540t1399r886b1458],
12	using	VBG	O	use	xcomp	11	SENT_105	[p9l923t1401r1106b1476],
13	multivariate	JJ	O	multivariate	amod	14	SENT_105	[p9l1143t1399r1560b1458],
14	analysis	NN	O	analysis	dobj	12	SENT_105	[p9l1596t1399r1854b1476],
15	of	IN	O	of	_	0	SENT_105	[p9l1891t1397r1962b1458],
16	variance	NN	O	variance	prep_of	14	SENT_105	[p9l1986t1401r2141b1458, p9l9t1519r154b1557],
17	(	CD	NUMBER	(	num	16	SENT_105	[p9l182t1499r634b1570],
18	MANOVA	NNP	O	MANOVA	tmod	12	SENT_105	[p9l182t1499r634b1570],
19	)	CD	NUMBER	)	num	18	SENT_105	[p9l182t1499r634b1570],
20	,	,	O	,	_	0	SENT_105	[p9l182t1499r634b1570],
21	with	IN	O	with	mark	25	SENT_105	[p9l663t1499r819b1557],
22	the	DT	O	the	det	24	SENT_105	[p9l847t1499r952b1557],
23	dependent	JJ	O	dependent	amod	24	SENT_105	[p9l980t1498r1332b1575],
24	variables	NNS	O	variable	nsubj	25	SENT_105	[p9l1359t1496r1652b1558],
25	averaged	VBD	O	average	dep	18	SENT_105	[p9l1682t1498r1975b1575],
26	over	IN	O	over	_	0	SENT_105	[p9l2003t1519r2144b1557],
27	replicate	VB	O	replicate	dep	28	SENT_105	[p9l10t1597r297b1675],
28	measurements	NNS	O	measurement	prep_over	25	SENT_105	[p9l337t1615r817b1657],
29	for	IN	O	for	_	0	SENT_105	[p9l857t1595r949b1657],
30	each	DT	O	each	det	31	SENT_105	[p9l987t1598r1132b1657],
31	subject	NN	O	subject	prep_for	28	SENT_105	[p9l1172t1595r1427b1674],
32	.	.	O	.	_	0	SENT_105	[p9l1172t1595r1427b1674],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_106	[p9l1470t1597r1763b1674],
2	were	VBD	O	be	auxpass	3	SENT_106	[p9l1803t1618r1958b1657],
3	conducted	VBN	O	conduct	_	0	SENT_106	[p9l1998t1618r2141b1657, p9l9t1695r238b1755],
4	in	IN	O	in	_	0	SENT_106	[p9l269t1698r334b1754],
5	2	CD	NUMBER	2	num	6	SENT_106	[p9l365t1699r400b1753],
6	ways	NNS	O	way	prep_in	3	SENT_106	[p9l432t1717r611b1773],
7	:	:	O	:	_	0	SENT_106	[p9l432t1717r611b1773],
8	with	IN	O	with	_	0	SENT_106	[p9l644t1696r800b1755],
9	data	NNS	O	datum	nn	10	SENT_106	[p9l829t1695r971b1755],
10	points	NNS	O	point	prep_with	3	SENT_106	[p9l996t1698r1206b1773],
11	unweighted	JJ	O	unweighted	amod	10	SENT_106	[p9l1237t1695r1639b1773],
12	and	CC	O	and	_	0	SENT_106	[p9l1669t1695r1788b1755],
13	with	IN	O	with	_	0	SENT_106	[p9l1817t1696r1973b1755],
14	data	NNS	O	datum	nn	15	SENT_106	[p9l2002t1695r2144b1755],
15	points	NNS	O	point	conj_and	10	SENT_106	[p9l7t1797r217b1872],
16	weighted	VBN	O	weight	partmod	15	SENT_106	[p9l254t1795r567b1872],
17	by	IN	O	by	_	0	SENT_106	[p9l605t1793r685b1872],
18	the	DT	O	the	det	19	SENT_106	[p9l722t1795r826b1854],
19	number	NN	O	number	agent	16	SENT_106	[p9l865t1793r1128b1854],
20	of	IN	O	of	_	0	SENT_106	[p9l1164t1793r1234b1854],
21	replicate	VB	O	replicate	dep	22	SENT_106	[p9l1262t1795r1549b1872],
22	sets	NNS	O	set	prep_of	19	SENT_106	[p9l1587t1812r1704b1854],
23	of	IN	O	of	_	0	SENT_106	[p9l1743t1793r1813b1854],
24	measurements	NNS	O	measurement	prep_of	22	SENT_106	[p9l1840t1815r2141b1854, p9l9t1887r231b1929],
25	.	.	O	.	_	0	SENT_106	[p9l1840t1815r2141b1854, p9l9t1887r231b1929],

1	Results	NNS	O	result	_	0	SENT_107	[p9l280t2089r665b2164],

1	Fifty	CD	NUMBER	fifty	num	2	SENT_108	[p9l277t2258r453b2346],
2	volunteers	NNS	O	volunteer	nsubj	3	SENT_108	[p9l494t2260r877b2326],
3	received	VBD	O	receive	_	0	SENT_108	[p9l924t2260r1246b2339],
4	,	,	O	,	_	0	SENT_108	[p9l924t2260r1246b2339],
5	in	IN	O	in	_	0	SENT_108	[p9l1294t2263r1366b2325],
6	random	JJ	O	random	amod	13	SENT_108	[p9l1411t2260r1694b2326],
7	order	NN	O	order	nn	9	SENT_108	[p9l1739t2260r1952b2339],
8	,	,	O	,	_	0	SENT_108	[p9l1739t2260r1952b2339],
9	placebo	NN	O	placebo	nn	13	SENT_108	[p9l1997t2260r2140b2346, p9l10t2367r174b2435],
10	and	CC	O	and	_	0	SENT_108	[p9l211t2369r343b2435],
11	single	JJ	O	single	conj_and	9	SENT_108	[p9l382t2369r599b2454],
12	therapeutic	JJ	O	therapeutic	amod	13	SENT_108	[p9l638t2369r1056b2454],
13	doses	NNS	O	dose	prep_in	3	SENT_108	[p9l1094t2369r1285b2435],
14	of	IN	O	of	_	0	SENT_108	[p9l1324t2367r1401b2435],
15	rofecoxib	NN	O	rofecoxib	prep_of	3	SENT_108	[p9l1428t2367r1765b2435],
16	and	CC	O	and	_	0	SENT_108	[p9l1803t2369r1934b2435],
17	celecoxib	NN	O	celecoxib	conj_and	15	SENT_108	[p9l1973t2369r2140b2435, p9l10t2483r206b2552],
18	to	TO	O	to	aux	19	SENT_108	[p9l259t2505r330b2551],
19	compare	VB	O	compare	xcomp	3	SENT_108	[p9l382t2508r693b2571],
20	directly	RB	O	directly	advmod	19	SENT_108	[p9l745t2485r1030b2571],
21	the	DT	O	the	det	22	SENT_108	[p9l1081t2486r1196b2551],
22	responses	NNS	O	response	dobj	19	SENT_108	[p9l1249t2508r1590b2571],
23	to	TO	O	to	_	0	SENT_108	[p9l1644t2505r1715b2551],
24	the	DT	O	the	det	25	SENT_108	[p9l1768t2486r1882b2551],
25	drugs	NNS	O	drug	prep_to	19	SENT_108	[p9l1934t2485r2141b2571],
26	within	IN	O	within	_	0	SENT_108	[p9l8t2594r256b2660],
27	the	DT	O	the	det	29	SENT_108	[p9l307t2594r422b2660],
28	same	JJ	O	same	amod	29	SENT_108	[p9l473t2618r653b2660],
29	subjects	NNS	O	subject	prep_within	25	SENT_108	[p9l704t2592r1018b2679],
30	.	.	O	.	_	0	SENT_108	[p9l704t2592r1018b2679],

1	Baseline	NN	O	baseline	nn	2	SENT_109	[p9l1074t2594r1380b2660],
2	levels	NNS	O	level	nsubj	8	SENT_109	[p9l1431t2594r1632b2660],
3	of	IN	O	of	_	0	SENT_109	[p9l1684t2592r1761b2660],
4	the	DT	O	the	det	7	SENT_109	[p9l1801t2594r1916b2660],
5	drug	NN	O	drug	nn	7	SENT_109	[p9l1967t2594r2141b2679],
6	response	NN	O	response	nn	7	SENT_109	[p9l10t2728r320b2791],
7	parameters	NNS	O	parameter	prep_of	2	SENT_109	[p9l368t2725r773b2791],
8	(	VBP	O	(	_	0	SENT_109	[p9l824t2706r1184b2783],
9	medians	NNS	O	median	dobj	8	SENT_109	[p9l824t2706r1184b2783],
10	)	CD	NUMBER	)	nsubj	11	SENT_109	[p9l824t2706r1184b2783],
11	were	VBD	O	be	rcmod	9	SENT_109	[p9l1233t2729r1404b2771],
12	as	IN	O	as	mark	13	SENT_109	[p9l1454t2730r1520b2771],
13	follows	VBZ	O	follow	advcl	11	SENT_109	[p9l1570t2703r1852b2771],
14	:	:	O	:	_	0	SENT_109	[p9l1570t2703r1852b2771],
15	Serum	NN	O	serum	nn	16	SENT_109	[p9l1907t2707r2142b2771],
16	TxB2	NN	O	txb2	dep	9	SENT_109	[p9l8t2816r199b2895],
17	408	CD	NUMBER	408	num	18	SENT_109	[p9l235t2811r376b2881],
18	ng/mL	NN	O	ng/ml	dep	16	SENT_109	[p9l414t2817r659b2900],
19	(	CD	PERCENT	(	number	20	SENT_109	[p9l693t2817r914b2892],
20	25	CD	PERCENT	25	num	21	SENT_109	[p9l693t2817r914b2892],
21	%	NN	PERCENT	%	dep	18	SENT_109	[p9l693t2817r914b2892],
22	:	:	O	:	_	0	SENT_109	[p9l693t2817r914b2892],
23	280	CD	NUMBER	280	num	24	SENT_109	[p9l955t2819r1094b2881],
24	ng/mL	NN	O	ng/ml	dep	9	SENT_109	[p9l1131t2817r1398b2900],
25	,	,	O	,	_	0	SENT_109	[p9l1131t2817r1398b2900],
26	75	CD	PERCENT	75	num	27	SENT_109	[p9l1436t2817r1629b2884],
27	%	NN	PERCENT	%	appos	24	SENT_109	[p9l1436t2817r1629b2884],
28	:	:	O	:	_	0	SENT_109	[p9l1436t2817r1629b2884],
29	557	CD	NUMBER	557	num	30	SENT_109	[p9l1672t2819r1805b2884],
30	ng/mL	NN	O	ng/ml	dep	9	SENT_109	[p9l1845t2817r2139b2900],
31	)	NN	O	)	dep	9	SENT_109	[p9l1845t2817r2139b2900],
32	;	:	O	;	_	0	SENT_109	[p9l1845t2817r2139b2900],
33	LPS	NN	O	lp	nsubj	34	SENT_109	[p9l8t2925r151b2989],
34	induced	VBD	O	induce	parataxis	8	SENT_109	[p9l182t2924r476b2989],
35	PGE2	NN	O	pge2	nn	37	SENT_109	[p9l507t2925r712b3003],
36	28	CD	NUMBER	28	num	37	SENT_109	[p9l745t2928r834b2989],
37	ng/mL	NN	O	ng/ml	dobj	34	SENT_109	[p9l867t2925r1113b3009],
38	(	CD	PERCENT	(	number	39	SENT_109	[p9l1141t2925r1363b3001],
39	25	CD	PERCENT	25	num	40	SENT_109	[p9l1141t2925r1363b3001],
40	%	NN	PERCENT	%	dep	37	SENT_109	[p9l1141t2925r1363b3001],
41	:	:	O	:	_	0	SENT_109	[p9l1141t2925r1363b3001],
42	16	CD	NUMBER	16	num	43	SENT_109	[p9l1405t2920r1490b2989],
43	ng/mL	NN	O	ng/ml	dep	37	SENT_109	[p9l1521t2925r1788b3009],
44	,	,	O	,	_	0	SENT_109	[p9l1521t2925r1788b3009],
45	75	CD	PERCENT	75	num	46	SENT_109	[p9l1821t2925r2014b2993],
46	%	NN	PERCENT	%	appos	43	SENT_109	[p9l1821t2925r2014b2993],
47	:	:	O	:	_	0	SENT_109	[p9l1821t2925r2014b2993],
48	47	CD	NUMBER	47	num	49	SENT_109	[p9l2047t2920r2137b2992],
49	ng/mL	NN	O	ng/ml	dep	37	SENT_109	[p9l11t3034r305b3117],
50	)	NN	O	)	dep	49	SENT_109	[p9l11t3034r305b3117],
51	;	:	O	;	_	0	SENT_109	[p9l11t3034r305b3117],
52	urine	NN	O	urine	nn	53	SENT_109	[p9l351t3035r542b3098],
53	Tx-M	NN	O	tx-m	dep	37	SENT_109	[p9l585t3034r800b3096],
54	293	CD	NUMBER	293	num	56	SENT_109	[p9l845t3037r981b3105],
55	pg/mg	NN	O	pg/mg	nn	56	SENT_109	[p9l1027t3034r1274b3117],
56	creatinine	NN	O	creatinine	dep	53	SENT_109	[p9l1320t3035r1684b3098],
57	(	CD	PERCENT	(	number	58	SENT_109	[p9l1729t3034r1950b3109],
58	25	CD	PERCENT	25	num	59	SENT_109	[p9l1729t3034r1950b3109],
59	%	NN	PERCENT	%	dep	56	SENT_109	[p9l1729t3034r1950b3109],
60	:	:	O	:	_	0	SENT_109	[p9l1729t3034r1950b3109],
61	185	CD	NUMBER	185	num	63	SENT_109	[p9l2008t3037r2135b3101],
62	pg/mg	NN	O	pg/mg	nn	63	SENT_109	[p9l7t3150r255b3234],
63	creatinine	NN	O	creatinine	dep	37	SENT_109	[p9l306t3151r693b3228],
64	,	,	O	,	_	0	SENT_109	[p9l306t3151r693b3228],
65	75	CD	PERCENT	75	num	66	SENT_109	[p9l747t3150r940b3218],
66	%	NN	PERCENT	%	appos	63	SENT_109	[p9l747t3150r940b3218],
67	:	:	O	:	_	0	SENT_109	[p9l747t3150r940b3218],
68	439	CD	NUMBER	439	num	69	SENT_109	[p9l994t3145r1136b3222],
69	pg/mg	NN	O	pg/mg	dep	37	SENT_109	[p9l1185t3150r1432b3234],
70	creatinine	NN	O	creatinine	nn	71	SENT_109	[p9l1484t3150r1899b3228],
71	)	NN	O	)	dep	69	SENT_109	[p9l1484t3150r1899b3228],
72	;	:	O	;	_	0	SENT_109	[p9l1484t3150r1899b3228],
73	urine	NN	O	urine	nn	74	SENT_109	[p9l1950t3151r2142b3214],
74	PGI-M	NN	O	pgi-m	dep	37	SENT_109	[p9l11t3259r278b3322],
75	81	CD	NUMBER	81	num	77	SENT_109	[p9l308t3261r392b3322],
76	pg/mg	NN	O	pg/mg	nn	77	SENT_109	[p9l427t3259r674b3342],
77	creatinine	NN	O	creatinine	dep	74	SENT_109	[p9l704t3260r1069b3322],
78	(	CD	PERCENT	(	number	79	SENT_109	[p9l1099t3259r1320b3333],
79	25	CD	PERCENT	25	num	80	SENT_109	[p9l1099t3259r1320b3333],
80	%	NN	PERCENT	%	dep	77	SENT_109	[p9l1099t3259r1320b3333],
81	:	:	O	:	_	0	SENT_109	[p9l1099t3259r1320b3333],
82	55	CD	NUMBER	55	num	84	SENT_109	[p9l1359t3261r1441b3325],
83	pg/mg	NN	O	pg/mg	nn	84	SENT_109	[p9l1475t3259r1722b3342],
84	creatinine	NN	O	creatinine	dep	37	SENT_109	[p9l1752t3260r2140b3335],
85	,	,	O	,	_	0	SENT_109	[p9l1752t3260r2140b3335],
86	75	CD	PERCENT	75	num	87	SENT_109	[p9l11t3369r205b3437],
87	%	NN	PERCENT	%	appos	84	SENT_109	[p9l11t3369r205b3437],
88	:	:	O	:	_	0	SENT_109	[p9l11t3369r205b3437],
89	117	CD	NUMBER	117	num	92	SENT_109	[p9l261t3371r391b3436],
90	pg/mg	NN	O	pg/mg	nn	92	SENT_109	[p9l437t3369r684b3453],
91	creatinine	NN	O	creatinine	nn	92	SENT_109	[p9l730t3369r1142b3445],
92	)	NN	O	)	dep	37	SENT_109	[p9l730t3369r1142b3445],
93	.	.	O	.	_	0	SENT_109	[p9l730t3369r1142b3445],

1	Both	DT	O	both	preconj	2	SENT_110	[p9l1191t3368r1371b3433],
2	rofecoxib	NN	O	rofecoxib	nsubj	5	SENT_110	[p9l1416t3365r1753b3434],
3	and	CC	O	and	_	0	SENT_110	[p9l1796t3368r1928b3433],
4	celecoxib	NN	O	celecoxib	conj_and	2	SENT_110	[p9l1973t3368r2140b3433, p9l10t3475r206b3543],
5	inhibited	VBD	O	inhibit	_	0	SENT_110	[p9l255t3475r598b3543],
6	COX	NNP	O	COX	iobj	5	SENT_110	[p9l646t3477r1348b3563],
7	—	CD	NUMBER	—	number	8	SENT_110	[p9l646t3477r1348b3563],
8	2	CD	NUMBER	2	num	9	SENT_110	[p9l646t3477r1348b3563],
9	—	NN	O	—	npadvmod	10	SENT_110	[p9l646t3477r1348b3563],
10	dependent	JJ	O	dependent	amod	12	SENT_110	[p9l646t3477r1348b3563],
11	PGE2	NN	O	pge2	nn	12	SENT_110	[p9l1397t3479r1602b3557],
12	formation	NN	O	formation	dobj	5	SENT_110	[p9l1651t3475r2018b3543],
13	ex	FW	O	ex	nn	14	SENT_110	[p9l2065t3502r2144b3543],
14	vivo	FW	O	vivo	dobj	5	SENT_110	[p9l7t3590r163b3653],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_110	[p9l205t3585r663b3673],
16	when	WRB	O	when	advmod	17	SENT_110	[p9l702t3588r901b3653],
17	compared	VBN	O	compare	advcl	5	SENT_110	[p9l942t3588r1302b3673],
18	with	IN	O	with	_	0	SENT_110	[p9l1342t3588r1513b3653],
19	placebo	NN	O	placebo	prep_with	17	SENT_110	[p9l1552t3585r1833b3673],
20	(	CD	NUMBER	(	num	23	SENT_110	[p9l1874t3589r2142b3673],
21	Figure	NNP	O	Figure	nn	23	SENT_110	[p9l1874t3589r2142b3673],
22	1A	NN	O	1a	nn	23	SENT_110	[p9l18t3699r166b3774],
23	)	NN	O	)	dep	19	SENT_110	[p9l18t3699r166b3774],
24	.	.	O	.	_	0	SENT_110	[p9l18t3699r166b3774],

1	Small	JJ	O	small	amod	3	SENT_111	[p9l201t3697r408b3763],
2	placebo	NN	O	placebo	nn	3	SENT_111	[p9l436t3695r717b3783],
3	effects	NNS	O	effect	nsubj	6	SENT_111	[p9l747t3695r975b3763],
4	may	MD	O	may	aux	6	SENT_111	[p9l1006t3722r1161b3783],
5	be	VB	O	be	cop	6	SENT_111	[p9l1190t3695r1272b3763],
6	attributable	JJ	O	attributable	_	0	SENT_111	[p9l1301t3695r1743b3763],
7	to	TO	O	to	_	0	SENT_111	[p9l1774t3716r1845b3763],
8	diurnal	JJ	O	diurnal	amod	9	SENT_111	[p9l1874t3697r2142b3763],
9	variation	NN	O	variation	prep_to	6	SENT_111	[p10l8t25r337b88],
10	because	IN	O	because	mark	16	SENT_111	[p10l385t21r663b89],
11	predrug	NN	O	predrug	nn	14	SENT_111	[p10l709t23r1005b108],
12	and	CC	O	and	_	0	SENT_111	[p10l1053t23r1185b88],
13	postdrug	NN	O	postdrug	conj_and	11	SENT_111	[p10l1231t23r1565b108],
14	measurements	NNS	O	measurement	nsubjpass	16	SENT_111	[p10l1613t42r2141b89],
15	were	VBD	O	be	auxpass	16	SENT_111	[p10l8t155r179b198],
16	performed	VBN	O	perform	advcl	6	SENT_111	[p10l225t130r608b218],
17	consistently	RB	O	consistently	advmod	16	SENT_111	[p10l656t132r1099b217],
18	at	IN	O	at	_	0	SENT_111	[p10l1145t151r1211b197],
19	0800	CD	DATE	0800	num	22	SENT_111	[p10l1260t136r1448b198],
20	and	CC	DATE	and	_	0	SENT_111	[p10l1497t132r1629b198],
21	1200	CD	DATE	1200	num	22	SENT_111	[p10l1685t136r1866b198],
22	hours	NNS	NUMBER	hour	prep_at	16	SENT_111	[p10l1915t133r2137b198],
23	.	.	O	.	_	0	SENT_111	[p10l1915t133r2137b198],

1	There	EX	O	there	expl	2	SENT_112	[p10l8t243r223b309],
2	was	VBD	O	be	_	0	SENT_112	[p10l256t267r388b309],
3	no	DT	O	no	det	4	SENT_112	[p10l425t266r511b309],
4	difference	NN	O	difference	nsubj	2	SENT_112	[p10l546t241r906b309],
5	in	IN	O	in	_	0	SENT_112	[p10l942t245r1013b307],
6	the	DT	O	the	det	7	SENT_112	[p10l1048t243r1162b308],
7	degree	NN	O	degree	prep_in	4	SENT_112	[p10l1197t243r1437b328],
8	of	IN	O	of	_	0	SENT_112	[p10l1472t241r1550b309],
9	COX-2	NN	MISC	cox-2	nn	10	SENT_112	[p10l1573t244r1847b309],
10	inhibition	NN	O	inhibition	prep_of	7	SENT_112	[p10l1887t241r2140b309, p10l10t353r158b416],
11	attained	VBN	O	attain	partmod	10	SENT_112	[p10l199t350r499b416],
12	by	IN	O	by	_	0	SENT_112	[p10l541t348r630b435],
13	the	DT	O	the	det	15	SENT_112	[p10l671t351r786b416],
14	2	CD	NUMBER	2	num	15	SENT_112	[p10l829t354r867b414],
15	drugs	NNS	O	drug	agent	11	SENT_112	[p10l913t350r1119b436],
16	(	CD	NUMBER	(	num	17	SENT_112	[p10l1163t348r1527b427],
17	rofecoxib	NN	O	rofecoxib	dobj	11	SENT_112	[p10l1163t348r1527b427],
18	44.8	CD	PERCENT	44.8	num	19	SENT_112	[p10l1568t346r1812b419],
19	%	NN	PERCENT	%	dep	17	SENT_112	[p10l1568t346r1812b419],
20	vs	CC	O	vs	_	0	SENT_112	[p10l1857t375r1930b416],
21	celecoxib	NN	O	celecoxib	dobj	11	SENT_112	[p10l1973t350r2140b416, p10l10t459r206b527],
22	47.5	CD	PERCENT	47.5	num	23	SENT_112	[p10l245t457r541b538],
23	%	NN	PERCENT	%	dep	21	SENT_112	[p10l245t457r541b538],
24	)	CD	NUMBER	)	dep	21	SENT_112	[p10l245t457r541b538],
25	.	.	O	.	_	0	SENT_112	[p10l245t457r541b538],

1	Celecoxib	NNP	O	Celecoxib	nsubj	3	SENT_113	[p10l585t459r944b527],
2	also	RB	O	also	advmod	3	SENT_113	[p10l983t461r1121b527],
3	depressed	VBD	O	depress	_	0	SENT_113	[p10l1160t461r1514b546],
4	COX	NNP	O	COX	nsubj	7	SENT_113	[p10l1554t461r2142b527],
5	—	CD	NUMBER	—	number	6	SENT_113	[p10l1554t461r2142b527],
6	1	CD	NUMBER	1	num	7	SENT_113	[p10l1554t461r2142b527],
7	—	NN	O	—	xcomp	3	SENT_113	[p10l1554t461r2142b527],
8	derived	VBN	O	derive	partmod	7	SENT_113	[p10l1554t461r2142b527],
9	serum	NN	O	serum	nn	10	SENT_113	[p10l10t593r234b636],
10	TxB2	NN	O	txb2	dobj	8	SENT_113	[p10l261t571r477b650],
11	,	,	O	,	_	0	SENT_113	[p10l261t571r477b650],
12	but	CC	O	but	_	0	SENT_113	[p10l508t568r633b636],
13	the	DT	O	the	det	14	SENT_113	[p10l663t571r777b636],
14	effect	NN	O	effect	nsubj	27	SENT_113	[p10l807t568r1003b636],
15	was	VBD	O	be	cop	27	SENT_113	[p10l1030t595r1163b636],
16	small	JJ	O	small	amod	27	SENT_113	[p10l1193t570r1388b636],
17	in	IN	O	in	_	0	SENT_113	[p10l1419t573r1490b635],
18	comparison	NN	O	comparison	prep_in	16	SENT_113	[p10l1518t573r1944b656],
19	with	IN	O	with	_	0	SENT_113	[p10l1971t571r2142b636],
20	the	DT	O	the	det	21	SENT_113	[p10l10t681r125b746],
21	inhibition	NN	O	inhibition	prep_with	18	SENT_113	[p10l181t679r557b747],
22	of	IN	O	of	_	0	SENT_113	[p10l611t679r689b746],
23	PGE2	NN	O	pge2	nn	26	SENT_113	[p10l733t682r939b761],
24	(	CD	NUMBER	(	num	26	SENT_113	[p10l996t682r1263b766],
25	Figure	NNP	O	Figure	nn	26	SENT_113	[p10l996t682r1263b766],
26	1B	NN	O	1b	prep_of	21	SENT_113	[p10l1326t682r1469b758],
27	)	NN	O	)	conj_but	3	SENT_113	[p10l1326t682r1469b758],
28	.	.	O	.	_	0	SENT_113	[p10l1326t682r1469b758],

1	Both	DT	O	both	det	2	SENT_114	[p10l1529t681r1709b747],
2	drugs	NNS	O	drug	nsubj	3	SENT_114	[p10l1764t681r1971b766],
3	depressed	VBD	O	depress	_	0	SENT_114	[p10l2026t681r2140b747, p10l7t790r277b876],
4	the	DT	O	the	det	5	SENT_114	[p10l329t791r444b856],
5	formation	NN	O	formation	dobj	3	SENT_114	[p10l495t788r861b856],
6	of	IN	O	of	_	0	SENT_114	[p10l912t788r990b856],
7	PGI2	NN	O	pgi2	prep_of	5	SENT_114	[p10l1031t792r1214b870],
8	in	IN	O	in	_	0	SENT_114	[p10l1269t793r1340b855],
9	Vivo	NNP	O	Vivo	prep_in	3	SENT_114	[p10l1389t793r1544b856],
10	as	IN	O	as	mark	11	SENT_114	[p10l1595t815r1661b856],
11	assessed	VBN	O	assess	advcl	3	SENT_114	[p10l1713t790r2002b856],
12	by	IN	O	by	_	0	SENT_114	[p10l2055t788r2143b876],
13	urinary	JJ	O	urinary	amod	14	SENT_114	[p10l9t903r278b986],
14	PGI	NNP	O	PGI	prep_by	11	SENT_114	[p10l312t902r579b967],
15	.	.	O	.	_	0	SENT_114	[p10l312t902r579b967],

1	—	NN	O	—	_	0	SENT_115	[p10l312t902r579b967],
2	.	.	O	.	_	0	SENT_115	[p10l312t902r579b967],

1	M	NN	O	m	nn	2	SENT_116	[p10l312t902r579b967],
2	excretion	NN	O	excretion	nsubj	10	SENT_116	[p10l612t904r950b967],
3	but	CC	O	but	_	0	SENT_116	[p10l984t899r1109b967],
4	not	RB	O	not	_	0	SENT_116	[p10l1144t920r1263b967],
5	the	DT	O	the	det	6	SENT_116	[p10l1297t901r1412b967],
6	formation	NN	O	formation	nsubj	10	SENT_116	[p10l1445t899r1812b967],
7	of	IN	O	of	_	0	SENT_116	[p10l1844t899r1922b967],
8	TxA2	NN	O	txa2	prep_of	6	SENT_116	[p10l1943t902r2139b981],
9	as	IN	O	as	advmod	10	SENT_116	[p10l9t1035r75b1076],
10	assessed	VBN	O	assess	_	0	SENT_116	[p10l109t1010r398b1076],
11	by	IN	O	by	_	0	SENT_116	[p10l432t1008r521b1096],
12	excretion	NN	O	excretion	prep_by	10	SENT_116	[p10l553t1013r892b1076],
13	of	IN	O	of	_	0	SENT_116	[p10l925t1008r1003b1076],
14	urinary	JJ	O	urinary	amod	15	SENT_116	[p10l1024t1013r1293b1096],
15	Tx-M	NN	O	tx-m	prep_of	12	SENT_116	[p10l1324t1011r1539b1075],
16	(	CD	NUMBER	(	num	18	SENT_116	[p10l1572t1012r1839b1096],
17	Figure	NNP	O	Figure	nn	18	SENT_116	[p10l1572t1012r1839b1096],
18	1C	NN	O	1c	dobj	10	SENT_116	[p10l1880t1012r1975b1076],
19	and	CC	O	and	_	0	SENT_116	[p10l2010t1010r2141b1076],
20	1D	NN	O	1d	nn	21	SENT_116	[p10l18t1121r172b1196],
21	)	NN	O	)	conj_and	18	SENT_116	[p10l18t1121r172b1196],
22	.	.	O	.	_	0	SENT_116	[p10l18t1121r172b1196],

1	There	EX	O	there	expl	2	SENT_117	[p10l209t1119r423b1185],
2	was	VBD	O	be	_	0	SENT_117	[p10l454t1143r586b1185],
3	no	DT	O	no	det	4	SENT_117	[p10l621t1142r709b1185],
4	difference	NN	O	difference	nsubj	2	SENT_117	[p10l741t1117r1101b1185],
5	between	IN	O	between	_	0	SENT_117	[p10l1135t1117r1441b1185],
6	the	DT	O	the	det	7	SENT_117	[p10l1474t1119r1588b1185],
7	drugs	NNS	O	drug	prep_between	4	SENT_117	[p10l1621t1119r1828b1204],
8	in	IN	O	in	_	0	SENT_117	[p10l1863t1122r1935b1183],
9	their	PRP$	O	they	poss	10	SENT_117	[p10l1968t1119r2144b1185],
10	effects	NNS	O	effect	prep_in	7	SENT_117	[p10l10t1228r238b1296],
11	on	IN	O	on	_	0	SENT_117	[p10l272t1254r361b1296],
12	these	DT	O	these	det	13	SENT_117	[p10l394t1231r579b1296],
13	measures	NNS	O	measure	prep_on	2	SENT_117	[p10l611t1253r944b1296],
14	of	IN	O	of	_	0	SENT_117	[p10l978t1228r1055b1296],
15	COX-2	NN	O	cox-2	nn	18	SENT_117	[p10l1077t1232r1351b1296],
16	and	CC	O	and	_	0	SENT_117	[p10l1388t1230r1520b1296],
17	COX-1	NN	O	cox-1	nn	18	SENT_117	[p10l1553t1232r1823b1296],
18	activity	NN	O	activity	prep_of	13	SENT_117	[p10l1863t1233r2143b1316],
19	in	IN	O	in	_	0	SENT_117	[p10l11t1342r82b1403],
20	Vivo	NNP	O	Vivo	nn	23	SENT_117	[p10l116t1342r272b1405],
21	(	NNP	O	(	nn	23	SENT_117	[p10l309t1341r608b1424],
22	Figures	NNS	O	figure	nn	23	SENT_117	[p10l309t1341r608b1424],
23	1C	NN	O	1c	prep_in	18	SENT_117	[p10l654t1341r749b1405],
24	and	CC	O	and	_	0	SENT_117	[p10l787t1340r919b1405],
25	1D	NN	O	1d	nn	26	SENT_117	[p10l964t1341r1118b1416],
26	)	NN	O	)	conj_and	23	SENT_117	[p10l964t1341r1118b1416],
27	.	.	O	.	_	0	SENT_117	[p10l964t1341r1118b1416],

1	The	DT	O	the	det	2	SENT_118	[p10l106t1450r250b1515],
2	degree	NN	O	degree	nsubjpass	20	SENT_118	[p10l277t1449r518b1535],
3	of	IN	O	of	_	0	SENT_118	[p10l545t1447r623b1515],
4	selectivity	NN	O	selectivity	prep_of	2	SENT_118	[p10l640t1449r1016b1535],
5	for	IN	O	for	_	0	SENT_118	[p10l1042t1447r1143b1515],
6	COX-2	NN	O	cox-2	prep_for	4	SENT_118	[p10l1169t1451r1443b1515],
7	in	IN	O	in	_	0	SENT_118	[p10l1476t1452r1547b1514],
8	Vitro	NNP	O	Vitro	prep_in	20	SENT_118	[p10l1572t1452r1887b1515],
9	—	CD	NUMBER	—	num	8	SENT_118	[p10l1572t1452r1887b1515],
10	a	DT	O	a	det	12	SENT_118	[p10l1572t1452r1887b1515],
11	chemical	NN	O	chemical	nn	12	SENT_118	[p10l1913t1450r2140b1515, p10l11t1560r135b1626],
12	property	NN	O	property	nsubjpass	20	SENT_118	[p10l191t1579r510b1645],
13	of	IN	O	of	_	0	SENT_118	[p10l567t1558r645b1626],
14	a	DT	O	a	det	17	SENT_118	[p10l690t1585r726b1625],
15	COX	NNP	O	COX	nn	17	SENT_118	[p10l781t1561r979b1626],
16	inhibitor	NN	O	inhibitor	nn	17	SENT_118	[p10l1036t1558r1524b1626],
17	—	NN	O	—	prep_of	12	SENT_118	[p10l1036t1558r1524b1626],
18	is	VBZ	O	be	auxpass	20	SENT_118	[p10l1036t1558r1524b1626],
19	commonly	RB	O	commonly	advmod	20	SENT_118	[p10l1582t1560r1976b1645],
20	expressed	VBN	O	express	_	0	SENT_118	[p10l2032t1584r2140b1625, p10l7t1669r277b1755],
21	as	IN	O	as	_	0	SENT_118	[p10l303t1694r368b1735],
22	the	DT	O	the	det	23	SENT_118	[p10l397t1670r511b1735],
23	ratio	NN	O	ratio	prep_as	20	SENT_118	[p10l538t1672r707b1735],
24	of	IN	O	of	_	0	SENT_118	[p10l733t1667r810b1735],
25	the	DT	O	the	det	27	SENT_118	[p10l826t1670r940b1735],
26	drug	NN	O	drug	nn	27	SENT_118	[p10l966t1669r1141b1755],
27	concentrations	NNS	O	concentration	prep_of	23	SENT_118	[p10l1168t1672r1706b1735],
28	required	VBN	O	require	partmod	27	SENT_118	[p10l1734t1669r2044b1755],
29	to	TO	O	to	aux	30	SENT_118	[p10l2071t1688r2142b1735],
30	inhibit	VB	O	inhibit	xcomp	28	SENT_118	[p10l11t1777r266b1846],
31	the	DT	O	the	det	33	SENT_118	[p10l293t1780r408b1845],
32	enzymatic	JJ	O	enzymatic	amod	33	SENT_118	[p10l434t1782r809b1865],
33	activities	NNS	O	activity	dobj	30	SENT_118	[p10l836t1782r1168b1845],
34	of	IN	O	of	_	0	SENT_118	[p10l1195t1777r1273b1845],
35	COX-2	NN	O	cox-2	prep_of	33	SENT_118	[p10l1288t1781r1561b1845],
36	and	CC	O	and	_	0	SENT_118	[p10l1591t1780r1723b1845],
37	COX-1	NN	O	cox-1	prep_of	33	SENT_118	[p10l1749t1781r2020b1845],
38	by	IN	O	by	_	0	SENT_118	[p10l2055t1777r2143b1865],
39	30	CD	PERCENT	30	num	40	SENT_118	[p10l14t1890r179b1957],
40	%	NN	PERCENT	%	prep_by	30	SENT_118	[p10l14t1890r179b1957],
41	(	CD	NUMBER	(	num	44	SENT_118	[p10l230t1890r497b1973],
42	Figure	NNP	O	Figure	nn	44	SENT_118	[p10l230t1890r497b1973],
43	2A	NN	O	2a	nn	44	SENT_118	[p10l545t1890r699b1965],
44	)	NN	O	)	dep	40	SENT_118	[p10l545t1890r699b1965],
45	.	.	O	.	_	0	SENT_118	[p10l545t1890r699b1965],

1	Based	VBN	O	base	_	0	SENT_119	[p10l749t1888r962b1954],
2	on	IN	O	on	prepc_based_on	9	SENT_119	[p10l1008t1911r1096b1954],
3	these	DT	O	these	det	4	SENT_119	[p10l1141t1888r1326b1954],
4	criteria	NNS	O	criterion	pobj	9	SENT_119	[p10l1372t1891r1656b1967],
5	,	,	O	,	_	0	SENT_119	[p10l1372t1891r1656b1967],
6	rofecoxib	NN	O	rofecoxib	nsubj	9	SENT_119	[p10l1704t1886r2041b1954],
7	is	VBZ	O	be	cop	9	SENT_119	[p10l2088t1891r2141b1954],
8	more	RBR	O	more	advmod	9	SENT_119	[p10l9t2022r195b2065],
9	selective	JJ	O	selective	dep	23	SENT_119	[p10l246t2000r556b2065],
10	than	IN	O	than	_	0	SENT_119	[p10l607t2000r771b2064],
11	celecoxib	NN	O	celecoxib	prep_than	9	SENT_119	[p10l821t1997r1212b2066],
12	.1	CD	NUMBER	.1	num	11	SENT_119	[p10l821t1997r1212b2066],
13	However	RB	O	however	advmod	9	SENT_119	[p10l1267t2002r1621b2079],
14	,	,	O	,	_	0	SENT_119	[p10l1267t2002r1621b2079],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_119	[p10l1671t1997r2140b2085, p10l11t2112r190b2175],
16	and	CC	O	and	_	0	SENT_119	[p10l225t2110r356b2175],
17	pharmacodynamic	JJ	O	pharmacodynamic	amod	18	SENT_119	[p10l389t2110r1072b2195],
18	variations	NNS	O	variation	attr	9	SENT_119	[p10l1105t2112r1466b2176],
19	between	IN	O	between	_	0	SENT_119	[p10l1502t2108r1808b2176],
20	individuals	NNS	O	individual	prep_between	18	SENT_119	[p10l1843t2110r2140b2175, p10l9t2220r151b2285],
21	would	MD	O	would	aux	23	SENT_119	[p10l194t2219r425b2285],
22	be	VB	O	be	auxpass	23	SENT_119	[p10l468t2217r550b2285],
23	expected	VBN	O	expect	_	0	SENT_119	[p10l593t2219r915b2305],
24	to	TO	O	to	aux	25	SENT_119	[p10l959t2239r1030b2285],
25	affect	VB	O	affect	xcomp	23	SENT_119	[p10l1073t2217r1269b2285],
26	the	DT	O	the	det	27	SENT_119	[p10l1313t2220r1428b2285],
27	degree	NN	O	degree	dobj	25	SENT_119	[p10l1471t2219r1711b2305],
28	of	IN	O	of	_	0	SENT_119	[p10l1754t2217r1832b2285],
29	COX-2	NN	MISC	cox-2	nn	30	SENT_119	[p10l1864t2221r2138b2285],
30	selectivity	NN	O	selectivity	prep_of	27	SENT_119	[p10l10t2330r387b2415],
31	actually	RB	O	actually	advmod	32	SENT_119	[p10l436t2330r727b2415],
32	attained	VBN	O	attain	partmod	30	SENT_119	[p10l776t2330r1076b2395],
33	in	IN	O	in	_	0	SENT_119	[p10l1128t2332r1199b2394],
34	humans	NNS	O	human	prep_in	32	SENT_119	[p10l1249t2330r1561b2409],
35	,	,	O	,	_	0	SENT_119	[p10l1249t2330r1561b2409],
36	which	WDT	O	which	nsubjpass	39	SENT_119	[p10l1612t2330r1838b2396],
37	can	MD	O	can	aux	39	SENT_119	[p10l1888t2353r2010b2395],
38	be	VB	O	be	auxpass	39	SENT_119	[p10l2060t2328r2142b2396],
39	described	VBN	O	describe	rcmod	34	SENT_119	[p10l9t2437r359b2505],
40	by	IN	O	by	_	0	SENT_119	[p10l402t2437r490b2525],
41	the	DT	O	the	det	42	SENT_119	[p10l532t2440r647b2505],
42	ratio	NN	O	ratio	agent	39	SENT_119	[p10l690t2442r859b2505],
43	of	IN	O	of	_	0	SENT_119	[p10l901t2437r979b2505],
44	COX-2	NN	O	cox-2	nn	45	SENT_119	[p10l1010t2441r1284b2505],
45	inhibition	NN	O	inhibition	prep_of	42	SENT_119	[p10l1332t2437r1708b2505],
46	vs	CC	O	vs	_	0	SENT_119	[p10l1747t2464r1820b2505],
47	COX-1	NN	O	cox-1	nn	48	SENT_119	[p10l1863t2441r2134b2505],
48	inhibition	NN	O	inhibition	prep_of	42	SENT_119	[p10l11t2553r387b2622],
49	at	IN	O	at	_	0	SENT_119	[p10l441t2575r507b2621],
50	any	DT	O	any	det	53	SENT_119	[p10l562t2579r690b2641],
51	given	VBN	O	give	amod	53	SENT_119	[p10l742t2558r946b2641],
52	plasma	NN	O	plasma	nn	53	SENT_119	[p10l998t2556r1260b2641],
53	concentration	NN	O	concentration	prep_at	39	SENT_119	[p10l1313t2558r1820b2621],
54	(	CD	NUMBER	(	num	55	SENT_119	[p10l1875t2557r2142b2641],
55	Figure	NN	O	figure	nsubjpass	23	SENT_119	[p10l1875t2557r2142b2641],

1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_120	[p10l986t2802r1654b2851],
2	Vol	NN	O	vol	dep	1	SENT_120	[p10l1677t2802r1784b2851],
3	.	.	O	.	_	0	SENT_120	[p10l1677t2802r1784b2851],

1	130	CD	NUMBER	130	_	0	SENT_121	[p10l1816t2801r1950b2861],
2	,	,	O	,	_	0	SENT_121	[p10l1816t2801r1950b2861],
3	No.	NN	O	no.	appos	1	SENT_121	[p10l1982t2802r2075b2851],
4	1	CD	NUMBER	1	num	3	SENT_121	[p10l2107t2801r2145b2851],

1	2B	NN	O	2b	_	0	SENT_122	[p10l12t3025r161b3101],
2	)	NN	O	)	dep	1	SENT_122	[p10l12t3025r161b3101],
3	.	.	O	.	_	0	SENT_122	[p10l12t3025r161b3101],

1	When	WRB	O	when	advmod	7	SENT_123	[p10l202t3024r433b3089],
2	the	DT	O	the	det	3	SENT_123	[p10l471t3024r585b3089],
3	degree	NN	O	degree	nsubj	7	SENT_123	[p10l622t3024r863b3109],
4	of	IN	O	of	_	0	SENT_123	[p10l900t3021r978b3089],
5	COX-2	NN	MISC	cox-2	nn	6	SENT_123	[p10l1004t3025r1277b3089],
6	selectivity	NN	O	selectivity	prep_of	3	SENT_123	[p10l1320t3024r1696b3109],
7	attained	VBN	O	attain	advcl	11	SENT_123	[p10l1732t3024r2033b3089],
8	in	IN	O	in	_	0	SENT_123	[p10l2071t3026r2143b3088],
9	subjects	NNS	O	subject	prep_in	7	SENT_123	[p10l10t3131r303b3218],
10	was	VBD	O	be	auxpass	11	SENT_123	[p10l347t3158r478b3199],
11	estimated	VBN	O	estimate	dep	18	SENT_123	[p10l523t3133r883b3199],
12	using	VBG	O	use	xcomp	11	SENT_123	[p10l926t3136r1128b3219],
13	this	DT	O	this	det	14	SENT_123	[p10l1173t3134r1308b3199],
14	measure	NN	O	measure	dobj	12	SENT_123	[p10l1353t3156r1676b3212],
15	,	,	O	,	_	0	SENT_123	[p10l1353t3156r1676b3212],
16	both	CC	O	both	dep	14	SENT_123	[p10l1722t3131r1891b3199],
17	drugs	NNS	O	drug	conj	14	SENT_123	[p10l1934t3133r2141b3219],
18	differed	VBD	O	differ	_	0	SENT_123	[p10l10t3241r293b3309],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_123	[p10l345t3241r803b3329],
20	from	IN	O	from	_	0	SENT_123	[p10l853t3241r1028b3309],
21	placebo	NN	O	placebo	prep_from	18	SENT_123	[p10l1077t3241r1358b3329],
22	but	CC	O	but	_	0	SENT_123	[p10l1409t3241r1535b3310],
23	not	RB	O	not	_	0	SENT_123	[p10l1587t3263r1706b3309],
24	from	IN	O	from	_	0	SENT_123	[p10l1757t3241r1932b3309],
25	each	DT	O	each	det	26	SENT_123	[p10l1983t3244r2142b3309],
26	other	JJ	O	other	conj_negcc	21	SENT_123	[p10l10t3354r203b3419],
27	at	IN	O	at	_	0	SENT_123	[p10l238t3372r304b3418],
28	this	DT	O	this	det	30	SENT_123	[p10l342t3354r477b3419],
29	time	NN	O	time	nn	30	SENT_123	[p10l516t3356r685b3419],
30	point	NN	O	point	prep_at	26	SENT_123	[p10l720t3356r918b3439],
31	after	IN	O	after	_	0	SENT_123	[p10l955t3351r1122b3419],
32	dosing	NN	O	dosing	prep_after	18	SENT_123	[p10l1157t3353r1402b3439],
33	(	CD	NUMBER	(	num	36	SENT_123	[p10l1440t3355r1707b3439],
34	Figure	NNP	O	Figure	nn	36	SENT_123	[p10l1440t3355r1707b3439],
35	2C	NN	O	2c	nn	36	SENT_123	[p10l1747t3355r1896b3430],
36	)	NN	O	)	nsubj	18	SENT_123	[p10l1747t3355r1896b3430],
37	.	.	O	.	_	0	SENT_123	[p10l1747t3355r1896b3430],

1	There	EX	O	there	expl	2	SENT_124	[p10l106t3464r320b3529],
2	was	VBD	O	be	_	0	SENT_124	[p10l350t3488r482b3529],
3	considerable	JJ	O	considerable	amod	4	SENT_124	[p10l514t3461r972b3530],
4	variability	NN	O	variability	nsubj	2	SENT_124	[p10l1000t3461r1385b3549],
5	in	IN	O	in	_	0	SENT_124	[p10l1417t3466r1488b3528],
6	both	CC	O	both	dep	12	SENT_124	[p10l1519t3461r1688b3530],
7	ex	FW	O	ex	nn	8	SENT_124	[p10l1718t3488r1797b3529],
8	vivo	FW	O	vivo	dep	6	SENT_124	[p10l1824t3466r1980b3529],
9	and	CC	O	and	_	0	SENT_124	[p10l2010t3464r2142b3529],
10	in	FW	O	in	nn	11	SENT_124	[p10l11t3575r82b3636],
11	vivo	FW	O	vivo	conj_and	6	SENT_124	[p10l111t3575r266b3637],
12	indices	NNS	O	index	prep_in	4	SENT_124	[p10l299t3572r553b3637],
13	of	IN	O	of	_	0	SENT_124	[p10l586t3570r664b3637],
14	inhibition	NN	O	inhibition	prep_of	4	SENT_124	[p10l685t3570r1061b3637],
15	of	IN	O	of	_	0	SENT_124	[p10l1092t3570r1169b3637],
16	both	CC	O	both	dep	22	SENT_124	[p10l1190t3570r1360b3637],
17	COX-2	NN	O	cox-2	dep	16	SENT_124	[p10l1391t3574r1664b3637],
18	and	CC	O	and	_	0	SENT_124	[p10l1700t3572r1832b3637],
19	COX-1	NN	O	cox-1	conj_and	16	SENT_124	[p10l1863t3574r2134b3637],
20	(	CD	NUMBER	(	num	21	SENT_124	[p10l10t3682r309b3765],
21	Figures	NNS	O	figure	dep	19	SENT_124	[p10l10t3682r309b3765],
22	1E	NN	O	1e	prep_of	14	SENT_124	[p10l388t3682r646b3757],
23	.	.	O	.	_	0	SENT_124	[p10l388t3682r646b3757],

1	—	NN	O	—	_	0	SENT_125	[p10l388t3682r646b3757],
2	.	.	O	.	_	0	SENT_125	[p10l388t3682r646b3757],

1	H	NN	O	h	_	0	SENT_126	[p10l388t3682r646b3757],
2	)	NN	O	)	dep	1	SENT_126	[p10l388t3682r646b3757],
3	.	.	O	.	_	0	SENT_126	[p10l388t3682r646b3757],

1	However	RB	O	however	advmod	5	SENT_127	[p10l722t3683r1077b3759],
2	,	,	O	,	_	0	SENT_127	[p10l722t3683r1077b3759],
3	drug	NN	O	drug	nn	4	SENT_127	[p10l1149t3681r1323b3765],
4	response	NN	O	response	nsubj	5	SENT_127	[p10l1396t3703r1706b3765],
5	correlated	VBD	O	correlate	_	0	SENT_127	[p10l1777t3681r2142b3745],
6	poorly	RB	O	poorly	amod	10	SENT_127	[p11l7t20r246b106],
7	with	IN	O	with	_	0	SENT_127	[p11l302t21r473b86],
8	plasma	NN	O	plasma	prep_with	6	SENT_127	[p11l529t20r791b106],
9	drug	NN	O	drug	nn	10	SENT_127	[p11l847t20r1021b106],
10	concentrations	NNS	O	concentration	dobj	5	SENT_127	[p11l1081t23r1619b86],
11	of	IN	O	of	_	0	SENT_127	[p11l1679t18r1757b86],
12	rofecoxib	NN	O	rofecoxib	prep_of	10	SENT_127	[p11l1805t18r2142b86],
13	(	CD	NUMBER	(	num	14	SENT_127	[p11l10t130r332b209],
14	median	NN	O	median	dep	12	SENT_127	[p11l10t130r332b209],
15	,	,	O	,	_	0	SENT_127	[p11l10t130r332b209],
16	215	CD	NUMBER	215	num	17	SENT_127	[p11l371t134r505b199],
17	ng/mL	NN	O	ng/ml	appos	14	SENT_127	[p11l547t131r815b215],
18	;	:	O	;	_	0	SENT_127	[p11l547t131r815b215],
19	range	NN	O	range	dep	14	SENT_127	[p11l853t153r1076b215],
20	,	,	O	,	_	0	SENT_127	[p11l853t153r1076b215],
21	115	CD	NUMBER	115	num	22	SENT_127	[p11l1121t126r1461b199],
22	—	NN	O	—	appos	19	SENT_127	[p11l1121t126r1461b199],
23	658	CD	NUMBER	658	num	25	SENT_127	[p11l1121t126r1461b199],
24	ng/mL	NN	O	ng/ml	nn	25	SENT_127	[p11l1499t131r1771b215],
25	)	NN	O	)	dep	22	SENT_127	[p11l1499t131r1771b215],
26	and	CC	O	and	_	0	SENT_127	[p11l1806t130r1937b195],
27	celecoxib	NN	O	celecoxib	nn	29	SENT_127	[p11l1972t130r2140b195, p11l10t237r206b305],
28	(	CD	NUMBER	(	num	29	SENT_127	[p11l240t239r563b318],
29	median	NN	O	median	appos	19	SENT_127	[p11l240t239r563b318],
30	,	,	O	,	_	0	SENT_127	[p11l240t239r563b318],
31	575	CD	NUMBER	575	num	32	SENT_127	[p11l603t243r733b308],
32	ng/mL	NN	O	ng/ml	appos	29	SENT_127	[p11l775t241r1041b325],
33	;	:	O	;	_	0	SENT_127	[p11l775t241r1041b325],
34	range	NN	O	range	dep	29	SENT_127	[p11l1078t262r1302b325],
35	,	,	O	,	_	0	SENT_127	[p11l1078t262r1302b325],
36	179-1372	CD	NUMBER	179-1372	num	37	SENT_127	[p11l1345t243r1732b312],
37	ng/ml	NN	O	ng/ml	appos	34	SENT_127	[p11l1770t241r2042b325],
38	.	.	O	.	_	0	SENT_127	[p11l1770t241r2042b325],
39	)	SYM	O	)	dep	10	SENT_127	[p11l1770t241r2042b325],

1	at	IN	O	at	advmod	9	SENT_128	[p11l2075t258r2141b304],
2	4	CD	DURATION	4	num	3	SENT_128	[p11l9t345r53b413],
3	hours	NNS	NUMBER	hour	pobj	1	SENT_128	[p11l82t349r283b415],
4	after	IN	O	after	_	0	SENT_128	[p11l311t347r477b415],
5	dosing	NN	O	dosing	prep_after	1	SENT_128	[p11l503t349r748b434],
6	(	CD	NUMBER	(	num	7	SENT_128	[p11l777t349r960b426],
7	data	NNS	O	datum	npadvmod	8	SENT_128	[p11l777t349r960b426],
8	not	RB	O	not	advmod	1	SENT_128	[p11l986t368r1105b415],
9	shown	VBN	O	show	_	0	SENT_128	[p11l1134t349r1415b426],
10	)	NN	O	)	dobj	9	SENT_128	[p11l1134t349r1415b426],
11	.	.	O	.	_	0	SENT_128	[p11l1134t349r1415b426],

1	Plasma	NN	O	plasma	nn	3	SENT_129	[p11l1448t349r1712b415],
2	drug	NN	O	drug	nn	3	SENT_129	[p11l1737t349r1911b434],
3	levels	NNS	O	level	nsubj	6	SENT_129	[p11l1940t349r2141b415],
4	after	IN	O	after	_	0	SENT_129	[p11l9t456r176b524],
5	dosing	NN	O	dosing	prep_after	3	SENT_129	[p11l205t458r450b544],
6	showed	VBD	O	show	_	0	SENT_129	[p11l483t458r755b524],
7	a	DT	O	a	det	8	SENT_129	[p11l787t483r823b523],
8	trend	NN	O	trend	dobj	6	SENT_129	[p11l853t458r1049b524],
9	toward	IN	O	toward	_	0	SENT_129	[p11l1081t458r1337b524],
10	lower	JJR	O	lower	amod	11	SENT_129	[p11l1369t458r1573b524],
11	concentrations	NNS	O	concentration	prep_toward	6	SENT_129	[p11l1603t461r2141b524],
12	with	IN	O	with	_	0	SENT_129	[p11l8t569r180b634],
13	increasing	VBG	O	increase	prepc_with	6	SENT_129	[p11l221t571r596b654],
14	body	NN	O	body	nn	16	SENT_129	[p11l638t567r819b654],
15	mass	NN	O	mass	nn	16	SENT_129	[p11l858t593r1033b635],
16	index	NN	O	index	iobj	13	SENT_129	[p11l1075t569r1278b634],
17	(	CD	NUMBER	(	num	19	SENT_129	[p11l1318t570r1561b646],
18	BMI	NN	O	bmus	nn	19	SENT_129	[p11l1318t570r1561b646],
19	)	NN	O	)	dobj	13	SENT_129	[p11l1318t570r1561b646],
20	.	.	O	.	_	0	SENT_129	[p11l1318t570r1561b646],

1	However	RB	O	however	advmod	4	SENT_130	[p11l1607t572r1962b648],
2	,	,	O	,	_	0	SENT_130	[p11l1607t572r1962b648],
3	this	DT	O	this	nsubj	4	SENT_130	[p11l2006t569r2141b634],
4	attained	VBD	O	attain	_	0	SENT_130	[p11l9t678r310b744],
5	signiﬁcance	NN	O	signiﬁcance	nsubj	8	SENT_130	[p11l343t676r773b764],
6	(	CD	NUMBER	(	num	7	SENT_130	[p11l806t680r883b755],
7	P	NN	O	p	npadvmod	8	SENT_130	[p11l806t680r883b755],
8	<	JJR	O	<	xcomp	4	SENT_130	[p11l922t682r988b738],
9	.05	CD	NUMBER	.05	num	10	SENT_130	[p11l1031t680r1171b755],
10	)	NN	O	)	npadvmod	11	SENT_130	[p11l1031t680r1171b755],
11	only	RB	O	only	advmod	4	SENT_130	[p11l1204t678r1364b764],
12	for	IN	O	for	_	0	SENT_130	[p11l1395t676r1496b744],
13	rofecoxib	NN	O	rofecoxib	prep_for	4	SENT_130	[p11l1528t676r1885b744],
14	:	:	O	:	_	0	SENT_130	[p11l1528t676r1885b744],
15	a	DT	O	a	det	17	SENT_130	[p11l1922t703r1959b743],
16	unit	NN	O	unit	nn	17	SENT_130	[p11l1988t681r2142b744],
17	increase	NN	O	increase	nsubjpass	21	SENT_130	[p11l11t790r299b853],
18	in	IN	O	in	_	0	SENT_130	[p11l345t790r416b851],
19	BMI	NNP	O	BMI	prep_in	17	SENT_130	[p11l460t790r629b851],
20	was	VBD	O	be	auxpass	21	SENT_130	[p11l673t811r805b853],
21	associated	VBN	O	associate	parataxis	4	SENT_130	[p11l851t788r1216b853],
22	with	IN	O	with	_	0	SENT_130	[p11l1260t788r1431b853],
23	a	DT	O	a	det	24	SENT_130	[p11l1476t812r1512b852],
24	drop	NN	O	drop	prep_with	21	SENT_130	[p11l1554t788r1724b872],
25	in	IN	O	in	_	0	SENT_130	[p11l1769t790r1841b851],
26	plasma	NN	O	plasma	nn	27	SENT_130	[p11l1883t788r2144b872],
27	concentration	NN	O	concentration	prep_in	24	SENT_130	[p11l10t900r517b963],
28	of	IN	O	of	_	0	SENT_130	[p11l554t895r631b963],
29	approximately	RB	O	approximately	quantmod	30	SENT_130	[p11l656t897r1192b983],
30	2	CD	PERCENT	2	num	31	SENT_130	[p11l1230t899r1373b966],
31	%	NN	PERCENT	%	prep_of	27	SENT_130	[p11l1230t899r1373b966],
32	.	.	O	.	_	0	SENT_130	[p11l1230t899r1373b966],

1	We	PRP	O	we	nsubj	2	SENT_131	[p11l107t1011r239b1074],
2	assessed	VBD	O	assess	_	0	SENT_131	[p11l282t1008r571b1074],
3	intra	JJ	O	intra	amod	4	SENT_131	[p11l616t1010r821b1073],
4	—	NN	O	—	dobj	2	SENT_131	[p11l616t1010r821b1073],
5	and	CC	O	and	_	0	SENT_131	[p11l866t1008r997b1073],
6	interindividual	JJ	O	interindividual	amod	7	SENT_131	[p11l1042t1008r1602b1074],
7	variability	NN	O	variability	conj_and	4	SENT_131	[p11l1643t1006r2028b1093],
8	in	IN	O	in	_	0	SENT_131	[p11l2071t1010r2143b1072],
9	drug	NN	O	drug	nn	10	SENT_131	[p11l10t1117r184b1203],
10	response	NN	O	response	prep_in	2	SENT_131	[p11l234t1140r544b1203],
11	to	TO	O	to	aux	12	SENT_131	[p11l593t1137r664b1183],
12	determine	VB	O	determine	xcomp	2	SENT_131	[p11l713t1117r1089b1183],
13	the	DT	O	the	det	15	SENT_131	[p11l1139t1118r1253b1183],
14	likely	JJ	O	likely	amod	15	SENT_131	[p11l1303t1115r1510b1203],
15	contribution	NN	O	contribution	dobj	12	SENT_131	[p11l1559t1115r2028b1183],
16	of	IN	O	of	_	0	SENT_131	[p11l2076t1115r2153b1183],
17	random	JJ	O	random	amod	20	SENT_131	[p11l10t1227r294b1292],
18	and	CC	O	and	_	0	SENT_131	[p11l336t1227r468b1292],
19	environmental	JJ	O	environmental	conj_and	17	SENT_131	[p11l510t1227r1049b1292],
20	ﬂuctuations	NNS	O	ﬂuctuations	prep_of	15	SENT_131	[p11l1093t1225r1527b1292],
21	rather	RB	O	rather	advmod	12	SENT_131	[p11l1571t1227r1790b1292],
22	than	IN	O	than	_	0	SENT_131	[p11l1832t1227r1996b1291],
23	interindividual	JJ	O	interindividual	prep_than	12	SENT_131	[p11l2039t1229r2140b1290, p11l10t1336r494b1402],

1	factors	NNS	O	factor	_	0	SENT_132	[p11l527t1334r767b1402],
2	to	TO	O	to	_	0	SENT_132	[p11l801t1356r871b1402],
3	variability	NN	O	variability	prep_to	1	SENT_132	[p11l902t1334r1305b1422],
4	.	.	O	.	_	0	SENT_132	[p11l902t1334r1305b1422],

1	Thus	RB	O	thus	advmod	4	SENT_133	[p11l1341t1337r1551b1416],
2	,	,	O	,	_	0	SENT_133	[p11l1341t1337r1551b1416],
3	5	CD	NUMBER	5	nsubj	4	SENT_133	[p11l1590t1340r1622b1405],
4	replicate	VBP	O	replicate	dep	9	SENT_133	[p11l1663t1336r1978b1422],
5	sets	NNS	O	set	dobj	4	SENT_133	[p11l2012t1356r2141b1402],
6	of	IN	O	of	_	0	SENT_133	[p11l10t1445r87b1513],
7	measurements	NNS	O	measurement	prep_of	5	SENT_133	[p11l107t1466r635b1513],
8	were	VBD	O	be	auxpass	9	SENT_133	[p11l666t1470r837b1512],
9	performed	VBN	O	perform	_	0	SENT_133	[p11l867t1445r1251b1532],
10	in	IN	O	in	_	0	SENT_133	[p11l1283t1449r1354b1511],
11	5	CD	NUMBER	5	num	12	SENT_133	[p11l1390t1451r1423b1516],
12	volunteers	NNS	O	volunteer	prep_in	9	SENT_133	[p11l1459t1447r1842b1513],
13	(	CD	NUMBER	(	num	15	SENT_133	[p11l1875t1448r2142b1532],
14	Figure	NN	O	figure	nn	15	SENT_133	[p11l1875t1448r2142b1532],
15	1I	NN	O	1us	nsubjpass	9	SENT_133	[p11l18t1558r237b1633],
16	.	.	O	.	_	0	SENT_133	[p11l18t1558r237b1633],

1	—	NN	O	—	_	0	SENT_134	[p11l18t1558r237b1633],
2	.	.	O	.	_	0	SENT_134	[p11l18t1558r237b1633],

1	L	NN	O	l	_	0	SENT_135	[p11l18t1558r237b1633],
2	)	NN	O	)	dep	1	SENT_135	[p11l18t1558r237b1633],
3	.	.	O	.	_	0	SENT_135	[p11l18t1558r237b1633],

1	The	DT	O	the	det	3	SENT_136	[p11l273t1557r416b1622],
2	simpliﬁed	JJ	O	simpliﬁed	amod	3	SENT_136	[p11l449t1554r819b1642],
3	model	NN	O	model	nsubj	4	SENT_136	[p11l851t1556r1080b1622],
4	underlying	VBG	O	underlie	dep	8	SENT_136	[p11l1112t1556r1521b1642],
5	this	DT	O	this	det	7	SENT_136	[p11l1554t1557r1689b1622],
6	experimental	JJ	O	experimental	amod	7	SENT_136	[p11l1722t1559r2140b1642, p11l10t1667r103b1732],
7	design	NN	O	design	dobj	4	SENT_136	[p11l130t1667r372b1752],
8	assumed	VBD	O	assume	_	0	SENT_136	[p11l398t1667r709b1733],
9	that	IN	O	that	complm	14	SENT_136	[p11l737t1667r884b1732],
10	the	DT	O	the	det	12	SENT_136	[p11l913t1667r1027b1732],
11	total	JJ	O	total	amod	12	SENT_136	[p11l1054t1665r1213b1732],
12	variability	NN	O	variability	nsubj	14	SENT_136	[p11l1233t1665r1600b1752],
13	as	IN	O	as	advmod	14	SENT_136	[p11l1627t1691r1693b1732],
14	observed	VBN	O	observe	ccomp	8	SENT_136	[p11l1721t1665r2043b1733],
15	in	IN	O	in	_	0	SENT_136	[p11l2071t1669r2143b1731],
16	the	DT	O	the	det	18	SENT_136	[p11l10t1777r125b1842],
17	whole	JJ	O	whole	amod	18	SENT_136	[p11l171t1776r391b1842],
18	population	NN	O	population	prep_in	14	SENT_136	[p11l437t1776r843b1862],
19	(	CD	NUMBER	(	num	21	SENT_136	[p11l890t1778r1158b1862],
20	Figure	NNP	O	Figure	nn	21	SENT_136	[p11l890t1778r1158b1862],
21	1E	NN	O	1e	nsubj	8	SENT_136	[p11l1214t1778r1435b1853],
22	.	.	O	.	_	0	SENT_136	[p11l1214t1778r1435b1853],

1	—	NN	O	—	_	0	SENT_137	[p11l1214t1778r1435b1853],
2	.	.	O	.	_	0	SENT_137	[p11l1214t1778r1435b1853],

1	H	NN	O	h	nn	2	SENT_138	[p11l1214t1778r1435b1853],
2	)	NN	O	)	nsubjpass	4	SENT_138	[p11l1214t1778r1435b1853],
3	was	VBD	O	be	auxpass	4	SENT_138	[p11l1482t1801r1614b1842],
4	composed	VBN	O	compose	_	0	SENT_138	[p11l1663t1776r2028b1862],
5	of	IN	O	of	_	0	SENT_138	[p11l2076t1774r2153b1842],
6	irrterimlivitlaal	JJ	O	irrterimlivitlaal	amod	7	SENT_138	[p11l10t1883r533b1949],
7	variability	NN	O	variability	prep_of	4	SENT_138	[p11l568t1883r958b1968],
8	,	,	O	,	_	0	SENT_138	[p11l568t1883r958b1968],
9	irrtraimlivitlaal	JJ	O	irrtraimlivitlaal	amod	10	SENT_138	[p11l1002t1883r1541b1949],
10	variability	NN	O	variability	prep_of	4	SENT_138	[p11l1576t1883r1966b1968],
11	,	,	O	,	_	0	SENT_138	[p11l1576t1883r1966b1968],
12	and	CC	O	and	_	0	SENT_138	[p11l2010t1884r2142b1949],
13	some	DT	O	some	det	14	SENT_138	[p11l10t2019r195b2060],
14	portion	NN	O	portion	prep_of	4	SENT_138	[p11l224t1997r500b2080],
15	of	IN	O	of	_	0	SENT_138	[p11l529t1992r607b2060],
16	random	JJ	O	random	amod	18	SENT_138	[p11l625t1994r877b2060],
17	variability	NN	O	variability	nn	18	SENT_138	[p11l905t1993r1272b2080],
18	(	NN	O	(	prep_of	14	SENT_138	[p11l1303t1996r1435b2080],
19	eg	FW	O	eg	tmod	4	SENT_138	[p11l1303t1996r1435b2080],
20	,	,	O	,	_	0	SENT_138	[p11l1303t1996r1435b2080],
21	technical	JJ	O	technical	amod	23	SENT_138	[p11l1468t1994r1800b2060],
22	variability	NN	O	variability	nn	23	SENT_138	[p11l1829t1992r2140b2060, p11l11t2106r156b2188],
23	)	NN	O	)	appos	19	SENT_138	[p11l1829t1992r2140b2060, p11l11t2106r156b2188],
24	.	.	O	.	_	0	SENT_138	[p11l1829t1992r2140b2060, p11l11t2106r156b2188],

1	The	DT	O	the	nsubj	2	SENT_139	[p11l188t2104r332b2169],
2	replicate	VBP	O	replicate	dep	4	SENT_139	[p11l361t2104r677b2188],
3	measurements	NNS	O	measurement	dobj	2	SENT_139	[p11l705t2123r1233b2169],
4	served	VBD	O	serve	_	0	SENT_139	[p11l1264t2104r1492b2169],
5	to	TO	O	to	aux	6	SENT_139	[p11l1522t2123r1593b2169],
6	determine	VB	O	determine	xcomp	4	SENT_139	[p11l1622t2104r1998b2169],
7	the	DT	O	the	det	8	SENT_139	[p11l2028t2104r2142b2169],
8	combination	NN	O	combination	dobj	6	SENT_139	[p11l10t2211r479b2279],
9	of	IN	O	of	_	0	SENT_139	[p11l542t2211r619b2279],
10	ivtraimlivitlaal	JJ	O	ivtraimlivitlaal	amod	11	SENT_139	[p11l670t2212r1210b2279],
11	variability	NN	O	variability	prep_of	8	SENT_139	[p11l1266t2212r1633b2299],
12	and	CC	O	and	_	0	SENT_139	[p11l1696t2213r1828b2279],
13	ramlom	NN	O	ramlom	nn	14	SENT_139	[p11l1890t2213r2142b2279],
14	variability	NN	O	variability	conj_and	11	SENT_139	[p11l8t2321r375b2407],
15	(	CD	NUMBER	(	num	17	SENT_139	[p11l421t2324r689b2407],
16	Figure	NNP	O	Figure	nn	17	SENT_139	[p11l421t2324r689b2407],
17	1I	NN	O	1us	nsubj	4	SENT_139	[p11l743t2324r962b2399],
18	.	.	O	.	_	0	SENT_139	[p11l743t2324r962b2399],

1	—	NN	O	—	_	0	SENT_140	[p11l743t2324r962b2399],
2	.	.	O	.	_	0	SENT_140	[p11l743t2324r962b2399],

1	L	NN	O	l	_	0	SENT_141	[p11l743t2324r962b2399],
2	)	NN	O	)	dep	1	SENT_141	[p11l743t2324r962b2399],
3	.	.	O	.	_	0	SENT_141	[p11l743t2324r962b2399],

1	Thus	RB	O	thus	dep	3	SENT_142	[p11l1013t2322r1222b2401],
2	,	,	O	,	_	0	SENT_142	[p11l1013t2322r1222b2401],
3	assessment	NN	O	assessment	_	0	SENT_142	[p11l1270t2341r1668b2388],
4	of	IN	O	of	_	0	SENT_142	[p11l1715t2320r1792b2388],
5	the	DT	O	the	det	7	SENT_142	[p11l1828t2322r1942b2388],
6	total	JJ	O	total	amod	7	SENT_142	[p11l1988t2321r2148b2388],
7	variability	NN	O	variability	prep_of	3	SENT_142	[p11l8t2432r375b2519],
8	(	CD	NUMBER	(	num	10	SENT_142	[p11l414t2435r681b2519],
9	Figure	NNP	O	Figure	nn	10	SENT_142	[p11l414t2435r681b2519],
10	1E	NN	O	1e	dep	7	SENT_142	[p11l728t2435r965b2510],
11	.	.	O	.	_	0	SENT_142	[p11l728t2435r965b2510],

1	—	NN	O	—	_	0	SENT_143	[p11l728t2435r965b2510],
2	.	.	O	.	_	0	SENT_143	[p11l728t2435r965b2510],

1	H	NN	O	h	nn	2	SENT_144	[p11l728t2435r965b2510],
2	)	NN	O	)	_	0	SENT_144	[p11l728t2435r965b2510],
3	and	CC	O	and	_	0	SENT_144	[p11l1004t2433r1135b2499],
4	its	PRP$	O	its	poss	6	SENT_144	[p11l1175t2436r1261b2499],
5	2	CD	NUMBER	2	num	6	SENT_144	[p11l1303t2437r1341b2498],
6	components	NNS	O	component	conj_and	2	SENT_144	[p11l1384t2453r1829b2519],
7	intramoliviclaal	JJ	O	intramoliviclaal	amod	10	SENT_144	[p11l1869t2436r2140b2499, p11l8t2540r304b2606],
8	and	CC	O	and	_	0	SENT_144	[p11l355t2541r486b2606],
9	ramlom	NN	O	ramlom	amod	10	SENT_144	[p11l541t2540r793b2606],
10	variability	NN	O	variability	dep	2	SENT_144	[p11l848t2540r1215b2625],
11	(	CD	NUMBER	(	num	13	SENT_144	[p11l1271t2542r1538b2625],
12	Figure	NNP	O	Figure	nn	13	SENT_144	[p11l1271t2542r1538b2625],
13	1I	NN	O	1us	dep	10	SENT_144	[p11l1603t2543r1802b2617],
14	.	.	O	.	_	0	SENT_144	[p11l1603t2543r1802b2617],

1	—	NN	O	—	_	0	SENT_145	[p11l1603t2543r1802b2617],
2	.	.	O	.	_	0	SENT_145	[p11l1603t2543r1802b2617],

1	L	NN	O	l	nn	2	SENT_146	[p11l1603t2543r1802b2617],
2	)	NN	O	)	nsubj	3	SENT_146	[p11l1603t2543r1802b2617],
3	allowed	VBD	O	allow	_	0	SENT_146	[p11l1858t2541r2142b2606],
4	estimation	NN	O	estimation	dobj	3	SENT_146	[p11l10t2654r403b2717],
5	of	IN	O	of	_	0	SENT_146	[p11l444t2649r521b2717],
6	the	DT	O	the	det	8	SENT_146	[p11l552t2652r666b2717],
7	third	JJ	ORDINAL	third	amod	8	SENT_146	[p11l708t2652r893b2717],
8	component	NN	O	component	prep_of	4	SENT_146	[p11l934t2671r1370b2737],
9	,	,	O	,	_	0	SENT_146	[p11l934t2671r1370b2737],
10	interimliviclaal	JJ	O	interimliviclaal	amod	11	SENT_146	[p11l1414t2650r1937b2717],
11	variability	NN	O	variability	appos	8	SENT_146	[p11l1971t2655r2141b2717, p11l6t2758r256b2843],
12	,	,	O	,	_	0	SENT_146	[p11l1971t2655r2141b2717, p11l6t2758r256b2843],
13	using	VBG	O	use	partmod	3	SENT_146	[p11l288t2761r490b2843],
14	a	DT	O	a	det	17	SENT_146	[p11l520t2783r556b2823],
15	variance	NN	O	variance	nn	17	SENT_146	[p11l582t2761r884b2824],
16	component	NN	O	component	nn	17	SENT_146	[p11l915t2778r1328b2843],
17	analysis	NN	O	analysis	dobj	13	SENT_146	[p11l1358t2759r1662b2843],
18	.	.	O	.	_	0	SENT_146	[p11l1358t2759r1662b2843],

1	The	DT	O	the	det	3	SENT_147	[p11l1696t2759r1839b2824],
2	average	JJ	O	average	amod	3	SENT_147	[p11l1869t2781r2142b2843],
3	responses	NNS	O	response	nsubj	9	SENT_147	[p11l10t2899r352b2962],
4	for	IN	O	for	_	0	SENT_147	[p11l393t2874r494b2942],
5	both	DT	O	both	det	6	SENT_147	[p11l533t2874r702b2943],
6	drugs	NNS	O	drug	prep_for	3	SENT_147	[p11l742t2877r948b2962],
7	in	IN	O	in	_	0	SENT_147	[p11l991t2879r1062b2941],
8	the	DT	O	the	prep_in	6	SENT_147	[p11l1102t2877r1216b2942],
9	replicate	VBP	O	replicate	_	0	SENT_147	[p11l1258t2877r1573b2962],
10	measurements	NNS	O	measurement	dobj	9	SENT_147	[p11l1613t2896r2141b2942],
11	closely	RB	O	closely	advmod	12	SENT_147	[p11l10t3018r256b3103],
12	approximate	JJ	O	approximate	dep	10	SENT_147	[p11l304t3020r768b3103],
13	the	DT	O	the	det	14	SENT_147	[p11l817t3019r931b3084],
14	observations	NNS	O	observation	dobj	12	SENT_147	[p11l980t3016r1437b3084],
15	made	VBN	O	make	dep	12	SENT_147	[p11l1486t3018r1683b3084],
16	within	IN	O	within	_	0	SENT_147	[p11l1731t3018r1979b3084],
17	the	DT	O	the	det	19	SENT_147	[p11l2028t3018r2142b3084],
18	whole	JJ	O	whole	amod	19	SENT_147	[p11l8t3128r228b3193],
19	population	NN	O	population	prep_within	15	SENT_147	[p11l273t3128r699b3213],
20	.	.	O	.	_	0	SENT_147	[p11l273t3128r699b3213],

1	Variability	NN	O	variability	nsubj	5	SENT_148	[p11l749t3125r1155b3213],
2	within	IN	O	within	_	0	SENT_148	[p11l1200t3128r1448b3193],
3	these	DT	O	these	det	4	SENT_148	[p11l1495t3128r1680b3193],
4	individuals	NNS	O	individual	prep_within	1	SENT_148	[p11l1729t3128r2141b3193],
5	(	VBP	O	(	_	0	SENT_148	[p11l10t3234r577b3311],
6	iritraimlivitlaal	JJ	O	iritraimlivitlaal	acomp	5	SENT_148	[p11l10t3234r577b3311],
7	and	CC	O	and	_	0	SENT_148	[p11l607t3235r739b3300],
8	ramlom	NN	O	ramlom	nn	10	SENT_148	[p11l775t3234r1027b3300],
9	variability	NN	O	variability	nn	10	SENT_148	[p11l1062t3234r1457b3319],
10	)	NN	O	)	nsubj	12	SENT_148	[p11l1062t3234r1457b3319],
11	was	VBD	O	be	cop	12	SENT_148	[p11l1493t3259r1624b3300],
12	less	JJR	O	less	conj_and	5	SENT_148	[p11l1663t3235r1788b3300],
13	than	IN	O	than	_	0	SENT_148	[p11l1826t3235r1991b3299],
14	the	DT	O	the	det	15	SENT_148	[p11l2027t3235r2142b3300],
15	variability	NN	O	variability	prep_than	12	SENT_148	[p11l8t3343r393b3431],
16	in	IN	O	in	_	0	SENT_148	[p11l423t3348r494b3410],
17	the	DT	O	the	det	18	SENT_148	[p11l525t3346r640b3411],
18	population	NN	O	population	prep_in	15	SENT_148	[p11l667t3346r1074b3431],
19	as	IN	O	as	_	0	SENT_148	[p11l1104t3370r1169b3411],
20	a	DT	O	a	det	25	SENT_148	[p11l1200t3371r1237b3411],
21	whole	JJ	O	whole	amod	25	SENT_148	[p11l1263t3346r1483b3411],
22	(	NN	O	(	nn	25	SENT_148	[p11l1514t3344r1700b3423],
23	total	JJ	O	total	amod	25	SENT_148	[p11l1514t3344r1700b3423],
24	variability	NN	O	variability	nn	25	SENT_148	[p11l1723t3344r2137b3431],
25	)	NN	O	)	prep_as	18	SENT_148	[p11l1723t3344r2137b3431],
26	.	.	O	.	_	0	SENT_148	[p11l1723t3344r2137b3431],

1	This	DT	O	this	nsubjpass	4	SENT_149	[p11l8t3456r173b3522],
2	can	MD	O	can	aux	4	SENT_149	[p11l210t3479r331b3522],
3	be	VB	O	be	auxpass	4	SENT_149	[p11l367t3454r448b3522],
4	visualized	VBN	O	visualize	dep	14	SENT_149	[p11l482t3456r849b3522],
5	by	IN	O	by	_	0	SENT_149	[p11l886t3454r974b3541],
6	expressing	VBG	O	express	agent	4	SENT_149	[p11l1009t3459r1395b3541],
7	for	IN	O	for	_	0	SENT_149	[p11l1431t3454r1532b3522],
8	each	DT	O	each	det	9	SENT_149	[p11l1566t3456r1725b3522],
9	individual	NN	O	individual	prep_for	6	SENT_149	[p11l1761t3456r2141b3522],
10	the	DT	O	the	det	11	SENT_149	[p11l10t3575r125b3640],
11	variances	NNS	O	variance	dobj	6	SENT_149	[p11l154t3577r488b3640],
12	of	IN	O	of	_	0	SENT_149	[p11l521t3572r599b3640],
13	the	DT	O	the	prep_of	11	SENT_149	[p11l619t3575r734b3640],
14	replicate	VBP	O	replicate	_	0	SENT_149	[p11l766t3575r1082b3660],
15	measurements	NNS	O	measurement	dobj	14	SENT_149	[p11l1113t3594r1641b3640],
16	and	CC	O	and	_	0	SENT_149	[p11l1673t3575r1805b3640],
17	comparing	VBG	O	compare	conj_and	14	SENT_149	[p11l1837t3598r2140b3660, p11l11t3687r129b3770],
18	the	DT	O	the	det	20	SENT_149	[p11l184t3685r298b3750],
19	average	JJ	O	average	amod	20	SENT_149	[p11l351t3707r624b3770],
20	variance	NN	O	variance	dobj	17	SENT_149	[p11l674t3687r976b3750],
21	of	IN	O	of	_	0	SENT_149	[p11l1029t3682r1106b3750],
22	measurements	NNS	O	measurement	prep_of	20	SENT_149	[p11l1147t3703r1675b3750],
23	within	IN	O	within	_	0	SENT_149	[p11l1727t3685r1975b3750],
24	the	DT	O	the	det	26	SENT_149	[p11l2028t3685r2142b3750],
25	same	JJ	O	same	amod	26	SENT_149	[p12l10t45r190b86],
26	subject	NN	O	subject	prep_within	17	SENT_149	[p12l222t18r483b106],
27	with	IN	O	with	_	0	SENT_149	[p12l512t21r683b86],
28	the	DT	O	the	det	30	SENT_149	[p12l714t21r829b86],
29	total	JJ	O	total	amod	30	SENT_149	[p12l860t21r1028b86],
30	variance	NN	O	variance	prep_with	26	SENT_149	[p12l1057t23r1359b86],
31	(	CD	NUMBER	(	num	33	SENT_149	[p12l1390t22r1657b106],
32	Figure	NNP	O	Figure	nn	33	SENT_149	[p12l1390t22r1657b106],
33	3A	NN	O	3a	nsubj	14	SENT_149	[p12l1692t22r1964b98],
34	.	.	O	.	_	0	SENT_149	[p12l1692t22r1964b98],

1	—	NN	O	—	_	0	SENT_150	[p12l1692t22r1964b98],
2	.	.	O	.	_	0	SENT_150	[p12l1692t22r1964b98],

1	D	NN	O	d	_	0	SENT_151	[p12l1692t22r1964b98],
2	)	NN	O	)	dep	1	SENT_151	[p12l1692t22r1964b98],
3	.	.	O	.	_	0	SENT_151	[p12l1692t22r1964b98],

1	The	DT	O	the	nsubj	2	SENT_152	[p12l1998t21r2142b86],
2	replicate	VBP	O	replicate	_	0	SENT_152	[p12l10t139r326b225],
3	measurements	NNS	O	measurement	nsubj	11	SENT_152	[p12l365t158r892b205],
4	in	IN	O	in	prep	3	SENT_152	[p12l933t142r1004b204],
5	3	CD	NUMBER	3	npadvmod	6	SENT_152	[p12l1046t143r1081b210],
6	out	IN	O	out	pcomp	4	SENT_152	[p12l1124t158r1245b205],
7	of	IN	O	of	_	0	SENT_152	[p12l1283t137r1362b205],
8	4	CD	NUMBER	4	num	10	SENT_152	[p12l1387t135r1432b203],
9	response	NN	O	response	nn	10	SENT_152	[p12l1472t162r1782b225],
10	Variables	NNS	O	variable	prep_of	3	SENT_152	[p12l1818t137r2141b205],
11	exhibited	VBD	O	exhibit	ccomp	2	SENT_152	[p12l10t246r359b314],
12	a	DT	O	a	det	14	SENT_152	[p12l385t273r421b313],
13	lower	JJR	O	lower	amod	14	SENT_152	[p12l445t249r649b313],
14	variation	NN	O	variation	dobj	11	SENT_152	[p12l671t251r1001b313],
15	within	IN	O	within	_	0	SENT_152	[p12l1025t249r1273b313],
16	individuals	NNS	O	individual	prep_within	11	SENT_152	[p12l1299t249r1712b313],
17	than	IN	O	than	prep	11	SENT_152	[p12l1739t249r1904b313],
18	in	IN	O	in	pcomp	17	SENT_152	[p12l1930t251r2002b312],
19	the	DT	O	the	det	21	SENT_152	[p12l2028t249r2142b313],
20	Whole	JJ	O	whole	amod	21	SENT_152	[p12l8t358r228b424],
21	population	NN	O	population	pobj	18	SENT_152	[p12l253t358r681b444],
22	,	,	O	,	_	0	SENT_152	[p12l253t358r681b444],
23	indicating	VBG	O	indicate	partmod	11	SENT_152	[p12l711t358r1090b444],
24	that	IN	O	that	complm	48	SENT_152	[p12l1119t359r1266b423],
25	im	NN	O	im	nsubj	48	SENT_152	[p12l1292t357r1816b424],
26	‘	CD	NUMBER	‘	num	25	SENT_152	[p12l1292t357r1816b424],
27	eVi7ia	NN	O	evi7ium	nn	29	SENT_152	[p12l1292t357r1816b424],
28	'	''	O	'	_	0	SENT_152	[p12l1292t357r1816b424],
29	i1/ia	NN	O	i1/ia	dep	25	SENT_152	[p12l1292t357r1816b424],
30	’	CD	NUMBER	’	num	31	SENT_152	[p12l1292t357r1816b424],
31	aa	NN	O	aa	dep	25	SENT_152	[p12l1292t357r1816b424],
32	/	:	O	/	punct	34	SENT_152	[p12l1292t357r1816b424],
33	1/aria	CD	NUMBER	1/aria	num	34	SENT_152	[p12l1835t357r2141b424],
34	éi	NN	O	éi	dep	31	SENT_152	[p12l1835t357r2141b424],
35	/	:	O	/	punct	34	SENT_152	[p12l1835t357r2141b424],
36	ity	NN	O	ity	dep	31	SENT_152	[p12l10t472r120b554],
37	,	,	O	,	_	0	SENT_152	[p12l10t472r120b554],
38	beyond	IN	O	beyond	_	0	SENT_152	[p12l152t466r418b554],
39	that	DT	O	that	prep_beyond	48	SENT_152	[p12l448t469r595b534],
40	attributable	JJ	O	attributable	amod	39	SENT_152	[p12l624t466r1066b535],
41	to	TO	O	to	_	0	SENT_152	[p12l1095t488r1166b534],
42	random	JJ	O	random	amod	45	SENT_152	[p12l1196t469r1479b534],
43	and	CC	O	and	_	0	SENT_152	[p12l1507t469r1639b534],
44	environmental	JJ	O	environmental	amod	45	SENT_152	[p12l1668t471r2140b534, p12l10t579r103b644],
45	inﬂuences	NNS	O	inﬂuences	prep_to	40	SENT_152	[p12l150t577r537b658],
46	,	,	O	,	_	0	SENT_152	[p12l150t577r537b658],
47	is	VBZ	O	be	cop	48	SENT_152	[p12l585t582r639b645],
48	detectable	JJ	O	detectable	ccomp	23	SENT_152	[p12l685t577r1061b645],
49	Within	IN	O	within	_	0	SENT_152	[p12l1105t579r1353b645],
50	the	DT	O	the	det	51	SENT_152	[p12l1399t579r1513b645],
51	population	NN	O	population	prep_within	2	SENT_152	[p12l1557t579r1982b664],
52	.	.	O	.	_	0	SENT_152	[p12l1557t579r1982b664],

1	Indeed	RB	O	indeed	advmod	6	SENT_153	[p12l2032t582r2140b643, p12l9t697r202b776],
2	,	,	O	,	_	0	SENT_153	[p12l2032t582r2140b643, p12l9t697r202b776],
3	variance	NN	O	variance	nn	5	SENT_153	[p12l238t700r540b762],
4	component	NN	O	component	nn	5	SENT_153	[p12l576t716r990b782],
5	analyses	NNS	O	analysis	nsubj	6	SENT_153	[p12l1026t697r1320b782],
6	suggested	VBD	O	suggest	_	0	SENT_153	[p12l1357t697r1722b782],
7	that	IN	O	that	complm	27	SENT_153	[p12l1758t698r1905b761],
8	up	RB	O	up	advmod	27	SENT_153	[p12l1941t720r2035b782],
9	to	TO	O	to	_	0	SENT_153	[p12l2071t716r2142b762],
10	approximately	RB	O	approximately	quantmod	11	SENT_153	[p12l9t808r545b893],
11	30	CD	PERCENT	30	num	12	SENT_153	[p12l592t809r758b879],
12	%	NN	PERCENT	%	prep_to	8	SENT_153	[p12l592t809r758b879],
13	of	IN	O	of	_	0	SENT_153	[p12l808t806r885b874],
14	the	DT	O	the	det	16	SENT_153	[p12l919t808r1034b874],
15	total	JJ	O	total	amod	16	SENT_153	[p12l1077t806r1237b873],
16	variability	NN	O	variability	prep_of	12	SENT_153	[p12l1274t806r1641b893],
17	in	IN	O	in	_	0	SENT_153	[p12l1686t810r1758b872],
18	the	DT	O	the	det	19	SENT_153	[p12l1802t808r1917b874],
19	measures	NNS	O	measure	prep_in	16	SENT_153	[p12l1961t832r2140b874, p12l10t940r189b983],
20	of	IN	O	of	_	0	SENT_153	[p12l216t915r294b983],
21	COX-1	NN	O	cox-1	nn	24	SENT_153	[p12l309t919r579b983],
22	and	CC	O	and	_	0	SENT_153	[p12l613t917r744b983],
23	COX-2	NN	O	cox-2	nn	24	SENT_153	[p12l771t919r1045b983],
24	inhibition	NN	O	inhibition	prep_of	19	SENT_153	[p12l1076t915r1452b983],
25	may	MD	O	may	aux	27	SENT_153	[p12l1477t942r1632b1003],
26	be	VB	O	be	auxpass	27	SENT_153	[p12l1657t915r1740b983],
27	attributed	VBN	O	attribute	dep	6	SENT_153	[p12l1765t915r2142b983],
28	to	TO	O	to	aux	29	SENT_153	[p12l10t1047r82b1093],
29	im	VB	O	im	xcomp	27	SENT_153	[p12l118t1026r642b1093],
30	‘	NN	O	‘	nn	31	SENT_153	[p12l118t1026r642b1093],
31	eViiia'i	NN	O	eviiia'us	dobj	29	SENT_153	[p12l118t1026r642b1093],
32	1/ia	CD	NUMBER	1/ia	num	31	SENT_153	[p12l118t1026r642b1093],
33	’	CD	NUMBER	’	num	34	SENT_153	[p12l118t1026r642b1093],
34	aa	NN	O	aa	nsubjpass	27	SENT_153	[p12l118t1026r642b1093],
35	/	:	O	/	punct	36	SENT_153	[p12l118t1026r642b1093],
36	variability	NN	O	variability	dep	6	SENT_153	[p12l671t1026r1038b1113],
37	(	CD	NUMBER	(	num	38	SENT_153	[p12l1076t1028r1258b1105],
38	data	NNS	O	datum	npadvmod	39	SENT_153	[p12l1076t1028r1258b1105],
39	not	RB	O	not	neg	40	SENT_153	[p12l1294t1047r1413b1093],
40	shown	VBN	O	show	partmod	36	SENT_153	[p12l1451t1028r1732b1105],
41	)	NN	O	)	dobj	40	SENT_153	[p12l1451t1028r1732b1105],
42	.	.	O	.	_	0	SENT_153	[p12l1451t1028r1732b1105],

1	January	NNP	DATE	January	_	0	SENT_154	[p12l42t1188r152b1217],
2	2006	CD	DATE	2006	num	1	SENT_154	[p12l165t1188r240b1211],
3	VARIABILITY	NNP	O	VARIABILITY	dep	1	SENT_154	[p12l1423t1188r1601b1211],
4	IN	IN	O	in	_	0	SENT_154	[p12l1614t1188r1640b1211],
5	THE	DT	O	the	det	6	SENT_154	[p12l1653t1188r1708b1211],
6	RESPONSE	NN	O	response	prep_in	3	SENT_154	[p12l1722t1188r1877b1211],
7	TO	TO	O	to	infmod	6	SENT_154	[p12l1889t1188r1926b1211],
8	COXIBS	NNP	O	COXIBS	dep	1	SENT_154	[p12l1939t1188r2045b1211],
9	59	CD	NUMBER	59	num	8	SENT_154	[p12l2080t1188r2117b1211],

1	Inhibition	NN	O	inhibition	_	0	SENT_155	[p12l117t1292r255b1317],
2	of	IN	O	of	_	0	SENT_155	[p12l267t1292r296b1317],
3	cox-2	NN	O	cox-2	prep_of	1	SENT_155	[p12l305t1292r398b1318],
4	ex	FW	O	ex	nn	6	SENT_155	[p12l408t1298r441b1316],
5	vivo	FW	O	vivo	nn	6	SENT_155	[p12l451t1292r513b1317],
6	Inhibition	NN	O	inhibition	dep	1	SENT_155	[p12l573t1292r711b1316],
7	of	IN	O	of	_	0	SENT_155	[p12l722t1292r751b1316],
8	cox-1	NN	O	cox-1	prep_of	6	SENT_155	[p12l761t1292r851b1316],
9	ex	FW	O	ex	nn	12	SENT_155	[p12l864t1298r897b1316],
10	vivo	FW	O	vivo	nn	12	SENT_155	[p12l907t1292r971b1316],
11	Urinary	JJ	O	urinary	amod	12	SENT_155	[p12l1030t1293r1138b1325],
12	prostacyclin	NN	O	prostacyclin	nn	13	SENT_155	[p12l1148t1293r1330b1325],
13	metabolite	NN	O	metabolite	dep	6	SENT_155	[p12l1341t1293r1496b1319],
14	Urinary	JJ	O	urinary	amod	20	SENT_155	[p12l1556t1293r1663b1325],
15	thromboxane	NN	O	thromboxane	nn	20	SENT_155	[p12l1672t1293r1870b1319],
16	metabolite	NN	O	metabolite	nn	20	SENT_155	[p12l1881t1293r2035b1319],
17	A	NN	O	a	nn	20	SENT_155	[p12l162t1360r207b1410],
18	B	NN	O	b	nn	20	SENT_155	[p12l645t1362r685b1410],
19	C	NN	O	c	nn	20	SENT_155	[p12l1139t1359r1183b1410],
20	D	NN	O	d	dep	13	SENT_155	[p12l1617t1360r1659b1410],

1	g	NN	O	g	npadvmod	2	SENT_156	[p12l331t1407r432b1436],
2	<	JJR	O	<	dep	5	SENT_156	[p12l331t1407r432b1436],
3	o.	CD	NUMBER	o.	num	5	SENT_156	[p12l331t1407r432b1436],
4	uoo1	NN	O	uoo1	nn	5	SENT_156	[p12l331t1407r432b1436],
5	g	NN	O	g	_	0	SENT_156	[p12l813t1407r914b1436],
6	<	VBG	O	<	partmod	5	SENT_156	[p12l813t1407r914b1436],
7	0.0001	CD	NUMBER	0.0001	num	8	SENT_156	[p12l813t1407r914b1436],
8	g	NN	O	g	npadvmod	9	SENT_156	[p12l1304t1411r1404b1436],
9	<	JJR	O	<	acomp	6	SENT_156	[p12l1304t1411r1404b1436],
10	D.	NNP	O	D.	nn	12	SENT_156	[p12l1304t1411r1404b1436],
11	QDO1	NNP	O	QDO1	nn	12	SENT_156	[p12l1304t1411r1404b1436],
12	n.s.	NNP	O	n.s.	dep	9	SENT_156	[p12l1855t1412r1893b1428],

1	$	$	MONEY	$	_	0	SENT_157	[p12l93t1437r123b1491],
2	1	CD	MONEY	1	num	1	SENT_157	[p12l93t1437r123b1491],
3	‘	CD	MONEY	‘	num	4	SENT_157	[p12l93t1437r123b1491],
4	g	NN	O	g	dep	1	SENT_157	[p12l287t1441r374b1469],
5	<	JJR	O	<	dep	4	SENT_157	[p12l287t1441r374b1469],
6	0.001	CD	NUMBER	0.001	num	9	SENT_157	[p12l287t1441r374b1469],
7	n.s.	NNP	O	n.s.	nn	9	SENT_157	[p12l416t1445r453b1461],
8	n.s.	NNP	O	n.s.	nn	9	SENT_157	[p12l789t1446r827b1461],
9	g	NN	O	g	dep	1	SENT_157	[p12l877t1441r954b1469],
10	=	JJ	O	=	rcmod	9	SENT_157	[p12l877t1441r954b1469],
11	0.04	CD	NUMBER	0.04	num	12	SENT_157	[p12l877t1441r954b1469],
12	50.0001	CD	NUMBER	50.0001	iobj	10	SENT_157	[p12l1256t1441r1357b1468],
13	n.s.	NN	O	n.s.	dobj	10	SENT_157	[p12l1397t1445r1435b1460],
14	500	CD	NUMBER	500	num	13	SENT_157	[p12l1648t1485r1689b1505],
15	'	''	O	'	_	0	SENT_157	[p12l1766t1431r1770b1450],
16	n.	FW	O	n.	dep	1	SENT_157	[p12l1795t1445r1831b1460],
17	s	NNS	O	s	dep	16	SENT_157	[p12l1795t1445r1831b1460],
18	,	,	O	,	_	0	SENT_157	[p12l1795t1445r1831b1460],
19	n.s.	NNP	O	n.s.	nn	25	SENT_157	[p12l1917t1445r1954b1460],
20	n.	NNP	O	n.	nn	25	SENT_157	[p12l93t1493r116b1510],
21	A	NNP	O	A	nn	25	SENT_157	[p12l133t1509r162b1518],
22	"	``	O	"	punct	25	SENT_157	[p12l583t1488r600b1500],
23	A	NN	O	a	nn	25	SENT_157	[p12l610t1502r639b1509],
24	7o	NN	O	7o	nn	25	SENT_157	[p12l1149t1492r1177b1512],
25	u	NN	O	u	appos	1	SENT_157	[p12l93t1521r117b1536],
26	on	IN	O	on	_	0	SENT_157	[p12l138t1519r156b1535],
27	1	CD	NUMBER	1	number	28	SENT_157	[p12l192t1503r201b1523],
28	3	CD	NUMBER	3	num	29	SENT_157	[p12l574t1502r597b1535],
29	3	CD	NUMBER	3	prep_on	25	SENT_157	[p12l615t1510r634b1539],
30	.	.	O	.	_	0	SENT_157	[p12l615t1510r634b1539],

1	?	.	O	?	_	0	SENT_158	[p12l615t1510r634b1539],

1	1	CD	NUMBER	1	_	0	SENT_159	[p12l675t1504r684b1524],
2	so	RB	O	so	quantmod	4	SENT_159	[p12l1149t1517r1177b1536],
3	8	CD	NUMBER	8	number	4	SENT_159	[p12l99t1537r117b1567],
4	3	CD	NUMBER	3	dep	1	SENT_159	[p12l138t1536r156b1565],
5	0.9	CD	NUMBER	0.9	dep	4	SENT_159	[p12l173t1542r207b1562],
6	"	``	O	"	punct	7	SENT_159	[p12l575t1535r598b1554],
7	o	NN	O	o	dep	1	SENT_159	[p12l615t1541r634b1556],
8	0.9	CD	NUMBER	0.9	num	7	SENT_159	[p12l655t1542r689b1562],
9	in	IN	O	in	_	0	SENT_159	[p12l1094t1539r1123b1562],
10	‘	CD	NUMBER	‘	npadvmod	11	SENT_159	[p12l1094t1539r1123b1562],
11	so	RB	O	so	advmod	12	SENT_159	[p12l1150t1544r1177b1564],
12	3	CD	NUMBER	3	prep_in	7	SENT_159	[p12l1597t1537r1625b1562],
13	?	.	O	?	_	0	SENT_159	[p12l1597t1537r1625b1562],

1	:	:	O	:	_	0	SENT_160	[p12l99t1569r117b1583],
2	‘	NN	O	‘	_	0	SENT_160	[p12l133t1567r156b1581],
3	D	NN	O	d	prep	2	SENT_160	[p12l133t1567r156b1581],
4	E	NN	O	e	nn	6	SENT_160	[p12l580t1554r597b1577],
5	.5	CD	NUMBER	.5	num	6	SENT_160	[p12l610t1557r634b1573],
6	E	NN	O	e	dep	3	SENT_160	[p12l1058t1561r1081b1583],
7	.5	CD	NUMBER	.5	num	6	SENT_160	[p12l1094t1564r1117b1584],
8	.	.	O	.	_	0	SENT_160	[p12l1597t1563r1619b1584],

1	E	NN	O	e	_	0	SENT_161	[p12l1597t1563r1619b1584],
2	1	CD	NUMBER	1	dep	1	SENT_161	[p12l93t1585r117b1599],
3	=	JJ	O	=	amod	2	SENT_161	[p12l93t1585r117b1599],
4	to	TO	O	to	_	0	SENT_161	[p12l139t1591r156b1607],
5	0.8	CD	NUMBER	0.8	num	6	SENT_161	[p12l173t1584r207b1604],
6	E	NN	O	e	prep_to	3	SENT_161	[p12l580t1578r598b1603],
7	93	CD	NUMBER	93	number	8	SENT_161	[p12l616t1581r635b1607],
8	0.8	CD	NUMBER	0.8	dep	1	SENT_161	[p12l655t1586r689b1605],
9	-5	CD	NUMBER	-5	num	10	SENT_161	[p12l1058t1587r1117b1607],
10	4	CD	NUMBER	4	dep	8	SENT_161	[p12l1148t1578r1177b1598],
11	°	NN	O	°	dep	1	SENT_161	[p12l1148t1578r1177b1598],
12	5.5	CD	NUMBER	5.5	number	11	SENT_161	[p12l1562t1569r1620b1607],
13	2	CD	NUMBER	2	number	11	SENT_161	[p12l1648t1572r1689b1592],
14	°	CD	NUMBER	°	number	11	SENT_161	[p12l1648t1572r1689b1592],
15	”	NN	O	”	dep	11	SENT_161	[p12l1648t1572r1689b1592],
16	5	CD	NUMBER	5	num	15	SENT_161	[p12l93t1602r117b1622],
17	a	DT	O	a	det	19	SENT_161	[p12l138t1606r162b1631],
18	3	CD	NUMBER	3	num	19	SENT_161	[p12l580t1605r598b1634],
19	Q	NNP	O	Q	dep	1	SENT_161	[p12l616t1608r640b1622],
20	<	JJR	O	<	dep	19	SENT_161	[p12l1059t1602r1082b1624],
21	9	CD	NUMBER	9	number	22	SENT_161	[p12l1059t1602r1082b1624],
22	15	CD	NUMBER	15	dep	1	SENT_161	[p12l1096t1608r1117b1632],
23	3	CD	NUMBER	3	num	24	SENT_161	[p12l1150t1623r1177b1642],
24	°	NN	O	°	dep	22	SENT_161	[p12l1150t1623r1177b1642],
25	.5	CD	NUMBER	.5	dep	1	SENT_161	[p12l1562t1602r1585b1634],
26	iii	LS	O	iii	prep	25	SENT_161	[p12l1598t1608r1620b1632],
27	m	NN	O	m	nn	29	SENT_161	[p12l93t1632r206b1653],
28	~	CD	NUMBER	~	num	29	SENT_161	[p12l93t1632r206b1653],
29	o.	NN	O	o.	dep	26	SENT_161	[p12l93t1632r206b1653],
30	7	CD	NUMBER	7	num	29	SENT_161	[p12l93t1632r206b1653],
31	.	.	O	.	_	0	SENT_161	[p12l575t1632r634b1652],

1	\	RB	O	\	dep	4	SENT_162	[p12l575t1632r634b1652],
2	0.7	CD	NUMBER	0.7	num	3	SENT_162	[p12l655t1634r689b1653],
3	‘	CD	NUMBER	‘	pobj	1	SENT_162	[p12l1059t1626r1117b1649],
4	La	NNP	O	La	dep	8	SENT_162	[p12l1059t1626r1117b1649],
5	:	:	O	:	_	0	SENT_162	[p12l1059t1626r1117b1649],
6	v	LS	O	v	dep	8	SENT_162	[p12l1603t1633r1620b1649],
7	100	CD	NUMBER	100	num	8	SENT_162	[p12l1649t1638r1689b1658],
8	n.	NN	O	n.	_	0	SENT_162	[p12l93t1652r117b1669],
9	.	.	O	.	_	0	SENT_162	[p12l139t1658r156b1674],

1	,	,	O	,	_	0	SENT_163	[p12l139t1658r156b1674],
2	,	,	O	,	_	0	SENT_163	[p12l139t1658r156b1674],
3	o	NN	O	o	nn	4	SENT_163	[p12l580t1652r599b1668],
4	o	NN	O	o	dep	16	SENT_163	[p12l616t1649r635b1665],
5	E.	NNP	O	E.	poss	8	SENT_163	[p12l1064t1653r1087b1676],
6	'	POS	O	'	_	0	SENT_163	[p12l1100t1649r1118b1674],
7	5	CD	NUMBER	5	num	8	SENT_163	[p12l1100t1649r1118b1674],
8	E	NN	O	e	dep	16	SENT_163	[p12l1568t1643r1591b1667],
9	-5	CD	NUMBER	-5	dep	16	SENT_163	[p12l1603t1649r1620b1673],
10	C	NN	O	c	prep	9	SENT_163	[p12l93t1671r117b1704],
11	’	CD	NUMBER	’	num	12	SENT_163	[p12l93t1671r117b1704],
12	3	CD	NUMBER	3	dep	10	SENT_163	[p12l138t1674r156b1705],
13	‘	NN	O	‘	prep	9	SENT_163	[p12l580t1677r599b1691],
14	8	CD	NUMBER	8	dep	13	SENT_163	[p12l616t1665r635b1695],
15	"	``	O	"	punct	9	SENT_163	[p12l1064t1677r1082b1693],
16	’	NN	O	’	dep	22	SENT_163	[p12l1064t1677r1082b1693],
17	D	NN	O	d	dep	16	SENT_163	[p12l1100t1683r1123b1697],
18	20	CD	NUMBER	20	num	17	SENT_163	[p12l1149t1684r1177b1704],
19	2	CD	NUMBER	2	dep	17	SENT_163	[p12l1568t1668r1585b1700],
20	or	CC	O	or	_	0	SENT_163	[p12l1603t1683r1626b1697],
21	O	NN	O	o	dep	16	SENT_163	[p12l99t1704r117b1720],
22	U	NN	O	u	dep	26	SENT_163	[p12l134t1706r156b1721],
23	0.5	CD	NUMBER	0.5	number	24	SENT_163	[p12l174t1691r207b1710],
24	3	CD	NUMBER	3	num	25	SENT_163	[p12l611t1697r635b1729],
25	0.5	CD	NUMBER	0.5	dep	26	SENT_163	[p12l655t1691r689b1710],
26	E	NN	O	e	dep	29	SENT_163	[p12l1064t1695r1082b1742],
27	E	NN	O	e	dep	26	SENT_163	[p12l1094t1699r1118b1731],
28	E	NN	O	e	dep	26	SENT_163	[p12l1568t1701r1585b1732],
29	E	NN	O	e	dep	30	SENT_163	[p12l1597t1699r1620b1731],
30	50	CD	NUMBER	50	_	0	SENT_163	[p12l1660t1704r1688b1724],
31	§	CD	NUMBER	§	advmod	30	SENT_163	[p12l94t1730r118b1781],
32	5	CD	NUMBER	5	dep	31	SENT_163	[p12l139t1739r162b1784],
33	‘	NN	O	‘	dep	30	SENT_163	[p12l139t1739r162b1784],
34	;	:	O	;	_	0	SENT_163	[p12l139t1739r162b1784],
35	0.5	CD	NUMBER	0.5	dep	30	SENT_163	[p12l174t1756r207b1776],
36	-	:	O	-	_	0	SENT_163	[p12l575t1731r599b1785],
37	.	.	O	.	_	0	SENT_163	[p12l575t1731r599b1785],

1	§	NN	O	§	_	0	SENT_164	[p12l575t1731r599b1785],
2	§	CD	NUMBER	§	num	3	SENT_164	[p12l616t1730r640b1775],
3	0.5	CD	NUMBER	0.5	rcmod	1	SENT_164	[p12l656t1757r689b1778],
4	E	NN	O	e	dep	3	SENT_164	[p12l1094t1733r1124b1772],
5	3	CD	NUMBER	3	num	6	SENT_164	[p12l1597t1733r1626b1772],
6	9	CD	NUMBER	9	dobj	4	SENT_164	[p12l94t1784r117b1805],
7	"	``	O	"	punct	6	SENT_164	[p12l133t1786r162b1794],
8	‘	CD	NUMBER	‘	dep	6	SENT_164	[p12l133t1786r162b1794],
9	"	``	O	"	punct	3	SENT_164	[p12l576t1787r598b1793],
10	H	NN	O	h	prep	3	SENT_164	[p12l611t1778r641b1785],
11	10	CD	NUMBER	10	num	12	SENT_164	[p12l1151t1790r1177b1810],
12	J	NN	O	j	dep	10	SENT_164	[p12l94t1806r117b1822],
13	:	:	O	:	_	0	SENT_164	[p12l94t1806r117b1822],
14	'	''	O	'	_	0	SENT_164	[p12l94t1823r117b1844],
15	5	CD	NUMBER	5	num	18	SENT_164	[p12l94t1823r117b1844],
16	placebo	NN	O	placebo	nn	18	SENT_164	[p12l215t1835r315b1865],
17	rofecoxib	NN	O	rofecoxib	nn	18	SENT_164	[p12l330t1835r447b1859],
18	celecoxib	NN	O	celecoxib	dep	1	SENT_164	[p12l465t1834r587b1859],
19	placebo	NN	O	placebo	nn	27	SENT_164	[p12l698t1834r799b1863],
20	rofecoxlb	NN	O	rofecoxlb	nn	27	SENT_164	[p12l817t1833r934b1858],
21	celecoxib	NN	O	celecoxib	nn	27	SENT_164	[p12l948t1833r1070b1858],
22	placebo	NN	O	placebo	nn	27	SENT_164	[p12l1187t1833r1288b1862],
23	rofeooxib	NN	O	rofeooxib	nn	27	SENT_164	[p12l1305t1833r1422b1858],
24	celecoxib	NN	O	celecoxib	nn	27	SENT_164	[p12l1438t1833r1560b1857],
25	placebo	NN	O	placebo	nn	27	SENT_164	[p12l1688t1833r1789b1862],
26	rafecnxib	NN	O	rafecnxib	nn	27	SENT_164	[p12l1807t1833r1924b1856],
27	celecoxib	NN	O	celecoxib	dep	18	SENT_164	[p12l1943t1833r2063b1856],

1	E	NN	O	e	nn	4	SENT_165	[p12l162t1923r200b1972],
2	F	NN	O	f	nn	4	SENT_165	[p12l645t1923r680b1973],
3	G	NN	O	g	nn	4	SENT_165	[p12l1139t1920r1185b1972],
4	H	NN	O	h	_	0	SENT_165	[p12l1617t1923r1657b1973],

1	ufi	NN	O	ufus	nn	4	SENT_166	[p12l95t1994r125b2024],
2	“	CD	NUMBER	“	num	4	SENT_166	[p12l95t1994r125b2024],
3	E	NN	O	e	nn	4	SENT_166	[p12l95t2027r119b2066],
4	N	NN	O	n	_	0	SENT_166	[p12l585t2048r602b2060],
5	13	CD	NUMBER	13	number	6	SENT_166	[p12l95t2076r119b2092],
6	-3	CD	NUMBER	-3	dep	4	SENT_166	[p12l135t2065r162b2104],
7	,	,	O	,	_	0	SENT_166	[p12l135t2065r162b2104],
8	;	:	O	;	_	0	SENT_166	[p12l135t2065r162b2104],
9	3	CD	NUMBER	3	dep	4	SENT_166	[p12l576t2061r600b2113],
10	'	''	O	'	_	0	SENT_166	[p12l612t2061r641b2099],
11	5	CD	NUMBER	5	dep	9	SENT_166	[p12l612t2061r641b2099],
12	?	.	O	?	_	0	SENT_166	[p12l612t2061r641b2099],

1	A	DT	O	a	predet	4	SENT_167	[p12l1096t2093r1125b2101],
2	A	DT	O	a	det	4	SENT_167	[p12l1598t2093r1626b2101],
3	2ooo	JJ	O	2ooo	amod	4	SENT_167	[p12l1639t2058r1695b2078],
4	§	NN	O	§	_	0	SENT_167	[p12l100t2093r158b2138],
5	e	SYM	O	e	dep	7	SENT_167	[p12l100t2093r158b2138],
6	2	CD	PERCENT	2	num	7	SENT_167	[p12l582t2100r635b2135],
7	%	NN	PERCENT	%	dep	11	SENT_167	[p12l582t2100r635b2135],
8	:2	CD	NUMBER	:2	num	9	SENT_167	[p12l1060t2102r1119b2139],
9	Egmm	NN	O	egmm	dep	7	SENT_167	[p12l1564t2099r1696b2147],
10	‘	CD	NUMBER	‘	num	11	SENT_167	[p12l96t2140r119b2171],
11	g	NN	O	g	dep	4	SENT_167	[p12l96t2140r119b2171],
12	on	IN	O	on	_	0	SENT_167	[p12l140t2146r158b2163],
13	E	NN	O	e	nn	14	SENT_167	[p12l582t2138r600b2163],
14	E	NN	O	e	prep_on	11	SENT_167	[p12l618t2141r635b2166],
15	-	:	O	-	_	0	SENT_167	[p12l1060t2139r1082b2156],
16	L	NN	O	l	dep	4	SENT_167	[p12l1060t2139r1082b2156],
17	E.	NNP	O	E.	nn	18	SENT_167	[p12l1096t2142r1120b2163],
18	E	NNP	O	E	dep	16	SENT_167	[p12l1598t2141r1621b2163],
19	.	.	O	.	_	0	SENT_167	[p12l96t2173r119b2178],

1	_	SYM	O	_	_	0	SENT_168	[p12l96t2173r119b2178],
2	-	:	O	-	_	0	SENT_168	[p12l141t2162r157b2170],
3	.	.	O	.	_	0	SENT_168	[p12l582t2164r600b2180],

1	.	.	O	.	_	0	SENT_169	[p12l582t2164r600b2180],

1	Q	NNP	O	Q	nn	2	SENT_170	[p12l618t2168r641b2182],
2	_	NN	O	_	_	0	SENT_170	[p12l618t2168r641b2182],
3	<	JJR	O	<	npadvmod	7	SENT_170	[p12l1060t2158r1084b2179],
4	9	CD	NUMBER	9	num	5	SENT_170	[p12l1060t2158r1084b2179],
5	~	NN	O	~	npadvmod	6	SENT_170	[p12l1097t2164r1119b2172],
6	>	JJR	O	>	amod	3	SENT_170	[p12l1569t2158r1587b2172],
7	<	JJR	O	<	amod	2	SENT_170	[p12l1569t2158r1587b2172],
8	-	:	O	-	_	0	SENT_170	[p12l1599t2164r1621b2172],
9	son	NN	O	son	dep	2	SENT_170	[p12l1653t2155r1695b2175],
10	to	TO	O	to	_	0	SENT_170	[p12l96t2188r119b2206],
11	3	CD	NUMBER	3	num	12	SENT_170	[p12l135t2173r164b2205],
12	‘	CD	NUMBER	‘	prep_to	9	SENT_170	[p12l135t2173r164b2205],
13	"	``	O	"	punct	12	SENT_170	[p12l582t2181r600b2194],
14	’	NN	O	’	nn	15	SENT_170	[p12l582t2181r600b2194],
15	~	NN	O	~	dep	12	SENT_170	[p12l612t2192r635b2201],
16	9	CD	NUMBER	9	dep	15	SENT_170	[p12l1060t2181r1083b2199],
17	-	:	O	-	_	0	SENT_170	[p12l1060t2181r1083b2199],
18	3	CD	NUMBER	3	dep	2	SENT_170	[p12l1102t2173r1120b2205],
19	"	``	O	"	punct	20	SENT_170	[p12l1564t2172r1587b2191],
20	E	NN	O	e	rcmod	18	SENT_170	[p12l1603t2172r1621b2213],
21	El	NNP	O	El	dep	20	SENT_170	[p12l96t2208r119b2241],
22	3	CD	NUMBER	3	num	21	SENT_170	[p12l140t2214r158b2244],
23	'	''	O	'	_	0	SENT_170	[p12l577t2202r600b2227],
24	5	CD	NUMBER	5	number	25	SENT_170	[p12l577t2202r600b2227],
25	3	CD	NUMBER	3	amod	20	SENT_170	[p12l618t2209r635b2239],
26	5	CD	NUMBER	5	number	27	SENT_170	[p12l1066t2209r1089b2248],
27	3	CD	NUMBER	3	dep	2	SENT_170	[p12l1102t2205r1119b2229],
28	‘	NN	O	‘	nn	30	SENT_170	[p12l1569t2199r1593b2239],
29	E	NN	O	e	nn	30	SENT_170	[p12l1569t2199r1593b2239],
30	o	NN	O	o	dep	27	SENT_170	[p12l1603t2214r1621b2229],

1	E	NN	O	e	_	0	SENT_171	[p12l582t2237r600b2251],

1	B	NN	O	b	_	0	SENT_172	[p12l96t2250r119b2275],
2	8	CD	NUMBER	8	number	3	SENT_172	[p12l135t2245r158b2277],
3	:3	CD	NUMBER	:3	dep	1	SENT_172	[p12l577t2240r635b2289],
4	e	LS	O	e	dep	5	SENT_172	[p12l1060t2250r1083b2281],
5	E	NN	O	e	dep	1	SENT_172	[p12l1096t2239r1125b2287],
6	’	CD	NUMBER	’	num	5	SENT_172	[p12l1096t2239r1125b2287],
7	#U	NN	O	#u	prep	5	SENT_172	[p12l1569t2238r1627b2288],
8	*	CD	NUMBER	*	num	9	SENT_172	[p12l1569t2238r1627b2288],
9	‘	CD	NUMBER	‘	dep	7	SENT_172	[p12l1655t2239r1695b2259],
10	°	NN	O	°	nn	12	SENT_172	[p12l1655t2239r1695b2259],
11	°	CD	NUMBER	°	num	12	SENT_172	[p12l1655t2239r1695b2259],
12	sf	NN	O	sf	dep	5	SENT_172	[p12l96t2284r119b2332],
13	.	.	O	.	_	0	SENT_172	[p12l96t2284r119b2332],

1	»	NN	O	»	nn	3	SENT_173	[p12l96t2284r119b2332],
2	3	CD	NUMBER	3	num	3	SENT_173	[p12l141t2294r159b2324],
3	D	NN	O	d	dep	10	SENT_173	[p12l171t2296r183b2316],
4	a	DT	O	a	det	6	SENT_173	[p12l576t2291r600b2328],
5	g	NN	O	g	nn	6	SENT_173	[p12l618t2290r641b2336],
6	°	NN	O	°	dep	3	SENT_173	[p12l1066t2283r1084b2297],
7	3	CD	NUMBER	3	number	8	SENT_173	[p12l1096t2288r1126b2328],
8	3	CD	NUMBER	3	dep	6	SENT_173	[p12l1598t2287r1627b2328],
9	5	CD	NUMBER	5	dep	10	SENT_173	[p12l1666t2281r1694b2301],
10	°	NN	O	°	dep	16	SENT_173	[p12l1666t2281r1694b2301],
11	'	''	O	'	_	0	SENT_173	[p12l96t2333r119b2354],
12	5	CD	NUMBER	5	number	13	SENT_173	[p12l96t2333r119b2354],
13	3	CD	NUMBER	3	dep	10	SENT_173	[p12l135t2326r164b2350],
14	5	CD	NUMBER	5	num	15	SENT_173	[p12l577t2331r600b2353],
15	E	NN	O	e	dep	13	SENT_173	[p12l612t2337r641b2345, p12l96t2356r119b2376],
16	5	CD	NUMBER	5	_	0	SENT_173	[p12l96t2379r119b2400],

1	placebo	NN	O	placebo	nn	3	SENT_174	[p12l216t2383r317b2412],
2	rofecoxib	NN	O	rofecoxib	nn	3	SENT_174	[p12l331t2383r447b2407],
3	celecoxib	NN	O	celecoxib	_	0	SENT_174	[p12l468t2383r588b2407],
4	placebo	NN	O	placebo	nn	6	SENT_174	[p12l699t2383r800b2412],
5	rofecoxlb	NN	O	rofecoxlb	nn	6	SENT_174	[p12l818t2382r935b2406],
6	celecoxlb	NN	O	celecoxlb	dep	3	SENT_174	[p12l950t2383r1072b2406],
7	placebo	NN	O	placebo	nn	12	SENT_174	[p12l1188t2382r1291b2412],
8	rofecoxib	NN	O	rofecoxib	nn	12	SENT_174	[p12l1306t2382r1423b2406],
9	oelecoxib	NN	O	oelecoxib	nn	12	SENT_174	[p12l1439t2382r1561b2406],
10	placebo	NN	O	placebo	nn	12	SENT_174	[p12l1690t2382r1791b2412],
11	rofeooxib	NN	O	rofeooxib	nn	12	SENT_174	[p12l1809t2382r1926b2406],
12	celecoxib	NN	O	celecoxib	dep	3	SENT_174	[p12l1940t2382r2061b2405],

1	I	PRP	O	I	_	0	SENT_175	[p12l159t2592r187b2703],
2	J	NN	O	j	dep	1	SENT_175	[p12l1269t2585r1343b2703],

1	(	NN	O	(	nn	3	SENT_176	[p12l104t3401r169b3551],
2	post	NN	O	post	nn	3	SENT_176	[p12l104t3401r169b3551],
3	dose	NN	O	dose	_	0	SENT_176	[p12l100t3239r156b3384],
4	I	PRP	O	I	nsubj	5	SENT_176	[p12l100t3197r153b3221],
5	prze	VBP	O	prze	rcmod	3	SENT_176	[p12l111t3083r166b3177],
6	d	NN	O	d	nn	7	SENT_176	[p12l100t3031r153b3062],
7	llnlhliihliion	NN	O	llnlhliihliion	dobj	5	SENT_176	[p12l1118t3301r1176b3568],
8	of	IN	O	of	_	0	SENT_176	[p12l1121t3221r1173b3280],
9	serumTxB2	NN	O	serumtxb2	prep_of	7	SENT_176	[p12l1117t2865r1176b3204],

1	(	NN	O	(	nn	3	SENT_177	[p12l1204t3391r1270b3540],
2	post	NN	O	post	nn	3	SENT_177	[p12l1204t3391r1270b3540],
3	close	NN	O	close	_	0	SENT_177	[p12l1201t3225r1256b3374],
4	I	CD	NUMBER	i	num	5	SENT_177	[p12l1201t3187r1256b3208],
5	pie	NN	O	pie	dep	3	SENT_177	[p12l1211t3073r1266b3166],
6	dose	NN	O	dose	nn	7	SENT_177	[p12l1200t2886r1266b3052],
7	)	NN	O	)	dep	3	SENT_177	[p12l1200t2886r1266b3052],

1	llnihilbitinnn	NN	O	llnihilbitinnn	_	0	SENT_178	[p12l10t3412r66b3675],
2	of	IN	O	of	_	0	SENT_178	[p12l10t3332r63b3391],
3	LP-B	NN	O	lp-b	nn	5	SENT_178	[p12l10t3190r62b3312],
4	induaedi	NN	O	induaedus	nn	5	SENT_178	[p12l7t2931r62b3166],
5	PGE2	NN	O	pge2	prep_of	1	SENT_178	[p12l7t2738r73b2907],

1	subject	NN	O	subject	_	0	SENT_179	[p12l117t3699r311b3756],
2	:	:	O	:	_	0	SENT_179	[p12l117t3699r311b3756],
3	ABGDE	NNP	O	ABGDE	dep	1	SENT_179	[p12l349t3699r557b3747],
4	.	.	O	.	_	0	SENT_179	[p12l591t3699r796b3747],

1	l5	NN	O	l5	_	0	SENT_180	[p12l591t3699r796b3747],
2	«	CD	NUMBER	«	number	3	SENT_180	[p12l591t3699r796b3747],
3	_	CD	NUMBER	_	num	6	SENT_180	[p12l591t3699r796b3747],
4	EC	NNP	ORGANIZATION	EC	poss	6	SENT_180	[p12l591t3699r796b3747],
5	'	POS	O	'	_	0	SENT_180	[p12l591t3699r796b3747],
6	DE	NN	O	de	dep	1	SENT_180	[p12l591t3699r796b3747],
7	AECUE	NNP	O	AECUE	dep	6	SENT_180	[p12l834t3699r1041b3747],
8	su	FW	O	su	dep	1	SENT_180	[p12l1225t3698r1415b3754],
9	'	''	O	'	_	0	SENT_180	[p12l1225t3698r1415b3754],
10	l	NN	O	l	dep	8	SENT_180	[p12l1225t3698r1415b3754],
11	:	:	O	:	_	0	SENT_180	[p12l1225t3698r1415b3754],
12	ujEc	NN	O	ujec	dep	8	SENT_180	[p12l1225t3698r1415b3754],
13	:	:	O	:	_	0	SENT_180	[p12l1225t3698r1415b3754],
14	t	NN	O	t	dep	12	SENT_180	[p12l1225t3698r1415b3754],
15	'	''	O	'	_	0	SENT_180	[p12l1225t3698r1415b3754],
16	.	.	O	.	_	0	SENT_180	[p12l1225t3698r1415b3754],

1	ABCDE	NNP	O	ABCDE	_	0	SENT_181	[p12l1456t3695r1664b3747],
2	.	.	O	.	_	0	SENT_181	[p12l1699t3695r1906b3744],

1	A	DT	O	a	det	3	SENT_182	[p12l1699t3695r1906b3744],
2	§	JJ	O	§	amod	3	SENT_182	[p12l1699t3695r1906b3744],
3	BC-JILJE	NN	O	bc-jilje	_	0	SENT_182	[p12l1699t3695r1906b3744],
4	ABCDE	NN	O	abcde	dep	3	SENT_182	[p12l1944t3695r2153b3743],

1	F'Gl	SYM	O	f'gl	dep	4	SENT_183	[p13l6t561r60b705],
2	-	:	O	-	_	0	SENT_183	[p13l6t561r60b705],
3	V.	NNP	O	V.	nn	4	SENT_183	[p13l6t561r60b705],
4	urwiznary	NNP	O	urwiznary	_	0	SENT_183	[p13l9t728r73b926],
5	.	.	O	.	_	0	SENT_183	[p13l58t527r59b530],

1	{	NN	O	{	nn	2	SENT_184	[p13l87t795r153b996],
2	pgimg	NN	O	pgimg	_	0	SENT_184	[p13l87t795r153b996],
3	=	JJ	O	=	amod	4	SENT_184	[p13l86t470r150b775],
4	E	NN	O	e	dep	2	SENT_184	[p13l86t470r150b775],
5	:	:	O	:	_	0	SENT_184	[p13l86t470r150b775],
6	l'E3	NN	O	l'e3	dep	2	SENT_184	[p13l86t470r150b775],
7	‘	CD	NUMBER	‘	num	6	SENT_184	[p13l86t470r150b775],
8	:	:	O	:	_	0	SENT_184	[p13l86t470r150b775],
9	l	NN	O	l	dep	6	SENT_184	[p13l86t470r150b775],
10	;	:	O	;	_	0	SENT_184	[p13l86t470r150b775],
11	ll	NN	O	ll	dep	9	SENT_184	[p13l86t470r150b775],
12	"	''	O	"	punct	11	SENT_184	[p13l86t470r150b775],
13	li'l	NN	O	li'l	dep	11	SENT_184	[p13l86t470r150b775],
14	'	''	O	'	_	0	SENT_184	[p13l86t470r150b775],
15	tE	FW	O	te	nn	16	SENT_184	[p13l86t470r150b775],
16	)	FW	O	)	dep	11	SENT_184	[p13l86t470r150b775],

1	urinary	JJ	O	urinary	amod	2	SENT_185	[p13l1134t708r1198b906],
2	T1ili	NN	O	t1ilus	_	0	SENT_185	[p13l1131t541r1216b688],
3	—	NN	O	—	nn	4	SENT_185	[p13l1131t541r1216b688],
4	llﬂ	NN	O	llﬂ	dep	2	SENT_185	[p13l1131t541r1216b688],

1	=	JJ	O	=	_	0	SENT_186	[p13l1208t792r1275b993],
2	[	CD	NUMBER	[	num	3	SENT_186	[p13l1208t792r1275b993],
3	pgl	NN	O	pgl	dep	1	SENT_186	[p13l1208t792r1275b993],
4	'n'	CC	O	'n'	_	0	SENT_186	[p13l1208t792r1275b993],
5	ig	NN	O	ig	nn	7	SENT_186	[p13l1208t792r1275b993],
6	creatinine	NN	O	creatinine	nn	7	SENT_186	[p13l1208t470r1272b772],
7	)	NN	O	)	conj_'n'	3	SENT_186	[p13l1208t470r1272b772],

1	subject	NN	O	subject	_	0	SENT_187	[p13l103t1184r291b1241],
2	:	:	O	:	_	0	SENT_187	[p13l103t1184r291b1241],
3	AEGDE	NNP	O	AEGDE	nn	5	SENT_187	[p13l327t1184r529b1228],
4	AECDE	NNP	O	AECDE	nn	5	SENT_187	[p13l562t1184r763b1228],
5	ABCDLE	NNP	O	ABCDLE	dep	1	SENT_187	[p13l797t1184r1001b1228],
6	subiect	JJ	O	subiect	amod	10	SENT_187	[p13l1262t1177r1450b1234],
7	ABCDE	NNP	O	ABCDE	nn	10	SENT_187	[p13l1483t1177r1684b1221],
8	AB	NNP	O	AB	nn	10	SENT_187	[p13l1721t1177r1795b1221],
9	GDE	NNP	O	GDE	nn	10	SENT_187	[p13l1804t1177r1919b1221],
10	ABGDE	NNP	O	ABGDE	dep	5	SENT_187	[p13l1955t1177r2153b1221],

1	placebo	NN	O	placebo	nn	3	SENT_188	[p13l216t1265r317b1294],
2	rofecoxib	NN	O	rofecoxib	nn	3	SENT_188	[p13l330t1265r448b1288],
3	celecoxib	NN	O	celecoxib	_	0	SENT_188	[p13l467t1265r587b1288],
4	placebo	NN	O	placebo	nn	6	SENT_188	[p13l699t1264r800b1294],
5	rofecoxib	NN	O	rofecoxib	nn	6	SENT_188	[p13l818t1263r935b1288],
6	celecoxib	NN	O	celecoxib	dep	3	SENT_188	[p13l945t1263r1066b1288],
7	placebo	NN	O	placebo	nn	12	SENT_188	[p13l1189t1263r1290b1293],
8	rofecoxib	NN	O	rofecoxib	nn	12	SENT_188	[p13l1306t1262r1423b1287],
9	celecoxib	NN	O	celecoxib	nn	12	SENT_188	[p13l1439t1262r1561b1287],
10	placebo	NN	O	placebo	nn	12	SENT_188	[p13l1690t1262r1791b1291],
11	rofecoxib	NN	O	rofecoxib	nn	12	SENT_188	[p13l1808t1262r1926b1286],
12	celecoxib	NN	O	celecoxib	dep	3	SENT_188	[p13l1939t1262r2061b1285],

1	Figure	NNP	O	Figure	_	0	SENT_189	[p13l42t1334r132b1364],
2	1	CD	NUMBER	1	dep	1	SENT_189	[p13l144t1334r171b1358],
3	.	.	O	.	_	0	SENT_189	[p13l144t1334r171b1358],

1	Comparison	NN	O	comparison	_	0	SENT_190	[p13l191t1334r362b1363],
2	of	IN	O	of	_	0	SENT_190	[p13l376t1334r404b1358],
3	4	CD	NUMBER	4	num	6	SENT_190	[p13l414t1334r432b1358],
4	primary	JJ	O	primary	amod	6	SENT_190	[p13l446t1334r551b1364],
5	drug	NN	O	drug	nn	6	SENT_190	[p13l562t1334r625b1364],
6	responses	NNS	O	response	prep_of	1	SENT_190	[p13l637t1340r787b1363],
7	to	TO	O	to	_	0	SENT_190	[p13l798t1336r826b1358],
8	placebo	NN	O	placebo	prep_to	1	SENT_190	[p13l840t1334r959b1363],
9	,	,	O	,	_	0	SENT_190	[p13l840t1334r959b1363],
10	rofecoxib	NN	O	rofecoxib	conj_and	8	SENT_190	[p13l975t1334r1111b1362],
11	,	,	O	,	_	0	SENT_190	[p13l975t1334r1111b1362],
12	and	CC	O	and	_	0	SENT_190	[p13l1126t1334r1177b1358],
13	celecoxib	NN	O	celecoxib	prep_to	1	SENT_190	[p13l1190t1334r1331b1358],
14	.	.	O	.	_	0	SENT_190	[p13l1190t1334r1331b1358],

1	The	DT	O	the	det	3	SENT_191	[p13l1345t1334r1396b1358],
2	4	CD	NUMBER	4	num	3	SENT_191	[p13l1409t1334r1427b1358],
3	columns	NNS	O	column	nsubj	4	SENT_191	[p13l1440t1334r1560b1358],
4	show	VBP	O	show	_	0	SENT_191	[p13l1573t1334r1647b1358],
5	the	DT	O	the	det	7	SENT_191	[p13l1658t1334r1703b1358],
6	drug	NN	O	drug	nn	7	SENT_191	[p13l1716t1334r1779b1364],
7	responses	NNS	O	response	dobj	4	SENT_191	[p13l1791t1340r1949b1363],
8	,	,	O	,	_	0	SENT_191	[p13l1791t1340r1949b1363],
9	COX-2	NN	O	cox-2	nn	12	SENT_191	[p13l1964t1334r2049b1358],
10	and	CC	O	and	_	0	SENT_191	[p13l2063t1334r2113b1358],
11	COX-1	NN	MISC	cox-1	nn	12	SENT_191	[p13l41t1375r127b1400],
12	inhibition	NN	O	inhibition	conj_and	7	SENT_191	[p13l143t1375r281b1404],
13	,	,	O	,	_	0	SENT_191	[p13l143t1375r281b1404],
14	and	CC	O	and	_	0	SENT_191	[p13l299t1375r349b1400],
15	urinary	JJ	O	urinary	amod	16	SENT_191	[p13l366t1375r462b1405],
16	excretion	NN	O	excretion	conj_and	7	SENT_191	[p13l476t1375r605b1399],
17	of	IN	O	of	_	0	SENT_191	[p13l621t1375r649b1399],
18	the	DT	O	the	det	23	SENT_191	[p13l661t1375r707b1399],
19	prostacyclin	NN	O	prostacyclin	nn	23	SENT_191	[p13l724t1375r892b1405],
20	metabolite	NN	O	metabolite	nn	23	SENT_191	[p13l909t1375r1061b1400],
21	(	CD	NUMBER	(	num	23	SENT_191	[p13l1077t1375r1178b1405],
22	PGI-M	NN	O	pgi-m	nn	23	SENT_191	[p13l1077t1375r1178b1405],
23	)	NN	O	)	prep_of	16	SENT_191	[p13l1077t1375r1178b1405],
24	and	CC	O	and	_	0	SENT_191	[p13l1194t1375r1245b1400],
25	the	DT	O	the	det	29	SENT_191	[p13l1260t1375r1305b1399],
26	thromboxane	NN	O	thromboxane	nn	29	SENT_191	[p13l1320t1375r1508b1400],
27	metabolite	NN	O	metabolite	nn	29	SENT_191	[p13l1524t1375r1676b1400],
28	(	CD	NUMBER	(	num	29	SENT_191	[p13l1692t1375r1784b1405],
29	Tx	NN	O	tx	conj_and	23	SENT_191	[p13l1692t1375r1784b1405],
30	.	.	O	.	_	0	SENT_191	[p13l1692t1375r1784b1405],

1	—	NN	O	—	_	0	SENT_192	[p13l1692t1375r1784b1405],
2	.	.	O	.	_	0	SENT_192	[p13l1692t1375r1784b1405],

1	M	NN	O	m	_	0	SENT_193	[p13l1692t1375r1784b1405],
2	)	NN	O	)	dep	1	SENT_193	[p13l1692t1375r1784b1405],
3	.	.	O	.	_	0	SENT_193	[p13l1692t1375r1784b1405],

1	The	DT	O	the	det	3	SENT_194	[p13l1800t1375r1851b1399],
2	3	CD	NUMBER	3	num	3	SENT_194	[p13l1867t1375r1884b1399],
3	rows	NNS	O	row	nsubj	4	SENT_194	[p13l1901t1381r1965b1400],
4	show	VBP	O	show	_	0	SENT_194	[p13l1981t1375r2055b1400],
5	the	DT	O	the	det	7	SENT_194	[p13l2069t1375r2114b1400],
6	average	JJ	O	average	amod	7	SENT_194	[p13l41t1419r152b1446],
7	effects	NNS	O	effect	dobj	4	SENT_194	[p13l163t1416r261b1440],
8	of	IN	O	of	_	0	SENT_194	[p13l272t1416r300b1440],
9	the	DT	O	the	det	11	SENT_194	[p13l307t1416r353b1440],
10	3	CD	NUMBER	3	num	11	SENT_194	[p13l364t1416r382b1440],
11	treatments	NNS	O	treatment	prep_of	7	SENT_194	[p13l391t1417r558b1444],
12	;	:	O	;	_	0	SENT_194	[p13l391t1417r558b1444],
13	the	DT	O	the	det	14	SENT_194	[p13l569t1416r614b1440],
14	variation	NN	O	variation	conj_and	7	SENT_194	[p13l624t1416r746b1440],
15	of	IN	O	of	_	0	SENT_194	[p13l758t1416r786b1440],
16	the	DT	O	the	det	17	SENT_194	[p13l793t1416r839b1440],
17	responses	NNS	O	response	prep_of	14	SENT_194	[p13l851t1422r1000b1445],
18	in	IN	O	in	_	0	SENT_194	[p13l1012t1416r1034b1440],
19	the	DT	O	the	det	21	SENT_194	[p13l1044t1416r1090b1440],
20	whole	JJ	O	whole	amod	21	SENT_194	[p13l1100t1416r1182b1440],
21	population	NN	O	population	prep_in	17	SENT_194	[p13l1195t1416r1352b1445],
22	,	,	O	,	_	0	SENT_194	[p13l1195t1416r1352b1445],
23	by	IN	O	by	_	0	SENT_194	[p13l1365t1416r1396b1446],
24	plotting	VBG	O	plot	prepc_by	17	SENT_194	[p13l1406t1416r1512b1446],
25	all	DT	O	all	det	27	SENT_194	[p13l1522t1416r1552b1440],
26	individual	JJ	O	individual	amod	27	SENT_194	[p13l1565t1416r1697b1440],
27	observations	NNS	O	observation	dobj	24	SENT_194	[p13l1709t1416r1894b1440],
28	from	IN	O	from	_	0	SENT_194	[p13l1904t1416r1968b1440],
29	which	WDT	O	which	dobj	34	SENT_194	[p13l1978t1416r2058b1440],
30	the	DT	O	the	det	32	SENT_194	[p13l2069t1416r2114b1440],
31	average	JJ	O	average	amod	32	SENT_194	[p13l41t1461r153b1487],
32	effects	NNS	O	effect	nsubjpass	34	SENT_194	[p13l164t1457r262b1481],
33	are	VBP	O	be	auxpass	34	SENT_194	[p13l274t1463r318b1481],
34	derived	VBN	O	derive	prepc_from	24	SENT_194	[p13l329t1457r441b1485],
35	;	:	O	;	_	0	SENT_194	[p13l329t1457r441b1485],
36	and	CC	O	and	_	0	SENT_194	[p13l454t1457r505b1481],
37	the	DT	O	the	det	38	SENT_194	[p13l516t1457r561b1481],
38	variability	NN	O	variability	dobj	4	SENT_194	[p13l572t1457r708b1487],
39	of	IN	O	of	_	0	SENT_194	[p13l718t1457r746b1481],
40	replicate	VB	O	replicate	dep	41	SENT_194	[p13l756t1457r878b1486],
41	measurements	NNS	O	measurement	prep_of	38	SENT_194	[p13l891t1459r1106b1481],
42	within	IN	O	within	_	0	SENT_194	[p13l1116t1457r1199b1481],
43	5	CD	NUMBER	5	num	44	SENT_194	[p13l1212t1457r1229b1481],
44	individuals	NNS	O	individual	prep_within	41	SENT_194	[p13l1242t1457r1401b1481],
45	.	.	O	.	_	0	SENT_194	[p13l1242t1457r1401b1481],

1	All	DT	O	all	det	2	SENT_195	[p13l1413t1457r1445b1481],
2	data	NNS	O	datum	nsubjpass	4	SENT_195	[p13l1458t1457r1520b1481],
3	are	VBP	O	be	auxpass	4	SENT_195	[p13l1532t1463r1576b1481],
4	plotted	VBN	O	plot	_	0	SENT_195	[p13l1589t1457r1686b1486],
5	on	IN	O	on	_	0	SENT_195	[p13l1698t1463r1731b1481],
6	log	NN	O	log	nn	7	SENT_195	[p13l1744t1457r1785b1487],
7	scales	NNS	O	scale	prep_on	4	SENT_195	[p13l1795t1457r1887b1481],
8	to	TO	O	to	aux	9	SENT_195	[p13l1898t1459r1925b1481],
9	visualize	VB	O	visualize	xcomp	4	SENT_195	[p13l1936t1457r2058b1481],
10	the	DT	O	the	det	12	SENT_195	[p13l2069t1457r2114b1481],
11	full	JJ	O	full	amod	12	SENT_195	[p13l40t1498r81b1522],
12	range	NN	O	range	dobj	9	SENT_195	[p13l96t1502r174b1528],
13	of	IN	O	of	_	0	SENT_195	[p13l187t1498r215b1522],
14	variability	NN	O	variability	prep_of	12	SENT_195	[p13l224t1498r367b1528],
15	.	.	O	.	_	0	SENT_195	[p13l224t1498r367b1528],

1	First	JJ	ORDINAL	first	amod	2	SENT_196	[p13l383t1498r445b1522],
2	row	NN	O	row	_	0	SENT_196	[p13l455t1504r506b1522],
3	(	NN	O	(	nn	4	SENT_196	[p13l515t1498r598b1527],
4	A	NN	O	a	dep	2	SENT_196	[p13l515t1498r598b1527],
5	.	.	O	.	_	0	SENT_196	[p13l515t1498r598b1527],

1	—	NN	O	—	_	0	SENT_197	[p13l515t1498r598b1527],
2	.	.	O	.	_	0	SENT_197	[p13l515t1498r598b1527],

1	D	NN	O	d	_	0	SENT_198	[p13l515t1498r598b1527],
2	)	CD	NUMBER	)	num	1	SENT_198	[p13l515t1498r598b1527],
3	:	:	O	:	_	0	SENT_198	[p13l515t1498r598b1527],
4	The	DT	O	the	det	6	SENT_198	[p13l611t1498r663b1522],
5	average	JJ	O	average	amod	6	SENT_198	[p13l676t1502r787b1528],
6	effects	NNS	O	effect	nsubjpass	8	SENT_198	[p13l799t1498r897b1522],
7	are	VBP	O	be	auxpass	8	SENT_198	[p13l910t1504r954b1522],
8	shown	VBN	O	show	dep	1	SENT_198	[p13l967t1498r1057b1522],
9	as	IN	O	as	_	0	SENT_198	[p13l1071t1504r1103b1522],
10	fitted	JJ	O	fitted	amod	11	SENT_198	[p13l1114t1498r1186b1522],
11	means	NNS	O	means	prep_as	8	SENT_198	[p13l1201t1504r1296b1522],
12	and	CC	O	and	_	0	SENT_198	[p13l1309t1498r1360b1522],
13	standard	JJ	O	standard	amod	14	SENT_198	[p13l1373t1498r1498b1522],
14	error	NN	O	error	prep_as	8	SENT_198	[p13l1512t1504r1579b1522],
15	of	IN	O	of	_	0	SENT_198	[p13l1590t1498r1618b1522],
16	the	DT	O	the	det	17	SENT_198	[p13l1627t1498r1672b1522],
17	mean	NN	O	mean	prep_of	14	SENT_198	[p13l1686t1504r1772b1522],
18	.	.	O	.	_	0	SENT_198	[p13l1686t1504r1772b1522],

1	There	EX	O	there	expl	2	SENT_199	[p13l1785t1498r1865b1522],
2	was	VBD	O	be	_	0	SENT_199	[p13l1877t1504r1933b1522],
3	inhibition	NN	O	inhibition	nsubj	2	SENT_199	[p13l1947t1498r2075b1522],
4	of	IN	O	of	_	0	SENT_199	[p13l2088t1498r2116b1522],
5	COX-2	NN	O	cox-2	prep_of	3	SENT_199	[p13l41t1539r126b1563],
6	by	IN	O	by	_	0	SENT_199	[p13l140t1539r170b1569],
7	both	CC	O	both	dep	8	SENT_199	[p13l182t1539r243b1563],
8	drugs	NNS	O	drug	prep_by	5	SENT_199	[p13l257t1539r335b1569],
9	(	CD	NUMBER	(	num	8	SENT_199	[p13l348t1539r393b1569],
10	A	DT	O	a	det	11	SENT_199	[p13l348t1539r393b1569],
11	)	NN	O	)	dep	8	SENT_199	[p13l348t1539r393b1569],
12	,	,	O	,	_	0	SENT_199	[p13l348t1539r393b1569],
13	a	DT	O	a	det	15	SENT_199	[p13l407t1545r422b1563],
14	minor	JJ	O	minor	amod	15	SENT_199	[p13l436t1539r516b1563],
15	degree	NN	O	degree	dep	8	SENT_199	[p13l527t1539r624b1569],
16	of	IN	O	of	_	0	SENT_199	[p13l637t1539r665b1563],
17	inhibition	NN	O	inhibition	prep_of	15	SENT_199	[p13l676t1539r805b1563],
18	of	IN	O	of	_	0	SENT_199	[p13l818t1539r846b1563],
19	COX-1	NN	O	cox-1	prep_of	17	SENT_199	[p13l857t1539r942b1563],
20	by	IN	O	by	_	0	SENT_199	[p13l956t1539r986b1569],
21	celecoxib	NN	O	celecoxib	nn	24	SENT_199	[p13l997t1539r1130b1563],
22	(	NN	O	(	nn	24	SENT_199	[p13l1143t1539r1189b1569],
23	B	NN	O	b	nn	24	SENT_199	[p13l1143t1539r1189b1569],
24	)	NN	O	)	prep_by	19	SENT_199	[p13l1143t1539r1189b1569],
25	,	,	O	,	_	0	SENT_199	[p13l1143t1539r1189b1569],
26	similar	JJ	O	similar	amod	27	SENT_199	[p13l1204t1539r1300b1563],
27	depression	NN	O	depression	dep	8	SENT_199	[p13l1311t1539r1469b1568],
28	by	IN	O	by	prep	5	SENT_199	[p13l1483t1539r1514b1569],
29	both	CC	O	both	dep	28	SENT_199	[p13l1526t1539r1587b1563],
30	drugs	NNS	O	drug	conj	28	SENT_199	[p13l1600t1539r1678b1569],
31	of	IN	O	of	_	0	SENT_199	[p13l1691t1539r1719b1563],
32	PG	NN	O	pg	nn	33	SENT_199	[p13l1730t1539r1810b1563],
33	|	NN	O	|	prep_of	3	SENT_199	[p13l1730t1539r1810b1563],
34	.	.	O	.	_	0	SENT_199	[p13l1730t1539r1810b1563],

1	—	NN	O	—	_	0	SENT_200	[p13l1730t1539r1810b1563],
2	.	.	O	.	_	0	SENT_200	[p13l1730t1539r1810b1563],

1	M	NN	O	m	nn	4	SENT_201	[p13l1730t1539r1810b1563],
2	(	NN	O	(	nn	4	SENT_201	[p13l1824t1539r1871b1569],
3	C	NN	O	c	nn	4	SENT_201	[p13l1824t1539r1871b1569],
4	)	NN	O	)	_	0	SENT_201	[p13l1824t1539r1871b1569],
5	,	,	O	,	_	0	SENT_201	[p13l1824t1539r1871b1569],
6	and	CC	O	and	dep	4	SENT_201	[p13l1885t1539r1936b1563],
7	no	DT	O	no	det	8	SENT_201	[p13l1950t1545r1983b1563],
8	effect	NN	O	effect	dep	4	SENT_201	[p13l1995t1539r2077b1563],
9	of	IN	O	of	dep	8	SENT_201	[p13l2089t1539r2117b1563],
10	either	DT	O	either	pobj	9	SENT_201	[p13l41t1580r123b1604],
11	on	IN	O	on	dep	8	SENT_201	[p13l134t1586r166b1604],
12	Tx	NN	O	tx	pobj	11	SENT_201	[p13l178t1580r241b1604],
13	.	.	O	.	_	0	SENT_201	[p13l178t1580r241b1604],

1	—	NN	O	—	_	0	SENT_202	[p13l178t1580r241b1604],
2	.	.	O	.	_	0	SENT_202	[p13l178t1580r241b1604],

1	M	NN	O	m	nn	3	SENT_203	[p13l178t1580r241b1604],
2	(	NN	O	(	nn	3	SENT_203	[p13l255t1580r302b1610],
3	D	NN	O	d	_	0	SENT_203	[p13l255t1580r302b1610],
4	)	CD	NUMBER	)	dep	3	SENT_203	[p13l255t1580r302b1610],
5	.	.	O	.	_	0	SENT_203	[p13l255t1580r302b1610],

1	Second	JJ	ORDINAL	second	amod	2	SENT_204	[p13l317t1580r425b1604],
2	row	NN	O	row	_	0	SENT_204	[p13l435t1580r577b1610],
3	(	CD	NUMBER	(	num	4	SENT_204	[p13l435t1580r577b1610],
4	E	NN	O	e	dep	2	SENT_204	[p13l435t1580r577b1610],
5	.	.	O	.	_	0	SENT_204	[p13l435t1580r577b1610],

1	—	NN	O	—	_	0	SENT_205	[p13l435t1580r577b1610],
2	.	.	O	.	_	0	SENT_205	[p13l435t1580r577b1610],

1	I-I	NN	O	i-i	_	0	SENT_206	[p13l435t1580r577b1610],
2	)	CD	NUMBER	)	num	1	SENT_206	[p13l435t1580r577b1610],
3	:	:	O	:	_	0	SENT_206	[p13l435t1580r577b1610],
4	Variation	NN	O	variation	dep	1	SENT_206	[p13l589t1580r715b1604],
5	of	IN	O	of	_	0	SENT_206	[p13l727t1580r755b1604],
6	the	DT	O	the	det	7	SENT_206	[p13l763t1580r809b1604],
7	responses	NNS	O	response	prep_of	4	SENT_206	[p13l822t1586r971b1610],
8	in	IN	O	in	_	0	SENT_206	[p13l984t1580r1006b1604],
9	the	DT	O	the	det	11	SENT_206	[p13l1017t1580r1062b1604],
10	study	NN	O	study	nn	11	SENT_206	[p13l1074t1580r1151b1610],
11	population	NN	O	population	prep_in	7	SENT_206	[p13l1163t1580r1320b1610],
12	.	.	O	.	_	0	SENT_206	[p13l1163t1580r1320b1610],

1	Whereas	IN	O	whereas	mark	15	SENT_207	[p13l1333t1580r1458b1604],
2	the	DT	O	the	det	4	SENT_207	[p13l1469t1580r1514b1604],
3	main	JJ	O	main	amod	4	SENT_207	[p13l1527t1580r1594b1604],
4	effects	NNS	O	effect	nsubj	15	SENT_207	[p13l1607t1580r1713b1608],
5	,	,	O	,	_	0	SENT_207	[p13l1607t1580r1713b1608],
6	such	JJ	O	such	_	0	SENT_207	[p13l1726t1580r1792b1604],
7	as	IN	O	as	_	0	SENT_207	[p13l1805t1586r1837b1604],
8	inhibition	NN	O	inhibition	prep_such_as	4	SENT_207	[p13l1850t1580r1979b1604],
9	of	IN	O	of	_	0	SENT_207	[p13l1991t1580r2019b1604],
10	COX-2	NN	O	cox-2	nn	13	SENT_207	[p13l2029t1580r2114b1604],
11	(	CD	NUMBER	(	num	13	SENT_207	[p13l41t1621r77b1651],
12	E	NN	O	e	nn	13	SENT_207	[p13l41t1621r77b1651],
13	)	NN	O	)	prep_of	8	SENT_207	[p13l41t1621r77b1651],
14	are	VBP	O	be	cop	15	SENT_207	[p13l93t1627r137b1645],
15	evident	JJ	O	evident	advcl	18	SENT_207	[p13l152t1621r263b1649],
16	,	,	O	,	_	0	SENT_207	[p13l152t1621r263b1649],
17	there	EX	O	there	expl	18	SENT_207	[p13l279t1621r353b1645],
18	is	VBZ	O	be	_	0	SENT_207	[p13l369t1621r391b1645],
19	a	DT	O	a	det	21	SENT_207	[p13l407t1627r422b1645],
20	striking	JJ	O	striking	amod	21	SENT_207	[p13l437t1621r542b1651],
21	variability	NN	O	variability	nsubj	18	SENT_207	[p13l555t1621r691b1651],
22	within	IN	O	within	_	0	SENT_207	[p13l704t1621r786b1645],
23	the	DT	O	the	det	24	SENT_207	[p13l801t1621r846b1645],
24	population	NN	O	population	prep_within	21	SENT_207	[p13l863t1621r1020b1650],
25	.	.	O	.	_	0	SENT_207	[p13l863t1621r1020b1650],

1	Third	JJ	ORDINAL	third	amod	2	SENT_208	[p13l1040t1621r1109b1645],
2	row	NN	O	row	_	0	SENT_208	[p13l1122t1627r1173b1645],
3	(	NN	O	(	dep	2	SENT_208	[p13l1185t1621r1253b1651],
4	l	NN	O	l	tmod	3	SENT_208	[p13l1185t1621r1253b1651],
5	.	.	O	.	_	0	SENT_208	[p13l1185t1621r1253b1651],

1	—	NN	O	—	_	0	SENT_209	[p13l1185t1621r1253b1651],
2	.	.	O	.	_	0	SENT_209	[p13l1185t1621r1253b1651],

1	L	NN	O	l	_	0	SENT_210	[p13l1185t1621r1253b1651],
2	)	CD	NUMBER	)	num	1	SENT_210	[p13l1185t1621r1253b1651],
3	:	:	O	:	_	0	SENT_210	[p13l1185t1621r1253b1651],
4	Variability	NN	O	variability	dep	1	SENT_210	[p13l1268t1621r1408b1651],
5	of	IN	O	of	prep	4	SENT_210	[p13l1422t1621r1450b1645],
6	replicate	VB	O	replicate	dep	5	SENT_210	[p13l1464t1621r1586b1650],
7	measurements	NNS	O	measurement	iobj	6	SENT_210	[p13l1602t1623r1817b1645],
8	within	IN	O	within	_	0	SENT_210	[p13l1831t1621r1914b1645],
9	5	CD	NUMBER	5	num	10	SENT_210	[p13l1930t1621r1947b1645],
10	individuals	NNS	O	individual	prep_within	7	SENT_210	[p13l1964t1621r2114b1645],
11	(	RB	O	(	advmod	12	SENT_210	[p13l41t1662r208b1692],
12	designated	VBN	O	designate	amod	7	SENT_210	[p13l41t1662r208b1692],
13	A	NN	O	a	dobj	6	SENT_210	[p13l221t1662r239b1686],
14	to	TO	O	to	_	0	SENT_210	[p13l249t1664r276b1686],
15	E	NN	O	e	prep_to	13	SENT_210	[p13l290t1662r309b1686],
16	on	IN	O	on	_	0	SENT_210	[p13l317t1668r350b1686],
17	the	DT	O	the	det	19	SENT_210	[p13l362t1662r407b1686],
18	abcissae	FW	O	abcissae	nn	19	SENT_210	[p13l420t1662r558b1692],
19	)	FW	O	)	prep_on	15	SENT_210	[p13l420t1662r558b1692],
20	as	IN	O	as	_	0	SENT_210	[p13l571t1668r603b1686],
21	repeatabi	NN	O	repeatabus	nn	28	SENT_210	[p13l616t1662r1002b1692],
22	|	NN	O	|	nn	28	SENT_210	[p13l616t1662r1002b1692],
23	ity	NN	O	ity	nn	28	SENT_210	[p13l616t1662r1002b1692],
24	—	NN	O	—	nn	28	SENT_210	[p13l616t1662r1002b1692],
25	reproducibi	NN	O	reproducibus	nn	28	SENT_210	[p13l616t1662r1002b1692],
26	|	NN	O	|	nn	28	SENT_210	[p13l616t1662r1002b1692],
27	ity	NN	O	ity	nn	28	SENT_210	[p13l616t1662r1002b1692],
28	plots	NNS	O	plot	prep_as	19	SENT_210	[p13l1014t1662r1091b1692],
29	.	.	O	.	_	0	SENT_210	[p13l1014t1662r1091b1692],

1	Data	NNS	O	datum	nn	2	SENT_211	[p13l1106t1662r1171b1686],
2	points	NNS	O	point	nsubj	4	SENT_211	[p13l1184t1662r1271b1692],
3	of	IN	O	of	prep	2	SENT_211	[p13l1283t1662r1311b1686],
4	replicate	VBP	O	replicate	_	0	SENT_211	[p13l1322t1662r1444b1692],
5	measurements	NNS	O	measurement	nsubjpass	7	SENT_211	[p13l1457t1663r1672b1686],
6	are	VBP	O	be	auxpass	7	SENT_211	[p13l1685t1668r1729b1686],
7	connected	VBN	O	connect	ccomp	4	SENT_211	[p13l1741t1662r1889b1686],
8	by	IN	O	by	_	0	SENT_211	[p13l1902t1662r1933b1692],
9	vertical	JJ	O	vertical	amod	11	SENT_211	[p13l1946t1662r2048b1686],
10	gray	JJ	O	gray	amod	11	SENT_211	[p13l2056t1665r2119b1692],
11	lines	NNS	O	line	agent	7	SENT_211	[p13l42t1703r116b1727],
12	.	.	O	.	_	0	SENT_211	[p13l42t1703r116b1727],

1	A	DT	O	a	det	3	SENT_212	[p13l129t1703r147b1727],
2	grey	NN	O	grey	nn	3	SENT_212	[p13l156t1707r219b1733],
3	box	NN	O	box	nsubj	4	SENT_212	[p13l227t1703r278b1727],
4	indicates	VBZ	O	indicate	_	0	SENT_212	[p13l287t1703r415b1727],
5	the	DT	O	the	det	7	SENT_212	[p13l426t1703r471b1727],
6	maximal	JJ	O	maximal	amod	7	SENT_212	[p13l484t1703r601b1727],
7	range	NN	O	range	dobj	4	SENT_212	[p13l615t1707r692b1733],
8	of	IN	O	of	_	0	SENT_212	[p13l704t1703r732b1727],
9	observations	NNS	O	observation	prep_of	7	SENT_212	[p13l741t1703r926b1727],
10	for	IN	O	for	_	0	SENT_212	[p13l936t1703r975b1727],
11	each	DT	O	each	det	13	SENT_212	[p13l985t1703r1052b1727],
12	drug	NN	O	drug	nn	13	SENT_212	[p13l1064t1703r1127b1733],
13	treatment	NN	O	treatment	prep_for	9	SENT_212	[p13l1136t1705r1285b1727],
14	.	.	O	.	_	0	SENT_212	[p13l1136t1705r1285b1727],

1	A	DT	O	a	det	4	SENT_213	[p13l1297t1703r1315b1727],
2	horizontal	JJ	O	horizontal	amod	4	SENT_213	[p13l1327t1703r1468b1727],
3	grey	NN	O	grey	nn	4	SENT_213	[p13l1475t1707r1538b1733],
4	line	NN	O	line	nsubj	8	SENT_213	[p13l1547t1703r1597b1727],
5	in	IN	O	in	_	0	SENT_213	[p13l1608t1703r1629b1727],
6	each	DT	O	each	det	7	SENT_213	[p13l1642t1703r1708b1727],
7	box	NN	O	box	prep_in	4	SENT_213	[p13l1722t1703r1770b1727],
8	represents	VBZ	O	represent	_	0	SENT_213	[p13l1782t1705r1935b1732],
9	the	DT	O	the	det	12	SENT_213	[p13l1945t1703r1991b1727],
10	average	JJ	O	average	amod	12	SENT_213	[p13l2003t1707r2114b1733],
11	overall	JJ	O	overall	amod	12	SENT_213	[p13l41t1744r133b1768],
12	measurements	NNS	O	measurement	dobj	8	SENT_213	[p13l147t1745r362b1768],
13	within	IN	O	within	_	0	SENT_213	[p13l373t1744r456b1768],
14	the	DT	O	the	det	15	SENT_213	[p13l467t1744r513b1768],
15	box	NN	O	box	prep_within	12	SENT_213	[p13l526t1744r582b1768],
16	.	.	O	.	_	0	SENT_213	[p13l526t1744r582b1768],

1	There	EX	O	there	expl	2	SENT_214	[p13l594t1744r674b1768],
2	was	VBD	O	be	_	0	SENT_214	[p13l685t1749r741b1768],
3	also	RB	O	also	advmod	2	SENT_214	[p13l754t1744r812b1768],
4	a	DT	O	a	det	7	SENT_214	[p13l825t1749r840b1768],
5	striking	JJ	O	striking	amod	7	SENT_214	[p13l852t1744r957b1774],
6	intraindividual	JJ	O	intraindividual	amod	7	SENT_214	[p13l969t1744r1166b1768],
7	variability	NN	O	variability	nsubj	2	SENT_214	[p13l1179t1744r1322b1774],
8	,	,	O	,	_	0	SENT_214	[p13l1179t1744r1322b1774],
9	which	WDT	O	which	nsubj	27	SENT_214	[p13l1334t1744r1414b1768],
10	appears	VBZ	O	appear	cop	13	SENT_214	[p13l1428t1749r1543b1773],
11	only	RB	O	only	advmod	13	SENT_214	[p13l1555t1744r1612b1774],
12	slightly	RB	O	slightly	advmod	13	SENT_214	[p13l1623t1744r1722b1774],
13	smaller	JJR	O	smaller	rcmod	7	SENT_214	[p13l1733t1744r1839b1768],
14	than	IN	O	than	_	0	SENT_214	[p13l1849t1744r1911b1768],
15	the	DT	O	the	det	16	SENT_214	[p13l1923t1744r1968b1768],
16	variability	NN	O	variability	prep_than	13	SENT_214	[p13l1980t1744r2116b1774],
17	of	IN	O	of	_	0	SENT_214	[p13l41t1785r69b1809],
18	the	DT	O	the	det	20	SENT_214	[p13l79t1785r124b1809],
19	whole	JJ	O	whole	amod	20	SENT_214	[p13l137t1785r219b1809],
20	population	NN	O	population	prep_of	16	SENT_214	[p13l234t1785r382b1814],
21	(	CD	NUMBER	(	num	24	SENT_214	[p13l397t1785r513b1814],
22	second	JJ	NUMBER	second	amod	24	SENT_214	[p13l397t1785r513b1814],
23	row	NN	O	row	nn	24	SENT_214	[p13l524t1785r590b1814],
24	)	NN	O	)	dep	20	SENT_214	[p13l524t1785r590b1814],
25	,	,	O	,	_	0	SENT_214	[p13l524t1785r590b1814],
26	and	CC	O	and	_	0	SENT_214	[p13l605t1785r656b1809],
27	replicate	VB	O	replicate	rcmod	7	SENT_214	[p13l671t1785r793b1814],
28	measurements	NNS	O	measurement	iobj	27	SENT_214	[p13l807t1787r1023b1809],
29	(	CD	NUMBER	(	num	32	SENT_214	[p13l1036t1785r1113b1814],
30	third	JJ	ORDINAL	third	amod	32	SENT_214	[p13l1036t1785r1113b1814],
31	row	NN	O	row	nn	32	SENT_214	[p13l1124t1785r1189b1814],
32	)	NN	O	)	dobj	27	SENT_214	[p13l1124t1785r1189b1814],
33	,	,	O	,	_	0	SENT_214	[p13l1124t1785r1189b1814],
34	which	WDT	O	which	nsubjpass	36	SENT_214	[p13l1203t1785r1283b1809],
35	are	VBP	O	be	auxpass	36	SENT_214	[p13l1298t1791r1342b1809],
36	plotted	VBN	O	plot	rcmod	32	SENT_214	[p13l1356t1785r1453b1814],
37	on	IN	O	on	_	0	SENT_214	[p13l1468t1791r1500b1809],
38	the	DT	O	the	det	40	SENT_214	[p13l1513t1785r1559b1809],
39	same	JJ	O	same	amod	40	SENT_214	[p13l1573t1791r1651b1809],
40	scales	NNS	O	scale	prep_on	36	SENT_214	[p13l1664t1785r1765b1809],
41	.	.	O	.	_	0	SENT_214	[p13l1664t1785r1765b1809],

1	Genetic	JJ	O	genetic	amod	2	SENT_215	[p13l87t1891r227b1921],
2	Variability	NN	O	variability	nsubj	6	SENT_215	[p13l249t1889r438b1930],
3	is	VBZ	O	be	cop	6	SENT_215	[p13l461t1891r487b1921],
4	a	DT	O	a	det	6	SENT_215	[p13l509t1902r526b1920],
5	likely	JJ	O	likely	amod	6	SENT_215	[p13l548t1889r650b1930],
6	contributor	NN	O	contributor	dep	16	SENT_215	[p13l672t1889r881b1921],
7	to	TO	O	to	_	0	SENT_215	[p13l903t1899r937b1921],
8	such	JJ	O	such	amod	9	SENT_215	[p13l960t1890r1039b1921],
9	enzymes	NNS	O	enzyme	prep_to	6	SENT_215	[p13l1116t1901r1266b1930],
10	or	CC	O	or	_	0	SENT_215	[p13l1282t1901r1317b1921],
11	their	PRP$	O	they	poss	12	SENT_215	[p13l1331t1890r1417b1921],
12	interaction	NN	O	interaction	conj_or	6	SENT_215	[p13l1431t1891r1629b1921],
13	with	IN	O	with	_	0	SENT_215	[p13l1643t1890r1726b1921],
14	the	DT	O	the	det	15	SENT_215	[p13l1741t1890r1796b1921],
15	coxibs	NNS	O	coxib	prep_with	12	SENT_215	[p13l1811t1889r1923b1921],
16	(	VBP	O	(	_	0	SENT_215	[p13l1938t1889r2052b1926],
17	Table	NNP	O	Table	dobj	16	SENT_215	[p13l1938t1889r2052b1926],
18	2	CD	NUMBER	2	num	17	SENT_215	[p13l2068t1891r2112b1926],
19	)	CD	NUMBER	)	nsubj	16	SENT_215	[p13l2068t1891r2112b1926],
20	.	.	O	.	_	0	SENT_215	[p13l2068t1891r2112b1926],

1	differences	NNS	O	difference	_	0	SENT_216	[p13l41t1939r233b1971],
2	in	IN	O	in	_	0	SENT_216	[p13l268t1941r303b1970],
3	drug	NN	O	drug	nn	4	SENT_216	[p13l336t1940r421b1980],
4	response	NN	O	response	prep_in	1	SENT_216	[p13l455t1951r607b1980],
5	between	IN	O	between	_	0	SENT_216	[p13l641t1939r790b1971],
6	individuals	NNS	O	individual	prep_between	1	SENT_216	[p13l824t1940r1037b1971],
7	.	.	O	.	_	0	SENT_216	[p13l824t1940r1037b1971],

1	Fourteen	CD	NUMBER	fourteen	num	2	SENT_217	[p13l1116t1942r1276b1971],
2	volunteers	NNS	O	volunteer	nsubj	3	SENT_217	[p13l1301t1940r1488b1971],
3	(	VBP	O	(	_	0	SENT_217	[p13l1515t1941r1626b1976],
4	28	CD	PERCENT	28	num	5	SENT_217	[p13l1515t1941r1626b1976],
5	%	NN	PERCENT	%	dobj	3	SENT_217	[p13l1515t1941r1626b1976],
6	)	CD	NUMBER	)	nsubj	8	SENT_217	[p13l1515t1941r1626b1976],
7	were	VBD	O	be	cop	8	SENT_217	[p13l1651t1951r1734b1971],
8	heterozygous	JJ	O	heterozygous	rcmod	5	SENT_217	[p13l1760t1940r1997b1980],
9	for	IN	O	for	mark	77	SENT_217	[p13l2023t1939r2073b1971],
10	a	DT	O	a	nsubj	77	SENT_217	[p13l2098t1952r2115b1970],
11	Thus	RB	O	thus	advmod	14	SENT_217	[p13l40t1990r142b2027],
12	,	,	O	,	_	0	SENT_217	[p13l40t1990r142b2027],
13	we	PRP	O	we	nsubj	14	SENT_217	[p13l166t2001r214b2021],
14	genotyped	VBD	O	genotype	dep	10	SENT_217	[p13l237t1990r426b2030],
15	the	DT	O	the	det	17	SENT_217	[p13l451t1990r506b2021],
16	study	NN	O	study	nn	17	SENT_217	[p13l530t1990r629b2030],
17	population	NN	O	population	nsubj	49	SENT_217	[p13l651t1990r850b2030],
18	for	IN	O	for	_	0	SENT_217	[p13l873t1989r922b2021],
19	poly	NN	O	poly	prep_for	17	SENT_217	[p13l944t1990r1038b2030],
20	-	:	O	-	_	0	SENT_217	[p13l944t1990r1038b2030],
21	variant	NN	O	variant	dep	17	SENT_217	[p13l1115t1991r1241b2021],
22	of	IN	O	of	_	0	SENT_217	[p13l1260t1989r1297b2021],
23	COX-1	NN	O	cox-1	prep_of	21	SENT_217	[p13l1311t1990r1441b2021],
24	located	JJ	O	located	amod	41	SENT_217	[p13l1463t1990r1591b2021],
25	in	IN	O	in	_	0	SENT_217	[p13l1610t1991r1645b2020],
26	the	DT	O	the	det	28	SENT_217	[p13l1664t1990r1719b2021],
27	signal	NN	O	signal	nn	28	SENT_217	[p13l1738t1990r1844b2030],
28	peptide	NN	O	peptide	prep_in	24	SENT_217	[p13l1862t1990r1999b2030],
29	or	CC	O	or	_	0	SENT_217	[p13l2018t2000r2053b2021],
30	its	PRP$	O	its	poss	31	SENT_217	[p13l2071t1991r2113b2021],
31	morphisms	NNS	O	morphism	prep_in	24	SENT_217	[p13l41t2040r242b2080],
32	in	IN	O	in	_	0	SENT_217	[p13l259t2041r294b2070],
33	COX-1	NN	O	cox-1	nn	35	SENT_217	[p13l310t2041r456b2077],
34	,	,	O	,	_	0	SENT_217	[p13l310t2041r456b2077],
35	COX-2	NN	O	cox-2	prep_in	31	SENT_217	[p13l474t2041r619b2077],
36	,	,	O	,	_	0	SENT_217	[p13l474t2041r619b2077],
37	and	CC	O	and	_	0	SENT_217	[p13l637t2040r700b2071],
38	cytochrome	NN	O	cytochrome	nn	39	SENT_217	[p13l717t2040r927b2080],
39	P430	NN	O	p430	prep_in	31	SENT_217	[p13l944t2038r1038b2072],
40	catalytic	JJ	O	catalytic	amod	41	SENT_217	[p13l1116t2040r1268b2080],
41	site	NN	O	site	dep	21	SENT_217	[p13l1288t2041r1361b2077],
42	;	:	O	;	_	0	SENT_217	[p13l1288t2041r1361b2077],
43	3	CD	PERCENT	3	num	44	SENT_217	[p13l1383t2042r1400b2073],
44	(	NN	PERCENT	(	dep	17	SENT_217	[p13l1422t2038r1509b2076],
45	6	CD	PERCENT	6	number	46	SENT_217	[p13l1422t2038r1509b2076],
46	%	NN	PERCENT	%	amod	44	SENT_217	[p13l1422t2038r1509b2076],
47	)	CD	NUMBER	)	dep	17	SENT_217	[p13l1422t2038r1509b2076],
48	Were	VBD	O	be	cop	49	SENT_217	[p13l1527t2051r1610b2071],
49	heterozygous	JJ	O	heterozygous	ccomp	14	SENT_217	[p13l1629t2040r1866b2080],
50	for	IN	O	for	_	0	SENT_217	[p13l1886t2039r1935b2071],
51	a	DT	O	a	det	52	SENT_217	[p13l1953t2052r1970b2070],
52	variant	JJ	O	variant	prep_for	49	SENT_217	[p13l1987t2041r2114b2071],
53	(	NN	O	(	nn	54	SENT_217	[p13l41t2090r152b2126],
54	CYP	NN	O	cyp	dep	52	SENT_217	[p13l41t2090r152b2126],
55	)	CD	NUMBER	)	num	56	SENT_217	[p13l41t2090r152b2126],
56	2C9	NN	O	2c9	dep	54	SENT_217	[p13l182t2090r266b2127],
57	,	,	O	,	_	0	SENT_217	[p13l182t2090r266b2127],
58	the	DT	O	the	det	61	SENT_217	[p13l297t2090r352b2121],
59	principal	JJ	O	principal	amod	61	SENT_217	[p13l380t2090r544b2130],
60	metabolizing	VBG	O	metabolize	amod	61	SENT_217	[p13l574t2089r813b2130],
61	enzyme	NN	O	enzyme	appos	54	SENT_217	[p13l843t2100r978b2130],
62	of	IN	O	of	prep	61	SENT_217	[p13l1007t2089r1044b2121],
63	in	IN	O	in	pcomp	62	SENT_217	[p13l1116t2091r1151b2120],
64	the	DT	O	the	det	66	SENT_217	[p13l1174t2090r1230b2121],
65	catalytic	JJ	O	catalytic	amod	66	SENT_217	[p13l1254t2090r1406b2130],
66	site	NN	O	site	pobj	63	SENT_217	[p13l1430t2091r1492b2121],
67	of	IN	O	of	_	0	SENT_217	[p13l1516t2089r1553b2121],
68	COX-2	NN	O	cox-2	prep_of	66	SENT_217	[p13l1571t2090r1717b2127],
69	;	:	O	;	_	0	SENT_217	[p13l1571t2090r1717b2127],
70	and	CC	O	and	_	0	SENT_217	[p13l1741t2090r1805b2121],
71	14	CD	PERCENT	14	number	72	SENT_217	[p13l1832t2088r1873b2120],
72	(	CD	PERCENT	(	appos	54	SENT_217	[p13l1897t2090r2008b2126],
73	28	CD	PERCENT	28	num	74	SENT_217	[p13l1897t2090r2008b2126],
74	%	NN	PERCENT	%	dep	72	SENT_217	[p13l1897t2090r2008b2126],
75	)	CD	NUMBER	)	num	52	SENT_217	[p13l1897t2090r2008b2126],
76	were	VBD	O	be	cop	77	SENT_217	[p13l2031t2100r2114b2121],
77	celecoxib	NN	O	celecoxib	advcl	8	SENT_217	[p13l41t2139r218b2177],
78	,	,	O	,	_	0	SENT_217	[p13l41t2139r218b2177],
79	to	TO	O	to	aux	80	SENT_217	[p13l248t2149r282b2171],
80	examine	VB	O	examine	xcomp	77	SENT_217	[p13l311t2141r460b2171],
81	their	PRP$	O	they	poss	83	SENT_217	[p13l489t2140r575b2171],
82	potential	JJ	O	potential	amod	83	SENT_217	[p13l602t2140r766b2180],
83	role	NN	O	role	dobj	80	SENT_217	[p13l795t2140r862b2171],
84	in	IN	O	in	_	0	SENT_217	[p13l891t2141r926b2170],
85	drug	NN	O	drug	nn	86	SENT_217	[p13l954t2140r1039b2180],
86	heterozygous	NN	O	heterozygous	prep_in	80	SENT_217	[p13l1116t2140r1352b2180],
87	for	IN	O	for	_	0	SENT_217	[p13l1382t2139r1432b2171],
88	a	DT	O	a	det	89	SENT_217	[p13l1460t2151r1477b2170],
89	variant	NN	O	variant	prep_for	86	SENT_217	[p13l1505t2141r1632b2171],
90	of	IN	O	of	_	0	SENT_217	[p13l1662t2139r1699b2171],
91	CYPZC9	NN	O	cypzc9	prep_of	89	SENT_217	[p13l1723t2140r1894b2174],
92	.	.	O	.	_	0	SENT_217	[p13l1723t2140r1894b2174],

1	Thus	RB	O	thus	dep	6	SENT_218	[p13l1925t2140r2027b2177],
2	,	,	O	,	_	0	SENT_218	[p13l1925t2140r2027b2177],
3	the	DT	O	the	dep	6	SENT_218	[p13l2058t2140r2114b2171],
4	response	NN	O	response	nn	6	SENT_218	[p13l41t2201r193b2230],
5	(	CD	NUMBER	(	num	6	SENT_218	[p13l215t2189r329b2226],
6	Table	NNP	O	Table	_	0	SENT_218	[p13l215t2189r329b2226],
7	2	CD	NUMBER	2	num	8	SENT_218	[p13l353t2191r396b2226],
8	)	CD	NUMBER	)	dep	6	SENT_218	[p13l353t2191r396b2226],
9	.	.	O	.	_	0	SENT_218	[p13l353t2191r396b2226],

1	We	PRP	O	we	nsubj	2	SENT_219	[p13l420t2191r483b2221],
2	targeted	VBD	O	target	dep	31	SENT_219	[p13l506t2190r655b2230],
3	variants	NNS	O	variant	dobj	2	SENT_219	[p13l676t2191r818b2221],
4	potentially	RB	O	potentially	advmod	2	SENT_219	[p13l840t2190r1039b2230],
5	population	NN	O	population	nsubj	31	SENT_219	[p13l1115t2190r1313b2230],
6	was	VBD	O	be	cop	31	SENT_219	[p13l1340t2201r1404b2221],
7	genetically	RB	O	genetically	advmod	9	SENT_219	[p13l1431t2190r1631b2230],
8	quite	RB	O	quite	advmod	9	SENT_219	[p13l1658t2191r1752b2230],
9	heterogeneous	JJ	O	heterogeneous	amod	31	SENT_219	[p13l1779t2190r2037b2230],
10	reaffecting	VBG	O	reaffect	dep	9	SENT_219	[p13l2066t2201r2113b2221, p13l41t2239r199b2280],
11	either	CC	O	either	prep	10	SENT_219	[p13l220t2240r325b2271],
12	baseline	NN	O	baseline	nn	13	SENT_219	[p13l345t2239r489b2271],
13	expression	NN	O	expression	dep	11	SENT_219	[p13l510t2241r697b2280],
14	or	CC	O	or	_	0	SENT_219	[p13l718t2251r753b2271],
15	activity	NN	O	activity	dep	11	SENT_219	[p13l773t2241r910b2280],
16	of	IN	O	of	_	0	SENT_219	[p13l930t2239r968b2271],
17	the	DT	O	the	prep_of	13	SENT_219	[p13l983t2240r1039b2271],
18	garding	VBG	O	gard	amod	17	SENT_219	[p13l1115t2240r1256b2280],
19	the	DT	O	the	det	20	SENT_219	[p13l1281t2240r1337b2271],
20	enzymes	NNS	O	enzyme	dobj	10	SENT_219	[p13l1362t2251r1512b2280],
21	most	RBS	O	most	advmod	22	SENT_219	[p13l1537t2249r1625b2271],
22	likely	JJ	O	likely	amod	20	SENT_219	[p13l1649t2239r1752b2280],
23	to	TO	O	to	aux	24	SENT_219	[p13l1776t2249r1810b2271],
24	affect	VB	O	affect	xcomp	22	SENT_219	[p13l1835t2239r1932b2271],
25	drug	NN	O	drug	nn	27	SENT_219	[p13l1956t2240r2041b2280],
26	re60	JJ	O	re60	amod	27	SENT_219	[p13l2066t2251r2113b2271, p13l42t2294r79b2318],
27	FRIES	NNS	O	fries	dobj	24	SENT_219	[p13l115t2294r196b2318],
28	ET	NNP	O	ET	nn	31	SENT_219	[p13l210t2294r243b2317],
29	AL	NNP	O	AL	nn	31	SENT_219	[p13l253t2294r290b2317],
30	GASTROENTEROLOGY	NNP	O	GASTROENTEROLOGY	nn	31	SENT_219	[p13l1574t2294r1887b2318],
31	Vol	NNP	O	Vol	_	0	SENT_219	[p13l1898t2294r1948b2318],
32	.	.	O	.	_	0	SENT_219	[p13l1898t2294r1948b2318],

1	130	CD	NUMBER	130	_	0	SENT_220	[p13l1963t2294r2025b2322],
2	,	,	O	,	_	0	SENT_220	[p13l1963t2294r2025b2322],
3	NO.	NNP	O	NO.	appos	1	SENT_220	[p13l2041t2294r2084b2318],
4	1	CD	NUMBER	1	num	3	SENT_220	[p13l2099t2294r2117b2317],

1	A	DT	O	a	det	3	SENT_221	[p13l191t2397r237b2447],
2	W	NN	O	w	nn	3	SENT_221	[p13l829t2397r870b2447],
3	o	NN	O	o	_	0	SENT_221	[p13l1473t2397r1517b2448],

1	Experimental	JJ	O	experimental	amod	3	SENT_222	[p13l272t2453r486b2490],
2	COX-2	NN	O	cox-2	nn	3	SENT_222	[p13l499t2453r611b2482],
3	selectivity	NN	O	selectivity	nsubj	4	SENT_222	[p13l622t2452r784b2490],
4	Attained	VBN	O	attain	_	0	SENT_222	[p13l898t2452r1035b2481],
5	COX-2	NN	O	cox-2	nn	7	SENT_222	[p13l1047t2452r1160b2481],
6	selectivity	NN	O	selectivity	nn	7	SENT_222	[p13l1172t2452r1332b2488],
7	p	NN	O	p	nsubj	15	SENT_222	[p13l1685t2456r1785b2481],
8	<	JJR	O	<	dep	15	SENT_222	[p13l1685t2456r1785b2481],
9	o.	CD	NUMBER	o.	number	10	SENT_222	[p13l1685t2456r1785b2481],
10	0001	CD	DATE	0001	num	11	SENT_222	[p13l1685t2456r1785b2481],
11	F	NN	O	f	npadvmod	12	SENT_222	[p13l1611t2507r1729b2546],
12	=	JJ	O	=	amod	14	SENT_222	[p13l1611t2507r1729b2546],
13	U.	NNP	O	U.	nn	14	SENT_222	[p13l1611t2507r1729b2546],
14	D0326	NNP	O	D0326	nsubj	15	SENT_222	[p13l1611t2507r1729b2546],
15	ns	VBZ	O	n	xcomp	4	SENT_222	[p13l1782t2510r1808b2527],

1	—	NN	O	—	nn	4	SENT_223	[p13l284t2573r294b2593, p13l298t2574r310b2593],
2	|	CD	NUMBER	|	num	4	SENT_223	[p13l284t2573r294b2593, p13l298t2574r310b2593],
3	G	NN	O	g	nn	4	SENT_223	[p13l284t2573r294b2593, p13l298t2574r310b2593],
4	G	NN	O	g	_	0	SENT_223	[p13l313t2573r325b2593],
5	-	:	O	-	_	0	SENT_223	[p13l888t2571r898b2592],
6	I	PRP	O	I	dep	4	SENT_223	[p13l888t2571r898b2592],
7	a	DT	O	a	dep	6	SENT_223	[p13l901t2572r915b2593],
8	e	SYM	O	e	dep	4	SENT_223	[p13l916t2573r930b2591],

1	.	.	O	.	_	0	SENT_224	[p13l1497t2573r1517b2593],
2	'	''	O	'	_	0	SENT_224	[p13l1497t2573r1517b2593],

1	°	NN	O	°	nn	2	SENT_225	[p13l1497t2573r1517b2593],
2	c	NN	O	c	_	0	SENT_225	[p13l1518t2573r1532b2593],

1	COX	NNP	O	COX	nn	3	SENT_226	[p13l832t2865r859b2936],
2	isoform	NN	O	isoform	nn	3	SENT_226	[p13l832t2746r858b2853],
3	inhibition	NN	O	inhibition	_	0	SENT_226	[p13l832t2606r858b2735],
4	(	NN	O	(	dep	3	SENT_226	[p13l831t2546r864b2594],
5	'	''	O	'	_	0	SENT_226	[p13l831t2546r864b2594],
6	’	CD	NUMBER	’	dep	4	SENT_226	[p13l831t2546r864b2594],
7	/	:	O	/	punct	8	SENT_226	[p13l831t2546r864b2594],
8	o	NN	O	o	dep	6	SENT_226	[p13l831t2546r864b2594],
9	)	CD	NUMBER	)	num	8	SENT_226	[p13l831t2546r864b2594],
10	o	NN	O	o	nn	12	SENT_226	[p13l898t2745r912b2766],
11	|	CD	NUMBER	|	num	12	SENT_226	[p13l898t2745r912b2766],
12	O	NN	O	o	dep	3	SENT_226	[p13l913t2746r926b2766],

1	COX	NNP	O	COX	nn	3	SENT_227	[p13l223t2866r249b2937],
2	isoform	NN	O	isoform	nn	3	SENT_227	[p13l222t2748r249b2856],
3	inhibition	NN	O	inhibition	_	0	SENT_227	[p13l221t2608r248b2737],
4	(	CD	NUMBER	(	dep	3	SENT_227	[p13l220t2547r254b2596],
5	"	``	O	"	punct	4	SENT_227	[p13l220t2547r254b2596],
6	/	:	O	/	punct	3	SENT_227	[p13l220t2547r254b2596],
7	o	NN	O	o	nn	9	SENT_227	[p13l220t2547r254b2596],
8	)	CD	NUMBER	)	num	9	SENT_227	[p13l220t2547r254b2596],
9	g	NN	O	g	dep	3	SENT_227	[p13l310t2914r324b2934],
10	3	CD	NUMBER	3	dep	9	SENT_227	[p13l293t2747r321b2768],

1	O	NN	O	o	_	0	SENT_228	[p13l914t2913r928b2933],

1	1.0	CD	NUMBER	1.0	num	2	SENT_229	[p13l1499t2912r1533b2933],
2	placebo	NN	O	placebo	_	0	SENT_229	[p13l1536t2943r1651b2976],
3	rofecoxib	NN	O	rofecoxib	nn	4	SENT_229	[p13l1673t2943r1805b2970],
4	celecoxib	NN	O	celecoxib	dep	2	SENT_229	[p13l1824t2943r1960b2970],

1	Achieved	VBN	O	achieve	_	0	SENT_230	[p13l1415t2801r1439b2922],
2	COX-2	NN	O	cox-2	nn	3	SENT_230	[p13l1415t2699r1439b2790],
3	selectivity	NN	O	selectivity	nsubj	7	SENT_230	[p13l1415t2564r1443b2691],
4	(	CD	NUMBER	(	num	6	SENT_230	[p13l1449t2874r1480b2956],
5	PGE2	NN	O	pge2	nn	6	SENT_230	[p13l1449t2874r1480b2956],
6	inhibition	NN	O	inhibition	dep	3	SENT_230	[p13l1449t2753r1473b2866],
7	I	PRP	O	I	xcomp	1	SENT_230	[p13l1449t2736r1472b2745],
8	Txlizinhibition	VBP	O	txlizinhibition	dep	1	SENT_230	[p13l1448t2538r1479b2729],
9	)	NN	O	)	dobj	8	SENT_230	[p13l1448t2538r1479b2729],
10	2	CD	NUMBER	2	nsubj	1	SENT_230	[p13l1497t2743r1532b2763],

1	Concentration	NN	O	concentration	_	0	SENT_231	[p13l391t2945r594b2972],
2	Plasma	NN	O	plasma	nn	3	SENT_231	[p13l953t2943r1062b2970],
3	concentration	NN	O	concentration	dep	1	SENT_231	[p13l1073t2928r1270b2970],

1	Figure	NN	O	figure	_	0	SENT_232	[p13l43t3017r133b3047],
2	2	CD	NUMBER	2	dep	1	SENT_232	[p13l142t3017r169b3041],
3	.	.	O	.	_	0	SENT_232	[p13l142t3017r169b3041],

1	(	NN	O	(	_	0	SENT_233	[p13l189t3017r225b3047],
2	A	NN	O	a	nn	4	SENT_233	[p13l189t3017r225b3047],
3	)	CD	NUMBER	)	num	4	SENT_233	[p13l189t3017r225b3047],
4	Model	NNP	O	Model	dep	1	SENT_233	[p13l237t3017r321b3041],
5	of	IN	O	of	_	0	SENT_233	[p13l333t3017r361b3041],
6	the	DT	O	the	det	7	SENT_233	[p13l367t3017r413b3041],
7	estimation	NN	O	estimation	prep_of	4	SENT_233	[p13l423t3017r574b3041],
8	of	IN	O	of	_	0	SENT_233	[p13l585t3017r613b3041],
9	the	DT	O	the	det	10	SENT_233	[p13l619t3017r665b3041],
10	degree	NN	O	degree	prep_of	7	SENT_233	[p13l675t3017r772b3047],
11	of	IN	O	of	_	0	SENT_233	[p13l783t3017r811b3041],
12	COX-2	NN	O	cox-2	nn	13	SENT_233	[p13l818t3017r904b3041],
13	selectivity	NN	O	selectivity	prep_of	10	SENT_233	[p13l914t3017r1057b3047],
14	in	IN	O	in	_	0	SENT_233	[p13l1067t3017r1088b3041],
15	test	NN	O	test	nn	16	SENT_233	[p13l1098t3019r1155b3041],
16	systems	NNS	O	system	prep_in	13	SENT_233	[p13l1164t3019r1292b3047],
17	.	.	O	.	_	0	SENT_233	[p13l1164t3019r1292b3047],

1	Selectivity	NN	O	selectivity	nsubjpass	3	SENT_234	[p13l1304t3017r1450b3047],
2	is	VBZ	O	be	auxpass	3	SENT_234	[p13l1459t3017r1481b3041],
3	described	VBN	O	describe	_	0	SENT_234	[p13l1491t3017r1630b3041],
4	as	IN	O	as	_	0	SENT_234	[p13l1642t3023r1674b3041],
5	the	DT	O	the	det	6	SENT_234	[p13l1683t3017r1729b3041],
6	ratio	NN	O	ratio	prep_as	3	SENT_234	[p13l1740t3017r1802b3041],
7	of	IN	O	of	_	0	SENT_234	[p13l1812t3017r1840b3041],
8	the	DT	O	the	det	9	SENT_234	[p13l1847t3017r1892b3041],
9	concentrations	NNS	O	concentration	prep_of	6	SENT_234	[p13l1902t3017r2116b3041],
10	required	VBN	O	require	partmod	9	SENT_234	[p13l43t3059r158b3088],
11	to	TO	O	to	aux	12	SENT_234	[p13l170t3060r198b3083],
12	inhibit	VB	O	inhibit	xcomp	10	SENT_234	[p13l212t3059r298b3083],
13	the	DT	O	the	det	14	SENT_234	[p13l308t3059r354b3083],
14	activity	NN	O	activity	dobj	12	SENT_234	[p13l367t3059r466b3089],
15	of	IN	O	of	prep	14	SENT_234	[p13l477t3059r505b3083],
16	the	DT	O	the	det	17	SENT_234	[p13l514t3059r559b3083],
17	isozymes	NNS	O	isozyme	dep	23	SENT_234	[p13l573t3059r704b3089],
18	by	IN	O	by	_	0	SENT_234	[p13l717t3059r747b3089],
19	50	CD	PERCENT	50	num	20	SENT_234	[p13l759t3059r820b3083],
20	%	NN	PERCENT	%	prep_by	17	SENT_234	[p13l759t3059r820b3083],
21	(	CD	NUMBER	(	num	22	SENT_234	[p13l833t3059r897b3089],
22	|	NN	O	|	dep	23	SENT_234	[p13l833t3059r897b3089],
23	C5o	NN	O	c5o	dep	28	SENT_234	[p13l833t3059r897b3089],
24	for	IN	O	for	_	0	SENT_234	[p13l908t3059r947b3083],
25	COX-1	NN	O	cox-1	prep_for	23	SENT_234	[p13l958t3059r1119b3089],
26	/	:	O	/	punct	28	SENT_234	[p13l958t3059r1119b3089],
27	|	CD	NUMBER	|	num	28	SENT_234	[p13l958t3059r1119b3089],
28	C50	NN	O	c50	dep	15	SENT_234	[p13l958t3059r1119b3089],
29	for	IN	O	for	_	0	SENT_234	[p13l1130t3059r1169b3083],
30	COX-2	NN	O	cox-2	nn	31	SENT_234	[p13l1180t3059r1284b3089],
31	)	NN	O	)	prep_for	12	SENT_234	[p13l1180t3059r1284b3089],
32	.	.	O	.	_	0	SENT_234	[p13l1180t3059r1284b3089],

1	(	NN	O	(	nn	2	SENT_235	[p13l1298t3059r1336b3089],
2	B	NN	O	b	nsubj	11	SENT_235	[p13l1298t3059r1336b3089],
3	)	CD	NUMBER	)	dep	2	SENT_235	[p13l1298t3059r1336b3089],
4	Model	NNP	O	Model	dep	2	SENT_235	[p13l1350t3059r1435b3083],
5	of	IN	O	of	_	0	SENT_235	[p13l1449t3059r1477b3083],
6	the	DT	O	the	det	7	SENT_235	[p13l1486t3059r1531b3083],
7	estimation	NN	O	estimation	prep_of	4	SENT_235	[p13l1544t3059r1695b3083],
8	of	IN	O	of	_	0	SENT_235	[p13l1708t3059r1736b3083],
9	COX-2	NN	MISC	cox-2	nn	10	SENT_235	[p13l1747t3059r1832b3083],
10	selectivity	NN	O	selectivity	prep_of	7	SENT_235	[p13l1845t3059r1987b3089],
11	attained	VBN	O	attain	_	0	SENT_235	[p13l1999t3059r2115b3083],
12	in	IN	O	in	_	0	SENT_235	[p13l43t3100r65b3124],
13	humans	NNS	O	human	prep_in	11	SENT_235	[p13l79t3100r201b3124],
14	.	.	O	.	_	0	SENT_235	[p13l79t3100r201b3124],

1	Selectivity	NN	O	selectivity	nsubjpass	3	SENT_236	[p13l216t3100r361b3130],
2	is	VBZ	O	be	auxpass	3	SENT_236	[p13l374t3100r396b3124],
3	described	VBN	O	describe	_	0	SENT_236	[p13l408t3100r547b3124],
4	as	IN	O	as	_	0	SENT_236	[p13l561t3106r594b3124],
5	the	DT	O	the	det	6	SENT_236	[p13l606t3100r651b3124],
6	ratio	NN	O	ratio	prep_as	3	SENT_236	[p13l665t3100r727b3124],
7	of	IN	O	of	_	0	SENT_236	[p13l740t3100r768b3124],
8	achieved	VBN	O	achieve	prepc_of	6	SENT_236	[p13l779t3100r904b3124],
9	isozyme	NN	O	isozyme	nn	10	SENT_236	[p13l919t3100r1032b3130],
10	inhibition	NN	O	inhibition	dobj	8	SENT_236	[p13l1046t3100r1174b3124],
11	at	IN	O	at	_	0	SENT_236	[p13l1188t3102r1216b3124],
12	a	DT	O	a	det	15	SENT_236	[p13l1227t3106r1243b3124],
13	given	VBN	O	give	amod	15	SENT_236	[p13l1255t3100r1328b3130],
14	plasma	NN	O	plasma	nn	15	SENT_236	[p13l1343t3100r1446b3129],
15	concentration	NN	O	concentration	prep_at	8	SENT_236	[p13l1458t3100r1663b3124],
16	.	.	O	.	_	0	SENT_236	[p13l1458t3100r1663b3124],

1	(	NN	O	(	_	0	SENT_237	[p13l1677t3100r1715b3129],
2	C	NN	O	c	nn	4	SENT_237	[p13l1677t3100r1715b3129],
3	)	CD	NUMBER	)	num	4	SENT_237	[p13l1677t3100r1715b3129],
4	Assessment	NNP	O	Assessment	dep	1	SENT_237	[p13l1727t3100r1907b3124],
5	of	IN	O	of	_	0	SENT_237	[p13l1919t3100r1947b3124],
6	the	DT	O	the	det	7	SENT_237	[p13l1956t3100r2002b3124],
7	ratio	NN	O	ratio	prep_of	1	SENT_237	[p13l2015t3100r2077b3124],
8	of	IN	O	of	_	0	SENT_237	[p13l2090t3100r2118b3124],
9	ex	FW	O	ex	nn	12	SENT_237	[p13l42t3147r73b3165],
10	vivo	FW	O	vivo	nn	12	SENT_237	[p13l83t3141r137b3165],
11	COX-2	NN	O	cox-2	nn	12	SENT_237	[p13l149t3141r234b3165],
12	inhibition	NN	O	inhibition	prep_of	7	SENT_237	[p13l247t3141r375b3165],
13	to	TO	O	to	_	0	SENT_237	[p13l386t3142r414b3165],
14	COX-1	NN	O	cox-1	nn	15	SENT_237	[p13l426t3141r512b3165],
15	inhibition	NN	O	inhibition	prep_to	12	SENT_237	[p13l524t3141r653b3165],
16	as	IN	O	as	_	0	SENT_237	[p13l666t3147r698b3165],
17	an	DT	O	a	det	18	SENT_237	[p13l710t3147r743b3165],
18	estimate	NN	O	estimate	prep_as	15	SENT_237	[p13l755t3141r881b3165],
19	of	IN	O	of	_	0	SENT_237	[p13l892t3141r920b3165],
20	attained	VBN	O	attain	amod	22	SENT_237	[p13l930t3141r1046b3165],
21	isoform	NN	O	isoform	nn	22	SENT_237	[p13l1060t3141r1165b3165],
22	selectivity	NN	O	selectivity	prep_of	18	SENT_237	[p13l1177t3141r1319b3171],
23	4	CD	DURATION	4	num	24	SENT_237	[p13l1329t3141r1348b3165],
24	hours	NNS	NUMBER	hour	dep	1	SENT_237	[p13l1360t3141r1439b3165],
25	postdosing	VBG	O	postdose	partmod	24	SENT_237	[p13l1451t3141r1616b3171],
26	.	.	O	.	_	0	SENT_237	[p13l1451t3141r1616b3171],

1	The	DT	O	the	det	3	SENT_238	[p13l1629t3141r1680b3165],
2	average	JJ	O	average	amod	3	SENT_238	[p13l1692t3144r1803b3171],
3	effects	NNS	O	effect	nsubjpass	5	SENT_238	[p13l1815t3141r1912b3165],
4	are	VBP	O	be	auxpass	5	SENT_238	[p13l1925t3147r1968b3165],
5	shown	VBN	O	show	_	0	SENT_238	[p13l1980t3141r2070b3165],
6	as	IN	O	as	_	0	SENT_238	[p13l2083t3147r2116b3165],
7	fitted	JJ	O	fitted	amod	8	SENT_238	[p13l41t3182r113b3206],
8	means	NNS	O	means	prep_as	5	SENT_238	[p13l128t3188r223b3206],
9	and	CC	O	and	_	0	SENT_238	[p13l238t3182r288b3206],
10	standard	JJ	O	standard	amod	11	SENT_238	[p13l303t3182r428b3206],
11	error	NN	O	error	conj_and	8	SENT_238	[p13l442t3188r510b3206],
12	of	IN	O	of	_	0	SENT_238	[p13l522t3182r550b3206],
13	the	DT	O	the	det	14	SENT_238	[p13l560t3182r605b3206],
14	mean	NN	O	mean	prep_of	11	SENT_238	[p13l620t3188r707b3206],
15	.	.	O	.	_	0	SENT_238	[p13l620t3188r707b3206],

1	Although	IN	O	although	mark	4	SENT_239	[p13l721t3182r844b3212],
2	both	DT	O	both	det	3	SENT_239	[p13l860t3182r920b3206],
3	drugs	NNS	O	drug	nsubj	4	SENT_239	[p13l935t3182r1013b3212],
4	differed	VBD	O	differ	advcl	17	SENT_239	[p13l1027t3182r1134b3206],
5	significantly	RB	O	significantly	advmod	4	SENT_239	[p13l1149t3182r1317b3212],
6	from	IN	O	from	_	0	SENT_239	[p13l1328t3182r1392b3206],
7	placebo	NN	O	placebo	prep_from	4	SENT_239	[p13l1408t3182r1527b3211],
8	,	,	O	,	_	0	SENT_239	[p13l1408t3182r1527b3211],
9	no	DT	O	no	det	10	SENT_239	[p13l1543t3188r1576b3206],
10	difference	NN	O	difference	nsubj	17	SENT_239	[p13l1589t3182r1732b3206],
11	in	IN	O	in	_	0	SENT_239	[p13l1747t3182r1768b3206],
12	selectivity	NN	O	selectivity	prep_in	10	SENT_239	[p13l1783t3182r1925b3212],
13	between	IN	O	between	_	0	SENT_239	[p13l1938t3182r2057b3206],
14	the	DT	O	the	det	15	SENT_239	[p13l2070t3182r2116b3206],
15	drugs	NNS	O	drug	prep_between	12	SENT_239	[p13l10t3238r175b3300],
16	was	VBD	O	be	cop	17	SENT_239	[p13l202t3249r320b3287],
17	evident	JJ	O	evident	_	0	SENT_239	[p13l349t3238r585b3287],
18	.	.	O	.	_	0	SENT_239	[p13l349t3238r585b3287],

1	sponse	NN	O	sponse	_	0	SENT_240	[p13l10t3486r281b3548],
2	;	:	O	;	_	0	SENT_240	[p13l10t3486r281b3548],
3	a	DT	O	a	det	4	SENT_240	[p13l329t3488r365b3527],
4	total	NN	O	total	nsubj	11	SENT_240	[p13l408t3463r583b3528],
5	of	IN	O	of	prep	4	SENT_240	[p13l629t3461r708b3528],
6	24	CD	NUMBER	24	npadvmod	7	SENT_240	[p13l744t3459r836b3527],
7	out	IN	O	out	pcomp	5	SENT_240	[p13l882t3482r1005b3528],
8	of	IN	O	of	_	0	SENT_240	[p13l1051t3461r1130b3528],
9	30	CD	NUMBER	30	num	10	SENT_240	[p13l1169t3467r1257b3531],
10	individuals	NNS	O	individual	prep_of	4	SENT_240	[p13l1305t3463r1733b3528],
11	had	VBD	O	have	dep	1	SENT_240	[p13l1779t3463r1914b3528],
12	1	CD	NUMBER	1	dobj	11	SENT_240	[p13l1967t3467r1996b3527],
13	or	CC	O	or	_	0	SENT_240	[p13l2049t3486r2124b3528],
14	more	JJR	O	more	conj_or	12	SENT_240	[p13l9t3596r200b3638],
15	genetic	JJ	O	genetic	amod	16	SENT_240	[p13l256t3576r534b3658],
16	Variant	JJ	O	variant	dep	12	SENT_240	[p13l590t3576r880b3638],
17	.	.	O	.	_	0	SENT_240	[p13l590t3576r880b3638],

1	No	DT	O	no	det	3	SENT_241	[p13l942t3576r1059b3640],
2	homozygous	JJ	O	homozygous	amod	3	SENT_241	[p13l1117t3574r1592b3658],
3	variants	NNS	O	variant	nsubj	4	SENT_241	[p13l1649t3576r1950b3638],
4	occurred	VBD	O	occur	_	0	SENT_241	[p13l2010t3597r2120b3638, p13l10t3684r276b3762],
5	,	,	O	,	_	0	SENT_241	[p13l2010t3597r2120b3638, p13l10t3684r276b3762],
6	and	CC	O	and	_	0	SENT_241	[p13l321t3684r455b3749],
7	they	PRP	O	they	nsubj	8	SENT_241	[p13l499t3684r662b3768],
8	did	VBD	O	do	conj_and	4	SENT_241	[p13l704t3684r827b3749],
9	not	RB	O	not	neg	10	SENT_241	[p13l872t3703r993b3749],
10	associate	JJ	O	associate	dobj	8	SENT_241	[p13l1037t3686r1366b3749],
11	with	IN	O	with	_	0	SENT_241	[p13l1408t3684r1583b3749],
12	gender	NN	O	gender	prep_with	8	SENT_241	[p13l1624t3684r1906b3768],
13	.	.	O	.	_	0	SENT_241	[p13l1624t3684r1906b3768],

1	This	DT	O	this	det	2	SENT_242	[p13l1952t3684r2121b3749],
2	study	NN	O	study	nsubjpass	5	SENT_242	[p14l10t19r219b104],
3	was	VBD	O	be	auxpass	5	SENT_242	[p14l269t43r404b84],
4	not	RB	O	not	neg	5	SENT_242	[p14l459t38r581b84],
5	designed	VBN	O	design	_	0	SENT_242	[p14l633t19r971b104],
6	to	TO	O	to	aux	7	SENT_242	[p14l1025t38r1097b84],
7	address	VB	O	address	xcomp	5	SENT_242	[p14l1150t19r1426b84],
8	comprehensively	RB	O	comprehensively	advmod	7	SENT_242	[p14l1480t19r2123b104],
9	the	DT	O	the	det	10	SENT_242	[p14l10t129r128b193],
10	impact	NN	O	impact	dobj	7	SENT_242	[p14l167t131r430b213],
11	of	IN	O	of	_	0	SENT_242	[p14l469t126r548b193],
12	SNPs	NNS	O	snp	prep_of	10	SENT_242	[p14l575t130r780b195],
13	on	IN	O	on	_	0	SENT_242	[p14l820t151r910b193],
14	drug	NN	O	drug	nn	15	SENT_242	[p14l948t128r1126b213],
15	response	NN	O	response	prep_on	12	SENT_242	[p14l1166t151r1511b213],
16	,	,	O	,	_	0	SENT_242	[p14l1166t151r1511b213],
17	so	IN	O	so	dep	5	SENT_242	[p14l1553t152r1625b193],
18	we	PRP	O	we	nsubj	19	SENT_242	[p14l1662t152r1764b193],
19	conﬁned	VBD	O	conﬁned	ccomp	5	SENT_242	[p14l1803t126r2122b193],
20	our	PRP$	O	we	poss	21	SENT_242	[p14l10t260r135b303],
21	analyses	NNS	O	analysis	dobj	19	SENT_242	[p14l192t238r497b322],
22	to	TO	O	to	_	0	SENT_242	[p14l559t257r631b303],
23	those	DT	O	those	det	24	SENT_242	[p14l691t238r888b303],
24	SNPS	NNS	O	snp	prep_to	19	SENT_242	[p14l948t239r1153b304],
25	that	WDT	O	that	nsubj	26	SENT_242	[p14l1214t238r1366b302],
26	occurred	VBD	O	occur	rcmod	24	SENT_242	[p14l1426t238r1752b303],
27	in	IN	O	in	_	0	SENT_242	[p14l1813t240r1886b301],
28	4	CD	NUMBER	4	num	31	SENT_242	[p14l1944t234r1988b301],
29	or	CC	O	or	_	0	SENT_242	[p14l2049t260r2124b303],
30	more	JJR	O	more	conj_or	28	SENT_242	[p14l9t369r200b411],
31	volunteers	NNS	O	volunteer	prep_in	26	SENT_242	[p14l241t346r659b411],
32	.	.	O	.	_	0	SENT_242	[p14l241t346r659b411],

1	Thus	RB	O	thus	advmod	17	SENT_243	[p14l706t347r921b424],
2	,	,	O	,	_	0	SENT_243	[p14l706t347r921b424],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_243	[p14l967t348r1403b418],
4	*	NN	O	*	nsubjpass	17	SENT_243	[p14l967t348r1403b418],
5	2	CD	NUMBER	2	number	6	SENT_243	[p14l967t348r1403b418],
6	(	CD	NUMBER	(	num	8	SENT_243	[p14l1450t342r1945b431],
7	Arg144Cys	NNS	O	arg144cy	nn	8	SENT_243	[p14l1450t342r1945b431],
8	)	NN	O	)	dep	4	SENT_243	[p14l1450t342r1945b431],
9	and	CC	O	and	_	0	SENT_243	[p14l1988t346r2122b411],
10	CYP2C9	NN	O	cyp2c9	conj_and	4	SENT_243	[p14l10t458r445b528],
11	*	CD	NUMBER	*	num	10	SENT_243	[p14l10t458r445b528],
12	3	CD	NUMBER	3	num	15	SENT_243	[p14l10t458r445b528],
13	(	NN	O	(	nn	15	SENT_243	[p14l486t457r932b532],
14	Ile359Leu	NN	O	ile359leu	nn	15	SENT_243	[p14l486t457r932b532],
15	)	NN	O	)	dep	10	SENT_243	[p14l486t457r932b532],
16	were	VBD	O	be	auxpass	17	SENT_243	[p14l966t479r1141b521],
17	tested	VBN	O	test	_	0	SENT_243	[p14l1177t456r1403b521],
18	for	IN	O	for	_	0	SENT_243	[p14l1438t454r1542b521],
19	their	PRP$	O	they	poss	20	SENT_243	[p14l1577t457r1759b521],
20	effect	NN	O	effect	prep_for	17	SENT_243	[p14l1793t454r1997b521],
21	on	IN	O	on	_	0	SENT_243	[p14l2033t479r2123b521],
22	plasma	NN	O	plasma	nn	23	SENT_243	[p14l7t565r276b649],
23	concentrations	NNS	O	concentration	prep_on	17	SENT_243	[p14l316t567r874b630],
24	of	IN	O	of	_	0	SENT_243	[p14l917t563r996b630],
25	celecoxib	NN	O	celecoxib	prep_of	23	SENT_243	[p14l1026t563r1401b643],
26	,	,	O	,	_	0	SENT_243	[p14l1026t563r1401b643],
27	and	CC	O	and	_	0	SENT_243	[p14l1445t565r1579b630],
28	the	DT	O	the	det	32	SENT_243	[p14l1622t565r1739b630],
29	Trp8Arg	NN	O	trp8arg	nn	32	SENT_243	[p14l1779t565r2121b649],
30	and	CC	O	and	_	0	SENT_243	[p14l9t673r144b738],
31	Pro17Leu	NN	O	pro17leu	nn	32	SENT_243	[p14l179t676r550b740],
32	variants	NNS	O	variant	nsubjpass	36	SENT_243	[p14l580t676r881b738],
33	of	IN	O	of	_	0	SENT_243	[p14l917t671r996b738],
34	COX-1	NN	O	cox-1	prep_of	32	SENT_243	[p14l1019t675r1294b738],
35	were	VBD	O	be	auxpass	36	SENT_243	[p14l1335t696r1510b738],
36	tested	VBN	O	test	conj_and	17	SENT_243	[p14l1545t673r1770b738],
37	for	IN	O	for	_	0	SENT_243	[p14l1804t671r1908b738],
38	their	PRP$	O	they	poss	39	SENT_243	[p14l1941t674r2124b738],
39	effects	NNS	O	effect	prep_for	36	SENT_243	[p14l10t780r247b847],
40	on	IN	O	on	_	0	SENT_243	[p14l289t805r379b847],
41	COX-1	NN	O	cox-1	nn	42	SENT_243	[p14l419t784r694b847],
42	response	NN	O	response	prep_on	36	SENT_243	[p14l743t805r1086b867],
43	.	.	O	.	_	0	SENT_243	[p14l743t805r1086b867],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_244	[p14l107t894r529b965],
2	*	NN	O	*	nsubj	8	SENT_244	[p14l107t894r529b965],
3	2	CD	NUMBER	2	nsubj	4	SENT_244	[p14l107t894r529b965],
4	occurred	VBD	O	occur	rcmod	2	SENT_244	[p14l591t893r905b957],
5	in	IN	O	in	_	0	SENT_244	[p14l963t895r1034b956],
6	8	CD	NUMBER	8	num	7	SENT_244	[p14l1093t896r1132b957],
7	individuals	NNS	O	individual	prep_in	4	SENT_244	[p14l1194t893r1603b957],
8	(	VBP	O	(	_	0	SENT_244	[p14l1661t894r1725b968],
9	5	CD	NUMBER	5	number	10	SENT_244	[p14l1661t894r1725b968],
10	white	JJ	O	white	amod	14	SENT_244	[p14l1789t893r2018b970],
11	,	,	O	,	_	0	SENT_244	[p14l1789t893r2018b970],
12	3	CD	NUMBER	3	number	13	SENT_244	[p14l2082t896r2117b963],
13	Asian	JJ	MISC	asian	amod	14	SENT_244	[p14l8t1002r242b1077],
14	)	NN	O	)	dobj	8	SENT_244	[p14l8t1002r242b1077],
15	and	CC	O	and	_	0	SENT_244	[p14l272t1001r403b1066],
16	was	VBD	O	be	auxpass	17	SENT_244	[p14l432t1025r563b1066],
17	associated	VBN	O	associate	conj_and	8	SENT_244	[p14l594t1001r956b1066],
18	with	IN	O	with	_	0	SENT_244	[p14l986t1002r1155b1066],
19	higher	JJR	O	higher	amod	21	SENT_244	[p14l1185t1002r1425b1086],
20	plasma	NN	O	plasma	nn	21	SENT_244	[p14l1451t1001r1711b1086],
21	concentrations	NNS	O	concentration	prep_with	17	SENT_244	[p14l1739t1020r2120b1066, p14l10t1113r187b1175],
22	of	IN	O	of	_	0	SENT_244	[p14l221t1108r298b1175],
23	celecoxib	NN	O	celecoxib	prep_of	21	SENT_244	[p14l319t1108r676b1189],
24	,	,	O	,	_	0	SENT_244	[p14l319t1108r676b1189],
25	after	IN	O	after	conj_and	8	SENT_244	[p14l709t1108r874b1175],
26	adjusting	VBG	O	adjust	pcomp	25	SENT_244	[p14l904t1110r1250b1195],
27	for	IN	O	for	_	0	SENT_244	[p14l1282t1108r1383b1175],
28	the	DT	O	the	det	30	SENT_244	[p14l1413t1111r1527b1175],
29	linear	JJ	O	linear	amod	30	SENT_244	[p14l1559t1110r1767b1175],
30	effects	NNS	O	effect	prep_for	26	SENT_244	[p14l1797t1108r2023b1175],
31	of	IN	O	of	prep	30	SENT_244	[p14l2057t1108r2133b1175],

1	A	DT	O	a	det	2	SENT_245	[p14l99t1354r198b1456],
2	B	NN	O	b	_	0	SENT_245	[p14l1188t1354r1274b1456],

1	lnhib	NN	O	lnhib	nn	3	SENT_246	[p14l229t1507r528b1561],
2	=	JJ	O	=	amod	3	SENT_246	[p14l229t1507r528b1561],
3	iti	NNS	O	itus	nsubj	4	SENT_246	[p14l229t1507r528b1561],
4	«	VBP	O	«	_	0	SENT_246	[p14l229t1507r528b1561],
5	on	IN	O	on	prep	4	SENT_246	[p14l229t1507r528b1561],
6	of	IN	O	of	pcomp	5	SENT_246	[p14l550t1507r616b1561],
7	COX-2	NN	O	cox-2	pobj	6	SENT_246	[p14l632t1507r836b1561],
8	ex	FW	O	ex	nn	10	SENT_246	[p14l855t1520r931b1561],
9	viva	FW	O	viva	nn	10	SENT_246	[p14l947t1507r1086b1558],
10	Inhibition	NN	O	inhibition	dobj	4	SENT_246	[p14l1296t1504r1595b1558],
11	of	IN	O	of	_	0	SENT_246	[p14l1619t1504r1683b1558],
12	GID	NNP	O	GID	prep_of	10	SENT_246	[p14l1702t1504r1896b1558],
13	}	CD	NUMBER	}	number	14	SENT_246	[p14l1702t1504r1896b1558],
14	(	CD	NUMBER	(	num	12	SENT_246	[p14l1702t1504r1896b1558],
15	.	.	O	.	_	0	SENT_246	[p14l1702t1504r1896b1558],

1	—	NN	O	—	_	0	SENT_247	[p14l1702t1504r1896b1558],
2	.	.	O	.	_	0	SENT_247	[p14l1702t1504r1896b1558],

1	:	:	O	:	_	0	SENT_248	[p14l1702t1504r1896b1558],
2	‘	CD	NUMBER	‘	_	0	SENT_248	[p14l1702t1504r1896b1558],
3	i	FW	O	i	dep	2	SENT_248	[p14l1702t1504r1896b1558],
4	:	:	O	:	_	0	SENT_248	[p14l1702t1504r1896b1558],
5	l	NN	O	l	dep	3	SENT_248	[p14l1702t1504r1896b1558],
6	ex	FW	O	ex	nn	7	SENT_248	[p14l1924t1517r2000b1558],
7	viva	FW	O	viva	dep	5	SENT_248	[p14l2017t1504r2153b1558],

1	-	:	O	-	_	0	SENT_249	[p14l204t1700r433b1745],
2	.	.	O	.	_	0	SENT_249	[p14l204t1700r433b1745],

1	—	NN	O	—	_	0	SENT_250	[p14l204t1700r433b1745],
2	.	.	O	.	_	0	SENT_250	[p14l204t1700r433b1745],

1	~	NN	O	~	nn	3	SENT_251	[p14l204t1700r433b1745],
2	Mevan	NN	MISC	mevan	nn	3	SENT_251	[p14l204t1700r433b1745],
3	variance	NN	O	variance	_	0	SENT_251	[p14l451t1703r658b1745],
4	whole	JJ	O	whole	amod	5	SENT_251	[p14l670t1700r816b1745],
5	population	NN	O	population	rcmod	3	SENT_251	[p14l832t1700r1083b1754],
6	it-Mean	JJ	MISC	it-mean	dep	5	SENT_251	[p14l1239t1700r1470b1744],
7	variant	NN	O	variant	dep	6	SENT_251	[p14l1486t1700r1693b1744],
8	:	:	O	:	_	0	SENT_251	[p14l1486t1700r1693b1744],
9	-	:	O	-	_	0	SENT_251	[p14l1486t1700r1693b1744],
10	e	SYM	O	e	dep	12	SENT_251	[p14l1486t1700r1693b1744],
11	whole	JJ	O	whole	amod	12	SENT_251	[p14l1708t1700r1851b1744],
12	population	NN	O	population	dep	26	SENT_251	[p14l1870t1700r2118b1754],
13	—	CD	NUMBER	—	num	15	SENT_251	[p14l207t1798r290b1808],
14	Mean	NN	O	mean	nn	15	SENT_251	[p14l302t1779r432b1823],
15	uariancE	NN	O	uariance	nsubj	26	SENT_251	[p14l451t1779r658b1823],
16	-	:	O	-	_	0	SENT_251	[p14l451t1779r658b1823],
17	repeat	NN	O	repeat	dep	15	SENT_251	[p14l674t1782r829b1833],
18	"	''	O	"	punct	15	SENT_251	[p14l674t1782r829b1833],
19	subjects	NNS	O	subject	nn	21	SENT_251	[p14l845t1779r1042b1833],
20	p	NN	O	p	nn	21	SENT_251	[p14l1242t1798r1325b1807],
21	Y	NN	O	y	dep	15	SENT_251	[p14l1242t1798r1325b1807],
22	+	CC	O	+	_	0	SENT_251	[p14l1242t1798r1325b1807],
23	Me-an	NN	O	me-an	nn	24	SENT_251	[p14l1337t1776r1468b1820],
24	van	NN	O	van	conj_+	21	SENT_251	[p14l1486t1779r1693b1820],
25	'	''	O	'	_	0	SENT_251	[p14l1486t1779r1693b1820],
26	am	VBP	O	be	dep	3	SENT_251	[p14l1486t1779r1693b1820],
27	:	:	O	:	_	0	SENT_251	[p14l1486t1779r1693b1820],
28	:	:	O	:	_	0	SENT_251	[p14l1486t1779r1693b1820],
29	e	LS	O	e	dep	31	SENT_251	[p14l1486t1779r1693b1820],
30	repeat	NN	O	repeat	nn	31	SENT_251	[p14l1712t1779r1864b1833],
31	subjects	NNS	O	subject	dep	3	SENT_251	[p14l1880t1776r2080b1830],
32	age	NN	O	age	prep	31	SENT_251	[p14l13t2020r134b2081],
33	(	CD	NUMBER	(	dep	32	SENT_251	[p14l176t1997r444b2081],
34	Figure	NNP	O	Figure	nn	36	SENT_251	[p14l176t1997r444b2081],
35	3A	NN	O	3a	nn	36	SENT_251	[p14l490t1997r643b2072],
36	)	NN	O	)	dep	31	SENT_251	[p14l490t1997r643b2072],
37	.	.	O	.	_	0	SENT_251	[p14l490t1997r643b2072],

1	BMI	NN	O	bmus	nsubj	7	SENT_252	[p14l690t1998r859b2060],
2	and	CC	O	and	_	0	SENT_252	[p14l901t1995r1033b2061],
3	age	NN	O	age	conj_and	1	SENT_252	[p14l1074t2020r1196b2081],
4	were	VBD	O	be	cop	7	SENT_252	[p14l1236t2018r1408b2061],
5	not	RB	O	not	neg	7	SENT_252	[p14l1451t2014r1570b2061],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_252	[p14l1613t1993r2000b2081],
7	covariates	NNS	O	covariate	_	0	SENT_252	[p14l2042t2020r2151b2061, p14l11t2108r291b2171],
8	in	IN	O	in	_	0	SENT_252	[p14l337t2108r408b2170],
9	this	DT	O	this	det	10	SENT_252	[p14l452t2106r587b2171],
10	model	NN	O	model	prep_in	7	SENT_252	[p14l632t2105r882b2171],
11	.	.	O	.	_	0	SENT_252	[p14l632t2105r882b2171],

1	Effects	NNS	O	effect	nsubj	10	SENT_253	[p14l931t2103r1176b2171],
2	on	IN	O	on	_	0	SENT_253	[p14l1221t2129r1310b2171],
3	the	DT	O	the	det	4	SENT_253	[p14l1353t2106r1468b2171],
4	response	NN	O	response	prep_on	1	SENT_253	[p14l1512t2128r1823b2191],
5	to	TO	O	to	_	0	SENT_253	[p14l1868t2125r1939b2171],
6	celecoxib	NN	O	celecoxib	prep_to	4	SENT_253	[p14l1983t2106r2151b2171, p14l13t2214r210b2282],
7	were	VBD	O	be	cop	10	SENT_253	[p14l250t2239r422b2282],
8	not	RB	O	not	neg	10	SENT_253	[p14l464t2235r584b2282],
9	statistically	RB	O	statistically	advmod	10	SENT_253	[p14l626t2216r1052b2301],
10	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_253	[p14l1094t2214r1501b2301],
11	.	.	O	.	_	0	SENT_253	[p14l1094t2214r1501b2301],

1	CYP2C9	NN	O	cyp2c9	nsubj	4	SENT_254	[p14l1547t2217r1974b2289],
2	*	CD	NUMBER	*	num	3	SENT_254	[p14l1547t2217r1974b2289],
3	3	CD	NUMBER	3	dep	1	SENT_254	[p14l1547t2217r1974b2289],
4	had	VBD	O	have	_	0	SENT_254	[p14l2021t2216r2152b2281],
5	no	DT	O	no	det	6	SENT_254	[p14l14t2348r101b2391],
6	effect	NN	O	effect	dobj	4	SENT_254	[p14l141t2323r338b2391],
7	on	IN	O	on	_	0	SENT_254	[p14l379t2348r467b2391],
8	plasma	NN	O	plasma	nn	9	SENT_254	[p14l504t2325r766b2411],
9	concentrations	NNS	O	concentration	prep_on	6	SENT_254	[p14l804t2328r1365b2391],
10	.	.	O	.	_	0	SENT_254	[p14l804t2328r1365b2391],

1	Only	RB	O	only	advmod	4	SENT_255	[p14l1410t2325r1597b2410],
2	the	DT	O	the	det	4	SENT_255	[p14l1637t2326r1751b2391],
3	Pro17Leu	NN	O	pro17leu	nn	4	SENT_255	[p14l1793t2328r2154b2393],
4	variant	NN	O	variant	nsubjpass	8	SENT_255	[p14l11t2438r270b2501],
5	of	IN	O	of	_	0	SENT_255	[p14l329t2433r407b2501],
6	COX-1	NN	O	cox-1	prep_of	4	SENT_255	[p14l454t2437r724b2501],
7	was	VBD	O	be	auxpass	8	SENT_255	[p14l789t2460r922b2501],
8	associated	VBN	O	associate	_	0	SENT_255	[p14l981t2435r1347b2501],
9	with	IN	O	with	_	0	SENT_255	[p14l1405t2436r1576b2501],
10	a	DT	O	a	det	16	SENT_255	[p14l1634t2460r1670b2500],
11	statistically	RB	O	statistically	advmod	12	SENT_255	[p14l1727t2435r2154b2521],
12	significant	JJ	O	significant	amod	16	SENT_255	[p14l14t2544r401b2631],
13	(	NN	O	(	nn	16	SENT_255	[p14l454t2546r925b2625],
14	MANOVA	NN	O	manova	nn	16	SENT_255	[p14l454t2546r925b2625],
15	,	,	O	,	_	0	SENT_255	[p14l454t2546r925b2625],
16	P	NN	O	p	prep_with	8	SENT_255	[p14l976t2548r1028b2610],
17	=	JJ	O	=	amod	16	SENT_255	[p14l1090t2566r1149b2589],
18	.009	CD	NUMBER	.009	tmod	17	SENT_255	[p14l1215t2550r1400b2625],
19	,	,	O	,	_	0	SENT_255	[p14l1215t2550r1400b2625],
20	unweighted	VBN	O	unweight	partmod	16	SENT_255	[p14l1453t2546r1919b2631],
21	;	:	O	;	_	0	SENT_255	[p14l1453t2546r1919b2631],
22	P	NN	O	p	nsubj	30	SENT_255	[p14l1970t2548r2022b2610],
23	=	JJ	O	=	amod	22	SENT_255	[p14l2084t2566r2143b2589],
24	.011	CD	NUMBER	.011	tmod	23	SENT_255	[p14l18t2659r203b2734],
25	,	,	O	,	_	0	SENT_255	[p14l18t2659r203b2734],
26	weighted	JJ	O	weighted	amod	29	SENT_255	[p14l230t2655r603b2741],
27	)	NN	O	)	nn	29	SENT_255	[p14l230t2655r603b2741],
28	pharmacodynamic	JJ	O	pharmacodynamic	amod	29	SENT_255	[p14l627t2655r1312b2741],
29	effect	NN	O	effect	appos	24	SENT_255	[p14l1339t2653r1675b2721],
30	—	VBD	O	—	parataxis	8	SENT_255	[p14l1339t2653r1675b2721],
31	a	DT	O	a	det	32	SENT_255	[p14l1339t2653r1675b2721],
32	reduction	NN	O	reduction	dobj	30	SENT_255	[p14l1699t2655r2055b2721],
33	in	IN	O	in	_	0	SENT_255	[p14l2082t2658r2153b2720],
34	COX-1	NN	O	cox-1	nn	35	SENT_255	[p14l13t2766r284b2830],
35	inhibition	NN	O	inhibition	prep_in	30	SENT_255	[p14l339t2762r717b2831],
36	both	CC	O	both	dep	35	SENT_255	[p14l763t2762r932b2831],
37	ex	FW	O	ex	nn	38	SENT_255	[p14l978t2789r1057b2830],
38	vivo	FW	O	vivo	dep	36	SENT_255	[p14l1099t2767r1255b2830],
39	and	CC	O	and	_	0	SENT_255	[p14l1301t2764r1433b2830],
40	in	FW	O	in	nn	41	SENT_255	[p14l1480t2767r1551b2829],
41	vivo	FW	O	vivo	conj_and	36	SENT_255	[p14l1594t2767r1770b2830],
42	.	.	O	.	_	0	SENT_255	[p14l1594t2767r1770b2830],

1	Post	NNP	O	Post	nsubj	4	SENT_256	[p14l1822t2767r1980b2830],
2	hoc	FW	O	hoc	dep	1	SENT_256	[p14l2026t2765r2152b2830],
3	analysis	NN	O	analysis	dep	1	SENT_256	[p14l13t2876r297b2961],
4	revealed	VBD	O	reveal	_	0	SENT_256	[p14l343t2876r643b2942],
5	an	DT	O	a	det	6	SENT_256	[p14l688t2899r772b2941],
6	association	NN	O	association	dobj	4	SENT_256	[p14l815t2878r1216b2942],
7	with	IN	O	with	_	0	SENT_256	[p14l1258t2876r1430b2941],
8	an	DT	O	a	det	9	SENT_256	[p14l1474t2899r1558b2941],
9	absence	NN	O	absence	prep_with	4	SENT_256	[p14l1602t2874r1881b2942],
10	of	IN	O	of	_	0	SENT_256	[p14l1926t2874r2004b2942],
11	the	DT	O	the	det	13	SENT_256	[p14l2038t2876r2153b2941],
12	COX-1	NN	MISC	cox-1	nn	13	SENT_256	[p14l13t2985r284b3049],
13	inhibition	NN	O	inhibition	prep_of	9	SENT_256	[p14l330t2981r707b3049],
14	by	IN	O	by	_	0	SENT_256	[p14l743t2981r832b3069],
15	celecoxib	NN	O	celecoxib	prep_by	4	SENT_256	[p14l868t2981r1206b3049],
16	ex	FW	O	ex	nn	15	SENT_256	[p14l1243t3008r1322b3049],
17	vivo	FW	O	vivo	nn	15	SENT_256	[p14l1354t2986r1511b3049],
18	(	FW	O	(	dep	15	SENT_256	[p14l1547t2985r1815b3069],
19	Figure	NN	O	figure	nn	21	SENT_256	[p14l1547t2985r1815b3069],
20	4B	NN	O	4b	nn	21	SENT_256	[p14l1851t2979r1984b3060],
21	)	NN	O	)	dep	15	SENT_256	[p14l1851t2979r1984b3060],
22	and	CC	O	and	_	0	SENT_256	[p14l2020t2983r2152b3049],
23	an	DT	O	a	det	24	SENT_256	[p14l13t3118r96b3159],
24	absence	NN	O	absence	prep_by	4	SENT_256	[p14l146t3092r425b3160],
25	of	IN	O	of	_	0	SENT_256	[p14l475t3092r554b3160],
26	COX-1	NN	O	cox-1	nn	27	SENT_256	[p14l592t3096r863b3160],
27	inhibition	NN	O	inhibition	prep_of	24	SENT_256	[p14l922t3092r1300b3160],
28	in	IN	O	in	_	0	SENT_256	[p14l1350t3097r1422b3159],
29	Vivo	NNP	O	Vivo	prep_in	27	SENT_256	[p14l1469t3097r1625b3160],
30	by	IN	O	by	_	0	SENT_256	[p14l1676t3092r1764b3180],
31	rofecoxib	NN	O	rofecoxib	prep_by	4	SENT_256	[p14l1814t3092r2152b3161],
32	(	CD	NUMBER	(	num	35	SENT_256	[p14l13t3205r282b3289],
33	Figure	NNP	O	Figure	nn	35	SENT_256	[p14l13t3205r282b3289],
34	4C	NN	O	4c	nn	35	SENT_256	[p14l307t3200r460b3281],
35	)	NN	O	)	dep	31	SENT_256	[p14l307t3200r460b3281],
36	.	.	O	.	_	0	SENT_256	[p14l307t3200r460b3281],

1	No	DT	O	no	det	2	SENT_257	[p14l491t3207r607b3271],
2	effects	NNS	O	effect	nsubjpass	8	SENT_257	[p14l635t3202r864b3270],
3	of	IN	O	of	_	0	SENT_257	[p14l891t3202r970b3270],
4	BMI	NN	O	bmus	prep_of	2	SENT_257	[p14l985t3206r1154b3268],
5	or	CC	O	or	_	0	SENT_257	[p14l1182t3227r1256b3270],
6	age	NN	O	age	prep_of	2	SENT_257	[p14l1281t3228r1402b3289],
7	were	VBD	O	be	auxpass	8	SENT_257	[p14l1428t3227r1599b3270],
8	found	VBN	O	find	_	0	SENT_257	[p14l1626t3202r1840b3270],
9	in	IN	O	in	_	0	SENT_257	[p14l1868t3206r1940b3268],
10	these	DT	O	these	det	11	SENT_257	[p14l1967t3204r2152b3270],
11	analyses	NNS	O	analysis	prep_in	8	SENT_257	[p14l13t3313r331b3398],
12	;	:	O	;	_	0	SENT_257	[p14l13t3313r331b3398],
13	males	NNS	O	male	nsubj	14	SENT_257	[p14l377t3313r585b3379],
14	showed	VBD	O	show	parataxis	8	SENT_257	[p14l630t3313r903b3379],
15	greater	JJR	O	greater	amod	16	SENT_257	[p14l946t3332r1207b3399],
16	Tx	NN	O	tx	dobj	14	SENT_257	[p14l1247t3314r1463b3377],
17	.	.	O	.	_	0	SENT_257	[p14l1247t3314r1463b3377],

1	—	NN	O	—	_	0	SENT_258	[p14l1247t3314r1463b3377],
2	.	.	O	.	_	0	SENT_258	[p14l1247t3314r1463b3377],

1	M	NN	O	m	nn	2	SENT_259	[p14l1247t3314r1463b3377],
2	suppression	NN	O	suppression	_	0	SENT_259	[p14l1507t3316r1939b3399],
3	with	IN	O	with	_	0	SENT_259	[p14l1981t3314r2153b3379],
4	both	CC	O	both	preconj	5	SENT_259	[p14l13t3420r183b3488],
5	rofecoxib	NN	O	rofecoxib	prep_with	2	SENT_259	[p14l221t3420r559b3488],
6	and	CC	O	and	_	0	SENT_259	[p14l596t3422r729b3487],
7	celecoxib	NN	O	celecoxib	conj_and	5	SENT_259	[p14l766t3420r1105b3488],
8	than	IN	O	than	_	0	SENT_259	[p14l1143t3423r1308b3487],
9	females	NNS	O	female	prep_than	2	SENT_259	[p14l1344t3420r1617b3487],
10	(	CD	NUMBER	(	num	11	SENT_259	[p14l1656t3424r1732b3499],
11	P	NN	O	p	dep	12	SENT_259	[p14l1656t3424r1732b3499],
12	<	JJR	O	<	dep	2	SENT_259	[p14l1776t3426r1842b3482],
13	.05	CD	NUMBER	.05	num	14	SENT_259	[p14l1890t3424r2050b3499],
14	)	NN	O	)	dep	12	SENT_259	[p14l1890t3424r2050b3499],
15	.	.	O	.	_	0	SENT_259	[p14l1890t3424r2050b3499],

1	C	NN	O	c	nn	2	SENT_260	[p14l25t3660r115b3769],
2	D	NN	O	d	_	0	SENT_260	[p14l1131t3663r1221b3766],

1	LIri	NNS	O	lirus	_	0	SENT_261	[p15l6t32r240b100],
2	.	.	O	.	_	0	SENT_261	[p15l6t32r240b100],

1	nary	DT	O	nary	det	8	SENT_262	[p15l6t32r240b100],
2	prostacyclin	NN	O	prostacyclin	nn	8	SENT_262	[p15l263t29r662b100],
3	n1etabol	NN	O	n1etabol	nn	8	SENT_262	[p15l685t29r1026b84],
4	~	NN	O	~	nn	8	SENT_262	[p15l685t29r1026b84],
5	ite	NN	O	ite	nn	8	SENT_262	[p15l685t29r1026b84],
6	Urinary	NN	O	urinary	nn	8	SENT_262	[p15l1099t29r1331b100],
7	'	''	O	'	_	0	SENT_262	[p15l1350t29r1784b84],
8	thl	NN	O	thl	_	0	SENT_262	[p15l1350t29r1784b84],
9	‘	CD	NUMBER	‘	number	10	SENT_262	[p15l1350t29r1784b84],
10	(	CD	NUMBER	(	dep	8	SENT_262	[p15l1350t29r1784b84],
11	"	``	O	"	punct	10	SENT_262	[p15l1350t29r1784b84],
12	:	:	O	:	_	0	SENT_262	[p15l1350t29r1784b84],
13	II1	NN	O	ii1	dep	10	SENT_262	[p15l1350t29r1784b84],
14	'	''	O	'	_	0	SENT_262	[p15l1350t29r1784b84],
15	lbiEixal	JJ	O	lbieixal	amod	18	SENT_262	[p15l1350t29r1784b84],
16	"	``	O	"	punct	18	SENT_262	[p15l1350t29r1784b84],
17	iE	NN	O	ie	nn	18	SENT_262	[p15l1350t29r1784b84],
18	metabolite	NN	O	metabolite	rcmod	13	SENT_262	[p15l1807t29r2145b84],

1	émean	NN	O	émean	nn	2	SENT_263	[p15l48t222r280b267],
2	variance	NN	O	variance	_	0	SENT_263	[p15l298t222r508b267],
3	whole	JJ	O	whole	amod	4	SENT_263	[p15l523t222r668b267],
4	population	NN	O	population	dep	2	SENT_263	[p15l685t222r939b280],
5	.	.	O	.	_	0	SENT_263	[p15l1160t222r1392b267],

1	—	NN	O	—	_	0	SENT_264	[p15l1160t222r1392b267],
2	.	.	O	.	_	0	SENT_264	[p15l1160t222r1392b267],

1	.	.	O	.	_	0	SENT_265	[p15l1160t222r1392b267],

1	—	NN	O	—	_	0	SENT_266	[p15l1160t222r1392b267],
2	. . .	CD	NUMBER	. . .	num	3	SENT_266	[p15l1160t222r1392b267],[p15l1160t222r1392b267],
3	—	NN	O	—	dep	1	SENT_266	[p15l1160t222r1392b267],
4	.	.	O	.	_	0	SENT_266	[p15l1160t222r1392b267],

1	&	CC	O	&	nsubj	4	SENT_267	[p15l1160t222r1392b267],
2	M.	NNP	O	M.	nn	4	SENT_267	[p15l1160t222r1392b267],
3	ean	NN	O	ean	nn	4	SENT_267	[p15l1160t222r1392b267],
4	tiarianoe	NN	O	tiarianoe	_	0	SENT_267	[p15l1411t222r1620b267],
5	=	JJ	O	=	amod	7	SENT_267	[p15l1411t222r1620b267],
6	whole	JJ	O	whole	amod	7	SENT_267	[p15l1633t222r1778b267],
7	population	NN	O	population	dep	4	SENT_267	[p15l1797t222r2048b277],
8	—	SYM	O	—	dep	4	SENT_267	[p15l48t327r135b337],
9	-	:	O	-	_	0	SENT_267	[p15l48t327r135b337],
10	Mean	NN	O	mean	nn	11	SENT_267	[p15l147t308r280b353],
11	variance	NN	O	variance	dep	12	SENT_267	[p15l299t308r508b353],
12	repeat	NN	O	repeat	parataxis	4	SENT_267	[p15l524t311r681b363],
13	‘	CD	NUMBER	‘	num	12	SENT_267	[p15l697t305r900b363],
14	-5	CD	NUMBER	-5	num	15	SENT_267	[p15l697t305r900b363],
15	UllIljI	NN	O	ulliljus	dep	12	SENT_267	[p15l697t305r900b363],
16	.	.	O	.	_	0	SENT_267	[p15l697t305r900b363],

1	E	NN	O	e	_	0	SENT_268	[p15l697t305r900b363],
2	‘	CD	NUMBER	‘	num	1	SENT_268	[p15l697t305r900b363],
3	C	NN	O	c	dep	1	SENT_268	[p15l697t305r900b363],
4	-:15	CD	NUMBER	-:15	num	5	SENT_268	[p15l697t305r900b363],
5	—	NN	O	—	dobj	3	SENT_268	[p15l1163t305r1392b350],
6	;	:	O	;	_	0	SENT_268	[p15l1163t305r1392b350],
7	lul	NN	O	lul	dep	5	SENT_268	[p15l1163t305r1392b350],
8	‘	SYM	O	‘	dep	5	SENT_268	[p15l1163t305r1392b350],
9	-	:	O	-	_	0	SENT_268	[p15l1163t305r1392b350],
10	earl	NN	O	earl	nn	11	SENT_268	[p15l1163t305r1392b350],
11	trariance	NN	O	trariance	dep	1	SENT_268	[p15l1411t305r1620b350],
12	repeal	NN	O	repeal	nn	13	SENT_268	[p15l1636t308r1791b360],
13	subjects	NNS	O	subject	dep	11	SENT_268	[p15l1807t305r2010b363],
14	.	.	O	.	_	0	SENT_268	[p15l86t391r110b398],

1	-	:	O	-	_	0	SENT_269	[p15l86t391r110b398],
2	.	.	O	.	_	0	SENT_269	[p15l86t391r110b398],

1	1.0	CD	NUMBER	1.0	_	0	SENT_270	[p15l143t378r172b396],
2	.	.	O	.	_	0	SENT_270	[p15l578t390r602b396],

1	.	.	O	.	_	0	SENT_271	[p15l578t390r602b396],

1	1.0	CD	NUMBER	1.0	_	0	SENT_272	[p15l620t378r649b396],
2	2	CD	NUMBER	2	num	3	SENT_272	[p15l1136t377r1148b394],
3	2	CD	NUMBER	2	dep	1	SENT_272	[p15l1676t376r1689b393],

1	ill	RB	O	ill	_	0	SENT_273	[p15l582t397r596b421],

1	Nw	NN	O	nw	dep	104	SENT_274	[p15l86t398r106b471],
2	+	CC	O	+	dep	104	SENT_274	[p15l86t398r106b471],
3	3	CD	NUMBER	3	dep	104	SENT_274	[p15l578t422r598b477],
4	E	NN	O	e	dep	104	SENT_274	[p15l1082t422r1106b456],
5	+	CC	O	+	dep	104	SENT_274	[p15l1633t421r1657b468],
6	t	NN	O	t	dep	104	SENT_274	[p15l51t479r68b524],
7	+	CC	O	+	dep	104	SENT_274	[p15l51t479r68b524],
8	5	CD	NUMBER	5	dep	104	SENT_274	[p15l86t470r110b506],
9	*	CD	NUMBER	*	dep	104	SENT_274	[p15l86t470r110b506],
10	§	NN	O	§	dep	104	SENT_274	[p15l542t479r560b521],
11	5	CD	NUMBER	5	dep	104	SENT_274	[p15l578t478r602b505],
12	§	NN	O	§	dep	104	SENT_274	[p15l1046t478r1063b521],
13	4	CD	PERCENT	4	dep	104	SENT_274	[p15l1083t457r1107b512],
14	%	NN	PERCENT	%	dep	104	SENT_274	[p15l1083t457r1107b512],
15	at	IN	O	at	dep	104	SENT_274	[p15l1597t476r1615b521],
16	P	NN	O	p	dep	104	SENT_274	[p15l1633t469r1658b512],
17	+	CC	O	+	dep	104	SENT_274	[p15l1633t469r1658b512],
18	+	CC	O	+	dep	104	SENT_274	[p15l1633t469r1658b512],
19	g	NN	O	g	dep	104	SENT_274	[p15l47t512r172b554],
20	§	CD	NUMBER	§	dep	104	SENT_274	[p15l47t512r172b554],
21	o.	NN	O	o.	dep	104	SENT_274	[p15l47t512r172b554],
22	5	CD	NUMBER	5	dep	104	SENT_274	[p15l47t512r172b554],
23	__	NN	O	__	dep	104	SENT_274	[p15l538t510r650b553],
24	:	:	O	:	_	0	SENT_274	[p15l538t510r650b553],
25	g	NN	O	g	dep	104	SENT_274	[p15l538t510r650b553],
26	§	CD	NUMBER	§	dep	104	SENT_274	[p15l538t510r650b553],
27	o5	NN	O	o5	dep	104	SENT_274	[p15l538t510r650b553],
28	E	NN	O	e	dep	104	SENT_274	[p15l1046t519r1147b566],
29	§	CD	NUMBER	§	dep	104	SENT_274	[p15l1046t519r1147b566],
30	1	CD	NUMBER	1	dep	104	SENT_274	[p15l1046t519r1147b566],
31	_	CD	NUMBER	_	dep	104	SENT_274	[p15l1592t518r1687b566],
32	g	NN	O	g	dep	104	SENT_274	[p15l1592t518r1687b566],
33	§	NN	O	§	dep	104	SENT_274	[p15l1592t518r1687b566],
34	1	CD	NUMBER	1	dep	104	SENT_274	[p15l1592t518r1687b566],
35	to	TO	O	to	dep	104	SENT_274	[p15l51t555r69b571],
36	g	NN	O	g	dep	104	SENT_274	[p15l86t551r106b587],
37	in	IN	O	in	dep	104	SENT_274	[p15l543t554r560b569],
38	'	''	DATE	'	_	0	SENT_274	[p15l578t549r598b575],
39	2	CD	DATE	2	dep	104	SENT_274	[p15l578t549r598b575],
40	to	TO	O	to	dep	104	SENT_274	[p15l1046t554r1063b569],
41	V	NNP	O	V	dep	104	SENT_274	[p15l1083t582r1107b588],
42	g	NN	O	g	dep	104	SENT_274	[p15l1597t553r1615b583],
43	E	NN	O	e	dep	104	SENT_274	[p15l1634t567r1657b587],
44	j	NN	O	j	dep	104	SENT_274	[p15l1879t574r1968b580],
45	1	CD	NUMBER	1	dep	104	SENT_274	[p15l51t570r110b656],
46	,	,	O	,	_	0	SENT_274	[p15l51t570r110b656],
47	as	IN	O	as	dep	104	SENT_274	[p15l293t539r491b647],
48	/	:	O	/	dep	104	SENT_274	[p15l543t570r602b655],
49	+	CC	O	+	dep	104	SENT_274	[p15l543t570r602b655],
50	at	IN	O	at	dep	104	SENT_274	[p15l1046t567r1107b634],
51	§	CD	NUMBER	§	dep	104	SENT_274	[p15l1634t594r1657b634],
52	'	''	O	'	_	0	SENT_274	[p15l1634t594r1657b634],
53	"	``	O	"	dep	104	SENT_274	[p15l86t656r106b668],
54	o.o	JJ	O	o.o	dep	104	SENT_274	[p15l143t665r173b682],
55	"	''	O	"	dep	104	SENT_274	[p15l578t654r598b668],
56	o.o	NN	O	o.o	dep	104	SENT_274	[p15l620t664r650b682],
57	o	NN	O	o	dep	104	SENT_274	[p15l1138t663r1150b680],
58	o	NN	O	o	dep	104	SENT_274	[p15l1678t662r1690b680],
59	subject	JJ	O	subject	dep	104	SENT_274	[p15l104t698r185b722],
60	ABCDE	NNP	O	ABCDE	dep	104	SENT_274	[p15l200t698r281b719],
61	ABCDE	NNP	O	ABCDE	dep	104	SENT_274	[p15l296t698r378b718],
62	ABCDE	NNP	O	ABCDE	dep	104	SENT_274	[p15l390t698r473b718],
63	subject	NN	O	subject	dep	104	SENT_274	[p15l591t698r671b722],
64	:	:	O	:	_	0	SENT_274	[p15l591t698r671b722],
65	ABCDE	NNP	O	ABCDE	dep	104	SENT_274	[p15l684t698r767b718],
66	AECDE	NNP	O	AECDE	dep	104	SENT_274	[p15l780t698r863b718],
67	ABCDE	NNP	O	ABCDE	dep	104	SENT_274	[p15l875t698r959b718],
68	subject	NN	O	subject	dep	104	SENT_274	[p15l1091t698r1171b721],
69	:	:	O	:	_	0	SENT_274	[p15l1091t698r1171b721],
70	A	DT	O	a	dep	104	SENT_274	[p15l1190t698r1207b716],
71	B	NN	O	b	dep	104	SENT_274	[p15l1216t698r1230b716],
72	C	NN	O	c	dep	104	SENT_274	[p15l1240t698r1256b716],
73	D	NN	O	d	dep	104	SENT_274	[p15l1265t698r1280b716],
74	E	NN	O	e	dep	104	SENT_274	[p15l1289t698r1303b716],
75	A	NN	O	a	dep	104	SENT_274	[p15l1335t698r1351b716],
76	B	NN	O	b	dep	104	SENT_274	[p15l1360t697r1375b716],
77	C	NN	O	c	dep	104	SENT_274	[p15l1384t698r1400b716],
78	D	NN	O	d	dep	104	SENT_274	[p15l1408t698r1423b716],
79	E	NN	O	e	dep	104	SENT_274	[p15l1432t697r1447b716],
80	subject	NN	O	subject	dep	104	SENT_274	[p15l1628t695r1710b719],
81	:	:	O	:	_	0	SENT_274	[p15l1628t695r1710b719],
82	A	DT	O	a	dep	104	SENT_274	[p15l1730t695r1747b713],
83	B	NN	O	b	dep	104	SENT_274	[p15l1756t695r1770b714],
84	C	NN	O	c	dep	104	SENT_274	[p15l1780t695r1795b715],
85	D	NN	O	d	dep	104	SENT_274	[p15l1804t695r1819b713],
86	E	NN	O	e	dep	104	SENT_274	[p15l1828t695r1842b714],
87	A	NN	O	a	dep	104	SENT_274	[p15l1873t695r1891b713],
88	B	NN	O	b	dep	104	SENT_274	[p15l1900t695r1914b713],
89	C	NN	O	c	dep	104	SENT_274	[p15l1922t695r1939b714],
90	D	NN	O	d	dep	104	SENT_274	[p15l1946t695r1962b713],
91	E	NN	O	e	dep	104	SENT_274	[p15l1970t695r1984b713],
92	placebo	NN	O	placebo	dep	104	SENT_274	[p15l176t743r266b769],
93	rofecoxib	NN	O	rofecoxib	dep	104	SENT_274	[p15l281t743r386b763],
94	celecoxib	NN	O	celecoxib	dep	104	SENT_274	[p15l399t743r506b763],
95	placebo	NN	O	placebo	dep	104	SENT_274	[p15l662t742r751b768],
96	rofeooxlb	NN	O	rofeooxlb	dep	104	SENT_274	[p15l765t741r871b763],
97	celecoxib	NN	O	celecoxib	dep	104	SENT_274	[p15l884t741r992b763],
98	rofeooxib	NN	O	rofeooxib	dep	104	SENT_274	[p15l1187t743r1291b765],
99	cele	NN	O	cele	dep	104	SENT_274	[p15l1333t743r1380b763],
100	‘	NN	O	‘	dep	104	SENT_274	[p15l1422t743r1441b763],
101	b	NN	O	b	dep	104	SENT_274	[p15l1422t743r1441b763],
102	rofefsoxib	NN	O	rofefsoxib	dep	104	SENT_274	[p15l1726t740r1831b786],
103	oe	NN	O	oe	dep	104	SENT_274	[p15l1873t744r1899b761],
104	xib	NN	O	xib	_	0	SENT_274	[p15l1946t740r1979b760],

1	VS	NNP	O	VS	nn	2	SENT_275	[p15l1226t773r1252b789],
2	V	NNP	O	V	_	0	SENT_275	[p15l1373t773r1387b789],
3	placebo	NN	O	placebo	nn	6	SENT_275	[p15l1195t799r1285b825],
4	placebo	NN	O	placebo	nn	6	SENT_275	[p15l1343t799r1432b825],
5	placebo	NN	O	placebo	nn	6	SENT_275	[p15l1735t796r1824b822],
6	placebo	NN	O	placebo	dep	2	SENT_275	[p15l1882t796r1971b822],

1	Figure	NNP	O	Figure	_	0	SENT_276	[p15l45t868r135b898],
2	3	CD	NUMBER	3	dep	1	SENT_276	[p15l146t868r174b892],
3	.	.	O	.	_	0	SENT_276	[p15l146t868r174b892],

1	Comparison	NN	O	comparison	_	0	SENT_277	[p15l194t868r364b898],
2	of	IN	O	of	_	0	SENT_277	[p15l378t868r406b892],
3	the	DT	O	the	det	5	SENT_277	[p15l415t868r461b892],
4	intraindividual	JJ	O	intraindividual	amod	5	SENT_277	[p15l475t868r672b892],
5	variability	NN	O	variability	prep_of	1	SENT_277	[p15l685t868r821b898],
6	with	IN	O	with	_	0	SENT_277	[p15l831t868r888b892],
7	total	JJ	O	total	amod	8	SENT_277	[p15l900t868r963b892],
8	variability	NN	O	variability	prep_with	5	SENT_277	[p15l976t868r1112b898],
9	in	IN	O	in	_	0	SENT_277	[p15l1125t868r1146b892],
10	the	DT	O	the	det	12	SENT_277	[p15l1159t868r1204b892],
11	study	NN	O	study	nn	12	SENT_277	[p15l1217t868r1294b898],
12	population	NN	O	population	prep_in	1	SENT_277	[p15l1307t868r1464b898],
13	.	.	O	.	_	0	SENT_277	[p15l1307t868r1464b898],

1	Variances	NNS	O	variance	nsubj	3	SENT_278	[p15l1477t868r1618b892],
2	of	IN	O	of	prep	1	SENT_278	[p15l1631t868r1659b892],
3	replicate	VBP	O	replicate	_	0	SENT_278	[p15l1671t868r1793b898],
4	measurements	NNS	O	measurement	nsubj	11	SENT_278	[p15l1806t870r2022b892],
5	of	IN	O	of	_	0	SENT_278	[p15l2035t868r2063b892],
6	the	DT	O	the	det	10	SENT_278	[p15l2072t868r2117b892],
7	4	CD	NUMBER	4	num	10	SENT_278	[p15l44t909r62b933],
8	primary	JJ	O	primary	amod	10	SENT_278	[p15l73t909r178b939],
9	drug	NN	O	drug	nn	10	SENT_278	[p15l187t909r249b939],
10	responses	NNS	O	response	prep_of	4	SENT_278	[p15l260t915r409b938],
11	(	VBP	O	(	ccomp	3	SENT_278	[p15l420t909r494b938],
12	A	NN	O	a	dobj	11	SENT_278	[p15l420t909r494b938],
13	.	.	O	.	_	0	SENT_278	[p15l420t909r494b938],

1	—	NN	O	—	_	0	SENT_279	[p15l420t909r494b938],
2	.	.	O	.	_	0	SENT_279	[p15l420t909r494b938],

1	D	NN	O	d	nn	2	SENT_280	[p15l420t909r494b938],
2	)	NN	O	)	nsubjpass	4	SENT_280	[p15l420t909r494b938],
3	are	VBP	O	be	auxpass	4	SENT_280	[p15l506t915r550b933],
4	plotted	VBN	O	plot	_	0	SENT_280	[p15l561t909r658b938],
5	for	IN	O	for	_	0	SENT_280	[p15l669t909r708b933],
6	each	DT	O	each	det	7	SENT_280	[p15l717t909r784b933],
7	subject	NN	O	subject	prep_for	4	SENT_280	[p15l795t909r899b939],
8	and	CC	O	and	_	0	SENT_280	[p15l909t909r960b933],
9	treatment	NN	O	treatment	prep_for	4	SENT_280	[p15l970t911r1112b933],
10	(	CD	NUMBER	(	num	12	SENT_280	[p15l1121t909r1239b939],
11	colored	VBN	O	color	amod	12	SENT_280	[p15l1121t909r1239b939],
12	dots	NNS	O	dot	dobj	4	SENT_280	[p15l1247t909r1309b933],
13	connected	VBN	O	connect	partmod	12	SENT_280	[p15l1318t909r1466b933],
14	by	IN	O	by	_	0	SENT_280	[p15l1478t909r1508b939],
15	grey	NN	O	grey	nn	17	SENT_280	[p15l1516t913r1579b939],
16	lines	NNS	O	line	nn	17	SENT_280	[p15l1587t909r1671b938],
17	)	NN	O	)	agent	13	SENT_280	[p15l1587t909r1671b938],
18	.	.	O	.	_	0	SENT_280	[p15l1587t909r1671b938],

1	Green	NNP	O	Green	nn	3	SENT_281	[p15l1685t909r1769b933],
2	horizontal	JJ	O	horizontal	amod	3	SENT_281	[p15l1779t909r1920b933],
3	lines	NNS	O	line	nsubj	4	SENT_281	[p15l1929t909r1996b933],
4	indicate	VBP	O	indicate	_	0	SENT_281	[p15l2006t909r2117b933],
5	the	DT	O	the	det	7	SENT_281	[p15l43t950r88b974],
6	average	JJ	O	average	amod	7	SENT_281	[p15l109t953r220b980],
7	variances	NNS	O	variance	nsubj	9	SENT_281	[p15l239t950r377b974],
8	of	IN	O	of	prep	7	SENT_281	[p15l397t950r425b974],
9	replicate	VBP	O	replicate	ccomp	4	SENT_281	[p15l444t950r566b979],
10	measurements	NNS	O	measurement	dobj	9	SENT_281	[p15l587t951r802b974],
11	(	JJ	O	(	amod	14	SENT_281	[p15l823t950r1031b980],
12	intraindividual	JJ	O	intraindividual	amod	14	SENT_281	[p15l823t950r1031b980],
13	variability	NN	O	variability	nn	14	SENT_281	[p15l1051t950r1205b980],
14	)	NN	O	)	dep	10	SENT_281	[p15l1051t950r1205b980],
15	.	.	O	.	_	0	SENT_281	[p15l1051t950r1205b980],

1	Blue	NNP	O	Blue	nn	3	SENT_282	[p15l1228t950r1290b974],
2	horizontal	JJ	O	horizontal	amod	3	SENT_282	[p15l1310t950r1451b974],
3	lines	NNS	O	line	nsubj	4	SENT_282	[p15l1470t950r1537b974],
4	represent	VBP	O	represent	_	0	SENT_282	[p15l1556t951r1694b979],
5	the	DT	O	the	det	7	SENT_282	[p15l1711t950r1757b974],
6	derived	VBN	O	derive	amod	7	SENT_282	[p15l1777t950r1879b974],
7	variance	NN	O	variance	dobj	4	SENT_282	[p15l1899t950r2019b974],
8	of	IN	O	of	_	0	SENT_282	[p15l2040t950r2068b974],
9	all	DT	O	all	det	10	SENT_282	[p15l2086t950r2116b974],
10	measurements	NNS	O	measurement	prep_of	7	SENT_282	[p15l45t993r260b1015],
11	within	IN	O	within	_	0	SENT_282	[p15l271t991r353b1015],
12	the	DT	O	the	det	14	SENT_282	[p15l365t991r410b1015],
13	whole	JJ	O	whole	amod	14	SENT_282	[p15l421t991r503b1015],
14	population	NN	O	population	prep_within	10	SENT_282	[p15l516t991r665b1021],
15	(	CD	NUMBER	(	num	18	SENT_282	[p15l677t991r749b1021],
16	total	JJ	O	total	amod	18	SENT_282	[p15l677t991r749b1021],
17	variability	NN	O	variability	nn	18	SENT_282	[p15l761t991r914b1021],
18	)	NN	O	)	dep	14	SENT_282	[p15l761t991r914b1021],
19	.	.	O	.	_	0	SENT_282	[p15l761t991r914b1021],

1	The	DT	O	the	det	2	SENT_283	[p15l926t991r977b1015],
2	variances	NNS	O	variance	nsubj	4	SENT_283	[p15l988t991r1125b1015],
3	of	IN	O	of	prep	2	SENT_283	[p15l1137t991r1165b1015],
4	replicate	VBP	O	replicate	dep	11	SENT_283	[p15l1175t991r1297b1021],
5	measurements	NNS	O	measurement	dobj	4	SENT_283	[p15l1309t993r1525b1015],
6	(	JJ	O	(	amod	9	SENT_283	[p15l1537t991r1745b1021],
7	intraindividual	JJ	O	intraindividual	amod	9	SENT_283	[p15l1537t991r1745b1021],
8	variability	NN	O	variability	nn	9	SENT_283	[p15l1757t991r1901b1021],
9	)	NN	O	)	dep	5	SENT_283	[p15l1757t991r1901b1021],
10	are	VBP	O	be	cop	11	SENT_283	[p15l1914t997r1957b1015],
11	lower	JJR	O	lower	_	0	SENT_283	[p15l1970t991r2045b1015],
12	than	IN	O	than	_	0	SENT_283	[p15l2054t991r2117b1015],
13	the	DT	O	the	det	14	SENT_283	[p15l43t1032r88b1056],
14	variances	NNS	O	variance	prep_than	11	SENT_283	[p15l102t1032r239b1056],
15	of	IN	O	of	_	0	SENT_283	[p15l253t1032r281b1056],
16	the	DT	O	the	det	22	SENT_283	[p15l292t1032r337b1056],
17	whole	JJ	O	whole	amod	22	SENT_283	[p15l351t1032r433b1056],
18	population	NN	O	population	nn	22	SENT_283	[p15l449t1032r597b1061],
19	(	CD	NUMBER	(	num	22	SENT_283	[p15l613t1032r684b1061],
20	total	JJ	O	total	amod	22	SENT_283	[p15l613t1032r684b1061],
21	variability	NN	O	variability	nn	22	SENT_283	[p15l699t1032r843b1062],
22	)	NN	O	)	prep_of	14	SENT_283	[p15l699t1032r843b1062],
23	for	IN	O	for	_	0	SENT_283	[p15l857t1032r896b1056],
24	the	DT	O	the	det	27	SENT_283	[p15l907t1032r953b1056],
25	drug	NN	O	drug	nn	27	SENT_283	[p15l967t1032r1030b1062],
26	responses	NNS	O	response	nn	27	SENT_283	[p15l1043t1038r1193b1061],
27	COX-2	NN	MISC	cox-2	prep_for	22	SENT_283	[p15l1207t1032r1292b1056],
28	inhibition	NN	O	inhibition	dep	27	SENT_283	[p15l1308t1032r1437b1056],
29	ex	FW	O	ex	nn	28	SENT_283	[p15l1452t1038r1483b1056],
30	vivo	FW	O	vivo	nn	28	SENT_283	[p15l1495t1032r1549b1056],
31	(	FW	O	(	dep	28	SENT_283	[p15l1564t1032r1609b1061],
32	A	DT	O	a	det	33	SENT_283	[p15l1564t1032r1609b1061],
33	)	NN	O	)	nsubj	11	SENT_283	[p15l1564t1032r1609b1061],
34	,	,	O	,	_	0	SENT_283	[p15l1564t1032r1609b1061],
35	depression	NN	O	depression	appos	33	SENT_283	[p15l1624t1032r1783b1061],
36	of	IN	O	of	_	0	SENT_283	[p15l1798t1032r1826b1056],
37	urinary	JJ	O	urinary	amod	40	SENT_283	[p15l1839t1032r1934b1062],
38	prostacyclin	NN	O	prostacyclin	nn	40	SENT_283	[p15l1948t1032r2117b1062],
39	metabolite	NN	O	metabolite	nn	40	SENT_283	[p15l45t1073r196b1097],
40	excretion	NN	O	excretion	prep_of	35	SENT_283	[p15l206t1073r335b1097],
41	as	IN	O	as	_	0	SENT_283	[p15l346t1078r379b1097],
42	a	DT	O	a	det	43	SENT_283	[p15l389t1078r404b1097],
43	marker	NN	O	marker	prep_as	40	SENT_283	[p15l415t1073r515b1097],
44	of	IN	O	of	_	0	SENT_283	[p15l523t1073r551b1097],
45	COX-2	NN	O	cox-2	nn	46	SENT_283	[p15l559t1073r644b1097],
46	inhibition	NN	O	inhibition	prep_of	43	SENT_283	[p15l655t1073r784b1097],
47	in	FW	O	in	prep	46	SENT_283	[p15l796t1073r817b1096],
48	vivo	FW	O	vivo	nn	51	SENT_283	[p15l827t1073r881b1097],
49	(	FW	O	(	nn	51	SENT_283	[p15l891t1073r938b1102],
50	C	NN	O	c	nn	51	SENT_283	[p15l891t1073r938b1102],
51	)	NN	O	)	pobj	47	SENT_283	[p15l891t1073r938b1102],
52	,	,	O	,	_	0	SENT_283	[p15l891t1073r938b1102],
53	and	CC	O	and	_	0	SENT_283	[p15l950t1073r1000b1097],
54	depression	NN	O	depression	pobj	47	SENT_283	[p15l1011t1073r1169b1102],
55	of	IN	O	of	_	0	SENT_283	[p15l1180t1073r1208b1097],
56	urinarythromboxane	NN	O	urinarythromboxane	nn	58	SENT_283	[p15l1216t1073r1507b1102],
57	metabolite	NN	O	metabolite	nn	58	SENT_283	[p15l1518t1073r1669b1097],
58	excretion	NN	O	excretion	prep_of	54	SENT_283	[p15l1679t1073r1808b1097],
59	as	IN	O	as	_	0	SENT_283	[p15l1819t1078r1852b1097],
60	a	DT	O	a	det	61	SENT_283	[p15l1862t1079r1877b1097],
61	marker	NN	O	marker	prep_as	58	SENT_283	[p15l1888t1073r1988b1097],
62	of	IN	O	of	_	0	SENT_283	[p15l1996t1073r2024b1097],
63	COX-1	NN	O	cox-1	nn	64	SENT_283	[p15l2032t1073r2117b1097],
64	inhibition	NN	O	inhibition	prep_of	61	SENT_283	[p15l45t1114r173b1138],
65	in	FW	O	in	prep	64	SENT_283	[p15l189t1114r210b1138],
66	vivo	FW	O	vivo	nn	68	SENT_283	[p15l224t1114r278b1138],
67	(	FW	O	(	nn	68	SENT_283	[p15l291t1114r339b1143],
68	D	NN	O	d	pobj	65	SENT_283	[p15l291t1114r339b1143],
69	)	NN	O	)	dep	68	SENT_283	[p15l291t1114r339b1143],
70	.	.	O	.	_	0	SENT_283	[p15l291t1114r339b1143],

1	January	NNP	DATE	January	_	0	SENT_284	[p15l6t1291r223b1347],
2	2006	CD	DATE	2006	dep	1	SENT_284	[p15l247t1291r396b1336],

1	Figure	NNP	O	Figure	_	0	SENT_285	[p15l10t1510r187b1568],
2	4	CD	NUMBER	4	dep	1	SENT_285	[p15l219t1511r273b1556],
3	.	.	O	.	_	0	SENT_285	[p15l219t1511r273b1556],

1	Association	NNP	O	Association	_	0	SENT_286	[p15l311t1511r624b1557],
2	of	IN	O	of	_	0	SENT_286	[p15l659t1510r712b1557],
3	polymorphisms	NNS	O	polymorphism	dep	5	SENT_286	[p15l743t1511r1153b1568],
4	`	``	O	`	_	0	SENT_286	[p15l1256t1495r1345b1592],
5	q	VBP	O	q	prep_of	1	SENT_286	[p15l1256t1495r1345b1592],
6	+	CC	O	+	_	0	SENT_286	[p15l1256t1495r1345b1592],
7	celecoxib	VBP	O	celecoxib	conj_+	5	SENT_286	[p15l1660t1524r2002b1590],
8	}	RB	O	}	advmod	18	SENT_286	[p15l1660t1524r2002b1590],
9	in	IN	O	in	_	0	SENT_286	[p15l11t1593r52b1639],
10	CYP2C9	NN	O	cyp2c9	prep_in	8	SENT_286	[p15l85t1592r307b1639],
11	and	CC	O	and	_	0	SENT_286	[p15l339t1593r436b1639],
12	COX-1	NN	O	cox-1	conj_and	10	SENT_286	[p15l469t1592r632b1639],
13	with	IN	O	with	_	0	SENT_286	[p15l661t1593r768b1639],
14	plasma	NN	O	plasma	nn	16	SENT_286	[p15l803t1593r999b1649],
15	ce	NN	O	ce	nn	16	SENT_286	[p15l1031t1593r1156b1639],
16	|	NN	O	|	prep_with	10	SENT_286	[p15l1031t1593r1156b1639],
17	e	SYM	O	e	dep	10	SENT_286	[p15l1031t1593r1156b1639],
18	—	FW	O	—	dobj	7	SENT_286	[p15l1031t1593r1156b1639],
19	'	''	O	'	_	0	SENT_286	[p15l1253t1587r1255b1589],
20	at	IN	O	at	_	0	SENT_286	[p15l1778t1657r1805b1666],
21	%	NN	O	%	nn	22	SENT_286	[p15l1901t1658r1902b1663],
22	coxib	NN	O	coxib	prep_at	18	SENT_286	[p15l9t1675r146b1721],
23	4	CD	DURATION	4	num	24	SENT_286	[p15l173t1675r209b1720],
24	hours	NNS	NUMBER	hour	tmod	18	SENT_286	[p15l238t1675r387b1721],
25	postdosing	VBG	O	postdose	xcomp	7	SENT_286	[p15l417t1675r716b1733],
26	(	CD	NUMBER	(	dobj	25	SENT_286	[p15l742t1675r825b1731],
27	A	DT	O	a	det	28	SENT_286	[p15l742t1675r825b1731],
28	)	NN	O	)	dep	26	SENT_286	[p15l742t1675r825b1731],
29	,	,	O	,	_	0	SENT_286	[p15l742t1675r825b1731],
30	COX-1	NN	O	cox-1	nn	31	SENT_286	[p15l856t1674r1019b1721],
31	inhi	NN	O	inhus	appos	26	SENT_286	[p15l1049t1675r1156b1720],
32	-	:	O	-	_	0	SENT_286	[p15l1049t1675r1156b1720],
33	$	$	MONEY	$	dep	31	SENT_286	[p15l1639t1648r2050b1740],
34	[	CD	MONEY	[	number	33	SENT_286	[p15l1639t1648r2050b1740],
35	+	CC	O	+	cc	33	SENT_286	[p15l1639t1648r2050b1740],

1	-	:	O	-	_	0	SENT_287	[p15l1412t1725r1434b1764],
2	F	NN	O	f	_	0	SENT_287	[p15l1412t1725r1434b1764],
3	3	CD	NUMBER	3	num	5	SENT_287	[p15l1436t1728r1461b1764],
4	GI	NN	O	gi	nn	5	SENT_287	[p15l1462t1728r1483b1764],
5	D	NN	O	d	dep	2	SENT_287	[p15l1486t1728r1510b1764],

1	bition	NN	O	bition	_	0	SENT_288	[p15l10t1757r155b1803],
2	ex	FW	O	ex	nn	3	SENT_288	[p15l177t1767r237b1803],
3	vivo	FW	O	vivo	dep	1	SENT_288	[p15l254t1757r356b1803],
4	by	IN	O	by	_	0	SENT_288	[p15l378t1757r436b1814],
5	celecoxib	NN	O	celecoxib	nn	8	SENT_288	[p15l453t1757r704b1803],
6	(	NN	O	(	nn	8	SENT_288	[p15l725t1757r812b1814],
7	B	NN	O	b	nn	8	SENT_288	[p15l725t1757r812b1814],
8	)	NN	O	)	prep_by	3	SENT_288	[p15l725t1757r812b1814],
9	,	,	O	,	_	0	SENT_288	[p15l725t1757r812b1814],
10	and	CC	O	and	_	0	SENT_288	[p15l837t1757r933b1803],
11	depression	NN	O	depression	dep	1	SENT_288	[p15l955t1757r1156b1813, p15l9t1839r119b1885],
12	of	IN	O	of	_	0	SENT_288	[p15l212t1838r266b1885],
13	the	DT	O	the	det	16	SENT_288	[p15l350t1839r437b1885],
14	urinary	JJ	O	urinary	amod	16	SENT_288	[p15l530t1839r710b1896],
15	thromboxane	NN	O	thromboxane	nn	16	SENT_288	[p15l796t1839r1153b1885],
16	metabolite	NN	O	metabolite	prep_of	11	SENT_288	[p15l11t1921r296b1967],
17	by	IN	O	by	_	0	SENT_288	[p15l324t1921r383b1978],
18	rofecoxib	NN	O	rofecoxib	nn	21	SENT_288	[p15l408t1920r650b1967],
19	(	NN	O	(	nn	21	SENT_288	[p15l677t1920r764b1977],
20	C	NN	O	c	nn	21	SENT_288	[p15l677t1920r764b1977],
21	)	NN	O	)	prep_by	16	SENT_288	[p15l677t1920r764b1977],
22	.	.	O	.	_	0	SENT_288	[p15l677t1920r764b1977],

1	(	NN	O	(	dep	5	SENT_289	[p15l794t1921r862b1977],
2	A	NN	O	a	dep	1	SENT_289	[p15l794t1921r862b1977],
3	)	CD	NUMBER	)	dep	5	SENT_289	[p15l794t1921r862b1977],
4	Eight	CD	NUMBER	eight	num	5	SENT_289	[p15l891t1921r1023b1979],
5	indi	NN	O	indus	dep	18	SENT_289	[p15l1049t1921r1156b1967],
6	—	NN	O	—	nn	7	SENT_289	[p15l1049t1921r1156b1967],
7	E	NN	O	e	dep	5	SENT_289	[p15l1356t1920r1415b1995],
8	5	CD	NUMBER	5	num	10	SENT_289	[p15l1436t1897r1535b1935],
9	””	NN	O	””	nn	10	SENT_289	[p15l1436t1897r1535b1935],
10	viduals	NNS	O	vidual	nsubj	18	SENT_289	[p15l7t2003r213b2057],
11	,	,	O	,	_	0	SENT_289	[p15l7t2003r213b2057],
12	heterozygous	JJ	O	heterozygous	amod	10	SENT_289	[p15l241t2003r597b2061],
13	for	IN	O	for	_	0	SENT_289	[p15l619t2002r693b2049],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_289	[p15l714t2002r1028b2057],
15	*	NN	O	*	prep_for	12	SENT_289	[p15l714t2002r1028b2057],
16	2	CD	NUMBER	2	num	15	SENT_289	[p15l714t2002r1028b2057],
17	,	,	O	,	_	0	SENT_289	[p15l714t2002r1028b2057],
18	had	VBD	O	have	_	0	SENT_289	[p15l1056t2003r1152b2049],
19	n	NN	O	n	dobj	18	SENT_289	[p15l1356t1996r1413b2077],
20	+	CC	O	+	_	0	SENT_289	[p15l1356t1996r1413b2077],
21	higher	JJR	O	higher	amod	23	SENT_289	[p15l11t2085r176b2143],
22	plasma	NN	O	plasma	nn	23	SENT_289	[p15l196t2085r392b2141],
23	concentrations	NNS	O	concentration	conj_+	19	SENT_289	[p15l412t2085r814b2131],
24	of	IN	O	of	_	0	SENT_289	[p15l835t2084r888b2131],
25	celecoxib	NN	O	celecoxib	prep_of	23	SENT_289	[p15l904t2085r1154b2131],
26	than	IN	O	than	_	0	SENT_289	[p15l7t2167r126b2213],
27	those	DT	O	those	prep_than	18	SENT_289	[p15l150t2167r304b2213],
28	without	IN	O	without	_	0	SENT_289	[p15l327t2167r526b2213],
29	this	DT	O	this	det	30	SENT_289	[p15l547t2167r646b2213],
30	variant	NN	O	variant	prep_without	27	SENT_289	[p15l670t2167r868b2213],
31	.	.	O	.	_	0	SENT_289	[p15l670t2167r868b2213],

1	(	NN	O	(	nn	2	SENT_290	[p15l897t2167r955b2223],
2	B	NN	O	b	nsubjpass	12	SENT_290	[p15l897t2167r955b2223],
3	and	CC	O	and	_	0	SENT_290	[p15l976t2167r1072b2213],
4	C	NN	O	c	nsubjpass	12	SENT_290	[p15l1103t2166r1153b2223],
5	)	CD	NUMBER	)	num	4	SENT_290	[p15l1103t2166r1153b2223],
6	The	DT	O	the	det	8	SENT_290	[p15l7t2249r105b2295],
7	Pro17Leu	NN	O	pro17leu	nn	8	SENT_290	[p15l131t2248r389b2295],
8	variant	NN	O	variant	dep	4	SENT_290	[p15l413t2249r598b2295],
9	of	IN	O	of	_	0	SENT_290	[p15l620t2248r673b2295],
10	COX-1	NN	O	cox-1	prep_of	8	SENT_290	[p15l693t2248r856b2295],
11	was	VBD	O	be	auxpass	12	SENT_290	[p15l878t2259r986b2295],
12	associated	VBN	O	associate	_	0	SENT_290	[p15l1011t2259r1156b2295, p15l9t2331r170b2377],
13	with	IN	O	with	_	0	SENT_290	[p15l193t2331r300b2377],
14	a	DT	O	a	det	15	SENT_290	[p15l327t2341r356b2377],
15	reduction	NN	O	reduction	prep_with	12	SENT_290	[p15l381t2331r629b2377],
16	in	IN	O	in	_	0	SENT_290	[p15l656t2331r698b2377],
17	COX-1	NN	O	cox-1	nn	18	SENT_290	[p15l723t2330r886b2377],
18	inhibition	NN	O	inhibition	prep_in	15	SENT_290	[p15l911t2331r1152b2377],
19	.	.	O	.	_	0	SENT_290	[p15l1735t2368r1737b2378],

1	both	DT	O	both	dep	4	SENT_291	[p15l10t2413r126b2459],
2	ex	FW	O	ex	nn	4	SENT_291	[p15l151t2424r212b2459],
3	vivo	FW	O	vivo	nn	4	SENT_291	[p15l232t2413r334b2459],
4	(	FW	O	(	nsubj	11	SENT_291	[p15l359t2413r430b2469],
5	B	NN	O	b	nn	6	SENT_291	[p15l359t2413r430b2469],
6	)	NN	O	)	dep	4	SENT_291	[p15l359t2413r430b2469],
7	and	CC	O	and	_	0	SENT_291	[p15l455t2413r552b2459],
8	in	FW	O	in	dep	4	SENT_291	[p15l580t2413r621b2458],
9	vivo	FW	O	vivo	nn	10	SENT_291	[p15l644t2413r747b2459],
10	(	FW	O	(	pobj	8	SENT_291	[p15l772t2412r859b2469],
11	C	NN	O	c	_	0	SENT_291	[p15l772t2412r859b2469],
12	)	NN	O	)	dobj	11	SENT_291	[p15l772t2412r859b2469],
13	.	.	O	.	_	0	SENT_291	[p15l772t2412r859b2469],

1	C	NNP	O	C	poss	5	SENT_292	[p15l1695t2429r1970b2476],
2	'	POS	O	'	_	0	SENT_292	[p15l1695t2429r1970b2476],
3	j	NN	O	j	nn	5	SENT_292	[p15l1695t2429r1970b2476],
4	«	CD	NUMBER	«	num	5	SENT_292	[p15l1695t2429r1970b2476],
5	_	NN	O	_	_	0	SENT_292	[p15l1695t2429r1970b2476],
6	{	CD	NUMBER	{	num	8	SENT_292	[p15l1695t2429r1970b2476],
7	P2	NN	O	p2	nn	8	SENT_292	[p15l1695t2429r1970b2476],
8	[	NN	O	[	dep	5	SENT_292	[p15l1695t2429r1970b2476],
9	;	:	O	;	_	0	SENT_292	[p15l1695t2429r1970b2476],
10	9	CD	NUMBER	9	num	11	SENT_292	[p15l1695t2429r1970b2476],
11	*	NN	O	*	dep	5	SENT_292	[p15l1695t2429r1970b2476],
12	2	CD	NUMBER	2	dep	11	SENT_292	[p15l1695t2429r1970b2476],

1	celecoxib	NN	O	celecoxib	_	0	SENT_293	[p15l1235t1879r1280b2134],
2	,	,	O	,	_	0	SENT_293	[p15l1292t1799r1293b1802],

1	plasma	NN	O	plasma	nn	2	SENT_294	[p15l1291t2083r1348b2266],
2	coincentratiion	NN	O	coincentratiion	_	0	SENT_294	[p15l1291t1719r1339b2066],

1	1U	NN	O	1u	_	0	SENT_295	[p15l1436t2299r1507b2335],
2	|	CD	NUMBER	|	num	3	SENT_295	[p15l1436t2299r1507b2335],
3	J	NN	O	j	dep	1	SENT_295	[p15l1436t2299r1507b2335],

1	Discussion	NN	O	discussion	_	0	SENT_296	[p15l280t2623r829b2699],

1	Variability	NN	O	variability	nsubjpass	11	SENT_297	[p15l275t2791r681b2879],
2	between	IN	O	between	_	0	SENT_297	[p15l718t2791r1023b2860],
3	individuals	NNS	O	individual	prep_between	1	SENT_297	[p15l1060t2794r1473b2859],
4	in	IN	O	in	_	0	SENT_297	[p15l1512t2796r1583b2858],
5	their	PRP$	O	they	poss	6	SENT_297	[p15l1620t2794r1796b2859],
6	response	NN	O	response	prep_in	3	SENT_297	[p15l1832t2816r2142b2879],
7	to	TO	O	to	_	0	SENT_297	[p15l10t2921r81b2967],
8	drugs	NNS	O	drug	prep_to	6	SENT_297	[p15l122t2902r329b2986],
9	is	VBZ	O	be	auxpass	11	SENT_297	[p15l373t2904r426b2967],
10	well	RB	O	well	advmod	11	SENT_297	[p15l467t2902r621b2967],
11	recognized	VBN	O	recognize	_	0	SENT_297	[p15l664t2902r1153b2986],
12	.	.	O	.	_	0	SENT_297	[p15l664t2902r1153b2986],

1	”	NN	O	”	ccomp	12	SENT_298	[p15l664t2902r1153b2986],
2	Nevertheless	RB	O	nevertheless	advmod	1	SENT_298	[p15l1193t2902r1691b2980],
3	,	,	O	,	_	0	SENT_298	[p15l1193t2902r1691b2980],
4	the	DT	O	the	det	6	SENT_298	[p15l1735t2902r1849b2967],
5	typical	JJ	O	typical	amod	6	SENT_298	[p15l1891t2902r2141b2986],
6	paradigms	NNS	O	paradigm	nsubj	12	SENT_298	[p15l7t3012r396b3098],
7	of	IN	O	of	_	0	SENT_298	[p15l450t3010r528b3078],
8	drug	NN	O	drug	nn	9	SENT_298	[p15l570t3012r744b3098],
9	development	NN	O	development	prep_of	6	SENT_298	[p15l798t3012r1277b3098],
10	and	CC	O	and	_	0	SENT_298	[p15l1330t3012r1462b3078],
11	approval	NN	O	approval	prep_of	6	SENT_298	[p15l1515t3012r1832b3098],
12	infer	VBP	O	infer	_	0	SENT_298	[p15l1887t3010r2057b3078],
13	a	DT	O	a	det	15	SENT_298	[p15l2108t3037r2145b3077],
14	common	JJ	O	common	amod	15	SENT_298	[p15l10t3146r332b3188],
15	response	NN	O	response	dobj	12	SENT_298	[p15l365t3145r675b3208],
16	to	TO	O	to	_	0	SENT_298	[p15l709t3142r780b3188],
17	a	DT	O	a	det	19	SENT_298	[p15l812t3148r849b3188],
18	limited	JJ	O	limited	amod	19	SENT_298	[p15l879t3123r1152b3188],
19	number	NN	O	number	prep_to	12	SENT_298	[p15l1186t3120r1476b3189],
20	of	IN	O	of	_	0	SENT_298	[p15l1507t3120r1585b3188],
21	doses	NNS	O	dose	prep_of	19	SENT_298	[p15l1605t3123r1796b3188],
22	within	IN	O	within	_	0	SENT_298	[p15l1828t3123r2076b3188],
23	a	DT	O	a	det	25	SENT_298	[p15l2108t3148r2145b3188],
24	therapeutic	JJ	O	therapeutic	amod	25	SENT_298	[p15l10t3231r429b3316],
25	category	NN	O	category	prep_within	21	SENT_298	[p15l463t3250r793b3316],
26	.	.	O	.	_	0	SENT_298	[p15l463t3250r793b3316],

1	Inhibitors	NNS	O	inhibitor	nsubj	6	SENT_299	[p15l832t3229r1201b3297],
2	of	IN	O	of	_	0	SENT_299	[p15l1236t3229r1314b3297],
3	COX-2	NN	O	cox-2	prep_of	1	SENT_299	[p15l1336t3232r1610b3297],
4	are	VBP	O	be	cop	6	SENT_299	[p15l1648t3254r1752b3297],
5	no	DT	O	no	det	6	SENT_299	[p15l1787t3254r1874b3297],
6	exception	NN	O	exception	_	0	SENT_299	[p15l1907t3254r2141b3316, p15l10t3345r177b3408],
7	.	.	O	.	_	0	SENT_299	[p15l1907t3254r2141b3316, p15l10t3345r177b3408],

1	Indeed	RB	O	indeed	advmod	26	SENT_300	[p15l234t3342r508b3422],
2	,	,	O	,	_	0	SENT_300	[p15l234t3342r508b3422],
3	a	DT	O	a	det	5	SENT_300	[p15l562t3367r599b3407],
4	considerable	JJ	O	considerable	amod	5	SENT_300	[p15l649t3340r1106b3408],
5	variability	NN	O	variability	nsubj	26	SENT_300	[p15l1157t3340r1542b3428],
6	in	IN	O	in	_	0	SENT_300	[p15l1594t3345r1666b3407],
7	the	DT	O	the	det	10	SENT_300	[p15l1718t3343r1833b3408],
8	plasma	NN	O	plasma	nn	10	SENT_300	[p15l1883t3342r2145b3428],
9	concentration/enzyme	NN	O	concentration/enzyme	nn	10	SENT_300	[p15l10t3460r827b3544],
10	inhibition	NN	O	inhibition	prep_in	5	SENT_300	[p15l879t3456r1255b3525],
11	response	NN	O	response	nn	12	SENT_300	[p15l1306t3481r1617b3544],
12	relationships	NNS	O	relationship	nsubjpass	14	SENT_300	[p15l1669t3459r2141b3544],
13	was	VBD	O	be	auxpass	14	SENT_300	[p15l8t3591r140b3632],
14	noted	VBN	O	note	rcmod	10	SENT_300	[p15l183t3567r389b3632],
15	as	IN	O	as	_	0	SENT_300	[p15l430t3591r495b3632],
16	the	DT	O	the	det	18	SENT_300	[p15l537t3567r651b3632],
17	first	JJ	ORDINAL	first	amod	18	SENT_300	[p15l693t3565r834b3632],
18	member	NN	O	member	prep_as	14	SENT_300	[p15l874t3565r1182b3633],
19	of	IN	O	of	_	0	SENT_300	[p15l1221t3565r1299b3632],
20	the	DT	O	the	det	21	SENT_300	[p15l1328t3567r1443b3632],
21	class	NN	O	class	prep_of	18	SENT_300	[p15l1483t3567r1670b3645],
22	,	,	O	,	_	0	SENT_300	[p15l1483t3567r1670b3645],
23	celecoxib	NN	O	celecoxib	appos	21	SENT_300	[p15l1713t3565r2142b3645],
24	,	,	O	,	_	0	SENT_300	[p15l1713t3565r2142b3645],
25	”	NN	O	”	appos	23	SENT_300	[p15l1713t3565r2142b3645],
26	entered	VBD	O	enter	_	0	SENT_300	[p15l10t3677r283b3743],
27	the	DT	O	the	det	29	SENT_300	[p15l310t3678r425b3743],
28	US	NNP	LOCATION	US	nn	29	SENT_300	[p15l451t3679r560b3743],
29	market	NN	O	market	dobj	26	SENT_300	[p15l588t3675r870b3743],
30	.	.	O	.	_	0	SENT_300	[p15l588t3675r870b3743],

1	Typically	RB	O	typically	advmod	10	SENT_301	[p15l900t3677r1273b3763],
2	,	,	O	,	_	0	SENT_301	[p15l900t3677r1273b3763],
3	assays	NNS	O	assay	nsubjpass	10	SENT_301	[p15l1301t3702r1513b3763],
4	in	IN	O	in	_	0	SENT_301	[p15l1542t3680r1614b3742],
5	whole	JJ	O	whole	amod	7	SENT_301	[p15l1638t3677r1858b3743],
6	human	JJ	O	human	amod	7	SENT_301	[p15l1885t3678r2143b3743],
7	blood	NN	O	blood	prep_in	3	SENT_301	[p16l10t18r217b87],
8	have	VBP	O	have	aux	10	SENT_301	[p16l259t21r423b86],
9	been	VBN	O	be	auxpass	10	SENT_301	[p16l466t18r635b87],
10	utilized	VBN	O	utilize	_	0	SENT_301	[p16l676t21r960b86],
11	to	TO	O	to	aux	12	SENT_301	[p16l1003t40r1074b86],
12	compare	VB	O	compare	xcomp	10	SENT_301	[p16l1116t43r1427b106],
13	the	DT	O	the	det	14	SENT_301	[p16l1469t21r1584b86],
14	selectivity	NN	O	selectivity	dobj	12	SENT_301	[p16l1626t21r2003b106],
15	for	IN	O	for	_	0	SENT_301	[p16l2043t18r2144b86],
16	inhibition	NN	O	inhibition	prep_for	14	SENT_301	[p16l11t129r387b197],
17	of	IN	O	of	_	0	SENT_301	[p16l446t129r523b197],
18	COX-2	NN	MISC	cox-2	prep_of	16	SENT_301	[p16l572t133r846b197],
19	among	IN	O	among	_	0	SENT_301	[p16l909t154r1160b216],
20	members	NNS	O	member	prep_among	12	SENT_301	[p16l1220t129r1558b197],
21	of	IN	O	of	_	0	SENT_301	[p16l1619t129r1697b197],
22	the	DT	O	the	det	23	SENT_301	[p16l1746t131r1860b197],
23	class	NN	O	class	prep_of	20	SENT_301	[p16l1920t131r2142b197],
24	.9	CD	NUMBER	.9	num	23	SENT_301	[p16l1920t131r2142b197],
25	Although	IN	O	although	mark	47	SENT_301	[p16l8t240r370b326],
26	the	DT	O	the	det	28	SENT_301	[p16l408t241r522b306],
27	multiple	JJ	O	multiple	amod	28	SENT_301	[p16l560t240r882b326],
28	factors	NNS	O	factor	nsubjpass	47	SENT_301	[p16l919t238r1159b306],
29	that	WDT	O	that	nsubj	31	SENT_301	[p16l1198t241r1345b305],
30	can	MD	O	can	aux	31	SENT_301	[p16l1384t264r1505b306],
31	distort	VB	O	distort	rcmod	28	SENT_301	[p16l1542t240r1787b306],
32	the	DT	O	the	det	33	SENT_301	[p16l1826t241r1940b306],
33	relationship	NN	O	relationship	dobj	31	SENT_301	[p16l1979t240r2140b306, p16l10t351r315b436],
34	between	IN	O	between	_	0	SENT_301	[p16l366t348r672b417],
35	the	DT	O	the	det	36	SENT_301	[p16l722t351r836b416],
36	degree	NN	O	degree	prep_between	33	SENT_301	[p16l886t351r1127b436],
37	of	IN	O	of	_	0	SENT_301	[p16l1177t348r1255b416],
38	selectivity	NN	O	selectivity	prep_of	36	SENT_301	[p16l1294t351r1671b436],
39	attained	VBN	O	attain	partmod	38	SENT_301	[p16l1720t351r2020b416],
40	in	FW	O	in	nn	41	SENT_301	[p16l2072t353r2143b415],
41	vitro	FW	O	vitro	dep	39	SENT_301	[p16l8t464r185b527],
42	and	CC	O	and	_	0	SENT_301	[p16l215t461r346b527],
43	in	FW	O	in	dep	39	SENT_301	[p16l378t464r449b525],
44	vivo	FW	O	vivo	pobj	43	SENT_301	[p16l477t464r632b527],
45	have	VBP	O	have	aux	47	SENT_301	[p16l663t461r827b527],
46	been	VBN	O	be	auxpass	47	SENT_301	[p16l858t459r1027b527],
47	noted	VBN	O	note	dep	10	SENT_301	[p16l1058t461r1405b540],
48	,1	CD	NUMBER	,1	number	49	SENT_301	[p16l1058t461r1405b540],
49	’28	CD	NUMBER	’28	num	51	SENT_301	[p16l1058t461r1405b540],
50	the	DT	O	the	det	51	SENT_301	[p16l1437t461r1552b527],
51	implications	NNS	O	implication	nsubj	56	SENT_301	[p16l1583t461r2044b546],
52	of	IN	O	of	_	0	SENT_301	[p16l2076t459r2153b527],
53	this	DT	O	this	det	54	SENT_301	[p16l10t569r146b633],
54	observation	NN	O	observation	prep_of	51	SENT_301	[p16l185t566r611b634],
55	have	VBP	O	have	aux	56	SENT_301	[p16l648t569r813b633],
56	received	VBN	O	receive	ccomp	47	SENT_301	[p16l852t568r1151b633],
57	little	JJ	O	little	amod	58	SENT_301	[p16l1190t568r1370b633],
58	attention	NN	O	attention	dobj	56	SENT_301	[p16l1408t571r1766b633],
59	.	.	O	.	_	0	SENT_301	[p16l1408t571r1766b633],

1	Evidence	NN	O	evidence	nsubj	2	SENT_302	[p16l1809t568r2142b633],
2	exists	VBZ	O	exist	ccomp	39	SENT_302	[p16l10t681r211b744],
3	in	IN	O	in	_	0	SENT_302	[p16l248t681r319b743],
4	animal	NN	O	animal	nn	5	SENT_302	[p16l354t679r605b744],
5	models	NNS	O	model	prep_in	2	SENT_302	[p16l640t679r901b744],
6	that	WDT	O	that	nsubj	7	SENT_302	[p16l938t679r1085b744],
7	suggests	VBZ	O	suggest	rcmod	5	SENT_302	[p16l1121t698r1431b764],
8	that	IN	O	that	complm	17	SENT_302	[p16l1468t679r1614b744],
9	the	DT	O	the	det	10	SENT_302	[p16l1651t679r1765b744],
10	degree	NN	O	degree	nsubj	17	SENT_302	[p16l1800t679r2041b764],
11	of	IN	O	of	_	0	SENT_302	[p16l2076t676r2153b744],
12	selectivity	NN	O	selectivity	prep_of	10	SENT_302	[p16l10t788r386b872],
13	attained	VBN	O	attain	partmod	12	SENT_302	[p16l426t788r726b853],
14	in	IN	O	in	_	0	SENT_302	[p16l767t790r839b851],
15	Vivo	NNP	O	Vivo	prep_in	13	SENT_302	[p16l876t790r1032b853],
16	may	MD	O	may	aux	17	SENT_302	[p16l1071t812r1226b872],
17	relate	VB	O	relate	ccomp	7	SENT_302	[p16l1266t788r1467b853],
18	to	TO	O	to	_	0	SENT_302	[p16l1508t807r1579b853],
19	cardiovascular	JJ	O	cardiovascular	amod	20	SENT_302	[p16l1619t788r2144b853],
20	outcomes	NNS	O	outcome	prep_to	17	SENT_302	[p16l10t916r381b977],
21	,	,	O	,	_	0	SENT_302	[p16l10t916r381b977],
22	including	VBG	O	include	_	0	SENT_302	[p16l446t897r804b983],
23	hypertension	NN	O	hypertension	prep_including	5	SENT_302	[p16l866t898r1368b983],
24	,	,	O	,	_	0	SENT_302	[p16l866t898r1368b983],
25	myocardial	JJ	O	myocardial	amod	26	SENT_302	[p16l1431t897r1840b983],
26	infarction	NN	O	infarction	conj_and	23	SENT_302	[p16l1903t895r2140b963, p16l10t1010r180b1087],
27	,	,	O	,	_	0	SENT_302	[p16l1903t895r2140b963, p16l10t1010r180b1087],
28	and	CC	O	and	_	0	SENT_302	[p16l215t1008r346b1073],
29	stroke	NN	O	stroke	prep_including	5	SENT_302	[p16l380t1005r778b1073],
30	.12	CD	NUMBER	.12	number	31	SENT_302	[p16l380t1005r778b1073],
31	’14	CD	NUMBER	’14	dep	29	SENT_302	[p16l380t1005r778b1073],
32	However	RB	O	however	advmod	31	SENT_302	[p16l812t1010r1166b1087],
33	,	,	O	,	_	0	SENT_302	[p16l812t1010r1166b1087],
34	this	DT	O	this	det	35	SENT_302	[p16l1202t1008r1337b1073],
35	hypothesis	NN	O	hypothesis	nsubjpass	39	SENT_302	[p16l1371t1008r1763b1093],
36	has	VBZ	O	have	aux	39	SENT_302	[p16l1797t1008r1911b1073],
37	never	RB	O	never	neg	39	SENT_302	[p16l1946t1031r2144b1073],
38	been	VBN	O	be	auxpass	39	SENT_302	[p16l10t1114r180b1181],
39	addressed	VBN	O	address	_	0	SENT_302	[p16l216t1116r571b1181],
40	in	IN	O	in	_	0	SENT_302	[p16l609t1118r680b1180],
41	clinical	JJ	O	clinical	amod	42	SENT_302	[p16l717t1116r984b1181],
42	studies	NNS	O	study	prep_in	39	SENT_302	[p16l1022t1116r1298b1181],
43	.	.	O	.	_	0	SENT_302	[p16l1022t1116r1298b1181],

1	Rofecoxib	NNP	O	Rofecoxib	nsubjpass	4	SENT_303	[p16l109t1222r478b1290],
2	has	VBZ	O	have	aux	4	SENT_303	[p16l522t1225r636b1289],
3	been	VBN	O	be	auxpass	4	SENT_303	[p16l682t1222r852b1290],
4	withdrawn	VBN	O	withdraw	_	0	SENT_303	[p16l894t1224r1300b1289],
5	from	IN	O	from	_	0	SENT_303	[p16l1342t1222r1518b1289],
6	the	DT	O	the	det	7	SENT_303	[p16l1562t1225r1677b1289],
7	market	NN	O	market	prep_from	4	SENT_303	[p16l1720t1222r1982b1289],
8	because	IN	O	because	prep	4	SENT_303	[p16l2028t1222r2140b1290, p16l10t1359r201b1400],

1	of	IN	O	of	_	0	SENT_304	[p16l236t1332r314b1400],
2	an	DT	O	a	det	3	SENT_304	[p16l336t1358r420b1400],
3	excess	NN	O	excess	nsubj	11	SENT_304	[p16l454t1359r671b1400],
4	of	IN	O	of	_	0	SENT_304	[p16l707t1332r785b1400],
5	myocardial	JJ	O	myocardial	amod	6	SENT_304	[p16l807t1335r1216b1420],
6	infarction	NN	O	infarction	prep_of	3	SENT_304	[p16l1252t1332r1612b1400],
7	and	CC	O	and	_	0	SENT_304	[p16l1645t1335r1777b1400],
8	stroke	NN	O	stroke	prep_of	3	SENT_304	[p16l1812t1332r2036b1400],
9	in	IN	O	in	_	0	SENT_304	[p16l2071t1337r2143b1399],
10	patients	NNS	O	patient	prep_in	6	SENT_304	[p16l8t1445r303b1527],
11	receiving	VBG	O	receive	prepc_of	32	SENT_304	[p16l342t1445r679b1527],
12	this	DT	O	this	det	17	SENT_304	[p16l718t1443r854b1508],
13	drug	NN	O	drug	nn	17	SENT_304	[p16l892t1443r1067b1527],
14	(	NN	O	(	nn	17	SENT_304	[p16l1105t1445r1219b1519],
15	25	CD	NUMBER	25	num	17	SENT_304	[p16l1105t1445r1219b1519],
16	mg/day	NN	O	mg/day	nn	17	SENT_304	[p16l1263t1443r1569b1527],
17	)	NN	O	)	nsubj	26	SENT_304	[p16l1263t1443r1569b1527],
18	in	IN	O	in	_	0	SENT_304	[p16l1608t1445r1679b1506],
19	the	DT	O	the	det	22	SENT_304	[p16l1717t1443r1832b1508],
20	Adenomatous	NNP	MISC	Adenomatous	nn	22	SENT_304	[p16l1868t1443r2140b1508, p16l9t1570r276b1616],
21	Polyp	NNP	MISC	Polyp	nn	22	SENT_304	[p16l308t1551r520b1636],
22	Prevention	NNP	MISC	Prevention	prep_in	17	SENT_304	[p16l552t1554r955b1616],
23	on	IN	O	on	_	0	SENT_304	[p16l984t1574r1072b1616],
24	VIOXX	NNP	O	VIOXX	prep_on	22	SENT_304	[p16l1100t1553r1409b1616],
25	(	CD	NUMBER	(	num	24	SENT_304	[p16l1437t1552r1901b1627],
26	APPROVe	VB	O	approve	ccomp	11	SENT_304	[p16l1437t1552r1901b1627],
27	)	CD	NUMBER	)	num	28	SENT_304	[p16l1437t1552r1901b1627],
28	trial	NN	O	trial	dobj	26	SENT_304	[p16l1932t1551r2139b1616],
29	.7	CD	NUMBER	.7	nsubj	32	SENT_304	[p16l1932t1551r2139b1616],
30	This	DT	O	this	det	31	SENT_304	[p16l8t1662r173b1727],
31	hazard	NN	O	hazard	dep	29	SENT_304	[p16l225t1662r465b1727],
32	evolved	VBD	O	evolve	_	0	SENT_304	[p16l517t1662r795b1727],
33	slowly	RB	O	slowly	advmod	32	SENT_304	[p16l847t1662r1083b1747],
34	over	IN	O	over	_	0	SENT_304	[p16l1133t1685r1288b1727],
35	time	NN	O	time	prep_over	32	SENT_304	[p16l1338t1664r1529b1741],
36	,	,	O	,	_	0	SENT_304	[p16l1338t1664r1529b1741],
37	becoming	VBG	O	become	xcomp	32	SENT_304	[p16l1583t1659r1947b1747],
38	ﬁrst	JJ	O	ﬁrst	amod	42	SENT_304	[p16l2001t1659r2141b1727],
39	evident	JJ	O	evident	amod	42	SENT_304	[p16l10t1772r282b1838],
40	after	IN	O	after	_	0	SENT_304	[p16l312t1770r478b1838],
41	18	CD	DURATION	18	prep_after	39	SENT_304	[p16l513t1776r596b1838],
42	months	NNS	NUMBER	month	attr	37	SENT_304	[p16l628t1772r906b1838],
43	of	IN	O	of	_	0	SENT_304	[p16l936t1770r1014b1838],
44	treatment	NN	O	treatment	prep_of	42	SENT_304	[p16l1033t1791r1420b1851],
45	,	,	O	,	_	0	SENT_304	[p16l1033t1791r1420b1851],
46	in	IN	O	in	_	0	SENT_304	[p16l1452t1775r1524b1836],
47	only	RB	O	only	quantmod	48	SENT_304	[p16l1553t1772r1712b1857],
48	1	CD	PERCENT	1	num	49	SENT_304	[p16l1749t1774r2040b1841],
49	%	NN	PERCENT	%	prep_in	42	SENT_304	[p16l1749t1774r2040b1841],
50	.	.	O	.	_	0	SENT_304	[p16l1749t1774r2040b1841],

1	—	NN	O	—	_	0	SENT_305	[p16l1749t1774r2040b1841],
2	.	.	O	.	_	0	SENT_305	[p16l1749t1774r2040b1841],

1	2	CD	PERCENT	2	num	2	SENT_306	[p16l1749t1774r2040b1841],
2	%	NN	PERCENT	%	_	0	SENT_306	[p16l1749t1774r2040b1841],
3	of	IN	O	of	_	0	SENT_306	[p16l2076t1770r2153b1838],
4	patients	NNS	O	patient	prep_of	2	SENT_306	[p16l7t1891r324b1973],
5	.	.	O	.	_	0	SENT_306	[p16l7t1891r324b1973],

1	A	DT	O	a	det	3	SENT_307	[p16l356t1889r420b1952],
2	similar	JJ	O	similar	amod	3	SENT_307	[p16l448t1888r706b1953],
3	pattern	NN	O	pattern	nsubj	50	SENT_307	[p16l730t1907r1023b1973],
4	,	,	O	,	_	0	SENT_307	[p16l730t1907r1023b1973],
5	again	RB	O	again	advmod	6	SENT_307	[p16l1053t1891r1251b1973],
6	consistent	JJ	O	consistent	dep	15	SENT_307	[p16l1280t1891r1650b1953],
7	with	IN	O	with	_	0	SENT_307	[p16l1678t1889r1849b1953],
8	a	DT	O	a	det	10	SENT_307	[p16l1877t1913r1913b1952],
9	timedependent	JJ	O	timedependent	amod	10	SENT_307	[p16l1940t1891r2140b1953, p16l9t1999r396b2084],
10	transformation	NN	O	transformation	prep_with	6	SENT_307	[p16l434t1996r984b2064],
11	of	IN	O	of	_	0	SENT_307	[p16l1019t1996r1097b2064],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_307	[p16l1122t1999r1647b2064],
13	risk	NN	O	risk	prep_of	10	SENT_307	[p16l1682t1996r1819b2064],
14	was	VBD	O	be	auxpass	15	SENT_307	[p16l1853t2023r1984b2064],
15	observed	VBN	O	observe	parataxis	50	SENT_307	[p16l2022t1996r2140b2065, p16l10t2108r239b2173],
16	in	IN	O	in	_	0	SENT_307	[p16l268t2111r340b2172],
17	the	DT	O	the	det	19	SENT_307	[p16l368t2108r483b2173],
18	Adenoma	NNP	O	Adenoma	nn	19	SENT_307	[p16l510t2108r868b2173],
19	Prevention	NNP	O	Prevention	prep_in	15	SENT_307	[p16l895t2111r1299b2173],
20	with	IN	O	with	_	0	SENT_307	[p16l1325t2108r1496b2173],
21	Celecoxib	NNP	MISC	Celecoxib	prep_with	15	SENT_307	[p16l1524t2106r1884b2174],
22	(	CD	NUMBER	(	num	25	SENT_307	[p16l1913t2109r2142b2184],
23	APC	NN	ORGANIZATION	apc	nn	25	SENT_307	[p16l1913t2109r2142b2184],
24	)	CD	NUMBER	)	num	25	SENT_307	[p16l1913t2109r2142b2184],
25	study	NN	O	study	nsubjpass	15	SENT_307	[p16l10t2217r213b2303],
26	of	IN	O	of	_	0	SENT_307	[p16l257t2215r334b2283],
27	celecoxib	NN	O	celecoxib	prep_of	15	SENT_307	[p16l368t2215r760b2283],
28	.5	CD	NUMBER	.5	num	27	SENT_307	[p16l368t2215r760b2283],
29	Thus	RB	O	thus	advmod	15	SENT_307	[p16l807t2218r1017b2296],
30	,	,	O	,	_	0	SENT_307	[p16l807t2218r1017b2296],
31	a	DT	O	a	det	33	SENT_307	[p16l1063t2242r1100b2282],
32	small	JJ	O	small	amod	33	SENT_307	[p16l1143t2217r1338b2283],
33	minority	NN	O	minority	nsubj	50	SENT_307	[p16l1384t2220r1712b2303],
34	of	IN	O	of	_	0	SENT_307	[p16l1756t2215r1834b2283],
35	the	DT	O	the	det	36	SENT_307	[p16l1867t2218r1982b2283],
36	patients	NNS	O	patient	prep_of	33	SENT_307	[p16l2024t2240r2140b2303, p16l10t2330r216b2393],
37	in	IN	O	in	_	0	SENT_307	[p16l253t2330r324b2392],
38	both	DT	O	both	det	39	SENT_307	[p16l359t2325r528b2394],
39	studies	NNS	O	study	prep_in	36	SENT_307	[p16l564t2328r842b2407],
40	,	,	O	,	_	0	SENT_307	[p16l564t2328r842b2407],
41	apparently	RB	O	apparently	rcmod	33	SENT_307	[p16l879t2328r1273b2413],
42	initially	RB	O	initially	advmod	43	SENT_307	[p16l1308t2328r1602b2413],
43	at	IN	O	at	dep	41	SENT_307	[p16l1636t2347r1702b2393],
44	low	JJ	O	low	amod	45	SENT_307	[p16l1738t2328r1870b2393],
45	risk	NN	O	risk	pobj	43	SENT_307	[p16l1905t2325r2042b2393],
46	of	IN	O	of	_	0	SENT_307	[p16l2076t2325r2153b2393],
47	cardiovascular	JJ	O	cardiovascular	amod	48	SENT_307	[p16l10t2436r535b2502],
48	disease	NN	O	disease	prep_of	45	SENT_307	[p16l568t2436r841b2515],
49	,	,	O	,	_	0	SENT_307	[p16l568t2436r841b2515],
50	proceeded	VBD	O	proceed	_	0	SENT_307	[p16l876t2436r1249b2521],
51	to	TO	O	to	aux	52	SENT_307	[p16l1285t2455r1356b2502],
52	increase	VB	O	increase	xcomp	50	SENT_307	[p16l1392t2439r1680b2502],
53	that	DT	O	that	det	54	SENT_307	[p16l1716t2436r1863b2501],
54	risk	NN	O	risk	dobj	52	SENT_307	[p16l1899t2434r2037b2502],
55	to	TO	O	to	_	0	SENT_307	[p16l2071t2455r2142b2502],
56	a	DT	O	a	det	57	SENT_307	[p16l9t2572r46b2612],
57	point	NN	O	point	prep_to	52	SENT_307	[p16l75t2550r274b2633],
58	that	WDT	O	that	nsubj	59	SENT_307	[p16l309t2548r456b2612],
59	culminated	VBD	O	culminate	rcmod	57	SENT_307	[p16l491t2547r911b2613],
60	in	IN	O	in	_	0	SENT_307	[p16l947t2550r1018b2612],
61	clinical	JJ	O	clinical	amod	62	SENT_307	[p16l1052t2547r1319b2613],
62	events	NNS	O	event	prep_in	59	SENT_307	[p16l1354t2545r1674b2613],
63	.	.	O	.	_	0	SENT_307	[p16l1354t2545r1674b2613],

1	“	NN	O	“	nsubj	18	SENT_308	[p16l1354t2545r1674b2613],
2	The	DT	O	the	det	3	SENT_308	[p16l1707t2548r1851b2613],
3	exploitation	NN	O	exploitation	nsubj	10	SENT_308	[p16l1885t2547r2140b2633, p16l10t2666r229b2729],
4	of	IN	O	of	_	0	SENT_308	[p16l260t2661r337b2729],
5	variability	NN	O	variability	prep_of	3	SENT_308	[p16l355t2661r740b2749],
6	in	IN	O	in	_	0	SENT_308	[p16l772t2666r843b2728],
7	drug	NN	O	drug	nn	8	SENT_308	[p16l874t2664r1048b2749],
8	response	NN	O	response	prep_in	5	SENT_308	[p16l1081t2686r1392b2749],
9	to	TO	O	to	aux	10	SENT_308	[p16l1424t2683r1495b2729],
10	identify	VB	O	identify	infmod	1	SENT_308	[p16l1527t2661r1817b2749],
11	patients	NNS	O	patient	dobj	10	SENT_308	[p16l1845t2666r2141b2749],
12	at	IN	O	at	_	0	SENT_308	[p16l9t2791r76b2837],
13	emerging	VBG	O	emerge	amod	14	SENT_308	[p16l109t2775r462b2857],
14	risk	NN	O	risk	prep_at	10	SENT_308	[p16l497t2770r635b2838],
15	of	IN	O	of	_	0	SENT_308	[p16l666t2770r744b2838],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_308	[p16l765t2772r1290b2838],
17	disease	NN	O	disease	prep_of	14	SENT_308	[p16l1321t2772r1572b2838],
18	requires	VBZ	O	require	_	0	SENT_308	[p16l1606t2775r1899b2857],
19	first	RB	ORDINAL	first	advmod	21	SENT_308	[p16l1934t2770r2075b2838],
20	a	DT	O	a	det	21	SENT_308	[p16l2108t2797r2145b2837],
21	determination	NN	O	determination	dobj	18	SENT_308	[p16l9t2883r539b2949],
22	of	IN	O	of	_	0	SENT_308	[p16l566t2881r644b2949],
23	whether	IN	O	whether	complm	29	SENT_308	[p16l659t2884r962b2949],
24	Variability	NN	O	variability	nsubj	29	SENT_308	[p16l986t2881r1371b2969],
25	in	IN	O	in	_	0	SENT_308	[p16l1399t2886r1471b2948],
26	response	NN	O	response	prep_in	24	SENT_308	[p16l1498t2906r1808b2969],
27	between	IN	O	between	_	0	SENT_308	[p16l1837t2881r2143b2950],
28	individuals	NNS	O	individual	prep_between	26	SENT_308	[p16l11t2992r423b3056],
29	exceeds	VBZ	O	exceed	prepc_of	21	SENT_308	[p16l473t2992r745b3056],
30	that	IN	O	that	dep	31	SENT_308	[p16l795t2992r942b3056],
31	attributable	JJ	O	attributable	dep	21	SENT_308	[p16l991t2989r1433b3057],
32	to	TO	O	to	_	0	SENT_308	[p16l1483t3011r1554b3056],
33	environmental	JJ	O	environmental	amod	34	SENT_308	[p16l1603t2992r2141b3056],
34	variability	NN	O	variability	prep_to	31	SENT_308	[p16l8t3100r393b3187],
35	within	IN	O	within	_	0	SENT_308	[p16l427t3102r675b3168],
36	individuals	NNS	O	individual	prep_within	34	SENT_308	[p16l712t3102r1146b3168],
37	.	.	O	.	_	0	SENT_308	[p16l712t3102r1146b3168],

1	COX-2	NN	MISC	cox-2	nn	2	SENT_309	[p16l108t3213r382b3277],
2	inhibitors	NNS	O	inhibitor	nsubj	3	SENT_309	[p16l419t3209r782b3277],
3	depress	VBP	O	depress	_	0	SENT_309	[p16l815t3211r1081b3297],
4	biosynthesis	NN	O	biosynthesis	dobj	3	SENT_309	[p16l1115t3209r1566b3297],
5	of	IN	O	of	_	0	SENT_309	[p16l1598t3209r1676b3277],
6	PGI2	NN	O	pgi2	prep_of	4	SENT_309	[p16l1698t3213r1905b3291],
7	,	,	O	,	_	0	SENT_309	[p16l1698t3213r1905b3291],
8	while	IN	O	while	mark	10	SENT_309	[p16l1938t3211r2142b3277],
9	not	RB	O	not	neg	10	SENT_309	[p16l11t3341r130b3387],
10	affecting	VBG	O	affect	dep	6	SENT_309	[p16l173t3319r494b3407],
11	platelet	NN	O	platelet	nn	12	SENT_309	[p16l536t3322r817b3407],
12	COX	NN	O	cox	dobj	10	SENT_309	[p16l860t3322r1448b3387],
13	—	CD	NUMBER	—	number	14	SENT_309	[p16l860t3322r1448b3387],
14	1	CD	NUMBER	1	num	15	SENT_309	[p16l860t3322r1448b3387],
15	—	NN	O	—	dep	12	SENT_309	[p16l860t3322r1448b3387],
16	derived	VBN	O	derive	partmod	12	SENT_309	[p16l860t3322r1448b3387],
17	TxA2	NN	O	txa2	dobj	16	SENT_309	[p16l1491t3322r1859b3401],
18	,1	CD	NUMBER	,1	num	17	SENT_309	[p16l1491t3322r1859b3401],
19	°	CD	NUMBER	°	num	20	SENT_309	[p16l1491t3322r1859b3401],
20	’”	NN	O	’”	advmod	17	SENT_309	[p16l1491t3322r1859b3401],
21	unlike	IN	O	unlike	_	0	SENT_309	[p16l1907t3319r2142b3387],
22	VARIABILITY	NN	O	variability	prep_unlike	20	SENT_309	[p16l552t3442r962b3494],
23	IN	IN	O	in	_	0	SENT_309	[p16l992t3442r1052b3494],
24	THE	DT	O	the	det	25	SENT_309	[p16l1082t3442r1208b3494],
25	RESPONSE	NN	O	response	prep_in	22	SENT_309	[p16l1241t3442r1599b3495],
26	TO	TO	O	to	infmod	17	SENT_309	[p16l1625t3442r1710b3495],
27	COXIBS	NNP	O	COXIBS	dobj	26	SENT_309	[p16l1741t3442r1985b3495],
28	61	CD	NUMBER	61	num	27	SENT_309	[p16l2066t3441r2153b3495],

1	B	NN	O	b	nn	4	SENT_310	[p16l183t3578r277b3689],
2	celecoxih	NN	O	celecoxih	nn	4	SENT_310	[p16l481t3616r879b3693],
3	*	NN	O	*	nn	4	SENT_310	[p16l1339t3575r1439b3692],
4	rofecoxlib	NN	O	rofecoxlib	_	0	SENT_310	[p16l1604t3620r1992b3696],

1	.	.	O	.	_	0	SENT_311	[p17l43t120r45b123],

1	E	NN	O	e	_	0	SENT_312	[p17l90t85r142b130],
2	-52	CD	NUMBER	-52	num	3	SENT_312	[p17l1162t85r1214b132],
3	E	NN	O	e	dep	1	SENT_312	[p17l1238t88r1290b134],
4	|	CD	NUMBER	|	number	5	SENT_312	[p17l10t216r59b258],
5	‘	CD	NUMBER	‘	dep	3	SENT_312	[p17l10t216r59b258],
6	an	DT	O	a	det	7	SENT_312	[p17l104t233r142b268],
7	1	CD	NUMBER	1	dep	1	SENT_312	[p17l218t182r280b223],
8	'	''	O	'	_	0	SENT_312	[p17l218t182r280b223],
9	1	CD	NUMBER	1	dep	7	SENT_312	[p17l218t182r280b223],
10	i	FW	O	i	nn	12	SENT_312	[p17l318t200r319b205],
11	f	FW	O	f	nn	12	SENT_312	[p17l1162t190r1290b279],
12	g	NN	O	g	dep	1	SENT_312	[p17l1162t190r1290b279],
13	+	CC	O	+	_	0	SENT_312	[p17l1162t190r1290b279],
14	@Y	NN	O	@y	nn	15	SENT_312	[p17l1352t178r1384b272],
15	g	NN	O	g	conj_+	12	SENT_312	[p17l1352t178r1384b272],
16	+	CC	O	+	_	0	SENT_312	[p17l1352t178r1384b272],
17	1	CD	NUMBER	1	conj_+	12	SENT_312	[p17l1441t206r1442b241],
18	.	.	O	.	_	0	SENT_312	[p17l118t282r120b284],

1	1	LS	NUMBER	1	dep	5	SENT_313	[p17l263t250r340b289],
2	-	:	O	-	_	0	SENT_313	[p17l263t250r340b289],
3	I	PRP	O	I	nsubj	5	SENT_313	[p17l1173t261r1175b278],
4	f	FW	O	f	dep	5	SENT_313	[p17l1249t251r1266b282],
5	g	NN	O	g	_	0	SENT_313	[p17l1249t251r1266b282],
6	+	CC	O	+	rcmod	5	SENT_313	[p17l1249t251r1266b282],
7	'	''	O	'	_	0	SENT_313	[p17l1359t252r1363b254],
8	‘	CD	NUMBER	‘	nsubj	16	SENT_313	[p17l1441t261r1442b265],
9	E	NN	O	e	amod	8	SENT_313	[p17l21t278r59b347],
10	3	CD	NUMBER	3	dep	8	SENT_313	[p17l104t271r142b337],
11	is	VBZ	O	be	cop	16	SENT_313	[p17l316t306r326b313],
12	an	DT	O	a	det	16	SENT_313	[p17l1173t303r1215b347],
13	3	CD	NUMBER	3	number	14	SENT_313	[p17l1249t275r1290b344],
14	4	CD	NUMBER	4	num	16	SENT_313	[p17l1352t292r1384b337],
15	‘	NN	O	‘	nn	16	SENT_313	[p17l1441t296r1442b303],
16	E	NN	O	e	dep	5	SENT_313	[p17l21t337r62b392],
17	-:5	CD	NUMBER	-:5	num	19	SENT_313	[p17l90t344r142b379],
18	ISLE	NNP	O	ISLE	nn	19	SENT_313	[p17l214t326r287b365],
19	g	NN	O	g	dep	16	SENT_313	[p17l318t383r329b392],
20	;	:	O	;	_	0	SENT_313	[p17l1173t337r1214b372],
21	.	.	O	.	_	0	SENT_313	[p17l1173t337r1214b372],

1	-	:	O	-	_	0	SENT_314	[p17l1173t337r1214b372],
2	:	:	O	:	_	0	SENT_314	[p17l1173t337r1214b372],
3	u	SYM	O	u	dep	5	SENT_314	[p17l1173t337r1214b372],
4	-	:	O	-	_	0	SENT_314	[p17l1173t337r1214b372],
5	1	CD	DATE	1	nsubj	25	SENT_314	[p17l1238t347r1290b382],
6	:	:	O	:	_	0	SENT_314	[p17l1238t347r1290b382],
7	y	NN	O	y	nn	8	SENT_314	[p17l1441t386r1442b389],
8	ﬁt	NN	O	ﬁt	dep	5	SENT_314	[p17l21t396r62b466],
9	E.	NNP	O	E.	dep	8	SENT_314	[p17l104t399r142b461],
10	-	:	O	-	_	0	SENT_314	[p17l104t399r142b461],
11	"	``	O	"	punct	15	SENT_314	[p17l104t399r142b461],
12	as	IN	O	as	amod	15	SENT_314	[p17l214t409r287b452],
13	a	DT	O	a	det	15	SENT_314	[p17l336t432r339b433],
14	X	NN	O	x	nn	15	SENT_314	[p17l1162t392r1214b480],
15	g	NN	O	g	dep	9	SENT_314	[p17l1162t392r1214b480],
16	+	CC	O	+	_	0	SENT_314	[p17l1162t392r1214b480],
17	E	NN	O	e	nn	19	SENT_314	[p17l1249t403r1290b465],
18	3	CD	NUMBER	3	num	19	SENT_314	[p17l1352t379r1383b421],
19	‘	NN	O	‘	dep	9	SENT_314	[p17l1352t379r1383b421],
20	p	NN	O	p	amod	22	SENT_314	[p17l1441t406r1442b429],
21	f	FW	O	f	dep	20	SENT_314	[p17l1441t406r1442b429],
22	g	NN	O	g	dep	19	SENT_314	[p17l1441t406r1442b429],
23	+	CC	O	+	cc	25	SENT_314	[p17l1441t406r1442b429],
24	v	LS	O	v	dep	25	SENT_314	[p17l7t480r59b510],
25	g	NN	O	g	_	0	SENT_314	[p17l7t480r59b510],
26	+	CC	O	+	cc	27	SENT_314	[p17l7t480r59b510],
27	5	LS	NUMBER	5	rcmod	25	SENT_314	[p17l104t459r156b494],
28	-	:	O	-	_	0	SENT_314	[p17l104t459r156b494],
29	.	.	O	.	_	0	SENT_314	[p17l228t504r232b506],

1	.	.	O	.	_	0	SENT_315	[p17l285t504r287b506],

1	}	NN	O	}	nsubj	4	SENT_316	[p17l318t474r338b519],
2	[	CD	NUMBER	[	num	1	SENT_316	[p17l1162t473r1214b521],
3	ii	LS	O	ii	dep	4	SENT_316	[p17l1162t473r1214b521],
4	5	LS	NUMBER	5	_	0	SENT_316	[p17l1252t466r1304b497],
5	-	:	O	-	_	0	SENT_316	[p17l1252t466r1304b497],
6	-	:	O	-	_	0	SENT_316	[p17l1360t497r1380b503],
7	.	.	O	.	_	0	SENT_316	[p17l1360t497r1380b503],

1	If	IN	O	if	_	0	SENT_317	[p17l21t507r59b542],
2	!	.	O	!	_	0	SENT_317	[p17l21t507r59b542],

1	o	NN	O	o	_	0	SENT_318	[p17l90t514r142b590],
2	u	FW	O	u	dep	1	SENT_318	[p17l90t514r142b590],
3	g	NN	O	g	dep	1	SENT_318	[p17l90t514r142b590],
4	+	CC	O	+	_	0	SENT_318	[p17l90t514r142b590],
5	o.	NN	O	o.	dep	1	SENT_318	[p17l214t504r287b546],
6	?	.	O	?	_	0	SENT_318	[p17l214t504r287b546],

1	—	NN	O	—	_	0	SENT_319	[p17l331t529r336b530],
2	.	.	O	.	_	0	SENT_319	[p17l1162t538r1214b560],

1	_	NN	O	_	_	0	SENT_320	[p17l1162t538r1214b560],
2	E	NN	O	e	nsubj	4	SENT_320	[p17l1238t518r1290b594],
3	2	CD	NUMBER	2	num	2	SENT_320	[p17l1352t500r1380b539],
4	I	PRP	O	I	xcomp	1	SENT_320	[p17l21t566r59b597],
5	:	:	O	:	_	0	SENT_320	[p17l21t566r59b597],
6	—	NN	O	—	nsubj	8	SENT_320	[p17l330t581r336b582],
7	D	NN	O	d	amod	6	SENT_320	[p17l1173t563r1214b597],
8	g	NN	O	g	dep	4	SENT_320	[p17l1285t585r1290b603],
9	,3	CD	NUMBER	,3	num	10	SENT_320	[p17l7t601r59b670],
10	E	NN	O	e	dobj	8	SENT_320	[p17l90t594r142b698],
11	as	IN	O	as	_	0	SENT_320	[p17l214t615r287b656],
12	E	NN	O	e	prepc_as	10	SENT_320	[p17l1173t618r1214b691],
13	3	CD	NUMBER	3	num	15	SENT_320	[p17l1249t597r1290b663],
14	u	NN	O	u	nn	15	SENT_320	[p17l7t673r59b722],
15	g	NN	O	g	dobj	12	SENT_320	[p17l7t673r59b722],
16	+	CC	O	+	rcmod	15	SENT_320	[p17l7t673r59b722],
17	~	SYM	O	~	dep	15	SENT_320	[p17l118t699r124b701],
18	-	:	O	-	_	0	SENT_320	[p17l318t688r340b700],
19	’	CD	NUMBER	’	dep	10	SENT_320	[p17l318t688r340b700],
20	"	``	O	"	punct	4	SENT_320	[p17l1162t694r1211b725],
21	.	.	O	.	_	0	SENT_320	[p17l1162t694r1211b725],

1	:	:	O	:	_	0	SENT_321	[p17l1162t694r1211b725],
2	-	:	O	-	_	0	SENT_321	[p17l1162t694r1211b725],
3	"	``	O	"	punct	4	SENT_321	[p17l1238t670r1290b724],
4	9	CD	NUMBER	9	_	0	SENT_321	[p17l1238t670r1290b724],
5	'	''	O	'	_	0	SENT_321	[p17l1370t698r1373b700],
6	:2	CD	NUMBER	:2	dep	4	SENT_321	[p17l7t725r59b774],
7	‘	CD	NUMBER	‘	num	8	SENT_321	[p17l93t718r142b770],
8	E	NN	O	e	dep	4	SENT_321	[p17l93t718r142b770],
9	[	CD	NUMBER	[	number	10	SENT_321	[p17l214t743r287b784],
10	15	CD	NUMBER	15	num	12	SENT_321	[p17l214t743r287b784],
11	W	NN	O	w	nn	12	SENT_321	[p17l317t746r340b768],
12	g	NN	O	g	dep	8	SENT_321	[p17l317t746r340b768],
13	+	CC	O	+	_	0	SENT_321	[p17l317t746r340b768],
14	Ea	NN	O	ea	nn	16	SENT_321	[p17l1162t704r1290b779],
15	“	CD	NUMBER	“	num	16	SENT_321	[p17l1356t701r1376b742],
16	E	NN	O	e	conj_+	4	SENT_321	[p17l7t780r59b829],
17	E.	NNP	O	E.	nn	18	SENT_321	[p17l103t774r156b846],
18	A	NNP	O	A	poss	16	SENT_321	[p17l338t780r339b785],
19	'	POS	O	'	_	0	SENT_321	[p17l1162t780r1211b829],
20	-	:	O	-	_	0	SENT_321	[p17l1162t780r1211b829],
21	E	NN	O	e	dep	16	SENT_321	[p17l1162t780r1211b829],
22	E.	NNP	O	E.	dep	4	SENT_321	[p17l1249t777r1304b847],

1	“	NN	O	“	_	0	SENT_322	[p17l90t850r155b867],
2	'	''	O	'	_	0	SENT_322	[p17l90t850r155b867],
3	+	CC	O	+	_	0	SENT_322	[p17l450t853r537b902],
4	f	FW	O	f	conj_+	1	SENT_322	[p17l450t853r537b902],
5	+	CC	O	+	_	0	SENT_322	[p17l450t853r537b902],
6	‘	FW	O	‘	conj_+	1	SENT_322	[p17l579t850r582b853],
7	+	CC	O	+	rcmod	6	SENT_322	[p17l803t853r879b905],
8	.	.	O	.	_	0	SENT_322	[p17l803t853r879b905],

1	r	NN	O	r	nn	2	SENT_323	[p17l803t853r879b905],
2	‘	NN	O	‘	_	0	SENT_323	[p17l803t853r879b905],
3	=	JJ	O	=	amod	4	SENT_323	[p17l803t853r879b905],
4	E	NN	O	e	dep	2	SENT_323	[p17l1162t836r1211b884],
5	‘“	CD	NUMBER	‘“	dep	4	SENT_323	[p17l1238t853r1304b871],
6	"	``	O	"	punct	5	SENT_323	[p17l1238t853r1304b871],
7	+	CC	O	+	cc	5	SENT_323	[p17l1563t853r1650b905],
8	.	.	O	.	_	0	SENT_323	[p17l1563t853r1650b905],

1	F	NN	O	f	nsubj	6	SENT_324	[p17l1563t853r1650b905],
2	+	CC	O	+	cc	6	SENT_324	[p17l1563t853r1650b905],
3	+	CC	O	+	cc	6	SENT_324	[p17l1964t853r2044b908, p17l360t953r554b1008],
4	£	CD	NUMBER	£	num	6	SENT_324	[p17l1964t853r2044b908, p17l360t953r554b1008],
5	CDX-1	NN	O	cdx-1	nn	6	SENT_324	[p17l1964t853r2044b908, p17l360t953r554b1008],
6	Pro1	NN	O	pro1	_	0	SENT_324	[p17l588t956r875b1009],
7	?	.	O	?	_	0	SENT_324	[p17l588t956r875b1009],
8	'	''	O	'	_	0	SENT_324	[p17l588t956r875b1009],

1	Leu	NN	O	leu	dep	164	SENT_325	[p17l588t956r875b1009],
2	~	NN	O	~	dep	164	SENT_325	[p17l1560t957r1754b1012],
3	CE	NN	O	ce	dep	164	SENT_325	[p17l1560t957r1754b1012],
4	)	NN	O	)	dep	164	SENT_325	[p17l1560t957r1754b1012],
5	X	NN	O	x	dep	164	SENT_325	[p17l1560t957r1754b1012],
6	-	:	O	-	_	0	SENT_325	[p17l1560t957r1754b1012],
7	=	JJ	O	=	dep	164	SENT_325	[p17l1560t957r1754b1012],
8	1	CD	NUMBER	1	dep	164	SENT_325	[p17l1560t957r1754b1012],
9	Pl	NN	O	pl	dep	164	SENT_325	[p17l1788t957r2078b1012],
10	[	NN	O	[	dep	164	SENT_325	[p17l1788t957r2078b1012],
11	'	POS	O	'	_	0	SENT_325	[p17l1788t957r2078b1012],
12	¥	NN	O	¥	dep	164	SENT_325	[p17l1788t957r2078b1012],
13	D17LEUi	NN	O	d17leuus	dep	164	SENT_325	[p17l1788t957r2078b1012],
14	aspirin	NN	O	aspirin	dep	164	SENT_325	[p17l8t1161r322b1244],
15	”	CD	NUMBER	”	dep	164	SENT_325	[p17l8t1161r322b1244],
16	or	CC	O	or	dep	164	SENT_325	[p17l358t1182r431b1224],
17	tNSAIDs	NNS	O	tnsaid	dep	164	SENT_325	[p17l462t1160r901b1226],
18	.20	CD	NUMBER	.20	dep	164	SENT_325	[p17l462t1160r901b1226],
19	PGI2	NN	O	pgi2	dep	164	SENT_325	[p17l934t1161r1117b1238],
20	acts	VBZ	O	act	dep	164	SENT_325	[p17l1151t1179r1287b1224],
21	as	IN	O	as	dep	164	SENT_325	[p17l1319t1183r1385b1224],
22	a	DT	O	a	dep	164	SENT_325	[p17l1417t1184r1453b1224],
23	constraint	NN	O	constraint	dep	164	SENT_325	[p17l1483t1162r1853b1224],
24	in	FW	O	in	dep	164	SENT_325	[p17l1886t1162r1957b1223],
25	vivo	FW	O	vivo	dep	164	SENT_325	[p17l1986t1162r2141b1224],
26	on	IN	O	on	dep	164	SENT_325	[p17l9t1292r98b1334],
27	the	DT	O	the	dep	164	SENT_325	[p17l144t1269r258b1334],
28	cardiovascular	JJ	O	cardiovascular	dep	164	SENT_325	[p17l305t1269r830b1334],
29	effects	NNS	O	effect	dep	164	SENT_325	[p17l874t1267r1102b1334],
30	of	IN	O	of	dep	164	SENT_325	[p17l1150t1267r1228b1334],
31	TxA2	NN	O	txa2	dep	164	SENT_325	[p17l1261t1269r1549b1348],
32	,12	CD	NUMBER	,12	dep	164	SENT_325	[p17l1261t1269r1549b1348],
33	which	WDT	O	which	dep	164	SENT_325	[p17l1596t1269r1822b1334],
34	include	VBP	O	include	dep	164	SENT_325	[p17l1869t1269r2141b1334],
35	platelet	NN	O	platelet	dep	164	SENT_325	[p17l6t1379r287b1464],
36	aggregation	NN	O	aggregation	dep	164	SENT_325	[p17l319t1380r852b1464],
37	,	,	O	,	_	0	SENT_325	[p17l319t1380r852b1464],
38	”	NN	O	”	dep	164	SENT_325	[p17l319t1380r852b1464],
39	elevation	NN	O	elevation	dep	164	SENT_325	[p17l884t1379r1217b1444],
40	of	IN	O	of	dep	164	SENT_325	[p17l1248t1376r1326b1444],
41	blood	NN	O	blood	dep	164	SENT_325	[p17l1347t1376r1554b1445],
42	pressure	NN	O	pressure	dep	164	SENT_325	[p17l1584t1381r1977b1464],
43	,30	CD	NUMBER	,30	dep	164	SENT_325	[p17l1584t1381r1977b1464],
44	and	CC	O	and	dep	164	SENT_325	[p17l2009t1379r2140b1444],
45	acceleration	NN	O	acceleration	dep	164	SENT_325	[p17l8t1488r445b1554],
46	of	IN	O	of	dep	164	SENT_325	[p17l479t1486r556b1554],
47	atherogenesis	NN	O	atherogenesis	dep	164	SENT_325	[p17l578t1486r1244b1574],
48	.14	NN	NUMBER	.14	dep	164	SENT_325	[p17l578t1486r1244b1574],
49	=	JJ	O	=	dep	164	SENT_325	[p17l578t1486r1244b1574],
50	31	CD	NUMBER	31	dep	164	SENT_325	[p17l578t1486r1244b1574],
51	This	DT	O	this	dep	164	SENT_325	[p17l1281t1489r1446b1554],
52	last	JJ	O	last	dep	164	SENT_325	[p17l1481t1488r1606b1554],
53	effect	NN	O	effect	dep	164	SENT_325	[p17l1641t1486r1837b1554],
54	may	MD	O	may	dep	164	SENT_325	[p17l1871t1513r2026b1574],
55	be	VB	O	be	dep	164	SENT_325	[p17l2059t1486r2141b1554],
56	particularly	RB	O	particularly	dep	164	SENT_325	[p17l6t1599r440b1684],
57	pertinent	JJ	O	pertinent	dep	164	SENT_325	[p17l481t1601r827b1684],
58	to	TO	O	to	dep	164	SENT_325	[p17l872t1618r943b1664],
59	the	DT	O	the	dep	164	SENT_325	[p17l987t1599r1102b1664],
60	“	NN	O	“	dep	164	SENT_325	[p17l1149t1599r1397b1664],
61	latent	JJ	O	latent	dep	164	SENT_325	[p17l1149t1599r1397b1664],
62	period	NN	O	period	dep	164	SENT_325	[p17l1438t1599r1711b1684],
63	”	NN	O	”	dep	164	SENT_325	[p17l1438t1599r1711b1684],
64	before	IN	O	before	dep	164	SENT_325	[p17l1759t1596r1982b1665],
65	the	DT	O	the	dep	164	SENT_325	[p17l2027t1599r2141b1664],
66	emergence	NN	O	emergence	dep	164	SENT_325	[p17l9t1731r401b1794],
67	of	IN	O	of	dep	164	SENT_325	[p17l442t1706r520b1774],
68	cardiovascular	JJ	O	cardiovascular	dep	164	SENT_325	[p17l550t1708r1074b1774],
69	risk	NN	O	risk	dep	164	SENT_325	[p17l1114t1706r1252b1774],
70	in	IN	O	in	dep	164	SENT_325	[p17l1292t1711r1364b1773],
71	the	DT	O	the	dep	164	SENT_325	[p17l1404t1709r1519b1774],
72	APPROVe	NN	O	approve	dep	164	SENT_325	[p17l1558t1709r1968b1774],
73	and	CC	O	and	dep	164	SENT_325	[p17l2009t1708r2141b1774],
74	APC	NN	O	apc	dep	164	SENT_325	[p17l7t1819r183b1884],
75	studies	NNS	O	study	dep	164	SENT_325	[p17l214t1816r575b1884],
76	.6	CD	NUMBER	.6	dep	164	SENT_325	[p17l214t1816r575b1884],
77	’	NN	O	’	dep	164	SENT_325	[p17l214t1816r575b1884],
78	7	CD	NUMBER	7	dep	164	SENT_325	[p17l214t1816r575b1884],
79	Deletion	NN	O	deletion	dep	164	SENT_325	[p17l606t1819r929b1884],
80	of	IN	O	of	dep	164	SENT_325	[p17l958t1816r1036b1884],
81	the	DT	O	the	dep	164	SENT_325	[p17l1054t1819r1168b1884],
82	PGI2	NN	O	pgi2	dep	164	SENT_325	[p17l1199t1820r1382b1898],
83	receptor	NN	O	receptor	dep	164	SENT_325	[p17l1414t1819r1931b1904],
84	—	IN	O	—	dep	164	SENT_325	[p17l1414t1819r1931b1904],
85	the	DT	O	the	dep	164	SENT_325	[p17l1414t1819r1931b1904],
86	IP	NNP	O	IP	dep	164	SENT_325	[p17l1960t1821r2144b1883],
87	—	NN	O	—	dep	164	SENT_325	[p17l1960t1821r2144b1883],
88	accelerates	VBZ	O	accelerate	dep	164	SENT_325	[p17l8t1929r395b1995],
89	the	DT	O	the	dep	164	SENT_325	[p17l437t1929r551b1995],
90	initiation	NN	O	initiation	dep	164	SENT_325	[p17l592t1932r941b1995],
91	and	CC	O	and	dep	164	SENT_325	[p17l980t1929r1112b1995],
92	early	JJ	O	early	dep	164	SENT_325	[p17l1152t1929r1328b2014],
93	development	NN	O	development	dep	164	SENT_325	[p17l1367t1929r1847b2014],
94	of	IN	O	of	dep	164	SENT_325	[p17l1887t1927r1965b1995],
95	atherosclerosis	NN	O	atherosclerosis	dep	164	SENT_325	[p17l1993t1929r2139b1994, p17l9t2038r422b2103],
96	in	IN	O	in	dep	164	SENT_325	[p17l484t2040r555b2101],
97	2	CD	NUMBER	2	dep	164	SENT_325	[p17l617t2041r655b2101],
98	mouse	NN	O	mouse	dep	164	SENT_325	[p17l718t2062r954b2103],
99	models	NNS	O	model	dep	164	SENT_325	[p17l1013t2035r1448b2103],
100	.1452	CD	NUMBER	.1452	dep	164	SENT_325	[p17l1013t2035r1448b2103],
101	In	IN	O	in	dep	164	SENT_325	[p17l1510t2040r1588b2101],
102	this	DT	O	this	dep	164	SENT_325	[p17l1648t2038r1783b2103],
103	context	NN	O	context	dep	164	SENT_325	[p17l1844t2057r2139b2116],
104	,	,	O	,	_	0	SENT_325	[p17l1844t2057r2139b2116],
105	COX-2-derived	JJ	O	cox-2-derived	dep	164	SENT_325	[p17l9t2147r597b2212],
106	PGI2	NN	O	pgi2	dep	164	SENT_325	[p17l648t2148r831b2226],
107	acts	VBZ	O	act	dep	164	SENT_325	[p17l882t2166r1018b2212],
108	to	TO	O	to	dep	164	SENT_325	[p17l1069t2166r1140b2212],
109	limit	VB	O	limit	dep	164	SENT_325	[p17l1190t2147r1375b2211],
110	the	DT	O	the	dep	164	SENT_325	[p17l1425t2147r1540b2212],
111	interactions	NNS	O	interaction	dep	164	SENT_325	[p17l1590t2150r2024b2212],
112	of	IN	O	of	dep	164	SENT_325	[p17l2075t2145r2152b2212],
113	leucocytes	NNS	O	leucocyte	dep	164	SENT_325	[p17l9t2254r384b2339],
114	and	CC	O	and	dep	164	SENT_325	[p17l437t2254r569b2319],
115	platelets	NNS	O	platelet	dep	164	SENT_325	[p17l619t2254r931b2339],
116	with	IN	O	with	dep	164	SENT_325	[p17l984t2255r1155b2319],
117	the	DT	O	the	dep	164	SENT_325	[p17l1208t2255r1322b2319],
118	vasculature	NN	O	vasculature	dep	164	SENT_325	[p17l1373t2254r1789b2319],
119	and	CC	O	and	dep	164	SENT_325	[p17l1841t2254r1973b2319],
120	the	DT	O	the	dep	164	SENT_325	[p17l2027t2255r2141b2319],
121	attendant	JJ	O	attendant	dep	164	SENT_325	[p17l8t2363r363b2429],
122	oxidant	JJ	O	oxidant	dep	164	SENT_325	[p17l403t2363r681b2429],
123	stress	NN	O	stress	dep	164	SENT_325	[p17l722t2382r940b2442],
124	,	,	O	,	_	0	SENT_325	[p17l722t2382r940b2442],
125	thereby	RB	O	thereby	dep	164	SENT_325	[p17l982t2361r1261b2448],
126	restraining	VBG	O	restrain	dep	164	SENT_325	[p17l1301t2366r1702b2448],
127	atherogen	NN	O	atherogen	dep	164	SENT_325	[p17l1743t2363r2139b2448],
128	—	NN	O	—	dep	164	SENT_325	[p17l1743t2363r2139b2448],
129	esis	VBZ	O	esis	dep	164	SENT_325	[p17l9t2472r307b2540],
130	.14	NN	NUMBER	.14	dep	164	SENT_325	[p17l9t2472r307b2540],
131	=	JJ	O	=	dep	164	SENT_325	[p17l9t2472r307b2540],
132	32	CD	NUMBER	32	dep	164	SENT_325	[p17l9t2472r307b2540],
133	Epidemiologic	JJ	O	epidemiologic	dep	164	SENT_325	[p17l347t2474r892b2560],
134	approaches	NNS	O	approach	dep	164	SENT_325	[p17l930t2475r1333b2560],
135	and	CC	O	and	dep	164	SENT_325	[p17l1371t2474r1525b2554],
136	,	,	O	,	_	0	SENT_325	[p17l1371t2474r1525b2554],
137	indeed	RB	O	indeed	dep	164	SENT_325	[p17l1566t2474r1834b2554],
138	,	,	O	,	_	0	SENT_325	[p17l1566t2474r1834b2554],
139	clinical	JJ	O	clinical	dep	164	SENT_325	[p17l1874t2475r2140b2540],
140	trials	NNS	O	trial	dep	164	SENT_325	[p17l9t2585r193b2651],
141	have	VBP	O	have	dep	164	SENT_325	[p17l233t2585r397b2650],
142	relatively	RB	O	relatively	dep	164	SENT_325	[p17l436t2585r780b2670],
143	poor	JJ	O	poor	dep	164	SENT_325	[p17l815t2608r983b2670],
144	precision	NN	O	precision	dep	164	SENT_325	[p17l1018t2587r1353b2670],
145	for	IN	O	for	dep	164	SENT_325	[p17l1391t2583r1492b2651],
146	detection	NN	O	detection	dep	164	SENT_325	[p17l1528t2585r1872b2651],
147	of	IN	O	of	dep	164	SENT_325	[p17l1910t2583r1988b2650],
148	uncommon	JJ	O	uncommon	dep	164	SENT_325	[p17l2015t2608r2139b2650, p17l9t2716r353b2772],
149	,	,	O	,	_	0	SENT_325	[p17l2015t2608r2139b2650, p17l9t2716r353b2772],
150	but	CC	O	but	dep	164	SENT_325	[p17l408t2691r533b2759],
151	serious	JJ	O	serious	dep	164	SENT_325	[p17l586t2696r859b2772],
152	,	,	O	,	_	0	SENT_325	[p17l586t2696r859b2772],
153	adverse	JJ	O	adverse	dep	164	SENT_325	[p17l913t2693r1180b2758],
154	effects	NNS	O	effect	dep	164	SENT_325	[p17l1233t2691r1485b2772],
155	,	,	O	,	_	0	SENT_325	[p17l1233t2691r1485b2772],
156	such	JJ	O	such	dep	164	SENT_325	[p17l1540t2694r1703b2758],
157	as	IN	O	as	dep	164	SENT_325	[p17l1755t2717r1820b2758],
158	clinical	JJ	O	clinical	dep	164	SENT_325	[p17l1874t2693r2140b2758],
159	events	NNS	O	event	dep	164	SENT_325	[p17l9t2829r237b2876],
160	prevalent	JJ	O	prevalent	dep	164	SENT_325	[p17l279t2810r625b2895],
161	in	IN	O	in	dep	164	SENT_325	[p17l669t2812r741b2874],
162	the	DT	O	the	dep	164	SENT_325	[p17l784t2810r898b2875],
163	relevant	JJ	O	relevant	dep	164	SENT_325	[p17l942t2810r1236b2876],
164	populations	NNS	O	population	_	0	SENT_325	[p17l1277t2810r1735b2895],
165	.	.	O	.	_	0	SENT_325	[p17l1277t2810r1735b2895],

1	Thus	RB	O	thus	advmod	10	SENT_326	[p17l1781t2810r1991b2889],
2	,	,	O	,	_	0	SENT_326	[p17l1781t2810r1991b2889],
3	biomarkers	NNS	O	biomarker	nsubjpass	10	SENT_326	[p17l2037t2808r2139b2876, p17l9t2917r346b2985],
4	of	IN	O	of	_	0	SENT_326	[p17l374t2917r452b2985],
5	these	DT	O	these	det	7	SENT_326	[p17l469t2920r654b2985],
6	mechanistic	JJ	O	mechanistic	amod	7	SENT_326	[p17l682t2920r1123b2985],
7	effects	NNS	O	effect	prep_of	3	SENT_326	[p17l1151t2917r1380b2985],
8	might	MD	O	might	aux	10	SENT_326	[p17l1408t2920r1637b3005],
9	be	VB	O	be	auxpass	10	SENT_326	[p17l1666t2917r1748b2985],
10	combined	VBN	O	combine	_	0	SENT_326	[p17l1776t2917r2141b2985],
11	with	IN	O	with	_	0	SENT_326	[p17l7t3037r178b3102],
12	measures	NNS	O	measure	prep_with	10	SENT_326	[p17l213t3059r545b3103],
13	of	IN	O	of	_	0	SENT_326	[p17l580t3035r658b3103],
14	drug	NN	O	drug	nn	15	SENT_326	[p17l681t3037r855b3122],
15	response	NN	O	response	prep_of	12	SENT_326	[p17l891t3060r1202b3122],
16	(	CD	NUMBER	(	num	15	SENT_326	[p17l1236t3038r1368b3122],
17	eg	FW	O	eg	tmod	10	SENT_326	[p17l1236t3038r1368b3122],
18	,	,	O	,	_	0	SENT_326	[p17l1236t3038r1368b3122],
19	blood	NN	O	blood	nn	21	SENT_326	[p17l1406t3035r1613b3103],
20	pressure	NN	O	pressure	nn	21	SENT_326	[p17l1645t3038r1975b3122],
21	)	NN	O	)	appos	17	SENT_326	[p17l1645t3038r1975b3122],
22	and	CC	O	and	_	0	SENT_326	[p17l2009t3037r2141b3102],
23	selectivity	NN	O	selectivity	conj_and	21	SENT_326	[p17l9t3146r386b3232],
24	to	TO	O	to	aux	25	SENT_326	[p17l430t3165r501b3212],
25	identify	VB	O	identify	xcomp	10	SENT_326	[p17l545t3144r835b3231],
26	individuals	NNS	O	individual	dobj	25	SENT_326	[p17l879t3146r1291b3212],
27	at	IN	O	at	_	0	SENT_326	[p17l1336t3165r1402b3211],
28	accelerated	VBN	O	accelerate	amod	29	SENT_326	[p17l1446t3146r1850b3212],
29	risk	NN	O	risk	prep_at	25	SENT_326	[p17l1894t3144r2032b3212],
30	of	IN	O	of	_	0	SENT_326	[p17l2075t3144r2153b3212],
31	cardiovascular	JJ	O	cardiovascular	amod	32	SENT_326	[p17l9t3257r534b3322],
32	disease	NN	O	disease	prep_of	29	SENT_326	[p17l566t3257r840b3336],
33	,	,	O	,	_	0	SENT_326	[p17l566t3257r840b3336],
34	prior	RB	O	prior	_	0	SENT_326	[p17l874t3259r1058b3342],
35	to	TO	O	to	_	0	SENT_326	[p17l1091t3276r1162b3322],
36	the	DT	O	the	det	37	SENT_326	[p17l1197t3257r1312b3322],
37	occurrence	NN	O	occurrence	prep_prior_to	25	SENT_326	[p17l1346t3279r1739b3322],
38	of	IN	O	of	_	0	SENT_326	[p17l1773t3254r1851b3322],
39	clinical	JJ	O	clinical	amod	40	SENT_326	[p17l1874t3257r2140b3322],
40	events	NNS	O	event	prep_of	37	SENT_326	[p17l9t3383r257b3429],
41	.	.	O	.	_	0	SENT_326	[p17l9t3383r257b3429],

1	Research	NNP	O	Research	nsubj	3	SENT_327	[p17l293t3365r620b3429],
2	is	VBZ	O	be	cop	3	SENT_327	[p17l650t3367r704b3429],
3	necessary	JJ	O	necessary	_	0	SENT_327	[p17l735t3386r1073b3449],
4	to	TO	O	to	aux	5	SENT_327	[p17l1103t3383r1174b3429],
5	determine	VB	O	determine	xcomp	3	SENT_327	[p17l1203t3364r1579b3429],
6	the	DT	O	the	det	7	SENT_327	[p17l1610t3365r1724b3429],
7	paradigms	NNS	O	paradigm	dobj	5	SENT_327	[p17l1751t3364r2140b3449],
8	within	IN	O	within	_	0	SENT_327	[p17l7t3475r255b3540],
9	which	WDT	O	which	dobj	14	SENT_327	[p17l301t3475r527b3540],
10	COX-2	NN	MISC	cox-2	nn	11	SENT_327	[p17l574t3476r848b3540],
11	inhibitors	NNS	O	inhibitor	nsubjpass	14	SENT_327	[p17l901t3472r1264b3541],
12	can	MD	O	can	aux	14	SENT_327	[p17l1314t3498r1435b3540],
13	be	VB	O	be	auxpass	14	SENT_327	[p17l1482t3472r1565b3541],
14	prescribed	VBN	O	prescribe	prepc_within	5	SENT_327	[p17l1610t3472r1994b3560],
15	for	IN	O	for	_	0	SENT_327	[p17l2042t3472r2142b3540],
16	extended	JJ	O	extended	amod	17	SENT_327	[p17l9t3585r341b3651],
17	periods	NNS	O	period	prep_for	14	SENT_327	[p17l389t3585r658b3670],
18	safely	RB	O	safely	advmod	14	SENT_327	[p17l710t3583r912b3670],
19	in	IN	O	in	_	0	SENT_327	[p17l963t3588r1034b3649],
20	individuals	NNS	O	individual	prep_in	14	SENT_327	[p17l1085t3585r1497b3651],
21	initially	RB	O	initially	advmod	14	SENT_327	[p17l1549t3585r1844b3670],
22	at	IN	O	at	_	0	SENT_327	[p17l1893t3604r1959b3650],
23	low	JJ	O	low	amod	25	SENT_327	[p17l2010t3585r2142b3651],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_327	[p17l9t3695r534b3760],
25	risk	NN	O	risk	prep_at	14	SENT_327	[p17l563t3692r722b3774],
26	,	,	O	,	_	0	SENT_327	[p17l563t3692r722b3774],
27	including	VBG	O	include	_	0	SENT_327	[p17l755t3695r1113b3780],
28	their	PRP$	O	they	poss	30	SENT_327	[p17l1145t3695r1321b3760],
29	potential	JJ	O	potential	amod	30	SENT_327	[p17l1347t3695r1682b3780],
30	use	NN	O	use	prep_including	14	SENT_327	[p17l1713t3719r1828b3760],
31	for	IN	O	for	_	0	SENT_327	[p17l1858t3692r1959b3760],
32	cancer	NN	O	cancer	prep_for	30	SENT_327	[p17l1988t3718r2139b3760, p18l9t39r115b82],

1	prevention	NN	O	prevention	_	0	SENT_328	[p18l148t19r636b101],
2	.	.	O	.	_	0	SENT_328	[p18l148t19r636b101],

1	“	NN	O	“	_	0	SENT_329	[p18l148t19r636b101],

1	We	PRP	O	we	nsubj	2	SENT_330	[p18l106t130r238b193],
2	sought	VBD	O	seek	_	0	SENT_330	[p18l284t128r534b213],
3	to	TO	O	to	aux	4	SENT_330	[p18l580t147r651b193],
4	explore	VB	O	explore	xcomp	2	SENT_330	[p18l697t128r964b213],
5	the	DT	O	the	det	6	SENT_330	[p18l1010t128r1124b193],
6	variability	NN	O	variability	dobj	4	SENT_330	[p18l1167t125r1552b213],
7	in	IN	O	in	_	0	SENT_330	[p18l1597t130r1668b192],
8	response	NN	O	response	prep_in	6	SENT_330	[p18l1714t150r2024b213],
9	to	TO	O	to	_	0	SENT_330	[p18l2070t147r2141b193],
10	coxibs	NNS	O	coxib	prep_to	4	SENT_330	[p18l9t243r237b311],
11	to	TO	O	to	aux	12	SENT_330	[p18l282t264r353b311],
12	examine	VB	O	examine	xcomp	4	SENT_330	[p18l396t248r702b311],
13	the	DT	O	the	det	14	SENT_330	[p18l745t245r860b311],
14	practicality	NN	O	practicality	dobj	12	SENT_330	[p18l901t245r1323b330],
15	of	IN	O	of	_	0	SENT_330	[p18l1366t243r1444b311],
16	such	PDT	O	such	predet	18	SENT_330	[p18l1476t245r1640b311],
17	an	DT	O	a	det	18	SENT_330	[p18l1682t268r1766b310],
18	approach	NN	O	approach	prep_of	14	SENT_330	[p18l1808t245r2141b330],
19	based	VBN	O	base	_	0	SENT_330	[p18l9t352r211b420],
20	on	IN	O	on	prepc_based_on	12	SENT_330	[p18l242t378r331b420],
21	biomarkers	NNS	O	biomarker	pobj	12	SENT_330	[p18l362t352r774b421],
22	of	IN	O	of	_	0	SENT_330	[p18l807t352r885b420],
23	drug	NN	O	drug	nn	24	SENT_330	[p18l904t354r1079b440],
24	response	NN	O	response	prep_of	21	SENT_330	[p18l1111t377r1441b440],
25	.	.	O	.	_	0	SENT_330	[p18l1111t377r1441b440],

1	We	PRP	O	we	nsubj	2	SENT_331	[p18l1477t357r1609b420],
2	assessed	VBD	O	assess	_	0	SENT_331	[p18l1640t354r1929b420],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_331	[p18l1961t355r2139b420, p18l8t466r276b548],
4	doses	NNS	O	dose	dobj	2	SENT_331	[p18l304t463r495b529],
5	of	IN	O	of	_	0	SENT_331	[p18l525t461r602b529],
6	celecoxib	NN	O	celecoxib	prep_of	4	SENT_331	[p18l620t461r957b529],
7	and	CC	O	and	_	0	SENT_331	[p18l985t463r1117b529],
8	rofecoxib	NN	O	rofecoxib	prep_of	4	SENT_331	[p18l1147t461r1507b542],
9	,	,	O	,	_	0	SENT_331	[p18l1147t461r1507b542],
10	using	VBG	O	use	partmod	2	SENT_331	[p18l1537t466r1739b548],
11	a	DT	O	a	det	15	SENT_331	[p18l1768t488r1804b528],
12	placebocontrolled	JJ	O	placebocontrolled	amod	15	SENT_331	[p18l1828t461r2139b548, p18l9t574r408b654],
13	,	,	O	,	_	0	SENT_331	[p18l1828t461r2139b548, p18l9t574r408b654],
14	crossover	JJ	O	crossover	amod	15	SENT_331	[p18l448t597r782b640],
15	design	NN	O	design	dobj	10	SENT_331	[p18l819t574r1060b660],
16	to	TO	O	to	aux	17	SENT_331	[p18l1098t594r1169b640],
17	investigate	VB	O	investigate	xcomp	10	SENT_331	[p18l1209t577r1611b660],
18	variability	NN	O	variability	dobj	17	SENT_331	[p18l1647t572r2032b660],
19	in	IN	O	in	_	0	SENT_331	[p18l2070t577r2142b639],
20	plasma	NN	O	plasma	nn	22	SENT_331	[p18l6t692r268b776],
21	drug	NN	O	drug	nn	22	SENT_331	[p18l315t692r489b776],
22	concentrations	NNS	O	concentration	prep_in	17	SENT_331	[p18l541t694r1079b757],
23	and	CC	O	and	_	0	SENT_331	[p18l1129t692r1261b757],
24	pharmacodynamic	JJ	O	pharmacodynamic	amod	25	SENT_331	[p18l1309t692r1992b776],
25	responses	NNS	O	response	prep_in	17	SENT_331	[p18l2043t714r2139b757, p18l9t824r304b887],
26	,	,	O	,	_	0	SENT_331	[p18l2043t714r2139b757, p18l9t824r304b887],
27	as	IN	O	as	mark	28	SENT_331	[p18l334t826r399b867],
28	assessed	VBN	O	assess	advcl	2	SENT_331	[p18l429t801r718b867],
29	by	IN	O	by	_	0	SENT_331	[p18l747t799r836b887],
30	both	DT	O	both	dep	32	SENT_331	[p18l864t799r1033b868],
31	ex	FW	O	ex	nn	32	SENT_331	[p18l1061t826r1139b867],
32	Vivo	FW	O	vivo	nn	36	SENT_331	[p18l1164t804r1320b867],
33	and	CC	O	and	cc	32	SENT_331	[p18l1347t801r1479b867],
34	in	FW	O	in	nn	35	SENT_331	[p18l1509t804r1580b866],
35	vivo	FW	O	vivo	advmod	32	SENT_331	[p18l1605t804r1761b867],
36	indices	NNS	O	index	prep_by	28	SENT_331	[p18l1791t801r2045b867],
37	of	IN	O	of	_	0	SENT_331	[p18l2075t799r2152b867],
38	COX-1	NN	O	cox-1	nn	41	SENT_331	[p18l9t913r279b978],
39	and	CC	O	and	_	0	SENT_331	[p18l337t912r469b977],
40	COX-2	NN	MISC	cox-2	nn	41	SENT_331	[p18l520t913r793b978],
41	activity	NN	O	activity	prep_of	36	SENT_331	[p18l848t914r1147b997],
42	.	.	O	.	_	0	SENT_331	[p18l848t914r1147b997],

1	Doses	NNS	O	dose	nsubjpass	15	SENT_332	[p18l1201t914r1414b978],
2	of	IN	O	of	_	0	SENT_332	[p18l1466t910r1543b977],
3	celecoxib	NN	O	celecoxib	nn	4	SENT_332	[p18l1582t910r1920b978],
4	(	NN	O	(	prep_of	1	SENT_332	[p18l1971t913r2139b989],
5	200	CD	NUMBER	200	num	7	SENT_332	[p18l1971t913r2139b989],
6	mg	NN	O	mg	nn	7	SENT_332	[p18l8t1023r157b1107],
7	)	NN	O	)	dep	4	SENT_332	[p18l8t1023r157b1107],
8	and	CC	O	and	_	0	SENT_332	[p18l183t1021r315b1087],
9	rofecoxib	NN	O	rofecoxib	prep_of	1	SENT_332	[p18l342t1019r679b1087],
10	(	CD	NUMBER	(	number	11	SENT_332	[p18l707t1023r820b1098],
11	25	CD	NUMBER	25	num	13	SENT_332	[p18l707t1023r820b1098],
12	mg	NN	O	mg	nn	13	SENT_332	[p18l853t1023r1002b1107],
13	)	NN	O	)	dep	9	SENT_332	[p18l853t1023r1002b1107],
14	were	VBD	O	be	auxpass	15	SENT_332	[p18l1027t1044r1198b1087],
15	selected	VBN	O	select	_	0	SENT_332	[p18l1226t1021r1514b1087],
16	that	WDT	O	that	nsubj	18	SENT_332	[p18l1541t1022r1688b1086],
17	have	VBP	O	have	aux	18	SENT_332	[p18l1715t1022r1879b1087],
18	shown	VBN	O	show	ccomp	15	SENT_332	[p18l1907t1022r2141b1087],
19	comparable	JJ	O	comparable	amod	20	SENT_332	[p18l9t1130r434b1217],
20	effectiveness	NN	O	effectiveness	dobj	18	SENT_332	[p18l499t1130r956b1198],
21	in	IN	O	in	_	0	SENT_332	[p18l1023t1134r1094b1196],
22	clinical	JJ	O	clinical	amod	23	SENT_332	[p18l1159t1132r1426b1197],
23	models	NNS	O	model	prep_in	20	SENT_332	[p18l1491t1132r1752b1198],
24	of	IN	O	of	_	0	SENT_332	[p18l1819t1130r1896b1198],
25	acute	JJ	O	acute	amod	27	SENT_332	[p18l1950t1151r2141b1198],
26	pain	NN	O	pain	nn	27	SENT_332	[p18l6t1239r338b1327],
27	.34	NN	NUMBER	.34	prep_of	23	SENT_332	[p18l6t1239r338b1327],
28	=	JJ	O	=	amod	27	SENT_332	[p18l6t1239r338b1327],
29	35	CD	NUMBER	35	tmod	28	SENT_332	[p18l6t1239r338b1327],
30	Thus	RB	O	thus	advmod	18	SENT_332	[p18l371t1242r581b1320],
31	,	,	O	,	_	0	SENT_332	[p18l371t1242r581b1320],
32	perceptible	JJ	O	perceptible	amod	34	SENT_332	[p18l610t1239r1027b1327],
33	pain	NN	O	pain	nn	34	SENT_332	[p18l1055t1244r1217b1327],
34	relief	NN	O	relief	nsubjpass	36	SENT_332	[p18l1247t1239r1444b1307],
35	is	VBZ	O	be	auxpass	36	SENT_332	[p18l1464t1244r1517b1307],
36	achieved	VBN	O	achieve	ccomp	15	SENT_332	[p18l1548t1241r1865b1307],
37	within	IN	O	within	_	0	SENT_332	[p18l1893t1242r2141b1307],
38	1	CD	DURATION	1	num	39	SENT_332	[p18l17t1354r45b1414],
39	hour	NN	NUMBER	hour	prep_within	36	SENT_332	[p18l91t1351r262b1416],
40	of	IN	O	of	_	0	SENT_332	[p18l298t1348r376b1416],
41	administration	NN	O	administration	prep_of	39	SENT_332	[p18l402t1351r954b1416],
42	of	IN	O	of	_	0	SENT_332	[p18l991t1348r1069b1416],
43	these	DT	O	these	det	44	SENT_332	[p18l1095t1351r1281b1416],
44	doses	NNS	O	dose	prep_of	41	SENT_332	[p18l1319t1351r1533b1429],
45	,	,	O	,	_	0	SENT_332	[p18l1319t1351r1533b1429],
46	and	CC	O	and	_	0	SENT_332	[p18l1572t1351r1704b1415],
47	their	PRP$	O	they	poss	51	SENT_332	[p18l1743t1351r1919b1416],
48	maximum	NN	O	maximum	nn	51	SENT_332	[p18l1955t1375r2139b1415, p18l10t1463r233b1526],
49	analgesic	JJ	O	analgesic	amod	51	SENT_332	[p18l266t1460r599b1546],
50	effect	NN	O	effect	nn	51	SENT_332	[p18l634t1458r830b1526],
51	(	NN	O	(	nsubj	85	SENT_332	[p18l864t1462r1028b1537],
52	2	CD	NUMBER	2	number	53	SENT_332	[p18l864t1462r1028b1537],
53	—	CD	NUMBER	—	amod	57	SENT_332	[p18l864t1462r1028b1537],
54	3	CD	DURATION	3	num	55	SENT_332	[p18l864t1462r1028b1537],
55	hours	NNS	NUMBER	hour	dep	53	SENT_332	[p18l1067t1461r1269b1526],
56	postdosing	VBG	O	postdose	amod	57	SENT_332	[p18l1301t1460r1734b1546],
57	)	NN	O	)	nsubj	61	SENT_332	[p18l1301t1460r1734b1546],
58	is	VBZ	O	be	cop	61	SENT_332	[p18l1769t1463r1822b1526],
59	approximately	RB	O	approximately	quantmod	60	SENT_332	[p18l1857t1483r2139b1546, p18l10t1571r288b1656],
60	two	CD	NUMBER	two	num	61	SENT_332	[p18l327t1590r463b1636],
61	thirds	NNS	O	third	rcmod	51	SENT_332	[p18l504t1571r720b1636],
62	that	IN	O	that	complm	63	SENT_332	[p18l761t1571r908b1636],
63	of	IN	O	of	dep	61	SENT_332	[p18l948t1568r1026b1636],
64	high	JJ	O	high	amod	65	SENT_332	[p18l1054t1571r1224b1656],
65	doses	NNS	O	dose	pobj	63	SENT_332	[p18l1263t1571r1453b1636],
66	of	IN	O	of	_	0	SENT_332	[p18l1494t1568r1571b1636],
67	tNSAID	NN	O	tnsaid	nn	68	SENT_332	[p18l1600t1571r1915b1638],
68	comparators	NNS	O	comparator	prep_of	65	SENT_332	[p18l1955t1595r2139b1636, p18l7t1677r474b1764],
69	.34	CD	NUMBER	.34	npadvmod	70	SENT_332	[p18l1955t1595r2139b1636, p18l7t1677r474b1764],
70	>	JJR	O	>	amod	68	SENT_332	[p18l1955t1595r2139b1636, p18l7t1677r474b1764],
71	35	CD	NUMBER	35	dep	70	SENT_332	[p18l1955t1595r2139b1636, p18l7t1677r474b1764],
72	Despite	IN	O	despite	dep	71	SENT_332	[p18l528t1681r812b1764],
73	the	DT	O	the	det	76	SENT_332	[p18l863t1679r978b1745],
74	higher	JJR	O	higher	amod	76	SENT_332	[p18l1028t1679r1271b1764],
75	COX-2	NN	MISC	cox-2	nn	76	SENT_332	[p18l1319t1681r1593b1745],
76	selectivity	NN	O	selectivity	pobj	72	SENT_332	[p18l1649t1679r2025b1764],
77	of	IN	O	of	_	0	SENT_332	[p18l2075t1677r2152b1745],
78	rofecoxib	NN	O	rofecoxib	prep_of	76	SENT_332	[p18l9t1788r346b1857],
79	in	FW	O	in	nn	80	SENT_332	[p18l401t1793r472b1855],
80	vitro	FW	O	vitro	advmod	61	SENT_332	[p18l522t1793r722b1870],
81	,	,	O	,	_	0	SENT_332	[p18l522t1793r722b1870],
82	the	DT	O	the	det	84	SENT_332	[p18l777t1791r892b1856],
83	average	JJ	O	average	amod	84	SENT_332	[p18l945t1814r1218b1876],
84	selectivity	NN	O	selectivity	attr	61	SENT_332	[p18l1272t1791r1648b1876],
85	attained	VBN	O	attain	conj_and	15	SENT_332	[p18l1700t1791r2000b1856],
86	by	IN	O	by	_	0	SENT_332	[p18l2054t1788r2142b1876],
87	62	CD	NUMBER	62	num	88	SENT_332	[p18l10t1907r87b1956],
88	FRIES	NNS	O	fries	prep_by	85	SENT_332	[p18l167t1907r340b1956],
89	ET	NNP	O	ET	nn	90	SENT_332	[p18l370t1907r438b1955],
90	AL	NNP	O	AL	dep	88	SENT_332	[p18l462t1907r539b1955],

1	these	DT	O	these	det	2	SENT_333	[p18l10t2119r195b2183],
2	doses	NNS	O	dose	nsubj	11	SENT_333	[p18l240t2119r431b2183],
3	of	IN	O	of	_	0	SENT_333	[p18l477t2116r554b2183],
4	rofecoxib	NN	O	rofecoxib	prep_of	2	SENT_333	[p18l588t2116r926b2184],
5	and	CC	O	and	_	0	SENT_333	[p18l970t2119r1102b2183],
6	celecoxib	NN	O	celecoxib	prep_of	2	SENT_333	[p18l1148t2116r1485b2184],
7	in	IN	O	in	_	0	SENT_333	[p18l1531t2121r1603b2182],
8	Vivo	NNP	O	Vivo	prep_in	4	SENT_333	[p18l1645t2121r1800b2183],
9	was	VBD	O	be	cop	11	SENT_333	[p18l1844t2142r1976b2183],
10	not	RB	O	not	neg	11	SENT_333	[p18l2023t2138r2141b2183],
11	different	JJ	O	different	_	0	SENT_333	[p18l9t2225r349b2306],
12	,	,	O	,	_	0	SENT_333	[p18l9t2225r349b2306],
13	suggesting	VBG	O	suggest	xcomp	11	SENT_333	[p18l387t2229r789b2312],
14	that	IN	O	that	complm	31	SENT_333	[p18l826t2227r973b2292],
15	both	CC	O	both	preconj	16	SENT_333	[p18l1009t2225r1179b2293],
16	efﬁcacy	NN	O	efﬁcacy	nsubj	31	SENT_333	[p18l1214t2225r1482b2312],
17	and	CC	O	and	_	0	SENT_333	[p18l1517t2227r1648b2293],
18	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_333	[p18l1685t2227r2140b2293, p18l10t2338r105b2403],
19	and	CC	O	and	_	0	SENT_333	[p18l140t2338r272b2404],
20	gastrointestinal	JJ	O	gastrointestinal	conj_and	18	SENT_333	[p18l309t2338r887b2424],
21	safety	NN	O	safety	nn	22	SENT_333	[p18l926t2336r1134b2424],
22	proﬁles	NNS	O	proﬁles	nsubj	31	SENT_333	[p18l1168t2336r1437b2424],
23	of	IN	O	of	_	0	SENT_333	[p18l1476t2336r1554b2404],
24	the	DT	O	the	det	25	SENT_333	[p18l1580t2339r1695b2404],
25	drugs	NNS	O	drug	prep_of	22	SENT_333	[p18l1732t2338r1939b2424],
26	after	IN	O	after	_	0	SENT_333	[p18l1978t2336r2144b2404],
27	acute	JJ	O	acute	amod	28	SENT_333	[p18l9t2468r201b2514],
28	dosing	NN	O	dosing	prep_after	25	SENT_333	[p18l238t2449r483b2534],
29	might	MD	O	might	aux	31	SENT_333	[p18l521t2449r751b2534],
30	be	VB	O	be	cop	31	SENT_333	[p18l789t2446r870b2515],
31	similar	JJ	O	similar	ccomp	13	SENT_333	[p18l908t2449r1184b2514],
32	.	.	O	.	_	0	SENT_333	[p18l908t2449r1184b2514],

1	This	DT	O	this	nsubj	3	SENT_334	[p18l1225t2449r1389b2514],
2	might	MD	O	might	aux	3	SENT_334	[p18l1428t2449r1657b2534],
3	differ	VB	O	differ	_	0	SENT_334	[p18l1694t2446r1893b2514],
4	under	IN	O	under	_	0	SENT_334	[p18l1928t2449r2144b2514],
5	chronic	JJ	O	chronic	amod	7	SENT_334	[p18l10t2557r282b2622],
6	dosing	NN	O	dosing	nn	7	SENT_334	[p18l341t2557r586b2641],
7	conditions	NNS	O	condition	prep_under	3	SENT_334	[p18l646t2557r1032b2622],
8	when	WRB	O	when	advmod	23	SENT_334	[p18l1090t2557r1289b2622],
9	the	DT	O	the	det	15	SENT_334	[p18l1348t2557r1462b2622],
10	more	JJR	O	more	dep	11	SENT_334	[p18l1521t2579r1707b2622],
11	prolonged	JJ	O	prolonged	amod	15	SENT_334	[p18l1763t2557r2142b2641],
12	half	NN	O	half	nn	15	SENT_334	[p18l10t2665r299b2733],
13	—	JJ	O	—	amod	15	SENT_334	[p18l10t2665r299b2733],
14	life	NN	O	life	nn	15	SENT_334	[p18l10t2665r299b2733],
15	(	NN	O	(	nsubjpass	23	SENT_334	[p18l339t2669r455b2744],
16	on	IN	O	on	_	0	SENT_334	[p18l339t2669r455b2744],
17	average	JJ	O	average	amod	18	SENT_334	[p18l493t2669r794b2753],
18	)	NN	O	)	prep_on	15	SENT_334	[p18l493t2669r794b2753],
19	of	IN	O	of	_	0	SENT_334	[p18l834t2665r912b2733],
20	rofecoxib	NN	O	rofecoxib	prep_of	18	SENT_334	[p18l940t2665r1277b2733],
21	would	MD	O	would	aux	23	SENT_334	[p18l1316t2667r1547b2733],
22	be	VB	O	be	auxpass	23	SENT_334	[p18l1587t2665r1669b2733],
23	expected	VBN	O	expect	advcl	3	SENT_334	[p18l1709t2667r2030b2753],
24	to	TO	O	to	_	0	SENT_334	[p18l2071t2686r2142b2733],
25	inﬂuence	NN	O	inﬂuence	prep_to	23	SENT_334	[p18l11t2775r342b2843],
26	both	CC	O	both	prep	25	SENT_334	[p18l397t2775r566b2844],
27	relative	JJ	O	relative	amod	28	SENT_334	[p18l621t2778r893b2843],
28	efﬁcacy	NN	O	efﬁcacy	dep	26	SENT_334	[p18l947t2775r1216b2863],
29	and	CC	O	and	_	0	SENT_334	[p18l1268t2778r1400b2843],
30	the	DT	O	the	det	33	SENT_334	[p18l1455t2778r1570b2843],
31	adverse	JJ	O	adverse	amod	33	SENT_334	[p18l1623t2778r1891b2843],
32	effect	NN	O	effect	nn	33	SENT_334	[p18l1945t2775r2142b2843],
33	proﬁle	NN	O	proﬁle	conj_and	28	SENT_334	[p18l8t2886r264b2973],
34	.	.	O	.	_	0	SENT_334	[p18l8t2886r264b2973],

1	However	RB	O	however	advmod	10	SENT_335	[p18l323t2891r678b2967],
2	,	,	O	,	_	0	SENT_335	[p18l323t2891r678b2967],
3	again	RB	O	again	advmod	10	SENT_335	[p18l733t2891r953b2973],
4	,	,	O	,	_	0	SENT_335	[p18l733t2891r953b2973],
5	interindividual	JJ	O	interindividual	amod	6	SENT_335	[p18l1010t2888r1570b2954],
6	differences	NNS	O	difference	nsubj	10	SENT_335	[p18l1623t2886r2015b2954],
7	in	IN	O	in	_	0	SENT_335	[p18l2071t2891r2142b2952],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	6	SENT_335	[p18l7t3002r662b3090],
9	might	MD	O	might	aux	10	SENT_335	[p18l715t3005r945b3090],
10	modulate	VB	O	modulate	_	0	SENT_335	[p18l997t3004r1346b3070],
11	that	IN	O	that	complm	12	SENT_335	[p18l1399t3005r1546b3069],
12	expectation	NN	O	expectation	dep	10	SENT_335	[p18l1599t3007r2024b3090],
13	at	IN	O	at	dep	12	SENT_335	[p18l2076t3023r2141b3069],
14	the	DT	O	the	det	16	SENT_335	[p18l10t3113r125b3177],
15	individual	JJ	O	individual	amod	16	SENT_335	[p18l185t3113r565b3177],
16	level	NN	O	level	pobj	13	SENT_335	[p18l625t3113r814b3177],
17	.	.	O	.	_	0	SENT_335	[p18l625t3113r814b3177],

1	We	PRP	O	we	nsubj	2	SENT_336	[p18l877t3115r1009b3177],
2	determined	VBD	O	determine	_	0	SENT_336	[p18l1069t3113r1494b3177],
3	both	CC	O	both	preconj	4	SENT_336	[p18l1554t3110r1723b3178],
4	interindividual	JJ	O	interindividual	amod	7	SENT_336	[p18l1783t3113r2140b3177, p18l8t3223r239b3289],
5	and	CC	O	and	_	0	SENT_336	[p18l280t3223r412b3289],
6	intraindividual	JJ	O	intraindividual	amod	7	SENT_336	[p18l454t3223r1013b3289],
7	variability	NN	O	variability	dobj	2	SENT_336	[p18l1053t3221r1438b3308],
8	in	IN	O	in	_	0	SENT_336	[p18l1479t3226r1550b3287],
9	drug	NN	O	drug	nn	10	SENT_336	[p18l1590t3223r1764b3308],
10	response	NN	O	response	prep_in	2	SENT_336	[p18l1808t3246r2140b3308],
11	,	,	O	,	_	0	SENT_336	[p18l1808t3246r2140b3308],
12	the	DT	O	the	det	13	SENT_336	[p18l10t3333r125b3398],
13	latter	JJ	O	latter	nsubj	24	SENT_336	[p18l162t3332r360b3398],
14	to	TO	O	to	aux	15	SENT_336	[p18l397t3351r467b3398],
15	assess	VB	O	assess	dep	2	SENT_336	[p18l504t3357r706b3398],
16	the	DT	O	the	det	17	SENT_336	[p18l744t3333r859b3398],
17	stability	NN	O	stability	dobj	15	SENT_336	[p18l897t3330r1202b3418],
18	of	IN	O	of	_	0	SENT_336	[p18l1238t3330r1316b3398],
19	the	DT	O	the	det	21	SENT_336	[p18l1342t3333r1457b3398],
20	biochemical	JJ	O	biochemical	amod	21	SENT_336	[p18l1495t3330r1940b3398],
21	phenotype	NN	O	phenotype	prep_of	17	SENT_336	[p18l1976t3333r2140b3418, p18l11t3468r261b3534],
22	and	CC	O	and	_	0	SENT_336	[p18l308t3449r440b3514],
23	to	TO	O	to	aux	24	SENT_336	[p18l489t3468r560b3514],
24	get	VB	O	get	dep	2	SENT_336	[p18l606t3468r723b3534],
25	an	DT	O	a	det	26	SENT_336	[p18l771t3472r854b3514],
26	impression	NN	O	impression	dobj	24	SENT_336	[p18l902t3451r1305b3534],
27	of	IN	O	of	_	0	SENT_336	[p18l1353t3446r1430b3514],
28	whether	IN	O	whether	complm	38	SENT_336	[p18l1465t3449r1769b3514],
29	variation	NN	O	variation	nsubj	38	SENT_336	[p18l1812t3451r2143b3514],
30	attributable	JJ	O	attributable	amod	29	SENT_336	[p18l9t3556r451b3623],
31	to	TO	O	to	_	0	SENT_336	[p18l486t3577r557b3623],
32	environmental	JJ	O	environmental	amod	35	SENT_336	[p18l591t3558r1130b3623],
33	and	CC	O	and	_	0	SENT_336	[p18l1165t3558r1296b3623],
34	random	JJ	O	random	conj_and	32	SENT_336	[p18l1331t3558r1615b3623],
35	effects	NNS	O	effect	prep_to	30	SENT_336	[p18l1649t3556r1877b3623],
36	would	MD	O	would	aux	38	SENT_336	[p18l1911t3558r2142b3623],
37	be	VB	O	be	cop	38	SENT_336	[p18l10t3665r92b3733],
38	sufﬁcient	JJ	O	sufﬁcient	prepc_of	26	SENT_336	[p18l135t3665r472b3733],
39	to	TO	O	to	aux	40	SENT_336	[p18l515t3686r586b3733],
40	obscure	VB	O	obscure	xcomp	38	SENT_336	[p18l628t3665r907b3733],
41	a	DT	O	a	det	43	SENT_336	[p18l948t3692r985b3732],
42	genetic	JJ	O	genetic	amod	43	SENT_336	[p18l1023t3670r1291b3753],
43	contribution	NN	O	contribution	dobj	40	SENT_336	[p18l1334t3665r1822b3733],
44	.	.	O	.	_	0	SENT_336	[p18l1334t3665r1822b3733],

1	Signiﬁcant	NN	O	signiﬁcant	_	0	SENT_337	[p18l1869t3665r2140b3753, p19l10t40r162b86],

1	intraindividual	JJ	O	intraindividual	amod	2	SENT_338	[p19l194t21r754b86],
2	variability	NN	O	variability	nsubj	4	SENT_338	[p19l782t18r1167b106],
3	was	VBD	O	be	cop	4	SENT_338	[p19l1195t45r1326b86],
4	evident	JJ	O	evident	_	0	SENT_338	[p19l1357t21r1630b86],
5	in	IN	O	in	_	0	SENT_338	[p19l1661t23r1733b85],
6	all	DT	O	all	det	7	SENT_338	[p19l1762t21r1850b86],
7	parameters	NNS	O	parameter	prep_in	4	SENT_338	[p19l1878t43r2140b106, p19l10t148r178b194],
8	as	IN	O	as	mark	11	SENT_338	[p19l206t153r271b194],
9	5	CD	NUMBER	5	num	10	SENT_338	[p19l304t133r336b197],
10	individuals	NNS	O	individual	nsubj	11	SENT_338	[p19l371t129r784b194],
11	progressed	VBD	O	progress	advcl	4	SENT_338	[p19l809t129r1204b213],
12	through	IN	O	through	_	0	SENT_338	[p19l1232t129r1531b213],
13	the	DT	O	the	det	15	SENT_338	[p19l1558t129r1673b194],
14	entire	JJ	O	entire	amod	15	SENT_338	[p19l1700t131r1913b194],
15	study	NN	O	study	prep_through	11	SENT_338	[p19l1940t129r2143b213],
16	on	IN	O	on	_	0	SENT_338	[p19l10t262r98b305],
17	5	CD	NUMBER	5	num	18	SENT_338	[p19l130t243r162b308],
18	occasions	NNS	O	occasion	prep_on	11	SENT_338	[p19l196t242r554b305],
19	.	.	O	.	_	0	SENT_338	[p19l196t242r554b305],

1	Some	DT	O	some	nsubj	12	SENT_339	[p19l586t241r783b305],
2	of	IN	O	of	_	0	SENT_339	[p19l810t237r887b305],
3	the	DT	O	the	det	4	SENT_339	[p19l904t240r1018b305],
4	variation	NN	O	variation	prep_of	1	SENT_339	[p19l1043t242r1395b318],
5	,	,	O	,	_	0	SENT_339	[p19l1043t242r1395b318],
6	evident	JJ	O	evident	amod	1	SENT_339	[p19l1424t239r1697b305],
7	on	IN	O	on	_	0	SENT_339	[p19l1724t262r1813b305],
8	placebo	NN	O	placebo	prep_on	6	SENT_339	[p19l1837t237r2140b325],
9	,	,	O	,	_	0	SENT_339	[p19l1837t237r2140b325],
10	may	MD	O	may	aux	12	SENT_339	[p19l9t374r164b435],
11	have	VB	O	have	aux	12	SENT_339	[p19l191t350r355b415],
12	derived	VBN	O	derive	_	0	SENT_339	[p19l384t350r657b415],
13	from	IN	O	from	_	0	SENT_339	[p19l685t347r861b415],
14	circadian	JJ	O	circadian	amod	15	SENT_339	[p19l889t350r1222b415],
15	variability	NN	O	variability	prep_from	12	SENT_339	[p19l1248t347r1633b435],
16	because	IN	O	because	mark	19	SENT_339	[p19l1661t347r1939b416],
17	samples	NNS	O	sample	nsubjpass	19	SENT_339	[p19l1968t374r2140b415, p19l8t458r151b543],
18	were	VBD	O	be	auxpass	19	SENT_339	[p19l189t481r360b524],
19	obtained	VBN	O	obtain	conj_and	19	SENT_339	[p19l399t456r720b524],
20	at	IN	O	at	_	0	SENT_339	[p19l758t477r824b523],
21	discrete	JJ	O	discrete	amod	23	SENT_339	[p19l863t458r1147b524],
22	time	NN	O	time	nn	23	SENT_339	[p19l1186t460r1355b524],
23	points	NNS	O	point	prep_at	19	SENT_339	[p19l1391t461r1621b543],
24	before	IN	O	before	_	0	SENT_339	[p19l1662t456r1885b524],
25	(	CD	NUMBER	(	number	26	SENT_339	[p19l1923t460r2140b535],
26	0800	CD	TIME	0800	num	27	SENT_339	[p19l1923t460r2140b535],
27	hours	NNS	NUMBER	hour	prep_before	19	SENT_339	[p19l10t570r239b646],
28	)	CD	NUMBER	)	tmod	19	SENT_339	[p19l10t570r239b646],
29	and	CC	O	and	_	0	SENT_339	[p19l278t569r409b635],
30	after	IN	O	after	_	0	SENT_339	[p19l448t567r614b635],
31	(	CD	NUMBER	(	number	32	SENT_339	[p19l652t571r869b646],
32	1200	CD	TIME	1200	num	33	SENT_339	[p19l652t571r869b646],
33	hours	NNS	NUMBER	hour	prep_after	19	SENT_339	[p19l909t570r1138b646],
34	)	CD	NUMBER	)	num	35	SENT_339	[p19l909t570r1138b646],
35	dosing	NN	O	dosing	dep	19	SENT_339	[p19l1177t569r1443b655],
36	.	.	O	.	_	0	SENT_339	[p19l1177t569r1443b655],

1	Diurnal	JJ	O	diurnal	amod	2	SENT_340	[p19l1486t569r1775b635],
2	variation	NN	O	variation	nsubjpass	12	SENT_340	[p19l1812t572r2143b635],
3	in	IN	O	in	_	0	SENT_340	[p19l11t682r82b744],
4	the	DT	O	the	det	5	SENT_340	[p19l123t680r238b745],
5	indices	NNS	O	index	prep_in	2	SENT_340	[p19l279t680r534b745],
6	of	IN	O	of	_	0	SENT_340	[p19l576t677r654b745],
7	COX	NN	O	cox	nn	8	SENT_340	[p19l683t681r881b745],
8	activity	NN	O	activity	prep_of	5	SENT_340	[p19l921t682r1200b765],
9	has	VBZ	O	have	aux	12	SENT_340	[p19l1240t680r1354b745],
10	not	RB	O	not	neg	12	SENT_340	[p19l1398t699r1517b745],
11	been	VBN	O	be	auxpass	12	SENT_340	[p19l1558t677r1728b746],
12	described	VBN	O	describe	ccomp	40	SENT_340	[p19l1768t677r2140b759],
13	,	,	O	,	_	0	SENT_340	[p19l1768t677r2140b759],
14	but	CC	O	but	_	0	SENT_340	[p19l10t788r135b856],
15	diurnal	JJ	O	diurnal	amod	16	SENT_340	[p19l219t790r487b856],
16	variation	NN	O	variation	ccomp	40	SENT_340	[p19l569t793r899b856],
17	in	IN	O	in	_	0	SENT_340	[p19l984t792r1055b854],
18	the	DT	O	the	det	19	SENT_340	[p19l1139t790r1254b856],
19	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	16	SENT_340	[p19l1336t788r1991b875],
20	of	IN	O	of	_	0	SENT_340	[p19l2076t788r2153b856],
21	NSAIDs	NNS	MISC	nsaid	prep_of	19	SENT_340	[p19l9t897r498b978],
22	,3657	CD	NUMBER	,3657	num	21	SENT_340	[p19l9t897r498b978],
23	including	VBG	O	include	_	0	SENT_340	[p19l540t899r898b985],
24	celecoxib	NN	O	celecoxib	prep_including	21	SENT_340	[p19l937t897r1366b978],
25	,38	CD	NUMBER	,38	num	24	SENT_340	[p19l937t897r1366b978],
26	attributable	JJ	O	attributable	amod	24	SENT_340	[p19l1404t897r1846b965],
27	in	IN	O	in	_	0	SENT_340	[p19l1885t902r1957b964],
28	part	NN	O	part	prep_in	26	SENT_340	[p19l1992t918r2141b985],
29	to	TO	O	to	_	0	SENT_340	[p19l10t1029r81b1075],
30	circadian	JJ	O	circadian	amod	31	SENT_340	[p19l111t1010r444b1075],
31	variation	NN	O	variation	prep_to	26	SENT_340	[p19l470t1012r801b1075],
32	in	IN	O	in	_	0	SENT_340	[p19l830t1012r902b1074],
33	drug	NN	O	drug	nn	35	SENT_340	[p19l931t1010r1105b1095],
34	metabolizing	VBG	O	metabolize	amod	35	SENT_340	[p19l1135t1007r1625b1095],
35	enzymes	NNS	O	enzyme	prep_in	31	SENT_340	[p19l1655t1012r2057b1095],
36	,	,	O	,	_	0	SENT_340	[p19l1655t1012r2057b1095],
37	”	NN	O	”	nsubjpass	40	SENT_340	[p19l1655t1012r2057b1095],
38	is	VBZ	O	be	auxpass	40	SENT_340	[p19l2088t1012r2141b1075],
39	well	RB	O	well	advmod	40	SENT_340	[p19l8t1120r162b1186],
40	recognized	VBN	O	recognize	_	0	SENT_340	[p19l214t1120r631b1205],
41	.	.	O	.	_	0	SENT_340	[p19l214t1120r631b1205],

1	The	DT	O	the	det	3	SENT_341	[p19l684t1120r828b1186],
2	intraindividual	JJ	O	intraindividual	amod	3	SENT_341	[p19l879t1120r1439b1186],
3	variability	NN	O	variability	nsubj	10	SENT_341	[p19l1487t1118r1872b1205],
4	in	IN	O	in	_	0	SENT_341	[p19l1922t1123r1994b1184],
5	response	NN	O	response	prep_in	3	SENT_341	[p19l2044t1143r2140b1186, p19l10t1252r250b1315],
6	to	TO	O	to	_	0	SENT_341	[p19l281t1248r352b1295],
7	both	DT	O	both	det	8	SENT_341	[p19l384t1227r553b1295],
8	drugs	NNS	O	drug	prep_to	5	SENT_341	[p19l583t1229r790b1315],
9	is	VBZ	O	be	cop	10	SENT_341	[p19l823t1232r876b1295],
10	striking	JJ	O	striking	_	0	SENT_341	[p19l908t1227r1222b1315],
11	.	.	O	.	_	0	SENT_341	[p19l908t1227r1222b1315],

1	This	DT	DATE	this	nsubj	3	SENT_342	[p19l1257t1230r1421b1295],
2	may	MD	DATE	may	aux	3	SENT_342	[p19l1452t1254r1607b1315],
3	reﬂect	VB	O	reﬂect	_	0	SENT_342	[p19l1638t1227r1860b1295],
4	in	IN	O	in	_	0	SENT_342	[p19l1892t1232r1964b1294],
5	part	NN	O	part	nn	6	SENT_342	[p19l1992t1248r2141b1315],
6	variability	NN	O	variability	prep_in	3	SENT_342	[p19l7t1337r392b1425],
7	in	IN	O	in	_	0	SENT_342	[p19l423t1342r494b1404],
8	assays	NNS	O	assay	prep_in	6	SENT_342	[p19l524t1364r737b1425],
9	(	CD	NUMBER	(	dep	16	SENT_342	[p19l768t1340r1129b1425],
10	although	IN	O	although	dep	16	SENT_342	[p19l768t1340r1129b1425],
11	all	DT	O	all	det	12	SENT_342	[p19l1159t1340r1247b1405],
12	coefﬁcients	NNS	O	coefﬁcients	nsubj	16	SENT_342	[p19l1278t1337r1686b1405],
13	of	IN	O	of	_	0	SENT_342	[p19l1718t1337r1796b1405],
14	variation	NN	O	variation	prep_of	12	SENT_342	[p19l1812t1342r2143b1405],
15	were	VBD	O	be	cop	16	SENT_342	[p19l8t1471r179b1514],
16	<	JJR	O	<	ccomp	3	SENT_342	[p19l222t1450r522b1527],
17	10	CD	PERCENT	10	number	18	SENT_342	[p19l222t1450r522b1527],
18	%	NN	PERCENT	%	amod	16	SENT_342	[p19l222t1450r522b1527],
19	)	CD	NUMBER	)	dep	16	SENT_342	[p19l222t1450r522b1527],
20	,	,	O	,	_	0	SENT_342	[p19l222t1450r522b1527],
21	sources	NNS	O	source	ccomp	3	SENT_342	[p19l561t1471r822b1514],
22	of	IN	O	of	_	0	SENT_342	[p19l859t1446r937b1514],
23	variability	NN	O	variability	prep_of	21	SENT_342	[p19l960t1446r1345b1533],
24	that	WDT	O	that	nsubjpass	27	SENT_342	[p19l1382t1448r1528b1513],
25	may	MD	O	may	aux	27	SENT_342	[p19l1565t1472r1720b1533],
26	be	VB	O	be	auxpass	27	SENT_342	[p19l1756t1446r1838b1514],
27	attenuated	VBN	O	attenuate	rcmod	21	SENT_342	[p19l1874t1467r2140b1514, p19l9t1557r163b1622],
28	under	IN	O	under	_	0	SENT_342	[p19l195t1557r410b1622],
29	steady-state	JJ	O	steady-state	amod	30	SENT_342	[p19l441t1557r876b1642],
30	conditions	NNS	O	condition	prep_under	27	SENT_342	[p19l908t1557r1318b1635],
31	,	,	O	,	_	0	SENT_342	[p19l908t1557r1318b1635],
32	and	CC	O	and	_	0	SENT_342	[p19l1352t1557r1483b1622],
33	random	JJ	O	random	amod	35	SENT_342	[p19l1516t1557r1799b1622],
34	environmental	JJ	O	environmental	amod	35	SENT_342	[p19l1831t1560r2140b1622, p19l9t1668r266b1733],
35	effects	NNS	O	effect	conj_and	16	SENT_342	[p19l320t1665r549b1733],
36	that	IN	O	that	complm	56	SENT_342	[p19l604t1668r773b1747],
37	,	,	O	,	_	0	SENT_342	[p19l604t1668r773b1747],
38	despite	IN	O	despite	_	0	SENT_342	[p19l829t1668r1091b1753],
39	standardization	NN	O	standardization	prep_despite	56	SENT_342	[p19l1146t1668r1718b1733],
40	of	IN	O	of	_	0	SENT_342	[p19l1771t1665r1849b1733],
41	certain	JJ	O	certain	amod	42	SENT_342	[p19l1891t1670r2143b1733],
42	conditions	NNS	O	condition	prep_of	39	SENT_342	[p19l10t1776r396b1842],
43	of	IN	O	of	_	0	SENT_342	[p19l440t1774r518b1842],
44	dosing	NN	O	dosing	prep_of	42	SENT_342	[p19l548t1776r793b1861],
45	(	CD	NUMBER	(	num	46	SENT_342	[p19l838t1778r1056b1855],
46	time	NN	O	time	tmod	42	SENT_342	[p19l838t1778r1056b1855],
47	,	,	O	,	_	0	SENT_342	[p19l838t1778r1056b1855],
48	posture	NN	O	posture	nsubj	56	SENT_342	[p19l1099t1795r1397b1861],
49	,	,	O	,	_	0	SENT_342	[p19l1099t1795r1397b1861],
50	environment	NN	O	environment	appos	48	SENT_342	[p19l1442t1779r1938b1855],
51	,	,	O	,	_	0	SENT_342	[p19l1442t1779r1938b1855],
52	fasting/feeding	VBG	O	fasting/feeding	amod	53	SENT_342	[p19l1983t1774r2140b1842, p19l11t1885r485b1973],
53	)	NN	O	)	appos	50	SENT_342	[p19l1983t1774r2140b1842, p19l11t1885r485b1973],
54	,	,	O	,	_	0	SENT_342	[p19l1983t1774r2140b1842, p19l11t1885r485b1973],
55	remain	VBP	O	remain	cop	56	SENT_342	[p19l517t1890r773b1953],
56	unrecognized	JJ	O	unrecognized	dep	35	SENT_342	[p19l802t1887r1318b1973],
57	.	.	O	.	_	0	SENT_342	[p19l802t1887r1318b1973],

1	Little	JJ	O	little	amod	3	SENT_343	[p19l1351t1887r1554b1953],
2	comparable	JJ	O	comparable	amod	3	SENT_343	[p19l1583t1885r2009b1973],
3	information	NN	O	information	nsubj	5	SENT_343	[p19l2039t1890r2140b1952, p19l9t1995r376b2063],
4	is	VBZ	O	be	cop	5	SENT_343	[p19l403t2000r457b2063],
5	available	JJ	O	available	_	0	SENT_343	[p19l485t1995r807b2064],
6	with	IN	O	with	_	0	SENT_343	[p19l833t1998r1004b2063],
7	other	JJ	O	other	amod	8	SENT_343	[p19l1031t1998r1225b2063],
8	drugs	NNS	O	drug	prep_with	5	SENT_343	[p19l1250t1998r1457b2083],
9	in	IN	O	in	_	0	SENT_343	[p19l1486t2000r1557b2062],
10	which	WDT	O	which	rel	11	SENT_343	[p19l1583t1998r1808b2063],
11	intra	NN	O	intra	rcmod	8	SENT_343	[p19l1837t2000r2041b2063],
12	-	:	O	-	_	0	SENT_343	[p19l1837t2000r2041b2063],
13	vs	CC	O	vs	cc	15	SENT_343	[p19l2068t2022r2141b2063],
14	interindividual	JJ	O	interindividual	amod	15	SENT_343	[p19l11t2108r570b2174],
15	variability	NN	O	variability	nsubjpass	20	SENT_343	[p19l595t2106r981b2193],
16	in	IN	O	in	_	0	SENT_343	[p19l1008t2111r1079b2172],
17	response	NN	O	response	prep_in	15	SENT_343	[p19l1106t2131r1416b2193],
18	has	VBZ	O	have	aux	20	SENT_343	[p19l1443t2108r1557b2174],
19	been	VBN	O	be	auxpass	20	SENT_343	[p19l1586t2106r1756b2174],
20	compared	VBN	O	compare	dep	11	SENT_343	[p19l1782t2108r2142b2193],
21	so	RB	O	so	prep	20	SENT_343	[p19l10t2242r81b2283],
22	comprehensively	RB	O	comprehensively	dep	21	SENT_343	[p19l119t2215r945b2303],
23	/	:	O	/	punct	22	SENT_343	[p19l119t2215r945b2303],
24	“	CD	NUMBER	“	num	25	SENT_343	[p19l119t2215r945b2303],
25	-42	CD	NUMBER	-42	dep	20	SENT_343	[p19l119t2215r945b2303],

1	Despite	IN	O	despite	_	0	SENT_344	[p19l107t2330r391b2413],
2	substantial	JJ	O	substantial	amod	4	SENT_344	[p19l439t2325r841b2394],
3	intraindividual	JJ	O	intraindividual	amod	4	SENT_344	[p19l889t2328r1449b2393],
4	variability	NN	O	variability	prep_despite	10	SENT_344	[p19l1494t2325r1879b2413],
5	in	IN	O	in	_	0	SENT_344	[p19l1926t2330r1997b2392],
6	response	NN	O	response	prep_in	4	SENT_344	[p19l2044t2350r2140b2393, p19l10t2459r272b2521],
7	,	,	O	,	_	0	SENT_344	[p19l2044t2350r2140b2393, p19l10t2459r272b2521],
8	this	DT	O	this	nsubjpass	10	SENT_344	[p19l308t2436r443b2502],
9	was	VBD	O	be	auxpass	10	SENT_344	[p19l475t2460r607b2502],
10	exceeded	VBN	O	exceed	_	0	SENT_344	[p19l640t2436r967b2502],
11	by	IN	O	by	_	0	SENT_344	[p19l1001t2434r1089b2521],
12	the	DT	O	the	det	13	SENT_344	[p19l1121t2436r1236b2502],
13	variation	NN	O	variation	agent	10	SENT_344	[p19l1266t2439r1596b2502],
14	in	IN	O	in	_	0	SENT_344	[p19l1629t2439r1700b2500],
15	the	DT	O	the	det	17	SENT_344	[p19l1733t2436r1847b2502],
16	subject	JJ	O	subject	amod	17	SENT_344	[p19l1881t2434r2141b2521],
17	population	NN	O	population	prep_in	13	SENT_344	[p19l7t2547r414b2633],
18	as	IN	O	as	_	0	SENT_344	[p19l443t2572r508b2613],
19	a	DT	O	a	det	20	SENT_344	[p19l539t2572r575b2612],
20	whole	NN	O	whole	prep_as	17	SENT_344	[p19l601t2547r840b2613],
21	.	.	O	.	_	0	SENT_344	[p19l601t2547r840b2613],

1	Thus	RB	O	thus	advmod	23	SENT_345	[p19l873t2548r1083b2626],
2	,	,	O	,	_	0	SENT_345	[p19l873t2548r1083b2626],
3	the	DT	O	the	det	4	SENT_345	[p19l1116t2548r1230b2613],
4	variance	NN	O	variance	nsubj	23	SENT_345	[p19l1258t2550r1560b2613],
5	of	IN	O	of	_	0	SENT_345	[p19l1590t2545r1668b2613],
6	both	CC	O	both	dep	7	SENT_345	[p19l1686t2545r1856b2613],
7	plasma	NN	O	plasma	prep_of	4	SENT_345	[p19l1883t2547r2145b2633],
8	drug	NN	O	drug	nn	9	SENT_345	[p19l9t2657r184b2742],
9	concentrations	NNS	O	concentration	nsubj	10	SENT_345	[p19l235t2659r773b2722],
10	(	VBP	O	(	rcmod	7	SENT_345	[p19l824t2657r1006b2733],
11	data	NNS	O	datum	dobj	10	SENT_345	[p19l824t2657r1006b2733],
12	not	RB	O	not	neg	13	SENT_345	[p19l1055t2676r1174b2722],
13	shown	VBN	O	show	rcmod	11	SENT_345	[p19l1225t2657r1486b2734],
14	)	NN	O	)	dobj	13	SENT_345	[p19l1225t2657r1486b2734],
15	and	CC	O	and	_	0	SENT_345	[p19l1535t2657r1667b2722],
16	3	CD	NUMBER	3	npadvmod	17	SENT_345	[p19l1721t2661r1757b2728],
17	out	IN	O	out	conj_and	14	SENT_345	[p19l1811t2676r1931b2722],
18	of	IN	O	of	_	0	SENT_345	[p19l1982t2654r2059b2722],
19	4	CD	NUMBER	4	num	21	SENT_345	[p19l2096t2653r2141b2721],
20	pharmacodynamic	JJ	O	pharmacodynamic	amod	21	SENT_345	[p19l8t2773r690b2857],
21	parameters	NNS	O	parameter	prep_of	17	SENT_345	[p19l725t2792r1130b2857],
22	were	VBD	O	be	cop	23	SENT_345	[p19l1167t2795r1337b2838],
23	greater	JJR	O	greater	_	0	SENT_345	[p19l1373t2792r1633b2857],
24	in	IN	O	in	_	0	SENT_345	[p19l1669t2775r1741b2836],
25	the	DT	O	the	det	27	SENT_345	[p19l1778t2773r1892b2838],
26	entire	JJ	O	entire	amod	27	SENT_345	[p19l1929t2775r2142b2838],
27	population	NN	O	population	prep_in	23	SENT_345	[p19l7t2915r414b3001],
28	than	IN	O	than	dep	23	SENT_345	[p19l446t2916r610b2980],
29	for	IN	O	for	_	0	SENT_345	[p19l641t2913r743b2981],
30	replicate	VB	O	replicate	dep	31	SENT_345	[p19l774t2915r1090b3001],
31	measurements	NNS	O	measurement	prep_for	23	SENT_345	[p19l1122t2934r1650b2981],
32	within	IN	O	within	_	0	SENT_345	[p19l1682t2916r1930b2981],
33	individuals	NNS	O	individual	prep_within	31	SENT_345	[p19l1963t2915r2140b2981, p19l8t3024r291b3088],
34	.	.	O	.	_	0	SENT_345	[p19l1963t2915r2140b2981, p19l8t3024r291b3088],

1	We	PRP	O	we	nsubj	3	SENT_346	[p19l325t3026r457b3088],
2	would	MD	O	would	aux	3	SENT_346	[p19l485t3024r716b3088],
3	anticipate	VB	O	anticipate	_	0	SENT_346	[p19l746t3026r1111b3108],
4	that	IN	O	that	complm	11	SENT_346	[p19l1141t3024r1288b3088],
5	this	DT	O	this	det	6	SENT_346	[p19l1319t3024r1454b3088],
6	divergence	NN	O	divergence	nsubj	11	SENT_346	[p19l1485t3024r1883b3108],
7	would	MD	O	would	aux	11	SENT_346	[p19l1911t3024r2142b3088],
8	be	VB	O	be	cop	11	SENT_346	[p19l10t3137r92b3205],
9	even	RB	O	even	advmod	11	SENT_346	[p19l125t3162r290b3205],
10	more	RBR	O	more	advmod	11	SENT_346	[p19l322t3162r508b3205],
11	pronounced	JJ	O	pronounced	conj_and	11	SENT_346	[p19l539t3139r977b3224],
12	with	IN	O	with	_	0	SENT_346	[p19l1009t3139r1181b3205],
13	comparison	NN	O	comparison	prep_with	11	SENT_346	[p19l1214t3142r1639b3224],
14	between	IN	O	between	_	0	SENT_346	[p19l1672t3137r1978b3205],
15	and	CC	O	and	_	0	SENT_346	[p19l2010t3139r2142b3205],
16	within	IN	O	within	_	0	SENT_346	[p19l8t3249r256b3313],
17	individuals	NNS	O	individual	prep_within	11	SENT_346	[p19l318t3248r730b3313],
18	when	WRB	O	when	advmod	21	SENT_346	[p19l791t3249r990b3313],
19	dosing	NN	O	dosing	nsubj	21	SENT_346	[p19l1051t3248r1296b3333],
20	had	VBD	O	have	aux	21	SENT_346	[p19l1358t3248r1490b3313],
21	attained	VBN	O	attain	advcl	11	SENT_346	[p19l1551t3248r1851b3313],
22	steady	JJ	O	steady	amod	23	SENT_346	[p19l1913t3248r2143b3333],
23	state	NN	O	state	dobj	21	SENT_346	[p19l10t3356r199b3402],
24	.	.	O	.	_	0	SENT_346	[p19l10t3356r199b3402],

1	Thus	RB	O	thus	_	0	SENT_347	[p19l106t3448r316b3527],
2	,	,	O	,	_	0	SENT_347	[p19l106t3448r316b3527],
3	additional	JJ	O	additional	dep	4	SENT_347	[p19l366t3448r742b3514],
4	to	TO	O	to	dep	1	SENT_347	[p19l792t3467r863b3514],
5	the	DT	O	the	det	7	SENT_347	[p19l911t3448r1026b3514],
6	potential	JJ	O	potential	amod	7	SENT_347	[p19l1072t3448r1406b3533],
7	value	NN	O	value	pobj	4	SENT_347	[p19l1453t3448r1647b3514],
8	of	IN	O	of	_	0	SENT_347	[p19l1695t3446r1773b3514],
9	measurements	NNS	O	measurement	prep_of	7	SENT_347	[p19l1809t3471r2140b3514, p19l9t3583r233b3630],
10	of	IN	O	of	_	0	SENT_347	[p19l295t3562r374b3630],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_347	[p19l421t3562r1044b3650],
12	and	CC	O	and	_	0	SENT_347	[p19l1106t3564r1238b3630],
13	pharmacodynamic	JJ	O	pharmacodynamic	amod	14	SENT_347	[p19l1298t3564r1981b3650],
14	response	NN	O	response	prep_of	9	SENT_347	[p19l2044t3587r2140b3630, p19l10t3730r272b3793],
15	,	,	O	,	_	0	SENT_347	[p19l2044t3587r2140b3630, p19l10t3730r272b3793],

1	genetic	JJ	O	genetic	amod	2	SENT_348	[p19l332t3710r601b3793],
2	sources	NNS	O	source	nsubj	6	SENT_348	[p19l661t3731r921b3773],
3	of	IN	O	of	_	0	SENT_348	[p19l982t3705r1059b3773],
4	variance	NN	O	variance	prep_of	2	SENT_348	[p19l1105t3710r1407b3773],
5	might	MD	O	might	aux	6	SENT_348	[p19l1466t3708r1695b3793],
6	contribute	VB	O	contribute	conj_and	6	SENT_348	[p19l1755t3705r2142b3774],
7	detectably	RB	O	detectably	advmod	6	SENT_348	[p20l9t17r393b104],
8	to	TO	O	to	_	0	SENT_348	[p20l422t38r492b85],
9	differences	NNS	O	difference	prep_to	6	SENT_348	[p20l522t17r914b85],
10	in	IN	O	in	_	0	SENT_348	[p20l946t22r1017b83],
11	drug	NN	O	drug	nn	12	SENT_348	[p20l1045t19r1220b104],
12	response	NN	O	response	prep_in	9	SENT_348	[p20l1251t42r1561b104],
13	over	IN	O	over	_	0	SENT_348	[p20l1591t42r1745b85],
14	and	CC	O	and	_	0	SENT_348	[p20l1773t19r1905b85],
15	above	IN	O	above	_	0	SENT_348	[p20l1934t17r2142b85],
16	the	DT	O	the	det	18	SENT_348	[p20l10t131r125b196],
17	background	NN	O	background	nn	18	SENT_348	[p20l159t128r600b216],
18	“	NN	O	“	prep_over	6	SENT_348	[p20l636t132r892b196],
19	noise	NN	O	noise	npadvmod	21	SENT_348	[p20l636t132r892b196],
20	”	CD	NUMBER	”	num	19	SENT_348	[p20l636t132r892b196],
21	attributable	JJ	O	attributable	amod	18	SENT_348	[p20l928t128r1370b196],
22	to	TO	O	to	_	0	SENT_348	[p20l1404t149r1475b196],
23	analytic	JJ	O	analytic	amod	24	SENT_348	[p20l1508t130r1797b215],
24	variability	NN	O	variability	prep_to	6	SENT_348	[p20l1829t128r2140b196, p20l11t243r110b326],
25	and	CC	O	and	_	0	SENT_348	[p20l163t241r294b306],
26	ﬂuctuating	VBG	O	ﬂuctuating	amod	27	SENT_348	[p20l350t238r757b326],
27	features	NNS	O	feature	conj_and	24	SENT_348	[p20l812t238r1095b306],
28	of	IN	O	of	_	0	SENT_348	[p20l1151t238r1228b306],
29	the	DT	O	the	det	30	SENT_348	[p20l1272t241r1386b306],
30	environment	NN	O	environment	prep_of	27	SENT_348	[p20l1441t243r1935b306],
31	.	.	O	.	_	0	SENT_348	[p20l1441t243r1935b306],

1	Our	PRP$	O	we	poss	2	SENT_349	[p20l1994t242r2144b306],
2	GASTROENTEROLOGY	NNP	O	GASTROENTEROLOGY	_	0	SENT_349	[p20l985t358r1653b407],
3	Vol	NNP	O	Vol	dep	2	SENT_349	[p20l1676t358r1783b407],
4	.	.	O	.	_	0	SENT_349	[p20l1676t358r1783b407],

1	130	CD	NUMBER	130	_	0	SENT_350	[p20l1815t357r1949b417],
2	,	,	O	,	_	0	SENT_350	[p20l1815t357r1949b417],
3	NO.	NNP	O	NO.	appos	1	SENT_350	[p20l1981t358r2074b407],
4	1	CD	NUMBER	1	num	3	SENT_350	[p20l2106t357r2144b407],

1	analysis	NN	O	analysis	nsubj	2	SENT_351	[p20l8t580r291b665],
2	showed	VBD	O	show	_	0	SENT_351	[p20l325t580r597b645],
3	that	IN	O	that	complm	10	SENT_351	[p20l631t580r777b645],
4	almost	RB	O	almost	quantmod	5	SENT_351	[p20l809t580r1055b645],
5	half	DT	O	half	nsubj	10	SENT_351	[p20l1088t577r1237b645],
6	of	IN	O	of	_	0	SENT_351	[p20l1257t577r1335b645],
7	the	DT	O	the	det	9	SENT_351	[p20l1356t580r1471b645],
8	study	NN	O	study	nn	9	SENT_351	[p20l1504t580r1706b665],
9	population	NN	O	population	prep_of	5	SENT_351	[p20l1735t580r2141b665],
10	had	VBD	O	have	ccomp	2	SENT_351	[p20l8t689r140b754],
11	Variants	NNS	O	variant	dobj	10	SENT_351	[p20l188t691r478b754],
12	in	IN	O	in	_	0	SENT_351	[p20l529t691r601b752],
13	the	DT	O	the	det	15	SENT_351	[p20l651t689r765b754],
14	target	NN	O	target	nn	15	SENT_351	[p20l815t708r1033b773],
15	enzymes	NNS	O	enzyme	prep_in	11	SENT_351	[p20l1083t711r1416b773],
16	,	,	O	,	_	0	SENT_351	[p20l1083t711r1416b773],
17	some	DT	O	some	appos	15	SENT_351	[p20l1468t713r1653b754],
18	with	IN	O	with	_	0	SENT_351	[p20l1702t689r1873b754],
19	allelic	JJ	O	allelic	amod	20	SENT_351	[p20l1922t689r2140b754],
20	frequencies	NNS	O	frequency	prep_with	10	SENT_351	[p20l8t796r422b884],
21	of	IN	O	of	_	0	SENT_351	[p20l466t796r544b864],
22	5	CD	PERCENT	5	number	23	SENT_351	[p20l579t800r695b868],
23	%	NN	PERCENT	%	prep_of	20	SENT_351	[p20l579t800r695b868],
24	or	CC	O	or	_	0	SENT_351	[p20l744t822r817b864],
25	more	JJR	O	more	prep_of	20	SENT_351	[p20l858t821r1064b864],
26	.	.	O	.	_	0	SENT_351	[p20l858t821r1064b864],

1	Information	NN	O	information	nsubj	4	SENT_352	[p20l1111t796r1559b864],
2	is	VBZ	O	be	aux	4	SENT_352	[p20l1602t801r1655b864],
3	only	RB	O	only	advmod	4	SENT_352	[p20l1699t799r1858b884],
4	beginning	VBG	O	begin	_	0	SENT_352	[p20l1901t796r2139b884, p20l10t910r177b992],
5	to	TO	O	to	aux	6	SENT_352	[p20l228t926r299b972],
6	emerge	VB	O	emerge	xcomp	4	SENT_352	[p20l348t929r615b992],
7	on	IN	O	on	_	0	SENT_352	[p20l665t930r754b972],
8	genetic	JJ	O	genetic	amod	9	SENT_352	[p20l800t910r1069b992],
9	Variation	NN	O	variation	prep_on	6	SENT_352	[p20l1116t910r1446b972],
10	in	IN	O	in	_	0	SENT_352	[p20l1496t910r1567b971],
11	the	DT	O	the	det	13	SENT_352	[p20l1616t908r1730b972],
12	COX	NNP	O	COX	nn	13	SENT_352	[p20l1780t909r1978b972],
13	enzymes	NNS	O	enzyme	prep_in	9	SENT_352	[p20l2026t930r2139b972, p20l9t1015r428b1103],
14	,45	CD	NUMBER	,45	number	15	SENT_352	[p20l2026t930r2139b972, p20l9t1015r428b1103],
15	—	CD	NUMBER	—	dobj	6	SENT_352	[p20l2026t930r2139b972, p20l9t1015r428b1103],
16	45	CD	NUMBER	45	nsubjpass	22	SENT_352	[p20l2026t930r2139b972, p20l9t1015r428b1103],
17	and	CC	O	and	_	0	SENT_352	[p20l471t1018r602b1083],
18	our	PRP$	O	we	poss	19	SENT_352	[p20l641t1041r764b1083],
19	study	NN	O	study	nsubjpass	22	SENT_352	[p20l802t1018r1004b1103],
20	was	VBD	O	be	auxpass	22	SENT_352	[p20l1041t1042r1173b1083],
21	not	RB	O	not	neg	22	SENT_352	[p20l1214t1037r1333b1083],
22	designed	VBN	O	design	rcmod	15	SENT_352	[p20l1372t1018r1700b1103],
23	or	CC	O	or	_	0	SENT_352	[p20l1739t1040r1812b1083],
24	sized	VBN	O	size	conj_or	22	SENT_352	[p20l1850t1018r2030b1083],
25	to	TO	O	to	aux	26	SENT_352	[p20l2070t1037r2141b1083],
26	afford	VB	O	afford	xcomp	22	SENT_352	[p20l8t1125r222b1193],
27	a	DT	O	a	det	29	SENT_352	[p20l289t1152r325b1192],
28	comprehensive	JJ	O	comprehensive	amod	29	SENT_352	[p20l390t1128r941b1213],
29	analysis	NN	O	analysis	dobj	26	SENT_352	[p20l1008t1127r1290b1213],
30	of	IN	O	of	_	0	SENT_352	[p20l1359t1125r1437b1193],
31	genetic	JJ	O	genetic	amod	32	SENT_352	[p20l1491t1130r1759b1213],
32	variants	NNS	O	variant	prep_of	29	SENT_352	[p20l1825t1130r2139b1206],
33	,	,	O	,	_	0	SENT_352	[p20l1825t1130r2139b1206],
34	which	WDT	O	which	nsubj	36	SENT_352	[p20l7t1238r233b1303],
35	may	MD	O	may	aux	36	SENT_352	[p20l275t1262r430b1323],
36	modulate	VB	O	modulate	rcmod	32	SENT_352	[p20l471t1238r821b1303],
37	the	DT	O	the	det	38	SENT_352	[p20l864t1238r978b1303],
38	response	NN	O	response	dobj	36	SENT_352	[p20l1022t1260r1333b1323],
39	to	TO	O	to	_	0	SENT_352	[p20l1376t1257r1447b1303],
40	coxibs	NNS	O	coxib	prep_to	36	SENT_352	[p20l1490t1235r1739b1304],
41	.	.	O	.	_	0	SENT_352	[p20l1490t1235r1739b1304],

1	Notwithstanding	IN	O	notwithstanding	_	0	SENT_353	[p20l1785t1238r2139b1305, p20l9t1347r330b1433],
2	these	DT	O	these	det	3	SENT_353	[p20l365t1348r550b1413],
3	restrictions	NNS	O	restriction	prep_notwithstanding	10	SENT_353	[p20l584t1350r1020b1426],
4	,	,	O	,	_	0	SENT_353	[p20l584t1350r1020b1426],
5	2	CD	NUMBER	2	nsubj	10	SENT_353	[p20l1057t1351r1095b1411],
6	of	IN	O	of	_	0	SENT_353	[p20l1133t1345r1211b1413],
7	the	DT	O	the	det	8	SENT_353	[p20l1233t1348r1347b1413],
8	SNPS	NN	O	snp	prep_of	5	SENT_353	[p20l1381t1349r1582b1414],
9	tested	VBN	O	test	partmod	8	SENT_353	[p20l1617t1347r1835b1413],
10	showed	VBD	O	show	_	0	SENT_353	[p20l1869t1347r2141b1413],
11	evidence	NN	O	evidence	dobj	10	SENT_353	[p20l9t1458r325b1524],
12	of	IN	O	of	_	0	SENT_353	[p20l382t1456r459b1523],
13	allelic	JJ	O	allelic	amod	14	SENT_353	[p20l504t1458r722b1524],
14	association	NN	O	association	prep_of	11	SENT_353	[p20l779t1460r1178b1524],
15	with	IN	O	with	_	0	SENT_353	[p20l1232t1458r1403b1523],
16	elements	NNS	O	element	prep_with	10	SENT_353	[p20l1460t1458r1786b1524],
17	of	IN	O	of	_	0	SENT_353	[p20l1843t1456r1921b1523],
18	drug	NN	O	drug	nn	19	SENT_353	[p20l1966t1458r2140b1543],
19	response	NN	O	response	prep_of	16	SENT_353	[p20l9t1587r339b1650],
20	.	.	O	.	_	0	SENT_353	[p20l9t1587r339b1650],

1	The	DT	O	the	det	3	SENT_354	[p20l392t1566r535b1630],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_354	[p20l585t1567r1011b1637],
3	*	NN	O	*	nsubj	7	SENT_354	[p20l585t1567r1011b1637],
4	2	CD	NUMBER	2	dep	3	SENT_354	[p20l585t1567r1011b1637],
5	is	VBZ	O	be	cop	7	SENT_354	[p20l1065t1568r1118b1630],
6	a	DT	O	a	det	7	SENT_354	[p20l1168t1589r1205b1629],
7	Variant	JJ	O	variant	_	0	SENT_354	[p20l1249t1568r1508b1630],
8	associated	VBN	O	associate	dep	7	SENT_354	[p20l1557t1565r1922b1630],
9	with	IN	O	with	_	0	SENT_354	[p20l1970t1566r2141b1630],
10	reduced	VBN	O	reduce	amod	11	SENT_354	[p20l9t1676r298b1742],
11	activity	NN	O	activity	prep_with	8	SENT_354	[p20l357t1678r637b1761],
12	of	IN	O	of	_	0	SENT_354	[p20l695t1674r773b1742],
13	a	DT	O	a	det	16	SENT_354	[p20l821t1701r857b1741],
14	major	JJ	O	major	amod	16	SENT_354	[p20l914t1678r1129b1761],
15	metabolizing	VBG	O	metabolize	amod	16	SENT_354	[p20l1186t1674r1677b1761],
16	enzyme	NN	O	enzyme	prep_of	11	SENT_354	[p20l1737t1699r2015b1761],
17	of	IN	O	of	_	0	SENT_354	[p20l2075t1674r2153b1742],
18	celecoXib46	NN	O	celecoxib46	prep_of	16	SENT_354	[p20l9t1783r414b1851],
19	and	CC	O	and	_	0	SENT_354	[p20l444t1785r576b1851],
20	was	VBD	O	be	auxpass	21	SENT_354	[p20l605t1810r737b1851],
21	associated	VBN	O	associate	conj_and	8	SENT_354	[p20l768t1785r1134b1851],
22	with	IN	O	with	_	0	SENT_354	[p20l1163t1786r1334b1851],
23	elevated	JJ	O	elevated	amod	25	SENT_354	[p20l1365t1785r1664b1851],
24	plasma	NN	O	plasma	nn	25	SENT_354	[p20l1693t1785r1954b1871],
25	concentrations	NNS	O	concentration	prep_with	21	SENT_354	[p20l1983t1808r2139b1851, p20l9t1897r416b1961],
26	of	IN	O	of	_	0	SENT_354	[p20l472t1893r550b1961],
27	the	DT	O	the	det	28	SENT_354	[p20l593t1895r708b1961],
28	drug	NN	O	drug	prep_of	25	SENT_354	[p20l762t1895r937b1980],
29	4	CD	DURATION	4	num	30	SENT_354	[p20l991t1891r1036b1959],
30	hours	NNS	NUMBER	hour	tmod	25	SENT_354	[p20l1091t1895r1292b1961],
31	after	IN	O	after	_	0	SENT_354	[p20l1347t1893r1513b1961],
32	administration	NN	O	administration	prep_after	21	SENT_354	[p20l1566t1895r2136b1961],
33	.	.	O	.	_	0	SENT_354	[p20l1566t1895r2136b1961],

1	However	RB	O	however	dep	12	SENT_355	[p20l9t2007r364b2083],
2	,	,	O	,	_	0	SENT_355	[p20l9t2007r364b2083],
3	although	IN	O	although	mark	12	SENT_355	[p20l417t2004r750b2090],
4	this	DT	O	this	nsubjpass	12	SENT_355	[p20l802t2005r937b2070],
5	and	CC	O	and	_	0	SENT_355	[p20l990t2004r1121b2070],
6	other	JJ	O	other	amod	8	SENT_355	[p20l1173t2005r1366b2070],
7	genetic	JJ	O	genetic	amod	8	SENT_355	[p20l1414t2007r1682b2090],
8	variants	NNS	O	variant	nsubjpass	12	SENT_355	[p20l1732t2007r2022b2070],
9	of	IN	O	of	_	0	SENT_355	[p20l2075t2002r2152b2070],
10	CYP2C9	NN	O	cyp2c9	prep_of	8	SENT_355	[p20l9t2116r340b2188],
11	are	VBP	O	be	auxpass	12	SENT_355	[p20l372t2138r476b2180],
12	thought	VBN	O	think	_	0	SENT_355	[p20l508t2115r807b2200],
13	to	TO	O	to	aux	14	SENT_355	[p20l839t2134r910b2181],
14	affect	VB	O	affect	xcomp	12	SENT_355	[p20l941t2113r1137b2180],
15	the	DT	O	the	det	17	SENT_355	[p20l1169t2115r1284b2181],
16	metabolic	JJ	O	metabolic	amod	17	SENT_355	[p20l1314t2113r1680b2181],
17	clearance	NN	O	clearance	dobj	14	SENT_355	[p20l1711t2115r2044b2181],
18	of	IN	O	of	_	0	SENT_355	[p20l2075t2113r2152b2180],
19	perhaps	RB	O	perhaps	advmod	21	SENT_355	[p20l6t2225r291b2310],
20	20	CD	PERCENT	20	num	21	SENT_355	[p20l328t2226r495b2293],
21	%	NN	PERCENT	%	prep_of	17	SENT_355	[p20l328t2226r495b2293],
22	of	IN	O	of	_	0	SENT_355	[p20l534t2222r611b2290],
23	all	DT	O	all	prep_of	21	SENT_355	[p20l633t2224r720b2289],
24	prescribed	VBN	O	prescribe	partmod	23	SENT_355	[p20l752t2222r1135b2310],
25	drugs	NNS	O	drug	dobj	24	SENT_355	[p20l1168t2222r1465b2310],
26	,47	CD	NUMBER	,47	num	30	SENT_355	[p20l1168t2222r1465b2310],
27	acquired	VBN	O	acquire	amod	30	SENT_355	[p20l1500t2224r1817b2310],
28	or	CC	O	or	_	0	SENT_355	[p20l1850t2247r1924b2290],
29	environmental	JJ	O	environmental	conj_or	27	SENT_355	[p20l1955t2227r2139b2290, p20l9t2335r390b2401],
30	factors	NNS	O	factor	nsubj	33	SENT_355	[p20l434t2333r674b2401],
31	may	MD	O	may	aux	33	SENT_355	[p20l718t2359r873b2420],
32	also	RB	O	also	advmod	33	SENT_355	[p20l916t2335r1053b2401],
33	contribute	VB	O	contribute	rcmod	25	SENT_355	[p20l1097t2333r1484b2401],
34	to	TO	O	to	_	0	SENT_355	[p20l1529t2354r1600b2400],
35	variability	NN	O	variability	prep_to	33	SENT_355	[p20l1641t2333r2026b2420],
36	in	IN	O	in	_	0	SENT_355	[p20l2070t2337r2142b2399],
37	drug	NN	O	drug	nn	38	SENT_355	[p20l8t2444r183b2530],
38	clearance	NN	O	clearance	prep_in	35	SENT_355	[p20l221t2442r644b2510],
39	.48	CD	NUMBER	.48	num	38	SENT_355	[p20l221t2442r644b2510],

1	The	DT	O	the	det	3	SENT_356	[p20l105t2555r249b2620],
2	Pro17Leu	NN	O	pro17leu	nn	3	SENT_356	[p20l280t2558r641b2623],
3	variant	NN	O	variant	nsubj	8	SENT_356	[p20l667t2557r925b2620],
4	of	IN	O	of	_	0	SENT_356	[p20l956t2553r1033b2621],
5	the	DT	O	the	det	7	SENT_356	[p20l1053t2555r1167b2621],
6	COX-1	NN	MISC	cox-1	nn	7	SENT_356	[p20l1197t2556r1467b2621],
7	enzyme	NN	O	enzyme	prep_of	3	SENT_356	[p20l1505t2578r1783b2640],
8	appeared	VBD	O	appear	_	0	SENT_356	[p20l1813t2555r2141b2640],
9	to	TO	O	to	aux	11	SENT_356	[p20l9t2681r80b2727],
10	be	VB	O	be	auxpass	11	SENT_356	[p20l111t2660r192b2728],
11	associated	VBN	O	associate	xcomp	8	SENT_356	[p20l222t2662r587b2727],
12	with	IN	O	with	_	0	SENT_356	[p20l616t2663r787b2727],
13	a	DT	O	a	det	14	SENT_356	[p20l817t2687r853b2726],
14	failure	NN	O	failure	prep_with	11	SENT_356	[p20l880t2660r1115b2727],
15	of	IN	O	of	_	0	SENT_356	[p20l1145t2660r1223b2727],
16	inhibition	NN	O	inhibition	prep_of	14	SENT_356	[p20l1242t2660r1618b2728],
17	of	IN	O	of	_	0	SENT_356	[p20l1647t2660r1725b2727],
18	thromboxane	NN	O	thromboxane	prep_of	16	SENT_356	[p20l1744t2660r2139b2728, p20l8t2796r129b2839],

1	formation	NN	O	formation	_	0	SENT_357	[p20l155t2771r522b2839],
2	with	IN	O	with	prep	1	SENT_357	[p20l546t2773r718b2838],
3	both	CC	O	both	prep	1	SENT_357	[p20l744t2771r914b2839],
4	drugs	NNS	O	drug	dep	3	SENT_357	[p20l939t2773r1167b2858],
5	.	.	O	.	_	0	SENT_357	[p20l939t2773r1167b2858],

1	All	DT	O	all	det	3	SENT_358	[p20l1197t2773r1313b2837],
2	COX-2	NN	MISC	cox-2	nn	3	SENT_358	[p20l1340t2774r1614b2839],
3	inhibitors	NNS	O	inhibitor	nsubj	57	SENT_358	[p20l1646t2771r2009b2839],
4	are	VBP	O	be	cop	5	SENT_358	[p20l2036t2796r2141b2838],
5	relatively	RB	O	relatively	_	0	SENT_358	[p20l9t2882r375b2968],
6	,	,	O	,	_	0	SENT_358	[p20l9t2882r375b2968],
7	as	IN	O	as	mark	8	SENT_358	[p20l411t2907r476b2948],
8	opposed	VBN	O	oppose	dep	21	SENT_358	[p20l511t2882r811b2968],
9	to	TO	O	to	prep	8	SENT_358	[p20l845t2902r916b2948],
10	absolutely	RB	O	absolutely	pcomp	9	SENT_358	[p20l950t2880r1349b2968],
11	,	,	O	,	_	0	SENT_358	[p20l950t2880r1349b2968],
12	selective	JJ	O	selective	conj_and	8	SENT_358	[p20l1386t2883r1696b2948],
13	for	IN	O	for	_	0	SENT_358	[p20l1730t2880r1831b2948],
14	COX-2	NN	O	cox-2	prep_for	12	SENT_358	[p20l1863t2884r2137b2948],
15	and	CC	O	and	_	0	SENT_358	[p20l8t2992r162b3070],
16	,	,	O	,	_	0	SENT_358	[p20l8t2992r162b3070],
17	at	IN	O	at	conj_and	8	SENT_358	[p20l219t3011r286b3056],
18	sufficient	JJ	O	sufficient	amod	19	SENT_358	[p20l342t2990r679b3057],
19	concentration	NN	O	concentration	pobj	17	SENT_358	[p20l735t2994r1263b3070],
20	,	,	O	,	_	0	SENT_358	[p20l735t2994r1263b3070],
21	become	VBP	O	become	ccomp	5	SENT_358	[p20l1321t2990r1599b3057],
22	inhibitors	NNS	O	inhibitor	nsubj	53	SENT_358	[p20l1655t2990r2019b3057],
23	of	IN	O	of	_	0	SENT_358	[p20l2075t2990r2152b3057],
24	both	DT	O	both	det	25	SENT_358	[p20l9t3099r178b3167],
25	COXs	NNS	O	cox	prep_of	22	SENT_358	[p20l204t3103r432b3167],
26	in	FW	O	in	prep	25	SENT_358	[p20l461t3104r532b3166],
27	vitro	FW	O	vitro	nn	30	SENT_358	[p20l555t3104r732b3167],
28	(	FW	O	(	nn	30	SENT_358	[p20l759t3103r1025b3187],
29	Figure	NN	O	figure	nn	30	SENT_358	[p20l759t3103r1025b3187],
30	2A	NN	O	2a	pobj	26	SENT_358	[p20l1054t3103r1211b3181],
31	)	NN	O	)	dep	30	SENT_358	[p20l1054t3103r1211b3181],
32	,	,	O	,	_	0	SENT_358	[p20l1054t3103r1211b3181],
33	just	RB	O	just	advmod	30	SENT_358	[p20l1241t3104r1376b3187],
34	like	IN	O	like	_	0	SENT_358	[p20l1403t3099r1539b3167],
35	tNSAIDs	NNS	O	tnsaid	prep_like	33	SENT_358	[p20l1566t3102r1967b3169],
36	.1	CD	NUMBER	.1	tmod	33	SENT_358	[p20l1566t3102r1967b3169],
37	The	DT	O	the	det	39	SENT_358	[p20l1997t3102r2140b3167],
38	interindividual	JJ	O	interindividual	amod	39	SENT_358	[p20l10t3212r569b3278],
39	variability	NN	O	variability	dep	30	SENT_358	[p20l612t3210r997b3297],
40	of	IN	O	of	_	0	SENT_358	[p20l1040t3210r1118b3278],
41	inhibition	NN	O	inhibition	prep_of	39	SENT_358	[p20l1151t3210r1527b3278],
42	of	IN	O	of	_	0	SENT_358	[p20l1571t3210r1649b3278],
43	COX-1	NN	O	cox-1	prep_of	41	SENT_358	[p20l1682t3213r1951b3278],
44	evident	JJ	O	evident	amod	43	SENT_358	[p20l2004t3214r2139b3277, p20l8t3320r172b3386],
45	4	CD	DURATION	4	num	46	SENT_358	[p20l204t3317r249b3385],
46	hours	NNS	NUMBER	hour	npadvmod	44	SENT_358	[p20l282t3321r483b3386],
47	after	IN	O	after	_	0	SENT_358	[p20l515t3318r682b3386],
48	dosing	NN	O	dosing	prep_after	44	SENT_358	[p20l712t3320r957b3406],
49	with	IN	O	with	prep	44	SENT_358	[p20l989t3321r1160b3386],
50	either	CC	O	either	dep	49	SENT_358	[p20l1192t3321r1407b3386],
51	coxib	NN	O	coxib	conj	49	SENT_358	[p20l1437t3318r1634b3386],
52	was	VBD	O	be	cop	53	SENT_358	[p20l1665t3345r1796b3386],
53	substantial	JJ	O	substantial	ccomp	21	SENT_358	[p20l1831t3318r2139b3387, p20l9t3431r129b3496],
54	and	CC	O	and	_	0	SENT_358	[p20l164t3431r296b3497],
55	may	MD	O	may	aux	57	SENT_358	[p20l331t3455r486b3516],
56	be	VB	O	be	cop	57	SENT_358	[p20l520t3429r602b3497],
57	attributable	JJ	O	attributable	conj_and	5	SENT_358	[p20l637t3429r1079b3497],
58	in	IN	O	in	_	0	SENT_358	[p20l1115t3434r1186b3495],
59	part	NN	O	part	prep_in	57	SENT_358	[p20l1218t3450r1368b3516],
60	to	TO	O	to	_	0	SENT_358	[p20l1404t3450r1475b3497],
61	this	DT	O	this	det	62	SENT_358	[p20l1511t3431r1646b3497],
62	variant	NN	O	variant	prep_to	57	SENT_358	[p20l1680t3434r1959b3497],
63	.	.	O	.	_	0	SENT_358	[p20l1680t3434r1959b3497],

1	The	DT	O	the	det	2	SENT_359	[p20l1997t3431r2141b3497],
2	greater	JJR	O	greater	_	0	SENT_359	[p20l7t3559r267b3626],
3	the	DT	O	the	det	4	SENT_359	[p20l320t3541r434b3606],
4	inhibition	NN	O	inhibition	dep	2	SENT_359	[p20l490t3538r865b3607],
5	of	IN	O	of	_	0	SENT_359	[p20l919t3538r996b3606],
6	COX-1-derived	JJ	O	cox-1-derived	amod	7	SENT_359	[p20l1039t3540r1627b3606],
7	TXA2	NN	O	txa2	prep_of	4	SENT_359	[p20l1680t3541r1876b3620],
8	in	IN	O	in	_	0	SENT_359	[p20l1934t3543r2005b3605],
9	an	DT	O	a	det	10	SENT_359	[p20l2058t3564r2141b3605],
10	individual	JJ	O	individual	prep_in	7	SENT_359	[p20l10t3650r413b3728],
11	,	,	O	,	_	0	SENT_359	[p20l10t3650r413b3728],
12	the	DT	O	the	det	13	SENT_359	[p20l454t3650r568b3715],
13	more	RBR	O	more	dep	15	SENT_359	[p20l606t3672r792b3715],
14	the	DT	O	the	det	15	SENT_359	[p20l832t3650r946b3715],
15	gastrointestinal	JJ	O	gastrointestinal	dep	7	SENT_359	[p20l983t3650r1561b3734],
16	and	CC	O	and	_	0	SENT_359	[p20l1600t3650r1732b3715],
17	cardiovascular	JJ	O	cardiovascular	dep	7	SENT_359	[p20l1770t3650r2139b3715, p21l9t21r191b86],

1	proﬁle	NN	O	proﬁle	nsubjpass	7	SENT_360	[p21l230t18r467b106],
2	of	IN	O	of	_	0	SENT_360	[p21l510t18r588b86],
3	a	DT	O	a	det	4	SENT_360	[p21l619t45r655b85],
4	coxib	NN	O	coxib	prep_of	1	SENT_360	[p21l696t18r893b86],
5	would	MD	O	would	aux	7	SENT_360	[p21l934t20r1165b86],
6	be	VB	O	be	auxpass	7	SENT_360	[p21l1209t18r1291b86],
7	expected	VBN	O	expect	_	0	SENT_360	[p21l1334t20r1656b106],
8	to	TO	O	to	aux	10	SENT_360	[p21l1700t39r1771b86],
9	resemble	VB	O	resemble	cop	10	SENT_360	[p21l1814t18r2141b86],
10	that	DT	O	that	xcomp	7	SENT_360	[p21l9t130r156b194],
11	of	IN	O	of	_	0	SENT_360	[p21l183t128r260b195],
12	a	DT	O	a	det	13	SENT_360	[p21l275t155r311b194],
13	tNSAID	NN	O	tnsaid	prep_of	10	SENT_360	[p21l335t130r671b197],
14	.	.	O	.	_	0	SENT_360	[p21l335t130r671b197],

1	Thus	RB	O	thus	advmod	21	SENT_361	[p21l700t130r910b208],
2	,	,	O	,	_	0	SENT_361	[p21l700t130r910b208],
3	determination	NN	O	determination	nsubj	21	SENT_361	[p21l938t130r1468b195],
4	of	IN	O	of	_	0	SENT_361	[p21l1493t128r1571b195],
5	the	DT	O	the	det	6	SENT_361	[p21l1586t130r1701b195],
6	factors	NNS	O	factor	prep_of	3	SENT_361	[p21l1726t128r1966b195],
7	that	WDT	O	that	nsubj	8	SENT_361	[p21l1994t130r2140b194],
8	inﬂuence	VBP	O	inﬂuence	rcmod	6	SENT_361	[p21l10t237r341b305],
9	the	DT	O	the	det	11	SENT_361	[p21l381t240r495b305],
10	actual	JJ	O	actual	amod	11	SENT_361	[p21l534t239r752b305],
11	selectivity	NN	O	selectivity	nsubj	16	SENT_361	[p21l792t240r1168b325],
12	for	IN	O	for	_	0	SENT_361	[p21l1205t237r1306b305],
13	inhibition	NN	O	inhibition	prep_for	11	SENT_361	[p21l1344t237r1720b305],
14	of	IN	O	of	_	0	SENT_361	[p21l1758t237r1836b305],
15	COX-2	NN	MISC	cox-2	prep_of	13	SENT_361	[p21l1863t241r2136b305],
16	attained	VBD	O	attain	ccomp	8	SENT_361	[p21l8t350r308b416],
17	within	IN	O	within	_	0	SENT_361	[p21l336t350r584b416],
18	an	DT	O	a	det	19	SENT_361	[p21l611t373r695b415],
19	individual	NN	O	individual	prep_within	16	SENT_361	[p21l724t350r1103b416],
20	may	MD	O	may	aux	21	SENT_361	[p21l1133t374r1287b435],
21	identify	VB	O	identify	_	0	SENT_361	[p21l1315t348r1604b435],
22	biomarkers	NNS	O	biomarker	dobj	21	SENT_361	[p21l1633t348r2045b416],
23	of	IN	O	of	_	0	SENT_361	[p21l2075t348r2152b416],
24	relevance	NN	O	relevance	prep_of	22	SENT_361	[p21l9t458r347b523],
25	to	TO	O	to	_	0	SENT_361	[p21l384t477r456b523],
26	clinical	JJ	O	clinical	amod	27	SENT_361	[p21l493t458r760b523],
27	outcome	NN	O	outcome	prep_to	21	SENT_361	[p21l797t477r1133b523],
28	.	.	O	.	_	0	SENT_361	[p21l797t477r1133b523],

1	In	IN	O	in	_	0	SENT_362	[p21l106t572r184b633],
2	summary	NN	O	summary	prep_in	5	SENT_362	[p21l236t592r601b654],
3	,	,	O	,	_	0	SENT_362	[p21l236t592r601b654],
4	we	PRP	O	we	nsubj	5	SENT_362	[p21l654t593r755b635],
5	report	VBP	O	report	conj_and	5	SENT_362	[p21l807t588r1030b654],
6	substantial	JJ	O	substantial	amod	7	SENT_362	[p21l1083t567r1485b635],
7	variability	NN	O	variability	dobj	5	SENT_362	[p21l1535t567r1920b654],
8	both	CC	O	both	preconj	5	SENT_362	[p21l1972t567r2141b635],
9	within	IN	O	within	_	0	SENT_362	[p21l7t679r255b744],
10	and	CC	O	and	_	0	SENT_362	[p21l281t679r413b744],
11	between	IN	O	between	_	0	SENT_362	[p21l440t676r746b745],
12	individuals	NNS	O	individual	prep_within	5	SENT_362	[p21l773t679r1185b744],
13	in	IN	O	in	_	0	SENT_362	[p21l1214t681r1286b743],
14	their	PRP$	O	they	poss	15	SENT_362	[p21l1312t679r1489b744],
15	response	NN	O	response	prep_in	5	SENT_362	[p21l1514t701r1824b764],
16	to	TO	O	to	_	0	SENT_362	[p21l1852t698r1923b744],
17	acute	JJ	O	acute	amod	18	SENT_362	[p21l1949t698r2141b744],
18	dosing	NN	O	dosing	prep_to	15	SENT_362	[p21l8t787r254b872],
19	with	IN	O	with	_	0	SENT_362	[p21l287t787r458b853],
20	both	CC	O	both	preconj	21	SENT_362	[p21l492t785r662b853],
21	celecoxib	NN	O	celecoxib	prep_with	18	SENT_362	[p21l696t785r1033b853],
22	and	CC	O	and	_	0	SENT_362	[p21l1067t787r1199b853],
23	rofecoxib	NN	O	rofecoxib	conj_and	21	SENT_362	[p21l1233t785r1590b853],
24	.	.	O	.	_	0	SENT_362	[p21l1233t785r1590b853],

1	SNPS	NNS	O	snp	nsubjpass	9	SENT_363	[p21l1629t789r1831b854],
2	in	IN	O	in	_	0	SENT_363	[p21l1867t790r1938b851],
3	both	DT	O	both	preconj	4	SENT_363	[p21l1972t785r2141b853],
4	COX-1	NN	O	cox-1	prep_in	1	SENT_363	[p21l9t898r279b961],
5	and	CC	O	and	_	0	SENT_363	[p21l336t897r467b961],
6	CYPZC9	NN	O	cypzc9	prep_in	1	SENT_363	[p21l516t898r848b969],
7	were	VBD	O	be	auxpass	9	SENT_363	[p21l897t919r1067b961],
8	apparently	RB	O	apparently	advmod	9	SENT_363	[p21l1116t897r1509b981],
9	associated	VBN	O	associate	_	0	SENT_363	[p21l1557t897r1922b961],
10	with	IN	O	with	_	0	SENT_363	[p21l1970t897r2141b961],
11	elements	NNS	O	element	prep_with	9	SENT_363	[p21l9t1005r335b1071],
12	of	IN	O	of	_	0	SENT_363	[p21l372t1003r451b1071],
13	drug	NN	O	drug	nn	14	SENT_363	[p21l475t1005r649b1090],
14	response	NN	O	response	prep_of	11	SENT_363	[p21l687t1028r1020b1090],
15	,	,	O	,	_	0	SENT_363	[p21l687t1028r1020b1090],
16	although	IN	O	although	mark	21	SENT_363	[p21l1058t1005r1392b1090],
17	population	NN	O	population	nn	19	SENT_363	[p21l1426t1005r1832b1090],
18	stratiﬁ	NN	O	stratiﬁ	nn	19	SENT_363	[p21l1869t1003r2139b1071],
19	cation	NN	O	cation	nsubj	21	SENT_363	[p21l9t1119r233b1182],
20	may	MD	O	may	aux	21	SENT_363	[p21l276t1141r431b1202],
21	confound	VB	O	confound	advcl	9	SENT_363	[p21l474t1114r817b1182],
22	these	DT	O	these	det	23	SENT_363	[p21l862t1117r1047b1182],
23	ﬁndings	NNS	O	ﬁndings	dobj	21	SENT_363	[p21l1092t1114r1411b1202],
24	.	.	O	.	_	0	SENT_363	[p21l1092t1114r1411b1202],

1	It	PRP	O	it	nsubj	3	SENT_364	[p21l1460t1119r1520b1181],
2	is	VBZ	O	be	cop	3	SENT_364	[p21l1566t1119r1619b1182],
3	likely	JJ	O	likely	_	0	SENT_364	[p21l1665t1114r1872b1202],
4	that	IN	O	that	complm	10	SENT_364	[p21l1916t1117r2063b1182],
5	a	DT	O	a	det	8	SENT_364	[p21l2107t1142r2143b1182],
6	more	RBR	O	more	advmod	7	SENT_364	[p21l8t1258r194b1301],
7	comprehensive	JJ	O	comprehensive	amod	8	SENT_364	[p21l228t1235r778b1320],
8	approach	NN	O	approach	nsubj	10	SENT_364	[p21l811t1235r1144b1320],
9	will	MD	O	will	aux	10	SENT_364	[p21l1175t1235r1319b1301],
10	shed	VB	O	shed	ccomp	3	SENT_364	[p21l1353t1235r1516b1301],
11	further	JJ	O	further	amod	12	SENT_364	[p21l1549t1233r1808b1301],
12	light	NN	O	light	dobj	10	SENT_364	[p21l1840t1235r2020b1320],
13	on	IN	O	on	_	0	SENT_364	[p21l2053t1258r2141b1301],
14	genetic	JJ	O	genetic	amod	15	SENT_364	[p21l7t1347r275b1430],
15	sources	NNS	O	source	prep_on	10	SENT_364	[p21l321t1367r581b1410],
16	of	IN	O	of	_	0	SENT_364	[p21l626t1342r704b1410],
17	variation	NN	O	variation	prep_of	15	SENT_364	[p21l733t1347r1083b1410],
18	.	.	O	.	_	0	SENT_364	[p21l733t1347r1083b1410],

1	Validated	VBN	O	validate	_	0	SENT_365	[p21l1130t1345r1491b1410],
2	genetic	JJ	O	genetic	amod	3	SENT_365	[p21l1533t1347r1802b1430],
3	markers	NNS	O	marker	dobj	1	SENT_365	[p21l1846t1342r2140b1410],
4	might	MD	O	might	aux	7	SENT_365	[p21l8t1455r238b1540],
5	be	VB	O	be	auxpass	7	SENT_365	[p21l275t1452r357b1520],
6	usefully	RB	O	usefully	advmod	7	SENT_365	[p21l393t1452r683b1540],
7	combined	VBN	O	combine	auxpass	1	SENT_365	[p21l719t1452r1084b1520],
8	with	IN	O	with	_	0	SENT_365	[p21l1119t1455r1290b1520],
9	biomarkers	NNS	O	biomarker	prep_with	7	SENT_365	[p21l1327t1452r1739b1520],
10	of	IN	O	of	_	0	SENT_365	[p21l1777t1452r1854b1520],
11	atherogenesis	NN	O	atherogenesis	prep_of	9	SENT_365	[p21l1879t1455r2139b1520, p21l7t1567r293b1650],
12	,	,	O	,	_	0	SENT_365	[p21l1879t1455r2139b1520, p21l7t1567r293b1650],
13	functional	JJ	O	functional	amod	14	SENT_365	[p21l333t1562r709b1630],
14	(	NN	O	(	appos	11	SENT_365	[p21l748t1566r857b1650],
15	eg	FW	O	eg	dep	14	SENT_365	[p21l748t1566r857b1650],
16	blood	NN	O	blood	nn	18	SENT_365	[p21l897t1562r1103b1631],
17	pressure	NN	O	pressure	nn	18	SENT_365	[p21l1139t1566r1491b1650],
18	)	NN	O	)	nsubjpass	1	SENT_365	[p21l1139t1566r1491b1650],
19	,	,	O	,	_	0	SENT_365	[p21l1139t1566r1491b1650],
20	kinetic	JJ	O	kinetic	appos	18	SENT_365	[p21l1531t1562r1810b1644],
21	,	,	O	,	_	0	SENT_365	[p21l1531t1562r1810b1644],
22	and	CC	O	and	_	0	SENT_365	[p21l1850t1565r1982b1630],
23	dynamic	JJ	O	dynamic	amod	24	SENT_365	[p21l2020t1565r2139b1650, p21l10t1677r232b1740],
24	parameters	NNS	O	parameter	conj_and	20	SENT_365	[p21l268t1693r673b1760],
25	of	IN	O	of	_	0	SENT_365	[p21l712t1672r789b1740],
26	drug	NN	O	drug	nn	27	SENT_365	[p21l815t1674r990b1760],
27	action	NN	O	action	prep_of	20	SENT_365	[p21l1028t1677r1253b1740],
28	to	TO	O	to	aux	29	SENT_365	[p21l1291t1693r1362b1740],
29	identify	VB	O	identify	infmod	20	SENT_365	[p21l1401t1672r1690b1760],
30	individuals	NNS	O	individual	dobj	29	SENT_365	[p21l1728t1674r2140b1740],
31	who	WP	O	who	nsubj	32	SENT_365	[p21l7t1785r162b1850],
32	accelerate	VBP	O	accelerate	rcmod	30	SENT_365	[p21l202t1785r557b1850],
33	their	PRP$	O	they	poss	34	SENT_365	[p21l599t1785r774b1850],
34	development	NN	O	development	dobj	32	SENT_365	[p21l813t1785r1292b1870],
35	of	IN	O	of	_	0	SENT_365	[p21l1334t1782r1412b1850],
36	cardiovascular	JJ	O	cardiovascular	amod	37	SENT_365	[p21l1441t1785r1965b1850],
37	risk	NN	O	risk	prep_of	34	SENT_365	[p21l2005t1782r2143b1850],
38	during	IN	O	during	_	0	SENT_365	[p21l8t1893r259b1978],
39	treatment	NN	O	treatment	prep_during	29	SENT_365	[p21l312t1912r676b1959],
40	with	IN	O	with	_	0	SENT_365	[p21l727t1893r898b1959],
41	coxibs	NNS	O	coxib	prep_with	29	SENT_365	[p21l949t1891r1198b1959],
42	.	.	O	.	_	0	SENT_365	[p21l949t1891r1198b1959],

1	Such	PDT	O	such	predet	3	SENT_366	[p21l1254t1893r1430b1959],
2	a	DT	O	a	det	3	SENT_366	[p21l1480t1918r1517b1958],
3	strategy	NN	O	strategy	nsubj	5	SENT_366	[p21l1566t1912r1861b1978],
4	might	MD	O	might	aux	5	SENT_366	[p21l1911t1893r2140b1978],
5	conserve	VB	O	conserve	_	0	SENT_366	[p21l9t2027r319b2070],
6	the	DT	O	the	det	7	SENT_366	[p21l376t2005r490b2070],
7	Value	NN	O	value	dobj	5	SENT_366	[p21l544t2005r738b2070],
8	of	IN	O	of	_	0	SENT_366	[p21l793t2002r871b2070],
9	extended	JJ	O	extended	amod	10	SENT_366	[p21l915t2004r1247b2070],
10	dosing	NN	O	dosing	prep_of	7	SENT_366	[p21l1303t2004r1548b2090],
11	with	IN	O	with	_	0	SENT_366	[p21l1604t2005r1775b2070],
12	selective	JJ	O	selective	amod	13	SENT_366	[p21l1831t2004r2141b2070],
13	inhibitors	NNS	O	inhibitor	prep_with	5	SENT_366	[p21l10t2113r373b2181],
14	of	IN	O	of	_	0	SENT_366	[p21l415t2113r493b2181],
15	COX-2	NN	O	cox-2	prep_of	13	SENT_366	[p21l523t2116r797b2181],
16	for	IN	O	for	_	0	SENT_366	[p21l842t2113r943b2181],
17	patients	NNS	O	patient	prep_for	15	SENT_366	[p21l980t2117r1276b2200],
18	at	IN	O	at	_	0	SENT_366	[p21l1318t2134r1384b2180],
19	low	JJ	O	low	amod	20	SENT_366	[p21l1426t2115r1558b2180],
20	risk	NN	O	risk	prep_at	17	SENT_366	[p21l1599t2113r1737b2181],
21	of	IN	O	of	_	0	SENT_366	[p21l1777t2113r1855b2180],
22	cardiovascular	JJ	O	cardiovascular	amod	23	SENT_366	[p21l1885t2115r2139b2181, p21l7t2224r305b2290],
23	diseases	NNS	O	disease	prep_of	20	SENT_366	[p21l344t2224r628b2290],
24	who	WP	O	who	nsubj	27	SENT_366	[p21l669t2225r823b2290],
25	have	VBP	O	have	aux	27	SENT_366	[p21l865t2225r1029b2290],
26	previously	RB	DATE	previously	advmod	27	SENT_366	[p21l1069t2224r1454b2310],
27	exhibited	VBN	O	exhibit	rcmod	13	SENT_366	[p21l1494t2222r1843b2290],
28	gastrointestinal	JJ	O	gastrointestinal	amod	29	SENT_366	[p21l1883t2243r2139b2310, p21l10t2333r357b2397],
29	intolerance	NN	O	intolerance	dobj	27	SENT_366	[p21l396t2333r804b2397],
30	of	IN	O	of	_	0	SENT_366	[p21l841t2330r918b2397],
31	tNSAIDs	NNS	O	tnsaid	prep_of	29	SENT_366	[p21l945t2333r1313b2399],
32	.	.	O	.	_	0	SENT_366	[p21l945t2333r1313b2399],

1	January	NNP	DATE	January	_	0	SENT_367	[p21l6t2441r242b2502],
2	2006	CD	DATE	2006	dep	1	SENT_367	[p21l269t2441r431b2490],

1	References	NNS	O	reference	_	0	SENT_368	[p21l280t2663r866b2739],

1	1	LS	NUMBER	1	_	0	SENT_369	[p21l47t2821r101b2871],
2	.	.	O	.	_	0	SENT_369	[p21l47t2821r101b2871],

1	FitzGera	NNP	O	FitzGera	_	0	SENT_370	[p21l148t2821r445b2871],
2	|	CD	NUMBER	|	num	4	SENT_370	[p21l148t2821r445b2871],
3	d	NN	O	d	nn	4	SENT_370	[p21l148t2821r445b2871],
4	GA	NN	O	ga	dep	1	SENT_370	[p21l481t2821r580b2880],
5	,	,	O	,	_	0	SENT_370	[p21l481t2821r580b2880],
6	Patrono	NNP	O	Patrono	nn	8	SENT_370	[p21l618t2821r851b2871],
7	C.	NNP	O	C.	nn	8	SENT_370	[p21l885t2821r942b2871],
8	The	NNP	O	The	appos	4	SENT_370	[p21l976t2821r1086b2871],
9	coxibs	NNS	O	coxib	dep	1	SENT_370	[p21l1118t2821r1329b2880],
10	,	,	O	,	_	0	SENT_370	[p21l1118t2821r1329b2880],
11	selective	JJ	O	selective	amod	12	SENT_370	[p21l1366t2821r1636b2871],
12	inhibitors	NNS	O	inhibitor	appos	9	SENT_370	[p21l1672t2821r1952b2871],
13	of	IN	O	of	_	0	SENT_370	[p21l1986t2821r2045b2871],
14	cyc	NN	O	cyc	nn	15	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],
15	|	NN	O	|	prep_of	12	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],
16	ooxygenase	NN	O	ooxygenase	nn	17	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],
17	—	NN	O	—	dep	1	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],
18	2	CD	NUMBER	2	dep	17	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],
19	.	.	O	.	_	0	SENT_370	[p21l2073t2833r2151b2884, p21l144t2913r633b2977],

1	N	NN	O	n	nn	3	SENT_371	[p21l669t2914r706b2963],
2	Engl	NNP	O	Engl	nn	3	SENT_371	[p21l740t2914r860b2977],
3	J	NNP	O	J	nsubj	4	SENT_371	[p21l890t2914r913b2964],
4	Med	VBD	O	med	_	0	SENT_371	[p21l947t2914r1073b2964],
5	2001	CD	DATE	2001	dobj	4	SENT_371	[p21l1105t2913r1762b2972],
6	;	:	O	;	_	0	SENT_371	[p21l1105t2913r1762b2972],
7	345:433	CD	NUMBER	345:433	num	8	SENT_371	[p21l1105t2913r1762b2972],
8	—	NN	O	—	dep	5	SENT_371	[p21l1105t2913r1762b2972],
9	442	CD	NUMBER	442	dep	8	SENT_371	[p21l1105t2913r1762b2972],
10	.	.	O	.	_	0	SENT_371	[p21l1105t2913r1762b2972],

1	2	LS	NUMBER	2	_	0	SENT_372	[p21l46t3005r100b3055],
2	.	.	O	.	_	0	SENT_372	[p21l46t3005r100b3055],

1	Bombardier	NNP	ORGANIZATION	Bombardier	nn	2	SENT_373	[p21l148t3006r502b3056],
2	C	NNP	ORGANIZATION	C	_	0	SENT_373	[p21l535t3005r593b3064],
3	,	,	O	,	_	0	SENT_373	[p21l535t3005r593b3064],
4	Laine	NNP	PERSON	Laine	nn	5	SENT_373	[p21l636t3006r796b3056],
5	L	NNP	PERSON	L	appos	2	SENT_373	[p21l837t3006r883b3064],
6	,	,	O	,	_	0	SENT_373	[p21l837t3006r883b3064],
7	Reicin	NNP	PERSON	Reicin	nn	8	SENT_373	[p21l926t3006r1106b3056],
8	A	NNP	O	A	appos	5	SENT_373	[p21l1143t3006r1198b3064],
9	,	,	O	,	_	0	SENT_373	[p21l1143t3006r1198b3064],
10	Shapiro	NNP	PERSON	Shapiro	nn	11	SENT_373	[p21l1239t3005r1472b3067],
11	D	NNP	O	D	appos	5	SENT_373	[p21l1512t3006r1569b3064],
12	,	,	O	,	_	0	SENT_373	[p21l1512t3006r1569b3064],
13	Burgos-Vargas	NNP	O	Burgos-Vargas	nn	14	SENT_373	[p21l1613t3006r2050b3069],
14	R	NNP	O	R	appos	5	SENT_373	[p21l2091t3006r2145b3064],
15	,	,	O	,	_	0	SENT_373	[p21l2091t3006r2145b3064],
16	Davis	NNP	PERSON	Davis	nn	17	SENT_373	[p21l148t3098r311b3148],
17	B	NNP	O	B	appos	5	SENT_373	[p21l343t3098r397b3157],
18	,	,	O	,	_	0	SENT_373	[p21l343t3098r397b3157],
19	Day	NNP	DURATION	Day	nn	20	SENT_373	[p21l432t3098r542b3160],
20	R	NNP	O	R	appos	5	SENT_373	[p21l571t3098r625b3157],
21	,	,	O	,	_	0	SENT_373	[p21l571t3098r625b3157],
22	Ferraz	NNP	PERSON	Ferraz	nn	23	SENT_373	[p21l660t3098r840b3148],
23	MB	NNP	O	MB	appos	5	SENT_373	[p21l870t3098r983b3157],
24	,	,	O	,	_	0	SENT_373	[p21l870t3098r983b3157],
25	Hawkey	NNP	ORGANIZATION	Hawkey	nn	26	SENT_373	[p21l1018t3098r1250b3160],
26	CJ	NNP	ORGANIZATION	CJ	appos	5	SENT_373	[p21l1276t3097r1361b3157],
27	,	,	O	,	_	0	SENT_373	[p21l1276t3097r1361b3157],
28	Hochberg	NNP	ORGANIZATION	Hochberg	nn	29	SENT_373	[p21l1396t3098r1685b3161],
29	MC	NNP	ORGANIZATION	MC	appos	5	SENT_373	[p21l1714t3097r1827b3157],
30	,	,	O	,	_	0	SENT_373	[p21l1714t3097r1827b3157],
31	Kvien	NNP	PERSON	Kvien	nn	32	SENT_373	[p21l1861t3098r2021b3148],
32	TK	NN	O	tk	appos	5	SENT_373	[p21l2050t3098r2145b3157],
33	,	,	O	,	_	0	SENT_373	[p21l2050t3098r2145b3157],
34	Schnitzer	NNP	O	Schnitzer	nn	35	SENT_373	[p21l145t3189r430b3240],
35	TJ	NNP	O	TJ	appos	5	SENT_373	[p21l468t3190r547b3240],
36	.	.	O	.	_	0	SENT_373	[p21l468t3190r547b3240],

1	Comparison	NN	O	comparison	_	0	SENT_374	[p21l594t3189r960b3251],
2	of	IN	O	of	_	0	SENT_374	[p21l1005t3189r1065b3240],
3	upper	JJ	O	upper	amod	5	SENT_374	[p21l1105t3202r1278b3251],
4	gastrointestinal	JJ	O	gastrointestinal	amod	5	SENT_374	[p21l1317t3190r1795b3253],
5	toxicity	NN	O	toxicity	prep_of	1	SENT_374	[p21l1839t3190r2053b3252],
6	of	IN	O	of	_	0	SENT_374	[p21l2093t3189r2153b3240],
7	rofecoxib	NN	O	rofecoxib	prep_of	1	SENT_374	[p21l147t3281r421b3332],
8	and	CC	O	and	_	0	SENT_374	[p21l467t3282r574b3332],
9	naproxen	NN	O	naproxen	prep_of	1	SENT_374	[p21l623t3294r899b3343],
10	in	IN	O	in	_	0	SENT_374	[p21l949t3282r995b3331],
11	patients	NNS	O	patient	prep_in	1	SENT_374	[p21l1043t3282r1290b3343],
12	with	IN	O	with	_	0	SENT_374	[p21l1332t3282r1453b3332],
13	rheumatoid	JJ	O	rheumatoid	amod	14	SENT_374	[p21l1502t3282r1846b3332],
14	arthritis	NN	O	arthritis	prep_with	11	SENT_374	[p21l1893t3282r2145b3332],
15	.	.	O	.	_	0	SENT_374	[p21l1893t3282r2145b3332],

1	VIGOR	NN	O	vigor	_	0	SENT_375	[p21l143t3374r336b3424],
2	Study	NNP	O	Study	nn	3	SENT_375	[p21l366t3374r538b3436],
3	Group	NNP	O	Group	dep	1	SENT_375	[p21l564t3374r763b3435],
4	.	.	O	.	_	0	SENT_375	[p21l564t3374r763b3435],

1	N	NN	O	n	nn	3	SENT_376	[p21l798t3374r835b3424],
2	Engl	NNP	O	Engl	nn	3	SENT_376	[p21l869t3374r989b3437],
3	J	NNP	O	J	nsubj	4	SENT_376	[p21l1020t3374r1042b3424],
4	Med	VBD	O	med	_	0	SENT_376	[p21l1077t3374r1202b3424],
5	2000	CD	DATE	2000	dobj	4	SENT_376	[p21l1234t3374r1976b3433],
6	;	:	O	;	_	0	SENT_376	[p21l1234t3374r1976b3433],
7	343:1520	CD	DURATION	343:1520	num	8	SENT_376	[p21l1234t3374r1976b3433],
8	-1530	CD	DURATION	-1530	dep	5	SENT_376	[p21l1234t3374r1976b3433],
9	.	.	O	.	_	0	SENT_376	[p21l1234t3374r1976b3433],

1	3	LS	NUMBER	3	_	0	SENT_377	[p21l45t3466r101b3516],
2	.	.	O	.	_	0	SENT_377	[p21l45t3466r101b3516],

1	Schnitzer	NNP	PERSON	Schnitzer	nn	2	SENT_378	[p21l145t3466r430b3516],
2	TJ	NNP	PERSON	TJ	_	0	SENT_378	[p21l452t3466r531b3525],
3	,	,	O	,	_	0	SENT_378	[p21l452t3466r531b3525],
4	Burmester	NNP	PERSON	Burmester	nn	5	SENT_378	[p21l564t3466r884b3516],
5	GR	NN	O	gr	appos	2	SENT_378	[p21l908t3466r1012b3525],
6	,	,	O	,	_	0	SENT_378	[p21l908t3466r1012b3525],
7	Mysler	NN	O	mysler	nn	8	SENT_378	[p21l1045t3466r1244b3528],
8	E	NN	O	e	appos	5	SENT_378	[p21l1271t3466r1321b3525],
9	,	,	O	,	_	0	SENT_378	[p21l1271t3466r1321b3525],
10	Hochberg	NNP	ORGANIZATION	Hochberg	nn	11	SENT_378	[p21l1354t3466r1643b3529],
11	MC	NNP	ORGANIZATION	MC	appos	5	SENT_378	[p21l1670t3466r1783b3525],
12	,	,	O	,	_	0	SENT_378	[p21l1670t3466r1783b3525],
13	Doherty	NNP	PERSON	Doherty	nn	14	SENT_378	[p21l1816t3466r2049b3528],
14	M	NNP	O	M	appos	5	SENT_378	[p21l2076t3466r2145b3525],
15	,	,	O	,	_	0	SENT_378	[p21l2076t3466r2145b3525],
16	Ehrsam	NNP	ORGANIZATION	Ehrsam	nn	17	SENT_378	[p21l148t3558r374b3609],
17	E	NNP	ORGANIZATION	E	appos	5	SENT_378	[p21l405t3558r455b3617],
18	,	,	O	,	_	0	SENT_378	[p21l405t3558r455b3617],
19	Gitton	NNP	PERSON	Gitton	nn	20	SENT_378	[p21l485t3558r664b3609],
20	X	NNP	O	X	appos	5	SENT_378	[p21l691t3558r744b3617],
21	,	,	O	,	_	0	SENT_378	[p21l691t3558r744b3617],
22	Krammer	NNP	PERSON	Krammer	nn	23	SENT_378	[p21l777t3558r1056b3609],
23	G	NNP	PERSON	G	appos	5	SENT_378	[p21l1080t3558r1139b3617],
24	,	,	O	,	_	0	SENT_378	[p21l1080t3558r1139b3617],
25	Mellein	NNP	PERSON	Mellein	nn	26	SENT_378	[p21l1172t3558r1388b3609],
26	B	NNP	PERSON	B	appos	5	SENT_378	[p21l1419t3558r1473b3617],
27	,	,	O	,	_	0	SENT_378	[p21l1419t3558r1473b3617],
28	Matchaba	NNP	PERSON	Matchaba	nn	29	SENT_378	[p21l1505t3558r1806b3609],
29	P	NN	PERSON	p	appos	5	SENT_378	[p21l1834t3558r1885b3617],
30	,	,	O	,	_	0	SENT_378	[p21l1834t3558r1885b3617],
31	Gimona	NNP	PERSON	Gimona	nn	32	SENT_378	[p21l1915t3558r2148b3609],
32	A	NNP	O	A	appos	5	SENT_378	[p21l143t3650r198b3709],
33	,	,	O	,	_	0	SENT_378	[p21l143t3650r198b3709],
34	Hawkey	NNP	O	Hawkey	nn	35	SENT_378	[p21l247t3650r479b3712],
35	CJ	NNP	O	CJ	appos	5	SENT_378	[p21l519t3650r605b3700],
36	.	.	O	.	_	0	SENT_378	[p21l519t3650r605b3700],

1	Comparison	NN	O	comparison	_	0	SENT_379	[p21l651t3650r1017b3712],
2	of	IN	O	of	_	0	SENT_379	[p21l1062t3650r1122b3700],
3	lumiracoxib	NN	O	lumiracoxib	prep_of	1	SENT_379	[p21l1163t3650r1508b3700],
4	with	IN	O	with	dep	1	SENT_379	[p21l1548t3650r1669b3700],
5	naproxen	NN	O	naproxen	pobj	4	SENT_379	[p21l1716t3662r1993b3711],
6	and	CC	O	and	_	0	SENT_379	[p21l2039t3650r2147b3700],
7	ibuprofen	NN	O	ibuprofen	conj_and	5	SENT_379	[p21l147t3742r431b3803],
8	in	IN	O	in	dep	1	SENT_379	[p21l464t3742r510b3792],
9	the	DT	O	the	det	12	SENT_379	[p21l539t3742r636b3792],
10	Therapeutic	JJ	O	therapeutic	amod	12	SENT_379	[p21l664t3742r1025b3803],
11	Arthritis	NNP	O	Arthritis	nn	12	SENT_379	[p21l1052t3742r1290b3792],
12	Research	NNP	O	Research	pobj	8	SENT_379	[p21l1322t3742r1605b3792],
13	and	CC	O	and	_	0	SENT_379	[p21l1638t3742r1745b3792],
14	Gastrointestinal	JJ	O	gastrointestinal	pobj	8	SENT_379	[p21l1777t3742r2151b3792, p22l142t22r271b72],

1	Event	NN	O	event	dep	5	SENT_380	[p22l307t22r472b72],
2	Trial	NN	O	trial	dep	1	SENT_380	[p22l498t22r624b72],
3	(	CD	NUMBER	(	num	4	SENT_380	[p22l657t22r955b84],
4	TARGET	NN	O	target	dep	5	SENT_380	[p22l657t22r955b84],
5	)	CD	NUMBER	)	dep	14	SENT_380	[p22l657t22r955b84],
6	,	,	O	,	_	0	SENT_380	[p22l657t22r955b84],
7	reduction	NN	O	reduction	appos	5	SENT_380	[p22l991t22r1271b72],
8	in	IN	O	in	_	0	SENT_380	[p22l1306t22r1352b72],
9	ulcer	NN	O	ulcer	nn	10	SENT_380	[p22l1386t22r1533b72],
10	complications	NNS	O	complication	prep_in	5	SENT_380	[p22l1560t22r2004b83],
11	:	:	O	:	_	0	SENT_380	[p22l1560t22r2004b83],
12	randomised	JJ	O	randomised	amod	14	SENT_380	[p22l2040t34r2151b72, p22l145t114r405b165],
13	controlled	JJ	O	controlled	amod	14	SENT_380	[p22l436t114r736b165],
14	trial	NN	O	trial	_	0	SENT_380	[p22l764t114r898b165],
15	.	.	O	.	_	0	SENT_380	[p22l764t114r898b165],

1	Lancet	NNP	O	Lancet	_	0	SENT_381	[p22l934t114r1137b165],
2	2004	CD	DATE	2004	num	1	SENT_381	[p22l1165t114r1821b173],
3	;	:	O	;	_	0	SENT_381	[p22l1165t114r1821b173],
4	364:665	CD	NUMBER	364:665	num	5	SENT_381	[p22l1165t114r1821b173],
5	—	NN	O	—	dep	1	SENT_381	[p22l1165t114r1821b173],
6	674	CD	NUMBER	674	dep	5	SENT_381	[p22l1165t114r1821b173],
7	.	.	O	.	_	0	SENT_381	[p22l1165t114r1821b173],

1	.	.	O	.	_	0	SENT_382	[p22l92t246r101b255],

1	Steinbach	NNP	PERSON	Steinbach	nn	2	SENT_383	[p22l145t205r449b255],
2	G	NNP	O	G	dep	45	SENT_383	[p22l474t205r534b264],
3	,	,	O	,	_	0	SENT_383	[p22l474t205r534b264],
4	Lynch	NNP	ORGANIZATION	Lynch	nn	5	SENT_383	[p22l563t205r730b268],
5	PM	NNP	ORGANIZATION	PM	appos	2	SENT_383	[p22l756t205r866b264],
6	,	,	O	,	_	0	SENT_383	[p22l756t205r866b264],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_383	[p22l893t205r1109b267],
8	RK	NNP	O	RK	appos	2	SENT_383	[p22l1135t205r1234b264],
9	,	,	O	,	_	0	SENT_383	[p22l1135t205r1234b264],
10	Wallace	NNP	PERSON	Wallace	nn	11	SENT_383	[p22l1258t205r1497b255],
11	MH	NNP	O	MH	appos	2	SENT_383	[p22l1523t205r1639b264],
12	,	,	O	,	_	0	SENT_383	[p22l1523t205r1639b264],
13	Hawk	NN	O	hawk	nn	14	SENT_383	[p22l1667t205r1830b255],
14	E	NN	O	e	appos	2	SENT_383	[p22l1854t205r1903b264],
15	,	,	O	,	_	0	SENT_383	[p22l1854t205r1903b264],
16	Gordon	NNP	PERSON	Gordon	nn	17	SENT_383	[p22l1930t205r2147b255],
17	GB	NNP	O	GB	appos	2	SENT_383	[p22l145t297r249b356],
18	,	,	O	,	_	0	SENT_383	[p22l145t297r249b356],
19	Wakabayashi	NNP	PERSON	Wakabayashi	nn	20	SENT_383	[p22l289t297r693b360],
20	N	NNP	O	N	appos	2	SENT_383	[p22l736t297r793b356],
21	,	,	O	,	_	0	SENT_383	[p22l736t297r793b356],
22	Saunders	NNP	PERSON	Saunders	nn	23	SENT_383	[p22l835t297r1126b347],
23	B	NNP	O	B	appos	2	SENT_383	[p22l1167t297r1222b356],
24	,	,	O	,	_	0	SENT_383	[p22l1167t297r1222b356],
25	Shen	NNP	O	Shen	nn	26	SENT_383	[p22l1263t297r1416b347],
26	Y	NN	O	y	appos	2	SENT_383	[p22l1454t297r1509b356],
27	,	,	O	,	_	0	SENT_383	[p22l1454t297r1509b356],
28	Fujimura	NNP	PERSON	Fujimura	nn	29	SENT_383	[p22l1553t297r1808b360],
29	T	NN	O	t	appos	2	SENT_383	[p22l1844t297r1895b356],
30	,	,	O	,	_	0	SENT_383	[p22l1844t297r1895b356],
31	Su	FW	ORGANIZATION	su	nn	32	SENT_383	[p22l1937t297r2012b347],
32	LK	FW	ORGANIZATION	lk	appos	2	SENT_383	[p22l2055t297r2145b356],
33	,	,	O	,	_	0	SENT_383	[p22l2055t297r2145b356],
34	Levin	NNP	PERSON	Levin	nn	37	SENT_383	[p22l148t389r299b439],
35	B.	NNP	O	B.	nn	37	SENT_383	[p22l333t389r387b439],
36	The	NNP	O	The	nn	37	SENT_383	[p22l417t389r527b439],
37	effect	NN	O	effect	appos	2	SENT_383	[p22l556t389r731b439],
38	of	IN	O	of	_	0	SENT_383	[p22l757t389r817b439],
39	celecoxib	NN	O	celecoxib	prep_of	37	SENT_383	[p22l841t389r1143b448],
40	,	,	O	,	_	0	SENT_383	[p22l841t389r1143b448],
41	a	DT	O	a	det	43	SENT_383	[p22l1176t401r1208b439],
42	cyclooxygenase	NN	O	cyclooxygenase	nn	43	SENT_383	[p22l1237t389r1771b452],
43	—	NN	O	—	appos	2	SENT_383	[p22l1237t389r1771b452],
44	2	CD	NUMBER	2	num	45	SENT_383	[p22l1237t389r1771b452],
45	inhibitor	NN	O	inhibitor	_	0	SENT_383	[p22l1804t389r2066b448],
46	,	,	O	,	_	0	SENT_383	[p22l1804t389r2066b448],
47	in	IN	O	in	_	0	SENT_383	[p22l2100t389r2147b439],
48	familial	JJ	O	familial	amod	50	SENT_383	[p22l143t481r363b531],
49	adenomatous	JJ	O	adenomatous	amod	50	SENT_383	[p22l392t481r812b531],
50	polyposis	NN	O	polyposis	prep_in	45	SENT_383	[p22l841t481r1144b544],
51	.	.	O	.	_	0	SENT_383	[p22l841t481r1144b544],

1	N	NN	O	n	nn	3	SENT_384	[p22l1175t481r1212b531],
2	Engl	NNP	O	Engl	nn	3	SENT_384	[p22l1243t481r1363b544],
3	J	NNP	O	J	nsubj	4	SENT_384	[p22l1389t481r1411b531],
4	Med	VBD	O	med	_	0	SENT_384	[p22l1442t481r1568b531],
5	2000	CD	DATE	2000	dobj	4	SENT_384	[p22l1596t481r2152b540, p22l147t573r329b623],
6	;	:	O	;	_	0	SENT_384	[p22l1596t481r2152b540, p22l147t573r329b623],
7	342:19461952	CD	NUMBER	342:19461952	dep	5	SENT_384	[p22l1596t481r2152b540, p22l147t573r329b623],
8	.	.	O	.	_	0	SENT_384	[p22l1596t481r2152b540, p22l147t573r329b623],

1	.	.	O	.	_	0	SENT_385	[p22l92t706r101b715],

1	Ott	NN	PERSON	ott	nn	2	SENT_386	[p22l145t665r235b716],
2	E	NN	O	e	_	0	SENT_386	[p22l268t665r318b724],
3	,	,	O	,	_	0	SENT_386	[p22l268t665r318b724],
4	Nussmeier	NNP	ORGANIZATION	Nussmeier	nn	5	SENT_386	[p22l357t665r688b716],
5	NA	NNP	ORGANIZATION	NA	appos	2	SENT_386	[p22l721t665r818b724],
6	,	,	O	,	_	0	SENT_386	[p22l721t665r818b724],
7	Duke	NNP	ORGANIZATION	Duke	nn	8	SENT_386	[p22l857t665r1008b716],
8	PC	NNP	O	PC	appos	5	SENT_386	[p22l1043t665r1138b724],
9	,	,	O	,	_	0	SENT_386	[p22l1043t665r1138b724],
10	Feneck	NNP	PERSON	Feneck	nn	11	SENT_386	[p22l1177t665r1391b716],
11	Ro	NN	PERSON	ro	appos	5	SENT_386	[p22l1425t665r1526b724],
12	,	,	O	,	_	0	SENT_386	[p22l1425t665r1526b724],
13	Alston	NNP	PERSON	Alston	nn	14	SENT_386	[p22l1561t665r1750b716],
14	RP	NNP	O	RP	appos	5	SENT_386	[p22l1787t665r1882b724],
15	,	,	O	,	_	0	SENT_386	[p22l1787t665r1882b724],
16	Snabes	NNP	O	Snabes	nn	17	SENT_386	[p22l1918t665r2148b716],
17	MC	NNP	O	MC	appos	5	SENT_386	[p22l148t757r261b816],
18	,	,	O	,	_	0	SENT_386	[p22l148t757r261b816],
19	Hubbard	NNP	PERSON	Hubbard	nn	20	SENT_386	[p22l290t757r543b807],
20	RC	NNP	O	RC	appos	5	SENT_386	[p22l571t757r670b816],
21	,	,	O	,	_	0	SENT_386	[p22l571t757r670b816],
22	Hsu	NNP	PERSON	Hsu	nn	23	SENT_386	[p22l698t757r811b807],
23	PH	NNP	O	PH	appos	5	SENT_386	[p22l838t757r936b816],
24	,	,	O	,	_	0	SENT_386	[p22l838t757r936b816],
25	Saidman	NNP	PERSON	Saidman	nn	26	SENT_386	[p22l963t757r1230b807],
26	LJ	NNP	PERSON	LJ	appos	5	SENT_386	[p22l1258t757r1332b816],
27	,	,	O	,	_	0	SENT_386	[p22l1258t757r1332b816],
28	Mangano	NNP	PERSON	Mangano	nn	29	SENT_386	[p22l1361t757r1640b820],
29	DT	NNP	O	DT	appos	5	SENT_386	[p22l1666t757r1759b807],
30	.	.	O	.	_	0	SENT_386	[p22l1666t757r1759b807],

1	Efficacy	NN	O	efficacy	_	0	SENT_387	[p22l1788t757r2018b820],
2	and	CC	O	and	_	0	SENT_387	[p22l2039t757r2147b807],
3	safety	NN	O	safety	conj_and	1	SENT_387	[p22l145t849r331b912],
4	of	IN	O	of	_	0	SENT_387	[p22l365t849r425b899],
5	the	DT	O	the	det	9	SENT_387	[p22l454t849r551b899],
6	cyclooxygenase	NN	O	cyclooxygenase	nn	9	SENT_387	[p22l588t849r1064b912],
7	2	CD	NUMBER	2	num	9	SENT_387	[p22l1103t849r1138b899],
8	inhibitors	NNS	O	inhibitor	nn	9	SENT_387	[p22l1178t849r1459b899],
9	parecoxib	NN	O	parecoxib	prep_of	1	SENT_387	[p22l1499t849r1790b911],
10	and	CC	O	and	_	0	SENT_387	[p22l1827t849r1935b899],
11	valdecoxib	NN	O	valdecoxib	prep_of	1	SENT_387	[p22l1971t849r2151b899, p22l144t942r300b992],
12	in	IN	O	in	_	0	SENT_387	[p22l349t942r394b991],
13	patients	NNS	O	patient	prep_in	11	SENT_387	[p22l445t942r692b1003],
14	undergoing	VBG	O	undergo	partmod	1	SENT_387	[p22l740t942r1079b1005],
15	coronary	JJ	O	coronary	amod	18	SENT_387	[p22l1122t953r1385b1004],
16	artery	NN	O	artery	nn	18	SENT_387	[p22l1429t944r1602b1004],
17	bypass	NN	O	bypass	nn	18	SENT_387	[p22l1647t942r1860b1004],
18	surgery	NN	O	surgery	dobj	14	SENT_387	[p22l1906t948r2145b1005],
19	.	.	O	.	_	0	SENT_387	[p22l1906t948r2145b1005],

1	J	NNP	O	J	nn	4	SENT_388	[p22l143t1034r166b1084],
2	Thorac	NNP	O	Thorac	nn	4	SENT_388	[p22l195t1034r401b1084],
3	Cardiovasc	NNP	O	Cardiovasc	nn	4	SENT_388	[p22l430t1033r766b1084],
4	Surg	NNP	O	Surg	_	0	SENT_388	[p22l796t1033r934b1097],
5	2003	CD	DATE	2003	num	4	SENT_388	[p22l961t1033r1695b1092],
6	;	:	O	;	_	0	SENT_388	[p22l961t1033r1695b1092],
7	125:1481	CD	DURATION	125:1481	number	8	SENT_388	[p22l961t1033r1695b1092],
8	-1492	CD	DURATION	-1492	dep	4	SENT_388	[p22l961t1033r1695b1092],
9	.	.	O	.	_	0	SENT_388	[p22l961t1033r1695b1092],

1	.	.	O	.	_	0	SENT_389	[p22l92t1166r100b1175],

1	Solomon	NNP	O	Solomon	nn	2	SENT_390	[p22l145t1125r412b1176],
2	SD	NN	O	sd	nsubj	31	SENT_390	[p22l439t1125r543b1184],
3	,	,	O	,	_	0	SENT_390	[p22l439t1125r543b1184],
4	McMurray	NNP	PERSON	McMurray	nn	5	SENT_390	[p22l574t1126r873b1188],
5	JJ	NN	PERSON	jj	appos	2	SENT_390	[p22l893t1126r965b1184],
6	,	,	O	,	_	0	SENT_390	[p22l893t1126r965b1184],
7	Pfeffer	NNP	PERSON	Pfeffer	nn	8	SENT_390	[p22l994t1125r1195b1176],
8	MA	NNP	PERSON	MA	appos	5	SENT_390	[p22l1219t1126r1328b1184],
9	,	,	O	,	_	0	SENT_390	[p22l1219t1126r1328b1184],
10	Wittes	NNP	PERSON	Wittes	nn	11	SENT_390	[p22l1353t1126r1547b1176],
11	J	NNP	PERSON	J	appos	5	SENT_390	[p22l1570t1126r1614b1184],
12	,	,	O	,	_	0	SENT_390	[p22l1570t1126r1614b1184],
13	Fowler	NNP	PERSON	Fowler	nn	14	SENT_390	[p22l1644t1126r1838b1176],
14	R	NNP	O	R	appos	5	SENT_390	[p22l1862t1126r1916b1184],
15	,	,	O	,	_	0	SENT_390	[p22l1862t1126r1916b1184],
16	Finn	NNP	O	Finn	nn	17	SENT_390	[p22l1947t1126r2065b1175],
17	P	NN	O	p	appos	5	SENT_390	[p22l2094t1126r2145b1184],
18	,	,	O	,	_	0	SENT_390	[p22l2094t1126r2145b1184],
19	Anderson	NNP	PERSON	Anderson	nn	20	SENT_390	[p22l143t1218r431b1268],
20	WF	NNP	PERSON	WF	appos	5	SENT_390	[p22l464t1218r572b1276],
21	,	,	O	,	_	0	SENT_390	[p22l464t1218r572b1276],
22	Zauber	NNP	O	Zauber	nn	23	SENT_390	[p22l606t1218r822b1268],
23	A	NNP	O	A	appos	5	SENT_390	[p22l850t1218r905b1276],
24	,	,	O	,	_	0	SENT_390	[p22l850t1218r905b1276],
25	Hawk	NN	O	hawk	nn	26	SENT_390	[p22l944t1218r1107b1268],
26	E	NN	O	e	appos	5	SENT_390	[p22l1141t1218r1191b1276],
27	,	,	O	,	_	0	SENT_390	[p22l1141t1218r1191b1276],
28	Bertagnolli	NNP	PERSON	Bertagnolli	nn	30	SENT_390	[p22l1230t1218r1551b1281],
29	M.	NNP	PERSON	M.	nn	30	SENT_390	[p22l1590t1218r1658b1267],
30	Cardiovascular	NNP	PERSON	Cardiovascular	appos	5	SENT_390	[p22l1695t1217r2152b1268],
31	risk	NN	O	risk	_	0	SENT_390	[p22l147t1309r255b1358],
32	associated	VBN	O	associate	dep	31	SENT_390	[p22l295t1309r629b1358],
33	with	IN	O	with	_	0	SENT_390	[p22l669t1309r791b1358],
34	celecoxib	NN	O	celecoxib	prep_with	32	SENT_390	[p22l833t1309r1117b1358],
35	in	IN	O	in	_	0	SENT_390	[p22l1161t1309r1208b1358],
36	a	DT	O	a	det	38	SENT_390	[p22l1252t1320r1284b1358],
37	clinical	JJ	O	clinical	amod	38	SENT_390	[p22l1325t1309r1532b1358],
38	trial	NN	O	trial	prep_in	34	SENT_390	[p22l1574t1309r1687b1358],
39	for	IN	O	for	_	0	SENT_390	[p22l1729t1308r1812b1358],
40	colorectal	JJ	O	colorectal	amod	42	SENT_390	[p22l1850t1309r2146b1358],
41	adenoma	NN	O	adenoma	nn	42	SENT_390	[p22l146t1401r430b1451],
42	prevention	NN	O	prevention	prep_for	38	SENT_390	[p22l461t1401r797b1462],
43	.	.	O	.	_	0	SENT_390	[p22l461t1401r797b1462],

1	N	NN	O	n	nn	3	SENT_391	[p22l833t1401r870b1450],
2	Engl	NNP	O	Engl	nn	3	SENT_391	[p22l904t1401r1024b1464],
3	J	NNP	O	J	nsubj	4	SENT_391	[p22l1054t1401r1077b1451],
4	Med	VBD	O	med	_	0	SENT_391	[p22l1111t1401r1237b1451],
5	2005	CD	DATE	2005	dobj	4	SENT_391	[p22l1269t1400r2002b1459],
6	;	:	O	;	_	0	SENT_391	[p22l1269t1400r2002b1459],
7	352:1071	CD	DURATION	352:1071	num	8	SENT_391	[p22l1269t1400r2002b1459],
8	-1080	CD	DURATION	-1080	dep	5	SENT_391	[p22l1269t1400r2002b1459],
9	.	.	O	.	_	0	SENT_391	[p22l1269t1400r2002b1459],

1	.	.	O	.	_	0	SENT_392	[p22l92t1533r100b1542],

1	Bresalier	NNP	PERSON	Bresalier	nn	2	SENT_393	[p22l148t1493r420b1543],
2	RS	NN	O	r	_	0	SENT_393	[p22l459t1492r558b1551],
3	,	,	O	,	_	0	SENT_393	[p22l459t1492r558b1551],
4	Sandler	NNP	PERSON	Sandler	nn	5	SENT_393	[p22l601t1492r838b1543],
5	RS	NN	O	r	appos	2	SENT_393	[p22l877t1492r975b1551],
6	,	,	O	,	_	0	SENT_393	[p22l877t1492r975b1551],
7	Quan	NN	PERSON	quan	nn	8	SENT_393	[p22l1019t1492r1174b1554],
8	H	NN	PERSON	h	appos	5	SENT_393	[p22l1218t1493r1276b1551],
9	,	,	O	,	_	0	SENT_393	[p22l1218t1493r1276b1551],
10	Bolognese	NNP	O	Bolognese	nn	11	SENT_393	[p22l1321t1493r1641b1556],
11	JA	NNP	O	JA	appos	5	SENT_393	[p22l1679t1493r1762b1551],
12	,	,	O	,	_	0	SENT_393	[p22l1679t1493r1762b1551],
13	Oxenius	NNP	O	Oxenius	nn	14	SENT_393	[p22l1805t1492r2048b1543],
14	B	NNP	O	B	appos	5	SENT_393	[p22l2091t1493r2145b1551],
15	,	,	O	,	_	0	SENT_393	[p22l2091t1493r2145b1551],
16	Horgan	NNP	PERSON	Horgan	nn	17	SENT_393	[p22l148t1585r359b1648],
17	K	NNP	PERSON	K	appos	5	SENT_393	[p22l395t1585r449b1644],
18	,	,	O	,	_	0	SENT_393	[p22l395t1585r449b1644],
19	Lines	NNP	O	Lines	nn	20	SENT_393	[p22l485t1585r644b1635],
20	C	NNP	O	C	appos	5	SENT_393	[p22l674t1584r732b1644],
21	,	,	O	,	_	0	SENT_393	[p22l674t1584r732b1644],
22	Riddell	NNP	PERSON	Riddell	nn	23	SENT_393	[p22l768t1585r968b1635],
23	R	NNP	PERSON	R	appos	5	SENT_393	[p22l1004t1585r1058b1644],
24	,	,	O	,	_	0	SENT_393	[p22l1004t1585r1058b1644],
25	Morton	NNP	PERSON	Morton	nn	26	SENT_393	[p22l1094t1585r1304b1635],
26	D	NNP	PERSON	D	appos	5	SENT_393	[p22l1340t1585r1397b1644],
27	,	,	O	,	_	0	SENT_393	[p22l1340t1585r1397b1644],
28	Lanas	NNP	O	Lanas	nn	29	SENT_393	[p22l1433t1585r1613b1635],
29	A	NNP	O	A	appos	5	SENT_393	[p22l1642t1585r1697b1644],
30	,	,	O	,	_	0	SENT_393	[p22l1642t1585r1697b1644],
31	Konstam	NNP	PERSON	Konstam	nn	32	SENT_393	[p22l1733t1585r2001b1635],
32	MA	NNP	O	MA	appos	5	SENT_393	[p22l2036t1585r2145b1644],
33	,	,	O	,	_	0	SENT_393	[p22l2036t1585r2145b1644],
34	Baron	NNP	PERSON	Baron	nn	35	SENT_393	[p22l148t1676r320b1726],
35	JA	NNP	PERSON	JA	appos	5	SENT_393	[p22l354t1676r437b1726],
36	.	.	O	.	_	0	SENT_393	[p22l354t1676r437b1726],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_394	[p22l474t1675r931b1726],
2	events	NNS	O	event	nsubj	3	SENT_394	[p22l961t1679r1163b1726],
3	associated	VBN	O	associate	_	0	SENT_394	[p22l1198t1676r1532b1726],
4	with	IN	O	with	_	0	SENT_394	[p22l1564t1676r1686b1726],
5	rofecoxib	NN	O	rofecoxib	prep_with	3	SENT_394	[p22l1723t1675r1998b1726],
6	in	IN	O	in	_	0	SENT_394	[p22l2034t1676r2079b1725],
7	a	DT	O	a	det	11	SENT_394	[p22l2116t1688r2148b1726],
8	colorectal	JJ	O	colorectal	amod	11	SENT_394	[p22l144t1768r440b1818],
9	adenoma	NN	O	adenoma	nn	11	SENT_394	[p22l475t1768r758b1818],
10	chemoprevention	NN	O	chemoprevention	nn	11	SENT_394	[p22l789t1768r1317b1829],
11	trial	NN	O	trial	prep_in	5	SENT_394	[p22l1347t1768r1481b1818],
12	.	.	O	.	_	0	SENT_394	[p22l1347t1768r1481b1818],

1	N	NN	O	n	nn	3	SENT_395	[p22l1518t1768r1555b1817],
2	Engl	NNP	O	Engl	nn	3	SENT_395	[p22l1591t1768r1711b1831],
3	J	NNP	O	J	nsubj	4	SENT_395	[p22l1743t1768r1766b1818],
4	Med	VBD	O	med	_	0	SENT_395	[p22l1802t1768r1928b1818],
5	2005	CD	DATE	2005	dobj	4	SENT_395	[p22l1962t1767r2145b1827],
6	;	:	O	;	_	0	SENT_395	[p22l1962t1767r2145b1827],
7	352:1092	CD	NUMBER	352:1092	number	8	SENT_395	[p22l145t1858r687b1909],
8	—	CD	NUMBER	—	dep	5	SENT_395	[p22l145t1858r687b1909],
9	1102	CD	DATE	1102	dep	8	SENT_395	[p22l145t1858r687b1909],
10	.	.	O	.	_	0	SENT_395	[p22l145t1858r687b1909],

1	.	.	O	.	_	0	SENT_396	[p22l92t1991r100b2000],

1	Nussmeier	NNP	PERSON	Nussmeier	nn	2	SENT_397	[p22l148t1951r479b2001],
2	NA	NNP	O	NA	_	0	SENT_397	[p22l515t1951r612b2010],
3	,	,	O	,	_	0	SENT_397	[p22l515t1951r612b2010],
4	Whelton	NNP	ORGANIZATION	Whelton	nn	5	SENT_397	[p22l649t1951r897b2001],
5	AA	NNP	ORGANIZATION	AA	appos	2	SENT_397	[p22l933t1951r1028b2010],
6	,	,	O	,	_	0	SENT_397	[p22l933t1951r1028b2010],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_397	[p22l1070t1951r1252b2001],
8	MT	NNP	O	MT	appos	5	SENT_397	[p22l1292t1951r1397b2010],
9	,	,	O	,	_	0	SENT_397	[p22l1292t1951r1397b2010],
10	Langford	NNP	ORGANIZATION	Langford	nn	11	SENT_397	[p22l1439t1950r1700b2014],
11	RM	NN	ORGANIZATION	rm	appos	5	SENT_397	[p22l1740t1951r1853b2010],
12	,	,	O	,	_	0	SENT_397	[p22l1740t1951r1853b2010],
13	Hoeft	NNP	PERSON	Hoeft	nn	14	SENT_397	[p22l1895t1950r2058b2001],
14	A	NNP	O	A	appos	5	SENT_397	[p22l2090t1951r2145b2010],
15	,	,	O	,	_	0	SENT_397	[p22l2090t1951r2145b2010],
16	Parlow	NNP	PERSON	Parlow	nn	17	SENT_397	[p22l146t2043r346b2093],
17	JL	NNP	O	JL	appos	5	SENT_397	[p22l376t2043r455b2102],
18	,	,	O	,	_	0	SENT_397	[p22l376t2043r455b2102],
19	Boyce	NNP	PERSON	Boyce	nn	20	SENT_397	[p22l495t2043r672b2105],
20	SW	NNP	O	SW	appos	5	SENT_397	[p22l707t2042r822b2102],
21	,	,	O	,	_	0	SENT_397	[p22l707t2042r822b2102],
22	Verburg	NNP	PERSON	Verburg	nn	23	SENT_397	[p22l857t2043r1094b2106],
23	KM	NNP	O	KM	appos	5	SENT_397	[p22l1128t2043r1241b2092],
24	.	.	O	.	_	0	SENT_397	[p22l1128t2043r1241b2092],

1	Complications	NNS	O	complication	nsubj	7	SENT_398	[p22l1278t2042r1714b2104],
2	of	IN	O	of	_	0	SENT_398	[p22l1748t2042r1807b2093],
3	the	DT	O	the	det	5	SENT_398	[p22l1833t2043r1931b2093],
4	COX	NNP	O	COX	nn	5	SENT_398	[p22l1965t2042r2147b2093],
5	—	NN	O	—	prep_of	1	SENT_398	[p22l1965t2042r2147b2093],
6	2	CD	NUMBER	2	num	7	SENT_398	[p22l1965t2042r2147b2093],
7	inhibitors	NNS	O	inhibitor	_	0	SENT_398	[p22l147t2135r428b2185],
8	parecoxib	NN	O	parecoxib	dobj	7	SENT_398	[p22l459t2135r750b2196],
9	and	CC	O	and	_	0	SENT_398	[p22l780t2135r887b2185],
10	valdecoxib	NN	O	valdecoxib	dobj	7	SENT_398	[p22l916t2135r1237b2185],
11	after	IN	O	after	_	0	SENT_398	[p22l1267t2134r1408b2185],
12	cardiac	JJ	O	cardiac	amod	13	SENT_398	[p22l1433t2135r1653b2185],
13	surgery	NN	O	surgery	prep_after	7	SENT_398	[p22l1681t2142r1920b2198],
14	.	.	O	.	_	0	SENT_398	[p22l1681t2142r1920b2198],

1	N	NN	O	n	nn	3	SENT_399	[p22l1955t2135r1991b2184],
2	Engl	NNP	O	Engl	nn	3	SENT_399	[p22l2025t2135r2146b2198],
3	J	NNP	O	J	nsubj	4	SENT_399	[p22l143t2227r166b2277],
4	Med	VBD	O	med	_	0	SENT_399	[p22l200t2227r326b2277],
5	2005	CD	DATE	2005	dobj	4	SENT_399	[p22l358t2226r1091b2286],
6	;	:	O	;	_	0	SENT_399	[p22l358t2226r1091b2286],
7	352:1081	CD	DURATION	352:1081	num	8	SENT_399	[p22l358t2226r1091b2286],
8	-1091	CD	DURATION	-1091	dep	5	SENT_399	[p22l358t2226r1091b2286],
9	.	.	O	.	_	0	SENT_399	[p22l358t2226r1091b2286],

1	.	.	O	.	_	0	SENT_400	[p22l92t2360r101b2368],

1	Tacconelli	NNP	PERSON	Tacconelli	nn	2	SENT_401	[p22l143t2319r448b2369],
2	S	NNP	O	S	_	0	SENT_401	[p22l473t2318r529b2378],
3	,	,	O	,	_	0	SENT_401	[p22l473t2318r529b2378],
4	Capone	NNP	PERSON	Capone	nn	5	SENT_401	[p22l556t2318r787b2380],
5	ML	NNP	O	ML	appos	2	SENT_401	[p22l812t2319r917b2378],
6	,	,	O	,	_	0	SENT_401	[p22l812t2319r917b2378],
7	Sciulli	NNP	PERSON	Sciulli	nn	8	SENT_401	[p22l943t2318r1121b2369],
8	MG	NN	O	mg	appos	2	SENT_401	[p22l1148t2318r1264b2378],
9	,	,	O	,	_	0	SENT_401	[p22l1148t2318r1264b2378],
10	Ricciotti	NNP	PERSON	Ricciotti	nn	11	SENT_401	[p22l1293t2319r1531b2369],
11	E	NNP	PERSON	E	appos	2	SENT_401	[p22l1559t2319r1609b2378],
12	,	,	O	,	_	0	SENT_401	[p22l1559t2319r1609b2378],
13	Patrignani	NNP	O	Patrignani	nn	17	SENT_401	[p22l1636t2319r1937b2382],
14	P.	NNP	O	P.	nn	17	SENT_401	[p22l1963t2319r2015b2368],
15	The	NNP	O	The	nn	17	SENT_401	[p22l2038t2319r2148b2369],
16	biochemical	JJ	O	biochemical	amod	17	SENT_401	[p22l146t2411r509b2461],
17	selectivity	NN	O	selectivity	appos	2	SENT_401	[p22l544t2411r849b2473],
18	of	IN	O	of	_	0	SENT_401	[p22l879t2410r939b2461],
19	novel	JJ	O	novel	amod	21	SENT_401	[p22l968t2411r1123b2461],
20	COX-2	NN	O	cox-2	nn	21	SENT_401	[p22l1159t2410r1341b2461],
21	inhibitors	NNS	O	inhibitor	prep_of	17	SENT_401	[p22l1377t2411r1658b2461],
22	in	IN	O	in	_	0	SENT_401	[p22l1694t2411r1740b2460],
23	whole	JJ	O	whole	amod	25	SENT_401	[p22l1772t2411r1949b2461],
24	blood	NN	O	blood	nn	25	SENT_401	[p22l1983t2411r2147b2461],
25	assays	NNS	O	assay	prep_in	21	SENT_401	[p22l146t2515r358b2565],
26	of	IN	O	of	_	0	SENT_401	[p22l398t2502r457b2553],
27	COX-isozyme	JJ	O	cox-isozyme	amod	28	SENT_401	[p22l492t2502r882b2565],
28	activity	NN	O	activity	prep_of	25	SENT_401	[p22l923t2503r1149b2565],
29	.	.	O	.	_	0	SENT_401	[p22l923t2503r1149b2565],

1	Curr	NNP	O	Curr	nn	4	SENT_402	[p22l1191t2502r1318b2553],
2	Med	NNP	O	Med	nn	4	SENT_402	[p22l1357t2503r1483b2553],
3	Res	NNP	O	Res	nn	4	SENT_402	[p22l1527t2503r1638b2553],
4	opin	NN	O	opin	_	0	SENT_402	[p22l1678t2502r1812b2564],
5	2002	CD	DATE	2002	num	4	SENT_402	[p22l1855t2502r2145b2562],
6	;	:	O	;	_	0	SENT_402	[p22l1855t2502r2145b2562],
7	18	CD	NUMBER	18	num	9	SENT_402	[p22l1855t2502r2145b2562],
8	:	:	O	:	_	0	SENT_402	[p22l1855t2502r2145b2562],
9	503-511	CD	NUMBER	503-511	dep	4	SENT_402	[p22l146t2593r451b2644],
10	.	.	O	.	_	0	SENT_402	[p22l146t2593r451b2644],

1	McAdam	NNP	PERSON	McAdam	nn	2	SENT_403	[p22l155t2686r414b2736],
2	BF	NNP	O	BF	_	0	SENT_403	[p22l444t2686r533b2745],
3	,	,	O	,	_	0	SENT_403	[p22l444t2686r533b2745],
4	Catella-Lawson	NNP	O	Catella-Lawson	nn	5	SENT_403	[p22l561t2685r1023b2736],
5	F	NN	O	f	appos	2	SENT_403	[p22l1053t2686r1098b2745],
6	,	,	O	,	_	0	SENT_403	[p22l1053t2686r1098b2745],
7	Mardini	NNP	ORGANIZATION	Mardini	nn	8	SENT_403	[p22l1129t2686r1350b2736],
8	IA	NNP	ORGANIZATION	IA	appos	5	SENT_403	[p22l1382t2686r1450b2745],
9	,	,	O	,	_	0	SENT_403	[p22l1382t2686r1450b2745],
10	Kapoor	NNP	PERSON	Kapoor	nn	11	SENT_403	[p22l1482t2686r1699b2747],
11	S	NNP	O	S	appos	5	SENT_403	[p22l1722t2685r1778b2745],
12	,	,	O	,	_	0	SENT_403	[p22l1722t2685r1778b2745],
13	Lawson	NNP	PERSON	Lawson	nn	14	SENT_403	[p22l1810t2686r2036b2736],
14	JA	NNP	O	JA	appos	5	SENT_403	[p22l2062t2686r2145b2745],
15	,	,	O	,	_	0	SENT_403	[p22l2062t2686r2145b2745],
16	FitzGerald	NNP	PERSON	FitzGerald	nn	17	SENT_403	[p22l155t2777r452b2828],
17	GA.	NNP	O	GA.	appos	5	SENT_403	[p22l484t2777r584b2828],
18	.	.	O	.	_	0	SENT_403	[p22l484t2777r584b2828],

1	Systemic	JJ	MISC	systemic	amod	2	SENT_404	[p22l618t2777r895b2840],
2	biosynthesis	NN	O	biosynthesis	_	0	SENT_404	[p22l926t2778r1311b2840],
3	of	IN	O	of	_	0	SENT_404	[p22l1341t2777r1401b2828],
4	prostacyclin	NN	O	prostacyclin	prep_of	2	SENT_404	[p22l1428t2778r1789b2840],
5	by	IN	O	by	_	0	SENT_404	[p22l1822t2778r1887b2840],
6	cyc	NN	O	cyc	nn	9	SENT_404	[p22l1913t2778r2151b2840],
7	|	CD	NUMBER	|	num	9	SENT_404	[p22l1913t2778r2151b2840],
8	oox	NN	O	oox	nn	9	SENT_404	[p22l1913t2778r2151b2840],
9	—	NN	O	—	prep_by	4	SENT_404	[p22l1913t2778r2151b2840],
10	ygenase	NN	O	ygenase	nn	12	SENT_404	[p22l149t2877r404b2933],
11	(	CD	NUMBER	(	num	12	SENT_404	[p22l434t2869r677b2932],
12	COX	NNP	O	COX	dep	2	SENT_404	[p22l434t2869r677b2932],
13	)	CD	NUMBER	)	num	14	SENT_404	[p22l434t2869r677b2932],
14	-2	CD	NUMBER	-2	dep	12	SENT_404	[p22l434t2869r677b2932],
15	:	:	O	:	_	0	SENT_404	[p22l434t2869r677b2932],
16	the	DT	O	the	det	18	SENT_404	[p22l707t2870r804b2920],
17	human	JJ	O	human	amod	18	SENT_404	[p22l836t2870r1040b2920],
18	pharmacology	NN	O	pharmacology	dep	2	SENT_404	[p22l1073t2870r1499b2933],
19	of	IN	O	of	_	0	SENT_404	[p22l1525t2869r1584b2920],
20	a	DT	O	a	det	22	SENT_404	[p22l1609t2882r1642b2920],
21	selective	JJ	O	selective	amod	22	SENT_404	[p22l1671t2870r1941b2920],
22	inhibitor	NN	O	inhibitor	prep_of	18	SENT_404	[p22l1973t2870r2151b2920, p22l149t2965r234b3013],
23	of	IN	O	of	_	0	SENT_404	[p22l260t2962r320b3013],
24	COX-2	NN	O	cox-2	prep_of	22	SENT_404	[p22l344t2962r545b3013],
25	.	.	O	.	_	0	SENT_404	[p22l344t2962r545b3013],

1	Proc	NNP	O	Proc	nn	7	SENT_405	[p22l579t2962r708b3013],
2	Natl	NNP	O	Natl	nn	7	SENT_405	[p22l740t2962r855b3013],
3	Acad	NNP	O	Acad	nn	7	SENT_405	[p22l885t2962r1032b3013],
4	Sci	NNP	O	Sci	nn	7	SENT_405	[p22l1063t2962r1150b3013],
5	U	NNP	O	U	nn	7	SENT_405	[p22l1185t2962r1219b3013],
6	S	NNP	O	S	nn	7	SENT_405	[p22l1251t2962r1290b3013],
7	A	NNP	O	A	_	0	SENT_405	[p22l1318t2962r1357b3012],
8	1999	CD	DATE	1999	num	7	SENT_405	[p22l1385t2962r1989b3021],
9	;	:	O	;	_	0	SENT_405	[p22l1385t2962r1989b3021],
10	96:272	CD	NUMBER	96:272	number	11	SENT_405	[p22l1385t2962r1989b3021],
11	-277	CD	NUMBER	-277	dep	7	SENT_405	[p22l1385t2962r1989b3021],
12	.	.	O	.	_	0	SENT_405	[p22l1385t2962r1989b3021],

1	Cate	NNP	O	Cate	nn	3	SENT_406	[p22l152t3054r614b3104],
2	|	NNP	O	|	nn	3	SENT_406	[p22l152t3054r614b3104],
3	la	NNP	O	la	_	0	SENT_406	[p22l152t3054r614b3104],
4	.	.	O	.	_	0	SENT_406	[p22l152t3054r614b3104],

1	—	NN	O	—	_	0	SENT_407	[p22l152t3054r614b3104],
2	.	.	O	.	_	0	SENT_407	[p22l152t3054r614b3104],

1	Lawson	NNP	PERSON	Lawson	nn	2	SENT_408	[p22l152t3054r614b3104],
2	F	NN	O	f	_	0	SENT_408	[p22l643t3054r688b3113],
3	,	,	O	,	_	0	SENT_408	[p22l643t3054r688b3113],
4	McAdam	NN	PERSON	mcadam	nn	5	SENT_408	[p22l718t3054r977b3104],
5	B	NN	O	b	appos	2	SENT_408	[p22l1006t3054r1061b3113],
6	,	,	O	,	_	0	SENT_408	[p22l1006t3054r1061b3113],
7	Morrison	NNP	PERSON	Morrison	nn	8	SENT_408	[p22l1091t3054r1356b3104],
8	BW	NN	O	bw	appos	5	SENT_408	[p22l1385t3054r1498b3113],
9	,	,	O	,	_	0	SENT_408	[p22l1385t3054r1498b3113],
10	Kapoor	NNP	PERSON	Kapoor	nn	11	SENT_408	[p22l1529t3054r1745b3115],
11	S	NNP	O	S	appos	5	SENT_408	[p22l1767t3054r1824b3113],
12	,	,	O	,	_	0	SENT_408	[p22l1767t3054r1824b3113],
13	Kujubu	NNP	PERSON	Kujubu	nn	14	SENT_408	[p22l1855t3054r2058b3116],
14	D	NNP	PERSON	D	appos	5	SENT_408	[p22l2088t3054r2145b3113],
15	,	,	O	,	_	0	SENT_408	[p22l2088t3054r2145b3113],
16	Antes	NNP	ORGANIZATION	Antes	nn	17	SENT_408	[p22l150t3146r323b3196],
17	L	NNP	ORGANIZATION	L	appos	5	SENT_408	[p22l351t3146r397b3205],
18	,	,	O	,	_	0	SENT_408	[p22l351t3146r397b3205],
19	Lasseter	NNP	PERSON	Lasseter	nn	20	SENT_408	[p22l427t3146r693b3196],
20	KC	NNP	PERSON	KC	appos	5	SENT_408	[p22l718t3146r816b3205],
21	,	,	O	,	_	0	SENT_408	[p22l718t3146r816b3205],
22	Quan	NNP	PERSON	Quan	nn	23	SENT_408	[p22l843t3146r999b3207],
23	H	NNP	PERSON	H	appos	5	SENT_408	[p22l1027t3146r1085b3205],
24	,	,	O	,	_	0	SENT_408	[p22l1027t3146r1085b3205],
25	Gertz	NNP	ORGANIZATION	Gertz	nn	26	SENT_408	[p22l1112t3146r1270b3196],
26	BJ	NNP	ORGANIZATION	BJ	appos	5	SENT_408	[p22l1295t3146r1378b3205],
27	,	,	O	,	_	0	SENT_408	[p22l1295t3146r1378b3205],
28	FitzGerald	NNP	PERSON	FitzGerald	nn	29	SENT_408	[p22l1408t3146r1706b3196],
29	GA.	NNP	O	GA.	appos	5	SENT_408	[p22l1732t3146r1832b3196],
30	.	.	O	.	_	0	SENT_408	[p22l1732t3146r1832b3196],

1	Effects	NNS	O	effect	_	0	SENT_409	[p22l1862t3146r2069b3196],
2	of	IN	O	of	_	0	SENT_409	[p22l2093t3146r2153b3196],
3	specific	JJ	O	specific	amod	4	SENT_409	[p22l152t3238r383b3299],
4	inhibition	NN	O	inhibition	prep_of	1	SENT_409	[p22l408t3238r682b3288],
5	of	IN	O	of	_	0	SENT_409	[p22l706t3238r766b3288],
6	cyc	NN	O	cyc	nn	9	SENT_409	[p22l783t3238r1318b3301],
7	|	NN	O	|	nn	9	SENT_409	[p22l783t3238r1318b3301],
8	ooxygenase	NN	O	ooxygenase	nn	9	SENT_409	[p22l783t3238r1318b3301],
9	—	NN	O	—	prep_of	1	SENT_409	[p22l783t3238r1318b3301],
10	2	CD	NUMBER	2	dep	1	SENT_409	[p22l783t3238r1318b3301],
11	on	IN	O	on	dep	1	SENT_409	[p22l1341t3250r1411b3288],
12	sodium	NN	O	sodium	nn	13	SENT_409	[p22l1435t3238r1657b3288],
13	balance	NN	O	balance	pobj	11	SENT_409	[p22l1682t3238r1938b3297],
14	,	,	O	,	_	0	SENT_409	[p22l1682t3238r1938b3297],
15	hemodynamics	NNS	O	hemodynamic	pobj	11	SENT_409	[p22l1966t3238r2151b3288, p22l152t3330r458b3392],
16	,	,	O	,	_	0	SENT_409	[p22l1966t3238r2151b3288, p22l152t3330r458b3392],
17	and	CC	O	and	_	0	SENT_409	[p22l502t3330r610b3380],
18	vasoactive	JJ	O	vasoactive	amod	19	SENT_409	[p22l650t3330r975b3380],
19	eicosanoids	NNS	O	eicosanoid	conj_and	13	SENT_409	[p22l1016t3330r1403b3380],
20	.	.	O	.	_	0	SENT_409	[p22l1016t3330r1403b3380],

1	J	NNP	O	J	nn	4	SENT_410	[p22l1445t3330r1468b3380],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_410	[p22l1512t3330r1830b3380],
3	Exp	NNP	O	Exp	nn	4	SENT_410	[p22l1876t3330r1978b3391],
4	Ther	NNP	O	Ther	_	0	SENT_410	[p22l2016t3330r2151b3380],
5	1999	CD	DATE	1999	num	4	SENT_410	[p22l155t3422r801b3481],
6	;	:	O	;	_	0	SENT_410	[p22l155t3422r801b3481],
7	289:735	CD	NUMBER	289:735	number	8	SENT_410	[p22l155t3422r801b3481],
8	-741	CD	NUMBER	-741	dep	4	SENT_410	[p22l155t3422r801b3481],
9	.	.	O	.	_	0	SENT_410	[p22l155t3422r801b3481],

1	Cheng	NNP	PERSON	Cheng	nn	2	SENT_411	[p22l152t3514r346b3577],
2	Y	NN	PERSON	y	_	0	SENT_411	[p22l365t3514r420b3573],
3	,	,	O	,	_	0	SENT_411	[p22l365t3514r420b3573],
4	Austin	NNP	ORGANIZATION	Austin	nn	5	SENT_411	[p22l446t3514r635b3564],
5	SC	NNP	ORGANIZATION	SC	appos	2	SENT_411	[p22l662t3514r764b3573],
6	,	,	O	,	_	0	SENT_411	[p22l662t3514r764b3573],
7	Rocca	NNP	PERSON	Rocca	nn	8	SENT_411	[p22l794t3514r976b3564],
8	B	NNP	PERSON	B	appos	5	SENT_411	[p22l1004t3514r1058b3573],
9	,	,	O	,	_	0	SENT_411	[p22l1004t3514r1058b3573],
10	Koller	NNP	ORGANIZATION	Koller	nn	11	SENT_411	[p22l1089t3514r1263b3564],
11	BH	NNP	ORGANIZATION	BH	appos	5	SENT_411	[p22l1287t3514r1389b3573],
12	,	,	O	,	_	0	SENT_411	[p22l1287t3514r1389b3573],
13	Coffman	NNP	ORGANIZATION	Coffman	nn	14	SENT_411	[p22l1416t3514r1671b3564],
14	TM	NNP	ORGANIZATION	TM	appos	5	SENT_411	[p22l1695t3514r1805b3573],
15	,	,	O	,	_	0	SENT_411	[p22l1695t3514r1805b3573],
16	Grosser	NNP	O	Grosser	nn	17	SENT_411	[p22l1833t3514r2075b3564],
17	T	NN	O	t	appos	5	SENT_411	[p22l2094t3514r2145b3573],
18	,	,	O	,	_	0	SENT_411	[p22l2094t3514r2145b3573],
19	Lawson	NNP	PERSON	Lawson	nn	20	SENT_411	[p22l155t3606r380b3656],
20	JA	NNP	O	JA	appos	5	SENT_411	[p22l411t3606r494b3665],
21	,	,	O	,	_	0	SENT_411	[p22l411t3606r494b3665],
22	FitzGerald	NNP	PERSON	FitzGerald	nn	23	SENT_411	[p22l530t3606r827b3656],
23	GA.	NNP	O	GA.	appos	5	SENT_411	[p22l860t3606r959b3656],
24	.	.	O	.	_	0	SENT_411	[p22l860t3606r959b3656],

1	Role	NN	O	role	_	0	SENT_412	[p22l995t3606r1125b3656],
2	of	IN	O	of	_	0	SENT_412	[p22l1156t3606r1215b3656],
3	prostacyclin	NN	O	prostacyclin	prep_of	1	SENT_412	[p22l1243t3606r1603b3668],
4	in	IN	O	in	_	0	SENT_412	[p22l1638t3606r1684b3656],
5	the	DT	O	the	det	7	SENT_412	[p22l1713t3606r1810b3656],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_412	[p22l1840t3606r2151b3656, p22l152t3697r301b3747],
7	response	NN	O	response	prep_in	1	SENT_412	[p22l345t3709r628b3759],
8	to	TO	O	to	_	0	SENT_412	[p22l670t3700r729b3747],
9	thromboxane	NN	O	thromboxane	nn	10	SENT_412	[p22l771t3697r1174b3747],
10	A2	NN	O	a2	prep_to	7	SENT_412	[p22l1217t3697r1304b3762],
11	.	.	O	.	_	0	SENT_412	[p22l1217t3697r1304b3762],

1	Science	NNP	O	Science	_	0	SENT_413	[p22l1352t3697r1593b3747],
2	2002	CD	DATE	2002	num	1	SENT_413	[p22l1639t3697r2151b3756, p23l153t20r293b70],
3	;	:	O	;	_	0	SENT_413	[p22l1639t3697r2151b3756, p23l153t20r293b70],
4	296:539541	CD	NUMBER	296:539541	dep	1	SENT_413	[p22l1639t3697r2151b3756, p23l153t20r293b70],
5	.	.	O	.	_	0	SENT_413	[p22l1639t3697r2151b3756, p23l153t20r293b70],

1	Qi	NNP	O	Qi	nn	2	SENT_414	[p23l152t112r209b173],
2	Z	NNP	O	Z	_	0	SENT_414	[p23l238t112r291b171],
3	,	,	O	,	_	0	SENT_414	[p23l238t112r291b171],
4	Hao	NNP	PERSON	Hao	nn	5	SENT_414	[p23l326t112r442b162],
5	CM	NN	O	cm	appos	2	SENT_414	[p23l471t112r586b171],
6	,	,	O	,	_	0	SENT_414	[p23l471t112r586b171],
7	Langenbach	NNP	PERSON	Langenbach	nn	8	SENT_414	[p23l621t112r987b175],
8	RI	NN	O	rus	appos	5	SENT_414	[p23l1020t112r1093b171],
9	,	,	O	,	_	0	SENT_414	[p23l1020t112r1093b171],
10	Breyer	NNP	PERSON	Breyer	nn	11	SENT_414	[p23l1128t112r1320b175],
11	RM	NN	O	rm	appos	5	SENT_414	[p23l1349t112r1462b171],
12	,	,	O	,	_	0	SENT_414	[p23l1349t112r1462b171],
13	Redha	NN	PERSON	redha	nn	14	SENT_414	[p23l1496t112r1686b162],
14	R	NN	PERSON	r	appos	5	SENT_414	[p23l1718t112r1773b171],
15	,	,	O	,	_	0	SENT_414	[p23l1718t112r1773b171],
16	Morrow	NNP	PERSON	Morrow	nn	17	SENT_414	[p23l1807t112r2030b162],
17	JD	NNP	O	JD	appos	5	SENT_414	[p23l2054t112r2145b171],
18	,	,	O	,	_	0	SENT_414	[p23l2054t112r2145b171],
19	Breyer	NNP	PERSON	Breyer	nn	20	SENT_414	[p23l155t204r347b267],
20	MD.	NNP	O	MD.	appos	5	SENT_414	[p23l377t204r492b254],
21	.	.	O	.	_	0	SENT_414	[p23l377t204r492b254],

1	Opposite	JJ	O	opposite	amod	2	SENT_415	[p23l526t204r798b266],
2	effects	NNS	O	effect	_	0	SENT_415	[p23l828t204r1037b254],
3	of	IN	O	of	_	0	SENT_415	[p23l1067t204r1126b254],
4	cyclooxygenase-1	NN	O	cyclooxygenase-1	prep_of	2	SENT_415	[p23l1151t204r1686b267],
5	and	CC	O	and	_	0	SENT_415	[p23l1717t204r1825b254],
6	-2	CD	NUMBER	-2	num	7	SENT_415	[p23l1854t204r1909b254],
7	activity	NN	O	activity	conj_and	4	SENT_415	[p23l1940t204r2151b267],
8	on	IN	O	on	_	0	SENT_415	[p23l152t308r222b346],
9	the	DT	O	the	det	11	SENT_415	[p23l256t296r353b346],
10	pressor	NN	O	pressor	nn	11	SENT_415	[p23l390t308r621b358],
11	response	NN	O	response	prep_on	2	SENT_415	[p23l654t308r937b358],
12	to	TO	O	to	_	0	SENT_415	[p23l969t299r1028b346],
13	angiotensin	NN	O	angiotensin	prep_to	2	SENT_415	[p23l1063t296r1417b359],
14	II	CD	NUMBER	ii	num	13	SENT_415	[p23l1456t296r1503b346],
15	.	.	O	.	_	0	SENT_415	[p23l1456t296r1503b346],

1	J	NNP	O	J	nn	3	SENT_416	[p23l1539t296r1561b346],
2	Clin	NNP	O	Clin	nn	3	SENT_416	[p23l1598t296r1708b346],
3	Invest	NNP	O	Invest	_	0	SENT_416	[p23l1748t296r1929b346],
4	2002	CD	DATE	2002	num	3	SENT_416	[p23l1962t296r2145b355],
5	;	:	O	;	_	0	SENT_416	[p23l1962t296r2145b355],
6	110:61	CD	NUMBER	110:61	number	7	SENT_416	[p23l155t388r531b438],
7	—	CD	NUMBER	—	dep	3	SENT_416	[p23l155t388r531b438],
8	69	CD	NUMBER	69	dep	7	SENT_416	[p23l155t388r531b438],
9	.	.	O	.	_	0	SENT_416	[p23l155t388r531b438],

1	Kobayashi	NNP	PERSON	Kobayashi	_	0	SENT_417	[p23l155t480r466b543],
2	T	NN	O	t	dep	1	SENT_417	[p23l502t480r553b539],
3	,	,	O	,	_	0	SENT_417	[p23l502t480r553b539],
4	Tahara	NNP	PERSON	Tahara	nn	5	SENT_417	[p23l590t480r800b530],
5	Y	NN	PERSON	y	conj_and	2	SENT_417	[p23l835t480r889b539],
6	,	,	O	,	_	0	SENT_417	[p23l835t480r889b539],
7	Matsumoto	NNP	ORGANIZATION	Matsumoto	nn	8	SENT_417	[p23l932t480r1278b530],
8	M	NN	ORGANIZATION	m	conj_and	2	SENT_417	[p23l1317t480r1386b539],
9	,	,	O	,	_	0	SENT_417	[p23l1317t480r1386b539],
10	lguchi	NN	O	lguchus	nn	11	SENT_417	[p23l1428t480r1600b543],
11	M	NN	O	m	conj_and	2	SENT_417	[p23l1642t480r1711b539],
12	,	,	O	,	_	0	SENT_417	[p23l1642t480r1711b539],
13	Sano	NNP	PERSON	Sano	nn	14	SENT_417	[p23l1750t480r1904b530],
14	H	NNP	PERSON	H	conj_and	2	SENT_417	[p23l1944t480r2001b539],
15	,	,	O	,	_	0	SENT_417	[p23l1944t480r2001b539],
16	Murayama	NNP	PERSON	Murayama	nn	17	SENT_417	[p23l2043t480r2151b530, p23l154t584r374b635],
17	T	NN	PERSON	t	conj_and	2	SENT_417	[p23l411t573r462b631],
18	,	,	O	,	_	0	SENT_417	[p23l411t573r462b631],
19	Arai	NNP	PERSON	Arai	nn	20	SENT_417	[p23l503t573r616b623],
20	H	NNP	O	H	dep	1	SENT_417	[p23l661t573r718b631],
21	,	,	O	,	_	0	SENT_417	[p23l661t573r718b631],
22	Oida	NNP	PERSON	Oida	nn	23	SENT_417	[p23l761t572r896b623],
23	H	NNP	O	H	conj_and	2	SENT_417	[p23l939t573r996b631],
24	,	,	O	,	_	0	SENT_417	[p23l939t573r996b631],
25	Yurugi-Kobayashi	NNP	ORGANIZATION	Yurugi-Kobayashi	nn	26	SENT_417	[p23l1037t573r1562b636],
26	T	NN	ORGANIZATION	t	conj_and	2	SENT_417	[p23l1601t573r1652b631],
27	,	,	O	,	_	0	SENT_417	[p23l1601t573r1652b631],
28	Yamashita	NNP	ORGANIZATION	Yamashita	nn	29	SENT_417	[p23l1693t573r2019b623],
29	JK	NNP	ORGANIZATION	JK	conj_and	2	SENT_417	[p23l2057t573r2145b631],
30	,	,	O	,	_	0	SENT_417	[p23l2057t573r2145b631],
31	Katagiri	NNP	PERSON	Katagiri	nn	32	SENT_417	[p23l155t665r381b728],
32	H	NNP	PERSON	H	dep	1	SENT_417	[p23l420t665r477b723],
33	,	,	O	,	_	0	SENT_417	[p23l420t665r477b723],
34	Majima	NNP	PERSON	Majima	nn	35	SENT_417	[p23l516t665r735b727],
35	M	NNP	O	M	dep	1	SENT_417	[p23l771t665r840b723],
36	,	,	O	,	_	0	SENT_417	[p23l771t665r840b723],
37	Yokode	NNP	O	Yokode	nn	38	SENT_417	[p23l874t665r1101b715],
38	M	NNP	O	M	dep	1	SENT_417	[p23l1137t665r1206b723],
39	,	,	O	,	_	0	SENT_417	[p23l1137t665r1206b723],
40	Kita	NNP	PERSON	Kita	nn	41	SENT_417	[p23l1245t665r1359b715],
41	T	NN	PERSON	t	dep	1	SENT_417	[p23l1390t665r1441b723],
42	,	,	O	,	_	0	SENT_417	[p23l1390t665r1441b723],
43	Narumiya	NNP	PERSON	Narumiya	nn	45	SENT_417	[p23l1480t665r1763b727],
44	S.	NNP	PERSON	S.	nn	45	SENT_417	[p23l1797t664r1853b715],
45	Roles	NNP	PERSON	Roles	dep	1	SENT_417	[p23l1892t665r2060b715],
46	of	IN	O	of	_	0	SENT_417	[p23l2093t664r2153b715],
47	thromboxane	NN	O	thromboxane	nn	48	SENT_417	[p23l149t757r552b807],
48	A2	NN	O	a2	prep_of	45	SENT_417	[p23l582t757r651b821],
49	and	CC	O	and	_	0	SENT_417	[p23l682t757r790b807],
50	prostacyclin	NN	O	prostacyclin	dep	1	SENT_417	[p23l826t757r1186b819],
51	in	IN	O	in	_	0	SENT_417	[p23l1221t757r1268b806],
52	the	DT	O	the	det	53	SENT_417	[p23l1298t757r1395b806],
53	development	NN	O	development	prep_in	1	SENT_417	[p23l1426t757r1824b818],
54	of	IN	O	of	_	0	SENT_417	[p23l1852t756r1912b806],
55	atherosclerosis	NN	O	atherosclerosis	prep_of	53	SENT_417	[p23l1939t757r2151b806, p23l152t849r426b899],
56	in	IN	O	in	_	0	SENT_417	[p23l465t849r511b898],
57	apoE-deficient	JJ	O	apoe-deficient	amod	58	SENT_417	[p23l549t848r981b910],
58	mice	NNS	O	mouse	prep_in	55	SENT_417	[p23l1016t849r1176b899],
59	.	.	O	.	_	0	SENT_417	[p23l1016t849r1176b899],

1	J	NNP	O	J	nn	3	SENT_418	[p23l1213t849r1235b899],
2	Clin	NNP	O	Clin	nn	3	SENT_418	[p23l1273t848r1383b899],
3	Invest	NNP	O	Invest	_	0	SENT_418	[p23l1424t849r1605b899],
4	2004	CD	DATE	2004	num	3	SENT_418	[p23l1639t848r2151b907, p23l154t941r293b991],
5	;	:	O	;	_	0	SENT_418	[p23l1639t848r2151b907, p23l154t941r293b991],
6	114:784794	CD	NUMBER	114:784794	dep	3	SENT_418	[p23l1639t848r2151b907, p23l154t941r293b991],
7	.	.	O	.	_	0	SENT_418	[p23l1639t848r2151b907, p23l154t941r293b991],

1	VARIABILITY	NN	O	variability	_	0	SENT_419	[p23l660t1043r1042b1091],
2	IN	IN	O	in	_	0	SENT_419	[p23l1070t1043r1126b1091],
3	THE	DT	O	the	det	4	SENT_419	[p23l1154t1043r1272b1091],
4	RESPONSE	NN	O	response	prep_in	1	SENT_419	[p23l1302t1043r1636b1092],
5	TO	TO	O	to	infmod	4	SENT_419	[p23l1662t1043r1740b1092],
6	COXIBS	NNP	O	COXIBS	dep	1	SENT_419	[p23l1769t1043r1997b1092],
7	63	CD	NUMBER	63	num	6	SENT_419	[p23l2073t1043r2151b1092],

1	FitzGerald	NNP	PERSON	FitzGerald	nn	2	SENT_420	[p23l152t1253r450b1305],
2	GA.	NNP	O	GA.	_	0	SENT_420	[p23l485t1253r585b1305],
3	.	.	O	.	_	0	SENT_420	[p23l485t1253r585b1305],

1	COX-2	NN	O	cox-2	_	0	SENT_421	[p23l621t1253r803b1305],
2	and	CC	O	and	_	0	SENT_421	[p23l838t1254r946b1305],
3	beyond	IN	O	beyond	conj_and	1	SENT_421	[p23l981t1254r1216b1317],
4	:	:	O	:	_	0	SENT_421	[p23l981t1254r1216b1317],
5	approaches	NNS	O	approach	dep	1	SENT_421	[p23l1253t1254r1611b1316],
6	to	TO	O	to	_	0	SENT_421	[p23l1641t1257r1700b1305],
7	prostaglandin	NN	O	prostaglandin	nn	8	SENT_421	[p23l1735t1254r2150b1318],
8	inhibition	NN	O	inhibition	prep_to	5	SENT_421	[p23l152t1344r428b1395],
9	in	IN	O	in	_	0	SENT_421	[p23l459t1344r506b1394],
10	human	JJ	O	human	amod	11	SENT_421	[p23l537t1344r742b1395],
11	disease	NN	O	disease	prep_in	8	SENT_421	[p23l771t1344r1030b1395],
12	.	.	O	.	_	0	SENT_421	[p23l771t1344r1030b1395],

1	Nat	NNP	PERSON	Nat	nn	3	SENT_422	[p23l1064t1344r1167b1395],
2	Rev	NN	PERSON	rev	nn	3	SENT_422	[p23l1195t1344r1305b1395],
3	Drug	NN	O	drug	_	0	SENT_422	[p23l1333t1344r1472b1408],
4	Discov	NNP	O	Discov	dep	3	SENT_422	[p23l1500t1344r1701b1395],
5	2003	CD	DATE	2003	num	4	SENT_422	[p23l1727t1343r2154b1404],
6	;	:	O	;	_	0	SENT_422	[p23l1727t1343r2154b1404],
7	2:879	CD	NUMBER	2:879	num	8	SENT_422	[p23l1727t1343r2154b1404],
8	—	NN	O	—	dep	3	SENT_422	[p23l1727t1343r2154b1404],
9	890	CD	NUMBER	890	dep	8	SENT_422	[p23l149t1433r291b1485],
10	.	.	O	.	_	0	SENT_422	[p23l149t1433r291b1485],

1	FitzGerald	NNP	PERSON	FitzGerald	nn	2	SENT_423	[p23l152t1523r450b1575],
2	GA.	NNP	O	GA.	_	0	SENT_423	[p23l481t1523r580b1575],
3	.	.	O	.	_	0	SENT_423	[p23l481t1523r580b1575],

1	Coxibs	NNS	O	coxib	_	0	SENT_424	[p23l612t1523r814b1575],
2	and	CC	O	and	_	0	SENT_424	[p23l843t1524r951b1575],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_424	[p23l981t1524r1429b1575],
4	disease	NN	O	disease	conj_and	1	SENT_424	[p23l1454t1524r1713b1575],
5	.	.	O	.	_	0	SENT_424	[p23l1454t1524r1713b1575],

1	N	NN	O	n	nn	3	SENT_425	[p23l1748t1524r1785b1574],
2	Engl	NNP	O	Engl	nn	3	SENT_425	[p23l1818t1524r1939b1588],
3	J	NNP	O	J	nsubj	4	SENT_425	[p23l1968t1524r1990b1575],
4	Med	VBD	O	med	_	0	SENT_425	[p23l2024t1524r2150b1575],
5	2004	CD	DATE	2004	dobj	4	SENT_425	[p23l150t1613r894b1673],
6	;	:	O	;	_	0	SENT_425	[p23l150t1613r894b1673],
7	351:1709	CD	DURATION	351:1709	num	8	SENT_425	[p23l150t1613r894b1673],
8	-1711	CD	DURATION	-1711	dep	5	SENT_425	[p23l150t1613r894b1673],
9	.	.	O	.	_	0	SENT_425	[p23l150t1613r894b1673],

1	Furberg	NNP	PERSON	Furberg	nn	2	SENT_426	[p23l152t1703r379b1767],
2	CD	NNP	O	CD	_	0	SENT_426	[p23l402t1702r507b1763],
3	,	,	O	,	_	0	SENT_426	[p23l402t1702r507b1763],
4	Psaty	NNP	PERSON	Psaty	nn	5	SENT_426	[p23l538t1703r703b1766],
5	BM	NN	O	bm	appos	2	SENT_426	[p23l729t1703r842b1763],
6	,	,	O	,	_	0	SENT_426	[p23l729t1703r842b1763],
7	FitzGerald	NNP	PERSON	FitzGerald	nn	8	SENT_426	[p23l874t1702r1173b1754],
8	GA.	NNP	O	GA.	appos	5	SENT_426	[p23l1201t1702r1301b1754],
9	.	.	O	.	_	0	SENT_426	[p23l1201t1702r1301b1754],

1	Parecoxib	NNP	O	Parecoxib	_	0	SENT_427	[p23l1331t1703r1644b1763],
2	,	,	O	,	_	0	SENT_427	[p23l1331t1703r1644b1763],
3	valdecoxib	NN	O	valdecoxib	appos	1	SENT_427	[p23l1670t1703r2011b1763],
4	,	,	O	,	_	0	SENT_427	[p23l1670t1703r2011b1763],
5	and	CC	O	and	_	0	SENT_427	[p23l2042t1703r2150b1754],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_427	[p23l149t1793r597b1844],
7	risk	NN	O	risk	appos	1	SENT_427	[p23l625t1793r749b1843],
8	.	.	O	.	_	0	SENT_427	[p23l625t1793r749b1843],

1	Circulation	NN	O	circulation	_	0	SENT_428	[p23l782t1792r1106b1843],
2	2005	CD	DATE	2005	num	1	SENT_428	[p23l1138t1792r1623b1852],
3	;	:	O	;	_	0	SENT_428	[p23l1138t1792r1623b1852],
4	111:249	CD	NUMBER	111:249	dep	1	SENT_428	[p23l1138t1792r1623b1852],
5	.	.	O	.	_	0	SENT_428	[p23l1138t1792r1623b1852],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_429	[p23l152t1882r315b1933],
2	E	NNP	O	E	dep	45	SENT_429	[p23l349t1882r399b1942],
3	,	,	O	,	_	0	SENT_429	[p23l349t1882r399b1942],
4	Chinchilli	NNP	PERSON	Chinchilli	nn	5	SENT_429	[p23l430t1881r703b1933],
5	VM	NNP	O	VM	appos	2	SENT_429	[p23l732t1882r846b1942],
6	,	,	O	,	_	0	SENT_429	[p23l732t1882r846b1942],
7	Ford	NNP	ORGANIZATION	Ford	nn	8	SENT_429	[p23l880t1882r1005b1933],
8	JG	NNP	O	JG	appos	2	SENT_429	[p23l1033t1881r1124b1941],
9	,	,	O	,	_	0	SENT_429	[p23l1033t1881r1124b1941],
10	Boushey	NNP	LOCATION	Boushey	nn	11	SENT_429	[p23l1158t1882r1420b1945],
11	HA	NNP	LOCATION	HA	appos	2	SENT_429	[p23l1447t1882r1545b1942],
12	,	,	O	,	_	0	SENT_429	[p23l1447t1882r1545b1942],
13	Cherniack	NNP	PERSON	Cherniack	nn	14	SENT_429	[p23l1576t1881r1883b1933],
14	R	NNP	PERSON	R	appos	2	SENT_429	[p23l1912t1882r1966b1941],
15	,	,	O	,	_	0	SENT_429	[p23l1912t1882r1966b1941],
16	Craig	NNP	PERSON	Craig	nn	17	SENT_429	[p23l1998t1881r2154b1946],
17	TJ	NNP	PERSON	TJ	appos	2	SENT_429	[p23l147t1972r227b2032],
18	,	,	O	,	_	0	SENT_429	[p23l147t1972r227b2032],
19	Deykin	NNP	O	Deykin	nn	20	SENT_429	[p23l262t1972r460b2035],
20	A	NNP	O	A	appos	2	SENT_429	[p23l489t1972r544b2032],
21	,	,	O	,	_	0	SENT_429	[p23l489t1972r544b2032],
22	Fagan	NNP	PERSON	Fagan	nn	23	SENT_429	[p23l579t1972r755b2036],
23	JK	NNP	O	JK	appos	2	SENT_429	[p23l784t1972r872b2032],
24	,	,	O	,	_	0	SENT_429	[p23l784t1972r872b2032],
25	Fahy	NNP	PERSON	Fahy	nn	26	SENT_429	[p23l907t1972r1044b2035],
26	JV	NNP	O	JV	appos	2	SENT_429	[p23l1068t1972r1151b2032],
27	,	,	O	,	_	0	SENT_429	[p23l1068t1972r1151b2032],
28	Fish	NN	O	fish	nn	29	SENT_429	[p23l1187t1972r1304b2023],
29	J	NN	O	j	appos	2	SENT_429	[p23l1333t1972r1377b2032],
30	,	,	O	,	_	0	SENT_429	[p23l1333t1972r1377b2032],
31	Kraft	NNP	PERSON	Kraft	nn	32	SENT_429	[p23l1412t1971r1556b2023],
32	M	NNP	O	M	appos	2	SENT_429	[p23l1586t1972r1655b2031],
33	,	,	O	,	_	0	SENT_429	[p23l1586t1972r1655b2031],
34	Kunselman	NNP	O	Kunselman	nn	35	SENT_429	[p23l1690t1972r2031b2023],
35	SJ	NNP	O	SJ	appos	2	SENT_429	[p23l2062t1971r2148b2032],
36	,	,	O	,	_	0	SENT_429	[p23l2062t1971r2148b2032],
37	Lazarus	NNP	ORGANIZATION	Lazarus	nn	38	SENT_429	[p23l152t2062r386b2113],
38	SC	NNP	ORGANIZATION	SC	appos	2	SENT_429	[p23l426t2061r527b2122],
39	,	,	O	,	_	0	SENT_429	[p23l426t2061r527b2122],
40	Lemanske	NNP	PERSON	Lemanske	nn	42	SENT_429	[p23l572t2062r886b2113],
41	RF	NNP	PERSON	RF	nn	42	SENT_429	[p23l928t2062r1004b2112],
42	Jr	NNP	PERSON	Jr	appos	2	SENT_429	[p23l1037t2062r1103b2122],
43	,	,	O	,	_	0	SENT_429	[p23l1037t2062r1103b2122],
44	Liggett	NNP	ORGANIZATION	Liggett	appos	2	SENT_429	[p23l1148t2062r1351b2126],
45	SB	NN	ORGANIZATION	sb	_	0	SENT_429	[p23l1388t2061r1490b2122],
46	,	,	O	,	_	0	SENT_429	[p23l1388t2061r1490b2122],
47	Martin	NNP	PERSON	Martin	nn	48	SENT_429	[p23l1535t2062r1724b2113],
48	RJ	NN	PERSON	rj	appos	45	SENT_429	[p23l1768t2062r1851b2121],
49	,	,	O	,	_	0	SENT_429	[p23l1768t2062r1851b2121],
50	Mitra	NNP	PERSON	Mitra	nn	51	SENT_429	[p23l1896t2062r2048b2113],
51	N	NNP	PERSON	N	appos	45	SENT_429	[p23l2090t2062r2148b2122],
52	,	,	O	,	_	0	SENT_429	[p23l2090t2062r2148b2122],
53	Peters	NNP	PERSON	Peters	nn	54	SENT_429	[p23l151t2152r344b2202],
54	SP	NN	O	sp	appos	45	SENT_429	[p23l375t2151r472b2211],
55	,	,	O	,	_	0	SENT_429	[p23l375t2151r472b2211],
56	Silverman	NNP	PERSON	Silverman	nn	57	SENT_429	[p23l505t2151r806b2202],
57	E	NNP	O	E	appos	45	SENT_429	[p23l840t2152r890b2211],
58	,	,	O	,	_	0	SENT_429	[p23l840t2152r890b2211],
59	Sorkness	NNP	O	Sorkness	nn	60	SENT_429	[p23l923t2151r1211b2202],
60	CA	NNP	O	CA	appos	45	SENT_429	[p23l1241t2151r1338b2211],
61	,	,	O	,	_	0	SENT_429	[p23l1241t2151r1338b2211],
62	Szefler	NNP	O	Szefler	nn	63	SENT_429	[p23l1372t2151r1580b2202],
63	SJ	NNP	O	SJ	appos	45	SENT_429	[p23l1607t2151r1692b2211],
64	,	,	O	,	_	0	SENT_429	[p23l1607t2151r1692b2211],
65	Wechsler	NNP	PERSON	Wechsler	nn	66	SENT_429	[p23l1723t2152r2010b2202],
66	ME	NNP	O	ME	appos	45	SENT_429	[p23l2039t2152r2148b2211],
67	,	,	O	,	_	0	SENT_429	[p23l2039t2152r2148b2211],
68	Weiss	NNP	ORGANIZATION	Weiss	appos	45	SENT_429	[p23l147t2241r333b2292],
69	ST	JJ	ORGANIZATION	st	dep	68	SENT_429	[p23l360t2240r453b2301],
70	,	,	O	,	_	0	SENT_429	[p23l360t2240r453b2301],
71	Drazen	NNP	PERSON	Drazen	nn	72	SENT_429	[p23l485t2241r692b2292],
72	JM	NN	PERSON	jm	appos	45	SENT_429	[p23l719t2241r820b2292],
73	.	.	O	.	_	0	SENT_429	[p23l719t2241r820b2292],

1	Use	NN	O	use	nsubj	4	SENT_430	[p23l853t2241r966b2292],
2	of	IN	O	of	prep	1	SENT_430	[p23l993t2240r1053b2292],
3	regularly	RB	O	regularly	pcomp	2	SENT_430	[p23l1077t2241r1334b2305],
4	scheduled	VBN	O	schedule	_	0	SENT_430	[p23l1358t2241r1672b2292],
5	albuterol	NN	O	albuterol	nn	6	SENT_430	[p23l1701t2241r1966b2292],
6	treatment	NN	O	treatment	tmod	4	SENT_430	[p23l1992t2244r2154b2292, p23l151t2334r305b2382],
7	in	IN	O	in	_	0	SENT_430	[p23l343t2331r390b2381],
8	asthma	NN	O	asthma	prep_in	6	SENT_430	[p23l430t2331r677b2382],
9	:	:	O	:	_	0	SENT_430	[p23l430t2331r677b2382],
10	genotype-stratified	JJ	O	genotype-stratified	amod	16	SENT_430	[p23l716t2330r1305b2395],
11	,	,	O	,	_	0	SENT_430	[p23l716t2330r1305b2395],
12	randomised	JJ	O	randomised	amod	16	SENT_430	[p23l1348t2331r1727b2391],
13	,	,	O	,	_	0	SENT_430	[p23l1348t2331r1727b2391],
14	placebocontrolled	JJ	O	placebocontrolled	amod	16	SENT_430	[p23l1771t2331r2154b2393, p23l147t2421r338b2471],
15	cross-over	JJ	O	cross-over	amod	16	SENT_430	[p23l369t2433r686b2471],
16	trial	NN	O	trial	dep	6	SENT_430	[p23l709t2421r844b2471],
17	.	.	O	.	_	0	SENT_430	[p23l709t2421r844b2471],

1	Lancet	NNP	O	Lancet	_	0	SENT_431	[p23l879t2421r1082b2471],
2	2004	CD	DATE	2004	num	1	SENT_431	[p23l1110t2420r1846b2480],
3	;	:	O	;	_	0	SENT_431	[p23l1110t2420r1846b2480],
4	364:1505	CD	DURATION	364:1505	number	5	SENT_431	[p23l1110t2420r1846b2480],
5	-1512	CD	DURATION	-1512	dep	1	SENT_431	[p23l1110t2420r1846b2480],
6	.	.	O	.	_	0	SENT_431	[p23l1110t2420r1846b2480],

1	Wood	NNP	O	Wood	nn	2	SENT_432	[p23l147t2510r317b2561],
2	AJ	NNP	O	AJ	_	0	SENT_432	[p23l347t2510r430b2561],
3	.	.	O	.	_	0	SENT_432	[p23l347t2510r430b2561],

1	Racial	JJ	O	racial	amod	2	SENT_433	[p23l466t2510r646b2561],
2	differences	NNS	O	difference	_	0	SENT_433	[p23l678t2509r1021b2561],
3	in	IN	O	in	_	0	SENT_433	[p23l1053t2510r1099b2560],
4	the	DT	O	the	det	5	SENT_433	[p23l1128t2510r1225b2561],
5	response	NN	O	response	prep_in	2	SENT_433	[p23l1258t2522r1541b2572],
6	to	TO	O	to	_	0	SENT_433	[p23l1568t2513r1627b2561],
7	drugs	NNS	O	drug	prep_to	5	SENT_433	[p23l1656t2510r2151b2574],
8	—	CD	NUMBER	—	num	9	SENT_433	[p23l1656t2510r2151b2574],
9	pointers	NNS	O	pointer	dep	2	SENT_433	[p23l1656t2510r2151b2574],
10	to	TO	O	to	_	0	SENT_433	[p23l147t2603r205b2651],
11	genetic	JJ	O	genetic	amod	12	SENT_433	[p23l233t2600r457b2664],
12	differences	NNS	O	difference	prep_to	9	SENT_433	[p23l485t2599r846b2651],
13	.	.	O	.	_	0	SENT_433	[p23l485t2599r846b2651],

1	N	NN	O	n	nn	3	SENT_434	[p23l882t2600r919b2650],
2	Engl	NNP	O	Engl	nn	3	SENT_434	[p23l953t2600r1074b2664],
3	J	NNP	O	J	nsubj	4	SENT_434	[p23l1104t2600r1126b2651],
4	Med	VBD	O	med	_	0	SENT_434	[p23l1161t2600r1288b2651],
5	2001	CD	DATE	2001	dobj	4	SENT_434	[p23l1319t2599r2063b2660],
6	;	:	O	;	_	0	SENT_434	[p23l1319t2599r2063b2660],
7	344:1394	CD	DURATION	344:1394	num	8	SENT_434	[p23l1319t2599r2063b2660],
8	-1396	CD	DURATION	-1396	dep	5	SENT_434	[p23l1319t2599r2063b2660],
9	.	.	O	.	_	0	SENT_434	[p23l1319t2599r2063b2660],

1	Catella-Lawson	JJ	O	catella-lawson	amod	2	SENT_435	[p23l149t2689r612b2740],
2	F	NN	O	f	_	0	SENT_435	[p23l646t2690r690b2749],
3	,	,	O	,	_	0	SENT_435	[p23l646t2690r690b2749],
4	Reilly	NNP	PERSON	Reilly	nn	5	SENT_435	[p23l725t2690r885b2752],
5	MP	NNP	O	MP	appos	2	SENT_435	[p23l912t2690r1022b2749],
6	,	,	O	,	_	0	SENT_435	[p23l912t2690r1022b2749],
7	Kapoor	NNP	ORGANIZATION	Kapoor	nn	8	SENT_435	[p23l1056t2690r1274b2751],
8	SC	NNP	ORGANIZATION	SC	appos	5	SENT_435	[p23l1299t2689r1401b2749],
9	,	,	O	,	_	0	SENT_435	[p23l1299t2689r1401b2749],
10	Cucchiara	NNP	PERSON	Cucchiara	nn	11	SENT_435	[p23l1432t2689r1735b2740],
11	AJ	NNP	O	AJ	appos	5	SENT_435	[p23l1762t2690r1846b2749],
12	,	,	O	,	_	0	SENT_435	[p23l1762t2690r1846b2749],
13	DeMarco	NNP	PERSON	DeMarco	nn	14	SENT_435	[p23l1880t2690r2151b2740],
14	S	NNP	O	S	appos	5	SENT_435	[p23l150t2778r207b2839],
15	,	,	O	,	_	0	SENT_435	[p23l150t2778r207b2839],
16	Tournier	NNP	PERSON	Tournier	nn	17	SENT_435	[p23l233t2779r487b2830],
17	B	NNP	O	B	appos	5	SENT_435	[p23l512t2779r567b2839],
18	,	,	O	,	_	0	SENT_435	[p23l512t2779r567b2839],
19	Vyas	NNP	PERSON	Vyas	nn	20	SENT_435	[p23l594t2779r736b2842],
20	SN	NNP	O	SN	appos	5	SENT_435	[p23l763t2778r867b2839],
21	,	,	O	,	_	0	SENT_435	[p23l763t2778r867b2839],
22	FitzGerald	NNP	PERSON	FitzGerald	nn	23	SENT_435	[p23l899t2778r1197b2830],
23	GA.	NNP	O	GA.	appos	5	SENT_435	[p23l1225t2778r1325b2830],
24	.	.	O	.	_	0	SENT_435	[p23l1225t2778r1325b2830],

1	Cyclooxygenase	NN	O	cyclooxygenase	_	0	SENT_436	[p23l1354t2778r1841b2843],
2	inhibitors	NNS	O	inhibitor	dep	1	SENT_436	[p23l1870t2779r2151b2830],
3	and	CC	O	and	_	0	SENT_436	[p23l150t2869r258b2920],
4	the	DT	O	the	det	6	SENT_436	[p23l287t2869r385b2920],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_436	[p23l415t2869r764b2931],
6	effects	NNS	O	effect	dep	1	SENT_436	[p23l791t2868r1001b2920],
7	of	IN	O	of	_	0	SENT_436	[p23l1030t2868r1090b2920],
8	aspirin	NN	O	aspirin	prep_of	1	SENT_436	[p23l1116t2869r1338b2931],
9	.	.	O	.	_	0	SENT_436	[p23l1116t2869r1338b2931],

1	N	NN	O	n	nn	3	SENT_437	[p23l1374t2869r1411b2919],
2	Engl	NNP	O	Engl	nn	3	SENT_437	[p23l1446t2869r1567b2933],
3	J	NNP	O	J	nsubj	4	SENT_437	[p23l1598t2869r1620b2920],
4	Med	VBD	O	med	_	0	SENT_437	[p23l1655t2869r1781b2920],
5	2001	CD	DATE	2001	dobj	4	SENT_437	[p23l1814t2868r2148b2928],
6	;	:	O	;	_	0	SENT_437	[p23l1814t2868r2148b2928],
7	345	CD	NUMBER	345	num	9	SENT_437	[p23l1814t2868r2148b2928],
8	:	:	O	:	_	0	SENT_437	[p23l1814t2868r2148b2928],
9	1809-1817	CD	DATE	1809-1817	dep	5	SENT_437	[p23l152t2958r550b3010],
10	.	.	O	.	_	0	SENT_437	[p23l152t2958r550b3010],

1	Patrignani	JJ	PERSON	patrignani	amod	2	SENT_438	[p23l151t3049r452b3113],
2	P	NN	PERSON	p	_	0	SENT_438	[p23l487t3049r538b3109],
3	,	,	O	,	_	0	SENT_438	[p23l487t3049r538b3109],
4	Filabozzi	NN	ORGANIZATION	filabozzus	nn	5	SENT_438	[p23l575t3049r826b3100],
5	P	NN	ORGANIZATION	p	appos	2	SENT_438	[p23l861t3049r912b3109],
6	,	,	O	,	_	0	SENT_438	[p23l861t3049r912b3109],
7	Patrono	NNP	O	Patrono	nn	8	SENT_438	[p23l948t3049r1181b3100],
8	C.	NNP	O	C.	appos	2	SENT_438	[p23l1212t3048r1269b3100],
9	Selective	JJ	O	selective	amod	11	SENT_438	[p23l1303t3048r1581b3100],
10	cumulative	JJ	O	cumulative	amod	11	SENT_438	[p23l1611t3049r1942b3100],
11	inhibition	NN	O	inhibition	dep	8	SENT_438	[p23l1976t3049r2154b3100, p23l147t3139r260b3189],
12	of	IN	O	of	_	0	SENT_438	[p23l298t3138r358b3189],
13	platelet	NN	O	platelet	nn	15	SENT_438	[p23l392t3139r622b3200],
14	thromboxane	NN	O	thromboxane	nn	15	SENT_438	[p23l653t3139r1058b3189],
15	production	NN	O	production	prep_of	11	SENT_438	[p23l1097t3139r1417b3200],
16	by	IN	O	by	_	0	SENT_438	[p23l1457t3139r1522b3201],
17	low-dose	JJ	O	low-dose	amod	18	SENT_438	[p23l1558t3139r1822b3189],
18	aspirin	NN	O	aspirin	prep_by	15	SENT_438	[p23l1860t3139r2063b3200],
19	in	IN	O	in	_	0	SENT_438	[p23l2103t3139r2150b3188],
20	healthy	JJ	O	healthy	amod	21	SENT_438	[p23l151t3228r372b3290],
21	subjects	NNS	O	subject	prep_in	18	SENT_438	[p23l398t3228r675b3290],
22	.	.	O	.	_	0	SENT_438	[p23l398t3228r675b3290],

1	J	NNP	O	J	nn	3	SENT_439	[p23l706t3228r728b3278],
2	Clin	NNP	O	Clin	nn	3	SENT_439	[p23l760t3227r870b3278],
3	Invest	NNP	O	Invest	_	0	SENT_439	[p23l904t3228r1086b3278],
4	1982	CD	DATE	1982	num	3	SENT_439	[p23l1115t3227r1815b3287],
5	;	:	O	;	_	0	SENT_439	[p23l1115t3227r1815b3287],
6	69:1366	CD	NUMBER	69:1366	number	7	SENT_439	[p23l1115t3227r1815b3287],
7	—	CD	NUMBER	—	dep	3	SENT_439	[p23l1115t3227r1815b3287],
8	1372	CD	DATE	1372	dep	7	SENT_439	[p23l1115t3227r1815b3287],
9	.	.	O	.	_	0	SENT_439	[p23l1115t3227r1815b3287],

1	Panara	NNP	PERSON	Panara	nn	2	SENT_440	[p23l151t3317r362b3367],
2	MR	NN	PERSON	mr	dep	32	SENT_440	[p23l390t3317r503b3376],
3	,	,	O	,	_	0	SENT_440	[p23l390t3317r503b3376],
4	Renda	NNP	PERSON	Renda	nn	5	SENT_440	[p23l534t3317r724b3367],
5	G	NNP	PERSON	G	appos	2	SENT_440	[p23l750t3316r809b3376],
6	,	,	O	,	_	0	SENT_440	[p23l750t3316r809b3376],
7	Sciulli	NNP	PERSON	Sciulli	nn	8	SENT_440	[p23l838t3316r1016b3367],
8	MG	NN	O	mg	appos	2	SENT_440	[p23l1046t3316r1163b3376],
9	,	,	O	,	_	0	SENT_440	[p23l1046t3316r1163b3376],
10	Santini	NNP	PERSON	Santini	nn	11	SENT_440	[p23l1191t3316r1401b3367],
11	G	NNP	PERSON	G	appos	2	SENT_440	[p23l1428t3316r1488b3376],
12	,	,	O	,	_	0	SENT_440	[p23l1428t3316r1488b3376],
13	Di	NNP	PERSON	Di	nn	15	SENT_440	[p23l1519t3317r1573b3367],
14	Giamberardino	NNP	PERSON	Giamberardino	nn	15	SENT_440	[p23l1600t3316r2052b3367],
15	M	NN	O	m	appos	2	SENT_440	[p23l2079t3317r2148b3376],
16	,	,	O	,	_	0	SENT_440	[p23l2079t3317r2148b3376],
17	Rotondo	NNP	ORGANIZATION	Rotondo	nn	18	SENT_440	[p23l152t3406r405b3457],
18	MT	NNP	ORGANIZATION	MT	appos	2	SENT_440	[p23l433t3406r537b3466],
19	,	,	O	,	_	0	SENT_440	[p23l433t3406r537b3466],
20	Tacconelli	NNP	PERSON	Tacconelli	nn	21	SENT_440	[p23l563t3406r868b3457],
21	S	NNP	O	S	appos	2	SENT_440	[p23l896t3405r953b3465],
22	,	,	O	,	_	0	SENT_440	[p23l896t3405r953b3465],
23	Seta	NNP	O	Seta	nn	24	SENT_440	[p23l982t3405r1121b3457],
24	F	NN	O	f	appos	2	SENT_440	[p23l1149t3406r1193b3466],
25	,	,	O	,	_	0	SENT_440	[p23l1149t3406r1193b3466],
26	Patrono	NN	O	patrono	nn	27	SENT_440	[p23l1223t3406r1457b3457],
27	C	NN	O	c	appos	2	SENT_440	[p23l1482t3405r1539b3466],
28	,	,	O	,	_	0	SENT_440	[p23l1482t3405r1539b3466],
29	Patrignani	NNP	O	Patrignani	nn	31	SENT_440	[p23l1569t3406r1870b3470],
30	P.	NNP	O	P.	nn	31	SENT_440	[p23l1899t3406r1951b3456],
31	Dosedependent	NNP	O	Dosedependent	appos	2	SENT_440	[p23l1982t3406r2154b3457, p23l149t3496r479b3558],
32	inhibition	NN	O	inhibition	_	0	SENT_440	[p23l507t3496r782b3547],
33	of	IN	O	of	_	0	SENT_440	[p23l812t3495r872b3547],
34	platelet	NN	O	platelet	nn	35	SENT_440	[p23l898t3496r1127b3558],
35	Cyclooxygenase-1	NN	O	cyclooxygenase-1	prep_of	32	SENT_440	[p23l1152t3496r1689b3560],
36	and	CC	O	and	_	0	SENT_440	[p23l1718t3496r1826b3547],
37	monocyte	NN	O	monocyte	nn	38	SENT_440	[p23l1858t3499r2151b3559],
38	cyclooxygenase-2	NN	O	cyclooxygenase-2	prep_of	32	SENT_440	[p23l149t3585r685b3650],
39	by	IN	O	by	_	0	SENT_440	[p23l712t3586r778b3649],
40	meloxicam	NN	O	meloxicam	prep_by	35	SENT_440	[p23l802t3586r1127b3637],
41	in	IN	O	in	_	0	SENT_440	[p23l1156t3586r1203b3636],
42	healthy	JJ	O	healthy	amod	43	SENT_440	[p23l1232t3586r1453b3649],
43	subjects	NNS	O	subject	prep_in	40	SENT_440	[p23l1475t3586r1751b3649],
44	.	.	O	.	_	0	SENT_440	[p23l1475t3586r1751b3649],

1	J	NNP	O	J	nn	4	SENT_441	[p23l1778t3586r1801b3637],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_441	[p23l1830t3586r2149b3637],
3	Exp	NNP	O	Exp	nn	4	SENT_441	[p23l152t3676r255b3737],
4	Ther	NNP	O	Ther	_	0	SENT_441	[p23l281t3676r418b3726],
5	1999	CD	DATE	1999	num	4	SENT_441	[p23l446t3675r1103b3735],
6	;	:	O	;	_	0	SENT_441	[p23l446t3675r1103b3735],
7	290:276	CD	NUMBER	290:276	num	8	SENT_441	[p23l446t3675r1103b3735],
8	—	NN	O	—	dep	4	SENT_441	[p23l446t3675r1103b3735],
9	280	CD	NUMBER	280	dep	8	SENT_441	[p23l446t3675r1103b3735],
10	.	.	O	.	_	0	SENT_441	[p23l446t3675r1103b3735],

1	FitzGerald	NNP	ORGANIZATION	FitzGerald	nn	2	SENT_442	[p24l152t20r450b71],
2	GA	NNP	ORGANIZATION	GA	_	0	SENT_442	[p24l482t20r582b80],
3	,	,	O	,	_	0	SENT_442	[p24l482t20r582b80],
4	Pedersen	NNP	ORGANIZATION	Pedersen	nn	5	SENT_442	[p24l617t21r902b71],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_442	[p24l932t21r1031b80],
6	,	,	O	,	_	0	SENT_442	[p24l932t21r1031b80],
7	Patrono	NNP	O	Patrono	nn	9	SENT_442	[p24l1066t21r1299b71],
8	C.	NNP	O	C.	nn	9	SENT_442	[p24l1329t20r1387b71],
9	Analysis	NN	O	analysis	appos	2	SENT_442	[p24l1418t21r1671b83],
10	of	IN	O	of	_	0	SENT_442	[p24l1701t20r1761b71],
11	prostacyclin	NN	O	prostacyclin	nn	14	SENT_442	[p24l1788t21r2150b83],
12	and	CC	O	and	_	0	SENT_442	[p24l150t110r258b160],
13	thromboxane	NN	O	thromboxane	conj_and	11	SENT_442	[p24l287t110r691b160],
14	biosynthesis	NN	O	biosynthesis	prep_of	9	SENT_442	[p24l722t110r1108b172],
15	in	IN	O	in	_	0	SENT_442	[p24l1140t110r1186b159],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_442	[p24l1217t110r1665b160],
17	disease	NN	O	disease	prep_in	14	SENT_442	[p24l1691t110r1951b160],
18	.	.	O	.	_	0	SENT_442	[p24l1691t110r1951b160],

1	Circulation	NN	O	circulation	_	0	SENT_443	[p24l1984t109r2154b160, p24l152t199r316b249],
2	1983	CD	DATE	1983	num	1	SENT_443	[p24l349t198r1049b258],
3	;	:	O	;	_	0	SENT_443	[p24l349t198r1049b258],
4	67:1174	CD	DURATION	67:1174	number	5	SENT_443	[p24l349t198r1049b258],
5	-1177	CD	DURATION	-1177	dep	1	SENT_443	[p24l349t198r1049b258],
6	.	.	O	.	_	0	SENT_443	[p24l349t198r1049b258],

1	Catella	NN	MISC	catellum	nn	2	SENT_444	[p24l149t287r362b338],
2	F	NN	MISC	f	_	0	SENT_444	[p24l394t288r438b347],
3	,	,	O	,	_	0	SENT_444	[p24l394t288r438b347],
4	FitzGerald	NNP	PERSON	FitzGerald	nn	5	SENT_444	[p24l473t287r771b338],
5	GA.	NNP	O	GA.	appos	2	SENT_444	[p24l802t287r902b338],
6	.	.	O	.	_	0	SENT_444	[p24l802t287r902b338],

1	Paired	JJ	O	paired	amod	2	SENT_445	[p24l936t288r1124b338],
2	analysis	NN	O	analysis	_	0	SENT_445	[p24l1155t288r1404b350],
3	of	IN	O	of	_	0	SENT_445	[p24l1433t287r1493b338],
4	urinary	JJ	O	urinary	amod	7	SENT_445	[p24l1519t288r1724b350],
5	thromboxane	NN	O	thromboxane	nn	7	SENT_445	[p24l1747t288r2151b338],
6	B2	NN	O	b2	nn	7	SENT_445	[p24l152t377r221b443],
7	metabolites	NNS	O	metabolite	prep_of	2	SENT_445	[p24l252t377r614b428],
8	in	IN	O	in	_	0	SENT_445	[p24l646t377r692b427],
9	humans	NNS	O	human	prep_in	2	SENT_445	[p24l725t377r987b428],
10	.	.	O	.	_	0	SENT_445	[p24l725t377r987b428],

1	Thromb	NNP	O	Thromb	nn	2	SENT_446	[p24l1017t377r1248b428],
2	Res	NNP	O	Res	_	0	SENT_446	[p24l1280t377r1392b428],
3	1987	CD	DATE	1987	num	2	SENT_446	[p24l1424t376r2037b436],
4	;	:	O	;	_	0	SENT_446	[p24l1424t376r2037b436],
5	47:647	CD	NUMBER	47:647	number	6	SENT_446	[p24l1424t376r2037b436],
6	-656	CD	NUMBER	-656	dep	2	SENT_446	[p24l1424t376r2037b436],
7	.	.	O	.	_	0	SENT_446	[p24l1424t376r2037b436],

1	Wiltshire	NNP	ORGANIZATION	Wiltshire	nn	2	SENT_447	[p24l147t467r415b517],
2	T	NN	ORGANIZATION	t	nsubj	55	SENT_447	[p24l447t467r498b526],
3	,	,	O	,	_	0	SENT_447	[p24l447t467r498b526],
4	Pletcher	NNP	PERSON	Pletcher	nn	5	SENT_447	[p24l536t467r786b517],
5	MT	NNP	O	MT	appos	2	SENT_447	[p24l820t467r924b526],
6	,	,	O	,	_	0	SENT_447	[p24l820t467r924b526],
7	Batalov	NNP	PERSON	Batalov	nn	8	SENT_447	[p24l965t467r1192b517],
8	S	NNP	O	S	appos	5	SENT_447	[p24l1223t466r1280b526],
9	,	,	O	,	_	0	SENT_447	[p24l1223t466r1280b526],
10	Barnes	NNP	ORGANIZATION	Barnes	nn	11	SENT_447	[p24l1320t467r1532b517],
11	SW	NNP	ORGANIZATION	SW	appos	5	SENT_447	[p24l1567t466r1682b526],
12	,	,	O	,	_	0	SENT_447	[p24l1567t466r1682b526],
13	Tarantino	NNP	ORGANIZATION	Tarantino	nn	14	SENT_447	[p24l1717t467r2007b517],
14	LM	NNP	ORGANIZATION	LM	appos	5	SENT_447	[p24l2043t467r2148b526],
15	,	,	O	,	_	0	SENT_447	[p24l2043t467r2148b526],
16	Cooke	NNP	PERSON	Cooke	nn	17	SENT_447	[p24l149t555r340b606],
17	MP	NNP	O	MP	appos	5	SENT_447	[p24l368t556r477b615],
18	,	,	O	,	_	0	SENT_447	[p24l368t556r477b615],
19	Wu	NNP	PERSON	Wu	nn	20	SENT_447	[p24l503t556r595b606],
20	H	NNP	PERSON	H	appos	5	SENT_447	[p24l624t556r682b615],
21	,	,	O	,	_	0	SENT_447	[p24l624t556r682b615],
22	Smylie	NNP	PERSON	Smylie	nn	23	SENT_447	[p24l710t555r911b618],
23	K	NNP	PERSON	K	appos	5	SENT_447	[p24l939t556r993b615],
24	,	,	O	,	_	0	SENT_447	[p24l939t556r993b615],
25	Santrosyan	NNP	MISC	Santrosyan	nn	26	SENT_447	[p24l1022t555r1365b618],
26	A	NNP	MISC	A	appos	5	SENT_447	[p24l1390t556r1445b615],
27	,	,	O	,	_	0	SENT_447	[p24l1390t556r1445b615],
28	Copeland	NNP	ORGANIZATION	Copeland	nn	29	SENT_447	[p24l1473t555r1760b617],
29	NG	NNP	ORGANIZATION	NG	appos	5	SENT_447	[p24l1789t555r1894b615],
30	,	,	O	,	_	0	SENT_447	[p24l1789t555r1894b615],
31	Jenkins	NNP	ORGANIZATION	Jenkins	nn	32	SENT_447	[p24l1919t556r2151b606],
32	NA	NNP	ORGANIZATION	NA	appos	5	SENT_447	[p24l152t645r250b704],
33	,	,	O	,	_	0	SENT_447	[p24l152t645r250b704],
34	Kalush	NNP	PERSON	Kalush	nn	35	SENT_447	[p24l283t645r488b695],
35	F	NN	O	f	appos	5	SENT_447	[p24l520t645r565b704],
36	,	,	O	,	_	0	SENT_447	[p24l520t645r565b704],
37	Mural	NNP	O	Mural	nn	38	SENT_447	[p24l598t645r764b695],
38	RJ	NN	O	rj	appos	5	SENT_447	[p24l796t645r880b704],
39	,	,	O	,	_	0	SENT_447	[p24l796t645r880b704],
40	Glynne	NNP	PERSON	Glynne	nn	41	SENT_447	[p24l911t644r1116b707],
41	RJ	NN	PERSON	rj	appos	5	SENT_447	[p24l1146t645r1229b704],
42	,	,	O	,	_	0	SENT_447	[p24l1146t645r1229b704],
43	Kay	NNP	ORGANIZATION	Kay	nn	44	SENT_447	[p24l1263t645r1371b707],
44	SA	NNP	ORGANIZATION	SA	appos	5	SENT_447	[p24l1396t644r1493b704],
45	,	,	O	,	_	0	SENT_447	[p24l1396t644r1493b704],
46	Adams	NNP	PERSON	Adams	nn	47	SENT_447	[p24l1521t645r1731b695],
47	MD	NNP	O	MD	appos	5	SENT_447	[p24l1761t645r1878b704],
48	,	,	O	,	_	0	SENT_447	[p24l1761t645r1878b704],
49	Fletcher	NNP	PERSON	Fletcher	nn	54	SENT_447	[p24l1911t645r2154b695],
50	CF.	NNP	O	CF.	nn	54	SENT_447	[p24l149t733r241b785],
51	Genome-wide	JJ	O	genome-wide	amod	54	SENT_447	[p24l286t733r699b785],
52	single-nucleotide	JJ	O	single-nucleotide	amod	54	SENT_447	[p24l740t734r1259b798],
53	polymorphism	NN	O	polymorphism	nn	54	SENT_447	[p24l1303t734r1729b797],
54	analysis	NN	O	analysis	appos	5	SENT_447	[p24l1773t734r2022b797],
55	defines	VBZ	O	define	_	0	SENT_447	[p24l2064t734r2154b785, p24l147t823r294b874],
56	haplotype	NN	O	haplotype	nn	57	SENT_447	[p24l335t824r630b886],
57	patterns	NNS	O	pattern	dobj	55	SENT_447	[p24l671t827r923b885],
58	in	IN	O	in	_	0	SENT_447	[p24l965t824r1011b873],
59	mouse	NN	O	mouse	prep_in	57	SENT_447	[p24l1053t836r1276b874],
60	.	.	O	.	_	0	SENT_447	[p24l1053t836r1276b874],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_448	[p24l1319t824r1449b874],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_448	[p24l1490t824r1605b874],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_448	[p24l1644t824r1791b874],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_448	[p24l1831t823r1919b874],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_448	[p24l1963t824r1997b874],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_448	[p24l2040t823r2078b874],
7	A	NNP	O	A	_	0	SENT_448	[p24l2114t824r2154b873],
8	2003	CD	DATE	2003	num	7	SENT_448	[p24l150t912r894b972],
9	;	:	O	;	_	0	SENT_448	[p24l150t912r894b972],
10	100:3380	CD	DURATION	100:3380	number	11	SENT_448	[p24l150t912r894b972],
11	-3385	CD	DURATION	-3385	dep	7	SENT_448	[p24l150t912r894b972],
12	.	.	O	.	_	0	SENT_448	[p24l150t912r894b972],

1	Yan	NNP	PERSON	Yan	nn	2	SENT_449	[p24l147t1002r260b1053],
2	J	NNP	PERSON	J	_	0	SENT_449	[p24l295t1002r338b1061],
3	,	,	O	,	_	0	SENT_449	[p24l295t1002r338b1061],
4	Fine	NNP	O	Fine	nn	7	SENT_449	[p24l380t1002r500b1053],
5	J.	NNP	O	J.	nn	7	SENT_449	[p24l534t1002r577b1053],
6	Estimating	NNP	O	Estimating	nn	7	SENT_449	[p24l620t1002r944b1066],
7	equations	NNS	O	equation	appos	2	SENT_449	[p24l976t1002r1280b1064],
8	for	IN	O	for	_	0	SENT_449	[p24l1313t1001r1396b1053],
9	association	NN	O	association	nn	10	SENT_449	[p24l1430t1002r1781b1053],
10	structures	NNS	O	structure	prep_for	7	SENT_449	[p24l1819t1005r2148b1053],
11	.	.	O	.	_	0	SENT_449	[p24l1819t1005r2148b1053],

1	Stat	NN	O	stat	nsubj	2	SENT_450	[p24l150t1091r275b1142],
2	Med	VBD	O	med	_	0	SENT_450	[p24l305t1092r431b1142],
3	2004	CD	DATE	2004	dobj	2	SENT_450	[p24l463t1091r1087b1151],
4	;	:	O	;	_	0	SENT_450	[p24l463t1091r1087b1151],
5	23:859	CD	NUMBER	23:859	num	6	SENT_450	[p24l463t1091r1087b1151],
6	-880	CD	NUMBER	-880	dep	3	SENT_450	[p24l463t1091r1087b1151],
7	.	.	O	.	_	0	SENT_450	[p24l463t1091r1087b1151],

1	Spiegelhalter	NNP	O	Spiegelhalter	nn	2	SENT_451	[p24l150t1180r557b1245],
2	DJ	NNP	O	DJ	_	0	SENT_451	[p24l583t1181r669b1241],
3	,	,	O	,	_	0	SENT_451	[p24l583t1181r669b1241],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_451	[p24l696t1181r940b1232],
5	A	NNP	O	A	appos	2	SENT_451	[p24l964t1181r1020b1241],
6	,	,	O	,	_	0	SENT_451	[p24l964t1181r1020b1241],
7	Best	JJS	O	best	amod	8	SENT_451	[p24l1051t1181r1189b1232],
8	NG	NN	O	ng	appos	5	SENT_451	[p24l1215t1180r1320b1232],
9	.	.	O	.	_	0	SENT_451	[p24l1215t1180r1320b1232],

1	(	NN	O	(	_	0	SENT_452	[p24l1350t1180r1577b1243],
2	1999	CD	DATE	1999	num	3	SENT_452	[p24l1350t1180r1577b1243],
3	)	NN	O	)	dep	1	SENT_452	[p24l1350t1180r1577b1243],
4	.	.	O	.	_	0	SENT_452	[p24l1350t1180r1577b1243],

1	WinBUGS	NNP	O	WinBUGS	nn	2	SENT_453	[p24l1604t1180r1897b1232],
2	Version	NNP	O	Version	_	0	SENT_453	[p24l1921t1181r2150b1232],
3	1.2	CD	NUMBER	1.2	num	5	SENT_453	[p24l152t1270r250b1321],
4	User	NN	O	user	nn	5	SENT_453	[p24l299t1271r438b1321],
5	Manual	NNP	O	Manual	dep	2	SENT_453	[p24l483t1271r723b1321],
6	.	.	O	.	_	0	SENT_453	[p24l483t1271r723b1321],

1	Technical	NNP	O	Technical	_	0	SENT_454	[p24l769t1271r1057b1321],
2	manual	NN	O	manual	dep	1	SENT_454	[p24l1107t1271r1348b1321],
3	.	.	O	.	_	0	SENT_454	[p24l1107t1271r1348b1321],

1	MRC	NNP	ORGANIZATION	MRC	nn	3	SENT_455	[p24l1399t1270r1538b1321],
2	Biostatistics	NNPS	ORGANIZATION	Biostatistics	nn	3	SENT_455	[p24l1586t1271r1966b1321],
3	Unit	NNP	ORGANIZATION	Unit	_	0	SENT_455	[p24l2013t1271r2148b1330],
4	,	,	O	,	_	0	SENT_455	[p24l2013t1271r2148b1330],
5	Cambridge	NNP	LOCATION	Cambridge	nn	7	SENT_455	[p24l149t1359r496b1424],
6	,	,	O	,	_	0	SENT_455	[p24l149t1359r496b1424],
7	UK	NNP	LOCATION	UK	appos	3	SENT_455	[p24l550t1360r650b1411],
8	.	.	O	.	_	0	SENT_455	[p24l550t1360r650b1411],

1	Available	JJ	O	available	_	0	SENT_456	[p24l699t1360r974b1411],
2	at	IN	O	at	advmod	1	SENT_456	[p24l1022t1363r1095b1411],
3	:	:	O	:	_	0	SENT_456	[p24l1022t1363r1095b1411],
4	http://www.mrc-bsu.cam.ac.uk/	JJ	O	http://www.mrc-bsu.cam.ac.uk/	amod	5	SENT_456	[p24l1148t1360r2153b1422],
5	bugs/winbugs/contents	NNS	O	bugs/winbugs/contents	dep	1	SENT_456	[p24l151t1450r1109b1514],
6	.	.	O	.	_	0	SENT_456	[p24l151t1450r1109b1514],

1	shtml	NN	O	shtml	_	0	SENT_457	[p24l151t1450r1109b1514],
2	.	.	O	.	_	0	SENT_457	[p24l151t1450r1109b1514],

1	Accessed	VBN	O	access	_	0	SENT_458	[p24l1140t1450r1435b1501],
2	November	NNP	DATE	November	tmod	1	SENT_458	[p24l1468t1450r1779b1501],
3	28	CD	DATE	28	num	2	SENT_458	[p24l1806t1449r1904b1510],
4	,	,	DATE	,	_	0	SENT_458	[p24l1806t1449r1904b1510],
5	2005	CD	DATE	2005	num	2	SENT_458	[p24l1937t1449r2121b1501],
6	.	.	O	.	_	0	SENT_458	[p24l1937t1449r2121b1501],

1	Patrono	NN	O	patrono	nn	2	SENT_459	[p24l151t1540r385b1590],
2	C	NN	O	c	_	0	SENT_459	[p24l421t1539r478b1599],
3	,	,	O	,	_	0	SENT_459	[p24l421t1539r478b1599],
4	Patrignani	NN	PERSON	patrignanus	nn	5	SENT_459	[p24l520t1540r821b1604],
5	P	NN	PERSON	p	appos	2	SENT_459	[p24l862t1540r913b1599],
6	,	,	O	,	_	0	SENT_459	[p24l862t1540r913b1599],
7	Garcia	NNP	PERSON	Garcia	nn	9	SENT_459	[p24l953t1539r1147b1590],
8	Rodriguez	NNP	PERSON	Rodriguez	nn	9	SENT_459	[p24l1186t1540r1485b1604],
9	LA.	NNP	O	LA.	appos	5	SENT_459	[p24l1523t1540r1608b1590],
10	.	.	O	.	_	0	SENT_459	[p24l1523t1540r1608b1590],

1	Cyclooxygenaseselective	JJ	O	cyclooxygenaseselective	amod	2	SENT_460	[p24l1648t1539r2154b1604, p24l150t1630r420b1680],
2	inhibition	NN	O	inhibition	_	0	SENT_460	[p24l471t1630r747b1680],
3	of	IN	O	of	_	0	SENT_460	[p24l797t1629r857b1680],
4	prostanoid	NN	O	prostanoid	nn	5	SENT_460	[p24l903t1630r1226b1692],
5	formation	NN	O	formation	prep_of	2	SENT_460	[p24l1274t1629r1587b1680],
6	:	:	O	:	_	0	SENT_460	[p24l1274t1629r1587b1680],
7	transducing	VBG	O	transduce	amod	9	SENT_460	[p24l1637t1630r2001b1694],
8	biochemical	JJ	O	biochemical	amod	9	SENT_460	[p24l2048t1630r2154b1680, p24l149t1719r419b1769],
9	selectivity	NN	O	selectivity	dep	2	SENT_460	[p24l458t1719r764b1782],
10	into	IN	O	into	_	0	SENT_460	[p24l800t1719r909b1769],
11	clinical	JJ	O	clinical	amod	12	SENT_460	[p24l945t1719r1153b1769],
12	read	NN	O	read	prep_into	9	SENT_460	[p24l1194t1719r1497b1769],
13	—	CD	NUMBER	—	num	14	SENT_460	[p24l1194t1719r1497b1769],
14	outs	NNS	O	out	dep	12	SENT_460	[p24l1194t1719r1497b1769],
15	.	.	O	.	_	0	SENT_460	[p24l1194t1719r1497b1769],

1	J	NNP	O	J	nn	3	SENT_461	[p24l1535t1719r1558b1769],
2	Clin	NNP	O	Clin	nn	3	SENT_461	[p24l1596t1719r1707b1769],
3	Invest	NNP	O	Invest	_	0	SENT_461	[p24l1748t1719r1930b1769],
4	2001	CD	DATE	2001	num	3	SENT_461	[p24l1965t1719r2148b1778],
5	;	:	O	;	_	0	SENT_461	[p24l1965t1719r2148b1778],
6	108:7	CD	NUMBER	108:7	number	7	SENT_461	[p24l152t1808r477b1859],
7	—	CD	NUMBER	—	dep	3	SENT_461	[p24l152t1808r477b1859],
8	13	CD	NUMBER	13	dep	7	SENT_461	[p24l152t1808r477b1859],
9	.	.	O	.	_	0	SENT_461	[p24l152t1808r477b1859],

1	Thomas	NNP	PERSON	Thomas	nn	2	SENT_462	[p24l147t1899r392b1950],
2	DW	NNP	PERSON	DW	_	0	SENT_462	[p24l426t1899r542b1958],
3	,	,	O	,	_	0	SENT_462	[p24l426t1899r542b1958],
4	Mannon	NNP	PERSON	Mannon	nn	5	SENT_462	[p24l579t1899r821b1950],
5	RB	NN	O	rb	appos	2	SENT_462	[p24l857t1899r956b1958],
6	,	,	O	,	_	0	SENT_462	[p24l857t1899r956b1958],
7	Mannon	NNP	PERSON	Mannon	nn	8	SENT_462	[p24l993t1899r1235b1950],
8	PJ	NNP	PERSON	PJ	appos	5	SENT_462	[p24l1270t1899r1350b1958],
9	,	,	O	,	_	0	SENT_462	[p24l1270t1899r1350b1958],
10	Latour	NNP	MISC	Latour	nn	11	SENT_462	[p24l1387t1899r1580b1950],
11	A	NNP	MISC	A	appos	5	SENT_462	[p24l1606t1899r1661b1958],
12	,	,	O	,	_	0	SENT_462	[p24l1606t1899r1661b1958],
13	Oliver	NNP	PERSON	Oliver	nn	14	SENT_462	[p24l1696t1899r1868b1950],
14	JA	NNP	PERSON	JA	appos	5	SENT_462	[p24l1894t1899r1978b1958],
15	,	,	O	,	_	0	SENT_462	[p24l1894t1899r1978b1958],
16	Hoffman	NNP	PERSON	Hoffman	nn	17	SENT_462	[p24l2015t1899r2154b1950, p24l151t2000r278b2038],
17	M	NNP	O	M	appos	5	SENT_462	[p24l307t1988r377b2047],
18	,	,	O	,	_	0	SENT_462	[p24l307t1988r377b2047],
19	Smithies	NNP	PERSON	Smithies	nn	20	SENT_462	[p24l405t1988r674b2038],
20	o	NN	O	o	appos	5	SENT_462	[p24l699t1988r759b2047],
21	,	,	O	,	_	0	SENT_462	[p24l699t1988r759b2047],
22	Koller	NNP	PERSON	Koller	nn	23	SENT_462	[p24l791t1988r964b2038],
23	BH	NNP	O	BH	appos	5	SENT_462	[p24l988t1988r1091b2047],
24	,	,	O	,	_	0	SENT_462	[p24l988t1988r1091b2047],
25	Coffman	NNP	PERSON	Coffman	nn	26	SENT_462	[p24l1118t1988r1374b2038],
26	TM	NNP	O	TM	appos	5	SENT_462	[p24l1398t1988r1507b2038],
27	.	.	O	.	_	0	SENT_462	[p24l1398t1988r1507b2038],

1	Coagulation	NN	MISC	coagulation	nn	2	SENT_463	[p24l1536t1988r1898b2051],
2	defects	NNS	O	defect	_	0	SENT_463	[p24l1924t1988r2151b2038],
3	and	CC	O	and	_	0	SENT_463	[p24l150t2077r258b2127],
4	altered	JJ	O	altered	amod	6	SENT_463	[p24l294t2077r504b2127],
5	hemodynamic	JJ	O	hemodynamic	amod	6	SENT_463	[p24l541t2077r966b2139],
6	responses	NNS	O	response	conj_and	2	SENT_463	[p24l1001t2089r1321b2138],
7	in	IN	O	in	_	0	SENT_463	[p24l1357t2077r1404b2126],
8	mice	NNS	O	mouse	prep_in	6	SENT_463	[p24l1441t2077r1582b2127],
9	lacking	VBG	O	lack	partmod	2	SENT_463	[p24l1618t2077r1831b2140],
10	receptors	NNS	O	receptor	dobj	9	SENT_463	[p24l1864t2080r2151b2138],
11	for	IN	O	for	_	0	SENT_463	[p24l147t2165r230b2217],
12	thromboxane	NN	O	thromboxane	nn	13	SENT_463	[p24l253t2166r658b2217],
13	A2	NN	O	a2	prep_for	10	SENT_463	[p24l685t2166r773b2232],
14	.	.	O	.	_	0	SENT_463	[p24l685t2166r773b2232],

1	J	NNP	O	J	nn	3	SENT_464	[p24l803t2166r826b2217],
2	Clin	NNP	O	Clin	nn	3	SENT_464	[p24l857t2165r967b2217],
3	Invest	NNP	O	Invest	_	0	SENT_464	[p24l1002t2166r1184b2217],
4	1998	CD	DATE	1998	num	3	SENT_464	[p24l1213t2165r1955b2226],
5	;	:	O	;	_	0	SENT_464	[p24l1213t2165r1955b2226],
6	102:1994	CD	DURATION	102:1994	number	7	SENT_464	[p24l1213t2165r1955b2226],
7	-2001	CD	DURATION	-2001	dep	3	SENT_464	[p24l1213t2165r1955b2226],
8	.	.	O	.	_	0	SENT_464	[p24l1213t2165r1955b2226],

1	Francois	NNP	PERSON	Francois	nn	2	SENT_465	[p24l152t2256r406b2306],
2	H	NNP	PERSON	H	_	0	SENT_465	[p24l431t2256r489b2315],
3	,	,	O	,	_	0	SENT_465	[p24l431t2256r489b2315],
4	Athirakul	NNP	PERSON	Athirakul	nn	5	SENT_465	[p24l512t2256r778b2306],
5	K	NNP	PERSON	K	appos	2	SENT_465	[p24l807t2256r861b2315],
6	,	,	O	,	_	0	SENT_465	[p24l807t2256r861b2315],
7	Mao	NNP	PERSON	Mao	nn	8	SENT_465	[p24l889t2256r1017b2306],
8	L	NNP	PERSON	L	appos	2	SENT_465	[p24l1042t2256r1088b2315],
9	,	,	O	,	_	0	SENT_465	[p24l1042t2256r1088b2315],
10	Rockman	NNP	PERSON	Rockman	nn	11	SENT_465	[p24l1116t2256r1396b2306],
11	H	NNP	O	H	appos	2	SENT_465	[p24l1423t2256r1480b2315],
12	,	,	O	,	_	0	SENT_465	[p24l1423t2256r1480b2315],
13	Coffman	NNP	PERSON	Coffman	nn	14	SENT_465	[p24l1506t2255r1761b2306],
14	TM	NNP	O	TM	appos	2	SENT_465	[p24l1783t2256r1892b2306],
15	.	.	O	.	_	0	SENT_465	[p24l1783t2256r1892b2306],

1	Role	NN	O	role	nsubj	10	SENT_466	[p24l1920t2256r2051b2306],
2	for	IN	O	for	_	0	SENT_466	[p24l2071t2255r2154b2306],
3	thromboxane	NN	O	thromboxane	nn	4	SENT_466	[p24l147t2345r551b2395],
4	receptors	NNS	O	receptor	prep_for	1	SENT_466	[p24l596t2348r883b2406],
5	in	IN	O	in	_	0	SENT_466	[p24l929t2345r975b2394],
6	angiotensin	NN	O	angiotensin	nn	9	SENT_466	[p24l1021t2345r1690b2408],
7	—	CD	NUMBER	—	num	9	SENT_466	[p24l1021t2345r1690b2408],
8	ll	NN	O	ll	nn	9	SENT_466	[p24l1021t2345r1690b2408],
9	—	NN	O	—	prep_in	4	SENT_466	[p24l1021t2345r1690b2408],
10	induced	VBD	O	induce	_	0	SENT_466	[p24l1021t2345r1690b2408],
11	hypertension	NN	O	hypertension	dobj	10	SENT_466	[p24l1736t2345r2148b2407],
12	.	.	O	.	_	0	SENT_466	[p24l1736t2345r2148b2407],

1	Hypertension	NN	O	hypertension	_	0	SENT_467	[p24l152t2434r552b2496],
2	2004	CD	DATE	2004	num	1	SENT_467	[p24l584t2433r1199b2492],
3	;	:	O	;	_	0	SENT_467	[p24l584t2433r1199b2492],
4	43:364	CD	NUMBER	43:364	number	5	SENT_467	[p24l584t2433r1199b2492],
5	-369	CD	NUMBER	-369	dep	1	SENT_467	[p24l584t2433r1199b2492],
6	.	.	O	.	_	0	SENT_467	[p24l584t2433r1199b2492],

1	Cayatte	NNP	O	Cayatte	nn	2	SENT_468	[p24l149t2522r380b2585],
2	AJ	NNP	O	AJ	_	0	SENT_468	[p24l417t2523r501b2581],
3	,	,	O	,	_	0	SENT_468	[p24l417t2523r501b2581],
4	Du	NNP	O	Du	nn	5	SENT_468	[p24l545t2523r620b2573],
5	Y	NN	O	y	appos	2	SENT_468	[p24l658t2523r714b2581],
6	,	,	O	,	_	0	SENT_468	[p24l658t2523r714b2581],
7	oliver	NN	O	oliver	appos	5	SENT_468	[p24l755t2522r1227b2573],
8	.	.	O	.	_	0	SENT_468	[p24l755t2522r1227b2573],

1	—	NN	O	—	_	0	SENT_469	[p24l755t2522r1227b2573],
2	.	.	O	.	_	0	SENT_469	[p24l755t2522r1227b2573],

1	Krasinski	NNP	PERSON	Krasinski	nn	2	SENT_470	[p24l755t2522r1227b2573],
2	J	NNP	PERSON	J	_	0	SENT_470	[p24l1266t2523r1309b2581],
3	,	,	O	,	_	0	SENT_470	[p24l1266t2523r1309b2581],
4	Lavielle	NNP	PERSON	Lavielle	nn	5	SENT_470	[p24l1354t2523r1580b2573],
5	G	NNP	O	G	appos	2	SENT_470	[p24l1619t2522r1679b2581],
6	,	,	O	,	_	0	SENT_470	[p24l1619t2522r1679b2581],
7	Verbeuren	NNP	O	Verbeuren	nn	8	SENT_470	[p24l1718t2523r2031b2573],
8	TJ	NNP	O	TJ	appos	2	SENT_470	[p24l2069t2523r2148b2581],
9	,	,	O	,	_	0	SENT_470	[p24l2069t2523r2148b2581],
10	Cohen	NNP	PERSON	Cohen	nn	11	SENT_470	[p24l149t2611r341b2661],
11	RA	NN	O	ra	appos	2	SENT_470	[p24l368t2611r463b2661],
12	.	.	O	.	_	0	SENT_470	[p24l368t2611r463b2661],

1	The	DT	O	the	det	2	SENT_471	[p24l486t2611r596b2661],
2	thromboxane	NN	O	thromboxane	nsubj	9	SENT_471	[p24l615t2611r1020b2661],
3	receptor	NN	O	receptor	nn	5	SENT_471	[p24l1044t2614r1298b2673],
4	antagonist	NN	O	antagonist	nn	5	SENT_471	[p24l1318t2611r1644b2674],
5	S18886	NN	O	s18886	dep	2	SENT_471	[p24l1664t2611r1917b2661],
6	but	CC	O	but	_	0	SENT_471	[p24l1941t2611r2037b2661],
7	not	RB	O	not	_	0	SENT_471	[p24l2058t2614r2154b2661],
8	aspirin	NN	O	aspirin	conj_negcc	2	SENT_471	[p24l150t2700r353b2762],
9	inhibits	VBZ	O	inhibit	_	0	SENT_471	[p24l389t2700r608b2750],
10	atherogenesis	NN	O	atherogenesis	dobj	9	SENT_471	[p24l641t2700r1079b2763],
11	in	IN	O	in	_	0	SENT_471	[p24l1114t2700r1160b2750],
12	apo	NN	O	apo	nn	16	SENT_471	[p24l1195t2712r1304b2762],
13	E	NN	O	e	nn	16	SENT_471	[p24l1339t2700r1654b2750],
14	—	CD	NUMBER	—	num	16	SENT_471	[p24l1339t2700r1654b2750],
15	deficient	JJ	O	deficient	amod	16	SENT_471	[p24l1339t2700r1654b2750],
16	mice	NNS	O	mouse	prep_in	10	SENT_471	[p24l1685t2700r1845b2750],
17	:	:	O	:	_	0	SENT_471	[p24l1685t2700r1845b2750],
18	evidence	NN	O	evidence	dep	10	SENT_471	[p24l1880t2700r2151b2750],
19	that	IN	O	that	complm	24	SENT_471	[p24l147t2790r270b2841],
20	eicosanoids	NNS	O	eicosanoid	nsubj	24	SENT_471	[p24l302t2790r672b2841],
21	other	JJ	O	other	dep	20	SENT_471	[p24l708t2790r867b2841],
22	than	IN	O	than	_	0	SENT_471	[p24l897t2790r1031b2841],
23	thromboxane	NN	O	thromboxane	prep_than	20	SENT_471	[p24l1066t2790r1469b2841],
24	contribute	VBP	O	contribute	dep	18	SENT_471	[p24l1505t2790r1813b2841],
25	to	TO	O	to	_	0	SENT_471	[p24l1846t2793r1905b2841],
26	atherosclerosis	NN	O	atherosclerosis	prep_to	24	SENT_471	[p24l1941t2790r2154b2841, p24l149t2880r443b2931],
27	.	.	O	.	_	0	SENT_471	[p24l1941t2790r2154b2841, p24l149t2880r443b2931],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_472	[p24l474t2880r828b2931],
2	Thromb	NNP	O	Thromb	nn	4	SENT_472	[p24l851t2880r1082b2931],
3	Vasc	NNP	O	Vasc	nn	4	SENT_472	[p24l1109t2880r1257b2931],
4	Biol	NNP	O	Biol	_	0	SENT_472	[p24l1288t2880r1395b2931],
5	2000	CD	DATE	2000	num	4	SENT_472	[p24l1428t2880r2129b2939],
6	;	:	O	;	_	0	SENT_472	[p24l1428t2880r2129b2939],
7	20:1724	CD	DURATION	20:1724	number	8	SENT_472	[p24l1428t2880r2129b2939],
8	-1728	CD	DURATION	-1728	dep	4	SENT_472	[p24l1428t2880r2129b2939],
9	.	.	O	.	_	0	SENT_472	[p24l1428t2880r2129b2939],

1	Egan	NNP	PERSON	Egan	nn	2	SENT_473	[p24l152t2969r295b3033],
2	KM	NNP	O	KM	_	0	SENT_473	[p24l337t2969r450b3029],
3	,	,	O	,	_	0	SENT_473	[p24l337t2969r450b3029],
4	Lawson	NNP	PERSON	Lawson	nn	5	SENT_473	[p24l493t2969r719b3020],
5	JA	NNP	O	JA	appos	2	SENT_473	[p24l756t2969r839b3029],
6	,	,	O	,	_	0	SENT_473	[p24l756t2969r839b3029],
7	Fries	NNP	O	Fries	nn	8	SENT_473	[p24l882t2969r1024b3020],
8	S	NNP	O	S	appos	5	SENT_473	[p24l1062t2968r1119b3029],
9	,	,	O	,	_	0	SENT_473	[p24l1062t2968r1119b3029],
10	Koller	NNP	PERSON	Koller	nn	11	SENT_473	[p24l1162t2969r1336b3020],
11	B	NNP	PERSON	B	appos	5	SENT_473	[p24l1372t2969r1426b3029],
12	,	,	O	,	_	0	SENT_473	[p24l1372t2969r1426b3029],
13	Rader	NNP	O	Rader	nn	14	SENT_473	[p24l1469t2969r1648b3020],
14	DJ	NNP	O	DJ	appos	5	SENT_473	[p24l1684t2969r1770b3029],
15	,	,	O	,	_	0	SENT_473	[p24l1684t2969r1770b3029],
16	Smyth	NNP	ORGANIZATION	Smyth	nn	17	SENT_473	[p24l1810t2968r1997b3032],
17	EM	NNP	ORGANIZATION	EM	appos	5	SENT_473	[p24l2039t2969r2148b3029],
18	,	,	O	,	_	0	SENT_473	[p24l2039t2969r2148b3029],
19	FitzGerald	NNP	PERSON	FitzGerald	nn	20	SENT_473	[p24l152t3058r450b3109],
20	GA.	NNP	O	GA.	appos	5	SENT_473	[p24l484t3058r584b3109],
21	.	.	O	.	_	0	SENT_473	[p24l484t3058r584b3109],

1	COX-2	NN	MISC	cox-2	nsubj	4	SENT_474	[p24l620t3058r802b3109],
2	derived	VBN	O	derive	partmod	1	SENT_474	[p24l835t3059r1054b3109],
3	prostacyclin	NN	O	prostacyclin	dobj	2	SENT_474	[p24l1091t3059r1452b3121],
4	confers	VBZ	O	confer	_	0	SENT_474	[p24l1485t3058r1712b3109],
5	atheroprotection	NN	O	atheroprotection	dobj	4	SENT_474	[p24l1745t3059r2154b3120, p24l147t3148r260b3198],
6	on	IN	O	on	_	0	SENT_474	[p24l291t3160r361b3198],
7	female	JJ	O	female	amod	8	SENT_474	[p24l390t3147r600b3198],
8	mice	NNS	O	mouse	prep_on	5	SENT_474	[p24l631t3148r791b3198],
9	.	.	O	.	_	0	SENT_474	[p24l631t3148r791b3198],

1	Science	NNP	O	Science	_	0	SENT_475	[p24l824t3147r1065b3198],
2	2004	CD	DATE	2004	num	1	SENT_475	[p24l1095t3147r1839b3207],
3	;	:	O	;	_	0	SENT_475	[p24l1095t3147r1839b3207],
4	360:1954	CD	DURATION	360:1954	number	5	SENT_475	[p24l1095t3147r1839b3207],
5	-1957	CD	DURATION	-1957	dep	1	SENT_475	[p24l1095t3147r1839b3207],
6	.	.	O	.	_	0	SENT_475	[p24l1095t3147r1839b3207],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_476	[p24l147t3237r319b3301],
2	D	NNP	PERSON	D	_	0	SENT_476	[p24l354t3237r411b3297],
3	,	,	O	,	_	0	SENT_476	[p24l354t3237r411b3297],
4	Mann	NNP	PERSON	Mann	nn	5	SENT_476	[p24l451t3237r616b3288],
5	JR	NNP	O	JR	appos	2	SENT_476	[p24l651t3237r738b3297],
6	,	,	O	,	_	0	SENT_476	[p24l651t3237r738b3297],
7	DuBois	NNP	PERSON	DuBois	nn	8	SENT_476	[p24l779t3237r994b3288],
8	RN	NNP	O	RN	appos	5	SENT_476	[p24l1032t3237r1134b3287],
9	.	.	O	.	_	0	SENT_476	[p24l1032t3237r1134b3287],

1	The	DT	O	the	det	2	SENT_477	[p24l1169t3237r1279b3288],
2	role	NN	O	role	_	0	SENT_477	[p24l1316t3237r1425b3288],
3	of	IN	O	of	_	0	SENT_477	[p24l1460t3236r1520b3288],
4	prostaglandins	NNS	O	prostaglandin	prep_of	2	SENT_477	[p24l1552t3237r2006b3301],
5	and	CC	O	and	_	0	SENT_477	[p24l2042t3237r2150b3288],
6	other	JJ	O	other	amod	7	SENT_477	[p24l149t3327r309b3377],
7	eicosanoids	NNS	O	eicosanoid	conj_and	4	SENT_477	[p24l333t3327r704b3377],
8	in	IN	O	in	_	0	SENT_477	[p24l734t3327r780b3377],
9	the	DT	O	the	det	11	SENT_477	[p24l807t3327r905b3377],
10	gastrointestinal	JJ	O	gastrointestinal	amod	11	SENT_477	[p24l930t3327r1410b3391],
11	tract	NN	O	tract	prep_in	2	SENT_477	[p24l1438t3329r1595b3377],
12	.	.	O	.	_	0	SENT_477	[p24l1438t3329r1595b3377],

1	Gastroenterology	NNP	O	Gastroenterology	_	0	SENT_478	[p24l1627t3326r2154b3391],
2	2005	CD	DATE	2005	num	1	SENT_478	[p24l150t3416r886b3473],
3	;	:	O	;	_	0	SENT_478	[p24l150t3416r886b3473],
4	128:1445	CD	DURATION	128:1445	number	5	SENT_478	[p24l150t3416r886b3473],
5	-1461	CD	DURATION	-1461	dep	1	SENT_478	[p24l150t3416r886b3473],
6	.	.	O	.	_	0	SENT_478	[p24l150t3416r886b3473],

1	FRIES	NNS	O	fries	_	0	SENT_479	[p24l164t3635r338b3685],
2	ET	NNP	O	ET	nn	3	SENT_479	[p24l368t3635r437b3684],
3	AL	NNP	O	AL	dep	1	SENT_479	[p24l460t3635r538b3684],

1	Malmstrom	NNP	ORGANIZATION	Malmstrom	nn	2	SENT_480	[p25l152t94r496b145],
2	K	NNP	ORGANIZATION	K	_	0	SENT_480	[p25l525t94r579b154],
3	,	,	O	,	_	0	SENT_480	[p25l525t94r579b154],
4	Daniels	NNP	PERSON	Daniels	appos	2	SENT_480	[p25l609t94r835b145],
5	8	CD	NUMBER	8	num	4	SENT_480	[p25l859t93r917b154],
6	,	,	O	,	_	0	SENT_480	[p25l859t93r917b154],
7	Kotey	NNP	PERSON	Kotey	nn	8	SENT_480	[p25l946t94r1116b157],
8	P	NN	O	p	appos	2	SENT_480	[p25l1138t94r1189b154],
9	,	,	O	,	_	0	SENT_480	[p25l1138t94r1189b154],
10	Seidenberg	NNP	PERSON	Seidenberg	nn	11	SENT_480	[p25l1216t93r1566b158],
11	BC	NNP	O	BC	appos	2	SENT_480	[p25l1590t93r1689b154],
12	,	,	O	,	_	0	SENT_480	[p25l1590t93r1689b154],
13	Desjardins	NNP	PERSON	Desjardins	nn	14	SENT_480	[p25l1719t94r2042b157],
14	PJ	NNP	PERSON	PJ	appos	2	SENT_480	[p25l2068t94r2148b145],
15	.	.	O	.	_	0	SENT_480	[p25l2068t94r2148b145],

1	Comparison	NN	O	comparison	_	0	SENT_481	[p25l149t185r516b248],
2	of	IN	O	of	_	0	SENT_481	[p25l559t185r619b236],
3	rofecoxib	NN	O	rofecoxib	prep_of	1	SENT_481	[p25l657t185r932b236],
4	and	CC	O	and	_	0	SENT_481	[p25l973t186r1081b236],
5	celecoxib	NN	O	celecoxib	conj_and	3	SENT_481	[p25l1124t186r1427b245],
6	,	,	O	,	_	0	SENT_481	[p25l1124t186r1427b245],
7	two	CD	NUMBER	two	num	9	SENT_481	[p25l1468t188r1574b236],
8	cyclooxygenase	NN	O	cyclooxygenase	nn	9	SENT_481	[p25l1615t185r2151b250],
9	—	NN	O	—	appos	3	SENT_481	[p25l1615t185r2151b250],
10	2	CD	NUMBER	2	num	11	SENT_481	[p25l1615t185r2151b250],
11	inhibitors	NNS	O	inhibitor	dep	9	SENT_481	[p25l152t278r452b337],
12	,	,	O	,	_	0	SENT_481	[p25l152t278r452b337],
13	in	IN	O	in	_	0	SENT_481	[p25l489t278r535b328],
14	postoperative	JJ	O	postoperative	amod	16	SENT_481	[p25l571t278r989b340],
15	dental	JJ	O	dental	amod	16	SENT_481	[p25l1020t278r1207b328],
16	pain	NN	O	pain	prep_in	3	SENT_481	[p25l1244t278r1388b339],
17	:	:	O	:	_	0	SENT_481	[p25l1244t278r1388b339],
18	a	DT	O	a	dep	1	SENT_481	[p25l1424t290r1455b328],
19	randomized	VBN	O	randomize	partmod	18	SENT_481	[p25l1489t278r1862b337],
20	,	,	O	,	_	0	SENT_481	[p25l1489t278r1862b337],
21	placeboand	JJ	O	placeboand	amod	24	SENT_481	[p25l1899t278r2154b339, p25l150t369r258b419],
22	active	JJ	O	active	amod	24	SENT_481	[p25l283t369r1154b430],
23	—	NN	O	—	nn	24	SENT_481	[p25l283t369r1154b430],
24	comparator	NN	O	comparator	appos	18	SENT_481	[p25l283t369r1154b430],
25	—	CD	NUMBER	—	num	28	SENT_481	[p25l283t369r1154b430],
26	controlled	JJ	O	controlled	amod	28	SENT_481	[p25l283t369r1154b430],
27	clinical	JJ	O	clinical	amod	28	SENT_481	[p25l1178t369r1385b419],
28	trial	NN	O	trial	dep	24	SENT_481	[p25l1408t369r1542b419],
29	.	.	O	.	_	0	SENT_481	[p25l1408t369r1542b419],

1	Clin	NNP	O	Clin	nn	2	SENT_482	[p25l1568t368r1678b419],
2	Ther	NNP	O	Ther	_	0	SENT_482	[p25l1700t369r1837b419],
3	1999	CD	DATE	1999	num	2	SENT_482	[p25l1858t368r2148b428],
4	;	:	O	;	_	0	SENT_482	[p25l1858t368r2148b428],
5	21	CD	NUMBER	21	num	7	SENT_482	[p25l1858t368r2148b428],
6	:	:	O	:	_	0	SENT_482	[p25l1858t368r2148b428],
7	1653-1663	CD	DATE	1653-1663	dep	2	SENT_482	[p25l152t459r542b510],
8	.	.	O	.	_	0	SENT_482	[p25l152t459r542b510],

1	Morrison	NNP	PERSON	Morrison	nn	2	SENT_483	[p25l152t552r417b602],
2	BW	NN	O	bw	dep	21	SENT_483	[p25l443t552r557b611],
3	,	,	O	,	_	0	SENT_483	[p25l443t552r557b611],
4	Fricke	NNP	PERSON	Fricke	nn	5	SENT_483	[p25l585t552r760b602],
5	J	NNP	PERSON	J	appos	2	SENT_483	[p25l780t552r823b611],
6	,	,	O	,	_	0	SENT_483	[p25l780t552r823b611],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_483	[p25l851t552r1033b602],
8	J	NNP	O	J	appos	2	SENT_483	[p25l1055t552r1098b611],
9	,	,	O	,	_	0	SENT_483	[p25l1055t552r1098b611],
10	Yuan	NNP	O	Yuan	nn	11	SENT_483	[p25l1121t552r1272b602],
11	W	NNP	O	W	appos	2	SENT_483	[p25l1294t552r1367b611],
12	,	,	O	,	_	0	SENT_483	[p25l1294t552r1367b611],
13	Kotey	NNP	PERSON	Kotey	nn	14	SENT_483	[p25l1395t552r1565b614],
14	P	NN	O	p	appos	2	SENT_483	[p25l1585t552r1636b611],
15	,	,	O	,	_	0	SENT_483	[p25l1585t552r1636b611],
16	Mehlisch	NNP	O	Mehlisch	nn	17	SENT_483	[p25l1664t552r1935b602],
17	D.	NNP	O	D.	appos	2	SENT_483	[p25l1961t552r2019b601],
18	The	NNP	O	The	dep	21	SENT_483	[p25l2041t552r2151b602],
19	optimal	JJ	O	optimal	amod	21	SENT_483	[p25l149t643r374b705],
20	analgesic	JJ	O	analgesic	amod	21	SENT_483	[p25l406t643r697b707],
21	dose	NN	O	dose	dep	25	SENT_483	[p25l725t643r873b693],
22	of	IN	O	of	_	0	SENT_483	[p25l902t642r962b693],
23	rofecoxib	NN	O	rofecoxib	prep_of	21	SENT_483	[p25l987t642r1280b693],
24	:	:	O	:	_	0	SENT_483	[p25l987t642r1280b693],
25	overview	NN	O	overview	_	0	SENT_483	[p25l1313t643r1576b693],
26	of	IN	O	of	_	0	SENT_483	[p25l1602t642r1662b693],
27	six	CD	NUMBER	six	prep_of	25	SENT_483	[p25l1686t643r1769b693],
28	randomized	VBN	O	randomize	partmod	25	SENT_483	[p25l1798t643r2150b693],
29	controlled	JJ	O	controlled	amod	30	SENT_483	[p25l149t735r450b786],
30	trials	NNS	O	trial	dobj	28	SENT_483	[p25l479t735r650b786],
31	.	.	O	.	_	0	SENT_483	[p25l479t735r650b786],

1	J	NNP	O	J	nn	4	SENT_484	[p25l681t735r704b786],
2	Am	NNP	O	Am	nn	4	SENT_484	[p25l734t735r827b785],
3	Dent	NNP	O	Dent	nn	4	SENT_484	[p25l861t735r1003b786],
4	Assoc	NNP	O	Assoc	_	0	SENT_484	[p25l1028t735r1212b786],
5	2000	CD	DATE	2000	num	4	SENT_484	[p25l1242t735r1986b794],
6	;	:	O	;	_	0	SENT_484	[p25l1242t735r1986b794],
7	131:1729	CD	DURATION	131:1729	number	8	SENT_484	[p25l1242t735r1986b794],
8	-1737	CD	DURATION	-1737	dep	4	SENT_484	[p25l1242t735r1986b794],
9	.	.	O	.	_	0	SENT_484	[p25l1242t735r1986b794],

1	Markiewicz	NNP	PERSON	Markiewicz	nn	2	SENT_485	[p25l152t826r487b877],
2	A	NNP	O	A	_	0	SENT_485	[p25l520t826r575b886],
3	,	,	O	,	_	0	SENT_485	[p25l520t826r575b886],
4	Semenowicz	NNP	O	Semenowicz	nn	8	SENT_485	[p25l615t825r998b877],
5	K.	NNP	O	K.	nn	8	SENT_485	[p25l1036t826r1090b876],
6	Time	NNP	O	Time	nn	8	SENT_485	[p25l1128t826r1275b877],
7	dependent	JJ	O	dependent	amod	8	SENT_485	[p25l1312t826r1641b888],
8	changes	NNS	O	change	appos	2	SENT_485	[p25l1675t826r1933b890],
9	in	IN	O	in	_	0	SENT_485	[p25l1972t826r2018b876],
10	the	DT	O	the	det	11	SENT_485	[p25l2054t826r2151b877],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	8	SENT_485	[p25l152t917r695b979],
12	of	IN	O	of	_	0	SENT_485	[p25l745t917r805b967],
13	aspirin	NN	O	aspirin	prep_of	11	SENT_485	[p25l851t917r1074b979],
14	.	.	O	.	_	0	SENT_485	[p25l851t917r1074b979],

1	Int	NN	O	int	nn	3	SENT_486	[p25l1129t917r1204b967],
2	J	NN	O	j	nn	3	SENT_486	[p25l1249t917r1272b967],
3	Clin	NN	O	clin	_	0	SENT_486	[p25l1324t917r1434b967],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_486	[p25l1487t917r1806b967],
5	Biopharm	NNP	O	Biopharm	dep	3	SENT_486	[p25l1861t917r2150b979],
6	1979	CD	DATE	1979	num	5	SENT_486	[p25l152t1008r774b1068],
7	;	:	O	;	_	0	SENT_486	[p25l152t1008r774b1068],
8	17:409	CD	NUMBER	17:409	num	9	SENT_486	[p25l152t1008r774b1068],
9	-411	CD	NUMBER	-411	dep	3	SENT_486	[p25l152t1008r774b1068],
10	.	.	O	.	_	0	SENT_486	[p25l152t1008r774b1068],

1	Clench	VB	PERSON	clench	_	0	SENT_487	[p25l149t1099r354b1150],
2	J	NNP	PERSON	J	dobj	1	SENT_487	[p25l386t1100r429b1159],
3	,	,	O	,	_	0	SENT_487	[p25l386t1100r429b1159],
4	Reinberg	NNP	O	Reinberg	nn	5	SENT_487	[p25l467t1100r737b1164],
5	A	NNP	O	A	appos	2	SENT_487	[p25l764t1100r819b1159],
6	,	,	O	,	_	0	SENT_487	[p25l764t1100r819b1159],
7	Dziewanowska	NNP	O	Dziewanowska	nn	8	SENT_487	[p25l856t1100r1304b1150],
8	Z	NNP	O	Z	appos	2	SENT_487	[p25l1334t1100r1387b1159],
9	,	,	O	,	_	0	SENT_487	[p25l1334t1100r1387b1159],
10	Ghata	NNP	PERSON	Ghata	nn	11	SENT_487	[p25l1422t1099r1602b1150],
11	J	NNP	PERSON	J	appos	2	SENT_487	[p25l1632t1100r1676b1159],
12	,	,	O	,	_	0	SENT_487	[p25l1632t1100r1676b1159],
13	Smolensky	NNP	PERSON	Smolensky	nn	14	SENT_487	[p25l1711t1099r2048b1163],
14	M.	NNP	O	M.	appos	2	SENT_487	[p25l2079t1100r2148b1150],
15	Circadian	JJ	O	circadian	amod	16	SENT_487	[p25l149t1191r433b1243],
16	changes	NNS	O	change	dep	14	SENT_487	[p25l462t1192r719b1256],
17	in	IN	O	in	_	0	SENT_487	[p25l750t1192r796b1242],
18	the	DT	O	the	det	19	SENT_487	[p25l823t1192r920b1243],
19	bioavailability	NN	O	bioavailability	prep_in	2	SENT_487	[p25l950t1192r1366b1255],
20	and	CC	O	and	_	0	SENT_487	[p25l1391t1192r1499b1243],
21	effects	NNS	O	effect	dobj	1	SENT_487	[p25l1528t1191r1738b1243],
22	of	IN	O	of	_	0	SENT_487	[p25l1766t1191r1826b1243],
23	indometh	JJ	O	indometh	amod	25	SENT_487	[p25l1851t1192r2154b1243],
24	—	NN	O	—	nn	25	SENT_487	[p25l1851t1192r2154b1243],
25	acin	NN	O	acin	prep_of	21	SENT_487	[p25l150t1284r271b1334],
26	in	IN	O	in	_	0	SENT_487	[p25l313t1284r360b1333],
27	healthy	JJ	O	healthy	amod	28	SENT_487	[p25l401t1284r622b1346],
28	subjects	NNS	O	subject	prep_in	25	SENT_487	[p25l657t1284r934b1346],
29	.	.	O	.	_	0	SENT_487	[p25l657t1284r934b1346],

1	EurJ	NN	O	eurj	nn	2	SENT_488	[p25l979t1284r1131b1334],
2	Clin	NN	O	clin	_	0	SENT_488	[p25l1171t1283r1281b1334],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_488	[p25l1323t1284r1641b1334],
4	1981	CD	DATE	1981	num	3	SENT_488	[p25l1685t1283r2154b1342, p25l150t1374r291b1426],
5	;	:	O	;	_	0	SENT_488	[p25l1685t1283r2154b1342, p25l150t1374r291b1426],
6	20:359369	CD	NUMBER	20:359369	dep	2	SENT_488	[p25l1685t1283r2154b1342, p25l150t1374r291b1426],
7	.	.	O	.	_	0	SENT_488	[p25l1685t1283r2154b1342, p25l150t1374r291b1426],

1	FDA	NNP	ORGANIZATION	FDA	_	0	SENT_489	[p25l152t1467r284b1517],
2	.	.	O	.	_	0	SENT_489	[p25l152t1467r284b1517],

1	New	NNP	O	New	nn	2	SENT_490	[p25l326t1467r453b1517],
2	Drug	NNP	O	Drug	_	0	SENT_490	[p25l491t1467r630b1531],
3	Application	NN	O	application	dep	2	SENT_490	[p25l662t1467r999b1529],
4	20-998	CD	NUMBER	20-998	num	3	SENT_490	[p25l1039t1466r1281b1517],
5	.	.	O	.	_	0	SENT_490	[p25l1039t1466r1281b1517],

1	Clinical	JJ	O	clinical	amod	2	SENT_491	[p25l1321t1466r1538b1517],
2	Pharmacology	NN	O	pharmacology	_	0	SENT_491	[p25l1578t1467r2008b1531],
3	and	CC	O	and	_	0	SENT_491	[p25l2042t1467r2150b1517],
4	Biopharmaceutics	NNP	ORGANIZATION	Biopharmaceutics	nn	6	SENT_491	[p25l152t1559r704b1620],
5	Review	NNP	O	Review	nn	6	SENT_491	[p25l745t1559r957b1609],
6	Celecoxib	NNP	O	Celecoxib	conj_and	2	SENT_491	[p25l993t1558r1305b1609],
7	.	.	O	.	_	0	SENT_491	[p25l993t1558r1305b1609],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_492	[p25l1349t1559r1657b1618],
2	,	,	O	,	_	0	SENT_492	[p25l1349t1559r1657b1618],
3	MD	NNP	O	MD	_	0	SENT_492	[p25l1700t1559r1817b1608],
4	:	:	O	:	_	0	SENT_492	[p25l1700t1559r1817b1608],
5	Food	NNP	O	Food	dep	3	SENT_492	[p25l1860t1559r2001b1609],
6	and	CC	O	and	_	0	SENT_492	[p25l2042t1559r2150b1609],
7	Drug	NNP	O	Drug	nn	8	SENT_492	[p25l152t1650r292b1714],
8	Administration	NNP	O	Administration	dep	3	SENT_492	[p25l316t1650r781b1709],
9	,	,	O	,	_	0	SENT_492	[p25l316t1650r781b1709],
10	1998:1	CD	NUMBER	1998:1	number	11	SENT_492	[p25l816t1649r1193b1700],
11	—	CD	NUMBER	—	num	12	SENT_492	[p25l816t1649r1193b1700],
12	60	CD	NUMBER	60	appos	3	SENT_492	[p25l816t1649r1193b1700],
13	.	.	O	.	_	0	SENT_492	[p25l816t1649r1193b1700],

1	Hogenesch	NNP	PERSON	Hogenesch	nn	2	SENT_493	[p25l152t1742r490b1805],
2	JB	NNP	O	JB	_	0	SENT_493	[p25l527t1742r615b1801],
3	,	,	O	,	_	0	SENT_493	[p25l527t1742r615b1801],
4	Panda	NNP	O	Panda	nn	5	SENT_493	[p25l656t1742r844b1792],
5	S	NNP	O	S	appos	2	SENT_493	[p25l881t1742r938b1801],
6	,	,	O	,	_	0	SENT_493	[p25l881t1742r938b1801],
7	Kay	NNP	PERSON	Kay	appos	2	SENT_493	[p25l981t1742r1089b1804],
8	8	CD	NUMBER	8	num	7	SENT_493	[p25l1122t1742r1179b1801],
9	,	,	O	,	_	0	SENT_493	[p25l1122t1742r1179b1801],
10	Takahashi	NNP	PERSON	Takahashi	nn	11	SENT_493	[p25l1217t1742r1531b1792],
11	JS	NNP	O	JS	appos	2	SENT_493	[p25l1568t1742r1656b1792],
12	.	.	O	.	_	0	SENT_493	[p25l1568t1742r1656b1792],

1	Circadian	JJ	O	circadian	amod	3	SENT_494	[p25l1696t1742r1979b1792],
2	transcriptional	JJ	O	transcriptional	amod	3	SENT_494	[p25l2015t1745r2154b1792, p25l150t1833r465b1894],
3	output	NN	O	output	_	0	SENT_494	[p25l503t1835r701b1894],
4	in	IN	O	in	_	0	SENT_494	[p25l736t1833r782b1882],
5	the	DT	O	the	det	6	SENT_494	[p25l816t1833r914b1883],
6	SCN	NN	O	scn	prep_in	3	SENT_494	[p25l949t1832r1077b1883],
7	and	CC	O	and	_	0	SENT_494	[p25l1115t1833r1223b1883],
8	liver	NN	O	liver	prep_in	3	SENT_494	[p25l1263t1833r1386b1883],
9	of	IN	O	of	_	0	SENT_494	[p25l1417t1832r1477b1883],
10	the	DT	O	the	det	11	SENT_494	[p25l1504t1833r1602b1883],
11	mouse	NN	O	mouse	prep_of	6	SENT_494	[p25l1639t1845r1862b1883],
12	.	.	O	.	_	0	SENT_494	[p25l1639t1845r1862b1883],

1	Novartis	NNP	ORGANIZATION	Novartis	nn	3	SENT_495	[p25l1903t1833r2151b1883],
2	Foundation	NNP	ORGANIZATION	Foundation	nn	3	SENT_495	[p25l152t1924r488b1974],
3	Symposium	NNP	O	Symposium	_	0	SENT_495	[p25l514t1924r869b1986],
4	2003	CD	DATE	2003	num	3	SENT_495	[p25l896t1924r1546b1983],
5	;	:	O	;	_	0	SENT_495	[p25l896t1924r1546b1983],
6	253:171	CD	NUMBER	253:171	number	7	SENT_495	[p25l896t1924r1546b1983],
7	-183	CD	NUMBER	-183	dep	3	SENT_495	[p25l896t1924r1546b1983],
8	;	:	O	;	_	0	SENT_495	[p25l896t1924r1546b1983],
9	discussion	NN	O	discussion	dep	7	SENT_495	[p25l1573t1924r1902b1974],
10	52-55	CD	NUMBER	52-55	num	9	SENT_495	[p25l1928t1924r2148b1983],
11	,	,	O	,	_	0	SENT_495	[p25l1928t1924r2148b1983],
12	102-109	CD	NUMBER	102-109	appos	9	SENT_495	[p25l152t2014r456b2065],
13	.	.	O	.	_	0	SENT_495	[p25l152t2014r456b2065],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_496	[p25l152t2107r359b2157],
2	JM	NN	PERSON	jm	_	0	SENT_496	[p25l390t2107r492b2166],
3	,	,	O	,	_	0	SENT_496	[p25l390t2107r492b2166],
4	Silverman	NNP	PERSON	Silverman	nn	5	SENT_496	[p25l526t2107r827b2157],
5	EK	NNP	PERSON	EK	appos	2	SENT_496	[p25l863t2107r958b2166],
6	,	,	O	,	_	0	SENT_496	[p25l863t2107r958b2166],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_496	[p25l995t2107r1099b2157],
8	TH	NN	O	th	appos	5	SENT_496	[p25l1128t2107r1227b2157],
9	.	.	O	.	_	0	SENT_496	[p25l1128t2107r1227b2157],

1	Heterogeneity	NN	O	heterogeneity	_	0	SENT_497	[p25l1264t2107r1691b2170],
2	of	IN	O	of	_	0	SENT_497	[p25l1718t2107r1778b2157],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_497	[p25l1801t2107r2152b2168],
4	responses	NNS	O	response	prep_of	1	SENT_497	[p25l151t2209r472b2259],
5	in	IN	O	in	_	0	SENT_497	[p25l504t2198r550b2247],
6	asthma	NN	O	asthma	prep_in	1	SENT_497	[p25l582t2198r829b2248],
7	.	.	O	.	_	0	SENT_497	[p25l582t2198r829b2248],

1	Br	NNP	O	Br	nn	3	SENT_498	[p25l865t2198r927b2247],
2	Med	NNP	O	Med	nn	3	SENT_498	[p25l955t2198r1082b2248],
3	Bull	NNP	O	Bull	_	0	SENT_498	[p25l1115t2198r1222b2248],
4	2000	CD	DATE	2000	num	3	SENT_498	[p25l1255t2197r1956b2256],
5	;	:	O	;	_	0	SENT_498	[p25l1255t2197r1956b2256],
6	56:1054	CD	DURATION	56:1054	number	7	SENT_498	[p25l1255t2197r1956b2256],
7	-1070	CD	DURATION	-1070	dep	3	SENT_498	[p25l1255t2197r1956b2256],
8	.	.	O	.	_	0	SENT_498	[p25l1255t2197r1956b2256],

1	Chladek	NNP	PERSON	Chladek	nn	2	SENT_499	[p25l149t2289r398b2340],
2	J	NNP	PERSON	J	_	0	SENT_499	[p25l444t2289r488b2348],
3	,	,	O	,	_	0	SENT_499	[p25l444t2289r488b2348],
4	Grim	NNP	O	Grim	nn	5	SENT_499	[p25l541t2289r680b2340],
5	J	NNP	O	J	appos	2	SENT_499	[p25l730t2289r773b2348],
6	,	,	O	,	_	0	SENT_499	[p25l730t2289r773b2348],
7	Martinkova	NNP	PERSON	Martinkova	nn	8	SENT_499	[p25l829t2289r1165b2340],
8	J	NNP	PERSON	J	appos	2	SENT_499	[p25l1213t2289r1256b2348],
9	,	,	O	,	_	0	SENT_499	[p25l1213t2289r1256b2348],
10	Simkova	NNP	O	Simkova	nn	11	SENT_499	[p25l1310t2289r1569b2340],
11	M	NNP	O	M	appos	2	SENT_499	[p25l1622t2289r1691b2348],
12	,	,	O	,	_	0	SENT_499	[p25l1622t2289r1691b2348],
13	Vaniekova	NNP	PERSON	Vaniekova	nn	14	SENT_499	[p25l1742t2289r2056b2340],
14	J	NNP	PERSON	J	appos	2	SENT_499	[p25l2104t2289r2148b2348],
15	,	,	O	,	_	0	SENT_499	[p25l2104t2289r2148b2348],
16	Koudelkova	NNP	O	Koudelkova	nn	17	SENT_499	[p25l152t2380r505b2430],
17	V	NNP	O	V	appos	2	SENT_499	[p25l534t2380r589b2439],
18	,	,	O	,	_	0	SENT_499	[p25l534t2380r589b2439],
19	Noiekova	NNP	O	Noiekova	nn	21	SENT_499	[p25l626t2380r905b2430],
20	M.	NNP	O	M.	nn	21	SENT_499	[p25l939t2380r1007b2429],
21	Pharmacokinetics	NNP	O	Pharmacokinetics	appos	2	SENT_499	[p25l1043t2380r1590b2430],
22	and	CC	O	and	_	0	SENT_499	[p25l1622t2380r1730b2430],
23	pharmacody	JJ	O	pharmacody	amod	25	SENT_499	[p25l1765t2380r2154b2442],
24	—	NN	O	—	nn	25	SENT_499	[p25l1765t2380r2154b2442],
25	namics	NNS	O	namic	appos	2	SENT_499	[p25l151t2471r368b2521],
26	of	IN	O	of	_	0	SENT_499	[p25l400t2471r460b2521],
27	low	JJ	O	low	amod	30	SENT_499	[p25l489t2471r753b2521],
28	—	NN	O	—	nn	30	SENT_499	[p25l489t2471r753b2521],
29	dose	NN	O	dose	nn	30	SENT_499	[p25l489t2471r753b2521],
30	methotrexate	NN	O	methotrexate	prep_of	25	SENT_499	[p25l786t2471r1193b2521],
31	in	IN	O	in	_	0	SENT_499	[p25l1227t2471r1274b2521],
32	the	DT	O	the	det	33	SENT_499	[p25l1304t2471r1401b2521],
33	treatment	NN	O	treatment	prep_in	30	SENT_499	[p25l1430t2474r1735b2521],
34	of	IN	O	of	_	0	SENT_499	[p25l1764t2471r1824b2521],
35	psoriasis	NN	O	psoriasis	prep_of	33	SENT_499	[p25l1853t2471r2148b2533],
36	.	.	O	.	_	0	SENT_499	[p25l1853t2471r2148b2533],

1	BrJ	NN	O	brj	nn	2	SENT_500	[p25l152t2562r261b2612],
2	Clin	NN	O	clin	_	0	SENT_500	[p25l293t2561r403b2612],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_500	[p25l436t2562r754b2612],
4	2002	CD	DATE	2002	num	3	SENT_500	[p25l788t2561r1394b2621],
5	;	:	O	;	_	0	SENT_500	[p25l788t2561r1394b2621],
6	54:147	CD	NUMBER	54:147	num	7	SENT_500	[p25l788t2561r1394b2621],
7	-156	CD	NUMBER	-156	dep	2	SENT_500	[p25l788t2561r1394b2621],
8	.	.	O	.	_	0	SENT_500	[p25l788t2561r1394b2621],

1	Stahle	NNP	ORGANIZATION	Stahle	nn	2	SENT_501	[p25l150t2653r345b2703],
2	L	NNP	ORGANIZATION	L	_	0	SENT_501	[p25l397t2653r443b2712],
3	,	,	O	,	_	0	SENT_501	[p25l397t2653r443b2712],
4	Moberg	NNP	ORGANIZATION	Moberg	nn	5	SENT_501	[p25l499t2653r728b2716],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_501	[p25l778t2653r823b2712],
6	,	,	O	,	_	0	SENT_501	[p25l778t2653r823b2712],
7	Svensson	NNP	PERSON	Svensson	nn	8	SENT_501	[p25l877t2653r1175b2703],
8	Jo	NNP	PERSON	Jo	appos	2	SENT_501	[p25l1225t2653r1315b2712],
9	,	,	O	,	_	0	SENT_501	[p25l1225t2653r1315b2712],
10	Sonnerborg	NNP	PERSON	Sonnerborg	nn	14	SENT_501	[p25l1368t2653r1724b2716],
11	A.	NNP	PERSON	A.	nn	14	SENT_501	[p25l1769t2653r1824b2703],
12	Efavirenz	NNP	PERSON	Efavirenz	nn	14	SENT_501	[p25l1881t2653r2153b2703],
13	plasma	NN	O	plasma	nn	14	SENT_501	[p25l152t2744r373b2805],
14	concentrations	NNS	O	concentration	appos	2	SENT_501	[p25l404t2744r862b2794],
15	in	IN	O	in	_	0	SENT_501	[p25l896t2744r942b2793],
16	HlV	NN	O	hlv	prep_in	14	SENT_501	[p25l978t2743r1341b2794],
17	—	CD	NUMBER	—	num	19	SENT_501	[p25l978t2743r1341b2794],
18	infected	JJ	O	infected	amod	19	SENT_501	[p25l978t2743r1341b2794],
19	patients	NNS	O	patient	dep	14	SENT_501	[p25l1376t2744r1642b2805],
20	:	:	O	:	_	0	SENT_501	[p25l1376t2744r1642b2805],
21	inter	NN	O	inter	nn	22	SENT_501	[p25l1679t2744r1830b2794],
22	—	NN	O	—	dep	2	SENT_501	[p25l1679t2744r1830b2794],
23	and	CC	O	and	_	0	SENT_501	[p25l1860t2744r1968b2794],
24	intraindividual	JJ	O	intraindividual	amod	25	SENT_501	[p25l2003t2744r2154b2794, p25l152t2835r435b2885],
25	variability	NN	O	variability	conj_and	22	SENT_501	[p25l466t2835r759b2897],
26	and	CC	O	and	_	0	SENT_501	[p25l787t2835r895b2885],
27	clinical	JJ	O	clinical	amod	28	SENT_501	[p25l927t2835r1135b2885],
28	effects	NNS	O	effect	conj_and	22	SENT_501	[p25l1168t2835r1396b2885],
29	.	.	O	.	_	0	SENT_501	[p25l1168t2835r1396b2885],

1	Ther	NNP	O	Ther	nn	3	SENT_502	[p25l1428t2835r1564b2885],
2	Drug	NNP	O	Drug	nn	3	SENT_502	[p25l1595t2835r1734b2898],
3	Monit	NNP	O	Monit	_	0	SENT_502	[p25l1765t2835r1935b2885],
4	2004	CD	DATE	2004	num	3	SENT_502	[p25l1965t2835r2148b2894],
5	;	:	O	;	_	0	SENT_502	[p25l1965t2835r2148b2894],
6	26:267	CD	NUMBER	26:267	number	7	SENT_502	[p25l150t2925r563b2977],
7	-270	CD	NUMBER	-270	dep	3	SENT_502	[p25l150t2925r563b2977],
8	.	.	O	.	_	0	SENT_502	[p25l150t2925r563b2977],

1	Ulrich	NNP	PERSON	Ulrich	nn	2	SENT_503	[p25l152t3017r318b3067],
2	CM	NN	PERSON	cm	nsubj	13	SENT_503	[p25l352t3017r468b3076],
3	,	,	O	,	_	0	SENT_503	[p25l352t3017r468b3076],
4	Bigler	NNP	PERSON	Bigler	nn	5	SENT_503	[p25l505t3017r676b3080],
5	J	NNP	PERSON	J	appos	2	SENT_503	[p25l703t3017r746b3076],
6	,	,	O	,	_	0	SENT_503	[p25l703t3017r746b3076],
7	Sibert	NNP	PERSON	Sibert	nn	8	SENT_503	[p25l781t3017r963b3067],
8	J	NNP	PERSON	J	appos	2	SENT_503	[p25l990t3017r1033b3076],
9	,	,	O	,	_	0	SENT_503	[p25l990t3017r1033b3076],
10	Greene	NNP	PERSON	Greene	nn	11	SENT_503	[p25l1068t3017r1287b3067],
11	EA	NN	PERSON	ea	appos	2	SENT_503	[p25l1322t3017r1412b3076],
12	,	,	O	,	_	0	SENT_503	[p25l1322t3017r1412b3076],
13	Sparks	VBZ	PERSON	spark	_	0	SENT_503	[p25l1447t3017r1659b3079],
14	R	NN	PERSON	r	dobj	13	SENT_503	[p25l1693t3017r1748b3076],
15	,	,	O	,	_	0	SENT_503	[p25l1693t3017r1748b3076],
16	Carlson	NNP	PERSON	Carlson	nn	17	SENT_503	[p25l1783t3017r2013b3067],
17	CS	NNP	O	CS	appos	14	SENT_503	[p25l2046t3017r2148b3076],
18	,	,	O	,	_	0	SENT_503	[p25l2046t3017r2148b3076],
19	Potter	NNP	PERSON	Potter	nn	20	SENT_503	[p25l151t3109r333b3160],
20	JD	NNP	O	JD	appos	17	SENT_503	[p25l357t3109r448b3160],
21	.	.	O	.	_	0	SENT_503	[p25l357t3109r448b3160],

1	Cyclooxygenase	NNP	O	Cyclooxygenase	_	0	SENT_504	[p25l480t3108r967b3173],
2	1	CD	NUMBER	1	num	3	SENT_504	[p25l998t3109r1034b3159],
3	polymorphisms	NNS	O	polymorphism	dep	1	SENT_504	[p25l1065t3109r1530b3172],
4	in	IN	O	in	_	0	SENT_504	[p25l1561t3109r1607b3159],
5	African-American	JJ	MISC	african-american	amod	8	SENT_504	[p25l1636t3108r2150b3160],
6	and	CC	O	and	_	0	SENT_504	[p25l150t3200r258b3250],
7	Caucasian	JJ	LOCATION	caucasian	conj_and	5	SENT_504	[p25l289t3200r609b3250],
8	populations	NNS	O	population	prep_in	3	SENT_504	[p25l642t3200r1018b3262],
9	.	.	O	.	_	0	SENT_504	[p25l642t3200r1018b3262],

1	Hum	NNP	O	Hum	nn	2	SENT_505	[p25l1054t3200r1189b3250],
2	Mutat	NNP	O	Mutat	_	0	SENT_505	[p25l1222t3200r1398b3250],
3	2002	CD	DATE	2002	num	2	SENT_505	[p25l1426t3200r2050b3259],
4	;	:	O	;	_	0	SENT_505	[p25l1426t3200r2050b3259],
5	20:409	CD	NUMBER	20:409	number	6	SENT_505	[p25l1426t3200r2050b3259],
6	-410	CD	NUMBER	-410	dep	2	SENT_505	[p25l1426t3200r2050b3259],
7	.	.	O	.	_	0	SENT_505	[p25l1426t3200r2050b3259],

1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_506	[p25l990t3304r1661b3353],
2	Vol	NN	O	vol	dep	1	SENT_506	[p25l1685t3304r1792b3353],
3	.	.	O	.	_	0	SENT_506	[p25l1685t3304r1792b3353],

1	130	CD	NUMBER	130	_	0	SENT_507	[p25l1824t3303r1959b3363],
2	,	,	O	,	_	0	SENT_507	[p25l1824t3303r1959b3363],
3	No.	NN	O	no.	appos	1	SENT_507	[p25l1991t3304r2084b3353],
4	1	CD	NUMBER	1	num	3	SENT_507	[p25l2117t3303r2154b3353],

1	Papafili	NNP	MISC	Papafili	nn	2	SENT_508	[p25l154t3524r371b3586],
2	A	NNP	MISC	A	_	0	SENT_508	[p25l393t3525r448b3584],
3	,	,	O	,	_	0	SENT_508	[p25l393t3525r448b3584],
4	Hill	NNP	PERSON	Hill	nn	5	SENT_508	[p25l476t3525r564b3574],
5	MR	NN	PERSON	mr	appos	2	SENT_508	[p25l592t3525r705b3584],
6	,	,	O	,	_	0	SENT_508	[p25l592t3525r705b3584],
7	Brull	NNP	PERSON	Brull	nn	8	SENT_508	[p25l733t3525r863b3575],
8	DJ	NNP	O	DJ	appos	5	SENT_508	[p25l890t3525r976b3584],
9	,	,	O	,	_	0	SENT_508	[p25l890t3525r976b3584],
10	McAnu	NNP	O	McAnu	nn	13	SENT_508	[p25l1004t3525r1280b3587],
11	|	NNP	O	|	nn	13	SENT_508	[p25l1004t3525r1280b3587],
12	ty	NNP	O	ty	nn	13	SENT_508	[p25l1004t3525r1280b3587],
13	RJ	NN	O	rj	appos	5	SENT_508	[p25l1302t3525r1385b3584],
14	,	,	O	,	_	0	SENT_508	[p25l1302t3525r1385b3584],
15	Marshall	NNP	ORGANIZATION	Marshall	nn	16	SENT_508	[p25l1413t3525r1671b3575],
16	RP	NNP	ORGANIZATION	RP	appos	5	SENT_508	[p25l1699t3525r1793b3584],
17	,	,	O	,	_	0	SENT_508	[p25l1699t3525r1793b3584],
18	Humphries	NNP	PERSON	Humphries	nn	19	SENT_508	[p25l1822t3525r2151b3586],
19	SE	NN	O	se	appos	5	SENT_508	[p25l153t3612r250b3671],
20	,	,	O	,	_	0	SENT_508	[p25l153t3612r250b3671],
21	Laurent	NNP	O	Laurent	nn	22	SENT_508	[p25l289t3612r520b3662],
22	GJ	NNP	O	GJ	appos	5	SENT_508	[p25l551t3612r640b3662],
23	.	.	O	.	_	0	SENT_508	[p25l551t3612r640b3662],

1	Common	JJ	O	common	amod	3	SENT_509	[p25l677t3612r947b3662],
2	promoter	NN	O	promoter	nn	3	SENT_509	[p25l985t3615r1262b3674],
3	variant	NN	O	variant	nsubj	8	SENT_509	[p25l1291t3612r1500b3662],
4	in	IN	O	in	_	0	SENT_509	[p25l1534t3612r1580b3662],
5	cyclooxygenase	NN	O	cyclooxygenase	nn	6	SENT_509	[p25l1615t3612r2151b3675],
6	—	NN	O	—	prep_in	3	SENT_509	[p25l1615t3612r2151b3675],
7	2	CD	NUMBER	2	num	6	SENT_509	[p25l1615t3612r2151b3675],
8	represses	VBZ	O	repress	_	0	SENT_509	[p25l154t3712r459b3762],
9	gene	NN	O	gene	nn	10	SENT_509	[p25l490t3707r638b3764],
10	expression	NN	O	expression	dobj	8	SENT_509	[p25l670t3701r1023b3762],
11	:	:	O	:	_	0	SENT_509	[p25l670t3701r1023b3762],
12	evidence	NN	O	evidence	dep	10	SENT_509	[p25l1058t3701r1329b3751],
13	of	IN	O	of	_	0	SENT_509	[p25l1362t3700r1422b3751],
14	role	NN	O	role	prep_of	12	SENT_509	[p25l1452t3701r1561b3751],
15	in	IN	O	in	_	0	SENT_509	[p25l1597t3701r1643b3750],
16	acute	JJ	O	acute	amod	18	SENT_509	[p25l1678t3701r2052b3762],
17	—	JJ	O	—	amod	18	SENT_509	[p25l1678t3701r2052b3762],
18	phase	NN	O	phase	prep_in	8	SENT_509	[p25l1678t3701r2052b3762],
19	inflammatory	JJ	O	inflammatory	amod	18	SENT_509	[p25l2088t3701r2154b3750, p26l150t19r495b82],

1	response	NN	O	response	_	0	SENT_510	[p26l532t32r833b81],
2	.	.	O	.	_	0	SENT_510	[p26l532t32r833b81],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_511	[p26l871t20r1225b70],
2	Thromb	NNP	O	Thromb	nn	4	SENT_511	[p26l1257t20r1487b70],
3	Vasc	NNP	O	Vasc	nn	4	SENT_511	[p26l1522t20r1670b70],
4	Biol	NNP	O	Biol	_	0	SENT_511	[p26l1709t20r1816b70],
5	2002	CD	DATE	2002	num	4	SENT_511	[p26l1857t19r2148b79],
6	;	:	O	;	_	0	SENT_511	[p26l1857t19r2148b79],
7	22	CD	NUMBER	22	num	9	SENT_511	[p26l1857t19r2148b79],
8	:	:	O	:	_	0	SENT_511	[p26l1857t19r2148b79],
9	1631-1636	CD	DATE	1631-1636	dep	4	SENT_511	[p26l155t106r544b156],
10	.	.	O	.	_	0	SENT_511	[p26l155t106r544b156],

1	45	CD	NUMBER	45	_	0	SENT_512	[p26l9t195r108b245],
2	.	.	O	.	_	0	SENT_512	[p26l9t195r108b245],

1	Halushka	NNP	PERSON	Halushka	nn	2	SENT_513	[p26l155t195r439b245],
2	MK	NNP	O	MK	_	0	SENT_513	[p26l474t195r588b253],
3	,	,	O	,	_	0	SENT_513	[p26l474t195r588b253],
4	Walker	NNP	ORGANIZATION	Walker	nn	5	SENT_513	[p26l621t195r833b245],
5	LP	NN	ORGANIZATION	lp	appos	2	SENT_513	[p26l866t195r951b253],
6	,	,	O	,	_	0	SENT_513	[p26l866t195r951b253],
7	Halushka	NNP	PERSON	Halushka	nn	8	SENT_513	[p26l990t195r1273b245],
8	PV	NNP	O	PV	appos	5	SENT_513	[p26l1308t195r1399b244],
9	.	.	O	.	_	0	SENT_513	[p26l1308t195r1399b244],

1	Genetic	JJ	O	genetic	amod	2	SENT_514	[p26l1436t194r1668b245],
2	variation	NN	O	variation	_	0	SENT_514	[p26l1698t195r1959b245],
3	in	IN	O	in	_	0	SENT_514	[p26l1996t195r2042b244],
4	cyclooxygenase	NN	O	cyclooxygenase	prep_in	2	SENT_514	[p26l2076t207r2154b257, p26l152t283r564b346],
5	1	CD	NUMBER	1	num	4	SENT_514	[p26l598t283r651b332],
6	:	:	O	:	_	0	SENT_514	[p26l598t283r651b332],
7	effects	NNS	O	effect	dep	2	SENT_514	[p26l684t282r894b333],
8	on	IN	O	on	_	0	SENT_514	[p26l925t295r995b333],
9	response	NN	O	response	prep_on	7	SENT_514	[p26l1029t295r1312b344],
10	to	TO	O	to	_	0	SENT_514	[p26l1340t286r1399b333],
11	aspirin	NN	O	aspirin	prep_to	9	SENT_514	[p26l1430t283r1653b344],
12	.	.	O	.	_	0	SENT_514	[p26l1430t283r1653b344],

1	Clin	NNP	O	Clin	nn	3	SENT_515	[p26l1687t282r1797b333],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_515	[p26l1831t283r2149b333],
3	Ther	NNP	O	Ther	_	0	SENT_515	[p26l150t370r286b421],
4	2003	CD	DATE	2003	num	3	SENT_515	[p26l313t370r919b429],
5	;	:	O	;	_	0	SENT_515	[p26l313t370r919b429],
6	73:122	CD	NUMBER	73:122	number	7	SENT_515	[p26l313t370r919b429],
7	-130	CD	NUMBER	-130	dep	3	SENT_515	[p26l313t370r919b429],
8	.	.	O	.	_	0	SENT_515	[p26l313t370r919b429],

1	46	CD	NUMBER	46	_	0	SENT_516	[p26l9t458r108b509],
2	.	.	O	.	_	0	SENT_516	[p26l9t458r108b509],

1	Tang	NNP	PERSON	Tang	nn	2	SENT_517	[p26l150t459r299b522],
2	C	NNP	PERSON	C	_	0	SENT_517	[p26l322t458r380b517],
3	,	,	O	,	_	0	SENT_517	[p26l322t458r380b517],
4	Shou	NNP	O	Shou	nn	5	SENT_517	[p26l409t458r562b509],
5	M	NNP	O	M	appos	2	SENT_517	[p26l593t459r662b517],
6	,	,	O	,	_	0	SENT_517	[p26l593t459r662b517],
7	Mei	NNP	O	Mei	nn	8	SENT_517	[p26l694t459r798b509],
8	Q	NNP	O	Q	appos	2	SENT_517	[p26l827t458r887b520],
9	,	,	O	,	_	0	SENT_517	[p26l827t458r887b520],
10	Rushmore	NNP	ORGANIZATION	Rushmore	nn	11	SENT_517	[p26l919t459r1229b509],
11	TH	NN	ORGANIZATION	th	appos	2	SENT_517	[p26l1253t459r1351b517],
12	,	,	O	,	_	0	SENT_517	[p26l1253t459r1351b517],
13	Rodrigues	NNP	PERSON	Rodrigues	nn	14	SENT_517	[p26l1383t459r1687b522],
14	AD	NN	O	ad	appos	2	SENT_517	[p26l1712t459r1814b508],
15	.	.	O	.	_	0	SENT_517	[p26l1712t459r1814b508],

1	Major	JJ	O	major	amod	2	SENT_518	[p26l1846t459r2016b521],
2	role	NN	O	role	_	0	SENT_518	[p26l2041t459r2151b509],
3	of	IN	O	of	_	0	SENT_518	[p26l152t546r212b597],
4	human	JJ	O	human	amod	5	SENT_518	[p26l243t547r447b597],
5	liver	NN	O	liver	prep_of	2	SENT_518	[p26l486t547r608b597],
6	microsomal	JJ	O	microsomal	amod	12	SENT_518	[p26l641t547r994b597],
7	cytochrome	NN	O	cytochrome	nn	12	SENT_518	[p26l1030t547r1383b609],
8	P450	NN	O	p450	nn	12	SENT_518	[p26l1419t546r1581b597],
9	2C9	NN	O	2c9	nn	12	SENT_518	[p26l1616t546r1740b597],
10	(	CD	NUMBER	(	num	12	SENT_518	[p26l1775t546r2066b609],
11	CYP2C9	NN	O	cyp2c9	nn	12	SENT_518	[p26l1775t546r2066b609],
12	)	NN	O	)	dep	2	SENT_518	[p26l1775t546r2066b609],
13	in	IN	O	in	_	0	SENT_518	[p26l2103t547r2150b596],
14	the	DT	O	the	det	16	SENT_518	[p26l150t634r247b684],
15	oxidative	JJ	O	oxidative	amod	16	SENT_518	[p26l274t634r544b684],
16	metabolism	NN	O	metabolism	prep_in	12	SENT_518	[p26l573t634r930b684],
17	of	IN	O	of	_	0	SENT_518	[p26l960t634r1019b684],
18	celecoxib	NN	O	celecoxib	prep_of	16	SENT_518	[p26l1041t634r1344b693],
19	,	,	O	,	_	0	SENT_518	[p26l1041t634r1344b693],
20	a	DT	O	a	det	27	SENT_518	[p26l1376t646r1408b684],
21	novel	JJ	O	novel	amod	27	SENT_518	[p26l1437t634r1592b684],
22	cyc	NN	O	cyc	nn	27	SENT_518	[p26l1621t634r2149b697],
23	|	NN	O	|	nn	27	SENT_518	[p26l1621t634r2149b697],
24	ooxygenase	NN	O	ooxygenase	nn	27	SENT_518	[p26l1621t634r2149b697],
25	—	CD	NUMBER	—	num	27	SENT_518	[p26l1621t634r2149b697],
26	ll	NN	O	ll	nn	27	SENT_518	[p26l1621t634r2149b697],
27	inhibitor	NN	O	inhibitor	appos	18	SENT_518	[p26l155t723r417b773],
28	.	.	O	.	_	0	SENT_518	[p26l155t723r417b773],

1	J	NNP	O	J	nn	4	SENT_519	[p26l448t723r470b773],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_519	[p26l504t723r822b773],
3	Exp	NNP	O	Exp	nn	4	SENT_519	[p26l856t723r959b784],
4	Ther	NNP	O	Ther	_	0	SENT_519	[p26l985t723r1121b773],
5	2000	CD	DATE	2000	num	4	SENT_519	[p26l1148t722r1805b781],
6	;	:	O	;	_	0	SENT_519	[p26l1148t722r1805b781],
7	293:453	CD	NUMBER	293:453	number	8	SENT_519	[p26l1148t722r1805b781],
8	-459	CD	NUMBER	-459	dep	4	SENT_519	[p26l1148t722r1805b781],
9	.	.	O	.	_	0	SENT_519	[p26l1148t722r1805b781],

1	47	CD	NUMBER	47	_	0	SENT_520	[p26l9t811r108b860],
2	.	.	O	.	_	0	SENT_520	[p26l9t811r108b860],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_521	[p26l155t811r260b861],
2	CR	NN	O	cr	_	0	SENT_521	[p26l286t810r387b870],
3	,	,	O	,	_	0	SENT_521	[p26l286t810r387b870],
4	Goldstein	NNP	PERSON	Goldstein	nn	5	SENT_521	[p26l416t810r705b861],
5	JA	NNP	O	JA	appos	2	SENT_521	[p26l730t811r814b870],
6	,	,	O	,	_	0	SENT_521	[p26l730t811r814b870],
7	Pieper	NNP	PERSON	Pieper	nn	8	SENT_521	[p26l844t811r1037b872],
8	JA	NNP	O	JA	appos	5	SENT_521	[p26l1057t811r1140b861],
9	.	.	O	.	_	0	SENT_521	[p26l1057t811r1140b861],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_522	[p26l1169t810r1531b873],
2	P450	NN	O	p450	nn	4	SENT_522	[p26l1558t810r1721b861],
3	2C9	NN	O	2c9	nn	4	SENT_522	[p26l1747t810r1871b861],
4	polymorphisms	NNS	O	polymorphism	_	0	SENT_522	[p26l1899t811r2154b873, p26l155t898r393b960],
5	:	:	O	:	_	0	SENT_522	[p26l1899t811r2154b873, p26l155t898r393b960],
6	a	DT	O	a	det	8	SENT_522	[p26l423t910r456b948],
7	comprehensive	JJ	O	comprehensive	amod	8	SENT_522	[p26l481t898r949b960],
8	review	NN	O	review	dep	4	SENT_522	[p26l977t898r1168b948],
9	of	IN	O	of	_	0	SENT_522	[p26l1192t898r1252b948],
10	the	DT	O	the	det	15	SENT_522	[p26l1270t898r1368b948],
11	in	FW	O	in	nn	12	SENT_522	[p26l1397t898r1443b948],
12	vitro	FW	O	vitro	dep	15	SENT_522	[p26l1469t898r1599b948],
13	and	CC	O	and	_	0	SENT_522	[p26l1626t898r1734b948],
14	human	JJ	O	human	conj_and	12	SENT_522	[p26l1764t898r1968b948],
15	data	NNS	O	datum	prep_of	8	SENT_522	[p26l1996t898r2148b948],
16	.	.	O	.	_	0	SENT_522	[p26l1996t898r2148b948],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_523	[p26l154t987r721b1050],
2	2002	CD	DATE	2002	num	1	SENT_523	[p26l751t986r1357b1045],
3	;	:	O	;	_	0	SENT_523	[p26l751t986r1357b1045],
4	12:251	CD	NUMBER	12:251	number	5	SENT_523	[p26l751t986r1357b1045],
5	-263	CD	NUMBER	-263	dep	1	SENT_523	[p26l751t986r1357b1045],
6	.	.	O	.	_	0	SENT_523	[p26l751t986r1357b1045],

1	48	CD	NUMBER	48	_	0	SENT_524	[p26l9t1074r108b1125],
2	.	.	O	.	_	0	SENT_524	[p26l9t1074r108b1125],

1	Scordo	NNP	O	Scordo	nn	2	SENT_525	[p26l153t1074r365b1125],
2	MG	NN	O	mg	_	0	SENT_525	[p26l401t1074r517b1134],
3	,	,	O	,	_	0	SENT_525	[p26l401t1074r517b1134],
4	Pengo	NNP	ORGANIZATION	Pengo	nn	5	SENT_525	[p26l556t1075r741b1138],
5	V	NNP	O	V	appos	2	SENT_525	[p26l773t1075r828b1134],
6	,	,	O	,	_	0	SENT_525	[p26l773t1075r828b1134],
7	Spina	NNP	ORGANIZATION	Spina	nn	8	SENT_525	[p26l866t1074r1038b1136],
8	E	NNP	ORGANIZATION	E	appos	2	SENT_525	[p26l1074t1075r1125b1134],
9	,	,	O	,	_	0	SENT_525	[p26l1074t1075r1125b1134],
10	Dahl	NNP	PERSON	Dahl	nn	11	SENT_525	[p26l1165t1075r1295b1125],
11	ML	NNP	O	ML	appos	2	SENT_525	[p26l1335t1075r1439b1134],
12	,	,	O	,	_	0	SENT_525	[p26l1335t1075r1439b1134],
13	Gusella	NNP	PERSON	Gusella	nn	14	SENT_525	[p26l1477t1074r1706b1125],
14	M	NNP	PERSON	M	appos	2	SENT_525	[p26l1743t1075r1812b1134],
15	,	,	O	,	_	0	SENT_525	[p26l1743t1075r1812b1134],
16	Padrini	NNP	PERSON	Padrini	nn	18	SENT_525	[p26l1850t1075r2054b1125],
17	R.	NNP	PERSON	R.	nn	18	SENT_525	[p26l2094t1075r2148b1124],
18	Influence	NN	PERSON	influence	appos	2	SENT_525	[p26l155t1162r429b1212],
19	of	IN	O	of	_	0	SENT_525	[p26l465t1162r525b1212],
20	CYP2C9	NN	O	cyp2c9	prep_of	18	SENT_525	[p26l557t1162r806b1212],
21	and	CC	O	and	_	0	SENT_525	[p26l844t1162r952b1212],
22	CYP2C19	NN	O	cyp2c19	prep_of	18	SENT_525	[p26l990t1162r1282b1212],
23	genetic	JJ	O	genetic	amod	24	SENT_525	[p26l1316t1162r1540b1225],
24	polymorphisms	NNS	O	polymorphism	dep	2	SENT_525	[p26l1578t1162r2043b1225],
25	on	IN	O	on	_	0	SENT_525	[p26l2079t1174r2150b1212],
26	warfarin	NN	O	warfarin	nn	28	SENT_525	[p26l150t1250r393b1301],
27	maintenance	NN	O	maintenance	nn	28	SENT_525	[p26l428t1251r824b1301],
28	dose	NN	O	dose	prep_on	24	SENT_525	[p26l855t1251r1003b1301],
29	and	CC	O	and	_	0	SENT_525	[p26l1036t1251r1144b1301],
30	metabolic	JJ	O	metabolic	amod	31	SENT_525	[p26l1179t1251r1477b1301],
31	clearance	NN	O	clearance	prep_on	24	SENT_525	[p26l1507t1251r1823b1301],
32	.	.	O	.	_	0	SENT_525	[p26l1507t1251r1823b1301],

1	Clin	NNP	O	Clin	nn	3	SENT_526	[p26l1858t1250r1967b1301],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_526	[p26l2002t1251r2154b1301, p26l154t1340r332b1390],
3	Ther	NNP	O	Ther	_	0	SENT_526	[p26l361t1340r498b1390],
4	2002	CD	DATE	2002	num	3	SENT_526	[p26l524t1339r1130b1399],
5	;	:	O	;	_	0	SENT_526	[p26l524t1339r1130b1399],
6	72:702	CD	NUMBER	72:702	number	7	SENT_526	[p26l524t1339r1130b1399],
7	-710	CD	NUMBER	-710	dep	3	SENT_526	[p26l524t1339r1130b1399],
8	.	.	O	.	_	0	SENT_526	[p26l524t1339r1130b1399],

1	Received	VBN	O	receive	_	0	SENT_527	[p26l83t1603r353b1652],
2	August	NNP	DATE	August	tmod	1	SENT_527	[p26l382t1603r593b1664],
3	22	CD	DATE	22	num	2	SENT_527	[p26l621t1602r715b1661],
4	,	,	DATE	,	_	0	SENT_527	[p26l621t1602r715b1661],
5	2005	CD	DATE	2005	num	2	SENT_527	[p26l746t1602r924b1652],
6	.	.	O	.	_	0	SENT_527	[p26l746t1602r924b1652],

1	Accepted	JJ	O	accepted	_	0	SENT_528	[p26l952t1603r1232b1663],
2	September	NNP	DATE	September	tmod	1	SENT_528	[p26l1261t1602r1600b1663],
3	28	CD	DATE	28	num	2	SENT_528	[p26l1627t1602r1721b1661],
4	,	,	DATE	,	_	0	SENT_528	[p26l1627t1602r1721b1661],
5	2005	CD	DATE	2005	num	2	SENT_528	[p26l1751t1602r1930b1652],
6	.	.	O	.	_	0	SENT_528	[p26l1751t1602r1930b1652],

1	Address	NN	O	address	nn	2	SENT_529	[p26l78t1691r314b1740],
2	requests	NNS	O	request	nsubj	4	SENT_529	[p26l341t1694r589b1751],
3	for	IN	O	for	prep	2	SENT_529	[p26l611t1691r692b1740],
4	reprints	VBZ	O	reprint	_	0	SENT_529	[p26l717t1691r936b1751],
5	to	TO	O	to	_	0	SENT_529	[p26l959t1694r1029b1740],
6	:	:	O	:	_	0	SENT_529	[p26l959t1694r1029b1740],
7	Garret	NNP	PERSON	Garret	nn	11	SENT_529	[p26l1056t1691r1238b1740],
8	A.	NNP	PERSON	A.	nn	11	SENT_529	[p26l1260t1691r1315b1739],
9	FitzGera	NNP	PERSON	FitzGera	nn	11	SENT_529	[p26l1344t1691r1647b1750],
10	|	NN	O	|	nn	11	SENT_529	[p26l1344t1691r1647b1750],
11	d	NN	O	d	prep_to	4	SENT_529	[p26l1344t1691r1647b1750],
12	,	,	O	,	_	0	SENT_529	[p26l1344t1691r1647b1750],
13	MD	NN	O	md	appos	11	SENT_529	[p26l1676t1691r1787b1750],
14	,	,	O	,	_	0	SENT_529	[p26l1676t1691r1787b1750],
15	Institute	NNP	ORGANIZATION	Institute	appos	11	SENT_529	[p26l1816t1691r2050b1740],
16	for	IN	ORGANIZATION	for	_	0	SENT_529	[p26l2073t1691r2154b1740],
17	Translational	JJ	ORGANIZATION	translational	amod	18	SENT_529	[p26l6t1779r383b1828],
18	Medicine	NN	ORGANIZATION	medicine	prep_for	15	SENT_529	[p26l435t1779r696b1828],
19	and	CC	ORGANIZATION	and	_	0	SENT_529	[p26l744t1780r850b1828],
20	Therapeutics	NNS	ORGANIZATION	therapeutics	prep_for	15	SENT_529	[p26l897t1780r1289b1840],
21	,	,	O	,	_	0	SENT_529	[p26l897t1780r1289b1840],
22	University	NNP	ORGANIZATION	University	appos	11	SENT_529	[p26l1340t1780r1620b1840],
23	of	IN	ORGANIZATION	of	_	0	SENT_529	[p26l1665t1779r1721b1828],
24	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	25	SENT_529	[p26l1770t1779r2151b1840],
25	School	NNP	ORGANIZATION	School	prep_of	22	SENT_529	[p26l7t1866r201b1916],
26	of	IN	ORGANIZATION	of	_	0	SENT_529	[p26l234t1866r290b1916],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	25	SENT_529	[p26l321t1867r597b1925],
28	,	,	O	,	_	0	SENT_529	[p26l321t1867r597b1925],
29	153	CD	NUMBER	153	num	30	SENT_529	[p26l631t1866r746b1916],
30	Johnson-Pavilion	NNP	O	Johnson-Pavilion	appos	27	SENT_529	[p26l775t1867r1277b1925],
31	,	,	O	,	_	0	SENT_529	[p26l775t1867r1277b1925],
32	3620	CD	NUMBER	3620	appos	11	SENT_529	[p26l1309t1866r1467b1916],
33	Hamilton	NNP	LOCATION	Hamilton	nsubj	34	SENT_529	[p26l1500t1867r1763b1916],
34	Walk	VB	LOCATION	walk	rcmod	32	SENT_529	[p26l1793t1867r1959b1925],
35	,	,	O	,	_	0	SENT_529	[p26l1793t1867r1959b1925],
36	Philadelphia	NNP	LOCATION	Philadelphia	appos	11	SENT_529	[p26l1993t1867r2154b1916, p26l9t1955r237b2015],
37	,	,	O	,	_	0	SENT_529	[p26l1993t1867r2154b1916, p26l9t1955r237b2015],
38	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	36	SENT_529	[p26l265t1955r646b2016],
39	19104-6084	CD	NUMBER	19104-6084	num	38	SENT_529	[p26l671t1954r1060b2004],
40	.	.	O	.	_	0	SENT_529	[p26l671t1954r1060b2004],

1	e-mail	VB	O	e-mail	dep	4	SENT_530	[p26l1085t1955r1278b2004],
2	:	:	O	:	_	0	SENT_530	[p26l1085t1955r1278b2004],
3	garret@spirit.gcrc.upenn.edu;	NN	O	garret@spirit.gcrc.upenn.edu;	nn	4	SENT_530	[p26l1302t1955r2150b2016],
4	fax	NN	O	fax	_	0	SENT_530	[p26l7t2043r109b2092],
5	:	:	O	:	_	0	SENT_530	[p26l7t2043r109b2092],
6	(215) 573-9135	CD	NUMBER	(215) 573-9135	dep	4	SENT_530	[p26l321t2043r631b2092],[p26l137t2043r295b2104],
7	.	.	O	.	_	0	SENT_530	[p26l321t2043r631b2092],

1	Supported	VBN	O	support	_	0	SENT_531	[p26l78t2130r391b2191],
2	by	IN	O	by	_	0	SENT_531	[p26l416t2131r481b2192],
3	The	DT	O	the	det	6	SENT_531	[p26l497t2131r606b2180],
4	National	NNP	O	National	nn	6	SENT_531	[p26l629t2131r879b2180],
5	Heart	NNP	O	Heart	nn	6	SENT_531	[p26l904t2131r1067b2180],
6	Lung	NN	O	lung	prep_by	1	SENT_531	[p26l1089t2131r1234b2192],
7	and	CC	O	and	_	0	SENT_531	[p26l1252t2131r1362b2180],
8	Blood	NN	ORGANIZATION	blood	prep_by	1	SENT_531	[p26l1387t2131r1553b2180],
9	Institute	NNP	ORGANIZATION	Institute	nn	11	SENT_531	[p26l1578t2131r1824b2180],
10	(	CD	NUMBER	(	num	11	SENT_531	[p26l1845t2130r2152b2191],
11	HL62250	NN	O	hl62250	dobj	1	SENT_531	[p26l1845t2130r2152b2191],
12	and	CC	O	and	_	0	SENT_531	[p26l9t2219r118b2268],
13	HL54500	CD	NUMBER	hl54500	num	14	SENT_531	[p26l168t2218r488b2279],
14	)	NN	O	)	conj_and	11	SENT_531	[p26l168t2218r488b2279],
15	,	,	O	,	_	0	SENT_531	[p26l168t2218r488b2279],
16	the	DT	O	the	det	18	SENT_531	[p26l534t2219r631b2268],
17	National	NNP	ORGANIZATION	National	nn	18	SENT_531	[p26l678t2219r927b2268],
18	Center	NNP	ORGANIZATION	Center	appos	11	SENT_531	[p26l975t2219r1174b2268],
19	for	IN	ORGANIZATION	for	_	0	SENT_531	[p26l1216t2219r1299b2268],
20	Research	NNP	ORGANIZATION	Research	nn	25	SENT_531	[p26l1345t2219r1624b2268],
21	Resources	NNP	ORGANIZATION	Resources	nn	25	SENT_531	[p26l1674t2219r1987b2268],
22	(	NNP	O	(	nn	25	SENT_531	[p26l2031t2219r2152b2279],
23	Mo	NNP	DURATION	Mo	nn	25	SENT_531	[p26l2031t2219r2152b2279],
24	1RR00040	NNP	O	1RR00040	nn	25	SENT_531	[p26l11t2307r384b2368],
25	)	NNP	O	)	prep_for	18	SENT_531	[p26l11t2307r384b2368],
26	,	,	O	,	_	0	SENT_531	[p26l11t2307r384b2368],
27	the	DT	O	the	det	88	SENT_531	[p26l412t2308r509b2356],
28	American	JJ	O	american	amod	88	SENT_531	[p26l534t2308r824b2356],
29	Heart	NNP	ORGANIZATION	Heart	nn	35	SENT_531	[p26l857t2307r1019b2356],
30	Association	NNP	ORGANIZATION	Association	nn	35	SENT_531	[p26l1044t2307r1392b2356],
31	(	NN	O	(	nn	35	SENT_531	[p26l1422t2307r2152b2368],
32	Pennsylvania-Delaware	NNP	O	Pennsylvania-Delaware	nn	35	SENT_531	[p26l1422t2307r2152b2368],
33	Affiliate	NNP	O	Affiliate	nn	35	SENT_531	[p26l7t2394r243b2444],
34	Postdoctoral	NNP	O	Postdoctoral	nn	35	SENT_531	[p26l271t2395r648b2444],
35	Fellowship	NNP	O	Fellowship	tmod	28	SENT_531	[p26l679t2395r1011b2455],
36	,	,	O	,	_	0	SENT_531	[p26l679t2395r1011b2455],
37	to	TO	O	to	_	0	SENT_531	[p26l1037t2398r1095b2444],
38	S.F.	NNP	LOCATION	S.F.	prep_to	35	SENT_531	[p26l1118t2394r1244b2453],
39	;	:	O	;	_	0	SENT_531	[p26l1118t2394r1244b2453],
40	Scientist	NNP	O	Scientist	nn	43	SENT_531	[p26l1269t2394r1532b2444],
41	Development	NNP	O	Development	nn	43	SENT_531	[p26l1559t2395r1962b2455],
42	Grant	NNP	O	Grant	nn	43	SENT_531	[p26l1986t2394r2153b2444],
43	0430148N	NNP	O	0430148N	dep	38	SENT_531	[p26l9t2482r359b2542],
44	,	,	O	,	_	0	SENT_531	[p26l9t2482r359b2542],
45	to	TO	O	to	_	0	SENT_531	[p26l395t2486r453b2532],
46	T.G.	NNP	O	T.G.	nn	47	SENT_531	[p26l487t2483r639b2543],
47	)	NNP	O	)	prep_to	28	SENT_531	[p26l487t2483r639b2543],
48	,	,	O	,	_	0	SENT_531	[p26l487t2483r639b2543],
49	the	DT	O	the	det	53	SENT_531	[p26l676t2483r772b2532],
50	Wellcome	NNP	ORGANIZATION	Wellcome	nn	53	SENT_531	[p26l807t2483r1111b2532],
51	Trust	NNP	ORGANIZATION	Trust	nn	53	SENT_531	[p26l1144t2483r1295b2532],
52	(	NNP	O	(	nn	53	SENT_531	[p26l1331t2483r1591b2543],
53	London	NNP	LOCATION	London	appos	47	SENT_531	[p26l1331t2483r1591b2543],
54	,	,	O	,	_	0	SENT_531	[p26l1331t2483r1591b2543],
55	United	NNP	LOCATION	United	nn	56	SENT_531	[p26l1631t2483r1820b2532],
56	Kingdom	NNP	LOCATION	Kingdom	appos	47	SENT_531	[p26l1862t2483r2152b2544],
57	)	CD	NUMBER	)	number	58	SENT_531	[p26l1862t2483r2152b2544],
58	(	CD	NUMBER	(	num	59	SENT_531	[p26l9t2571r213b2632],
59	T.S.P.	NNP	O	T.S.P.	dep	56	SENT_531	[p26l9t2571r213b2632],
60	:	:	O	:	_	0	SENT_531	[p26l9t2571r213b2632],
61	Training	VBG	O	train	partmod	47	SENT_531	[p26l241t2572r488b2632],
62	Fellowship	NNP	O	Fellowship	dobj	61	SENT_531	[p26l517t2571r834b2632],
63	in	IN	O	in	_	0	SENT_531	[p26l864t2571r911b2620],
64	Mathematical	NNP	O	Mathematical	nn	65	SENT_531	[p26l944t2571r1362b2620],
65	Biology	NNP	O	Biology	prep_in	62	SENT_531	[p26l1395t2571r1612b2632],
66	to	TO	O	to	_	0	SENT_531	[p26l1638t2574r1696b2620],
67	T.S.P.	NNP	O	T.S.P.	nn	68	SENT_531	[p26l1721t2571r1929b2632],
68	)	NNP	O	)	prep_to	61	SENT_531	[p26l1721t2571r1929b2632],
69	,	,	O	,	_	0	SENT_531	[p26l1721t2571r1929b2632],
70	Orchid	NNP	ORGANIZATION	Orchid	nn	73	SENT_531	[p26l1959t2571r2150b2620],
71	Biosciences	NNP	ORGANIZATION	Biosciences	nn	73	SENT_531	[p26l11t2659r367b2708],
72	(	NNP	O	(	nn	73	SENT_531	[p26l388t2659r714b2719],
73	Princeton	NNP	ORGANIZATION	Princeton	conj_and	68	SENT_531	[p26l388t2659r714b2719],
74	,	,	O	,	_	0	SENT_531	[p26l388t2659r714b2719],
75	NJ	NNP	O	NJ	nn	76	SENT_531	[p26l740t2659r844b2719],
76	)	NNP	O	)	prep_to	61	SENT_531	[p26l740t2659r844b2719],
77	,	,	O	,	_	0	SENT_531	[p26l740t2659r844b2719],
78	and	CC	O	and	_	0	SENT_531	[p26l868t2659r977b2708],
79	the	DT	O	the	det	81	SENT_531	[p26l999t2659r1096b2708],
80	Genomics	NNP	ORGANIZATION	Genomics	nn	81	SENT_531	[p26l1118t2658r1419b2708],
81	Institute	NNP	ORGANIZATION	Institute	conj_and	68	SENT_531	[p26l1443t2659r1689b2708],
82	of	IN	ORGANIZATION	of	_	0	SENT_531	[p26l1710t2658r1768b2708],
83	the	DT	ORGANIZATION	the	det	85	SENT_531	[p26l1787t2659r1883b2708],
84	Novartis	NNP	ORGANIZATION	Novartis	nn	85	SENT_531	[p26l1907t2659r2153b2708],
85	Foundation	NNP	ORGANIZATION	Foundation	prep_of	81	SENT_531	[p26l11t2747r348b2796],
86	(	NN	O	(	nn	88	SENT_531	[p26l378t2747r771b2808],
87	genotyping	VBG	O	genotype	amod	88	SENT_531	[p26l378t2747r771b2808],
88	)	NN	O	)	appos	11	SENT_531	[p26l378t2747r771b2808],
89	.	.	O	.	_	0	SENT_531	[p26l378t2747r771b2808],

1	S.F.	NNP	LOCATION	S.F.	nsubj	4	SENT_532	[p26l78t2835r187b2884],
2	and	CC	O	and	_	0	SENT_532	[p26l217t2836r326b2884],
3	T.G.	NNP	PERSON	T.G.	conj_and	1	SENT_532	[p26l354t2835r466b2884],
4	contributed	VBD	O	contribute	_	0	SENT_532	[p26l496t2835r840b2884],
5	equally	RB	O	equally	advmod	4	SENT_532	[p26l870t2835r1088b2896],
6	to	TO	O	to	_	0	SENT_532	[p26l1113t2838r1171b2884],
7	this	DT	O	this	det	8	SENT_532	[p26l1198t2836r1307b2884],
8	paper	NN	O	paper	prep_to	4	SENT_532	[p26l1337t2847r1523b2896],
9	.	.	O	.	_	0	SENT_532	[p26l1337t2847r1523b2896],

